JP2022069685A - Control method of harmful arthropod using heterocyclic compound - Google Patents

Abstract

To provide a control method of a harmful arthropod.SOLUTION: A harmful arthropod can be controlled with a compound represented by formula (I) or its N-oxide. In the formula, Z represents an oxygen atom, G1 represents CR3a and the like, G2 represents CR3b and the like, G3 represents CR3c and the like, G4 represents CR3d and the like, A1 represents CR4a and the like, A2 represents CR4b and the like, A3 represents CR4c, A4 represents CR4d and the like, A5 represents CR4e and the like, R1 represents a C1-C6 chain hydrocarbon group and the like, R2 represents a C1-C6 alkyl group and the like, R3a, R3b, R3c and R3d represent each independently a C1-C6 chain hydrocarbon group and the like, R4a, R4b, R4c, R4d and R4e represent each independently a C1-C6 chain hydrocarbon and the like, and n represent 0, 1, or 2.SELECTED DRAWING: None

Description

The present invention relates to a method for controlling harmful arthropods using a heterocyclic compound.

So far, various compounds have been studied for the purpose of controlling harmful arthropods. For example, Patent Document 1 describes that certain compounds have an effect of controlling harmful arthropods.

International Publication No. 2016/129884

An object of the present invention is to provide a method for controlling harmful arthropods.

〔式中、
Ｚは、酸素原子又は硫黄原子を表し、
Ｒ¹は、群Ｗより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｕより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルキル基、群Ｖより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｖより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、Ｃ（Ｏ）Ｒ⁵¹、Ｃ（Ｏ）ＯＲ⁵¹、又はＣ（Ｏ）ＮＲ⁵¹Ｒ⁵²を表し、
Ｒ⁵¹及びＲ⁵²は、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｖより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｖより選ばれる１以上の置換基で置換されていてもよい５若しくは６員複素環基、又は水素原子を表し、
Ｒ²は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、シクロプロピル基、又はシクロプロピルメチル基を表し、
ｎは、０、１又は２を表し、
Ｇ¹は、窒素原子又はＣＲ^3aを表し、
Ｇ²は、窒素原子又はＣＲ^3bを表し、
Ｇ³は、窒素原子又はＣＲ^3cを表し、
Ｇ⁴は、窒素原子又はＣＲ^3dを表し、
Ｒ^3a、Ｒ^3b、Ｒ^3c及びＲ^3dは、同一又は相異なり、群Ｂより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルキル基、群Ｈより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｈより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ＯＲ¹²、ＮＲ¹¹Ｒ¹²、ＮＲ^11aＲ^12a、ＮＲ²⁴ＮＲ¹¹Ｒ¹²、ＮＲ²⁴ＯＲ¹¹、ＮＲ¹¹Ｃ（Ｏ）Ｒ¹³、ＮＲ²⁴ＮＲ¹¹Ｃ（Ｏ）Ｒ¹³、ＮＲ¹¹Ｃ（Ｏ）ＯＲ¹⁴、ＮＲ²⁴ＮＲ¹¹Ｃ（Ｏ）ＯＲ¹⁴、ＮＲ¹¹Ｃ（Ｏ）ＮＲ³¹Ｒ³²、ＮＲ²⁴ＮＲ¹¹Ｃ（Ｏ）ＮＲ³¹Ｒ³²、Ｎ＝ＣＨＮＲ³¹Ｒ³²、Ｎ＝Ｓ（Ｏ）_pＲ¹⁵Ｒ¹⁶、Ｃ（Ｏ）Ｒ¹³、Ｃ（Ｏ）ＯＲ¹⁷、Ｃ（Ｏ）ＮＲ³¹Ｒ³²、Ｃ（Ｏ）ＮＲ¹¹Ｓ（Ｏ）₂Ｒ²³、ＣＲ³⁰＝ＮＯＲ¹⁷、ＮＲ¹¹ＣＲ²⁴＝ＮＯＲ¹⁷、Ｓ（Ｏ）_mＲ²³、シアノ基、ニトロ基、水素原子、又はハロゲン原子を表し、
ｐは、０又は１を表し、
ｍは、０、１又は２を表し、
Ｒ³⁰は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、ハロゲン原子、ＯＲ³⁵、ＮＲ³⁶Ｒ³⁷、又は水素原子を表し、
Ｒ³⁵は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基を表し、
Ｒ¹⁷は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｄより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は水素原子を表し、
Ｒ¹¹、Ｒ²⁴、Ｒ³⁶及びＲ³⁷は、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子を表し、
Ｒ¹²は、群Ｆより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｊより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルキル基、群Ｊより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルケニル基、群Ｄより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｄより選ばれる１以上の置換基で置換されていてもよい６員芳香族複素環基、水素原子、又はＳ（Ｏ）₂Ｒ²³を表し、
Ｒ²³は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は群Ｄより選ばれる１以上の置換基で置換されていてもよいフェニル基を表し、
Ｒ^11a及びＲ^12aは、それらが結合する窒素原子と一緒になって、群Ｅより選ばれる１以上の置換基で置換されていてもよい３－７員非芳香族複素環基を形成し、
Ｒ¹³は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ７シクロアルキル基、１以上のハロゲン原子で置換されていてもよい（Ｃ３－Ｃ６シクロアルキル）Ｃ１－Ｃ３アルキル基、群Ｄより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｄより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、又は水素原子を表し、
Ｒ¹⁴は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ７シクロアルキル基、１以上のハロゲン原子で置換されていてもよい（Ｃ３－Ｃ６シクロアルキル）Ｃ１－Ｃ３アルキル基、又はフェニルＣ１－Ｃ３アルキル基｛該フェニルＣ１－Ｃ３アルキル基におけるフェニル部分は、群Ｄより選ばれる１以上の置換基で置換されていてもよい｝を表し、
Ｒ¹⁵及びＲ¹⁶は、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基を表し、
Ｒ³¹は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、又は水素原子を表し、
Ｒ³²は、群Ｆより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｊより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルキル基、Ｓ（Ｏ）₂Ｒ²³、又は水素原子を表し、
Ａ¹は、窒素原子又はＣＲ^4aを表し、
Ａ²は、窒素原子又はＣＲ^4bを表し、
Ａ³は、窒素原子又はＣＲ^4cを表し、
Ａ⁴は、窒素原子又はＣＲ^4dを表し、
Ａ⁵は、窒素原子又はＣＲ^4eを表し（但し、Ａ²、Ａ³及びＡ⁴の全てが窒素原子を表すことはない）、
Ｒ^4a及びＲ^4eは、同一又は相異なり、群Ｘより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｙより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、群Ｚより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｚより選ばれる１以上の置換基で置換されていてもよい５若しくは６員複素環基、ＯＲ⁴⁴、Ｓ（Ｏ）_kＲ⁴¹、Ｓ（Ｏ）₂ＮＲ⁴¹Ｒ⁴²、ＮＲ⁴¹Ｒ⁴³、ＮＲ⁴¹Ｃ（Ｏ）Ｒ⁴²、ＮＲ⁴¹Ｃ（Ｏ）ＯＲ⁴²、ＮＲ⁴¹Ｓ（Ｏ）₂Ｒ⁴³、Ｃ（Ｏ）Ｒ⁴¹、Ｃ（Ｏ）ＯＲ⁴¹、Ｃ（Ｏ）ＮＲ⁴¹Ｒ⁴²、ＣＲ⁴²＝ＮＯＲ⁴¹、ヒドロキシ基、シアノ基、ニトロ基、ハロゲン原子、又は水素原子を表し、
Ａ⁵がＣＲ^4eである場合、Ｒ^4e及びＲ¹が一緒になって－ＮＲ⁴⁵－ＣＲ⁴¹Ｒ⁴²－＃を形成していてもよく｛＃はＲ¹が結合している窒素原子との結合位置を表す｝、
Ｒ^4b、Ｒ^4c及びＲ^4dは、同一又は相異なり、群Ｘより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｙより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、群Ｚより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｚより選ばれる１以上の置換基で置換されていてもよい５若しくは６員複素環基、ＯＲ⁴⁴、Ｓ（Ｏ）_qＲ⁴¹、Ｓ（Ｏ）₂ＮＲ⁴¹Ｒ⁴²、ＮＲ⁴¹Ｒ⁴²、ＮＲ⁴¹Ｃ（Ｏ）Ｒ⁴²、ＮＲ⁴¹Ｃ（Ｏ）ＯＲ⁴²、ＮＲ⁴¹Ｓ（Ｏ）₂Ｒ⁴³、Ｃ（Ｏ）Ｒ⁴¹、Ｃ（Ｏ）ＯＲ⁴¹、Ｃ（Ｏ）ＮＲ⁴¹Ｒ⁴²、ＣＲ⁴²＝ＮＯＲ⁴¹、ヒドロキシ基、シアノ基、ニトロ基、ハロゲン原子、又は水素原子を表し（但し、存在するＲ^4a、Ｒ^4b、Ｒ^4c、Ｒ^4d、及びＲ^4eの全てが水素原子を表すことはない）、
ｋは、０、１又は２を表し
ｑは、０、１又は２を表し、
Ｒ⁴¹及びＲ⁴²は、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｚより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｚより選ばれる１以上の置換基で置換されていてもよい５若しくは６員複素環基、又は水素原子を表し、
Ｒ⁴³は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｚより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は群Ｚより選ばれる１以上の置換基で置換されていてもよい５若しくは６員複素環基を表し、
Ｒ⁴⁴は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基を表し、
Ｒ⁴⁵は、群Ｗ²より選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｙより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルキル基、群Ｚより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｚより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、Ｃ（Ｏ）Ｒ⁴⁶、Ｃ（Ｏ）ＯＲ⁴⁶、Ｃ（Ｏ）ＮＲ⁴⁶Ｒ⁴⁷、又は水素原子を表し、
Ｒ⁴⁶及びＲ⁴⁷は、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｚより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｚより選ばれる１以上の置換基で置換されていてもよい５若しくは６員複素環基、又は水素原子を表す。
群Ｂ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６アルケニルオキシ基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６アルキニルオキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルフィニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、シアノ基、ヒドロキシ基、及びハロゲン原子からなる群。
群Ｃ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６アルケニルオキシ基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６アルキニルオキシ基、及びハロゲン原子からなる群。
群Ｄ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、ヒドロキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６アルケニルオキシ基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６アルキニルオキシ基、スルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルフィニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、アミノ基、ＮＨＲ²¹、ＮＲ²¹Ｒ²²、Ｃ（Ｏ）Ｒ²¹、ＯＣ（Ｏ）Ｒ²¹、Ｃ（Ｏ）ＯＲ²¹、シアノ基、ニトロ基、及びハロゲン原子からなる群。
Ｒ²¹及びＲ²²は、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基を表す。
群Ｅ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６アルケニルオキシ基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６アルキニルオキシ基、ハロゲン原子、オキソ基、ヒドロキシ基、シアノ基、及びニトロ基からなる群。
群Ｆ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、群Ｄより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｄより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ７シクロアルキル基、群Ｃより選ばれる１以上の置換基で置換されていてもよい３－７員非芳香族複素環基、アミノ基、ＮＨＲ²¹、ＮＲ²¹Ｒ²²、ハロゲン原子、及びシアノ基からなる群。
群Ｈ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、群Ｄより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ＯＲ¹⁰、ＮＲ⁹Ｒ¹⁰、Ｃ（Ｏ）Ｒ¹⁰、Ｃ（Ｏ）ＮＲ⁹Ｒ¹⁰、ＯＣ（Ｏ）Ｒ⁹、ＯＣ（Ｏ）ＯＲ⁹、ＮＲ¹⁰Ｃ（Ｏ）Ｒ⁹、ＮＲ¹⁰Ｃ（Ｏ）ＯＲ⁹、Ｃ（Ｏ）ＯＲ¹⁰、ハロゲン原子、ニトロ基、シアノ基、及びアミノ基からなる群。
Ｒ⁹は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、又は１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基を表し、
Ｒ¹⁰は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表す。
群Ｊ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、ハロゲン原子、及びシアノ基からなる群。
群Ｕ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルフィニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、及びハロゲン原子からなる群。
群Ｖ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルフィニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルアミノ基、ジ（１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル）アミノ基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルキルカルボニル基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルコキシカルボニル基、ヒドロキシ基、スルファニル基、アミノ基、シアノ基、ニトロ基、及びハロゲン原子からなる群。
群Ｗ：ハロゲン原子及びＣ１－Ｃ３アルキル基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルフィニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルキルカルボニル基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルコキシカルボニル基、群Ｚより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｚより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ヒドロキシ基、シアノ基、及びハロゲン原子からなる群。
群Ｘ：ハロゲン原子及びＣ１－Ｃ３アルキル基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルフィニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルキルカルボニル基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルコキシカルボニル基、ヒドロキシ基、スルファニル基、シアノ基、及びハロゲン原子からなる群。
群Ｙ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルフィニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、及びハロゲン原子からなる群。
群Ｚ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルフィニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルアミノ基、ジ（１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル）アミノ基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルキルカルボニル基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルコキシカルボニル基、ヒドロキシ基、スルファニル基、アミノ基、シアノ基、ニトロ基、及びハロゲン原子からなる群。
群Ｗ²：ハロゲン原子及びＣ１－Ｃ３アルキル基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルファニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルフィニル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルキルカルボニル基、１以上のハロゲン原子で置換されていてもよいＣ２－Ｃ６アルコキシカルボニル基、群Ｚより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｚより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ヒドロキシ基、スルファニル基、シアノ基、及びハロゲン原子からなる群。〕
で示される化合物又はそのＮオキシド（以下、式（Ｉ）で示される化合物又はそのＮオキシドを本化合物と記す）の有効量を有害節足動物、有害節足動物の生息場所、植物、又は植物の栽培担体に施用する工程を含む有害節足動物の防除方法。
〔２〕 植物の栽培担体が、土壌である、〔１〕に記載の有害節足動物の防除方法。
〔３〕 〔１〕に記載の式（Ｉ）で示される化合物、又はそのＮオキシド若しくは農業上許容可能な塩と、群（ａ）、群（ｂ）、群（ｃ）、群（ｄ）、群（ｅ）、群（ｆ）、群（ｇ）、群（ｈ）、群（ｉ）及び群（ｊ）からなる群より選ばれる１以上の成分とを含有する組成物：
群（ａ）：殺虫活性成分、殺ダニ活性成分及び殺線虫活性成分からなる群；
群（ｂ）：殺菌活性成分；
群（ｃ）：植物成長調整成分；
群（ｄ）：薬害軽減成分；
群（ｅ）：共力剤；
群（ｆ）：忌避成分；
群（ｇ）：殺軟体動物成分；
群（ｈ）：昆虫フェロモン；
群（ｉ）：除草活性成分；
群（ｊ）：生物防除資材。
〔４〕 〔３〕に記載の組成物の有効量を有害節足動物、有害節足動物の生息場所、植物、又は植物の栽培担体に施用する工程を含む有害節足動物の防除方法。
〔５〕 植物の栽培担体が、土壌である、〔４〕に記載の有害節足動物の防除方法。
〔６〕 〔１〕に記載の式（Ｉ）で示される化合物、若しくは、そのＮオキシド若しくは農業上許容可能な塩、又は〔３〕に記載の組成物の有効量を保持してなる種子又は栄養生殖器官。 The present invention is as follows.
[1] Equation (I)

[In the ceremony,
Z represents an oxygen atom or a sulfur atom.
R ¹ is a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from the group W, and C3-C7 which may be substituted with one or more substituents selected from the group U. A cycloalkyl group, a phenyl group optionally substituted with one or more substituents selected from group V, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group V. , C (O) R ⁵¹ , C (O) OR ⁵¹ , or C (O) NR ⁵¹ R ⁵² .
R ⁵¹ and R ⁵² are the same or different, and may be substituted with a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, or one or more substituents selected from the group V. Represents a phenyl group, a 5- or 6-membered heterocyclic group optionally substituted with one or more substituents selected from group V, or a hydrogen atom.
R ² represents a C1-C6 alkyl group, cyclopropyl group, or cyclopropylmethyl group that may be substituted with one or more halogen atoms.
n represents 0, 1 or 2 and represents
G ¹ represents a nitrogen atom or CR ^3a
G ² represents a nitrogen atom or CR ^3b
G ³ represents a nitrogen atom or CR ^3c
G ⁴ represents a nitrogen atom or CR ^3d
R ^3a , R ^3b , R ^3c and R ^3d are the same or different, and may be substituted with one or more substituents selected from group B. C1-C6 chain hydrocarbon group, selected from group E 1 C3-C7 cycloalkyl group optionally substituted with the above substituents, phenyl group optionally substituted with one or more substituents selected from group H, substituted with one or more substituents selected from group H May be 5- or 6-membered aromatic heterocyclic groups, OR ¹² , NR ¹¹ R ¹² , NR ^11a R ^12a , NR ²⁴ NR ¹¹ R ¹² , NR ²⁴ OR ¹¹ , NR ¹¹ C (O) R ¹³ , NR. ²⁴ NR ¹¹ C (O) R ¹³ , NR ¹¹ C (O) OR ¹⁴ , NR ²⁴ NR ¹¹ C (O) OR ¹⁴ , NR ¹¹ C (O) NR ³¹ R ³² , NR ²⁴ NR ¹¹ C (O) NR ³¹ R ³² , N = CHNR ³¹ R ³² , N = S (O) _p R ¹⁵ R ¹⁶ , C (O) R ¹³ , C (O) OR ¹⁷ , C (O) NR ³¹ R ³² , C (O) Represents NR ¹¹ S (O) ₂ R ²³ , CR ³⁰ = NOR ¹⁷ , NR ¹¹ CR ²⁴ = NOR ¹⁷ , S (O) _m R ²³ , cyano group, nitro group, hydrogen atom, or halogen atom.
p represents 0 or 1 and represents
m represents 0, 1 or 2 and represents
R ³⁰ represents a C1-C6 chain hydrocarbon group, a halogen atom, OR ³⁵ , NR ³⁶ R ³⁷ , or a hydrogen atom which may be substituted with one or more halogen atoms.
R ³⁵ represents a C1-C6 chain hydrocarbon group that may be substituted with one or more halogen atoms.
R ¹⁷ represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from Group D, or a hydrogen atom. ,
R ¹¹ , R ²⁴ , R ³⁶ and R ³⁷ represent C1-C6 chain hydrocarbon groups or hydrogen atoms that are the same or different and may be substituted with one or more halogen atoms.
R ¹² is a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group F, and C3-C7 which may be substituted with one or more substituents selected from group J. Cycloalkyl group, C3-C7 cycloalkenyl group optionally substituted with 1 or more substituents selected from group J, phenyl group optionally substituted with 1 or more substituents selected from group D, group D Represents a 6-membered aromatic heterocyclic group, a hydrogen atom, or S (O) ₂ R ²³ , which may be substituted with one or more substituents of choice.
R ²³ represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms or a phenyl group optionally substituted with one or more substituents selected from Group D.
R ^11a and R ^12a together with the nitrogen atom to which they bind form a 3-7 member non-aromatic heterocyclic group which may be substituted with one or more substituents selected from group E.
R ¹³ is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C7 cycloalkyl group optionally substituted with one or more halogen atoms, and one or more halogen atoms. May be substituted (C3-C6 cycloalkyl) C1-C3 alkyl group, phenyl group optionally substituted with one or more substituents selected from group D, one or more substituents selected from group D Represents a optionally substituted 5- or 6-membered aromatic heterocyclic group, or a hydrogen atom.
R ¹⁴ is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C7 cycloalkyl group optionally substituted with one or more halogen atoms, and one or more halogen atoms. May be substituted (C3-C6 cycloalkyl) C1-C3 alkyl group or phenyl C1-C3 alkyl group {The phenyl moiety in the phenyl C1-C3 alkyl group is one or more substituents selected from Group D. May be replaced}
R ¹⁵ and R ¹⁶ represent C1-C6 alkyl groups that are identical or different and may be substituted with one or more halogen atoms.
R ³¹ represents a C1-C6 alkyl group or a hydrogen atom which may be substituted with one or more halogen atoms.
R ³² is a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group F, and C3-C7 which may be substituted with one or more substituents selected from group J. Represents a cycloalkyl group, S (O) ₂ R ²³ , or a hydrogen atom.
A ¹ represents a nitrogen atom or CR ^4a .
A ² represents a nitrogen atom or CR ^4b .
A ³ represents a nitrogen atom or CR ^4c .
A ⁴ represents a nitrogen atom or CR ^4d .
A ⁵ represents a nitrogen atom or CR ^4e (however, not all of A ² , A ³ and A ⁴ represent a nitrogen atom).
R ^4a and R ^4e are the same or different, and are substituted with a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from the group X, and one or more substituents selected from the group Y. C3-C6 cycloalkyl group may be substituted, a phenyl group may be substituted with one or more substituents selected from group Z, and one or more substituents selected from group Z may be substituted. Or 6-membered heterocyclic group, OR ⁴⁴ , S (O) _k R ⁴¹ , S (O) ₂ NR ⁴¹ R ⁴² , NR ⁴¹ R ⁴³ , NR ⁴¹ C (O) R ⁴² , NR ⁴¹ C (O) OR ⁴² , NR ⁴¹ S (O) ₂ R ⁴³ , C (O) R ⁴¹ , C (O) OR ⁴¹ , C (O) NR ⁴¹ R ⁴² , CR ⁴² = NOR ⁴¹ , hydroxy group, cyano group, nitro group, halogen Represents an atom or a hydrogen atom
When A ⁵ is CR ^4e , R ^4e and R ¹ may be combined to form -NR ⁴⁵ -CR ⁴¹ R ^42- # {# is with the nitrogen atom to which R ¹ is bonded. Represents the bond position},
R ^4b , R ^4c and R ^4d are the same or different and may be substituted with one or more substituents selected from group X, C1-C6 chain hydrocarbon groups, one or more substituteds selected from group Y. It is substituted with a C3-C6 cycloalkyl group which may be substituted with a group, a phenyl group which may be substituted with one or more substituents selected from group Z, and one or more substituents selected from group Z. Maybe 5- or 6-membered heterocyclic group, OR ⁴⁴ , S (O) _q R ⁴¹ , S (O) ₂ NR ⁴¹ R ⁴² , NR ⁴¹ R ⁴² , NR ⁴¹ C (O) R ⁴² , NR ⁴¹ C (O) ) OR ⁴² , NR ⁴¹ S (O) ₂ R ⁴³ , C (O) R ⁴¹ , C (O) OR ⁴¹ , C (O) NR ⁴¹ R ⁴² , CR ⁴² = NOR ⁴¹ , hydroxy group, cyano group, nitro Represents a group, halogen atom, or hydrogen atom (however, not all of the existing R ^4a , R ^4b , R ^4c , R ^4d , and R ^4e represent a hydrogen atom).
k represents 0, 1 or 2, and q represents 0, 1 or 2.
R ⁴¹ and R ⁴² may be substituted with a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, and may be substituted with one or more substituents selected from the group Z, which are the same or different from each other. Represents a phenyl group, a 5- or 6-membered heterocyclic group optionally substituted with one or more substituents selected from Group Z, or a hydrogen atom.
R ⁴³ is selected from a C1-C6 chain hydrocarbon group that may be substituted with one or more halogen atoms, a phenyl group that may be substituted with one or more substituents selected from group Z, or group Z. Represents a 5- or 6-membered heterocyclic group that may be substituted with one or more substituents.
^R44 represents a C1-C6 chain hydrocarbon group that may be substituted with one or more halogen atoms.
R ⁴⁵ is a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group W ² , and C3- which may be substituted with one or more substituents selected from group Y. A C7 cycloalkyl group, a phenyl group optionally substituted with one or more substituents selected from group Z, a 5- or 6-membered aromatic heterocycle optionally substituted with one or more substituents selected from group Z. Represents a group, C (O) R ⁴⁶ , C (O) OR ⁴⁶ , C (O) NR ⁴⁶ R ⁴⁷ , or a hydrogen atom.
R ⁴⁶ and R ⁴⁷ are the same or different, and may be substituted with a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, or one or more substituents selected from Group Z. Represents a phenyl group, a 5- or 6-membered heterocyclic group optionally substituted with one or more substituents selected from Group Z, or a hydrogen atom.
Group B: A C1-C6 alkoxy group that may be substituted with one or more halogen atoms, a C3-C6 alkenyloxy group that may be substituted with one or more halogen atoms, and one or more halogen atoms. A C3-C6 alkynyloxy group may be substituted with one or more halogen atoms, a C1-C6 alkylsulfanyl group may be substituted with one or more halogen atoms, and a C1-C6 alkylsulfinyl group may be substituted with one or more halogen atoms. A group consisting of a C1-C6 alkylsulfonyl group which may be substituted with a halogen atom, a C3-C6 cycloalkyl group which may be substituted with one or more halogen atoms, a cyano group, a hydroxy group, and a halogen atom.
Group C: C1-C6 chain hydrocarbon group optionally substituted with 1 or more halogen atoms, C1-C6 alkoxy group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms A group consisting of a C3-C6 alkenyloxy group which may be present, a C3-C6 alkynyloxy group which may be substituted with one or more halogen atoms, and a halogen atom.
Group D: C1-C6 chain hydrocarbon group optionally substituted with 1 or more halogen atoms, hydroxy group, C1-C6 alkoxy group optionally substituted with 1 or more halogen atoms, 1 or more halogen atoms C3-C6 alkenyloxy group optionally substituted with 1 or more halogen atoms C3-C6 alkynyloxy group, sulfanyl group optionally substituted with 1 or more halogen atoms C1- C6 alkylsulfanyl group, C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, amino group, NHR ²¹ , NR A group consisting of ²¹ R ²² , C (O) R ²¹ , OC (O) R ²¹ , C (O) OR ²¹ , a cyano group, a nitro group, and a halogen atom.
R ²¹ and R ²² represent C1-C6 alkyl groups that are identical or different and may be substituted with one or more halogen atoms.
Group E: C1-C6 chain hydrocarbon group optionally substituted with 1 or more halogen atoms, C1-C6 alkoxy group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms A group consisting of a C3-C6 alkenyloxy group which may be present, a C3-C6 alkynyloxy group which may be substituted with one or more halogen atoms, a halogen atom, an oxo group, a hydroxy group, a cyano group, and a nitro group.
Group F: C1-C6 alkoxy group optionally substituted with 1 or more halogen atoms, phenyl group optionally substituted with 1 or more substituents selected from group D, 1 or more substitutions selected from group D A 5- or 6-membered aromatic heterocyclic group optionally substituted with a group, a C3-C7 cycloalkyl group optionally substituted with one or more halogen atoms, substituted with one or more substituents selected from Group C. A group consisting of a 3-7-membered non-aromatic heterocyclic group, an amino group, NHR ²¹ , NR ²¹ R ²² , a halogen atom, and a cyano group.
Group H: C1-C6 alkyl group optionally substituted with one or more halogen atoms, 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from Group D, OR ¹⁰ , NR ⁹ R ¹⁰ , C (O) R ¹⁰ , C (O) NR ⁹ R ¹⁰ , OC (O) R ⁹ , OC (O) OR ⁹ , NR ¹⁰ C (O) R ⁹ , NR ¹⁰ C (O) ) OR ⁹ , C (O) OR ¹⁰ , halogen atom, nitro group, cyano group, and amino group.
R ⁹ represents a C1-C6 alkyl group optionally substituted with one or more halogen atoms or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms.
R ¹⁰ represents a C1-C6 alkyl group which may be substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be substituted with one or more halogen atoms, or a hydrogen atom.
Group J: A group consisting of C1-C6 alkyl groups, halogen atoms, and cyano groups that may be substituted with one or more halogen atoms.
Group U: A C1-C6 alkyl group that may be substituted with one or more halogen atoms, a C1-C6 alkoxy group that may be substituted with one or more halogen atoms, or a C1-C6 alkoxy group that may be substituted with one or more halogen atoms. From a good C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, and a halogen atom. A group of
Group V: A C1-C6 alkyl group that may be substituted with one or more halogen atoms, a C1-C6 alkoxy group that may be substituted with one or more halogen atoms, or a C1-C6 alkoxy group that may be substituted with one or more halogen atoms. Good C1-C6 alkyl sulfanyl group, C1-C6 alkyl sulphinyl group which may be substituted with one or more halogen atoms, C1-C6 alkyl sulfonyl group which may be substituted with one or more halogen atoms, one or more halogens. C1-C6 alkyl amino group optionally substituted with an atom, di (C1-C6 alkyl optionally substituted with 1 or more halogen atoms) amino group, C2 optionally substituted with 1 or more halogen atoms -A group consisting of a C6-C6 alkylcarbonyl group, a C2-C6 alkoxycarbonyl group which may be substituted with one or more halogen atoms, a hydroxy group, a sulfanyl group, an amino group, a cyano group, a nitro group, and a halogen atom.
Group W: C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from the group consisting of a halogen atom and a C1-C3 alkyl group, and C1- which may be substituted with one or more halogen atoms. C6 alkoxy group, C1-C6 alkylsulfanyl group optionally substituted with 1 or more halogen atoms, C1-C6 alkylsulfinyl group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms C1-C6 alkylsulfonyl group which may be substituted, C2-C6 alkylcarbonyl group which may be substituted with one or more halogen atoms, C2-C6 alkoxycarbonyl group which may be substituted with one or more halogen atoms, group. A phenyl group optionally substituted with one or more substituents selected from Z, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group Z, a hydroxy group, a cyano A group consisting of groups and halogen atoms.
Group X: C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from the group consisting of a halogen atom and a C1-C3 alkyl group, and C1- which may be substituted with one or more halogen atoms. C6 alkoxy group, C1-C6 alkylsulfanyl group optionally substituted with 1 or more halogen atoms, C1-C6 alkylsulfinyl group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms C1-C6 alkylsulfonyl group optionally substituted C2-C6 alkylcarbonyl group optionally substituted with 1 or more halogen atoms C2-C6 alkoxycarbonyl group optionally substituted with 1 or more halogen atoms, hydroxy A group consisting of a group, a sulfanyl group, a cyano group, and a halogen atom.
Group Y: A C1-C6 alkyl group that may be substituted with one or more halogen atoms, a C1-C6 alkoxy group that may be substituted with one or more halogen atoms, or a C1-C6 alkoxy group that may be substituted with one or more halogen atoms. From a good C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, and a halogen atom. A group of
Group Z: A C1-C6 alkyl group that may be substituted with one or more halogen atoms, a C1-C6 alkoxy group that may be substituted with one or more halogen atoms, or a C1-C6 alkoxy group that may be substituted with one or more halogen atoms. Good C1-C6 alkyl sulfanyl group, C1-C6 alkyl sulphinyl group which may be substituted with one or more halogen atoms, C1-C6 alkyl sulfonyl group which may be substituted with one or more halogen atoms, one or more halogens. C1-C6 alkyl amino group optionally substituted with an atom, di (C1-C6 alkyl optionally substituted with 1 or more halogen atoms) amino group, C2 optionally substituted with 1 or more halogen atoms -A group consisting of a C6-C6 alkylcarbonyl group, a C2-C6 alkoxycarbonyl group which may be substituted with one or more halogen atoms, a hydroxy group, a sulfanyl group, an amino group, a cyano group, a nitro group, and a halogen atom.
Group W ² : C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from the group consisting of a halogen atom and a C1-C3 alkyl group, and C1 which may be substituted with one or more halogen atoms. -C6 alkoxy group, C1-C6 alkylsulfanyl group optionally substituted with 1 or more halogen atoms, C1-C6 alkylsulfinyl group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms C1-C6 alkylsulfonyl group which may be substituted, C2-C6 alkylcarbonyl group which may be substituted with one or more halogen atoms, C2-C6 alkoxycarbonyl group which may be substituted with one or more halogen atoms, A phenyl group optionally substituted with one or more substituents selected from group Z, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group Z, a hydroxy group, A group consisting of a sulfanyl group, a cyano group, and a halogen atom. ]
The effective amount of the compound represented by (I) or its N oxide (hereinafter, the compound represented by the formula (I) or its N oxide is referred to as this compound) is defined as a harmful arthropod, a habitat of the harmful arthropod, a plant, or a plant. A method for controlling harmful arthropods, which comprises a step of applying to a cultivation carrier of.
[2] The method for controlling harmful arthropods according to [1], wherein the cultivation carrier of the plant is soil.
[3] A compound represented by the formula (I) described in [1], or an N oxide thereof or an agriculturally acceptable salt thereof, and group (a), group (b), group (c), group (d). , A composition containing one or more components selected from the group consisting of group (e), group (f), group (g), group (h), group (i) and group (j):
Group (a): A group consisting of an insecticidal active ingredient, an acaricidal active ingredient and a nematode active ingredient;
Group (b): bactericidal active ingredient;
Group (c): Plant growth regulating component;
Group (d): Ingredients for reducing phytotoxicity;
Group (e): synergist;
Group (f): repellent component;
Group (g): mollusc component;
Group (h): Insect pheromone;
Group (i): herbicidal active ingredient;
Group (j): Biological control material.
[4] A method for controlling harmful arthropods, which comprises a step of applying an effective amount of the composition according to [3] to a harmful arthropod, a habitat of the harmful arthropod, a plant, or a cultivation carrier of the plant.
[5] The method for controlling harmful arthropods according to [4], wherein the cultivation carrier of the plant is soil.
[6] A compound represented by the formula (I) described in [1], or an N oxide thereof or an agriculturally acceptable salt thereof, or a seed obtained by retaining an effective amount of the composition described in [3]. Vegetative reproduction organ.

According to the present invention, harmful arthropods can be controlled.

First, this compound will be described.

The substituent in the present invention will be described.
The halogen atom means a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom.
When the substituents are substituted with two or more halogen atoms or substituents, the halogen atoms or substituents may be the same or different, respectively.
The notation "CX-CY" in the present specification means that the number of carbon atoms is X to Y. For example, the notation "C1-C6" means that the number of carbon atoms is 1 to 6.
The chain hydrocarbon group represents an alkyl group, an alkenyl group or an alkynyl group.
Examples of the alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a 1,1-dimethylpropyl group, a 1,2-dimethylpropyl group, a 1-ethylpropyl group, a butyl group, a sec-butyl group, and a tert. -Butyl group, pentyl group, and hexyl group can be mentioned.
Examples of the alkenyl group include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 1-methyl-1-propenyl group, a 1-methyl-2-propenyl group, a 1,2-dimethyl-1-propenyl group and 1 Included are an ethyl-2-propenyl group, a 3-butenyl group, a 4-pentenyl group, and a 5-hexenyl group.
Examples of the alkynyl group include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 1-methyl-2-propynyl group, a 1,1-dimethyl-2-propynyl group, a 1-ethyl-2-propynyl group, and 2 -Butynyl group, 4-pentynyl group, and 5-hexynyl group can be mentioned.
Examples of the alkoxy group include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, a tert-butoxy group, a pentyloxy group, and a hexyloxy group.
Examples of the alkenyloxy group include a 2-propenyloxy group, a 2-butenyloxy group, and a 5-hexenyloxy group.
Examples of the alkynyloxy group include a 2-propynyloxy group, a 2-butynyloxy group, and a 5-hexynyloxy group.

Examples of the cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group.
Examples of the cycloalkenyl group include a cyclopropenyl group, a cyclobutenyl group, a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group.

５若しくは６員芳香族複素環基とは、５員芳香族複素環基又は６員芳香族複素環基を表す。５員芳香族複素環基とはピロリル基、フリル基、チエニル基、ピラゾリル基、イミダゾリル基、トリアゾリル基、テトラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、オキサジアゾリル基、又はチアジアゾリル基を表し、６員芳香族複素環基とは、ピリジル基、ピリダジニル基、ピリミジニル基、ピラジニル基、トリアジニル基、又はテトラジニル基を表す。
５若しくは６員複素環基とは、５若しくは６員芳香族複素環基又は５若しくは６員非芳香族複素環基を表し、例えば、ピロリル基、フリル基、チエニル基、ピラゾリル基、イミダゾリル基、トリアゾリル基、テトラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、オキサジアゾリル基、チアジアゾリル基、ピリジル基、ピリダジニル基、ピリミジニル基、ピラジニル基、トリアジニル基、テトラジニル基、ピロリジニル基、イミダゾリニル基、イミダゾリジニル基、ピペリジニル基、テトラヒドロピリミジニル基、ヘキサヒドロピリミジニル基、ピペラジニル基、オキサゾリジニル基、イソオキサゾリジニル基、１，３－オキサジナニル基、モルホリニル基、チアゾリジニル基、イソチアゾリジニル基、１，３－チアジナニル基、及びチオモルホリニル基が挙げられる。
１以上のハロゲン原子で置換されていてもよい（Ｃ３－Ｃ６シクロアルキル）Ｃ１－Ｃ３アルキル基としては、例えば、シクロプロピルメチル基、（２－フルオロシクロプロピル）メチル基、シクロプロピル（フルオロ）メチル基、及び（２－フルオロシクロプロピル）（フルオロ）メチル基が挙げられる。
フェニルＣ１－Ｃ３アルキル基｛該フェニルＣ１－Ｃ３アルキル基におけるフェニル部分は、群Ｄより選ばれる１以上の置換基で置換されていてもよい｝としては、例えば、ベンジル基、２－フルオロベンジル基、４－クロロベンジル基、４－（トリフルオロメチル）ベンジル基、及び２－［４－（トリフルオロメチル）フェニル］エチル基が挙げられる。
アルキルスルファニル基としては、例えば、メチルスルファニル基、エチルスルファニル基、プロピルスルファニル基、及びイソプロピルスルファニル基が挙げられる。
アルキルスルフィニル基としては、例えば、メチルスルフィニル基、エチルスルフィニル基、プロピルスルフィニル基、及びイソプロピルスルフィニル基が挙げられる。
アルキルスルホニル基としては、例えば、メチルスルホニル基、エチルスルホニル基、プロピルスルホニル基、及びイソプロピルスルホニル基が挙げられる。
アルキルアミノ基としては、例えば、メチルアミノ基、エチルアミノ基、イソプロピルアミノ基、及びヘキシルアミノ基が挙げられる。
ジアルキルアミノ基としては、例えば、ジメチルアミノ基、エチルメチルアミノ基、イソプロピルメチルアミノ基、及びジヘキシルアミノ基が挙げられる。
アルキルカルボニル基としては、例えば、アセチル基、プロパノイル基、２－メチルプロパノイル基、及びヘキサノイル基が挙げられる。
アルコキシカルボニル基としては、例えば、メトキシカルボニル基、エトキシカルボニル基、イソプロポキシカルボニル基、及びペンチルオキシカルボニル基が挙げられる。 The 3-7 member non-aromatic heterocyclic group includes an aziridine ring, an azetidine ring, a pyrrolidine ring, an imidazoline ring, an imidazolidine ring, a piperidine ring, a tetrahydropyrimidine ring, a hexahydropyrimidine ring, a piperazine ring, an azepane ring, and an oxazolidine ring. It represents an isooxazolidine ring, a 1,3-oxadinane ring, a morpholine ring, a 1,4-oxazepane ring, a thiazolidine ring, an isothiazolidine ring, a 1,3-thiadinane ring, a thiomorpholin ring, or a 1,4-thiazepane ring.
Examples of the 3-7-membered non-aromatic heterocyclic group which may be substituted with one or more substituents selected from the group E include the groups shown below.

The 5- or 6-membered aromatic heterocyclic group represents a 5-membered aromatic heterocyclic group or a 6-membered aromatic heterocyclic group. The 5-membered aromatic heterocyclic group represents a pyrrolyl group, a furyl group, a thienyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group, an isooxazolyl group, a thiazolyl group, an isothiazolyl group, an oxadiazolyl group, or a thiadiazolyl group. , The 6-membered aromatic heterocyclic group represents a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, or a tetrazinyl group.
The 5- or 6-membered heterocyclic group represents a 5- or 6-membered aromatic heterocyclic group or a 5- or 6-membered non-aromatic heterocyclic group, for example, a pyrrolyl group, a frill group, a thienyl group, a pyrazolyl group, an imidazolyl group, and the like. Triazolyl group, tetrazolyl group, oxazolyl group, isooxazolyl group, thiazolyl group, isothiazolyl group, oxadiazolyl group, thiadiazolyl group, pyridyl group, pyridazinyl group, pyrimidinyl group, pyrazinyl group, triazinyl group, tetrazinyl group, pyrrolidinyl group, imidazolinyl group, imidazolinyl group. , Piperidinyl group, tetrahydropyrimidinyl group, hexahydropyrimidinyl group, piperazinyl group, oxazolidinyl group, isooxazolidinyl group, 1,3-oxadinanyl group, morpholinyl group, thiazolidinyl group, isothiazolidinyl group, 1,3-thiazinyl Groups and thiomorpholinyl groups are mentioned.
Examples of the (C3-C6 cycloalkyl) C1-C3 alkyl group substituted with one or more halogen atoms include a cyclopropylmethyl group, a (2-fluorocyclopropyl) methyl group, and a cyclopropyl (fluoro) methyl group. Groups and (2-fluorocyclopropyl) (fluoro) methyl groups can be mentioned.
Examples of the phenyl C1-C3 alkyl group {the phenyl moiety in the phenyl C1-C3 alkyl group may be substituted with one or more substituents selected from Group D} include, for example, a benzyl group and a 2-fluorobenzyl group. , 4-Chlorobenzyl group, 4- (trifluoromethyl) benzyl group, and 2- [4- (trifluoromethyl) phenyl] ethyl group.
Examples of the alkylsulfanil group include a methylsulfanil group, an ethylsulfanil group, a propylsulfanil group, and an isopropylsulfanil group.
Examples of the alkylsulfinyl group include a methylsulfinyl group, an ethylsulfinyl group, a propylsulfinyl group, and an isopropylsulfinyl group.
Examples of the alkylsulfonyl group include a methylsulfonyl group, an ethylsulfonyl group, a propylsulfonyl group, and an isopropylsulfonyl group.
Examples of the alkylamino group include a methylamino group, an ethylamino group, an isopropylamino group, and a hexylamino group.
Examples of the dialkylamino group include a dimethylamino group, an ethylmethylamino group, an isopropylmethylamino group, and a dihexylamino group.
Examples of the alkylcarbonyl group include an acetyl group, a propanoyl group, a 2-methylpropanol group, and a hexanoyl group.
Examples of the alkoxycarbonyl group include a methoxycarbonyl group, an ethoxycarbonyl group, an isopropoxycarbonyl group, and a pentyloxycarbonyl group.

［式中、波線部はＣ（Ｚ）との結合位置を表し、その他の記号は前記と同じ意味を表す。］
で示されるフェニル基又は６員芳香族複素環基は、いずれも無置換ではない。 In R ^4a , R ^4b , R ^4c , R ^4d , and R ^4e , "However, not all of the existing R ^4a , R ^4b , R ^4c , R ^4d , and R ^4e represent hydrogen atoms." , A ¹ , A ² , A ³ , A ⁴ and A ⁵ are present, meaning that a 6-membered ring (ie, a phenyl group or a 6-membered aromatic heterocyclic group) has one or more substituents. It means that at least one of R ^4a , R ^4b , R ^4c , R ^4d , and R ^4e is not a hydrogen atom. For example, in a compound where A ¹ is CR ^4a , A ² is CR ^4b , A ³ is CR ^4c , A ⁴ is CR ^4d , and A ⁵ is CR ^4e , R ^4a , R ^4b , Unless all of R ^4c , R ^4d , and R ^4e are hydrogen atoms, A ¹ is CR ^4a , A ² is CR ^4b , A ³ is CR ^4c , and A ⁴ is a nitrogen atom. Except when all of R ^4a , R ^4b , R ^4c , and R ^4e are hydrogen atoms in the compound in which A ⁵ is CR ^4e .
In other words, in formula (I) or formula (II), formula (IP)

[In the formula, the wavy line portion represents the coupling position with C (Z), and the other symbols represent the same meanings as described above. ]
Neither the phenyl group represented by the above nor the 6-membered aromatic heterocyclic group is unsubstituted.

［式中、記号は前記と同じ意味を表す。］ Examples of the N oxide of the compound represented by the formula (I) include a compound represented by the following formula.

[In the formula, the symbols have the same meanings as described above. ]

This compound may have one or more stereoisomers. Examples of the stereoisomer include enantiomers, diastereomers and geometric isomers. This compound contains each stereoisomer and a mixture of stereoisomers in any ratio.

The compound may form acid addition salts. Examples of the acid forming the acid addition salt include inorganic acids such as hydrogen chloride, phosphoric acid and sulfuric acid, and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid and p-toluenesulfonic acid. The acid addition salt is obtained by mixing the present compound with an acid.

Next, a method for producing this compound will be described.

［式中、記号は前記と同じ意味を表す。］ Manufacturing method 1
The compound represented by the formula (Ib) (hereinafter referred to as the compound (Ib)) or the compound represented by the formula (Ic) (hereinafter referred to as the compound (Ic)) is the formula (I). It can be produced by reacting the compound represented by —a) (hereinafter referred to as compound (IA)) with an oxidizing agent.

[In the formula, the symbols have the same meanings as described above. ]

First, a method for producing compound (Ib) from compound (Ia) will be described.
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include halogenated hydrocarbons such as dichloromethane and chloroform (hereinafter referred to as halogenated hydrocarbons); nitriles such as acetonitrile (hereinafter referred to as nitriles); alcohols such as methanol and ethanol. (Hereinafter referred to as alcohols); acetic acid; water and mixtures of two or more of these can be mentioned.
Examples of the oxidizing agent used in the reaction include sodium periodate, m-chloroperbenzoic acid (hereinafter referred to as mCPBA), and hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be added as needed.
Examples of the base used in the reaction include sodium carbonate. When a base is used in the reaction, the base is usually used in a ratio of 0.01 to 1 mol per 1 mol of compound (IA).
Examples of the catalyst used in the reaction include tungstic acid and sodium tungstate. When a catalyst is used in the reaction, the catalyst is usually used at a ratio of 0.01 to 0.5 mol per 1 mol of compound (IA).
In the reaction, an oxidizing agent is usually used in a ratio of 1 to 1.2 mol to 1 mol of compound (Ia).
The reaction temperature is usually in the range of −20 to 80 ° C. The reaction time is usually in the range of 0.1-12 hours.
After completion of the reaction, water is added to the reaction mixture, the mixture is extracted with an organic solvent, and the organic layer is prepared with an aqueous solution of a reducing agent (for example, sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (for example, sodium hydrogencarbonate) as needed. To wash. The compound (Ib) can be obtained by drying and concentrating the organic layer.

Next, a method for producing the compound (IC) from the compound (Ib) will be described.
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include halogenated hydrocarbons, nitriles, alcohols, acetic acid, water and mixtures of two or more thereof.
Examples of the oxidizing agent used in the reaction include mCPBA and hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be added as needed.
Examples of the base used in the reaction include sodium carbonate. When a base is used in the reaction, the base is usually used in a ratio of 0.01 to 1 mol per 1 mol of compound (Ib).
Examples of the catalyst used in the reaction include sodium tungstate. When a catalyst is used in the reaction, the catalyst is usually used at a ratio of 0.01 to 0.5 mol per 1 mol of compound (Ib).
In the reaction, an oxidizing agent is usually used in a ratio of 1 to 2 mol to 1 mol of compound (Ib).
The reaction temperature is usually in the range of −20 to 120 ° C. The reaction time is usually in the range of 0.1-12 hours.
After completion of the reaction, water is added to the reaction mixture, the mixture is extracted with an organic solvent, and the organic layer is prepared with an aqueous solution of a reducing agent (for example, sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (for example, sodium hydrogencarbonate) as needed. To wash. Compound (Ic) can be obtained by drying and concentrating this organic layer.

Further, the compound (Ic) can also be produced by a one-step reaction (one pot) by reacting the compound (Ia) with an oxidizing agent.
The reaction is carried out according to the method for producing compound (Ic) from compound (Ib), usually using an oxidizing agent at a ratio of 2 to 5 mol per 1 mol of compound (Ia). Can be done.

［式中、Ｒ^Aは、群Ｗより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｕより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルキル基、群Ｖより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｖより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基を表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば、テトラヒドロフラン（以下、ＴＨＦと記す）、メチルｔｅｒｔ－ブチルエーテル（以下、ＭＴＢＥと記す）等のエーテル（以下、エーテル類と記す）；ハロゲン化炭化水素類；トルエン、キシレン等の芳香族炭化水素（以下、芳香族炭化水素類と記す）；酢酸エチル、酢酸ブチル等のエステル（以下、エステル類と記す）；ニトリル類；Ｎ－メチルピロリドン（以下、ＮＭＰと記す）、Ｎ，Ｎ－ジメチルホルムアミド（以下、ＤＭＦと記す）、ジメチルスルホキシド（以下、ＤＭＳＯと記す）等の非プロトン性極性溶媒（以下、非プロトン性極性溶媒と記す）；ピリジン、ピコリン、ルチジン、キノリン等の含窒素芳香族化合物（以下、含窒素芳香族化合物類と記す）及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる縮合剤としては、例えば１－エチル－３－［３－（ジメチルアミノ）プロピル］カルボジイミド塩酸塩、１，３－ジシクロヘキシルカルボジイミド等のカルボジイミド類が挙げられる。
反応には、必要に応じて触媒を用いることができる。反応に用いられる触媒としては、例えば１－ヒドロキシベンゾトリアゾールが挙げられる。反応に触媒が用いられる場合、化合物（Ｍ１－１－Ａ）１モルに対して、触媒が通常０．０１～０．５モルの割合で用いられる。
反応には、必要に応じて塩基を用いることができる。反応に用いられる塩基としては、例えばトリエチルアミン、Ｎ，Ｎ－ジイソプロピルエチルアミン、ピリジン、４－（ジメチルアミノ）ピリジン等の有機塩基（以下、有機塩基類と記す）が挙げられる。反応に塩基が用いられる場合、化合物（Ｍ１－１－Ａ）１モルに対して、塩基が通常１～２モルの割合で用いられる。
反応には、化合物（Ｍ１－１－Ａ）１モルに対して、化合物（Ｍ２－１）が通常１～２モルの割合、縮合剤が通常１～２モルの割合で用いられる。
反応温度は、通常０～２００℃の範囲である。反応時間は通常０．１～１２時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－１－Ａ）を得ることができる。
化合物（Ｍ２－１）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Manufacturing method 2
The compound represented by the formula (I-1-A) (hereinafter referred to as compound (I-1-A)) is a compound represented by the formula (M1-1-A) (hereinafter referred to as compound (M1-1-A)). ) And the compound represented by the formula (M2-1) (hereinafter referred to as compound (M2-1)) can be produced by reacting in the presence of a condensing agent.

[In the formula, ^RA may be substituted with one or more substituents selected from group W, C1-C6 chain hydrocarbon groups, even if substituted with one or more substituents selected from group U. A good C3-C7 cycloalkyl group, a phenyl group which may be substituted with one or more substituents selected from group V, a 5- or 6-membered aromatic which may be substituted with one or more substituents selected from group V. It represents a group heterocyclic group, and other symbols have the same meanings as described above. ]
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers (hereinafter referred to as ethers) such as tetrahydrofuran (hereinafter referred to as THF) and methyl tert-butyl ether (hereinafter referred to as MTBE); halogenated hydrocarbons; toluene, Aromatic hydrocarbons such as xylene (hereinafter referred to as aromatic hydrocarbons); esters such as ethyl acetate and butyl acetate (hereinafter referred to as esters); nitriles; N-methylpyrrolidone (hereinafter referred to as NMP) , N, N-dimethylformamide (hereinafter referred to as DMF), dimethylsulfoxide (hereinafter referred to as DMSO) and other aprotonic polar solvents (hereinafter referred to as aprotonic polar solvent); pyridine, picolin, lutidine, quinoline. Examples thereof include nitrogen-containing aromatic compounds (hereinafter referred to as nitrogen-containing aromatic compounds) and mixtures of two or more of these.
Examples of the condensing agent used in the reaction include carbodiimides such as 1-ethyl-3- [3- (dimethylamino) propyl] carbodiimide hydrochloride and 1,3-dicyclohexylcarbodiimide.
A catalyst can be used for the reaction, if necessary. Examples of the catalyst used in the reaction include 1-hydroxybenzotriazole. When a catalyst is used in the reaction, the catalyst is usually used at a ratio of 0.01 to 0.5 mol per 1 mol of compound (M1-1-A).
A base can be used in the reaction if necessary. Examples of the base used in the reaction include organic bases such as triethylamine, N, N-diisopropylethylamine, pyridine and 4- (dimethylamino) pyridine (hereinafter referred to as organic bases). When a base is used in the reaction, the base is usually used in a ratio of 1 to 2 mol to 1 mol of compound (M1-1-A).
In the reaction, the compound (M2-1) is usually used in a ratio of 1 to 2 mol and the condensing agent is usually used in a ratio of 1 to 2 mol with respect to 1 mol of the compound (M1-1-A).
The reaction temperature is usually in the range of 0 to 200 ° C. The reaction time is usually in the range of 0.1-12 hours.
After completion of the reaction, the compound (I-1-A) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.
The compound (M2-1) is a commercially available compound or can be produced by a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類；ヘキサン、ヘプタン、オクタン等の脂肪族炭化水素（以下、脂肪族炭化水素類と記す）；芳香族炭化水素類；ハロゲン化炭化水素類；エステル類；ニトリル類；非プロトン性極性溶媒及びこれらの２種類以上の混合物が挙げられる。
反応には必要に応じて塩基を用いることができる。反応に用いられる塩基としては、例えば炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩（以下、アルカリ金属炭酸塩類と記す）；水酸化ナトリウム、水酸化カリウム等のアルカリ金属水酸化物（以下、アルカリ金属水酸化物類と記す）；及び有機塩基類が挙げられる。反応に塩基が用いられる場合、化合物（Ｍ１－１－Ａ）１モルに対して、塩基が通常１～２モルの割合で用いられる。
反応には、化合物（Ｍ１－１－Ａ）１モルに対して、化合物（Ｍ２－２）が通常０．８～１．２モルの割合で用いられる。
反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－１－Ａ）を得ることができる。
化合物（Ｍ２－２）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Manufacturing method 3
Compound (I-1-A) is produced by reacting compound (M1-1-A) with a compound represented by the formula (M2-2) (hereinafter referred to as compound (M2-2)). You can also.

[In the formula, the symbols have the same meanings as described above. ]
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers; aliphatic hydrocarbons such as hexane, heptane, and octane (hereinafter referred to as aliphatic hydrocarbons); aromatic hydrocarbons; halogenated hydrocarbons; esters; Hydrocarbons; examples include aprotonic polar solvents and mixtures of two or more of these.
A base can be used in the reaction if necessary. Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate (hereinafter referred to as alkali metal carbonates); alkali metal hydroxides such as sodium hydroxide and potassium hydroxide (hereinafter referred to as alkali metals). Hydroxides); and organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 2 mol to 1 mol of compound (M1-1-A).
In the reaction, compound (M2-2) is usually used in a ratio of 0.8 to 1.2 mol to 1 mol of compound (M1-1-A).
The reaction temperature is usually in the range of −20 to 200 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (I-1-A) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.
The compound (M2-2) is a commercially available compound or can be produced by a known method.

［式中、Ｒ^Bは、群Ｗより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｕより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルキル基、Ｃ（Ｏ）Ｒ⁵¹、Ｃ（Ｏ）ＯＲ⁵¹、又はＣ（Ｏ）ＮＲ⁵¹Ｒ⁵²を表し、Ｌは塩素原子、臭素原子等の脱離基を表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類、ニトリル類、非プロトン性極性溶媒及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる塩基としては、例えば水素化ナトリウム等のアルカリ金属水素化物（以下、アルカリ金属水素化物類と記す）、アルカリ金属炭酸塩類及び有機塩基類が挙げられる。
反応には、化合物（ＩＩ）１モルに対して、化合物（Ｒ－１）が通常１～５モルの割合、塩基が通常１～２モルの割合で用いられる。
反応温度は、通常０～１００℃の範囲である。反応時間は通常０．１～２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－２－Ｂ）を得ることができる。
化合物（Ｒ－１）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Manufacturing method 4
The compound represented by the formula (I-2-B) (hereinafter referred to as compound (I-2-B)) is the compound represented by the formula (II) (hereinafter referred to as compound (II)) and the formula (R). It can be produced by reacting the compound represented by -1) (hereinafter referred to as compound (R-1)) in the presence of a base.

[In the formula, RB may be substituted with one or more substituents selected from group W, C1 ^- C6 chain hydrocarbon groups, even if substituted with one or more substituents selected from group U. Good C3-C7 cycloalkyl group, C (O) R ⁵¹ , C (O) OR ⁵¹ , or C (O) NR ⁵¹ R ⁵² , L represents a leaving group such as a chlorine atom, a bromine atom, etc. The symbol has the same meaning as described above. ]
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, nitriles, aprotic polar solvents and mixtures of two or more thereof.
Examples of the base used in the reaction include alkali metal hydrides such as sodium hydride (hereinafter referred to as alkali metal hydrides), alkali metal carbonates and organic bases.
In the reaction, the compound (R-1) is usually used in a ratio of 1 to 5 mol and the base is usually used in a ratio of 1 to 2 mol with respect to 1 mol of the compound (II).
The reaction temperature is usually in the range of 0 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (I-2-B) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.
Compound (R-1) is a commercially available compound or can be produced by a known method.

［式中、Ｖ¹はハロゲン原子を表し、その他の記号は前記と同じ意味を表す。］ Manufacturing method 5
The compound represented by the formula (I-1) (hereinafter referred to as compound (I-1)) is the compound represented by the formula (M1-2) (hereinafter referred to as compound (M1-2)) and the formula (M2). It can be produced by reacting with the compound represented by -3) (hereinafter referred to as compound (M2-3)).

[In the formula, V ¹ represents a halogen atom, and other symbols have the same meanings as described above. ]

When V ¹ is a fluorine atom, compound (I-1) can be produced by reacting compound (M1-2) with compound (M2-3) in the presence of a base.
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, nitriles, aprotic polar solvents, water and mixtures of two or more thereof.
Examples of the base used in the reaction include alkali metal carbonates and alkali metal hydrides.
In the reaction, the compound (M2-3) is usually used in a ratio of 0.8 to 1.2 mol and the base is usually used in a ratio of 1 to 2 mol with respect to 1 mol of the compound (M1-2).
The reaction temperature is usually in the range of 0 to 200 ° C. The reaction time is usually in the range of 0.5 to 24 hours.
After completion of the reaction, the compound (I-1) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.

When V ¹ is a chlorine atom, a bromine atom or an iodine atom, the compound (I-1) contains a compound (M1-2) and a compound (M2-3) in the presence of a base and a copper catalyst or a palladium catalyst. It can be produced by reacting with.
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, nitriles, aprotic polar solvents, water and mixtures of two or more thereof.
Examples of the bases used in the reaction include alkali metal carbonates; phosphates such as trisodium phosphate and tripotassium phosphate; alkali metal hydrides; organic bases; and 1,4-diazabicyclo [2,2]. 2] Cyclic amines such as octane and diazabicycloundecene can be mentioned.
Examples of the copper catalyst used in the reaction include copper (I) iodide, copper (I) bromide, copper (I) chloride, and copper (I) oxide. When a copper catalyst is used in the reaction, the copper catalyst is usually used at a ratio of 0.01 to 0.5 mol per 1 mol of compound (M1-2).
Examples of the palladium catalyst used in the reaction include palladium (II) acetate, tris (dibenzylideneacetone) dipalladium (0) and the like. When a palladium catalyst is used in the reaction, a palladium catalyst is usually used at a ratio of 0.01 to 0.2 mol per 1 mol of compound (M1-2).
If necessary, a ligand can be used in the reaction. Examples of the ligand used in the reaction include acetylacetone, salen, phenanthroline, triphenylphosphine, 4,5'-bis (diphenylphosphino) -9,9'-dimethylxanthene and the like. When a ligand is used in the reaction, the ligand is usually used at a ratio of 0.01 to 0.5 mol per 1 mol of compound (M1-2).
In the reaction, the compound (M2-3) is usually used in a ratio of 0.8 to 1.2 mol and the base is usually used in a ratio of 1 to 2 mol with respect to 1 mol of the compound (M1-2).
The reaction temperature is usually in the range of 0 to 200 ° C. The reaction time is usually in the range of 0.5 to 24 hours.
After completion of the reaction, the compound (I-1) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.
In the compound (M2-3), the compound in which ^{R 1} is ^RA or RB is a commercially available compound or can be produced by a known method.

［式中、Ｘ^aは塩素原子、臭素原子又はヨウ素原子を表し、Ｘ^bはＳＲ²又は水素原子を表し、その他の記号は前記と同じ意味を表す。］ Manufacturing method 6
Compound (IA) can be produced according to the following scheme.

[In the formula, X ^a represents a chlorine atom, a bromine atom or an iodine atom, X ^b represents SR ² or a hydrogen atom, and other symbols have the same meanings as described above. ]

First, a compound represented by the formula (M3-1) (hereinafter referred to as compound (M3-1)) is produced from the compound represented by the formula (III-1) (hereinafter referred to as compound (III-1)). The process (hereinafter referred to as process 6-A) will be described.
The compound (M3-1) can be produced by reacting the compound (III-1) with a halogenating agent.
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include alcohols, nitriles, ethers, aromatic hydrocarbons, aprotonic polar solvents, halogenated hydrocarbons, water and mixtures of two or more thereof.
Examples of the halogenating agent include chlorine, bromine, iodine, N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide and the like.
In the reaction, a halogenating agent is usually used in a ratio of 1 to 20 mol to 1 mol of compound (III-1).
The reaction temperature is usually in the range of −20 ° C. to 200 ° C. The reaction time is usually in the range of 0.1 to 72 hours.
After completion of the reaction, the compound (M3-1) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.

Next, a step of producing the compound (Ia) from the compound (M3-1) will be described.
The compound (Ia) is a reaction between the compound (M3-1) and the compound represented by the formula (R-2) (hereinafter referred to as compound (R-2)) in the presence of a metal catalyst and a base. Can be manufactured by
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include alcohols, nitriles, ethers, aromatic hydrocarbons, aprotic polar solvents, water and mixtures of two or more thereof.
Examples of the metal catalyst used in the reaction include tetrakis (triphenylphosphine) palladium (0), 1,1'-bis (diphenylphosphino) ferrocenepalladium (II) dichloride, and tris (dibenzylideneacetone) dipalladium (0). ), Palladium catalyst such as palladium (II) acetate; nickel catalyst such as bis (cyclooctadien) nickel (0), nickel chloride (II); and copper catalyst such as copper (I) iodide, copper (I) chloride. Can be mentioned.
Examples of the base used in the reaction include alkali metal hydrides, alkali metal carbonates, and organic bases.
A ligand can also be used in the reaction. As ligands, triphenylphosphine, xanthhos, 2,2'-bis (diphenylphosphino) -1,1'-binaphthyl, 1,1'-bis (diphenylphosphino) ferrocene, 2-dicyclohexylphosphino- 2', 4', 6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2', 6'-dimethoxybiphenyl, 1,2-bis (diphenylphosphino) ethane, 2,2'-bipyridine, 2-amino Examples thereof include ethanol, 8-hydroxyquinoline, 1,10-phenanthroline and the like. When a ligand is used in the reaction, the ligand is usually used at a ratio of 0.01 to 1 mol per 1 mol of compound (M3-1).
In the reaction, the ratio of compound (R-2) is usually 1 to 20 mol, the ratio of metal catalyst is usually 0.01 to 0.5 mol, and the ratio of base is usually 0 to 1 mol of compound (M3-1). . Used in proportions of 1-5 mol.
The reaction temperature is usually in the range of −20 ° C. to 200 ° C. The reaction time is usually in the range of 0.1 to 72 hours.
After completion of the reaction, the compound (IA) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.
Compound (R-2) is known or can be produced according to a known method.

Next, a step of producing compound (IA) from compound (III-1) will be described.
The compound (IA) is prepared by reacting compound (III-1) with a compound represented by the formula (R-3) (hereinafter referred to as compound (R-3)) in the presence of a halogenating agent. It can also be manufactured.
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include alcohols, nitriles, ethers, aromatic hydrocarbons, aprotic polar solvents, water and mixtures of two or more thereof.
Examples of the halogenating agent include bromine, iodine, sodium bromide, potassium bromide, sodium iodide, potassium iodide and the like.
If necessary, an oxidizing agent can be used in the reaction. Examples of the oxidizing agent used in the reaction include hydrogen peroxide, tert-butyl hydroperoxide, DMSO and the like. When an oxidizing agent is used in the reaction, the oxidizing agent is usually used in a ratio of 1 to 20 mol to 1 mol of compound (III-1).
In the reaction, the compound (R-3) is usually used in a ratio of 0.5 to 10 mol and the halogenating agent is usually used in a ratio of 0.05 to 10 mol with respect to 1 mol of the compound (III-1).
The reaction temperature is usually in the range of 0 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 72 hours.
After completion of the reaction, the compound (IA) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.
Compound (R-3) is known or can be produced according to a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、溶媒中又は溶媒非存在下で行われる。溶媒としては、例えば、エーテル類、ハロゲン化炭化水素類、芳香族炭化水素類、ニトリル類、含窒素芳香族化合物類及びこれらの２種類以上の混合物が挙げられる。
硫化剤としては、五硫化二リン、ローソン試薬（２，４－ビス（４－メトキシフェニル）－１，３－ジチア－２，４－ジホスフェタン－２，４－ジスルフィド）等が挙げられる。
反応には、化合物（Ｉ－１）１モルに対して、硫化剤が通常１モル～３モルの割合で用いられる。
反応温度は、通常０℃～２００℃の範囲である。反応時間は通常１～２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（Ｉ－Ｓ）を得ることができる。 Manufacturing method 7
The compound represented by the formula (IS) (hereinafter referred to as compound (IS)) can be produced by reacting compound (I-1) with a sulfurizing agent.

[In the formula, the symbols have the same meanings as described above. ]
The reaction is carried out in the solvent or in the absence of the solvent. Examples of the solvent include ethers, halogenated hydrocarbons, aromatic hydrocarbons, nitriles, nitrogen-containing aromatic compounds, and mixtures of two or more thereof.
Examples of the sulfurizing agent include diphosphorus pentasulfide and Lawesson's reagent (2,4-bis (4-methoxyphenyl) -1,3-dithia-2,4-diphosfetan-2,4-disulfide).
In the reaction, a sulfurizing agent is usually used in a ratio of 1 mol to 3 mol with respect to 1 mol of compound (I-1).
The reaction temperature is usually in the range of 0 ° C to 200 ° C. The reaction time is usually in the range of 1 to 24 hours.
After completion of the reaction, the compound (IS) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（Ｉ－１）に代えて化合物（ＩＩ－Ｏ）を用い、製造法７に準じて実施することができる。 Manufacturing method 8
The compound represented by the formula (II-S) (hereinafter referred to as compound (II-S)) can be produced by reacting the compound (II-O) with a sulfurizing agent.

[In the formula, the symbols have the same meanings as described above. ]
The reaction can be carried out according to the production method 7 using compound (II-O) instead of compound (I-1).

［式中、記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、アルコール類及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる還元剤としては、例えば水素化ホウ素ナトリウム、シアノ水素化ホウ素ナトリウム、及び水素化アルミニウムリチウムが挙げられる。
反応には、化合物（Ｍ４－１）１モルに対して、還元剤が通常１～２モルの割合で用いられる。
反応温度は、通常０～１００℃の範囲である。反応時間は通常０．１～２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－３－Ｈ）を得ることができる。 Manufacturing method 9
The compound represented by the formula (I-3-H) (hereinafter referred to as compound (I-3-H)) is the compound represented by the formula (M4-1) (hereinafter referred to as compound (M4-1)). It can be produced by reacting with a reducing agent.

[In the formula, the symbols have the same meanings as described above. ]
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, alcohols and mixtures of two or more thereof.
Examples of the reducing agent used in the reaction include sodium borohydride, sodium cyanoborohydride, and lithium aluminum hydride.
In the reaction, a reducing agent is usually used in a ratio of 1 to 2 mol to 1 mol of compound (M4-1).
The reaction temperature is usually in the range of 0 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (I-3-H) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.

［式中、Ｒ^Cは、群Ｘより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｙより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルキル基、Ｃ（Ｏ）Ｒ⁴⁶、Ｃ（Ｏ）ＯＲ⁴⁶、又はＣ（Ｏ）ＮＲ⁴⁶Ｒ⁴⁷を表し、その他の記号は前記と同じ意味を表す。］
反応は、化合物（ＩＩ）に代えて化合物（Ｉ－３－Ｈ）を用い、製造法４に準じて実施することができる。
化合物（Ｒ－４）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Manufacturing method 10
The compound represented by the formula (I-3-C) includes a compound (I-3-H) and a compound represented by the formula (R-4) (hereinafter referred to as compound (R-4)) in the presence of a base. It can be produced by reacting below.

[In the formula, ^RC may be substituted with one or more substituents selected from group X, C1-C6 chain hydrocarbon groups, even if substituted with one or more substituents selected from group Y. It represents a good C3-C7 cycloalkyl group, C (O) R ⁴⁶ , C (O) OR ⁴⁶ , or C (O) NR ⁴⁶ R ⁴⁷ , with other symbols having the same meanings as above. ]
The reaction can be carried out according to the production method 4 using compound (I-3-H) instead of compound (II).
Compound (R-4) is a commercially available compound or can be produced using a known method.

Manufacturing method 11
The N oxide of the compound represented by the formula (I) can be produced by reacting the compound represented by the formula (I) with an oxidizing agent. The reaction can be carried out, for example, according to the method described in Production Method 1, US Patent Application Publication No. 2018/0009778 or International Publication No. 2016/12970.

The manufacturing method of the manufacturing intermediate is described below.

［式中、Ｒ^Dは、群Ｗより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は群Ｕより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ７シクロアルキル基を表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類、ニトリル類、非プロトン性極性溶媒及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる塩基としては、例えばアルカリ金属水素化物類、アルカリ金属炭酸塩類、及び有機塩基類が挙げられる。
反応には、化合物（Ｍ１－３）１モルに対して、化合物（Ｒ－５）が通常１～５モルの割合、塩基が通常１～２モルの割合で用いられる。
反応温度は、通常０～１００℃の範囲である。反応時間は通常０．１～２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｍ１－１－Ｄ）を得ることができる。 Reference manufacturing method 1
The compound represented by the formula (M1-1-D) (hereinafter referred to as compound (M1-1-D)) is a compound represented by the formula (M1-3) (hereinafter referred to as compound (M1-3)). It can be produced by reacting with a compound represented by the formula (R-5) (hereinafter referred to as compound (R-5)) in the presence of a base.

[In the formula, ^RD is substituted with a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group W, or one or more substituents selected from group U. May represent a C3-C7 cycloalkyl group, with other symbols having the same meanings as above. ]
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, nitriles, aprotic polar solvents and mixtures of two or more thereof.
Examples of the base used in the reaction include alkali metal hydrides, alkali metal carbonates, and organic bases.
In the reaction, the compound (R-5) is usually used in a ratio of 1 to 5 mol and the base is usually used in a ratio of 1 to 2 mol with respect to 1 mol of the compound (M1-3).
The reaction temperature is usually in the range of 0 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M1-1-1-D) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.

［式中、Ｘ^dはフッ素原子又は塩素原子を表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば非プロトン性極性溶媒、アルコール類及びこれらの２種類以上の混合物が挙げられる。
反応には、必要に応じて塩基を用いることができる。反応に用いられる塩基としては、例えば、有機塩基類及びアルカリ金属炭酸塩類が挙げられる。反応に塩基が用いられる場合、化合物（Ｍ１－２－２）１モルに対して、塩基が通常０．１～５モルの割合で用いられる。
反応には、化合物（Ｍ１－２－２）１モルに対して、化合物（Ｒ－６）が通常１～１００モルの割合で用いられる。
反応温度は、通常２５℃～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｍ１－１－Ａ）を得ることができる。
化合物（Ｒ－６）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference manufacturing method 2
The compound (M1-1-A) is a compound represented by the formula (M1-2-2) (hereinafter referred to as a compound (M1-2-2)) and a compound represented by the formula (R-6) (hereinafter referred to as a compound). It can be produced by reacting with compound (R-6)).

[In the formula, X ^d represents a fluorine atom or a chlorine atom, and other symbols have the same meanings as described above. ]
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include an aprotic polar solvent, alcohols, and a mixture of two or more thereof.
A base can be used in the reaction if necessary. Examples of the base used in the reaction include organic bases and alkali metal carbonates. When a base is used in the reaction, the base is usually used in a ratio of 0.1 to 5 mol to 1 mol of the compound (M1-2-2).
In the reaction, compound (R-6) is usually used in a ratio of 1 to 100 mol to 1 mol of compound (M1-2-2).
The reaction temperature is usually in the range of 25 ° C to 200 ° C. The reaction time is usually in the range of 0.1-48 hours.
After completion of the reaction, the compound (M1-1-1-A) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.
Compound (R-6) is a commercially available compound or can be produced using a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、ニトリル類、非プロトン性極性溶媒、アルコール類、水及びこれらの２種類以上の混合物が挙げられる。
反応には、必要に応じて塩基を用いることができる。反応に用いられる塩基としては、例えば、有機塩基類及びアルカリ金属炭酸塩類が挙げられる。反応に塩基が用いられる場合、化合物（Ｍ１－２－２）１モルに対して、塩基が通常０．１～５モルの割合で用いられる。
アンモニアは、アンモニア水及びアンモニアメタノール溶液等の溶液として用いることもできる。
反応には、化合物（Ｍ１－２－２）１モルに対して、アンモニアが通常１～１００モルの割合で用いられる。
反応温度は、通常－２０℃～１００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｍ１－３）を得ることができる。 Reference manufacturing method 3
The compound (M1-3) can be produced by reacting the compound (M1-2-2) with ammonia.

[In the formula, the symbols have the same meanings as described above. ]
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, nitriles, aprotic polar solvents, alcohols, water and mixtures of two or more thereof.
A base can be used in the reaction if necessary. Examples of the base used in the reaction include organic bases and alkali metal carbonates. When a base is used in the reaction, the base is usually used in a ratio of 0.1 to 5 mol to 1 mol of the compound (M1-2-2).
Ammonia can also be used as a solution such as ammonia water and ammonia methanol solution.
Ammonia is usually used in a ratio of 1 to 100 mol to 1 mol of compound (M1-2-2) in the reaction.
The reaction temperature is usually in the range of −20 ° C. to 100 ° C. The reaction time is usually in the range of 0.1-48 hours.
After completion of the reaction, the compound (M1-3) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、製造法１に準じて実施することができる。 Reference manufacturing method 4
The compound represented by the formula (M1-2b) and the compound represented by the formula (M1-2c) react with the compound represented by the formula (M1-2a) (hereinafter referred to as compound (M1-2a)) with an oxidizing agent. It can be manufactured by allowing it to be produced. Further, the compound represented by the formula (M1-2c) can also be produced by reacting the compound represented by the formula (M1-2b) with an oxidizing agent.

[In the formula, the symbols have the same meanings as described above. ]
These reactions can be carried out according to the production method 1.

［式中、記号は前記と同じ意味を表す。］ Reference manufacturing method 5
Compound (M1-2a) can be produced according to the scheme below.

[In the formula, the symbols have the same meanings as described above. ]

These reactions can be carried out according to the production method 6.
The compound represented by the formula (M1-4) (hereinafter referred to as compound (M1-4)) is known or is published in International Publication No. 2015/157093, International Publication No. 2016/109706, Organic & Biomolecular Chemistry, It can be manufactured according to the method described in 2017, 15, 4199., European Journal of Medicinal Chemistry, 2016, 123, 916. Etc.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、化合物（Ｍ１－１－Ａ）に代えて化合物（Ｍ１－３）を用い、製造法２又は製造法３に準じて実施することができる。 Reference manufacturing method 6
Compound (II-O) can be produced by reacting compound (M1-3) with compound (M2-1) or compound (M2-2).

[In the formula, the symbols have the same meanings as described above. ]
These reactions can be carried out according to the production method 2 or the production method 3 by using the compound (M1-3) instead of the compound (M1-1-A).

［式中、記号は前記と同じ意味を表す。］
これらの反応は、化合物（Ｍ１－１－Ａ）に代えて化合物（Ｍ１－６－Ａ）を用い、製造法２又は製造法３に準じて実施することができる。 Reference manufacturing method 7
The compound represented by the formula (M3-1-A) is a compound represented by the formula (M1-6-A) (hereinafter referred to as a compound (M1-6-A)) and a compound (M2-1) or a compound. It can be produced by reacting with (M2-2).

[In the formula, the symbols have the same meanings as described above. ]
These reactions can be carried out according to the production method 2 or the production method 3 by using the compound (M1-6-A) instead of the compound (M1-1-A).

［式中、記号は前記と同じ意味を表す。］ Reference manufacturing method 8
The compound represented by the formula (M1-6-D) (hereinafter referred to as compound (M1-6-D)) can be produced according to the following scheme.

[In the formula, the symbols have the same meanings as described above. ]

First, a method for producing a compound represented by the formula (M1-7) (hereinafter referred to as compound (M1-7)) will be described.
The compound (M1-7) can be produced by reacting a compound represented by the formula (M1-5) (hereinafter referred to as compound (M1-5)) with ammonia. The reaction can be carried out according to Reference Production Method 3 using compound (M1-5) instead of compound (M1-2-2).

Next, a method for producing the compound (M1-6-D) will be described.
Compound (M1-6-D) can be produced by reacting compound (M1-7) with compound (R-5) in the presence of a base. The reaction can be carried out according to Reference Production Method 1 using compound (M1-7) instead of compound (M1-3).

［式中、記号は前記と同じ意味を表す。］ Reference manufacturing method 9
Compound (M1-6-A) can be produced according to the scheme below.

[In the formula, the symbols have the same meanings as described above. ]

First, a method for producing a compound represented by the formula (M1-8-A) (hereinafter referred to as compound (M1-8-A)) will be described.
Compound (M1-8-A) can be produced by reacting compound (M1-4) with compound (R-6). The reaction can be carried out according to the reference production method 2 by using the compound (M1-4) instead of the compound (M1-2-2).

Next, a method for producing the compound (M1-6-A) will be described.
The compound (M1-6-A) can be produced by reacting the compound (M1-8-A) with a halogenating agent. The reaction can be carried out according to Step 6-A of Production Method 6 using compound (M1-8-A) instead of compound (III-1).

［式中、記号は前記と同じ意味を表す。］ Reference manufacturing method 10
The compound represented by the formula (M3-1-B) (hereinafter referred to as compound (M3-1-B)) can be produced according to the following scheme.

[In the formula, the symbols have the same meanings as described above. ]

First, a method for producing a compound represented by the formula (M3-2) (hereinafter referred to as compound (M3-2)) will be described.
The compound (M3-2) can be produced by reacting the compound (M1-7) with the compound (M2-1) or the compound (M2-2). These reactions can be carried out according to the production method 2 or the production method 3 by using the compound (M1-7) instead of the compound (M1-1-A).

Next, a method for producing the compound (M3-1-B) will be described.
Compound (M3-1-B) can be produced by reacting compound (M3-2) with compound (R-1) in the presence of a base. The reaction can be carried out according to the production method 4 using compound (M3-2) instead of compound (II).

［式中、記号は前記と同じ意味を表す。］
化合物（ＩＩＩ－１－Ａ）は、化合物（Ｍ１－８－Ａ）と、化合物（Ｍ２－１）又は化合物（Ｍ２－２）とを反応させることにより製造することができる。これらの反応は、化合物（Ｍ１－１－Ａ）に代えて化合物（Ｍ１－８－Ａ）を用い、製造法２又は製造法３に準じて実施することができる。 Reference manufacturing method 11
The compound represented by the formula (III-1-A) (hereinafter referred to as compound (III-1-A)) can be produced according to the following scheme.

[In the formula, the symbols have the same meanings as described above. ]
Compound (III-1-A) can be produced by reacting compound (M1-8-A) with compound (M2-1) or compound (M2-2). These reactions can be carried out according to the production method 2 or the production method 3 by using the compound (M1-8-A) instead of the compound (M1-1-A).

［式中、記号は前記と同じ意味を表す。］ Reference manufacturing method 12
The compound represented by the formula (III-1-B) (hereinafter referred to as compound (III-1-B)) can be produced according to the following scheme.

[In the formula, the symbols have the same meanings as described above. ]

First, a method for producing a compound represented by the formula (III-2-B) (hereinafter referred to as compound (III-2-B)) will be described.
The compound (III-2-B) is a reaction between the compound represented by the formula (M1-9) (hereinafter referred to as compound (M1-9)) and the compound (M2-1) or the compound (M2-2). It can be manufactured by allowing it to be produced. These reactions can be carried out according to the production method 2 or the production method 3 by using the compound (M1-9) instead of the compound (M1-1-A).

Next, a method for producing the compound (III-1-B) will be described.
Compound (III-1-B) can be produced by reacting compound (III-2-B) with compound (R-1) in the presence of a base. The reaction can be carried out according to the production method 4 using compound (III-2-B) instead of compound (II).

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（Ｍ１－２－２）に代えて化合物（Ｍ１－４）を用い、参考製造法３に準じて実施することができる。 Reference manufacturing method 13
Compound (M1-9) can be produced by reacting compound (M1-4) with ammonia.

[In the formula, the symbols have the same meanings as described above. ]
The reaction can be carried out according to the reference production method 3 by using the compound (M1-4) instead of the compound (M1-2-2).

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（Ｍ１－２）に代えて化合物（Ｍ１－４）を用い、化合物（Ｍ２－３）に代えて化合物（Ｍ２－３－Ｐ）を用い、製造法５に準じて実施することができる。 Reference manufacturing method 14
The compound represented by the formula (III-1-P) (hereinafter referred to as compound (III-1-P)) is a compound represented by the formula (M2-3-P) (hereinafter referred to as compound (M2-3-P). ) And the compound (M1-4) to be reacted.

[In the formula, the symbols have the same meanings as described above. ]
The reaction shall be carried out according to the production method 5, using compound (M1-4) instead of compound (M1-2) and compound (M2-3-P) instead of compound (M2-3). Can be done.

［式中、Ｒ⁶⁰はメチル基又はエチル基を表し、その他の記号は前記と同じ意味を表す。］ Reference manufacturing method 15
Compound (M4-1) can be produced according to the following scheme.

[In the formula, R ⁶⁰ represents a methyl group or an ethyl group, and other symbols have the same meanings as described above. ]

First, a method for producing the compound represented by the formula (M5) (hereinafter referred to as compound (M5)) will be described.
The compound (M5) can be produced by reacting the compound represented by the formula (M6) (hereinafter referred to as compound (M6)) with the compound (M1-3).
The reaction is usually carried out in a solvent. Examples of the solvent include alcohols, ethers, aromatic hydrocarbons, nitriles, aprotic polar solvents, and mixtures of two or more of these.
A base may be used in the reaction if necessary. Examples of the base include organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 5 mol per 1 mol of compound (M6).
In the reaction, compound (M1-3) is usually used in a ratio of 1 to 5 mol to 1 mol of compound (M6).
The reaction temperature is usually in the range of 0 ° C to 150 ° C. The reaction time is usually in the range of 0.5-12 hours.
After completion of the reaction, the compound (M5) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.
The compound (M6) can be produced, for example, according to the method described in Journal of Biological Chemistry, 2016, 291, 14146.

Next, a method for producing the compound (M4-1) from the compound (M5) will be described.
The compound (M4-1) can be produced by reacting the compound (M5) with the compound represented by the formula (R-7) (hereinafter referred to as compound (R-7)).
The reaction is usually carried out in a solvent or in the absence of a solvent. Examples of the solvent include ethers, aromatic hydrocarbons, halogenated hydrocarbons, nitriles, aprotonic polar solvents and mixtures of two or more thereof.
In the reaction, compound (R-7) is usually used in a ratio of 1 to 50 mol to 1 mol of compound (M5).
Acids or bases may be used in the reaction, if necessary.
Examples of the acid used in the reaction include sulfonic acids such as paratoluenesulfonic acid, carboxylic acids such as acetic acid, and polyphosphoric acid. When an acid is used in the reaction, the acid is usually used in a proportion of 0.01-5 mol to 1 mol of compound (M5).
Examples of the base used in the reaction include organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 5 mol to 1 mol of compound (M5).
The reaction temperature is usually in the range of 0 ° C to 150 ° C. The reaction time is usually in the range of 0.5 to 24 hours.
After completion of the reaction, the compound (M4-1) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.
Compound (R-7) is a commercially available compound or can be produced using a known method.

Further, the compound (M4-1) can be produced by a one-step reaction (one pot) by reacting the compound (M6), the compound (M1-3) and the compound (R-7).
In the reaction, compound (M1-3) is usually used in a ratio of 1 to 5 mol and compound (R-7) is usually used in a ratio of 1 to 50 mol with respect to 1 mol of compound (M6) from compound (M5). It can be carried out according to the method for producing the compound (M4-1).

［式中、記号は前記と同じ意味を表す。］
反応は、例えばOrganic Letters, 2020, 22, 3825.に記載の方法に準じて実施することができる。
化合物（Ｍ７）及び化合物（Ｒ－８）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference manufacturing method 16
The compound (M2-3-P) is referred to as a compound represented by the formula (M7) (hereinafter referred to as compound (M7)) and a compound represented by the formula (R-8) (hereinafter referred to as compound (R-8)). ) Can be produced.

[In the formula, the symbols have the same meanings as described above. ]
The reaction can be carried out, for example, according to the method described in Organic Letters, 2020, 22, 3825.
Compound (M7) and compound (R-8) are commercially available compounds or can be produced using known methods.

This compound contains the following groups (a), group (b), group (c), group (d), group (e), group (f), group (g), group (h), group (i) and It can be mixed or used in combination with one or more components selected from the group consisting of group (j) (hereinafter referred to as this component).
The above-mentioned mixed use or combined use means that the present compound and the present component are used at the same time, separately or at time intervals.
When the present compound and the present component are used at the same time, the present compound and the present component may be contained in separate preparations or may be contained in one preparation.
One aspect of the present invention is group (a), group (b), group (c), group (d), group (e), group (f), group (g), group (h), group ( It is a composition containing one or more components (that is, this component) selected from the group consisting of i) and group (j), and this compound.

Group (a) includes acetylcholine esterase inhibitors (eg, carbamate pesticides, organic phosphorus pesticides), GABAergic chlorine ion channel blockers (eg, phenylpyrazole pesticides), sodium channel modulators (eg, pyrethroid pesticides). ), Nicotinic Acetylcholine Receptor Competitive Modulators (eg Neonicotinoid Insecticide), Nicotinic Acetylcholine Receptor Allosteric Modulators, Glutamic Acidic Chlorine Channel Allosteric Modulators (eg Macrolide Insecticide),
Immature hormone mimics, multisite inhibitors, chord organ TRPV channel modulators, tick growth inhibitors, mitochondrial ATP synthase inhibitors, oxidative phosphorylation decoupling agents, nicotinic acetylcholine receptor channel blockers (eg, nelystoxins) Inhibitors), chitin biosynthesis inhibitors, dehulling inhibitors, ecdison receptor agonists, octopamine receptor agonists, inhibitors of mitochondrial electron transfer complex I, II, III and IV, potential-dependent sodium channel blockers, acetyl It is a group consisting of CoA carboxylase inhibitors, rianodin receptor modulators (eg, diamide-based insecticides), chord organ modulators, and other insecticidal, acaricide, and nematode-killing active ingredients. These are described in the classification based on the mechanism of action of IRAC.

Group (b) includes nucleic acid synthesis inhibitors (eg, phenylamide fungicides, acylaminomic fungicides), cell division and cytoskeletal inhibitors (eg, MBC fungicides), respiratory inhibitors (eg, QoI fungicides). , QiI fungicides), amino acid synthesis and protein synthesis inhibitors (eg, anilinopyridine fungicides), signal transduction inhibitors, lipid synthesis and membrane synthesis inhibitors, sterol biosynthesis inhibitors (eg, triazole-based DMIs) It is a group consisting of fungicides), cell wall biosynthesis inhibitors, melanin synthesis inhibitors, plant defense inducers, contact-active fungicides at other points of action, fungicides, and other fungicides. These are described in the classification based on the mechanism of action of FRAC.

Group (c) is a group of plant growth regulating components.

Group (d) is a group of phytotoxicity reducing components.

Group (e) is a group of synergists.

Group (f) is a group of repellent components composed of a bird repellent component, an insect repellent component, and an animal repellent component.

Group (g) is a group of mollusc components.

The group (h) is a group of insect pheromones.

Group (i) includes acetyl CoA carboxylase (ACCase) inhibitors, acetolactic synthase (ALS) inhibitors, photosynthesis (photochemical system II) inhibitors, photochemical system I electron converters, and protoporphyrinogen oxidase (PPO). Inhibitors, Phytoen Desaturation Enzymes (PDS) Inhibitors, 4-Hydroxyphenylpyruvate Dioxygenase (4-HPPD) Inhibitors, Carotinoid Biosynthesis Inhibitors, EPSP Synthesizer Inhibitors, Glutamine Synthesizer Inhibitors, Dihydroptero In acid (DHP) synthase inhibitor, microtube polymerization inhibitor, thread splitting / microtube formation inhibitor, super long chain fatty acid (VLCFA) inhibitor, cellulose synthesis inhibitor, uncoupling agent, lipid synthesis inhibitor It is a group consisting of agents, indol acetic acid-like activators, auxin migration inhibitors, and other herbicidal active ingredients. These are described in the classification based on the mechanism of action of HRAC.

Group (j) is a bacterium having a control effect on pests (for example, insecticidal activity, mite killing activity, nematode killing activity, bactericidal activity, herbicidal activity, etc.) or a plant growth regulating effect such as root grain fungus and mycorrhizal fungus. , Fungi, yeast, protists, viruses, products produced by organisms, plants and a group of biocontrol materials consisting of plant extracts. Specifically, the group (j) is subgroup (j-1): bacteria, subgroup (j-2): fungus / yeast, subgroup (j-3): protozoa, subgroup (j-4). ): Virus, subgroup (j-5): nematode, subgroup (j-6): product produced by an organism, and subgroup (j-7): plant and plant extract.

The following is an example of the combination of this component and this compound. For example, alanic carb + SX means a combination of alanic carb and SX.
The abbreviation of SX means any one of the present compounds selected from the compound groups SX1 to SX2299. In addition, all of the following components are known components and can be obtained from commercially available formulations or manufactured by a known method. If this ingredient is a microorganism, it can also be obtained from a fungus depository. The numbers in parentheses represent CAS RN (registered trademark).

Combination of this component of the above group (a) and this compound:
Abamectin + SX, acephate + SX, acequinocyl + SX, acetamiprid + SX, acetic acid + SX, acetoprole + SX, acrinathrin + SX , Acynonapyr + SX, afidopyropen + SX, afoxolaner + SX, alanycarb + SX, aldicarb + SX, allethrin + SX, alpha cypermethrin ) + SX, alpha-endosulfan + SX, aluminum phosphide + SX, amitraz + SX, ascorbic acid + SX, azamethiphos + SX, azinphos -ethyl + SX, azinphos-methyl + SX, azocyclotin + SX, bendiocarb + SX, benfluthrin + SX, benfuracarb + SX, bensultap + SX, benzoic acid + SX, benzoximate + SX, benzpyrimoxan + SX, beta-cyfluthrin + SX, beta-cypermethrin + SX, bifenazate + SX, bifenthrin + SX, bilobaride + SX, bioallethrin + SX, bioresmethrin + SX, bist Bistrifluron + SX, borax + SX, boric acid + SX, broflanilide + SX, bromopropylate + SX, buprofezin + SX, butyric acid) + SX, butocarboxim + SX, butoxycarboxim + SX, cadusafos + SX, calcium phosphide + SX, carbaryl + SX, carbofuran ) + SX, carbosulfan + SX, cartap hydrochloride + SX, cartap + SX, chinomethionat + SX, chlorantraniliprole + SX, chlordane ( chlordane + SX, chlorethoxyfos + SX, chlorfenapyr + SX, chlorfenvinphos + SX, chlorfluazuron + SX, chlormephos + SX, chlorpyrifos + SX, chlorpyrifos + SX, chlorpyrifos-methyl + SX, chromafenozide + SX, citric acid + SX, clofentezine + SX, clothianidin + SX, concanamycin A + SX, coumaphos + SX, cryolite + SX, cyanophos + SX, cyantranilip role) + SX, cyclaniliprole + SX, cyclobutrifluram + SX, cycloprothrin + SX, cycloxaprid + SX, cyenopyrafen + SX, cyetpyrafen + SX, cyflumetofen + SX, cyfluthrin + SX, cyhalodiamide + SX, cyhalothrin + SX, cyhexatin + SX, cypermethrin + SX, cyphenothrin + SX, cyproflanilide + SX, cyromazine + SX, dazomet + SX, deltamethrin + SX, dimeton-S-methyl + SX, diazinon (diafenthiuron) + SX, diatomaceous earth + SX diazinon + SX, dichlorvos + SX, dichlorromezotiaz + SX, dicofol + SX, dichlorophos + SX , Diflovidazin + SX, diflubenzuron + SX, dimefluthrin + SX, dimethoate + SX, dimethylvinphos + SX, dimpropyridaz + SX SX, disodium octaborate + SX, disulfoton + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX, de Lamectin + SX, emamectin-benzoate + SX, empentrin + SX, endosulfan + SX, EPN (O-ethyl O- (4-nitrophenyl) phenylphosphonothioate + SX, Epsilon-metofluthrin + SX, epsilon-momfluorothrin + SX, esfenvalerate + SX, ethiofencarb + SX, ethion + SX, ethip ) + SX, ethoprophos + SX, etofenprox + SX, etoxazole + SX, famphur + SX, fenamiphos + SX, fenazaquin + SX, oxidation Fenbutatin oxide + SX, fenitrothion + SX, fenmezoditiaz + SX, fenobucarb + SX, fenoxycarb + SX, fenpropathrin + SX, fenpropathrin (fenpyroximate) + SX, fenthion + SX, fenvalerate + SX, fipronil + SX, flometoquin + SX, flonicamid + SX, fluacrypyrim + SX Fluazaindolizine + SX, fluazuron + SX, flubendiamide + SX, fluchlordinilipro le) + SX, flucycloxuron + SX, flucythrinate + SX, fluensulfone + SX, flufenoprox + SX, flufenoxuron + SX, Flufiprole + SX, flumethrin + SX, flupentiofenox + SX, flupyradifurone + SX, flupyrimin + SX, fluralaner + SX, fluvalanate fluvalinate + SX, fluxametamide + SX, formetanate + SX, fosthiazate + SX, fumaric acid + SX, furamethrin + SX, furathiocarb + SX, Gamma-cyhalothrin + SX, halfenprox + SX, halofenozide + SX, heptafluthrin + SX, heptenophos + SX, hexaflumuron + SX, hexythiazox + SX, potassium salt of hop beta acid + SX, hydramethylnon + SX, hydroprene + SX, imicyafos + SX, imidacloprid (imidacloprid) + SX, imidaclothiz + SX, imiprothrin + SX, indazapyroxamet + SX, indoxacarb + SX, Isocycloseram + SX, isofenphos + SX, isoprocarb + SX, isopropyl O- (methoxyaminothiophosphoryl) salicylate + SX, isoxathion + SX, ivermectin + SX, kadethrin + SX, kappa-tefluthrin + SX, kappa-bifenthrin + SX, kinoprene + SX, lactic acid + SX, lambda-cyhalothrin + SX, lavandulyl senecioate + SX, lenoremycin + SX, lepimectin + SX, lime sulfur + SX, rothiranel (lotilaner) + SX, lufenuron + SX, machine oil + SX, malathion + SX, malic acid + SX, mecarbam + SX, meperfluthrin + SX, metaflumizone + SX, metam + SX, metamidophos + SX, methidathion + SX, methiocarb + SX, methomyl + SX, metoprene + SX , Methoxychlor + SX, methoxyfenozide + SX, methyl bromide + SX, metofluthrin + SX, metolcarb + SX, metoxadia Metoxadiazone + SX, mevinphos + SX, milbemectin + SX, milbemycin oxime + SX, monfluorothrin + SX, monocrotophos + SX, moxidectin ) + SX, naled + SX, nicofluprole + SX, nicotine + SX, nicotine-sulfate + SX, nitenpyram + SX, novaluron + SX , Noviflumuron + SX, omethoate + SX, organic acid + SX, oxalic acid + SX, oxamyl + SX, oxazosulfyl + SX, Oxydemeton-methyl + SX, parathion + SX, parathion-methyl + SX, permethrin + SX, phenothrin + SX, phenthoate + SX, holate (phorate) + SX, phosalone + SX, phosmet + SX, phosphamidon + SX, phosphine + SX, phoxim + SX, pyrimicarb + SX, pyrimiphosmethyl pirimiphos-methyl + SX, prallethrin + SX, profenofos + SX, profluthrin + SX, propionic acid + SX, propargite + SX, propetam phos + SX, propoxur + SX, propylene glycol alginate + SX, prothiofos + SX, pyflubumide + SX, pymetrozine + SX, pyraclofos + SX, pyrethrins + SX, pyridaben + SX, pyridalyl + SX, pyridaphenthion + SX, pyrifluquinazone + SX, pyrimidifen (pyrimidifen) + SX, pyrimidifen ) + SX, pyriprole + SX, pyriproxyfen + SX, quinalphos + SX, resmethrin + SX, sarolaner + SX, selamectin + SX, sigmashi Permethrin (sigma-cypermethrin) + SX, silafluofen + SX, sodium borate + SX, sodium metaborate + SX, spidoxamat + SX, spinosad + SX, Spinosad + SX, spirodiclofen + SX, spiromesifen + SX, spiropidion + SX, spirotetramat + SX, sulfluramid + SX, sulfotep sulfotep) + SX, sulfoxaflor + SX, sulfur + SX, sulfuryl fluoride + SX, tartar emeti c) + SX, tartaric acid + SX, tau-fluvalinate + SX, tebufenozide + SX, tebufenpyrad + SX, tebupirimfos + SX, tebupirimfos SX, tefluthrin + SX, temephos + SX, terbufos + SX, tetrachlorantraniliprole + SX, tetrachlorvinphos + SX, tetradifon + SX, tetramethrin + SX, tetramethylfluthrin + SX, tetraniliprole + SX, theta-cypermethrin + SX, thiacloprid + SX, thiamethoxam + SX, thiocyclam + SX, thiodicarb + SX, thiofanox + SX, thiometon + SX, thiosultap-disodium + SX, thiosultap monosodium salt thiosultap-monosodium + SX, tioxazafen + SX, tolfenpyrad + SX, tralomethrin + SX, transfluthrin + SX, triazamate + SX, triazos , Trichlorfon + SX, trifluenfuronate + SX, triflumezopyrim + SX, triflume Ron (triflumuron) + SX, trimethacarb + SX, tyclopyrazoflor + SX, vamidothion + SX, XMC (3,5-dimethylphenyl N-methylcarbamate) + SX, xylylcarb + SX, zeta-cypermethrin + SX, zinc phosphide + SX, N- [3-chloro-1- (pyridin-3-yl) -1H-pyrazol-4-yl]-N -ethyl-3- (3,3,3-trifluoropropanesulfinyl) propanamide (1477923-37-7) + SX, 4- [5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydro- 1,2-oxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl) benzamide (1241050-20-3) + SX, 3-methoxy-N- (5- {5- (5- (5-) trifluoromethyl) -5- [3- (trifluoromethyl) phenyl] -4,5-dihydro-1,2-oxazol-3-yl} indan-1-yl) propanamide (1118626-57-5) + SX, 2- ( {2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl) sulfinyl] phenyl} imino) -3- (2,2,2-trifluoroethyl) -1,3-thiazolidin-4-one ( 1445683-71-5) + SX, (2Z) -2-({2-fluoro-4-methyl-5-[(R)-(2,2,2-trifluoroethyl) sulfinyl] phenyl} imino) -3- (2,2,2-trifluoroethyl) -1,3-thiazolidin-4-one (2377084-09-6) + SX, 2-chloro-N-cyclopropyl-5- {1-[2,6-dichloro-4 -(1,1,1,2,3,3,3-heptafluoropro pan-2-yl) phenyl] -1H-pyrazol-4-yl}-N-methylpyridine-3-carboxamide (1771741-86-6) + SX, N- {4-chloro-3-[(1-cyanocyclopropyl)) carbamoyl] phenyl} -1-methyl-4- (methanesulfonyl) -3- (1,1,2,2,2-pentafluoroethyl) -1H-pyrazole-3-carboxamide (1400768-21-9) + SX, N- [3-chloro-1- (pyridin-3-yl) -1H-pyrazol-4-yl] -2- (methanesulfonyl) propanamide (2396747-83-2) + SX, 1,4-dimethyl-2- [2] -(pyridin-3-yl) -2H-indazol-5-yl] -1,2,4-triazolidine-3,5-dione (2171099-09-3) + SX, 2-isopropyl-5-[(3) , 4,4-trifluoro-3-buten-1-yl) sulfonyl] -1,3,4-thiadiazole (2058052-95-0) + SX, N- ({2-fluoro-4- [(2S, 3S) ) -2-hydroxy-3- (3,4,5-trichlorophenyl) -3- (trifluoromethyl) pyrrolidin-1-yl] phenyl} methyl) cyclopropanecarboxamide + SX, 7-fluoro-N-[1- (methylsulfanyl)- 2-methylpropan-2-yl] -2- (pyridin-3-yl) -2H-indazole-4-carboxamide + SX, 7-fluoro-N- [1- (methanesulfinyl) -2-methylpropan-2-yl] -2- (pyridin-3-yl) -2H-indazole-4-carboxamide + SX, 7-fluoro-N- [1- (methanesulfonyl) -2-methylpropan-2-yl] -2- (pyridin-3-) yl) -2H-indazole-4-carboxamide + SX, N- [1- (difluorometh yl) cyclopropyl] -2- (pyridin-3-yl) -2H-indazole-4-carboxamide + SX, 2,9-dihydro-9- (methoxymethyl) -2- (pyridin-3-yl) -10H-pyrazolo [3,4-f] pyrido [2,3-b] [1,4] oxazepin-10-one (2607927-97-7) + SX.

Combination of this component of the above group (b) and this compound:
Acibenzolar-S-methyl + SX, aldimorph + SX, ametoctradin + SX, aminopyrifen + SX, amisulbrom + SX, anilazine + SX, Azaconazole + SX, azoxystrobin + SX, basic copper sulfate + SX, benaluxyl + SX, benaluxyl-M + SX, benodanil + SX, benomyl + SX, benthiavalicarb + SX, benthiavalicarb-isopropyl + SX, benzovindiflupyr + SX, binapacryl + SX, Biphenyl + SX, bitertanol + SX, bixafen + SX, blasticidin-S + SX, Bordeaux mixture + SX, boscalid + SX, bromotalonyl ( bromothalonil + SX, bromuconazole + SX, bupirimate + SX, captafol + SX, captan + SX, carbendazim + SX, carboxin + SX, carpropamid + SX, chinomethionat + SX, chloroinconazide + SX, chloroneb + SX, chlorothalonil + SX, chlozolinate + S X, colletochlorin B + SX, copper acetate (II) (copper (II) acetate) + SX, copper hydroxide (II) (copper (II) hydroxide) + SX, basic copper chloride (copper oxychloride) + SX, copper (II) sulphate (copper (II) sulfate) + SX, cumoxystrobin + SX, cyazofamid + SX, cyflufenamid + SX, cymoxanil + SX, cymoxanil Proconazole + SX, cyprodinil + SX, dichlobentiazox + SX, dichlofluanid + SX, dichlocymet + SX, dichromezine + SX, dichromezine dicloran + SX, diethofencarb + SX, difenoconazole + SX, diflumetorim + SX, dimethachlone + SX, dimethirimol + SX, dimethomorph + SX Robin (dimoxystrobin) + SX, diniconazole (diniconazole) + SX, diniconazole M (diniconazole-M) + SX, dinocap + SX, dipotassium hydrogenphosphite + SX, dipymetitrone + SX , Dithianon + SX, dodecylbenzenesulphonic acid bisethylenediamine copper (II) salt + SX, dodemorph + SX, dod ine) + SX, edifenphos + SX, enoxastrobin + SX, epoxiconazole + SX, etaconazole + SX, ethaboxam + SX, ethirimol + SX , Etridiazole + SX, famoxadone + SX, fenamidone + SX, fenaminstrobin + SX, fenarimol + SX, fenbuconazole + SX, fenbuconazole fenfuram + SX, fenhexamid + SX, fenoxanil + SX, fenpiclonil + SX, fenpicoxamid + SX, fenpropidin + SX, fenpropidin (fenpropimorph) + SX, fenpyrazamine + SX, fentin acetate + SX, fentin chloride + SX, fentin hydroxide + SX, ferbam ) + SX, ferimzone + SX, florylpicoxamid + SX, fluazinam + SX, flubeneteram + SX, fludioxonil + SX, flufenoxadiazam + SX, flufenoxystrobin + SX, fluindapyr + SX, flumetylsulforim + SX, flumorph + SX, fluopicolide + SX, fluopyram + SX, fluopimomide + SX, fluoxytioconazole + SX, fluoxapiprolin + SX, fluoxastrobin + SX, fluoxytioconazole ) + SX, fluquinconazole + SX, flusilazole + SX, flusulfamide + SX, flutianil + SX, flutolanil + SX, flutriafol + SX, Fluxapyroxad + SX, folpet + SX, fosetyl + SX, fosetyl-aluminium + SX, fuberidazole + SX, furalaxyl + SX furametpyr + SX, guazatine + SX, hexaconazole + SX, hymexazole + SX, imazalil + SX, iminoctadine + SX, iminoctadine + SX , Iminoctadine triacetate + SX, iminoctadine trialbesilate + SX, impyrfluxam + SX, iodocarb + SX, ipconazole + SX, ipfentri Fluconazole + SX, ipflufenoquin + SX, iprobenfos + SX, iprodione + SX, iprov alicarb + SX, isofetamid + SX, isoflucypram + SX, isoprothiolane + SX, isopyrazam + SX, isotianil + SX, kasugamycin + SX (kresoxim-methyl) + SX, laminarin + SX, mancozeb + SX, mandestrobin + SX, mandipropamid + SX, maneb + SX, mefentrifluconazole ( mefentrifluconazole) + SX, mepanipyrim + SX, mepronil + SX, meptyldinocap + SX, metalaxyl + SX, metalaxyl-M + SX, metalyl picoxa Mid (metaryl picoxamid) + SX, metconazole + SX, metasulfocarb + SX, metiram + SX, metomirostrobin + SX, metraffenone + SX, methyltetraprol metyltetraprole + SX, machine oils (mineral oils) + SX, microbutanil + SX, naftifine + SX, nuarimol + SX, octhilinone + SX, ofurace + SX, orisastrobin (orysastrobin) + SX, oxadixyl + SX, oxathiapiprolin + SX, oxine-copper + SX, oxolinic acid + SX, oxpoconazo Le (oxpoconazole) + SX, oxpoconazole fumarate + SX, oxycarboxin + SX, oxytetracycline + SX, pefurazoate + SX, penconazole + SX, penitycuron + SX, penflufen + SX, penthiopyrad + SX, phenamacril + SX, phosphorous acid + SX, phthalide + SX, picalbutrazo Picarbutrazox + SX, picoxystrobin + SX, piperalin + SX, polyoxins + SX, potassium hydrogencarbonate + SX, potassium dihydrogenphosphite ) + SX, probenazole + SX, prochloraz + SX, procymidone + SX, propamidine + SX, propamocarb + SX, propiconazole + SX, propiconazole propineb + SX, proquinazid + SX, prothiocarb + SX, prothioconazole + SX, pydiflumetofen + SX, pyraclostrobin + SX, pyramethrostrobin (pyrametostrobin) + SX, pyraoxystrobin + SX, pyrapropoyne + SX, pyraziflumid + SX, pyra Pyrazophos + SX, pyribencarb + SX, pyributicarb + SX, pyridachlometyl + SX, pyrifenox + SX, pyrimethanil + SX, pyrimethanil + SX, pyriofenone + SX, pyrisoxazole + SX, pyroquilon + SX, quinconazole + SX, quinofumelin + SX, quinophane + SX, quintozen + SX, seboctylamine + SX, sedaxane + SX, silthiofam + SX, simeconazole + SX, sodium hydrogencarbonate + SX, spiroxamine + SX, stryptomycin streptomycin) + SX, sulfur (sulfur) + SX, tebuconazole + SX, tebufloquin + SX, teclofthalam + SX, tecnazene + SX, terbinafine + SX, terbinafine (tetraconazole) + SX, thiabendazole + SX, thifluzamide + SX, thiophanate + SX, thiophanate-methyl + SX, thiram + SX, tiadinil + SX Tolclofos-methyl + SX, tolfenpyrad + SX, tolprocarb + S X, tolylfluanid + SX, triadimefon + SX, triadimenol + SX, triazoxide + SX, trilopyricarb + SX, tricyclazole + SX Tridemorph + SX, trifloxystrobin + SX, triflumizole + SX, triforine + SX, triticonazole + SX, validamycin + SX, variamycin Valifenalate + SX, vinclozolin + SX, zinc thiazole + SX, zineb + SX, ziram + SX, zoxamide + SX, 3- (difluoromethyl) -N-methoxy -1-methyl-N-[(1R) -1-methyl-2- (2,4,6-trichlorophenyl) ethyl] -1H-pyrazole-4-carboxamide (1639015-48-7) + SX, 3-( difluoromethyl) -N-methoxy-1-methyl-N-[(1S) -1-methyl-2- (2,4,6-trichlorophenyl) ethyl] -1H-pyrazole-4-carboxamide (1639015-49-8) + SX, 3- (difluoromethyl) -1-methyl-N- (1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl) -1H-pyrazole-4-carboxamide (141573-94) -6) + SX, 3- (difluoromethyl) -N-[(3R) -7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl] -1-methyl- 1H-pyrazole-4-carboxamide (1513466-73-3) + SX, N' -[4-({3-[(4-chlorophenyl) methyl] -1,2,4-thiadiazol-5-yl} oxy) -2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide (1202781-91) -6) + SX, N'-{4-[(4,5-dichlorothiazol-2-yl) oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylmethanimidamide (929908-57-6) + SX , N'-(2,5-dimethyl-4-phenoxyphenyl) -N-ethyl-N-methylmethanimidamide (1052688-31-9) + SX,
N'-[5-chloro-4- (2-fluorophenoxy) -2-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055589-28-9) + SX, N'-[2-chloro-4- (2) -fluorophenoxy) -5-methylphenyl] -N-ethyl-N-methylmethanimidamide (2055756-21-1) + SX, N'-(2-chloro-4-phenoxy-5-methylphenyl)-N-ethyl-N-methylmethanimidamide (2062599-39-5) + SX, N'-[4- (1-hydroxy-1-phenyl-2,2,2-trifluoroethyl) -2-methyl-5-methoxyphenyl] -N-isopropyl-N-methylmethanimidamide (2101814-55-3) + SX, N'-[5-bromo-6-(1-methyl-2-propoxyethoxy) -2-methylpyridin-3-yl]-N-ethyl-N-methylmethanimidamide (1817828-69) -5) + SX, 4- (2-bromo-4-fluorophenyl) -N- (2-chloro-6-fluorophenyl) -1,3-dimethyl-1H-pyrazol-5-amine (1362477-26-6) + SX, 2- [6- (3-fluoro-4-methoxyphenyl) -5-methylpyridin-2-yl] quinazoline (1257056-97-5) + SX, ethyl (2Z) -3-amino-2-cyano- 3-phenylacrylate (39491-78-6) + SX, N-[(2-chlorothiazol-5-yl) methyl]-N-ethyl-6-methoxy-3-nitropyridin-2-amine (1446247-98-8) + SX, α- [3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4-yl] -3-pyridinemethanol (1229605-96-2) + SX, (αS)-[3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4-yl] -3-pyridinemethanol (1229606-46-5) ) + SX, (αR)-[3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4-yl] -3-pyridinemethanol (1229606-02- 3) + SX, 5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1394057-11-) 4) + SX, (1R, 2S, 5S) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan- 1-ol (1801930-06-2) + SX, (1S, 2R, 5R) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-) triazol-1-ylmethyl) cyclopentan-1-ol (1801930-07-3) + SX, (1R, 2R, 5R) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- ( 1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-53-8) + SX, (1S, 2S, 5S) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-54-9) + SX, (1R, 2R, 5S) -5- (4- chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-55-0) + SX, (1S, 2S, 5R) -5- (4-chloro benzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-56-1) + SX, (1R, 2S, 5R) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-57-2) + SX, (1S, 2R, 5S) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1- ol (1801919-58-3) + SX, methyl 3-[(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane- 1-carboxylate (1791398-02-1) + SX, methyl (1R, 2S, 3S) -3- [(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2, 4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2080743-90-2) + SX, methyl (1S, 2R, 3R) -3-[(4-chlorophenyl) methyl] -2-hydroxy-1-methyl -2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2080743-91-3) + SX, methyl (1R, 2R, 3R) -3-[(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2080743-92-4) + SX, methyl (1S, 2S, 3S) ) -3- [(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-) ylmethyl) cyclopentane-1-carboxylate (2080743-93-5) + SX, methyl (1R, 2R, 3S) -3- [(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-) 1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2080743-94-6) + SX, methyl (1S, 2S, 3R) -3-[(4-chlorophenyl) methyl] -2-hydroxy -1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2080743-95-7) + SX, methyl (1R, 2S, 3R) -3-[( 4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2081061-22-3) + SX, methyl (1S) , 2R, 3S) -3- [(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2081061-) 23-4) + SX,2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1394057-) 13-6) + SX, (1R, 2S, 5S) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801930-08-4) + SX, (1S, 2R, 5R) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2, 4-triazol-1-ylmethyl) cyclopentan-1-ol (1801930-09-5) + SX, (1R, 2R, 3) R) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1638898-08-4) + SX, (1S, 2S, 3S) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1- ol (1638898-10-8) + SX, (1R, 2R, 3S) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-) 1-ylmethyl) cyclopentan-1-ol (1638898-13-1) + SX, (1S, 2S, 5R) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-) 1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1638898-16-4) + SX, (1R, 2S, 5R) -2- (chloromethyl) -5- (4-fluorobenzyl) -2 -methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1638898-20-0) + SX, (1S, 2R, 5S) -2- (chloromethyl) -5 -(4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1638898-24-4) + SX, 1- (2,4-) difluorophenyl) -2- (1H-1,2,4-triazol-1-yl) -1- [1- (4-bromo-2,6-difluorophenoxy) cyclopropyl] ethanol (2019215-86-0) + SX, 1- (2,4-difluorophenyl) -2- (1H-1,2,4-triazol-1-yl) -1- [1- (4-chloro-2,6-difluorophenoxy) cyclopropyl] ethanol (2019215- 84-8) + SX, 1- [2- (1-c) hlorocyclopropyl) -3- (2-fluorophenyl) -2-hydroxypropyl] -1H-imidazole-5-carbonitrile (2018316-13-5) + SX, 1- [2- (1-chlorocyclopropyl) -3- (2,3) -difluorophenyl) -2-hydroxypropyl] -1H-imidazole-5-carbonitrile (2018317-25-2) + SX, 2- [6- (4-bromophenoxy) -2- (trifluoromethyl) pyridin-3-yl] -1 -(1H-1,2,4-triazol-1-yl) propan-2-ol (2082661-43-4) + SX, 2- [6- (4-chlorophenoxy) -2- (trifluoromethyl) pyridin-3 -yl] -1- (1H-1,2,4-triazol-1-yl) propan-2-ol (2082660-27-1) + SX, methyl ({2-methyl-5- [1- (4) -methoxy-2-methylphenyl) -1H-pyrazol-3-yl] phenyl} methyl) carbamate (1605879-98-8) + SX, 2- (difluoromethyl) -N- [1,1,3-trimethyl-2, 3-dihydro-1H-inden-4-yl] pyridine-3-carboxamide (1616239-21-4) + SX, 2- (difluoromethyl) -N- [(3R) -1,1,3-trimethyl-2, 3-dihydro-1H-inden-4-yl] Pyridine-3-carboxamide (1616239-33-8) + SX, 2- (difluoromethyl) -N- [3-ethyl-1,1-dimethyl-2,3- dihydro-1H-inden-4-yl] pyridine-3-carboxamide (1847460-02-9) + SX, 2- (difluoromethyl) -N-[(3R) -3-ethyl-1,1-dimethyl-2, 3-dihydro-1H-inden-4-yl] pyridine-3-carboxamide (1952305-97- 3) + SX, 2- (difluoromethyl) -N- [3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl] pyridine-3-carboxamide (1847460-05-2) + SX, 2- (difluoromethyl) -N-[(3R) -3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl] pyridine-3-carboxamide (1952306-00- 1) + SX, (2E, 3Z) -5-{[1- (4-chlorophenyl) -1H-pyrazol-3-yl] oxy} -2- (methoxyimino) -N, 3-dimethylpent-3-enamide ( 1445331-27-0) + SX, (2E, 3Z) -5-{[1- (2,4-dichlorophenyl) -1H-pyrazol-3-yl] oxy} -2- (methoxyimino) -N,3- dimethylpent-3-enamide (1445331-54-3) + SX, 5-chloro-4-({2- [6- (4-chlorophenoxy) pyridin-3-yl] ethyl} amino)-6-methylpyrimidine (1605340-) 92-8) + SX, N- (1-benzyl-1,3-dimethylbutyl) -8-fluoroquinoline-3-carboxamide (2132414-04-9) + SX, N-[(1S) -1-benzyl-1 , 3-dimethylbutyl] -8-fluoroquinoline-3-carboxamide + SX, N-[(1R) -1-benzyl-1,3-dimethylbutyl] -8-fluoroquinoline-3-carboxamide (2132414-06-1) + SX , N- (1-benzyl-3,3,3-trifluoro-1-methylpropyl) -8-fluoroquinoline-3-carboxamide (2132414-00-5) + SX, N-[(1S) -1-benzyl-3 , 3,3-trifluoro-1-methylpropyl] -8-fluoroquinoline-3-carbox amide (2132414-01-6) + SX, N-[(1R) -1-benzyl-3,3,3-trifluoro-1-methylpropyl] -8-fluoroquinoline-3-carboxamide + SX, 4,4-dimethyl -2- ({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) isoxazolidin-3-one (2098918-25-1) + SX, 5,5-dimethyl -2- ({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) isoxazolidin-3-one (2098918-26-2) + SX, N-ethyl-2 -methyl-N-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) propanamide + SX, N, 2-dimethoxy-N-({4- [5 -(Trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) propanamide + SX, N-methoxy-N-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol- 3-yl] phenyl} methyl) cyclopropanecarboxamide + SX, N-methoxy-N'-methyl-N-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) urea + SX, N'-ethyl-N-methoxy-N-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) urea + SX, N, N' -dimethoxy-N-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) urea + SX, N-acetyl-2- (ethanesulfonyl) -N- [2 -(methoxycarbonyl) -4- (trifluoromethoxy) phenyl] -4- (trifl) uoromethyl) benzamide (2043675-28-9) + SX, 3- (4-bromo-7-fluoroindol-1-yl) butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl) carbonyl ] -L-alaninate + SX, 3- (7-bromoindol-1-yl) butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl) carbonyl]-L-alaninate + SX, 3 -(7-bromo-4-fluoroindol-1-yl) butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl) carbonyl]-L-alaninate + SX, 3- (3,5) -dichloropyridin-2-yl) butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl) carbonyl]-L-alaninate + SX, 3- (3,5-dichloropyridin-2-yl) butan-2-yl N-{[3- (acetoxymethoxy) -4-methoxypyridin-2-yl] carbonyl} -L-alaninate + SX, (1S) -1- [1- (naphthalen-1-yl) cyclopropyl] ethyl N-[(3-hydroxy-4-methoxypyridin-2-yl) carbonyl]-L-alaninate + SX, (1S) -1- [1- (naphthalen-1-yl) cyclopropyl] ethyl N-[(3) -acetoxy-4-methoxypyridin-2-yl) carbonyl]-L-alaninate + SX, (1S) -1- [1- (naphthalen-1-yl) cyclopropyl] ethyl N-{[3- (acetoxymethoxy) -4 -methoxypyridin-2-yl] carbonyl} -L-alaninate + SX, N-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) cyclopropanecarboxamide + SX, N -allyl-N -({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) acetamide + SX, N-allyl-N-({4- [5- (trifluoromethyl) -1 , 2,4-oxadiazol-3-yl] phenyl} methyl) propanamide + SX, N-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) propanamide + SX, 3,3,3-trifluoro-N-({2-fluoro-4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) propanamide + SX, 3,3 , 3-trifluoro-N-({3-fluoro-4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) propanamide + SX, 3,3,3-trifluoro- N-({2,3-difluoro-4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) propanamide + SX, N- ({2,3-difluoro-4) -[5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) butanamide + SX, N-methoxy-N-methyl-N'-({4- [5- (trifluoromethyl)- 1,2,4-oxadiazol-3-yl] phenyl} methyl) urea + SX, N, N-diethyl-N'-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3- yl] phenyl} methyl) urea + SX, N-methyl-N'-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) urea + SX, 1- ({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) pyrrolidin-2-one + SX, 1-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) piperidin-2-one + SX, 4-({4- [5- ({4- [5- ( trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) morpholin-3-one + SX, 2-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3- yl] phenyl} methyl) is
oxazolidin-3-one + SX, 3,3-dimethyl-1-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) piperidin-2-one + SX , 2-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) -1,2-oxazinan-3-one + SX, 1-({3-fluoromethyl) -4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) azepan-2-one + SX, 4,4-dimethyl-1-({4- [5- (5-( trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) pyrrolidin-2-one + SX, 5-methyl-1-({4- [5- (trifluoromethyl) -1,2,4- oxadiazol-3-yl] phenyl} methyl) pyrrolidin-2-one + SX, ethyl 1-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) -1H -pyrazole-4-carboxylate + SX, N-methyl-1-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) -1H-pyrazole-4-carboxamide + SX, N-propyl-1-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) -1H-pyrazole-4-carboxamide + SX, N-methoxy -1- ({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) -1H-pyrazole-4-carboxamide + SX, N-methoxy-N-methyl-1 -({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) -1H-pyrazole-4- carboxamide + SX, N, N-dimethyl-1-({4- [5- (trifluoromethyl) -1,2,4-oxadiazol-3-yl] phenyl} methyl) -1H-1,2,4-triazol- 3-amine + SX, ethyl 1-[(4-{[2- (trifluoromethyl) -1,3-dioxolan-2-yl] methoxy} phenyl) methyl] -1H-pyrazole-4-carboxylate + SX, ethyl 1 -[(4-{[(1Z) -2-ethoxy-3,3,3-trifluoro-1-propen-1-yl] oxy} phenyl) methyl] -1H-pyrazole-4-carboxylate + SX, 6- chloro-3- (3-cyclopropyl-2-fluorophenoxy) -N- [2- (2,4-dimethylphenyl) -2,2-difluoroethyl] -5-methylpyridazine-4-carboxamide + SX, 6-chloro-3- (3-cyclopropyl-2-fluorophenoxy) -N- [2- (3,4-dimethylphenyl) -2,2-difluoroethyl] -5-methylpyridazine-4-carboxamide + SX, 6-chloro-N-[2-( 2-chloro-4-methylphenyl) -2,2-difluoroethyl] -3- (3-cyclopropyl-2-fluorophenoxy) -5-methylpyridazine-4-carboxamide + SX, 2- [cyano (2,6-difluoropyridin-4) -yl) amino] -N- (2,2-dimethylcyclobutyl) -5-methylthiazole-4-carboxamide + SX, 2- [cyano (2,6-difluoropyridin-4-yl) amino] -N- (spiro [3.4) ] octan-1-yl) -5-methylthiazole-4-carboxamide + SX, 2- [cyano (2,6-difluoropyridin-4-yl) amino]-N-hexyl-5-methylthiazole -4-carboxamide + SX, 2- [acetyl (2,6-difluoropyridin-4-yl) amino] -N- (2,2-dimethylcyclobutyl) -5-methylthiazole-4-carboxamide + SX, 2-[(2) -methoxyacetyl) (2,6-difluoropyridin-4-yl) amino] -N- (2,2-dimethylcyclobutyl) -5-methylthiazole-4-carboxamide + SX, 2-[(2-methylpropanoyl) (2,6-) difluoropyridin-4-yl) amino] -N- (2,2-dimethylcyclobutyl) -5-methylthiazole-4-carboxamide + SX, 5- [5- (difluoromethyl) -1,3,4-oxadiazol-2-yl] -N- [1- (2-fluorophenyl) ethyl] pyrimidin-2-amine + SX, 5- [5- (difluoromethyl) -1,3,4-oxadiazol-2-yl]-N- [1- (2) , 6-difluorophenyl) ethyl] pyrimidin-2-amine + SX, 5- [5- (difluoromethyl) -1,3,4-oxadiazol-2-yl] -N- [1- (3,5-difluorophenyl) ethyl ] pyrimidin-2-amine + SX, 5- [5- (difluoromethyl) -1,3,4-oxadiazol-2-yl] -N- [1- (6-chloropyridin-3-yl) ethyl] pyrimidin-2 -amine + SX, 5- [5- (difluoromethyl) -1,3,4-oxadiazol-2-yl]-N-[1- (2-fluorophenyl) cyclopropyl] pyrimidin-2-amine + SX, 5- [ 5- (difluoromethyl) -1,3,4-oxadiazol-2-yl]-N- [1- (2,6-difluorophenyl) cyclopropyl] pyrimidin-2-amine + SX, 5- [5- (difluoromethyl)- 1,3,4-oxadiazol -2-yl] -N- [1- (2-fluoro-3-methoxyphenyl) cyclopropyl] pyrimidin-2-amine + SX, 5- [5- (difluoromethyl) -1,3,4-oxadiazol-2-yl ] -2-{[1- (2,6-difluorophenyl) cyclopropyl] oxy} pyrimidine + SX, 3- [3- (3-cyclopropyl-2-fluorophenoxy) -6-methylpyridazin-4-yl] -5- [ (2,4-dimethylphenyl) methyl] -5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S) -3- [3- (3-cyclopropyl-2-fluorophenoxy) -6-methylpyridazin -4-yl] -5- [(2,4-dimethylphenyl) methyl] -5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3- [3- (3-chloro-2-fluorophenoxy) )-6-methylpyridazin-4-yl] -5-[(4-bromo-2-methylphenyl) methyl] -5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3- [3-( 3-chloro-2-fluorophenoxy) -6-methylpyridazin-4-yl] -5-[(2-chloro-4-methylphenyl) methyl] -5,6-dihydro-4H-1,2,4-oxadiazine + SX , (5S) -3- [3- (3-chloro-2-fluorophenoxy) -6-methylpyridazin-4-yl] -5- [(2-chloro-4-methylphenyl) methyl] -5,6-dihydro- 4H-1,2,4-oxadiazine + SX, (5R) -3- [3- (3-chloro-2-fluorophenoxy) -6-methylpyridazin-4-yl] -5- [(2-chloro-4-) methylphenyl) methyl] -5,6-dihydro-4H-1,2,4-oxadiazine + SX.

Combination of this component of the above group (c) and this compound:
1-methylcyclopropene + SX, 1,3-diphenylurea + SX, 1,3,5-triazinane-2,4,6-trithione + SX, 2,3,5-triiodobenzoic acid + SX, IAA ((1H-indol-) 3-yl) acetic acid) + SX, IBA (4- (1H-indol-3-yl) butyric acid) + SX, MCPA (2- (4-chloro-2-methylphenoxy) acetic acid) + SX, MCPB ( 4- (4-chloro-2-methylphenoxy) butyric acid) + SX, 4-CPA (4-chlorophenoxyacetic acid) + SX, 5-aminolevulinic acid hydrochloride + SX, 6-benzylaminopurine + SX, abscisic acid + SX, AVG ( aminoethoxyvinylglycine + SX, anisiflupurin + SX, ancymidol + SX, butralin + SX, calcium carbonate + SX, calcium chloride + SX, calcium formate (calcium formate) + SX, calcium peroxide + SX, calcium polysulfide + SX, calcium sulfate + SX, chlormequat-chloride + SX, chloroprofem (chlorpropham) + SX, choline chloride + SX, cloprop + SX, cyanamide + SX, cyclanilide + SX, cyprosulfamide + SX, daminozide ) + SX, decan-1-ol + SX, Dichlorprop + SX, dikegulac + SX, dimethipin + SX, diquat + SX, ethephon + SX, ethychlozate + SX, flumetralin + SX Flurprimidol + SX, forchlorfenuron + SX, formononetin + SX, Gibberellin A + SX, Gibberellin A3 + SX, inabenfide Kinetin + SX, lipochitooligosaccharide MOR116 + SX, lipochitooligosaccharide SP104 + SX, maleic hydrazide + SX, mefluidide + SX, mepiquat-chloride + SX, methyl α-D -Mennopyranoside (methyl-alpha-D-mannopyranoside) + SX, oxidized glutathione + SX, paclobutrazol + SX, pendimethalin + SX, prohexadione- calcium + SX, prohydrojasmon + SX, pyraflufen-ethyl + SX, pyroglutamic acid + SX, sintofen + SX, 1-sodium cyanate acetate (sodium 1) -naphthaleneacetate) + SX, sodium cyanate + SX, thidiazuron + SX, titanium apatite + SX, Triapenthenol + SX, tribufos + SX, trinexapac-ethyl + SX, uniconazole-P + SX, 2- (naphthalen-1-yl) acetamide (2) -(naphthalen-1-yl) acetamide) + SX, [4-oxo-4- (2-phenylethyl) amino] butyric acid + SX, 5- (trifluoromethyl) benzo [b] thiophene-2-carboxylate methyl + SX, 3-[(6-Chloro-4-phenylquinazoline-2-yl) amino] Propane-1-ol + SX, Strigolactone + SX, International Publication No. 2018/145979 (1E)- 1-[[1- [3,5-bis (trifluoromethyl) phenyl] -4-methyl-5-oxo-2H-pyrrol-2-yl] oxygenethylene] -3,3a, 4,8b-tetrahydroindeno [2,1 -b] pyrrol-2-one + SX, (2R) -1- [3,5-bis (trifluoromethyl) phenyl] -4-methyl-2- [(E)-" described in International Publication No. 2018/145979 (2-oxo-4,8b-dihydro-3aH-indeno [2,1-b] furan-1-ylidene) methoxy] -2H-pyrrol-5-one + SX, described in International Publication No. 2018/145979 (2S) -1- [3,5-bis (trifluoromethyl) phenyl] -4-methyl-2- [(E)-(2-oxo-4,8b-dihydro-3aH-indeno [2,1-b]] furan-1-ylidene) methoxy] -2H-pyrrol-5-one + SX.

Combination of this component of the above group (d) and this compound:
Allidochlor + SX, benoxacor + SX, cloquintocet + SX, cloquintocet-mexyl + SX, cyometrinil + SX, cyprosulfamide + SX, dichlormid + SX, dicyclonone + SX, dimepiperate + SX, disulfoton + SX, dymron + SX, fenchlorazole + SX, fenchlorazole Ethyl (fenchlorazole-ethyl) + SX, fenclorim + SX, flurazole + SX, furilazole + SX, fluxofenim + SX, Hexim + SX, isoxadifen + SX , Isoxadifen-ethyl + SX, Jiecaowan + SX, Jiecaoxi + SX, mecoprop + SX, mefenpyr + SX, mefenpyr-ethyl + SX, mefen Mefenpyr-diethyl + SX, mephenate + SX, metcamifen + SX, oxabetrinil + SX, 1,8-naphthalic anhydride + SX, Octane-1,8-diamine + SX, AD-67 (4- (dichloroacetyl) -1-oxa-4-azaspiro [4.5] decane) + SX, CL-304415 (4-) carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid) + SX, CSB ( 1-bromo-4- [(chloromethyl) sulfonyl] benzene) + SX, DKA-24 (2,2-dichloro-N- [2-oxo-2- (2-propenylamino) ethyl] -N- (2-propenyl) ) acetamide) + SX, MG191 (2- (dichloromethyl) -2-methyl-1,3-dioxolane) + SX, MG-838 (2-propenyl 1-oxa-4-azaspiro [4.5] decane-4-carbodithioate) + SX, PPG-1292 (2,2-dichloro-N-(1,3-dioxan-2-ylmethyl)-N-(2-propenyl) acetamide) + SX, R-28725 (3- (dichloroacetyl) -2 , 2-dimethyl-1,3-oxazolidine) + SX, R-29148 (3- (dichloroacetyl) -2,2,5-trimethyl-1,3-oxazolidine) + SX, TI-35 (1- (dichloroacetyl) azepane) + SX.

Combination of this component of the above group (e) and this compound:
1-dodecyl-1H-imidazole + SX, N- (2-ethylhexyl) -8,9,10-trinorborn-5-ene-2,3-dicarboxyimide (N) -(2-ethylhexyl) -8,9,10-trinorborn-5-ene-2,3-dicarboximide) + SX, bucarpolate + SX, N, N-dibutyl-4-chlorobenzenesulfonamide (N, N) -dibutyl-4-chlorobenzenesulfonamide + SX, dietholate + SX, diethylmaleate + SX, Jiajizengxiaolin + SX, octachlorodipropyl ether + SX, perbutin + SX, piperonyl butoxide (piperonyl butoxide) + SX, piperonyl cyclonene + SX, piperonyl + SX, propyl isome + SX, safroxan + SX, sesamex + SX, sesamolin ( sesamolin) + SX, Sulfoxide + SX, Verbutin + SX, DMC (1,1-bis (4-chlorophenyl) ethanol) + SX, FDMC (1,1-bis (4-chlorophenyl) -2 , 2,2-trifluoroethanol) + SX, ETN (1,2-epoxy-1,2,3,4-tetrahydronaphthalene) + SX, ETP (1,1,1-trichloro-2,3-expoxypropane) + SX, PSCP (phenylsaligenin cyclic phosphate) + SX, TBPT (S, S, S-tributyl phosphorotrithioate) + SX, TPP (triphenyl phosphate) + SX.

Combination of this component of the above group (f) and this compound:
Anthraquinone + SX, chloralose + SX, acrep + SX, butopyronoxyl + SX, camphor + SX, d-camphor + SX, carboxide ) + SX, dibutyl phthalate + SX, deet + SX, dimethyl carbate + SX, dimethyl phthalate + SX, dibutyl succinate + SX , Dibutyl adipate + SX, ethohexadiol + SX, hexamide + SX, icaridin + SX, methoquin-butyl + SX, methylneodecanamide (methylneodecanamide) + SX, 2- (octylthio) ethanol + SX, butoxypolypropylene glycol + SX, oxamate + SX, quwenzhi + SX, quyingding + SX, zengxiaon + SX, rebemide + SX, copper naphthenate + SX, zinc naphthenate + SX.

Combination of this component of the above group (g) and this compound:
Bis (tributyltin) oxide + SX, allicin + SX, bromoacetamide + SX, calcium arsenate + SX, cloethocarb + SX, copper sulphate (copper sulfate) + SX, fentin + SX, iron phosphate (III) (ferric phosphate) + SX, metaaldehyde + SX, nicrosamide + SX, Paris green + SX , Pentachlorophenol + SX, sodium pentachlorophenoxide + SX, tazimcarb + SX, tralopyril + SX, tributyltin oxide + SX trifenmorph + SX.

Combination of this component of the above group (h) and this compound:
(E) -2-hexenal + SX, (E) -2-octadecenal + SX, (E) -4-tridecen-1-yl acetate + SX, (E) -5-decen-1-yl acetate + SX, (E) -5-decen-1-ol + SX, (E) -3,3-dimethylcyclohexylideneacetaldehyde + SX, (E) -7-dodecen-1-yl acetate + SX, (E) -8-dodecen-1 -yl acetate + SX, (E) -9-dodecen-1-yl acetate + SX, (E) -10-hexadecenal + SX, (E) -11-hexadecen-1-yl acetate + SX, (E)- 11-tetradecen-1-yl acetate + SX, (E) -11-tetradecen-1-ol + SX, (E) -4-tridecen-1-yl acetate + SX, (E) -6-methylhept-2- en-4-ol + SX, (Z) -2- (3,3-dimethylcyclohexylidene) ethanol + SX, (Z) -4-decen-1-yl acetate + SX, (Z) -4-tridecen-1- yl acetate + SX, (Z) -5-decen-1-yl acetate + SX, (Z) -5-decen-1-ol + SX, (Z) -7-tetradecenal + SX, (Z) -7- dodecen-1-yl acetate + SX, (Z) -8-dodecen-1-yl acetate + SX, (Z) -9-dodecen-1-yl acetate + SX, (Z) -8-dodecen-1-ol + SX, (Z) -9-hexadecenal + SX, (Z) -10-hexadecen-1-yl acetate + SX, (Z) -11-hexadecen-1-ol + SX, (Z) -11-hexadecenal + SX, (Z) -11-hexadecen-1-yl acetate + SX, (Z) -11-octadecenal + SX, (Z) -13-octadecenal + SX, (Z) -hexad ec-13-en-11-yn-1-yl acetate + SX, (Z) -13-octadecenal + SX, (Z) -icos-13-en-10-one + SX, (Z) -7-tetradecenal + SX, (Z) -tetradec-9-en-1-ol + SX, (Z) -9-tetradecen-1-yl acetate + SX, (Z) -11-tetradecen-1-yl acetate + SX, ( Z) -13-icosen-10-one + SX, (Z, E) -7,11-hexadecadien-1-yl acetate + SX, (Z, E) -9,12-tetradecadien-1-yl acetate + SX , (E, Z) -4,10-tetradecadien-1-yl acetate + SX, (E, E) -8,10-dodecadien-1-ol + SX, (E, E) -10,12-hexadecadienal + SX, (E, E) -9,11-tetradecadien-1-yl acetate + SX, (E, Z) -2,13-octadecadien-1-ol + SX, (E, Z) -3,13-octadecadien -1-ol + SX, (E, Z) -2,13-octadecadien-1-yl acetate + SX, (E, Z) -3,13-octadecadien-1-yl acetate + SX, (E, Z) -7,9-dodecadien-1-yl acetate + SX, (E, E) -7,9-dodecadien-1-yl acetate + SX, (Z, E) -9,12-tetradecadien-1-yl acetate + SX, (Z, E) -9,11-tetradecadien-1-yl acetate + SX, (Z, E) -7,11-hexadecadien-1-yl acetate + SX, (Z, Z) -3,13- octadecadien-1-ol + SX, (Z, Z) -4,7-decadien-1-yl acetate + SX, (Z, Z) -3,13-octadecadien-1-yl acetate + SX, (Z, Z) )-7,11-hexadecadien-1-yl acetat e + SX, (Z, Z, E) -7,11,13-hexadecatrienal + SX, (5R) -5-[(1Z) -1-decen-1-yl] dihydro-2 (3H) -furanone + SX, (2R, 5R)-ethyl-1,6-dioxaspiro [4,4] nonane + SX, (2R, 5S)-ethyl-1,6-dioxaspiro [4,4] nonane + SX, (4R, 8R) )-4,8-dimethyldecanal + SX, (4R, 8S) -4,8-dimethyldecanal + SX, 2,4-dimethyl-5-ethyl-6,8-dioxabicyclo [3,2,1] octane + SX, (-)-4-methyl-3-heptanol + SX, 1,7-dioxaspiro [5,5] undecane + SX, 3-carene + SX, 3-methylcyclohex-2-en-1-one + SX, 14- methyloctadec-1-ene + SX, 4-methylnonan-5-ol + SX, 4-methylnonan-5-one + SX, 4- (3-oxobutyl) phenyl acetate + SX, dodecyl acetate + SX, dodeca-8,10 -dien-1-yl acetate + SX, ethyl (2E, 4Z)-decadienoate + SX, ethyl 4-methyloctanoate + SX, methyl 2,6,10-trimethyldodecanoate + SX, tetradecan-1-ol + SX, tetradec-11 -en-1-ol + SX, tetradec-11-en-1-yl acetate + SX, tridec-4-en-1-yl acetate + SX, (3S, 6R) -3-methyl-6-isopropenyl-9 -decen-1-yl acetate + SX, (3S, 6S) -3-methyl-6-isopropenyl-9-decen-1-yl acetate + SX, alpha-multistriatin + SX, alpha-pinene + SX, endo-brevicomin + + SX, exo-brevicomin + SX, camphene + SX, codlelure + SX, codlemone + SX, cuelure + SX, disparlure + SX, dominicalure + SX, eugenol + SX, farnesol + SX, ferrolure + SX, frontalin + SX, gossyplure + SX, grandlure + SX, grandlure I + SX, grandlure II + SX, grandlure III + SX, grandlure IV + SX, hexalure + SX, ipsdienol + SX, ipsenol + SX, japonilure + SX, lineatin + SX, litlue + SX, looplure + SX, medlure + SX, megatomoic acid + SX, methyl eugenol + SX, muscalure + SX, nerolidol + SX, orfralure + SX, oryctalure + SX, ostramone + SX, rhyncolure + SX, siglure + SX, sordidin + SX, sulcatol + SX, trimedlure + SX, trimedlure A + SX, trimedlure B1 + SX, trimedlure B2 + SX, trimedlure C + SX, trunc-call + SX, (E) -verbenol + SX, (Z) -verbenol + SX, trans-verbenol + SX, (S)-verbenone + SX.

Combination of this component of the above group (i) and this compound:
2,3,6-TBA (2,3,6-trichlorobenzoic acid) + SX, 2,3,6-TBA Dimethylammonium (2,3,6-TBA-dimethylammonium) + SX, 2,3,6-TBA Lithium salt (2,3,6-TBA-lithium) + SX, 2,3,6-TBA potassium salt (2,3,6-TBA-potassium) + SX, 2,3,6-TBA sodium salt (2) , 3,6-TBA-sodium) + SX, 2,4-D + SX, 2,4-D choline salt + SX, 2,4-D biproamine (2,4-D) D-biproamine) + SX, 2,4-D doboxyl (2,4-D-doboxyl) + SX, 2,4-D 2-ethylhexyl (2,4-D-2-ethylhexyl) + SX, 2,4 -D 3-D-3-butoxypropyl (2,4-D-3-butoxypropyl) + SX, 2,4-D Ammonium (2,4-D-ammonium) + SX, 2,4-D Buttotyl (2,4-D) -butotyl) + SX, 2,4-D butyl (2,4-D-butyl) + SX, 2,4-D diethylammonium (2,4-D-diethylammonium) + SX, 2,4-D dimethylammonium (2,4-D-dimethylammonium) + SX, 2,4-D diolamine salt (2,4-D-diolamine) + SX, 2,4-D dodecylammonium (2,4-D-dodecylammonium) + SX , 2,4-D ethyl (2,4-D-ethyl) + SX, 2,4-D heptylammonium (2,4-D-heptylammonium) + SX, 2,4-D isobutyl (2,4-D) -isobutyl) + SX, 2,4-D isooctyl (2,4-D-isooctyl) + SX, 2,4-D isopropyl (2,4-D-isopropyl) + SX, 2,4-D isopropylammonium ( 2,4-D-isopropylammonium) + SX, 2,4-D lithium salt (2,4-D-lithium) + SX, 2,4-D Mepty (2,4-D-mepty) + SX, 2, 4-D methyl (2,4-D-methyl) + SX, 2,4-D octyl (2,4-D-octyl) + SX, 2,4-D pentyl (2,4-D-pentyl) + SX, 2,4-Dpropyl (2,4-D) -propyl) + SX, 2,4-D sodium salt (2,4-D-sodium) + SX, 2,4-D tefuryl (2,4-D-tefuryl) + SX, 2,4-D tetradecyl Ammonium (2,4-D-tetradecylammonium) + SX, 2,4-D Triethylammonium (2,4-D-triethylammonium) + SX, 2,4-D Tris (2-hydroxypropyl) ammonium (2,4-) D-tris (2-hydroxypropyl) ammonium) + SX, 2,4-D trolamine salt (2,4-D-trolamine) + SX, 2,4-DB + SX, 2,4-DB choline salt (2, 4-DB choline salt) + SX, 2,4-DB biproamine + SX, 2,4-DB-butyl (2,4-DB-butyl) + SX, 2,4-DB Dimethylammonium (2,4-DB-dimethylammonium) + SX, 2,4-DB isooctyl (2,4-DB-isoctyl) + SX, 2,4-DB potassium salt (2,4-DB-potassium) + SX , 2,4-DB-sodium salt (2,4-DB-sodium) + SX, acetochlor + SX, acifluorfen + SX, acifluorfen-sodium + SX, Aclonifen + SX, ACN (2-amino-3-chloronaphthalene-1,4-dione) + SX, alachlor + SX, alloxydim + SX, ametryn + SX, amycarbazone ( amicarbazone) + SX, amidosulfuron + SX, aminocyclopyrachlor + SX, aminocyclopyrac hlor-methyl + SX, aminocyclopyrachlor-potassium + SX, aminopyralid + SX, aminopyralid choline salt + SX, aminopyralid-potassium ) + SX, aminopyralid-tripromine + SX, amiprophos-methyl + SX, amitrole + SX, anilofos + SX, ashlam + SX, atrazine ) + SX, azafenidin + SX, azimsulfuron + SX, beflubutamid + SX, benazolin-ethyl + SX, bencarbazone + SX, benfluralin + SX, benfluralin (benfuresate) + SX, benquitrione + SX, bensulfuron + SX, bensulfuron-methyl + SX, bensulide + SX, bentazon + SX, benthiocarb ) + SX, benzfendizone + SX, benzobicyclon + SX, benzofenap + SX, benzthiazuron + SX, bialafos bialaphos + SX, bicyclopyrone ) + SX, bifenox + SX, bipyrazone + SX, bispyribac + SX, bispyribac-sodiu m) + SX, bixlozone + SX, bromacil + SX, bromobutide + SX, bromofenoxim + SX, bromoxynil + SX, bromoxynil -octanoate + SX, butachlor + SX, butafenacil + SX, butamifos + SX, butroxydim + SX, butylate + SX, cafenstrole + SX, carbetamid carbetamide) + SX, carfentrazone + SX, carfentrazone-ethyl + SX, chlomethoxyfen + SX, chloramben + SX, chloridazon + SX , Chlorimuron + SX, chlorimuron-ethyl + SX, chlorobromuron + SX, chlorotoluron + SX, chloroxuron + SX, chlorpropham + SX, chlorsulfuron + SX, chlorthal-dimethyl + SX, chlorthiamid + SX, cinidon + SX, cinidon-ethyl + SX, cinmethylin + SX, cinosulfuron + SX, clethodim + SX, clodinafop + SX, clodinafop-propargyl + SX, clomazone + SX, Clomeprop + SX, clopyralid + SX, clopyralid choline salt + SX, clopyralid-methyl + SX, clopyralid-olamine + SX, clopyralid potassium salt (clopyralid-potassium) + SX, clopyralid-tris (2-hydroxypropyl) ammonium (clopyralid-tris (2-hydroxypropyl) ammonium) + SX, cloransulam + SX, cloransulam-methyl + SX, Cumyluron + SX, cyanazine + SX, cycloate + SX, cyclopyranil + SX, cyclopyrimorate + SX, cyclosulfamuron + SX, cycloxyluron (cyclosulfamuron) cycloxydim + SX, cyhalofop + SX, cyhalofop-butyl + SX, cypyrafluone + SX, dalapon + SX, dazomet + SX, desmedipham + SX, desmetryn + SX, di-allate + SX, dicamba + SX, dicamba choline salt + SX, dicamba-biproamine + SX, dicambatrol Amine salt (dicamba -trolamine) + SX, dicamba-diglycolamine + SX, dicamba-dimethylammonium + SX, dicamba-diolamine + SX, Dicamba-isopropylammonium + SX, dicamba-methyl + SX, dicamba-olamine + SX, dicamba-potassium + SX, dicamba sodium salt (dicamba-potassium) + SX, dicamba sodium salt (dicamba-potassium) + SX dicamba-sodium + SX, dichlobenil + SX, dichlorprop choline salt + SX, dichlorprop-biproamine + SX, dichlorprop-dichlorprop- 2-ethylhexyl) + SX, dichlorprop-butotyl + SX, dichlorprop-dimethylammonium + SX, dichlorprop-ethylammonium + SX, dichlorprop-ethylammonium Chill (dichlorprop-isoctyl) + SX, dichlorprop-methyl + SX, dichlorprop-P (dichlorprop-P) + SX, dichlorprop-P choline salt + SX, dichlorprop-P choline salt Chlorprop-P-biproamine + SX, Dichlorprop-P-etexyl + SX, Dichlorprop-P-dimethylammonium + SX, Dichlorprop-potassium salt (dichlorprop-potassium) + SX, dichlorprop-sodium + SX, dichlorofop + SX, dichlorofop-methyl + SX, diclosulam + SX, difenoxuron + SX, Ziffen Zocote (difenzoquat) + SX, difenzoquat methylsulfate + SX, diflufenican + SX, diflufenzopyr + SX, diflufenzopyr-sodium + SX, dimefuron + SX, dimepiperate + SX, dimesulfazet + SX, dimethachlor + SX, dimethametryn + SX, dimethenamid + SX, dimethenamid dimethenamid-P + SX, dinitramine + SX, dinoseb + SX, dinoterb + SX, dioxopyritrione + SX, diphenamid + SX, diquat -dibromide + SX, DSMA (disodium methylarsonate) + SX, dithiopyr + SX, diuron + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX, epiyrifenacil + SX, Esprocarb + SX, ethalfluralin + SX, ethametsulfuron + SX, ethametsulfuron-methyl + SX, ethidimuron + SX, etofumesate , Ethoxyfen-ethyl + SX, ethoxysulfuron + SX, etobenzanid + SX, fenoxaprop + SX, phenoxaprop ech Le (fenoxaprop-ethyl) + SX, fenoxaprop-P (fenoxaprop-P) + SX, fenoxaprop-P-ethyl (fenoxaprop-P-ethyl) + SX, fenoxasulfone + SX, fenpyrazone + SX, fenquinotrione + SX, fentrazamide + SX, fenuron + SX, flamprop-M + SX, flazasulfuron + SX, flora sulfuron + SX, florpyrauxifen + SX, florpyrauxifen-benzyl + SX, fluazifop + SX, fluazifop-butyl + SX, fluazifop-P ) + SX, fluazifop-P-butyl + SX, fluazolate + SX, flucarbazone + SX, flucarbazone-sodium + SX, flucetosulfuron + SX, flufenacet + SX, flufenpyr + SX, flufenpyr-ethyl + SX, flumetsulam + SX, flumetsulam + SX, flumiclorac ) + SX, flumiclorac-pentyl + SX, flumioxazin + SX, fluometuron + SX, fluoroglycofen-ethyl + SX, flupoxam + SX, Flupropanate + SX, flupyrsulfuron + SX, flupyrsulfuron-methyl-sodium + SX, flurenol + SX, fluridone + SX, flurochloridone + SX, Fluoxypill (f)
luroxypyr + SX, fluroxypyr-butometyl + SX, fluroxypyr-meptyl + SX, flurtamone + SX, fluthiacet + SX, fluthiacet fluthiacet-methyl + SX, homesafen + SX, homesafen-sodium + SX, foramsulfuron + SX, fosamine + SX, glufosinate + SX, glufosinate Ammonium salt (glufosinate-ammonium) + SX, glufosinate P (glufosinate-P) + SX, glufosinate P ammonium salt (glufosinate-P-ammonium) + SX, glufosinate P sodium salt (glufosinate-P-sodium) + SX, glyphosate (glufosinate-P-sodium) glyphosate + SX, glyphosate choline salt + SX, glyphosate-isopropylammonium + SX, glyphosate-biproamine + SX, glyphosate-ammonium Glyphosate-diammonium + SX, glyphosate-potassium + SX, glyphosate-sodium + SX, glyphosate-trimesium + SX, halauxifen ) + SX, halauxifen-methyl + SX, halosafen + SX, halosulfuron + SX, halosulfuron-methyl + SX, haloxyhop (haloxyfop) + SX, haloxyhop-etotyl + SX, haloxyhop methyl (haloxyfop-methyl) + SX, haloxyhop P (haloxyfop-P) + SX, haloxyhop P etothyl (haloxyfop-) P-etotyl + SX, haloxifop-P-methyl + SX, hexazinone + SX, imazamethabenz + SX, imazamethabenz-methyl + SX, imazamox ) + SX, imazamox-ammonium salt (imazamox-ammonium) + SX, imazapic + SX, imazapic-ammonium salt (imazapic-ammonium) + SX, imazapyr + SX, imazapill isopropylammonium salt (imazapyr-isopropylammonium) + SX, imazaquin + SX, imazaquin-ammonium salt (imazaquin-ammonium) + SX, imazethapyr + SX, imazethapyr-ammonium salt (imazethapyr-ammonium) + SX imazosulfuron + SX, indanofan + SX, indaziflam + SX, iodosulfuron + SX, iodosulfuron-methyl-sodium + SX, iofensulfuron SX, iofensulfuron-sodium + SX, ioxynil + SX, ioxynil-octanoate + SX, ipfencarbazone + SX, isoproturon + SX, ammonium (i souron + SX, isoxaben + SX, isoxachlortole + SX, isoxaflutole + SX, lactofen + SX, lenacil + SX, linuron + SX, maleic hydrazide + SX, MCPA choline salt + SX, MCPA-biproamine + SX, MCPA-etexyl + SX, MCPA-butotyl ) + SX, MCPA butyl (MCPA-butyl) + SX, MCPA dimethylammonium + SX, MCPA diolamine salt (MCPA-diolamine) + SX, MCPA ethyl (MCPA-ethyl) + SX, MCPA isobutyl ( MCPA-isobutyl) + SX, MCPA isooctyl (MCPA-isoctyl) + SX, MCPA isopropyl (MCPA-isopropyl) + SX, MCPA methyl (MCPA-methyl) + SX, MCPA allamine salt (MCPA-olamine) + SX, MCPA Sodium salt (MCPA-sodium) + SX, MCPA-trolamine salt (MCPA-trolamine) + SX, MCPB (4- (4-chloro-2-methylphenoxy) butanoic acid) + SX, MCPB choline salt (MCPB choline salt) + SX, MCPB-biproamine + SX, MCPB-ethyl + SX, MCPB-methyl + SX, MCPB sodium salt (MCPB-sodium) + SX, mecoprop choline salt) + SX, mecoprop-biproamine + SX, mecoprop-2-ethylhexyl + SX, mecoprop-dimethylammonium + SX, mecoprop-diolamine + SX, mecoprop-ethadyl + SX, mecoprop-isoctyl + SX, mecoprop-methyl + SX, mecoprop-potassium + SX, mecoprop-sodium + SX, mecoprop-trolamine + SX, Mecoprop-P (mecoprop-P) + SX, Mecoprop-P choline salt + SX, Mecoprop P 2-ethylhexyl + SX, Mecoprop P dimethylammonium (mecoprop-P-) dimethylammonium) + SX, mecoprop-P-isobutyl + SX, mecoprop-P-potassium + SX, mefenacet + SX, mesosulfuron + SX, mesosulfuron methyl mesosulfuron-methyl + SX, mesotrione + SX, metam + SX, metamifop + SX, metamitron + SX, metazachlor + SX, metazosulfuron + SX, metazosulfuron Metabenzthiazuron + SX, methiozolin + SX, methyldymron + SX, metobromuron + SX, metolachlor + SX, metosulam + SX, metosulon metoxuron) + S X, metribuzin + SX, metsulfuron + SX, metsulfuron-methyl + SX, molinate + SX, monolinuron + SX, naproanilide + SX, naproanilide napropamide + SX, napropamide-M + SX, naptalam + SX, neburon + SX, nicosulfuron + SX, norflurazon + SX, oleic acid + SX, orbencarb + SX, orthosulfamuron + SX, oryzalin + SX, oxadiargyl + SX, oxadiazon + SX, oxasulfuron + SX, Oxiclomefone + SX, oxyfluorfen + SX, paraquat + SX, paraquat-dichloride + SX, pebulate + SX, pelargonic acid + SX, pendy Pendimethalin + SX, penoxsulam + SX, pentanochlor + SX, pentoxazone + SX, petthoxamid + SX, phenisopham + SX, phenmedipham + SX, picloram, picolinafen + SX, picolinafen + SX, pinoxaden + SX, piperophos + SX, pretilacro Pretilachlor + SX, primisulfuron + SX, primisulfuron-methyl + SX, prodiamine + SX, profluazol + SX, profoxydim ) + SX, prometon + SX, prometryn + SX, propachlor + SX, propanil + SX, propaquizafop + SX, propazine + SX, propam (propham) + SX, propisochlor + SX, propoxycarbazone + SX, propoxycarbazone-sodium + SX, propyrisulfuron + SX, propyzamide + SX, prosulfocarb + SX, prosulfuron + SX, pyraclonil + SX, pyrasulfotole + SX, pyrazolynate + SX, pyrazosulfuron + SX, Pyrazosulfuron-ethyl + SX, pyrazoxyfen + SX, pyribenzoxim + SX, pyributicarb + SX, pyridafol + SX, pyridate + SX, pyridate SX, pyriminobac + SX, pyriminobac-methyl + SX, pyrimisulfan + SX, pyrithiobac + SX, pyritiova Pyrthiobac-sodium + SX, pyroxasulfone + SX, pyroxsulam + SX, quinclorac + SX, quinmerac + SX, quizalofop + SX, Kiza Lohop ethyl (quizalofop-ethyl) + SX, quizalofop-tefuryl + SX, quizalofop-P + SX, quizalofop-P-ethyl + SX, quizalofop-tefuryl (quizalofop-P-tefuryl) + SX, rimisoxafen + SX, rimsulfuron + SX, saflufenacil + SX, setoxydim (sethoxydim) + SX, EPTC (S-ethyl N, N-dipropylcarbamothioate) + SX, siduron + SX, simazine + SX, simetryn + SX, S-metolachlor + SX, MSMA (sodium hydrogen methylarsonate) + SX, sulcotrione + SX, sulfentrazone + SX, sulfometuron + SX, sulfometuron-methyl + SX, sulfosulfuron + SX, swep + SX, TCA ( 2,2,2-trichloroacetic acid) + SX, TCA ammonium (TCA-ammonium) + SX, TCA calcium (TCA-calcium) + SX, TCA ethadyl (TCA-ethadyl) + SX, TCA magnesium (TCA-magnesium) + SX, TCA sodium (TCA-sodium) + SX, tebu tam) + SX, tebuthiuron + SX, tefuryltrione + SX, tembotrione + SX, tepraloxydim + SX, terbacil + SX, terbumeton + SX , Terbuthylazine + SX, terbutryn + SX, tetflupyrolimet + SX, taxtomin A + SX, thenylchlor + SX, thiazopyr + SX, thidiazimin + SX, thiencarbazone + SX, thiencarbazone-methyl + SX, thifensulfuron + SX, thifensulfuron-methyl + SX, tiafenacil + SX, tiocarbazil + SX, tolpyralate + SX, topramezone + SX, tralkoxydim + SX, triafamone + SX, tri-allate + SX, tri-allate (triasulfuron) + SX, triaziflam + SX, tribenuron + SX, tribenuron-methyl + SX, triclopyr + SX, triclopyr-butotyl + SX, triclopyr-ethyl + SX, triclopyr-triethylammonium + SX, tridiphane + SX, trietazine + SX, Trifloxysulfuron + SX, trifloxysulfuron-sodium + SX, trifludimoxazin + SX, triflura
lin) + SX, triflusulfuron + SX, triflusulfuron-methyl + SX, tripyrasulfone + SX, tritosulfuron + SX, vernolate + SX, 4- (4-fluorophenyl) -6- [(2-hydroxy-6-oxo-1-cyclohexen-1-yl) carbonyl] -2-methyl-1,2,4-triazine-3,5 (2H) , 4H) -dione + SX, 2-chloro-N-(1-methyl-1H-tetrazol-5-yl) -3- (methylthio) -4- (trifluoromethyl) benzamide + SX, 2-methyl-N-( 5-methyl-1,3,4-oxadiazol-2-yl) -3- (methanesulfonyl) -4- (trifluoromethyl) benzamide + SX, 4-amino-3-chloro-5-fluoro-6- (7-fluoromethyl) -1H-indol-6-yl) pyridine-2-carboxylic acid + SX, cyanomethyl 4-amino-3-chloro-5-fluoro-6- (7-fluoro-1H-indol-6-yl) pyridine-2- carboxylate (2251111-18-7) + SX, methyl (2R, 4R) -4-({[(5S) -3- (3,5-difluorophenyl) -5-vinyl-4,5-dihydroisoxazol-5-yl ] carbonyl} amino) tetrahydrofurane-2-carboxylate + SX, methyl (2S, 4S) -4-({[(5R) -3- (3,5-difluorophenyl) -5-vinyl-4,5-dihydroisoxazol-5 -yl] carbonyl} amino) tetrahydrofurane-2-carboxylate + SX, 3-[(isopropylsulfonyl) methyl] -N- (5-methyl-1,3,4-oxadiazol-2-yl) -5- (tri fluoromethyl) -1,2,4-triazolo [4,3-a] pyridine-8-carboxamide (1994348-72-9) + SX, 1- {2-chloro-6-[(5-chloropyrimidin-2-yl) ) Oxy] phenyl} -4,4,4-trifluorobutan-1-one (2052297-97-7) + SX, 5-chloro-2- {3-chloro-2- [5- (difluoromethyl) isoxazol-3- yl] phenoxy} pyrimidine (1801862-60-1) + SX.

Combination of this component of the above group (j) and this compound:

Subgroup (j-1): Combination of this component of bacteria and this compound:
Agrobacterium radiobacter strain K1026 + SX, Agrobacterium radiobacter strain K84 + SX, Agrobacterium vitis strain VAR03-1 ) + SX, Azorhizobium spp. + SX, Azorhizobium caulinodans strain ZB-SK-5 + SX, Azospirillum amazonense + SX, Azorhizobium Azospirillum brasilense + SX, Azospirillum brasilense strain XOH + SX, Azospirillum brasilense strain Ab-V5 + SX, Azospirillum brasilense strain Ab-V6 strain (Azospirillum brasilense strain Ab-V6) + SX, Azospirillum caulinodans + SX, Azospirillum halopraeferens + SX, Azospirillum halopraeferens + SX, Azospirillum irakense + SX, Azotobacter chroococcum strain H23 + SX, Azotobacter chroocuccum + SX, Azotobacter vinelandii strain ATCC12837 + SX, Azotobacter・ Acid Cardarius ( Bacillus acidocaldarius + SX, Bacillus acidoterrestris + SX, Bacillus agri + SX, Bacillus albolactis + SX, Bacillus alcalophilus + SX Bacillus alvei + SX, Bacillus aminoglucosidicus + SX, Bacillus aminovorans + SX, Bacillus amyloliquefaciens PTA-4838 strain (Aveo ™ EZ nematicide) ) (Bacillus amyloliquefaciens strain PTA-4838 (Aveo ™ EZ Nematicide)) + SX, Bacillus amyloliquefaciens strain AT332 + SX, Bacillus amyloliquefaciens strain B3 strain (Bacillus amylolique) ) + SX, Bacillus amyloliquefaciens strain D747 + SX, Bacillus amyloliquefaciens strain DB101 + SX, Bacillus amyloliquefaciens strain DB102 DB102) + SX, Bacillus amyloliquefaciens strain F727 + SX, Bacillus amyloliquefaciens strain FZB24 + SX, Bacillus amyloliquefaciens strain FZB strain FZB42) + SX, Bacillus amilo Bacillus amyloliquefaciens strain GB03 + SX, Bacillus amyloliquefaciens IN937a + SX, Bacillus amyloliquefaciens MBI 600 strain (Bacillus amyloliquefaciens strain MBI Bacillus amyloliquefaciens strain QST713 + SX, Bacillus amyloliquefaciens isolate strain B246 + SX, Bacillus amyloliquefaciens plantalum subspecies D747 (Bacillus amylo Plantarum strain D747) + SX, Bacillus amylolyticus + SX, Bacillus aneurinolyticus + SX, Bacillus atrophaeus + SX, Bacillus azotoformus ) + SX, Bacillus badius + SX, Bacillus cereus strain BP01 + SX, Bacillus cereus CNCM strain I-1562 + SX, Bacillus Bacillus chitinosporus strain AQ746 + SX, Bacillus chitinosporus strain CM-1 + SX, Bacillus circulans + SX, Bacillus coagulans TQ33 strain TQ33) + SX, Bacillus Fosty Bacillus fastidiosus + SX, Bacillus firmus strain GB-126 + SX, Bacillus firmus strain I-1582 + SX, Bacillus films NCIM2637 strain (Bacillus firmus strain NCIM2637) + SX, Bacillus lacticola + SX, Bacillus lactimorbus + SX, Bacillus lactis + SX, Bacillus lactis , Bacillus lentimorbus + SX, Bacillus lentus + SX, Bacillus licheniformis strain FMCH001 + SX, Bacillus licheniformis strain FMCH001 + SX, Bacillus strain HB-2 strain + SX, Bacillus licheniformis strain SB3086 + SX, Bacillus maroccanus + SX, Bacillus medusa + SX, Bacillus megaterium YFM3.25 strain (Bacillus) 25) + SX, Bacillus methylotrophicus strain BAC-9912 + SX, Bacillus metiens + SX, Bacillus mojavensis strain SR11 + SX, Bacillus・ Bacillus mycoides strain AQ726 + SX, Bacillus mycois isolate J (Bacillus mycoi) des isolate J) + SX, Bacillus nematocida + SX, Bacillus nigrificans + SX, Bacillus nigrum + SX, Bacillus popilliae + SX, Bacillus popilliae Bacillus psychrosaccharolyticus + SX, Bacillus pumilus strain AQ717 + SX, Bacillus pumilus strain BUF-33 + SX, Bacillus pumilus strain GB34 pumilus strain GB34) + SX, Bacillus pumilus strain QST2808 + SX, Bacillus siamensis + SX, Bacillus simplex strain CGF2856 + SX, Bacillus simplex strain CGF2856 smithii) + SX, Bacillus sp. AQ175 strain (Bacillus sp. Strain AQ175) + SX, Bacillus sp. AQ177 strain (Bacillus sp. Strain AQ177) + SX, Bacillus sp. AQ178 strain (Bacillus sp. Strain AQ178) + SX, Bacillus sphaericus strain 2362 strain H5a5b (Bacillus sphaericus strain 2362 serotype H5a5b) + SX, Bacillus sphaericus strain ABTS1743 + SX, Bacillus sphaericus strain ABTS1743 + SX, Bacillus sphaericus strain AFS032321 strain AQ153 strain (Bacillus subtilis strain AQ153) + SX, Bacillus subtilis strain AQ743 strain (B) acillus subtilis strain AQ743) + SX, Bacillus subtilis strain B246 + SX, Bacillus subtilis strain C-3102 + SX, Bacillus subtilis strain D747 ) + SX, Bacillus subtilis strain DB101 + SX, Bacillus subtilis strain DB102 + SX, Bacillus subtilis strain FMCH002 + SX, Bacillus subtilis strain FZ24 Bacillus subtilis strain FZB24 + SX, Bacillus subtilis strain GB03 + SX, Bacillus subtilis strain HAI0404 + SX, Bacillus subtilis IAB / BS03 strain / BS03) + SX, Bacillus subtilis strain MBI600 + SX, Bacillus subtilis QST30002 / AQ30002 strain (Bacillus subtilis strain QST30002 / AQ30002) + SX, Bacillus subtilis QST30004 / AQ30004 strain (Bacillus sub / AQ30004) + SX, Bacillus subtilis strain QST713 + SX, Bacillus subtilis strain QST714 + SX, Bacillus subtilis strain FZB24 strain FZB24 strain (Bacillus subtilis) strai n FZB24) + SX, Bacillus subtilis strain Y1336 + SX, Bacillus subtilis subsp.natto + SX, Bacillus subtilis strain RTI477 + SX, Bacillus tequilensis strain NII-0943 + SX, Bacillus thuringiensis strain AQ52 + SX, Bacillus thuringiensis strain BD # 32 + SX, Bacillus thuringiensis strain CR-371 + SX, Bacillus thuringiensis strain EX297512 + SX, Bacillus thuringiensis strain ABTS-1857 strain (Bacillus) thuringiensis subsp. Aizawai strain ABTS-1857) + SX, Bacillus thuringiensis subsp. Aizawai strain GC-91 + SX, Bacillus thuringiensis subsp. Aizawai strain NB200 strain (Bacillus) thuringiensis subsp. Aizawai strain NB200) + SX, Bacillus thuringiensis subsp. Aizawai Serotype H-7) + SX, Bacillus thuringiensis subsp. (Bacillus thuringiensis subsp. Israelensis strain AM65-52) + SX, Bacillus thuringiensis islaelensis (antigen type H) -14) Bacillus thuringiensis subsp. Israelensis (serotype H-14) strain AM65-52) + SX, Bacillus thuringiensis subsp. Israelensis strain BMP144 + SX, Bacillus thuringiensis subsp. Israelensis strain EG2215 + SX, Bacillus thuringiensis subsp. Israelensis strain SA3A + SX , Bacillus thuringiensis subsp. Israelensis strain SUM-6218 + SX, Bacillus thuringiensis subsp. VCRC B17 strain antigen type 11-14 (Bacillus thuringiensis) subsp. israelensis strain VCRC B17 serotype 11-14) + SX, Bacillus thuringiensis subsp. Kurstaki strain ABTS351 + SX, Bacillus thuringiensis subsp. . Kurstaki strain BMP123) + SX, Bacillus thuringiensis subsp. Kurstaki strain CCT1306 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG2348 SX, Bacillus thuringensis Krustaki subspecies EG2371 Strain (Bacillus thuringiensis subsp. Kurstaki strain EG2371) + SX, Bacillus thuringiensis subspecies EG7673 strain (Bacillus thuringiensis subsp. Kurstaki strain EG7673) + SX, Bacillus thuringiensis subspecies EG7841 strain (Bacillus thuringiensis subsp. Kurstaki strain EG7841) + SX, Bacillus thuringiensis subsp. Kurstaki strain EVB113-19 + SX, Bacillus thuringiensis subsp. Kurstaki strain F810) + SX, Bacillus thuringiensis subsp. Kurstaki strain HD-1) + SX, Bacillus thuringiensis subsp. Kurstaki strain M-200) + SX,
Bacillus thuringiensis subsp. Kurstaki strain NCIM2514 + SX, Bacillus thuringiensis subsp. Kurstaki strain PB54 + SX, Bacillus thuringiensis subsp. Kurstaki strain NCIM2514 + SX, Bacillus thuringiensis subsp. Subspecies SA-11 strain (Bacillus thuringiensis subsp. Kurstaki strain SA-11) + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12・ Bacillus thuringiensis subsp. Kurstaki strain VBTS-2546 + SX, Bacillus thuringiensis subsp. Kurstaki strain Z-52 (Bacillus thuringiensis subsp. Kurstaki strain Z-) 52, serotype H-3a, 3b) + SX, Bacillus thuringiensis subsp. Morrisoni + SX, Bacillus thuringiensis subsp. Tenebriosis strain NB 176 + SX, Bacillus thuringiensis subsp. Tenebriosis strain SA-10 + SX, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002 + SX, Bacillus thuringiensis subsp. Var. Colmeri + SX, Bacillus thuringiensis subsp. Var. Darmstadiensis strain 24-91 + SX, Bacillus thuringiensis subsp. Var. Dendrolimus + SX, Bacillus thuringiensis subsp. Var. Dendrolimus + SX, Bacillus thuringiensis subsp. Var. Dendrolimus Bacillus thuringiensis subsp. Var. Galleriae + SX, Bacillus thuringiensis subsp. Var. Japonensis strain buibui + SX, Bacillus thuringiensis subsp. Var. Japonensis strain buibui + SX, Bacillus thuringiensis subsp. Var. Japonensis strain buibui + SX, Bacillus thuringiensis subsp. thuringiensis subsp. var. Aegypti) + SX, Bacillus thuringiensis 7216 variant (Bacillus thuringiensis var. 7216) + SX, Bacillus thuringiensis var. Sandiego strain M-7 + SX , Bacillus thuringiensis T36 variant (Bacillus thuringiensis var. T36) + SX, Bacillus velezensis + SX, Bacillus velezensis strain RTI301 + SX, .) + SX, Bradyrhizobium elkanii + SX, Bradyrhizobium elkanii strain SEMIA 587 + SX, Bradyrisobium elkanii SEMIA 5019 strain (Bradyrhizob) SEMIA 5019) + SX, Bradyrhizobium japo nicum) + SX, Bradyrhizobium japonicum strain TA-11 (Bradyrhizobium japonicum strain TA-11) + SX, Bradyrhizobium japonicum USDA 110 (Bradyrhizobium japonicum strain USDA 110) + SX, Bradyrhizobium Bradyrhizobium liaoningense + SX, Bradyrhizobium lupini + SX, Bradyrhizobium spp. (Arachis) + SX, Bradyrhizobium species Bradyrhizobium spp. (Vigna)) + SX, Bradyrhizobium brevis strain 2904 + SX, Bradyrhizobium spp. (Vigna) + SX, Bradyrhizobium brevis strain SS86-4 + SX, Bradyrhizobium brevis strain SS86-5 + SX, Bradyrhizobium laterosporus strain ATCC64 + SX, Bradyrhizobium Bradyrhizobium BPM3 strain (Brevibacillus laterosporus strain BPM3) + SX, Bradyrhizobium laterosporus strain G4 (Brevibacillus laterosporus strain G4) + SX, Bradyrhizobium lateosporus NCIMB 41419 strain (Brevibacillus laterosporus strain NCIMB laterosporus strain NRS1111) + SX, Bradybacillus lat erosporus strain NRS1645) + SX, Burkholderia cepacia type Wisconsin strain J82 + SX, Burkholderia cepacia type Wisconsin strain J82 + SX, Burkholderia cepacia type Wisconsin strain J82 M54 strain (Burkholderia cepacia type Wisconsin strain M54) + SX, Burkholderia cepacia + SX, Burkholderia gladii strain BA-7 strain (Burkholderia gladii strain BA-7) + SX, Burkholderia renogensis A396 strain (Burkholderia rinojensis strain A396) + SX, Chromobacterium subtsugae strain PRAA4-1T strain (Chromobacterium subtsugae strain PRAA4-1T) + SX, Delftia acidovorans + SX, Delftia acidovorans RAY209 strain RAY209 RAY209) + SX, Erwinia carotovora subsp. Carotovora CGE234M403 strain (Erwinia carotovora subsp. Carotovora strain CGE234M403) + SX, Gluconacetobacter diazotrophicus + SX, lactobacillus sid Lactobacillus brevis + SX, Lactobacillus plantarum + SX, Lactobacillus spp. + SX, Lysobacter antibioticus strain 1 3-1) + SX, Lysobacter enzymogenes strain C3 + SX, Metylobacterium spp. + SX, Mesorhizobium ciceri + SX, Mesorhizobium zobium huakii) + SX, Mesorhizobium loti + SX, Mesorhizobium spp. + SX, Paenibacillus alvei strain 2771 + SX, Paenibacillus alvei strain 2771 + SX, Paenibacillus albay 46C + SX, Paenibacillus alvei strain III2E + SX, Paenibacillus alvei strain III3DT-1A + SX, Paenibacillus alvei strain T36 + SX・ Macerans (Paenibacillus macerans) + SX, Paenibacillus polymyxa strain AC-1 + SX, Paenibacillus polymyxa strain BS-0105 (Paenibacillus polymyxa strain BS-0105) + SX, Paenibacillus popilia popilliae) + SX, Pantoea agglomerans strain E325 + SX, Pantoea vagans strain C9-1 + SX, Pasteuria nishizawae strain Pn1 + SX , Pasteuria penetrans + SX, Pasteuri a ramose) + SX, Pasteuria usgae + SX, Pectobacterium carotovorum + SX, Pasteuria thornei + SX, Pseudomonas aeruginosa PN1 strain SX, Pseudomonas aeruginosa strain WS-1 + SX, Pseudomonas aureofaciens strain TX-1 + SX, Pseudomonas Wisconsin type J82 strain (Pseudomonas) cepacia type Wisconsin strain J82) + SX, Pseudomonas cepacia type Wisconsin strain M54 + SX, Pseudomonas chlororaphis strain 63-28 + SX, Pseudomonas chlororaphis strain 63-28 AFS009 strain (Pseudomonas chlororaphis strain AFS009) + SX, Pseudomonas chlororaphis strain MA342 + SX, Pseudomonas fluorescens strain 1629RS (Pseudomonas fluorescens strain 1629RS) + SX, Pseudomonas fluorescens strain 1629RS strain A506) + SX, Pseudomonas fluorescens strain ACK55 + SX, Pseudomonas fluorescens strain CL145A + SX, Pseudomonas fluorescens G7090 strain (Pseudomonas fluo) rescens strain G7090) + SX, Pseudomonas fluorescens biover B strain XJ3 + SX, Pseudomonas fluorescens biover B strain XS18 + SX, Pseudomonas fluorescens biover B strain XS18 A LRS12 strain (Pseudomonas fluorescens biover A strain LRS12) + SX, Pseudomonas proradix + SX, Pseudomonas putida + SX, Pseudomonas reactans + SX, Pseudomonas reactans + SX resinovorans) + SX, Pseudomonas rhodesiae strain HAI-0804 + SX, Pseudomonas sp. Strain CAB-02 + SX, Pseudomonas syringae strain 742RS) + SX, Pseudomonas syringae strain MA-4 + SX, Rhizobium etli + SX, Rhizobium galegae + SX, Rizobium regminosalm bv. Rhizobium leguminosarum bv. Phaseoli) + SX, Rhizobium leguminosarum bv. Trifolii + SX, Rhizobium leguminosarum bv. , Pseudomonas Rhizobium tropici + SX, Rhodococcus globerulus strain AQ719 + SX, Serratia entomophila + SX, Serratia marcescens strain 35 + SX, Serratia marcescens strain 35 SRM strain (Serratia marcescens strain SRM) + SX, Sinorhizobium fredii + SX, Sinorhizobium meliloti + SX, Streptomyces acidiscabies strain RL-110T strain , Streptomyces candidus strain Y21007-2 + SX, Streptomyces colombiensis + SX, Streptomyces galbus strain QST6047 + SX, Streptomyces goshikiensis + SX, Streptomyces griseoviridis strain K61 + SX, Streptomyces lavendulae + SX, Streptomyces lavendulae + SX, Streptomyces WCD 108 lydicus strain WYCD108US) + SX, Streptomyces lydicus strain WYEC108 + SX, Streptomyces microflavus strain AQ6121 + SX, Streptomyces prac SX, Streptomyces rimosus + SX, Streptomyces saraceticus + SX, Streptomyces sp. NRRL No.B-30145 strain (Streptomyces sp. Strain NRRL No.B-3)
0145) + SX, Streptomyces sp. WYE20 strain (Streptomyces sp. Strain WYE20) + SX, Streptomyces sp. WYE 324 strain (Streptomyces sp. Strain WYE 324) + SX, Streptomyces venezuelae + SX, Thiobacills spp. (Thiobacillus spp.) + SX, Variovorax paradoxus strain GF4526 + SX, Virgibacillus pantothenticus ATCC14576 (Virgibacillus pantothenticus strain ATCC14576) Virgibacillus pantothenticus strain DSM491) + SX, Volbachia pipientis + SX, Xanthomonas campestris pv poae + SX, Xanthomonas campestris SX, Xanthomonas campestris SX, Xenorhabdus nematophila + SX.

Subgroup (j-2): Combination of this component of fungus / yeast and this compound Acaulospora spp. + SX, Acaulospora longula + SX, Alternaria destruens + SX, Alternaria destruens strain 59 + SX, Ambispora spp. + SX, Ambispora leptoticha + SX, Ampelomyces quisqualis strain AQ10 SX, Archaeos pora spp. + SX, Arkansas Fungus 18 + SX, Arthrobotrys dactyloides + SX, Arthrobotrys superba + SX, Asher Aschersonia aleyrodis + SX, Aspergillus flavus strain AF36 + SX, Aspergillus flavus strain NRRL21882 + SX, Aureobasidium pulllance DSM14940 strain DSM14940 ) + SX, Aureobasidium pullulans strain DSM14941 + SX, Beauveria bassiana strain ANT-03 + SX, Beauveria bassiana strain ATCC74040 + SX, Beauveria bassiana strain ATP02 + SX, Beauveria bassiana strain ATP02 Beauveria bassiana strain CG716 + SX, Beauveria bassiana strain GHA + SX, Beauveria bassiana strain IMI389521 + SX, Beauveria bassiana PPRI 5339 strain (Beauveria bassiana) strain PPRI 5339) + SX, Beauveria brongniartii + SX, Candida oleophila strain O + SX, Candida oleophila isolate I-182 + SX, Candida saitoana + SX, Candida spp. (Candida spp.) + SX, cell walls of Saccharomyces cerevisiae strain LAS117 + SX, Chaetomium cupreum + SX , Murasakiurokotake (Chondrostereum purpureum) + SX, Cladosporium cladosporioides strain H39 + SX, Claroideoglomus spp., Formerly Glomus spp. Claroideoglomus claroideum (formerly Glomus claroideum) + SX, Claroideoglomus etunicatum (formerly Glomus etunicatum) + SX, Claroideoglomus spoulomus (Colletotrichum gloeosporioides) + SX, Conidioboras Obscurus (Conidiobolus obscurus) + SX, Coniothyrium minitans strain CGMCC8325 strain (Coniothyrium minitans strain CGMCC8325) + SX, Coniothyrium minitans strain CON / M / 91-08 strain (Coniothyrium minitans strain CON / M / 91-08) + SX, Cryptococcus Cryptococcus albidus + SX, Cryptococcus flavescens + SX, Dactyllela ellipsospora + SX, Dectylaria thaumasia + SX, Dectylaria thaumasia Diversispora spp. + SX, Entomophthora virulenta + SX, Entrophospora spp. + SX, Funneliformis spp., Formerly Glomus spp. .) + SX, Funneliformis mosseae (formerly Glomus mosseae) + SX, Fusarium oxysporum strain Fo47 + SX, Fusarium oxysporum strain RS- 21) + SX, Fusarium oxysporum strain RS-25 + SX, Fusarium proliferatum + SX, Geosiphon spp. + SX, Glioclady Gliocladium catenulatum strain J1446 + SX, Gliocladium roseum + SX, Gigaspora Species (Gigaspora spp.) + SX, Gigaspora margarita + SX, Gigaspora rosea + SX, Glomus spp. + SX, Glomus aggregatum Glomus deserticola + SX, Glomus etunicatum + SX, Glomus iranicum + SX, Glomus monosporum + SX, Hirstella mines Hirsutella rhossiliensis + SX, Hirsutella thompsonii + SX, Isaria fumosorosea + SX, Laccaria bicolor + SX, Lacaria la cc SX, Lagenidium giganteum + SX, Lecanicillium lecanii KV01 + SX, Lecanicillium lecanii DAOM198499 sprouting (Lecanicillium lecanii conidia of strain DAOM198499) + SX Lecanicillium lecanii conidia of strain DAOM216596 + SX, Lecanicillium muscarium (formerly Verticillium lecanii) strain 1/1) + SX, Lecanicillium muscarium Ve6 strain (formerly Lecanicillium muscarium) Verticillium lecanii) strain Ve6) + SX, Metallidium anisopriae F52 strain (Verticillium lecanii) strain Ve6) + SX, Metarhizium anisopliae strain F52) + SX, Metarhizium anisopliae var. Acridum + SX, Metarhizium anisopliae acridum variant IMI 330189 Isolate (Metarhizium anisopliae var. Acridum isolate IMI 330189) Anisopliae variant BIPESCO 5 / F52 strain (Metarhizium anisopliae var. Anisopliae BIPESCO 5 / F52) + SX, Metarhizium flavoviride + SX, Methnicobia fructicola NRRLY-30752 strain (Metschnikow)・ Microdochium dimerum strain L13 + SX, Microsphaeropsis ochracea + SX, Monacrosporium phymatopagum + SX, Mucor hiemalis + SX, Muscodor albus strain 620 + SX, Muscodor albus strain QST 20799 + SX, Muscodor albus strain SA13 + SX, Muscodor albus strain A3-5 strain (Muscodor albus strain SA13) + SX, Muscodor albus strain A3-5 Muscodor roseus strain A3-5) + SX, Myrothecium verrucaria strain AARC-0255 + SX, Nomuraea rileyi strain CG128 + SX, Nomuraea rileyi GU87401 strain (Nomuraea rileyi) strain GU87401) + SX, Nomuraea rileyi strain SA86101 + SX, Nomuraea rileyi strain SR86151 + SX, Nomuraea rileyi strain VA9101 + SX, Ophiostoma D Ophiostoma piliferum strain D97) + SX, Pacispora spp. + SX, Paecilomyces fumosoroseus Apopka 97 strain (now known as Isaria fumosoroseus Apopka 97 strain) (Paecilomyces fumosoroseus Apopka strain 97, Now, Isaria) fumosorosea Apopka strain 97) + SX, Paecilomyces fumosoroseus strain FE9901, Now, Isaria fumosorosea strain FE9901 + SX, Paecilomyces FE9901 strain lilacinus strain 251) + SX, Paecilomyces tenuipes strain T1 + SX, Paecilomyces variotii strain Q-09 + SX, Pandora delphacis + SX, Paraglomus spp. + SX, Paraglomus brasilianum (formerly Glomus brasilianum) + SX, Penicillium bilaiae strain ATCC22348 + SX, Penicillium citriium strain VFI-51) + SX, Paecilomyces Penicillium vermiculatum + SX, Phlebiopsis gigantea strain VRA1992 + SX, Ferrebiopsis spp. (Phlebiopsis) + SX, Foma macrostroma 94-44B strain (Phoma) macrostroma strain94-44B) + SX, Phytophthora palmivora + SX, Pichia anomala strain WRL-076 + SX, Pichia guilliermondii strain Z1 + SX, Pichia guilliermondii strain Z8 + SX, Pisolithus tinctorius + SX, Pochonia chlamydosporia isolate strain PC10 + SX, Pochonia SXporia ch , Pseudozyma flocculosa strain PF-A22UL + SX, Puccinia thlaspeos strain woad + SX, Purpureocillium lilacinum + SX, Pichia DV74 strain (Pythium oligandrum strain DV74) + SX, Pythium oligandrum strain M1 + SX, Racocetra spp. + SX, Rhizophagus spp., Formerly Glomus spp. ) + SX, Rhizophagus clarus (formerly Glomus clarum) + SX, Rhizophagus intraradi Rhizophagus intraradices (formerly Glomus intraradices) + SX, Rhizophagus intraradices strain RTI-801 + SX, Rhizophagus irregularis (formerly Glomus intraradices) + SX, Irregularis DAOM 197198 strain DAOM 197198 + SX, Scutellospora spp. + SX, Rhizopogon amylopogon + SX, Rhizopogon fulvigleba Rhizopogon luteolus + SX, Rhizopogon villosullus + SX, Saccharomyces cerevisiae strain LAS02 + SX, Saccharomyces cerevisiae strain LAS02 + SX, Saccharomyces cerevisiae DDSF623 strain ) + SX, Scleroderma citrinum + SX, Sclerotinia minor strain IMI34414 + SX, Sporothrix insectorum + SX, Suillus granulatus・ Suillus punctatapies + SX, Talaromyces flavus strain SAY-Y-94-01 strain (Talaromyces flavus strain SAY-Y-94-01) + SX, Talaromyces flavus strain V11 7b) + SX, Trichoderma album + SX, Trichoderma asperelloides strain JM41R + SX, Trichoderma asperelloides strain ICC012 (Trichoderma asperellum strain ICC012) + Trichoderma asperellum strain ICC012 a
sperellum strain kd) + SX, Trichoderma asperellum T25 + SX, Trichoderma asperellum strain T34 + SX, Trichoderma asperellum SKT-1 strain SX, Trichoderma asperellum strain TV1 + SX, Trichoderma atroviride strain CNCM 1-1237 + SX, Trichoderma atroviride strain 77B + SX Trichoderma atroviride strain LC52 + SX, Trichoderma atroviride strain LU132 + SX, Trichoderma atroviride strain IMI 206040 (Trichoderma atroviride strain IMI 206040) + SX, Trichoderma atroviride strain IMI 206040 Trichoderma atroviride strain SC1) + SX, Trichoderma atroviride strain SKT-1 strain (Trichoderma atroviride strain SKT-1) + SX, Trichoderma atroviride strain T11 + SX, Trichoderma ICC080 strain ICC080 strain ) + SX, Trichoderma harmatum strain TH382 + SX, Trichoderma harzianum strain 21 + SX, Trichoderma harzianum strain D 104 B 104) + SX, Trichoderma harzianum strain DSM 14944 (Trichoderma harzianum strain DSM 14944) + SX, Trichoderma harzianum strain ESALQ-1303 (Trichoderma harzianum strain ESALQ-1303) + SX, Trichoderma harzianum ESALQ-1306 strain ESALQ-1306) + SX, Trichoderma harzianum strain IIHR-Th-2 strain IIHR-Th-2 + SX, Trichoderma harzianum strain ITEM908 + SX, Trichoderma harzianum strain ITEM908 Trichoderma harzianum strain kd + SX, Trichoderma harzianum strain MO1 + SX, Trichoderma harzianum strain SF + SX, Trichoderma harzianum T22 strain Trichoderma harzianum strain T39 + SX, Trichoderma harzianum strain T78 + SX, Trichoderma harzianum strain TH35 + SX, Trichoderma harzianum strain TH35 + SX, rifai + SX, Trichoderma koningii + SX, Trichoderma lignorum strain TL-0601 + SX, Trichoderma lignorum + SX, Trichoderma polysporum IMI206 polysporum strain IMI206039) + SX, Trichoderma spp. (Trichoderma spp.) + SX, Trichoderma saturnisporium strain PBP-TH-001 + SX, Trichoderma stromaticum Trichoderma virens strain G-41 + SX, Trichoderma virens strain GL-21, formaly Gliocladium virens GL-21 + SX, Trichoderma viride + SX, Tsukamurella paurometabola strain C-924 + SX, Tsukamurella paurometabola + SX, Typhula phacorrhiza strain 94671 + SX, Urocladium o HRU3 strain (Ulocladium oudemansii strain HRU3) + SX, Verticillium alboatrum strain WCS850 + SX, Verticillium chlamydosporium + SX, Verticillium dahliae ) + SX, Verticillium lecani strain NCIM1312 + SX, Zoophtora radicans + SX.

Subgroup (j-3): Combination of this component of protozoa with this compound:
Nosema locustae + SX, Thelohania solenopsis + SX, Vairimorpha spp. Strain Q-09 + SX.

Subgroup (j-4): Combination of this component of virus and this compound:
Bacteriophage of Clavibacter michiganesis + SX, Bacteriophage active against Clavibacter michiganensis subsp. Michiganensis + SX, Bacteriophage active against Xanthomonas campestris pv. Virus BV-0001 strain (Adoxophyes orana granulosis virus strain BV-0001) + SX, Agrotis segetum nuclear polyhedrosis virus (NPV) + SX, Anagraoha falcifera Nuclear polyhedrosis virus (Anagraoha falcifera NPV) ) + SX, Antigrapha californica mNPV + SX, Autographa californica mNPV + SX, Autographa californica mNPV + SX, Autographa California nuclear polyhedrosis virus R3 strain ( Autographa californica mNPV strain R3) + SX, Biston suppressaria NPV + SX, Bombyx mori NPV + SX, Kirosodixis Includens Nuclear Polyhedrosis Virus 460 strain (Chrysodeixis includens NPV isolate 460) + SX, Cryptophlebia leucotreta GV + SX, Cydia pomonella GV + SX, Cydia pomonella granule virus CP4 Strain (Cydia pomonella GV strain CP4) + SX, Cydia pomonella GV strain R5 + SX, Cydia pomonella GV strain V15 + SX, Cydia pomonella GV strain V22 ) + SX, Dendrolimus punctatus cypovirus + SX, Helicoverpa armigera NPV + SX, Helicoverpa armigera BV-0003 NPV strain BV-0003) + SX, Helicoverpa zea NPV + SX, Leucoma salicis NPV + SX, Lumantoria Dispal nuclear polyhedrosis virus ( Lymantria dispar NPV) + SX, Mamestra brassicae NPV + SX, Mamestra configurata NPV + SX, Neodiprion Avientis Nuclear Polyhedrosis Virus (Neodiprion abietis NPV) + SX, Neodiprion lecontei NPV + SX, Neodiprion sertifer NPV + SX, Orgia Psoid Tsugata Nuclear Polyhedrosis Orgyia pseudotsugata NPV + SX, Pepino mosaic virus strain CH2 isolate 1906 + SX, Phthhorimaea operculella GV + SX, Pieris Lapae Granular disease virus (Pieris rapae GV) ) + SX, Prodia interpunctella GV + SX, Plutella xylostella GV + SX, Spodoptera albula mNPV + SX, Spodoptera exempta mNPV + SX, Spodoptera exigua mNPV strain BV-0004 + SX, Spodoptera exigua mNPV strain BV-0004 + SX, Spodoptera frugiperda mNPV) + SX, Spodoptera littoralis mNPV + SX, Spodoptera litura NPV + SX, Tobacco mild green tobacco virus U2 strain tobamovirus strain U2) + SX, Zucchini Yellow Mosaik Virus weak strain + SX.

Subgroup (j-5): Combination of this component of C. elegans and this compound:
Abbreviata caucasica + SX, Acuaria spp. (Acuaria spp.) + SX, Agamermis decaudata + SX, Allantonema spp. (Allantonema spp.) + SX, Amphimermis spp. .) + SX, Deladenus siricidicola + SX, Bobienema spp. (Bovienema spp.) + SX, Cameronia spp. (Cameronia spp.) + SX, Chitwoodiella ovofilamenta , Contortylenchus spp. (Contortylenchus spp.) + SX, Culicimermis spp. (Culicimermis spp.) + SX, Diplotriaena spp. (Diplotriaena spp.) + SX, Empidomermis spp. Filipjevimermis leipsandra + SX, Gastromermis spp. (Gastromermis spp.) + SX, Gongylonema spp. + SX, Gynopoecilia pseudovipara + SX, Heterorhabditis bacteriophora + SX, Heterorhabditis baujardi + SX, Heterorhabditis heliothidis + SX, Heterolabditis heliothidis + SX, Heterorhabditis heliothidis + SX, Heterorhabditis marelatus + SX, Heterorhabditis megidis + SX, Heterorhabditis megidis Ka (Heterorhabditis zealandica) + SX, Hexamermis spp. (Hexamermis spp.) + SX, Hydromermis spp. (Hydromermis spp.) + SX, Isomermis spp. ) + SX, Maupasina weissi + SX, Mermis nigrescens + SX, Mesomermis spp. (Mesomermis spp.) + SX, Neomesomermis spp. (Neomesomermis spp.) + SX, Neoparasici Neoparasitylenchus rugulosi + SX, Octomyomermis spp. (Octomyomermis spp.) + SX, Parasitaphelenchus spp. + SX, Parasitorhabditis spp. ) + SX, Parasitylenchus spp. (Parasitylenchus spp.) + SX, Perutilimermis culicis + SX, Phasmarhabditis hermaphrodita + SX, Phisaloptera spp. Physaloptera spp.) + SX, Protrellatus spp. (Protrellatus spp.) + SX, Pterygodermatites spp. (Pterygodermatites spp.) + SX, Romanomermis spp. ) + SX, Sphaerulariopsis spp. (Sphaerulariopsis spp.) + SX, Spirura guianensis + SX, Steinernema bibionis + SX, Steinernema carpocapsae ( Steinernema carpocapsae + SX, Steinernema feltiae + SX, Steinernema glaseri + SX, Steinernema kraussei + SX, Steinernema kraussei + SX, Steinernema kraussei + SX, Steinernema kraussei + SX Steinernema scapterisci + SX, Steinernema scarabaei + SX, Steinernema siamkayai + SX, Steinernema thailandse + SX, Steinernema thailandse + SX, Steinernema spp. Strelkovimermis peterseni + SX, Subulura spp. (Subulura spp.) + SX, Sulphuretylenchus elongatus + SX, Tetrameles spp. (Tetrameres spp.) + SX.

Subgroup (j-6): Combination of this compound with this component of a product produced by an organism:
BT crop protein Cry1Ab (BT crop protein Cry1Ab) + SX, BT crop protein Cry1Ac (BT crop protein Cry1Ac) + SX, BT crop protein Cry1Fa (BT crop protein Cry1Fa) + SX, BT crop protein Cry1A.105 ( BT crop protein Cry1A.105) + SX, BT crop protein Cry2Ab (BT crop protein Cry2Ab) + SX, BT crop protein Vip3A (BT crop protein Vip3A) + SX, BT crop protein mCry3A (BT crop protein mCry3A) + SX, BT crop protein Cry3Ab (BT crop protein Cry3Ab) + SX, BT crop protein Cry3Bb (BT crop protein Cry3Bb) + SX, BT crop protein Cry34Ab1 / Cry35Ab1 (BT crop protein Cry34Ab1 / Cry35Ab1) + SX, chitin + SX, cow's milk + SX, Ea peptide 91398 (Ea peptide 91398) + SX, Gougerotin + SX, GS-omega / kappa HXTX-Hv1a peptide (GS-omega / kappa HXTX-Hv1a peptide) ) + SX, Harpin protein + SX,

Subgroup (j-7): Combination of this compound with this component of plants and plant extracts:
Ascaridole + SX, azadirachtin + SX, Celastrus angulatus bark of Celastrus angulatus + SX, cevadine + SX, dried leaves of Dryopteris filix-mas + SX, Extract of Allium sativum + SX, extract of Artemisia absinthium + SX, extract of Azadirachta indica + SX, capsicin + SX, deguelin + SX , Cassia nigricans extract of Cassia nigricans + SX, extract of Clitoria ternatea + SX, extract of Equisetum arvense + SX, extract of Matricaria chamomilla + SX, tea tree extract (extract of Melaleuca alternifolia) + SX, insecticide chrysanthemum extract (extract of Pyrethrum), neem tree extract (extract of Reynoutria sachalinensis) + SX, tabog extract (extract from Swinglea glutinosa) + SX, Extract of Symphytum officinale + SX, extract of Tanacetum vulgare + SX, extract of the cotyledons of lupine plantlets ("BLAD")) + SX, neem extract (e) xtract of Tropaeolum majus + SX, extract of Urtica dioica + SX, extract of Viscum album + SX, ginkgolide A + SX, ginkgolide B + SX , Ginkgolide C + SX, Ginkgolide J + SX, Ginkgolide M + SX, leaves and bark of Quercus + SX, matrine + SX, Nootkatone + SX, oil of the seeds of Chenopodium anthelminticum + SX, pellitorine + SX, piperine + SX, Quillaja extract + SX, Rotenone + SX, ryanodine + SX, Saponins of Chenopodium quinoa + SX, seed extract of Schoenocaulon spp. + SX, terpene constituents of the extract of chenopodium ambrosioides near ambrosioides, Brand name: Terpenoid blend QRD 460) + SX, thymol + SX, veratridine + SX, wood extract of Quassia amara + SX, mustard Powder (yellow mustard powder) + SX.

The components selected from group (j) are usually prepared by methods known in the art. For example, in the case of (j-1) bacteria or (j-2) fungi / yeasts, they are prepared by a medium known in the art and a fermentation method known. When this component is (j-1) bacterium or (j-2) fungus / yeast, the preparation thereof is × 10 ⁴ to 1 × 10 ¹³ CFU (colony forming unit) per 1 g, preferably 1 × 10. Contains this component of ⁸ to 1 × 10 ¹² CFU. When this component is a (j-4) virus, the preparation is 1 × 10 ⁴ to 1 × 10 ¹³ inclusions per gram (sometimes referred to as occupation bodies, Obs), preferably 1 ×. Includes this component of 10 ⁸ to 1 × 10 ¹² inclusion bodies (sometimes referred to as Obs). When this component is (j-5) nematode, the preparation contains 1 × 10 ⁴ to 1 × 10 ¹³ individuals, preferably 1 × 10 ⁸ to 1 × 10 ¹² individuals per gram.

This compound can be mixed or used in combination with chemical fertilizers (ammonium sulfate, ammonium nitrate, ammonium nitrate, urea, ammonium chloride, etc.).

The weight ratio between the application rate of this compound and the application rate of this component in Composition A is not particularly limited, but the type of plant to be protected, harmful arthropods to be controlled, harmful nematodes, etc. The weight ratio can be appropriately adjusted according to the type and frequency of occurrence of harmful arthropods, phytopathogenic microorganisms or weeds, formulation form, application time, application method, application location, weather conditions and the like. For example, in the agricultural field, when applied to plants (particularly foliage, seeds, vegetative reproduction organs) or applied to cultivation carriers (particularly soil) for cultivating plants, the following weight ratios can be mentioned.
The weight of this component selected from the group (j) means the weight of the preparation. For example, a weight ratio of 1: 500 means that the application rate of the preparation of one or more components selected from the group (j) is 500 parts by weight with respect to 1 part by weight of the present compound.

Weight ratio [(this compound): (this component)] = 1:10 ^ 15 to 10 ^ 15: 1, specifically, for example, approximately 1:10 ^ 15, 1:10 ^ 14, 1:10 ^ 13, 1:10 ^ 12, 1:10 ^ 11, 1:10 ^ 10, 1:10 ^ 9, 1:10 ^ 8, 1:10 ^ 7, 1:10 ^ 6, 1:10 ^ 5, 1: 10000, 1: 9000, 1: 8000, 1: 7000, 1: 6000, 1: 5000, 1: 4000, 1: 3000, 1: 2000, 1: 1000, 1: 900, 1: 800, 1: 700, 1: 600, 1: 500, 1: 400, 1: 350, 1: 300, 1: 250, 1: 200, 1: 150, 1: 100, 1:90, 1:80, 1:70, 1:60, 1:50, 1:40, 1:30, 1:20, 1:19, 1:18, 1:17, 1:16, 1:15, 1:14, 1:13, 1: 12, 1:11, 1:10, 1: 9, 1: 8, 1: 7, 1: 6, 1: 5, 2: 9, 1: 4, 2: 7, 3:10, 1: 3, 3: 8, 2: 5, 3: 7, 4: 9, 1: 2, 5: 9, 4: 7, 3: 5, 5: 8, 2: 3, 7:10, 5: 7, 3: 4, 7: 9, 4: 5, 5: 6, 6: 7, 7: 8, 8: 9, 9:10, 1: 1, 10: 9, 9: 8, 8: 7, 7: 6, 6: 5, 5: 4, 9: 7, 4: 3, 7: 5, 10: 7, 3: 2, 8: 5, 5: 3, 7: 4, 9: 5, 2: 1, 9: 4, 7: 3, 5: 2, 8: 3, 3: 1, 10: 3, 7: 2, 4: 1, 9: 2, 5: 1, 6: 1, 7: 1, 8: 1, 9: 1, 10: 1, 11: 1, 12: 1, 13: 1, 14: 1, 15: 1, 16: 1, 17: 1, 18: 1, 19: 1, 20: 1, 30: 1, 40: 1, 50: 1, 60: 1, 70: 1, 80: 1, 90: 1, 100: 1, 150: 1, 200: 1, 250: 1, 300: 1, 400: 1, 500: 1, 600: 1, 700: 1, 800: 1, 900: 1, 1000: 1, 2000: 1, 3000: 1, 4000: 1, 5000: 1, 6000: 1, 7000: 1, 8000: 1,9000: 1,10000: 1, 10 ^ 5: 1, 10 ^ 6: 1, 10 ^ 7: 1, 10 ^ 8: 1, 10 ^ 9: 1, 10 ^ 10: 1, 10 ^ 11: 1, 10 ^ 12: 1, 10 ^ 13: 1, 10 ^ 14: 1, 10 ^ 15: 1. Here, the caret symbol "^" is an operator representing a power, and for example, "10 ^ ⁵ " means "105" (that is, 10 to the 5th power). Approximately in the preceding paragraph includes the range of the ratio increased or decreased by 10% by weight with respect to the specified ratio. For example, if it is about 1: 2, it includes the range of 1: 1.8 to 1: 2.2.

This compound or composition A is usually used as a composition further containing an inert carrier (hereinafter referred to as composition B). The composition B is usually a mixture of the present compound or the composition A with a solid carrier, a liquid carrier, a surfactant, or the like, and if necessary, a pharmaceutical auxiliary such as a binder, a dispersant, a stabilizer, or a gas. Add to aqueous suspension, oil-based suspension, emulsion, emulsion, microemulsion, microcapsule, wettable powder, granule wettable powder, powder, granule, tablet, aerosol, resin, etc. It is formulated and used. Not limited to these formulations, Manual on development and use of FAO and WHO Specifications for pesticides, FAO Plant Production and Protection Papers-271-276, prepared by the FAO / WHO Joint Meeting on Pesticide Specifications, 2016, ISSN: 0259-2517 It can be formulated and used in the dosage form described in 1.
Further, the composition B is, for example, a spray agent (aerosol agent, pump spray agent, ultrasonic vibration type preparation, electrostatic spray type preparation, etc.), poison bait agent, burning agent (incense, etc.), heat evaporative agent (electric mosquito repellent mat, etc.). , Liquid mosquito repellent, etc.), Blower-type evaporative (fan-type mosquito repellent, etc.), Smoke agent (self-combustible smoke agent, chemical reaction type smoke agent, porous ceramic plate smoke agent, etc.), smoke agent, smoke mist Agents, ULV agents, mist agents, foam agents, paste-like formulations, paints, wood protective paints, sealants, carbon dioxide gas formulations, sheet formulations, tape formulations, paper formulations, non-woven formulations, animal collars, animal ear tags, shampoos. Processed into agents, spot-on agents, poreon agents, suppositories, injections, oral treatment agents (capsules, tablets, chewable agents, feeds, etc.), sublimative tablets, mosquito nets, attracting strings, garden stanchions, and net doors. , May be used.
These preparations usually contain 0.0001 to 99%, preferably 0.1 to 99%, more preferably 0.2 to 90% of the present compound by weight.

When the compound or composition A is formulated into an aqueous suspension, an oil suspension, a wettable powder, or a granule wettable powder, the particle size of the compound or composition A is usually 0.1 to 20 μm, preferably 0.1 to 20 μm. Is in the range of 0.2 μm to 15 μm. When the compound or composition A is formulated into granules, the particle size of the compound or composition A is usually in the range of 0.1 to 200 μm, preferably 0.5 μm to 100 μm. The particle size of this compound or composition A means a particle size (medium volume size) in which the cumulative frequency is 50% in a volume-based frequency distribution, and is obtained by wet measurement using a laser diffraction type particle size distribution measuring device. be able to. Examples of the laser diffraction type particle size measuring device include a master sizer 3000 manufactured by Malvern.
The cumulative frequency in the volume-based frequency distribution can be expressed based on any percentage other than the medium (50%), and the preferable range is "a volume of 40% diameter is 2.5 μm to a volume of 60% diameter is 2. It can also be expressed as "5 μm" or the like. Further, it can be expressed by a weight middle diameter other than the volume middle diameter, and can be further expressed by an arbitrary percentage.

Examples of the solid carrier include the following.
Inorganic substances: Minerals (natural silicate, marble, peatstone, limestone, rare earth minerals, glacial stone, activated white clay, lime, activated charcoal, talc, attapargit, sodium montmorillonite, calcium montmorillonite, kaolinite, calcite, dolomite, diatomite, Bentnite, zeolite, sepiolite, pyrophyllite, vermiculite, crystalline silica, amorphous silica, etc.), silicon dioxide, calcium sulfate, magnesium sulfate, barium sulfate, magnesium oxide, aluminum oxide, ammonium sulfate, ammonium phosphate, ammonium nitrate, calcium phosphate , Sulfur, calcium carbonate, sodium hydrogen carbonate, sodium carbonate, synthetic silicates, and pulverized products thereof;
Organics: Grain powders (rice bran, rice flour, corn powder, wheat flour, etc.), sugars (cellulose, starch, lignin, glucose, fructose, sucrose, etc.), plant-derived powders (ground nutshell (coconut, walnut, peanut, etc.) Nut shell crushed product), tree-derived powder (bark powder, shavings, etc.), other plant crushed products (cigarette stalk, soybean, cotton husk, etc.), lignin, wax, shell, urea, polyethylene, polypropylene, Polyvinyl alcohol, polycarbonate, polyester, polyamide, polyurethane, polyvinyl chloride, polyvinyl acetate, ethylene-vinyl acetate copolymer, ethylene-methyl methacrylate copolymer, polyvinylpyrrolidone-methacrylic acid copolymer, polyvinylpyrrolidone-acetic acid Vinyl copolymers, cellulose derivatives, phenol resins, melamine resins, epoxy resins.
Further, the above solid carrier can also be used as an adsorption carrier.

Examples of the liquid carrier include water, aliphatic hydrocarbons (hexane, 1-hexene, cyclohexane, octane, isooctane, 1-heptene, d-limonene, pinene, hexadecane, etc.).
Aromatic hydrocarbons (alkylbenzene (toluene, xylene, isopropylbenzene, p-diethylbenzene, etc.), alkylbenzene derivatives, alkylnaphthalene, alkylnaphthalene derivatives, tetrahydronaphthalene, etc.), chlorinated hydrocarbons (monochromoethylene, dichloroethylene, trichloroethylene, tetrachloroethylene, etc.) , Dichloromethane, 1,1,1-trichloroethane, 1,1,2-trichloroethane, 1,2-dichloropropane, etc.), ketones (cyclohexanone, acetone, 2-heptanone, isophorone, mesityl oxide, methylisoamylketone, methylethylketone , Methylisobutylketone, acetophenone, diacetone alcohol, methylcyclohexanone, etc.), Esters (fatty acid esters (ethyl acetate, butyl acetate, amyl acetate, isoamyl acetate, isobornyl acetate, hexyl acetate, heptyl acetate, octyl acetate, isopropyl myristate, etc.) Methyl octanate, methyl oleate, methyl laurate, dibutyl adipate, tributyl citrate, dibutyl phthalate, etc.), lactic acid ester (ethyl lactam, propyl lactam, etc.), carbonate ester (ethylene carbonate, propylene carbonate, butylene carbonate, carbonic acid, etc.) Diethyl, dibutyl carbonate, etc.), esterified polyols (glycerol acetate, glycol acetate, glycerin monoacetate, glycerin diacetate, glycerin triacetate, diethylene glycol aviatete, dipropylene glycol dibenzoate, dipropylene glycol monomethyl ester, etc.), lactone (γ) -Butyl lactone, etc.), ethers (1,4-dioxane, tetrahydrofuran, dipropylene glycol methyl ether, ethylene glycol methyl ether, propylene glycol methyl ether, etc.), amides (N-octyl-caprolactam, N-dodecyl-caprolactam, etc.) N, N-dimethylformamide, fatty acid dimethylamide (N, N-dimethylacetamide, N, N-dimethyldecaneamide, N, N-dimethyloctaneamide, etc.), alkylpyrrolidone (N-methylpyrrolidone, N-octyl-pyrrolidone, etc.) N-dodecyl-pyrrolidone, etc.), lactam (α-lactam, β-lactam, γ-lactam, δ-lactam, etc.), amines (octylamine, octylamine acetate, oleylamine, diethanolamine, laurylamine, etc.), alcohol Lus (methanol, ethanol, butanol, propanol, isopropanol, butanol, amyl alcohol, hexanol, heptanol, octanol, 2-ethylhexanol, etc.), hexylene glycol, cyclohexanol, phenol, benzyl alcohol, methoxypropanol (1-methoxy- 2-propanol), tetrahydrofurfuryl alcohol, furfuryl alcohol, polyethylene glycol, ethylene glucol, diethylene glycol, hexylene glycol, ethylene glycol methyl ether, diethylene glycol methyl ether, diethylene glycol butyl ether, triethylene glycol, propylene glycol methyl ether, dipropylene Glycol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol butyl ether, dipropylene glycol methyl ether, dipropylene glycol ether, dipropylene glycol monomethyl ether, glycerin, etc.), mineral oils (naphtha, petroleum ether, kerosene, diesel) Oils (oils, paraffins, olefins, etc.), animal and plant-derived oils, plant-derived oils (palm oil, rapeseed oil, castor oil, coconut oil, soybean oil and derivatives thereof, etc.), animal-derived oils (squid oil, saury) Oils, whale oils and derivatives thereof, etc.), dimethyl sulfoxide, silicone oil, acetonitrile, propanenitrile, acid anhydrides (such as anhydrous acetic acid), triethyl phosphate, oleic acid, propionic acid, lactic acid, and xylene sulfonic acid.

Examples of the gaseous carrier include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, nitrogen, and carbon dioxide gas.

Examples of the anionic surfactant include carboxylic acids, sulfonic acids, sulfuric acid esters, and phosphoric acid esters, and specific examples thereof include the following.
Carboxyl acids: fatty acid salts (octanate, decanoate, laurate, myristate, palmitate, stearate, behenate, oleate, polyoxyethylene alkyl ether carboxylate (laures-3) -Carboxate, α- (carboxymethyl) -ω- (dodecyloxy) poly (oxyethylene) salt, etc.), N-acylsulfosin salt (N-lauroylsulfosin salt, etc.), N-acylglutamate (N-lauroyl) Glutamate, etc.), Polycarboxylate (polyacrylic acid, polyvinyl acetate, comb polymer of polyate, and derivatives thereof, etc.), Sulfonic acids: Alkyl sulfonic acid and its salts (dodecyl sulfonic acid, etc.), Alpha Olefin Sulfonate (Alken (C14-18) Hydroxysphonate, Alkapoliene (C12-20) Hydroxyshonate, Alken (C14-18) Hydroxyshonate, Alken (C12-20) Hydroxyshonate , Tetradecene-1-sulfonate, α-olefin (C14-16) sulfonate, etc.), Alkylbenzene sulfonate (decylbenzene sulfonate, dodecylbenzene sulfonate, tridecylbenzene sulfonate, diphenylsulfonic acid) (Salt, etc.), Alkylnaphthalene sulfonate (naphthalene sulfonate, 6-methyl-2-naphthalene sulfonate, dibutylnaphthalene sulfonate, 2,2'-dinaphthylmethane-6,6'-disulfonate, Diisopropylnaphthalene sulfonate, triisopropylnaphthalene sulfonate, 1-isopropyl2-naphthalene sulfonate, etc.), sulfosuccinic acid, monoalkyl sulfosuccinate, dialkyl sulfosuccinate, (di (2-ethylhexyl) sulfosuccinate, etc.) ), N-Methyl-N-acyltaurine salt (oleoylmethyltaurate, etc.), lignin sulfonate, alkylphenol sulfonate, naphthalene sulfonate-formaldehyde condensate, benzimidazole sulfonate and its derivatives, sulfuric acid As esters, alkyl sulfates (hexyl sulfate, heptyl sulfate, octyl sulfate, lauryl sulfate, lauryl sulfate diethanol salt, hexadecyl sulfate, octadecyl sulfate, etc.), polyoxyethylene alkyl ether sulfate and salts thereof (laures). -3-Sulfonate, polyoxyethylene monotridecyl ether sulfate, α-sulfo-ω-hydroxyalkyl (C6-10) Ether poly (oxyethylene) salt, etc.), Polyoxyethylene alkylphenyl ether sulfate (poly (oxyethylene) 2-decylphenyl ether sulfate, poly (oxyethylene) 3-decylphenyl ether sulfate, etc.) α-sulfo-ω- [2,4-bis (1,1,3,3-tetramethylbutyl) phenoxy] poly (oxyethylene) salt, etc.), polyoxypropylene alkyl ether sulfate, ligno sulfite waste liquid, and These derivatives;
Phosphoric acid esters: alkyl phosphates (propyl phosphates, hexadecyl phosphates, lauryl phosphates, dioctyl phosphates, etc.), polyoxyethylene alkyl ether phosphates (polyoxyethylene decyl phosphate esters, etc.) α-Phonono-ω-butoxypoly (oxyethylene), etc.), polyoxyethylene alkylphenyl ether phosphate (α- (dinonylphenyl) -ω-hydroxypoly (oxyethylene) phosphate ester, α- (dodecylphenyl) -Ω-Hydroxypoly (oxyethylene) phosphate ester, α- (nonylphenyl) -ω-hydroxypoly (oxyethylene) phosphate ester, etc.), polyoxypropylene alkyl ether phosphate, and derivatives thereof.

Examples of the cationic surfactant include amine salts and quaternary ammonium salts, and specific examples thereof include the following.
Amine salts: Alkylamine salts (monomethylamine salt, dimethylamine salt, trimethylamine salt, etc.), fatty acid amidoamine salts (stealamidopropyldimethylamine, behenamidepropyldimethylamine, etc.), polyamine salts (polyvinylamine, polyethyleneimine, etc.), And its derivatives;
Tertiary ammonium salts: lauryltrimethylammonium salt, cetyltrimethylammonium salt, dodecyltrimethylammonium salt, stearyltrimethylammonium salt, pensalconium chloride, benzethonium chloride, benzylbis (2-chloroethyl) brominated ethylammonium salt.

Examples of the zwitterionic surfactant include betaine, alkylbetaine, alkyldimethylbetaine, imidazoline, taurine, alkyltaurine, dodecyldimethylammonioacetate, 4-carboxy-N, N, N-trimethyl-1-butanaminium, and the like. 1-carboxy-N, N, N-2-tetramethyl-1-propanaminium, N-alkyl (or alkenyl) (C12-18) glycine and its salts, N-dodecylglycine and its salts, and derivatives thereof. Can be mentioned.

Examples of the nonionic surfactant include alcohols, amides, amines, esters, ethers, ether esters, and carboxylic acids, and specific examples thereof include the following.
Alcohols: Aromatic alcohols (alkylphenols (allylphenols, octylphenols, nonylphenols, octylcresols, etc.), acylphenols, etc.), aliphatic alcohols (isotridecyl alcohols, oleyl alcohols, cetyl alcohols, etc.), polyhydric alcohols (polysaccharides, etc.) Starch, starch derivative, sucrose, alkylpolyglucoside, sorbitan, ethoxylated sorbitan, cellulose derivative, arabic rubber, etc.), synthetic polymer (polyvinyl alcohol, polyethylene glycol, etc.);
Amides: alkanol amides (fatty acid alkanol amides (lauric acid diethanolamides, etc.), fatty acid glucamides (alkenylated propylene oxide fatty acid glucamides, etc.), alkoxylated amides (polyoxyethylene oleic acid amides, polyoxyethylene stearate amides, etc.), synthetic Polymers (polyvinylpyrrolidone, etc.),
Amines: Alkoxyylated amines (polyoxyethylene oleylamine, α, α'-[(9-octadecenylimino) di2,1-ethandyl] bis (ω-hydroxy) polyoxyethylene, etc.);
Esters: fatty acid esters (polypolymer fatty acid esters, monoglycerides, phospholipids, etc.), sugar-derived esters (sucrose fatty acid esters (sucrose stearic acid diesters, etc.), sorbitan fatty acid esters (sorbitan oleic acid monoesters, etc.), glucose esters. , Cellulous ester, etc.), Synthetic polymer (vinyl acetate copolymer, polymethacrylic acid, copolymer of methacrylic acid and methacrylic ester, etc.);
Ethers: alcohol ethoxylates (aliphatic alcohol ethoxylates (tridecyl alcohol ethoxylates, isooctyl alcohol ethoxylates, lauryl alcohol ethoxylates, hexadecyl alcohol ethoxylates, stearyl alcohol ethoxylates), etc.), alkylphenol ethoxylates (nonylphenolethoxylates), etc. Rate, tristylylphenol ethoxylate, tributylphenol ethoxylate, octylphenol ethoxylate, etc.), arylalkylphenol ethoxylate, arylphenol ethoxylate (monobenzylbiphenol alcohol ethoxylate, etc.), alcohol propoxylate (aliphatic alcohol propoxylate, alkylphenol propoxylate, etc.) Rate, arylalkylphenol propoxylate, etc.), block polymer (block polymer of polyethylene oxide and polypropylene oxide, polyethylene oxide block polymer, polypropylene oxide block polymer, block polymer of alkanol, polyethylene oxide and polypropylene oxide, etc.);
Ether esters: polyoxyethylene fatty acid esters (polyoxyethylene castor oil ester, polyoxyethylene stearate ester, polyoxyethylene beef fatty acid ester, etc.), polyoxyethylene sorbitan fatty acid ester (polyoxyethylene sorbitan monooleic acid ester, poly) Oxyethylene sorbitan trioleic acid ester, polyoxyethylene sorbitan monolauric acid ester, polyoxyethylene sorbitan stearate ester, etc.), polyoxyethylene fatty acid amine ester, polyoxyethylene rosin ester, polyoxypropylene fatty acid ester (polyoxypropylene bean oil) Esters, etc.), Polyoxypropylene fatty acid amine esters;
Carvones: Undecafluorohexanoic acid.

Other pharmaceutical aids include, for example, thickeners, antifreeze / moisturizers, defoamers, antioxidants, pH adjusters, colorants, preservatives / fungicides, binders, binders / spreading agents. Binders, lubricants / lubricants, anti-caking agents, light stabilizers, fragrances, propellants, fertilizers, film agents, deodorants, plasticizers, desiccants / moisture proofing agents, smoke agents, auxiliary materials, attractants There are agents, inclusion agents, and efficacy enhancers, and specific examples thereof include the following.
Thickeners: polysaccharides (xanthan gum, cellulose ester, cellulose ether, carboxymethyl cellulose and its salts, dextrin, starch, guar gum, arabic gum, hydroxypropyl guar gum, tyrose, caraginan, etc.), clays (organic clay, organic modified clay, etc.) Inorganic clay, inorganic modified clay, etc.), minerals (bentonite, attapulsite, silica, silicate, etc.), synthetic polymers (polycarboxylate, polysaccharide derivative, polyvinylpyrrolidone, polyvinyl alcohol, etc.);
Antifreeze / Moisturizer: Alcohols (ethylene glycol, propylene glycol, dipropylene glycol, triethylene glycol, ethylene glycol methyl ether, propylene glycol methyl ether, dipropylene glycol methyl ether, ethylene glycol butyl ether, glycerin, polyethylene glycol, etc.) , Esters (dipropylene glycol dibenzoate, glycerol acetate, glycerol diacetate, glycerol triacetate, gamma butyrolactone, etc.), ethers (1,4-dioxane, etc.), urea;
Defoamers: Silicones (polysiloxane, diblockethoxylsiloxane, triblockethoxylsiloxane, etc.), alkylsulfosuccinates, higher alcohols, higher alcohol derivatives, fatty acid salts, fatty acid derivatives;
Antioxidants: Phenols (2,6-di-t-butyl-p-cresol, 2,2'-methylenebis (4-methyl-6-t-butylphenol), etc.), amines (p, p'-dioctyl) Diphenylamine, N, N'-diphenyl-p-phenylenediamine, etc.), dibutylhydroxytoluene, butylhydroxyanisole, sodium erythorbic acid, sodium sulfite, potassium sulfite, potassium pyrosulfate, catechin, propyl gallate, sulfurs (thiodipropion) Acid didodecyl, etc.), phosphates (trisnonylphenylphosphite, etc.), vitamins (alphatocopherol, L-ascorbic acid, sodium ascorbic acid, ascorbic acid palmitate, etc.);
Acidity regulators: sulfuric acid, nitric acid, hydrochloric acid, acetic acid, carbonic acid, oxalic acid, lactic acid, succinic acid, gluconic acid, citric acid, phosphoric acid, sorbic acid, and salts thereof, sodium hydrogencarbonate, sodium hydroxide, potassium hydroxide. , Calcium Hydroxide, Aluminum Hydroxide, Copper Hydroxide, Magnesium Hydroxide;
Colorants: Monoazos (Pigment Red 48: 1, Pigment Red 48: 2, Pigment Red 53: 1, Pigment Red 57: 1, Pigment Red 112, Pigment Brown 25, Cl Solvent Red 1, Pigment Yellow 1, Pigment Orange 5 , Acid Red 14, Acid Yellow 23, etc.), Zinc Oxides (Pigment Yellow 13, Pigment Orange 34, etc.), Phthalocyanins (Pigment Blue 15: 1, Pigment Blue 15: 2, Pigment Blue 15: 3, Pigment Blue 15: 4) , Pigment Green 7, Pigment Green 36, etc.), Anthraquinone (Pigment Red 83, etc.), Zinc Oxide (Pigment Blue 80, etc.), Xantene (Basic Violet 10 (Rhodamine B), Acid Red 51, Acid Red 52, etc.), Triarylmethane (Acid Blue 9 etc.), Pigment Orange 43, Iron Oxide, Titanium, Titanium Oxide, Zinc Oxide, Zinc Sulfide, Hexacyanoate Iron Salt, Chrome Vermillion, Chrome Yellow, Calcium Carbonate, Barite Powder, Aluminum Powder;
Preservatives / bactericides: Phenols (orthophenylphenol, timol, 3,5-dimethyl-4-chlorophenol, etc.), isothiazolinone derivatives (methylisothiazolinone (2-methyl-4-isothiazolin-3-one), chloro Methylisothiazolinone (5-chloro-2-methyl-4-isothiazolin-3-one), octylisothiazolinone (2-n-octyl-4-isothiazolin-3-one), dichlorooctylisothiazolinone (4,) 5-Dichloro-2-octyl-4-isothiazolin-3-one), benzisothiazolinone (1,2-benzisothiazolin-3-one), etc.)), bronopol derivative (bronopol (2-bromo-2-nitropropane) -1,3-diol), etc.) benzyl alcohol hemihomal, isopropylmethylphenol, parabens (methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, heptylparaben, benzylparaben), imidazoles (thiabendazole) ), Benzalconium chloride, glyceryl caprylate, glyceryl caprate, glycerin fatty acid ester, sodium dehydroacetate, hinokithiol, acids (citrate, phosphate, sorbic acid, salicylic acid, benzoic acid, and salts thereof);
Binders: Polysaccharides (xanthan gum, cellulose ester, cellulose ether, carboxymethyl cellulose, hydroxypropyl guar gum, guar gum, natural arabic gum, synthetic arabic gum, dextrin, starch, caraginan, etc.), clays (organic clay, organic modified clay, inorganic) Clays, inorganic modified clays), minerals (bentonites), synthetic polymers (polycarboxylic acids or salts thereof, polyvinylpyrrolidone, vinyl acetate, polyvinyl alcohols, polyacrylic acids or salts thereof), waxes (vegetable fats and oils, animal fats and oils, and these). Derivatives, paraffins, olefins, etc.);
Fixing agent / spreading agent: Esters (alkyl fatty acid ester, sorbitan fatty acid ester, ethoxylated fatty acid ester, ethoxysorbitan fatty acid, etc.), alcohols (ethoxylated aliphatic alcohol, ethoxylsorbitan, etc.) and liquid carriers described above. (Adipose alcohols, etc.), waxes (vegetable fats and oils, animal fats and oils, and derivatives thereof, paraffins, olefins, etc.), vegetable oils (alkylated vegetable oils, etc.), mineral oils (mineral oils, etc.), silicone emulsions, synthetic polymers (styrene). -Butadiene copolymer, methyl methacrylate-butadiene copolymer, polyacrylic acid or a salt thereof, polyvinyl acetate, polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol, polypropylene glycol, etc.), natural polymers (xanthan gum, cellulose ester, etc.) Cellulose ether, carboxymethyl cellulose or a salt thereof, dextrin, starch, guar gum, arabic gum, hydroxypropyl guar gum, tyrose, etc.);
Lubricants / Lubricants: Alcohols, fatty acid esters, sucrose fatty acid esters, glycerin fatty acid esters, hydrocarbons, paraffins, ethylene waxes, aliphatic amides, elca described in the liquid carriers and surfactants described above. Acid amide, stearic acid amide, oleic acid amide, methylene bisstearic acid amide, ethylene bisstearic acid amide, metal soaps, lead stearate, zinc stearate, calcium stearate, magnesium stearate, mineral oil, vegetable oil, kerosene, diesel oil;
Anti-caking agents: solid or liquid carriers described above, calcium phosphate, sodium phosphate, sodium carbonate, sodium silicate, calcium silicate, magnesium silicate, aluminum potassium silicate, silicon dioxide, talc, sodium aluminosilicate, aluminokei. Calcium phosphate, bentonite, stearic acid, dimethylpolysiloxane, powdered cellulose;
Photostabilizers: titanium oxide, zinc oxide, activated carbon, carbon black, ethylhexyl methoxycinnamate, tert-butylmethoxydibenzoylmethane, hindered amines, ferulic acid, phenyl hydroxybenzoate, ethyl paraaminobenzoate, octyl salicylate, salicylic acid- t-butylphenyl, salicylic acid-4-tert-octylphenyl, 2-cyano-3,3-diphenylprop-2-enoic acid-2-ethylhexyl ester (octocrylene), drometrizoletrisiloxane, 2,4,6- Tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine (octylriazone, TEAT), 2,2'-methylenebis [6- (2H-benzotriazole-2-yl) -4 -(1,1,3,3-Tetramethylbutyl) Phenol] (MBP), 2-ethylhexyl paradimethylaminobenzoate (EDB), homomentyl salicylate (HS), phenylbenzimidazole sulfonic acid (PBS), hydroxy Methoxybenzophenone sulfonic acid (oxybenzone 4, OXB4), sodium hydroxymethoxybenzophenone sulfonate (oxybenzone 5, OXB5), sodium dihydroxydimethoxybenzophenone disulfonate (oxybenzone 9, OXB9), tetrahydroxybenzophenone, dihydroxybenzophenone, dihydroxydimethoxybenzophenone, 2- Hydroxy-4-methoxybenzophenone, dimethoxybenzilidendioxoimidazolidinepropionate-2-ethylhexyl, 2,4-dihydroxybenzophenone, bis (2-methoxy-4-hydroxy-5-benzoylphenyl) methane;
Fragrances: Hydrocarbons, α-Limonene, β-cariophyllene, alcohols, cis-3-hexenol, linalol, phenolesole, β-phenylethyl alcohol, aldehydes, 2,6-nonagenal, citral, α-hexyl cinnamic aldehyde , Ketones, β-ionone, L-carboxylic, cyclopentadecanone, esters, linaryl acetate, benzylbenzoate, lactones, γ-undecalactone, phenols, eugenol, oxides, rose oxides, acetals, phenyl Acetaldehyde dimethyl acetal, α pinen, β pinen;
Propellant: liquefied petroleum gas, propane, normal butane, isopentane, normal pentane, isopentane and other aliphatic hydrocarbons having 3 to 5 carbon atoms, trans-1,3,3,3-tetrafluoropropa-1-ene, Hydrofluoroolefins such as trans-2,3,3,3-tetrafluoropropa-1-ene, dimethyl ether, nitrogen gas, carbon dioxide gas, nitrous oxide gas, compressed air, and mixtures thereof;
Fertilizer: Nitrogen fertilizer components (urea, ammonium nitrate, ammonium nitrate, ammonium chloride, ammonium sulfate, ammonium phosphate, sodium nitrate, calcium nitrate, potassium nitrate, lime nitrogen, formaldehyde processed urea (UF), acetaldehyde processed urea (CDU), Isobutylaldehyde processed urea (IBDU), guanyureurea (GU)), phosphoric acid fertilizer components (lime perphosphate, lime overphosphate, fused phosphorus, phosphorus rot, calcined phosphorus, heavy burned phosphorus, bitter soil excess Phosphoric acid, ammonium polyphosphate, potassium metaphosphate, calcium metaphosphate, bittersweet phosphoric acid, phosphorus sulfur, potassium phosphorus, potassium salt phosphorus, etc.), potassium fertilizer components (potassium chloride, potassium sulfate, potassium sulfate, potassium sulfate) Soil, potassium bicarbonate, potassium phosphate, etc.), siliceous fertilizer component (calcium silicate, etc.), magnesium fertilizer component (magnesium sulfate, magnesium chloride, etc.), calcium fertilizer component (fresh lime, slaked lime, calcium carbonate, etc.) , Manganese fertilizer component (manganese sulfate, sulphate manganese, mineral manganese, etc.), boron fertilizer component (boric acid, borate, etc.), iron-containing fertilizer component (steel slag, etc.), other fertilizer components (copper, cobalt, etc.) , Zinc, etc.);
Membrane: Natural rubber, synthetic rubber, resin (styrene butadiene copolymer, polyacrylonitrile, polyester, polyamide, polyurethane, polyurea, polyether, rosin, melamine, etc.), wax (vegetable fat, animal fat, and derivatives thereof, etc.) Paraffins, olefins, etc.), polysaccharides (xanthan gum, cellulose esters, cellulose ethers, carboxymethyl cellulose or salts thereof, dextrin, starch, guar gum, Arabic gum, hydroxypropyl guar gum, tyrose, starch xanthate, caraginan, etc.), proteins (gelatin, etc.) ;
Deodorant: organic clay, organic modified clay, unmodified clay, zinc silicate, silica gel;
Plastics: Triethyl Phosphate, Citrate Ester, Phthalate Ester, Adipic Acid Ester, Sebasic Acid Ester, Phosphate Ester;
Desiccant / moisture proofing agent: silica gel, calcium chloride, quicklime, aluminum oxide, zeolite, allophane;
Smoker aids: nitrocellulose, potassium chlorate, calcium oxide, melamine, potassium nitrate, azodicarbonamide;
Attractants: starch, cellulose, dextrins, vinegars, alcoholic beverages, yeast extract;
Encapsulation agents: cyclodextrins, α-cyclodextrins, β-cyclodextrins, γ-cyclodextrins;
Efficacy enhancer: The liquid carrier or surfactant described above.

When the present compound or composition A is formulated into an aqueous suspension preparation or an oil suspension preparation, an antifreeze agent and / or a preservative is usually added. Preferred examples of the antifreeze agent include ethylene glycol, propylene glycol and glycerin. As the preservative, isothiazolinone derivatives (eg 2-methyl-4-isothiazolin-3-one, 5-chloro-2-methyl-4-isothiazolin-3-one, 2-n-octyl-4-isothiazolin-) are preferable. 3-on), and proxel (1,2-benzisothiazolin-3-one).
Ethylene glycol (hereinafter referred to as EG), propylene glycol (hereinafter referred to as PG), glycerin (hereinafter referred to as GL), 2-methyl-4-isothiazolin-3-one (hereinafter referred to as EG) used as antifreeze agents and preservatives. Hereinafter referred to as MIT), 5-chloro-2-methyl-4-isothiazolin-3-one (hereinafter referred to as CMIT), 2-n-octyl-4-isothiazolin-3-one (hereinafter referred to as OIT). , 4,5-Dichloro-2-octyl-4-isothiazolin-3-one (hereinafter referred to as DCOIT), 1,2-benzisothiazolin-3-one (hereinafter referred to as BIT) and 2-bromo-2- Nitropropane-1,3-diol (hereinafter referred to as BNPD) is available as a commercial product.

Examples of combinations of the present compound or composition A with the antifreeze agent or preservative are described below.
SX + EG, SX + PG, SX + GL, SX + MIT, SX + CMIT, SX + OIT, SX + DCOIT, SX + BIT, SX + BNPD, Composition A + EG, Composition A + PG, Composition A + GL, composition A + MIT, composition A + CMIT, composition A + OIT, composition A + DCOIT, composition A + BIT, composition A + BNPD.

The weight ratio of the compound or composition A to the antifreeze agent or preservative is in the range of 1: 0.0001 to 1: 100, for example, 1: 0.0001 to 1: 1, 1: 0.005. The range of ~ 1: 0.01, 1: 0.15 to 1: 0.35, 1: 0.125 to 1: 0.25 can be mentioned. As specific weight ratios, 1: 0.0001, 1: 0.0002, 1: 0.0003, 1: 0.0004, 1: 0.0005, 1: 0.0006, 1: 0.0007, 1 : 0.0008, 1: 0.0009, 1: 0.001, 1: 0.002, 1: 0.003, 1: 0.004, 1: 0.005, 1: 0.006, 1: 0 .007, 1: 0.008, 1: 0.009, 1: 0.01, 1: 0.02, 1: 0.03, 1: 0.04, 1: 0.05, 1: 0.06 , 1: 0.07, 1: 0.08, 1: 0.09, 1: 0.1, 1: 0.125, 1: 0.15, 1: 0.2, 1: 0.25, 1 : 0.3, 1: 0.4, 1: 0.5, 1: 0.6, 1: 0.7, 1: 0.8, 1: 0.9, 1: 1, 1: 2, 1 : 3, 1: 4, 1: 5, 1: 6, 1: 7, 1: 8, 1: 9, 1:10, 1:20, 1:30, 1:40, 1:50, 1:60 , 1:70, 1:80, 1:90, 1: 100. The above weight ratio can also be expressed as approximately. Approximately means plus or minus 10%, for example, "approximately 1: 2" is 1: 1.8 to 1: 2.2.

Examples of combinations of the present compound or composition A with the antifreeze agent and the preservative are described below.
SX + EG + MIT, SX + EG + CMIT, SX + EG + OIT, SX + EG + DCOIT, SX + EG + BIT, SX + EG + BNPD, SX + PG + MIT, SX + PG + CMIT, SX + PG + OIT, SX + PG + DCOIT, SX + PG + BIT, SX + PG + BNPD, SX + GL + MIT, SX + GL + CMIT, SX + GL + OIT, SX + GL + DCOIT, SX + GL + BIT, SX + GL + BNPD, Composition A + EG + MIT, Composition A + EG + CMIT, Composition A + EG + OIT, Composition A + EG + DCOIT, Composition A + EG + BIT, Composition A + EG + BNPD, Composition A + PG + MIT, Composition A + PG + CMIT, Composition A + PG + OIT, Composition A + PG + DCOIT, Composition A + PG + BIT, Composition A + PG + BNPD, Composition A + GL + MIT, Composition A + GL + CMIT, Composition A + GL + OIT, Composition A + GL + DCOIT, Composition A + GL + BIT, Composition A + GL + BNPD.
When the compound or composition A is combined with the antifreeze agent and the preservative, the mixing ratio of the compound or composition A with the antifreeze agent and the compound or composition A with the preservative is in the same range as the ratio described above. Can be used in.

In the case of granules and fine granules, a colorant can be added to make it easier to check the granules and fine granules at the time of application and after application. Further, when the composition B is applied to plant seeds and vegetative reproduction organs, a coloring agent can be added in order to make it easy to confirm that the composition B has been applied.

Examples of the base material of the resin preparation include polyethylene, polypropylene, polyvinyl alcohol, polycarbonate, polyester, polyamide, polyurethane, polyvinyl chloride, polyvinyl acetate, ethylene-vinyl acetate copolymer, ethylene-methyl methacrylate copolymer, and the like. Examples thereof include polyvinylpyrrolidone-methacrylic acid copolymer, polyvinylpyrrolidone-vinyl acetate copolymer, cellulose derivatives, phenol resin, melamine resin, and epoxy resin. If necessary, plasticizers such as phthalates (dimethyl phthalate, dioctyl phthalate, etc.), adipates, stearic acid, etc. may be added to these substrates. The resin preparation can be processed into various forms by molding as necessary, and examples thereof include a plate shape, a film shape, a tape shape, a thread shape, a net shape, a cloth shape, a string shape, and a block shape. It can be used in the form of an animal collar, an animal ear tag, clothing, a protective hat, an arm / foot cover, an attracting string, a gardening prop, a screen door, a mosquito net, or the like. It can also be obtained by post-treating the composition B after molding the resin.
Examples of the base material of the poison bait include grain flour, vegetable oil, sugar, crystalline cellulose and the like, and if necessary, storage of antioxidants such as dibutylhydroxytoluene and nordihydroguairetinic acid, and dehydroacetic acid. Additives, anti-ingestion agents for children and pets such as sugar cane powder, cheese flavors, onion flavors, pest-attracting flavors such as peanut oil, and the like.

It can be controlled by applying an effective amount of the compound, composition A or composition B directly to pest arthropods or to the habitat of pests. The habitat referred to here includes not only the place where harmful arthropods inhabit but also the place where they are expected to inhabit. Specific examples thereof include plants, plant cultivation areas, plant cultivation carriers, indoor and outdoor buildings, building materials, foods, daily necessities, wood, vehicles, animals and the like.

In the present invention, the plant includes the whole plant and a specific part of the plant. Specific parts of the plant include, for example, foliage, flowers, ears, fruits, trunks, branches, crowns, seeds, vegetative reproduction organs and seedlings.

The vegetative reproduction organ means a plant's roots, stems, leaves, etc., which have the ability to grow when the part is separated from the main body and placed in the soil. The vegetative organs include, for example, tuberous root, creeping root, bulb, corm or solid bulb, tuber, rhizome, stolon. , Rhizophore, cane cuttings, propagule and vine cutting. The stolon is sometimes called a runner, and the propagule is also called a pearl bud, and is divided into a broad bud and a bulbil. Vine means seedlings (collective term for leaves and stems, shoot) such as sweet potato and yam. Bulbs, corms, tubers, rhizomes, stem fragments, rhizomes or tubers are collectively also called bulbs. Cultivation of potatoes begins by planting tubers in the soil, but the tubers used are commonly referred to as seed potatoes.

Seedlings include seedlings and saplings.

Examples of the cultivated land of plants include cultivated lands such as fields, paddy fields and orchards, and non-agricultural lands such as lawns and forests.

The plant cultivation carrier may be a support of the plant and may be made of a material capable of growing the plant, and examples thereof include soil, a nursery mat, and water. Specific materials for soil and nursery mats include, for example, sand, pumice, vermiculite, diatomaceous earth, gelled substances, polymeric substances, rock wool, glass wool, wood chips and bark.

Buildings include, for example, private homes, commercial facilities, stations, airports, hospitals, factories, offices, schools, lodging facilities, waste disposal facilities, barns, and warehouses. Examples of indoors of a building include a closet, a closet, a chest of drawers, a cupboard, a toilet, a bath, a storeroom, a living room, a bedroom, and a dining room.

Outdoors include, for example, ground, outer walls, walls, ditches, spaces, puddles, reservoir tanks, wells, puddles, rain gutters, gutters, septic tanks, old tires, reservoirs, rivers, waterways, forests, lakes and marshes.

Examples of building materials include wood, concrete, brick, plastic, glass, wallpaper, heat insulating materials, packings, pipes, electric wires and cables, paints, and sealing materials.

Examples of foods include agricultural products (grains, fruits, spices, and processed products thereof, etc.) and livestock and marine products (meat, fish, eggs, milk, and processed products thereof, etc.). In addition, daily necessities include plant-derived products (cotton, paper, tobacco, and processed products), animal-derived products (skin, hair, wool, feathers, silk, and processed products), electrical appliances, and others. Products (furniture, stationery, toys, tableware) can be mentioned.

Examples of wood include wood processed for construction (high density wood, laminated wood, plywood and fiberboard, hardboard, MDF, insulation board, particle board, insulation hardboard, OSB, LSL, laminated wood, etc. Orthogonal laminated lumber, flooring, composite flooring, etc.).

Vehicles include, for example, bicycles, cars (private cars, buses, taxis, luggage carriers, etc.), trains, planes, and ships.

Examples of animal bodies include domestic animals (cattle, horses, pigs, sheep, goats, chickens, etc.) and small animals (dogs, cats, rats, mice, etc.).

When the composition B is used for controlling harmful arthropods in the agricultural field, the application rate is determined by the type of plant to be applied, the type and frequency of occurrence of harmful arthropods to be controlled, the form of the preparation, the timing of application, the method of application, and the like. It can be changed in a wide range depending on the place of application, weather conditions, etc. Usually, the application rate of the compound or one of the components is 1 to 10000 g, preferably 5 to 5000 g, more preferably 50 to 2000 g (specifically, for example, 100 g, 200 g, 300 g, 500 g) per ha. Can be mentioned. When the composition B is formulated into an emulsion, a wettable powder, a flowable agent, etc., the concentration of this compound or one of the present components is usually 0.01 to 10000 ppm, preferably 0.1 to 5000 ppm. It is preferably diluted with water to 1 to 1000 ppm (specifically, for example, 10 ppm, 100 ppm, 500 ppm) before application. When the composition B is formulated as a granule, a powder, or the like, it is usually applied as it is.

The water-diluted solutions of these formulations and formulations may be sprayed directly onto the harmful arthropods or plants to be protected from the harmful arthropods, and to control the harmful arthropods that occur on the cultivation carrier. The cultivation carrier may be treated.

Further, the composition B, which is a resin preparation processed into a sheet shape or a string shape, can be treated by wrapping it around a plant, stretching it near the plant, laying it on a cultivation carrier, or the like.

When the composition B is applied to a plant or a plant cultivation area, it is applied once or multiple times. The plant or plant cultivated area may already have an outbreak of harmful arthropods or may be pre-occurrence.

Examples of the treatment method of the composition B include foliage treatment, soil treatment, root treatment, shower treatment, mist spray treatment, smoke treatment, water surface treatment, hydroponic liquid treatment and seed treatment.

Examples of the foliage treatment include a method of treating the surface of the foliage, a tree trunk, a fruit, a flower or an ear with the composition B.
Examples of the root treatment include a method of immersing the root in a chemical solution containing the composition B and a method of adhering a solid preparation containing the composition B to the root of a plant.
Soil treatment includes, for example, soil spraying, soil miscibility and chemical irrigation into the soil. In addition, as places for soil treatment, for example, planting holes, crops, near planting holes, near crops, the entire cultivation area, near the plant area, between stocks, under the trunk, main trunk ridges, soil cultivation, nursery boxes, seedling raising. Examples include trays and nurseries. Examples of the treatment time include pre-sowing, sowing, post-sowing, seedling raising period, pre-planting, planting, and post-sowing growing period. Further, in the above soil treatment, the composition B may be treated simultaneously on the plant, or a paste fertilizer, a liquid fertilizer, a solid fertilizer or the like containing the composition B may be applied to the soil. Further, it may be mixed with the irrigation liquid, and examples thereof include injection into irrigation equipment (irrigation tube, irrigation pipe, sprinkler, etc.), mixing into interstitial flooding liquid, mixing into hydroponic liquid, and the like. Further, the irrigation solution and the active ingredient can be mixed in advance and treated by using, for example, the above irrigation method or an appropriate irrigation method such as watering or flooding.
Examples of the shower treatment include a method of showering a diluted solution of composition B on the fruit after harvesting.
Examples of the mist spraying treatment include a method in which a diluted solution of composition B is made into a mist and scattered in the air to be attached to the foliage and fruits of a plant. Examples of the smoke treatment include a method in which a solid preparation containing the composition B is heated to form a smoke and suspended in the air to adhere to the foliage and fruits of a plant.
Examples of the water surface treatment include a method of spraying a chemical solution containing the composition B or a solid preparation containing the composition B on a paddy field in a flooded state.
The hydroponic liquid treatment includes, for example, a method of mixing or mixing a chemical solution containing the composition B or a solid preparation containing the composition B with the hydroponic liquid (hydroponic liquid miscibility treatment, hydroponic liquid mixing treatment, etc.) and the like. Can be mentioned.

Seed treatment Seed treatment means the treatment of composition B on seeds or vegetative reproduction organs. As a method for treating the seed of the composition B, for example, a spray treatment in which the suspension of the composition B is atomized and sprayed on the seed surface or the surface of the vegetative reproduction organ, or the composition B is applied to the seed or the vegetative reproduction organ. Examples thereof include a smear treatment, a dipping treatment in which seeds are immersed in a chemical solution of composition B for a certain period of time, and a method of coating seeds or vegetative reproduction organs with a carrier containing composition B (film coating treatment, pellet coating treatment, etc.). The above-mentioned vegetative organs include seed potatoes in particular.
When the composition A is treated into seeds or vegetative reproduction organs, the composition A can be treated into seeds or vegetative reproduction organs as one preparation, or the composition A can be divided into multiple different preparations and seeds. Alternatively, it can be processed into vegetative reproduction organs. As a method of treating the composition A as a plurality of different preparations in a plurality of times, for example, a preparation containing only the present compound as an active ingredient is treated, the seed or the vegetative reproductive organ is air-dried, and then the present ingredient is contained. Method of treating the preparation; and the method of treating the present compound as an active ingredient and the preparation containing the present ingredient, air-drying the seed or the vegetative reproductive organ, and then treating the preparation containing the present ingredient other than the treated main ingredient. , Can be mentioned.
After seed treatment, the active ingredient may completely or partially cover the seed or vegetative reproduction organ, may be interspersed on its surface, and / or may be present within it. In the case of treatment, it is particularly preferable to use a composition containing the present component having one or more bactericidal activity selected from the group (b) and the group (j) among the composition B. At this time, the compound may be treated on a commercially available seed or vegetative reproduction organ treated with the present component having one or more bactericidal activity selected from the group (b) and the group (j).
When the composition B is treated on seeds or vegetative reproduction organs, manganese, copper, zinc and the like may be treated at the same time.
When the composition B is treated with seeds, the application rate of the composition B is usually 0.001 to 100 g, preferably 0.02 to 50 g per 1 kg of seeds or vegetative reproduction organs, and the active ingredient contained in the composition B is contained. The application rate per application is usually 0.001 to 100 g, preferably 0.01 to 50 g, more preferably 0.1 to 10 g per 1 kg of seeds or vegetative organs, and specifically, for example, for example. The following processing amount can be mentioned.
0.05 g of active ingredient per 1 kg of seeds or vegetative reproduction organs;
0.5 g of active ingredient per 1 kg of seeds or vegetative reproduction organs;
5 g of active ingredient per 1 kg of seeds or vegetative reproduction organs.
The seed or vegetative reproduction organ holding the present compound or composition A in the present invention means a state in which the present compound or composition A is attached to the surface of the seed or vegetative reproduction organ. The seed or vegetative reproduction organ holding the above-mentioned compound or composition A contains materials other than the present compound or the present composition A before and after the present compound or the composition A is attached to the seed or the vegetative reproduction organ. It may be attached.
Further, when the composition A is attached as a layer to the surface of the seed or vegetative reproduction organ, the layer comprises one layer or a plurality of layers. Further, when it is composed of a plurality of layers, each layer is a layer containing one or more active ingredients, or is composed of a layer containing one or more active ingredients and a layer containing no active ingredient. Become.
The seed or vegetative reproduction organ carrying the compound or composition A is to apply, for example, the composition B containing the compound or composition A to the seed or vegetative reproduction organ by the above-mentioned seed treatment method. Can be obtained by

Generally, DS, ES, FS, LS, WS, CF, GF, SS and the like are known as seed treatment preparations, but CS, EG, EW, GW, ME, OD, OF, SC, SE , SG, SL, SP, ST, WG, WP, WT, ZC, ZE, ZW, etc. can also be used. These preparations contain one compound or this component in an amount of 0.01 to 70%, preferably 0.1 to 50% by weight. When these preparations are treated on seeds or vegetative reproduction organs, they may be used as they are or diluted with water. When the product diluted in water is processed into seeds or vegetative reproduction organs, it can be arbitrarily diluted depending on the content of the active ingredient in the preparation and the amount of the active ingredient desired to be retained in the seeds or vegetative reproduction organs. In many cases, it is diluted 2 to 1000 times before use.
When the seeds are treated, the seeds before sowing may be treated, or the seeds after germination may be treated.
When the present compound or composition A is seed-treated, it may be mixed when an adjuvant such as a colorant or a binder is formulated, or further when the formulated composition B is seed-treated. It may be mixed.
The colorant facilitates confirmation of whether the composition B can be applied to each of the seeds or vegetative reproduction organs. Binders can also be added to improve the attachment of the active ingredient to seeds or vegetative reproduction organs. Examples of specific colorants and binders are shown below.
Colorants: For example, monoazos (Pigment Red 48: 1, Pigment Red 48: 2, Pigment Red 53: 1, Pigment Red 57: 1, Pigment Red 112, Pigment Brown 25, Cl Solvent Red 1, Pigment Yellow 1, Pigment Orange 5, acid red 14, acid yellow 23, etc.), disuazos (pigment yellow 13, pigment orange 34, etc.), phthalocyanines (pigment blue 15: 1, pigment blue 15: 2, pigment blue 15: 3, pigment blue 15) : 4, Pigment Green 7, Pigment Green 36, etc.), Anthraquinone (Pigment Red 83, etc.), Zinc Oxide (Pigment Blue 80, etc.), Xantene (Basic Violet 10 (Rhodamine B), Acid Red 51, Acid Red 52, etc.) ), Triarylmethane (Acid Blue 9 etc.), Pigment Orange 43, Iron Oxide, Titanium, Titanium Oxide, Zinc Oxide, Zinc Sulfide, Iron Hexacyanoate, Chrome Vermillion, Chrome Yellow, Calcium Carbonate, Barite Powder, Aluminum powder;
Binders: Polysaccharides (xanthan gum, cellulose ester, cellulose ether, carboxymethyl cellulose, hydroxypropyl guar gum, guar gum, natural arabic gum, synthetic arabic gum, dextrin, starch, caraginan, etc.), clays (organic clay, organic modified clay, inorganic) Clays, inorganically modified clays, etc.), minerals (ventonite, etc.), synthetic polymers (polycarboxylic acid or its salts, polyvinylpyrrolidone, polyvinylacetate, polyvinyl alcohol, polyacrylic acid or its salts, styrene-butadiene copolymers, methacrylic acid Methyl-butadiene copolymer, polyacrylic acid or a salt thereof, polyvinyl acetate, polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol, polypropylene glycol, etc.), wax (vegetable oil, animal oil, and derivatives thereof, paraffin, olefin) etc).
When the composition B is processed into seeds or vegetative reproduction organs, an adjuvant may be mixed with the composition B, if necessary.
Seeds or vegetative reproduction organs treated with Composition B are sown or planted in the field in the usual way.

This compound and this ingredient may be applied to plants or soils where plants are cultivated separately at the same time, or to the place of occurrence of harmful arthropods, or this compound and this ingredient may be applied separately at different times. It may be applied to a plant or cultivation carrier, or the place of occurrence of harmful arthropods. Specifically, for example, before and after planting a seed or a vegetative reproduction organ treated with either the present compound or the present component on a cultivation carrier (for example, soil), the other may be applied to the cultivation carrier.

The composition B can be applied to a plant in which one or more components selected from the present components have been seed-treated in advance and a cultivation carrier of the plant. Examples of the application method include foliage treatment, soil treatment, root treatment, shower treatment, mist spray treatment, smoke treatment, water surface treatment, and hydroponic liquid treatment.

Examples of the seed treatment agent to be treated in advance for soybean include the following.
STANDAK-TOP 500FS (Fipronil / Pyraclostrobin / Thiophanate-m), DERMACOR 625FS (Chlorantraniliprole), CRUISER 350FS (Thiamethoxam), CROPSTAR 600FS (Imidacloprid / Thiodicarb), FORTENZA 600FS (Cyantraniliprole), S-UNSPEC-INS (Verticillium), FIPRONIL-ALTA 250FS (Fipronil), MAXIM-ADVANCED 195FS (Fludioxonil / Metalaxyl-M / Thiabendazole), SHELTER 250SC (Fipronil), MAXIM-XL 035FS (Fludioxonil / Metalaxyl-M), DEROSAL Plus (Carb) ), Vitavax --THIRAM (Carboxin / Thiram).

Examples of the seed treatment agent to be treated in advance on corn include the following.
PONCHO-VOTIVO 601EC (Bacillus-firmus / Clothianidin), ACCELERON-IC-609 600EC (Clothianidin), CRUISER 600FS (Thiamethoxam), ACCELERON-D-342 480FS (Prothioconazole), PONCHO 600FS (Clothianidin), MAXIM-QUATTRO 382.5FS Azoxystrobin / Fludioxonil / Metalaxyl-M / Thiamethoxam), AVICTA-COMPLETE-CORN-250 280FS, Abamectin / Azoxystrobin / Fludioxonil / Metalaxyl-M / Thiabendazole / Thiamethoxam, AVICTA-COMPLETE-CORN-500stro / Metalaxyl-M / Thiabendazole / Thiamethoxam), LUMIVIA 625FS (Chlorantraniliprole), ACCELERON-D-281 480FS (Fluoxastrobin), ACCELERON-DC-309 312FS (Metalaxyl).

Examples of the seed potato treatment agent to be treated into potatoes in advance include the following.
Maxim 4FS (fludioxonil), Maxim MZ (fludioxonil + Mancozeb), Cruiser MAXX Vibrance Potato (fludioxonil + difenoconazole + Sedaxane + Thiamethoxam), Emesto Silver (penflufen + prothioconazole), MonCoatMZ (flutolanil + Mancozeb), Moncut + benzovindiflupyr), Quadris (azoxystrobin), Serenade ASO (Bacillus subtillis), DoubleNickel LC (Bacillus amyloliquefaciens), Attackin (streptomycin, thiophanate M), frontside (fluazinum), basidac (mepronil), moncat (flutranyl) ), Moncat (Frutranil), Benlate (Benomil).

A spraying device can be used when applying the composition B. Examples of the equipment used at the time of application include a hand-cranked spreader, a power spreader, a punkle sprayer, a manned aircraft (manned helicopter, etc.), an unmanned aerial vehicle (radio-controlled helicopter, drone, etc.), a tractor, a planter, and the like. Further, it may be applied by hand without using a spraying device.

When a sprayer is used when applying the composition B, the spraying pressure is not particularly limited, but is usually 30 to 120 PSI, preferably 40 to 80 PSI. Here, the spray pressure is a setting before introduction to the nozzle.

When the composition B is applied in the form of a solution, the pH and hardness of the solution are not particularly limited, but the pH is usually in the range of 5 to 9, and the hardness is usually in the range of 0 to 500. The time zone for applying the composition B is not particularly limited, but it is generally in the range of 5 am to 9 pm. In addition, the photon flux degree at the canopy level at the place where the composition B is applied is usually 10 to 2500 micromol / m ² / sec. The weather conditions for applying the composition B are not particularly limited, but the air temperature is usually 0 to 30 ° C., preferably 10 to 20 ° C., and the ground temperature is usually 0 to 30 ° C., preferably 10 to 20 ° C. The relative humidity is 50 to 90%, preferably 40 to 80%, and the wind speed is 0 to 2 MPH.

When spraying the composition B, it is usually carried out by spraying a spraying liquid obtained by mixing the composition B with water, and the amount of the spraying liquid is not particularly limited, but is usually 5 to 5000 L / ha, preferably 5 to 5000 L / ha. It is in the range of 20 to 1000 L / ha, more preferably 140 to 300 L / ha. Specific spray liquid volumes are 10L / ha, 30L / ha, 50L / ha, 70L / ha, 90L / ha, 100L / ha, 120L / ha, 150L / ha, 180L / ha, 200L / ha, 250L / Examples include ha, 300L / ha, 400L / ha, 500L / ha, 700L / ha, 900L / ha, 2000L / ha, and 4000L / ha.

The composition B and the adjuvant may be mixed in carrying out the foliage treatment, soil treatment, root treatment, shower treatment, smoke treatment, water surface treatment, seed treatment and hydroponic liquid treatment of the composition B. It may be mixed in advance when it is formulated (premix), or it may be mixed immediately before use (tank mix). The type of adjuvant is not particularly limited, but is COC (Crop oil concentrate) derived from mineral oil, MSO (methylated seed oil) derived from vegetable oil, alcohol. Examples thereof include based solvents, nonionic surfactants, anionic surfactants, cationic surfactants, silicone-based surfactants, nitrogen fertilizers and the like, and mixtures thereof. Specifically, AgriDex (registered trademark), Induce (registered trademark), Gramin S (registered trademark), Genamin T 200BM (registered trademark), Silwet L77 (registered trademark), Nimbus (registered trademark), Assist (registered trademark). , Aureo®, Iharol Gold®, BreakThru®, SundanceII®, Lutensol A8®, NP-7®, Triton®, Nufilm® Trademark), Emulgator NP7®, Emulad®, TRITON X 45®, AGRAL 90®, AGROTIN®, ARPON®, EnSpray N®, Examples include BANOLE®, Ochima®, Agris®, AMS (Ammonium Sulfate), UAN (Urea Ammonium Nitrate) and the like. Further, a drift reducing agent such as Intact (registered trademark) may be mixed. The weight ratio of the composition B to the above-mentioned adjuvant or drift reducing agent is not particularly limited, and examples thereof include a range of 1: 100 to 100: 1.

Composition B and fertilizer can be mixed or used in combination. In the case of mixed use, it may be mixed in advance at the time of formulation (premix) or immediately before application (tank mix). Examples of fertilizers include substances containing various elements such as nitrogen (N), phosphorus (P), potassium (K), silicon, magnesium, calcium, manganese, boron, iron, copper, zinc, sulfur, molybdenum, and cobalt. Be done. Substances containing nitrogen, phosphorus and potassium include, for example, urea, ammonia nitrate (glass cheap), ammonia chloride (salt cheap), ammonia sulfate (sulfur cheap), sodium nitrate, magnesium nitrate, nitrate, anhydrous ammonia, ammonium nitrate and nitrate. Lime, lime nitrogen, phosphoric acid, lime perphosphate, lime polyperphosphate, potassium sulfate, potassium chloride, potassium silicate, caustic potassium, potassium nitrate, potassium phosphate, MAP (phosphoric acid-ammonium), DAP (phosphate) (Phosphoric acid). The form of the fertilizer may be granular, powdery, lumpy, liquid or the like, and various forms of fertilizer can be used. Places of application include, for example, soil surfaces, in soil, and on plants. Equipment used for application includes, for example, hand-cranked spreaders, power spreaders, punkle sprayers, manned aircraft (manned helicopters, etc.), unmanned aerial vehicles (radio-controlled helicopters, drones, etc.), tractors, planters, broadcasters, sowers, etc. Cedar and the like can be mentioned. Further, it may be applied by hand without using a spraying device.
As a specific application method, for example, at the time of sowing or planting a plant, or at the time before and after sowing or planting (for example, sowing ± 0, 1, 2, 3, 4, 5 days), composition B and fertilizer are combined. There is a method of processing near seeds, vegetative reproduction organs, or seedlings (sometimes called in-furrow application). The fertilizer applied at the time of sowing or planting of the plant, or before and after sowing or planting may be a solid fertilizer and / or a liquid fertilizer, and includes, for example, a fertilizer having an N: P: K ratio (starter). Sometimes called fertilizer, pop-up fertilizer, etc.). The composition B and the fertilizer may be mixed and used immediately before application, or may be applied separately and simultaneously. The place of application is not particularly limited as long as it is in the vicinity of seeds, vegetative reproduction organs, or seedlings, but may be seeds, vegetative reproduction organs, or seedling planting grooves, or seeds, vegetative reproduction organs, or seedlings. It may be a few inches away from the groove, for example, 2 inches wide and 2 inches below the seed, vegetative, or seedling groove (sometimes called a 2-by2 band). Crops include corn, soybeans, sugar cane, potatoes, wheat, barley, rye, embaku, rice and the like. The ratio of the weight of one active ingredient contained in the composition B to the total weight of the NPK contained in the fertilizer is not particularly limited, and examples thereof include a range of 1: 1 to 1: 10000.

The composition B can be applied by spot treatment. Spot treatment is a concept relative to the uniform treatment of composition B, and is selectively performed in places where harmful arthropods are occurring or where harmful arthropods are likely to occur. It means a process of spraying the composition B. By "treating to a place" is meant treating a plant or soil in which or is likely to develop harmful arthropods, but preferably in the case of treating the plant. When treating plants, it also includes treating only individuals that have or are likely to develop harmful arthropods in the plant population, and harmful arthropods occur in individual plants. It also includes processing the parts that are or may occur.
Even when the composition B is sprayed to a place where no harmful arthropods are generated due to scattering or transpiration or where there is no risk of harmful arthropods, unless it is a uniform surface treatment, Included in spot processing. In addition, spot treatment is not considered only when all the places where harmful arthropods are occurring or where harmful arthropods are likely to occur are selectively treated in a continuous cultivation area. .. That is, when a part of the cultivated area is subjected to surface treatment, or a part of the place where harmful arthropods are occurring or where there is a possibility that harmful arthropods are generated is treated by the composition B. Even if it does not exist, if there is a spot-treated place in a continuous cultivation area, it is included in the spot treatment.

Specific examples of the spot processing method are given below. Spot by spraying composition B visually using a handheld nozzle or robotic arm nozzle while the sprayer walks or rides on a device or flight device traveling on the ground in a plant growing area. Processing may be performed. Further, the spot treatment may be performed by mapping the place where the harmful arthropod is occurring or is likely to occur in advance and spraying the composition B based on the map information. In spraying based on map information, in addition to the above method, the nozzle on the boom or the robot arm nozzle is used based on the position information of the sprayer (obtained by GPS or the like) and the map information while the sprayer is running or flying. Spot processing may be performed by opening and closing automatically or manually. The map information may be created based on image information taken by a manned or unmanned flying object, or an observer walking on the ground, an observer riding on a device traveling on the ground, or an observation on a flying device. It may be created visually by a person. Furthermore, the traveling or flying sprayer has a function to detect the place where harmful arthropods are occurring or may occur, and spot processing is performed by the boom or robot arm while performing real-time mapping. You may go.

The place where harmful arthropods occur can be recognized by image analysis with visible light in addition to visual recognition by the sprayer or observer, but it is recognized by image analysis with a specific wavelength using hyperspectral images. You may. Image analysis may be in the form of visually recognizing the occurrence of harmful arthropods on the screen, but image recognition by artificial intelligence can also be used (for example, OPTiM Corporation, December 26, 2017 Press). release). These images may be taken by a manned or unmanned flying object, or may be taken by a photographer walking on the ground, a photographer riding on a device traveling on the ground, or a photographer riding on a flying device. good. Locations where harmful arthropods may occur may be estimated based on the fact that the harmful arthropods had patchy outbreaks in the past growing season of the crop, or harmful in soil. It may be estimated from the distribution of arthropods. The distribution of harmful arthropods in soil may be investigated by soil sampling or estimated by remote sensing. In addition, the fact that harmful arthropods are hiding in plants may be sensed and estimated by image analysis. Such a technique is known as a form of emerging agriculture called precision agriculture, smart agriculture, digital agriculture, etc., and the non-uniform spraying mode generated by the spot treatment is referred to as VRA (Variable Rate Application) in the term of the emerging agriculture. ).

As a method of spot-treating the composition B, a method of spraying it on the soil of a place where harmful arthropods occur or a place where harmful arthropods may occur (soil treatment), and a method of composition B. There is a method (stem and foliage treatment) of spraying the above on a plant in which harmful arthropods are occurring or a plant in which harmful arthropods are likely to occur. Spraying is usually carried out using a spraying solution prepared by mixing composition B with water. Although the amount of the spray liquid is not particularly limited, it is usually 50 to 1000 L / ha, preferably 100 to 500 L / ha, and more preferably 140 to 300 L / ha inside the spot-treated section. The ratio of the area to be spot-treated in the plant cultivated area (the ratio of the area of the portion where the composition B is sprayed to the total area of the continuous cultivated area) is usually 1 to 99%, preferably 10 to 80. %. Specific examples include 20%, 30%, 40%, 50%, 60%, and 70%.
The treatment amount of the composition B at the time of spot treatment is 5 to 2000 g per 1 ha, preferably 50 to 1500 g per 1 ha, and more preferably 200 per 1 ha, as the treatment amount of one active ingredient inside the section to be spot treated. It is ~ 1000 g, more preferably 400-700 g per 1 ha.
An adjuvant or a drift reducing agent may be mixed when performing the spot treatment. The type of the adjuvant or the drift reducing agent is not particularly limited, and examples thereof include the above-mentioned ones.
The pH and hardness of the spray liquid are not particularly limited, but the pH is usually in the range of 5 to 9, and the hardness is usually in the range of 0 to 500.
The time zone for performing spot treatment is not particularly limited, but it is usually in the range of 5 am to 9 pm, and the photon flux degree at the canopy level at the place where spot treatment is performed is usually 10 to 2500 micromol / m ² . / Seconds. On the other hand, the spot processing can also be performed at night using the map information and the position information.
The spraying pressure when performing the spot treatment is not particularly limited, but is usually 30 to 120 PSI, preferably 40 to 80 PSI. Here, the spray pressure is a setting before introduction to the nozzle.
The weather conditions for performing the spot treatment are not particularly limited, but the air temperature is usually 0 to 30 ° C, preferably 10 to 20 ° C, and the ground temperature is usually 0 to 30 ° C, preferably 10 to 20 ° C. The relative humidity is 50 to 90%, preferably 40 to 80%, and the wind speed is 0 to 2 MPH.

More specifically, the treatment method of the composition B is as follows: planting hole treatment (planting hole spraying, planting hole treatment soil mixing), stocking treatment (stocking spraying, stocking soil mixing, stocking irrigation, seedling raising late stage stock). Original treatment), planting groove treatment (planting groove spraying, planting groove soil mixing), rowing treatment (stripe spraying, cropping soil mixing, growing season cropping spraying), seeding cropping treatment (sowing row cropping, At the time of sowing, cropping soil mixing), full surface treatment (full surface soil spraying, full surface soil mixing), side row treatment, water surface treatment (water surface application, after flooding water surface application), other soil spraying treatment (growth season granule foliar spraying, Under-tree canopy or around the main trunk, soil surface spray, soil surface mixing, seed hole spraying, ridge surface spraying, inter-strain spraying), and other irrigation treatments (soil irrigation, seedling raising period irrigation, chemical injection treatment, ground irrigation, chemical solution) Drip irrigation, chemigation), nursery box treatment (nursery box spraying, nursery box irrigation, nursery box chemical flooding), nursery tray treatment (nursery tray spraying, nursery tray irrigation, nursery tray chemical flooding), nursery bed treatment (nursery spraying) , Nursery irrigation, water seedling nursery spraying, seedling immersion), bed soil mixing treatment (bed soil mixing, pre-sowing bed soil mixing, seeding pre-soil covering spraying, sowing soil covering post-spraying, soil covering mixing), and other treatments (cultivation mixing) , Tsumugi, surface soil mixing, raindrop soil mixing, planting position treatment, granule flower cluster spraying, paste fertilizer mixing, hydroponic solution mixing, hydroponic solution mixing), etc.

Application of the compound or composition A may reduce the content of mycotoxins in the produced and harvested material and the foods and feeds prepared from it. The mechanism of the mycotoxin-reducing effect is not limited, but is exerted by, for example, a direct action or an indirect action on mycotoxin-producing bacteria. Examples of direct actions include a bactericidal effect on mycotoxin-producing bacteria and an inhibitory effect on mycotoxin biosynthesis. Examples of indirect actions include effects on the microbiome such as the abundance ratio of mycotoxins-producing bacteria and non-mycotoxins-producing bacteria, and reduction of fungal infections by suppressing feeding damage to harmful arthropods. The mycotoxins are not particularly limited, but include the following.
Deoxynivalenol (DON), Nivalenol, Fuzarenone X, 15-Ac-DON, 3-Ac-DON, T2- and HT2-toxins, Neosolaniol, Rugulosin, Zearalenone, Moniliformin, Fuzarin, Diacetoxysilpenol (DAS) , Bubericin, enniatin, fusaroproliferin, fusarenol, ochratoxin, patulin, sterigmatocystin, maltridine, citrinine, rugulosin, rubratoxin, citreoviridine, cyclochlorotin, luteoskyrin, loritrem B, Slaphramine, sporidesmin, arsenic alkaloids (eg, lysergic acid, ergotamine, ergomethrin), aflatoxin, and cyclopiazonic acid.
These mycotoxins can be produced, for example, by the following fungi:
Fusarium species, such as F. acuminatum, F. asiaticum, F. avenaceum, F. crookwellense, F. crookwellense (F. crookwellense) F.culmorum), F.graminearum (Gibberella zeae), F.equiseti, F.fujikoroi, F.moniliforme, F. musarum, F. oxysporum, F. proliferatum, F. poae, F. pseudograminearum, F. F.sam-bucinum, F.scirpi, F.semitectum, F.solani, F.sporotrichoides, F. langsethiae, F. subglutinans, F. tricinctum, F. verticillioides, etc .; Aspergillus species, such as A. flavus. (A.flavus), A.parasiticus, A.nomius, A.ochraceus, A.carbonarius, A.clavatus ), A. terreus, A. versicolor; Penicillium species, such as P. verrucosum, P. viridicatum, P. citrinum (. P.citrinum), P.expansum, P.claviforme, P.roqueforti, Claviceps species, such as C.purpurea, C. fusi formis, C. paspali, C. africana, etc .; Stachybotrys species; Slafractonia species, such as S. leguminicola; neotyphodium Genus (Neotyphodium) species, such as N. lolii; species of the genus Pithomyces, such as P. chartarum.

By applying this compound or composition A, the seedling rate of plants is improved and the growth of plants is improved according to the plant species or varieties, their habitats and growing conditions (soil, climate, growing season, nutritional value). , Increased resistance to abiotic stress (eg, increased resistance or tolerance to high or low temperatures, drought, over-humidity or increased resistance to salt contained in water or soil, increased resistance to osmotic stress, dryness Improved resistance to stress, improved resistance to ozone exposure, improved resistance to UV stress, improved resistance to wind stress, and improved resistance to sunshine stress), improved flowering ability, improved ease of harvesting, maturity Promote, increase yield, increase seed or fruit number, size or weight, improve leaf greenness, maintain leaf green for a long time, increase healthy leaf number, control aging progression, reduce plant lodging , Faster flowering, increased flower or fruit set, increased fruit set rate, improved quality and / or nutritional value of harvested products (eg, increased sugar content in fruits, increased gluten strength) , Optimization of protein content, optimization of oil content, improvement of nutritional value), improvement of storage stability and / or improvement of processability of the harvested product may be possible. More specifically, as the improvement of plant growth, promotion of stem elongation, promotion of stem enlargement, promotion of increase in the number of leaves or total area, increase in healthy leaves, and promotion of stem branching (for example, promotion of stem branching). Promotion of increase in the number of stem branches), promotion of lateral root formation (for example, increase in the number of lateral roots), increase in auxin-producing sites in the root (main root or lateral root), promotion of root elongation, improvement of root tension, and root enlargement Promotion of. It may also be possible to improve tolerance to nutritional stress caused by a deficiency of any of the 17 essential nutrients (essential elements) for plant growth.

When composition B is used for harmful arthropods in the non-agricultural field, the application dose thereof includes the type and frequency of occurrence of harmful arthropods to be controlled, the form of the drug, the time of application, the method of application, the place of application, the weather conditions, etc. Can be changed over a wide range.
As a specific application method, for example, when applied to a building, treatment to the wall surface, floor, underfloor, ceiling, roof, attic, door, window, screen door, etc. of the building, or to the indoor space of the building. Treatment, installation of poison bait and resin preparations can be mentioned.
When applied outdoors, treatment of the ground, outer wall, fence, groove, soil injection into the underfloor, ground, etc., treatment into space, treatment of granules, resin preparations, etc. into water can be mentioned.
When applied to building materials, for example, methods such as kneading or coating on building materials can be mentioned.
When applied to foods and daily necessities, for example, treatment of emulsions, wettable powders, flowable agents, oils, etc. on the walls, floors, and ceilings of the places where the foods and daily necessities are stored, smoke agents for spaces, etc. Examples thereof include treatment of smoke agents, smoke agents, etc., installation of poison bait agents, resin preparations, etc., kneading and coating of the daily necessities, and treatment of powders, emulsions, etc.
When applied to wood, examples thereof include coating, spraying, dipping, impregnating, injecting, mixing during wood processing, and mixing with an adhesive.
When applied to a vehicle, the space inside the vehicle, treatment on the wall surface, installation of a poison bait agent or a resin preparation can be mentioned.
When applied to animals, it is administered orally by mixing with capsules, chewables, syrups, tablets, powders, feeds / drinking waters, etc., suppositories and injections (intramuscular, subcutaneous, intravenous, intraperitoneal). Etc.), a method of spraying, applying, or dropping a liquid agent such as a spot-on agent, a pore-on agent, a shampoo agent, a lotion agent, or a paste agent, or a resin preparation on a collar, ear tag, bracelet, clothing, etc. There is a method of processing and mounting.

When composition B is used for the control of harmful arthropods in the non-agricultural field, the application rate when treated on the surface is the amount of one active ingredient per 1 m ² of treated area, usually 0.01 to 1000 mg. It is preferably 10 to 500 mg, more preferably 20 to 400 mg (specifically, for example, 25 mg, 50 mg, 400 mg), and the application rate when treated in a space is one active ingredient per 1 m ³ of the treatment space. The amount is usually 0.01-500 mg. The application rate when treated in water is the amount of one active ingredient per 1 L of water volume, usually 0.001 to 1000 mg, more preferably 0.01 to 100 mg. When treated on an animal body, the application rate is usually the amount of one active ingredient per kg body weight of the animal, usually in the range of 0.01 to 1000 mg. When the composition B is formulated into an emulsion, a wettable powder, a flowable agent, or the like, it is usually diluted with water so that the concentration of one active ingredient is 0.1 to 10000 ppm before application. When it is formulated as an oil or the like, it is applied as it is or diluted with kerosene or light oil so that the concentration of one active ingredient is usually 0.1 to 10000 ppm. Granules, powders, aerosols, smoke agents, fumigants, poison bait agents, resin preparations, etc. are applied as they are. In addition, the incense stick is ignited and applied. Electric mosquito repellent mats, liquid mosquito repellent preparations, fan-type mosquito repellent preparations, ultrasonic vibration-type preparations, electrostatic spray-type preparations, etc. are usually applied using a power source or a battery.

The composition B can be used for the purpose of suppressing the biting behavior and unpleasant behavior of harmful arthropods such as mosquitoes and flies by applying it to the body surface of humans and animals. In addition, by blending it with feed and giving it orally to an animal body, it can be used for the purpose of suppressing the generation and growth of flies and the like generated in excretion.

In addition, composition B is used for infectious diseases transmitted by harmful arthropods (malaria, dengue fever, West Nile fever, yellow fever, Zika fever, filariasis, onchocerciasis, Leeshmania, Shark's disease, African sleep disease, etc.). It can also be used to prevent the spread. Specific application methods include treatment of composition B on the inner wall of a house (Indoor Residual Spray; IRS), treatment of outdoor space (Space spray), and mosquito net treated with composition B (Long lasting insecticidal net). , Wallpapers, poison bait, spawning traps, killing traps, space repellent devices, use of automatic propagation devices, treatment of composition B on water jars, reservoirs, mountain streams, etc. (measures against pest sources, Larvicide), etc.

Examples of plants that can use the composition B include the following.
Agricultural crops; corn (horse tooth, hard grain, soft grain, explosive, sardine, sweet, field corn), rice (long grain, short grain, medium grain, japonica, tropical japonica, indica, Javanica) Seeds, paddy rice, land rice, floating rice, direct sowing, transplantation, rice bran), wheat (pan wheat (hard, soft, medium, red wheat, white wheat), duram wheat, spert wheat, club wheat, each winter wheat type, spring Wheat type), Omugi (Nijo Omugi (= beer wheat), Rokujo Omugi, Hadakamugi, Mochimugi, each winter Omugi type, Spring Omugi type), Limegi (Winter Limegi type, Spring Limegi type), Triticale (Winter Triticale type, Spring) Triticale type), wheat (winter wheat type, spring wheat type), sorghum, cotton (upland species, pima species), soybeans (ripe seed harvesting varieties, edible bean varieties, green-cut varieties, infinite growth type, finite growth, respectively Breeding type, semi-finite growth type), laccasei (peanut), Saito (green bean), rye bean, azuki, sasage, ryokuto, uradomame, benivana greenen, takeazuki, moss bean, teparly bean, soramame, pea, chick, lymame , Alfalfa, buckwheat, tensai (for sugar production, feed, root vegetables, leafy vegetables, fuel), rapeseed (winter rapeseed type, spring rapeseed type), canola (winter canola type, spring canola type), sunflower (for oil extraction, edible, Ornamental), sugar cane, tobacco, wheat, wheat, etc.
Vegetables; Vegetables of the family Eggaceae (egg, tomato, pepper, pepper, bell pepper, potato, etc.), Vegetables of the family Uri (cucumber, pumpkin, zucchini, watermelon, melon, squash, etc.), Vegetables of the family Abrana (daikon, cub, sardine, etc.) Cole rabbi, hakusai, cabbage, kalashina, broccoli, cauliflower, etc.), Kiku family vegetables (gobo, shungiku, artichoke, lettuce, etc.), lily family vegetables (negi, onion, garlic, asparagus, etc.), celery family vegetables (carrot, parsley, etc.) , Celery, American bofu, etc.), Akaza family vegetables (Horensou, Fudansou, etc.), Perilla family vegetables (Shiso, Mint, Basil, Lavender, etc.), Strawberries, Sweet potatoes, Yamanoimo, Satoimo, etc.
Fruit trees; nuts (apples, pears, Japanese pears, cranberries, karin, marmelo, etc.), drupes (peaches, plums, nectarins, sea urchins, pistachios, apricots, prunberries, etc.), citrus fruits (unshu mikan, oranges, lemons, etc.) Lime, grapefruit, etc.), fruit nuts (kuri, walnut, mustard, almond, pistachio, cashew nut, macadamia nut, etc.), berries (blueberry, cranberry, blackberry, raspberry, etc.), grape, oyster, fig, olive, biwa , Banana, coffee, nut palm, coco palm, etc.
Ornamental plants; flowering trees, roadside trees (ash, kabanoki, hanamizuki, eucalyptus, ginkgo, lilac, maple, oak, poplar, hanazuou, fu, sycamore, zelkova, kurobe, mominoki, tsuga, rat, pine, touhi, ichii), flower , Ornamental plants, zelkova.

The above-mentioned plants are not limited as long as they are generally cultivated varieties.

Examples of corn varieties include:
P30F53, P30F53RR, P30F53YHV, DKB390, DKB390IPRO3, DKC62-08, DKC35-88RIB RR2 BT, P7958AM RR2 LL BT, NK1120-3122 RR + GLU + ECB + CRW, P9608AM LL RR2 CRW ECB, Golden Bantam

Examples of wheat varieties include the following.
PAKITO; KWS Zyatt; Skyfall; Crusoe; RGT Illustrious; KWS Extrase; KWS Extase; KWS Siskin; LG Detroit; KWS Lili; KWS Firefly; KWS Barrel; Elicit; KWS Basset; Zulu; LGSkyscraper; RGT Saki; LG Spotlight; Elation; Bennington; LG Sundance; LG Motown; Leeds; Viscount; Revelation; SY Insitor; KWS Kinetic; Gleam; RGT Gravity; KWS Kerrin; Shabras; Graham; KWS Crispin; Theodore; Dunston; Costello

Examples of barley varieties include the following.
Electrum; Craft; SY Venture; KWS Hawking; LG Mountain; KWS Gimlet; Jordan; LG Flynn; KWS Orwell; Valerie; Surge; KWS Creswell; KWS Tower; KWS Glacier; California; KWS Cassia; Belmont; SY Kingsbarn; SY Baracooda; Bazooka; Belfry; KWS Astaire; Funky; Libra; SY Splendor; Firefoxx; Cosmopolitan; SY Tungsten; LG Diablo; Laureate; RGT Planet; RGT Asteroid; Iconic; KWS Sassy; Sienna; Propino; Fairing; Concerto; Fairway; Prospect

Examples of soybean varieties include the following.
5G8015 RR IPRO; ANTA 82 PR; AS 3797 IPRO; BMX POTENCIA RR; BRS 8170 IPRO; BRS 8280 RR; DM 6583 IPRO; M 5947 IPRO; M 6410 IPRO; M 8644 IPRO; M8372 IPRO; M9114PR; MONSOY 5947 IPRO; MONSOY 7730 IPRO; MSOY 8372 IPRO; NA 5909 RG; NS 5445 IPRO; NS 5909 PR; NS 5969 IPRO; NS 6700 IPRO; ST 797; TMG 1180 RR; TMG 1188 RR NS 4823 RR; NS 5445 IPRO; NA 5909 RR; NS 6209 RR; NS 6601 IPRO; NS 6823 RR; NS 6906 IPRO; NS 7000 IPRO; NS 7200 RR; NS 7227 RR; NS 7300 IPRO; NS 7474 IPRO; NS 7505 IPRO; NS 7709 IPRO; NS 8270 IPRO; NS 8393 IPRO RR NS 5106 IPRO; NS 5727 IPRO; NS 5959 IPRO; NS 6390; NS 6700 IPRO; NS 6828; NS 6909 IPRO -Centro; NS 7000 IPRO -SUL; NS 7202 IPRO; NS 7237 IPRO; NA 7337 RR; NS 7490 RR NS 7667 IPRO; NS 7901; NS 8338 IPRO; NS 8490 IPRO; NS 5160 IPRO; NA 5909- RG IPRO; NS 6006 IPRO; NS 6535 IPRO; NS 6767 RR; NS 6906 IPRO --Centro; NS 6909 IPRO --Sul; NS 7070 IPRO; NS 7209 IPRO; NS 7300 IPRO --Centro; NS 7338 IPRO; NS 7497 RR; NS 7670 RR; NS 8094 RR; NS 8383 RR; Syn 15600 IPRO; Syn 16861 IPRO; Syn 1059 RR; Syn 1163 RR; Syn 1258 RR; Syn 1281 RR; Syn 1683 IPRO; Syn 1785 IPRO; Syn 1687 IPRO; Syn 13610 IPRO; Syn 15640 IPRO; Syn 15630 IPRO; Syn 1562 IPRO; Syn 1561 IPRO; Syn 1366 IPRO; CZ 15B64 IPRO; CZ15B70 IPRO; CZ 15B92 IPRO; CZ 26B05 IPRO; CZ 26B10 IPRO; CZ 26B77 IPRO; CZ 7022 IPRO; CZ 26B42 IPRO; CZ 26B36 IPRO; CZ 26B42 IPRO; CZ 26B77 IPRO; CZ 37B22 IPRO; CZ 37B43 IPRO; CZ 47B90 IPRO; CZ 58B28 IPRO; CZ 48B32 IPRO; CZ 58B61 IPRO; W 791 RR; W 842 RR; CZ 58B61 IPRO; BS 1511 IPRO; BS 1543 IPRO; ST 575 IPRO; BS 1580 IPRO; ST 592 IPRO; BS 2590 IPRO; BS 2606 IPRO- SUL; ST 644 IPRO
BSIRGA 1642 IPRO; TEC 6702 IPRO; BS 1691 IPRO; TEC 7849 IPRO; TECIRGA 6070 RR; BS 1519 LL; BS 2606 IPRO -CERRADO; TEC 6702 IPRO -CERRADO; TEC 7849 IPRO-CERRADO; ST 721 IPRO; TEC 7578 IPRO; ST 777 IPRO; ST 797 IPRO; ST 804 IPRO; ST 830 IPRO; ST 845 IPRO; W 787 IPRO; W 799 RR; ST 815 RR; ST 820 RR; ST 860 RR; ST 920 RR; W 870; BRASMAX COMPACTA IPRO BRASMAX FIBRA IPRO
BRASMAX ZEUS IPRO; BRASMAX DELTA IPRO; BRASMAX RAIO IPRO; BRASMAX ICONE IPRO; BRASMAX LANCA IPRO; BRASMAX GARRA IPRO; BRASMAX PONTA IPRO
BRASMAX VALENTE RR; BRASMAX POTENCIA RR; BRASMAX TORNADO RR; BRASMAX ALVO RR; BRASMAX ATIVA RR; BRASMAX VELOZ RR; BRASMAX VELOZ RR; BRASMAX VORAZ IPRO; BRASMAX EXTREMA IPRO; BRASMAX UNICA IPRO; IPRO; BRASMAX EXTRA IPRO; BRASMAX CERTA IPRO; BRASMAX POWER IPRO; BRASMAX ULTRA IPRO; BRASMAX FLX IPRO; BRASMAX BONUS; BRASMAX PONTA IPRO; BRASMAX OPUS IPRO; BRASMAX DESAFIO RR; M5705IPRO; MS5838IPRO; M7739IPRO; M8349IPRO; M8372IPRO; M6410IPRO; M7110IPRO; M7198IPRO; M8210IPRO; M8808IPRO; 95R51; 95Y52; 97R22IPRO; 99R03; P98Y70; 95R90IPRO; 95Y72; 98Y21IPRO; 99R09; CD2728 IPRO; CD2820 IPRO; CD2851 IPRO; CD2857 RR; DS5916 IPRO; 5D6215 IPRO; 5D634 RR; 5G8015 IPRO; DS6017 IPRO; DS7417 IRPO; B5860 IPRO; BG4781 IPRO; DS6217 IPRO; TMG2375 IPRO; TMG2165 IPRO; TMG4377 IPRO; TMG1180 RR; TMG7063I PRO; TMG7062 IPRO; TMG7067 IPRO; TMG4182; TMG4182; TMG7262 RR; TMG2185 IPRO; TMG7061 IPRO; TMG2381 IPRO; TMG2383 IPRO; TMG1288 RR; TMG2181 IPRO; TMG1188 RR; TMG2378 IPRO; TMG133 RR; TMG132 RR; ANTA82; TMG1182 RR; TMG2182 IPRO; TMG7161 RR; TMG2183 IPRO; TMG2286 IPRO; K8620 IPRO; RK5519 RR; M6210 IPRO; RK6719 IPRO; RK6316 IPRO; RK7518 IPRO; RK6813 RR; BRS 1001IPRO; BRS 1074IPRO; BRS 6970IPRO; BRS 7570IPRO; BRS 9383IPRO; BRS 1003IPRO; BRS 706IPRO
BRS 7170IPRO; BRS 7780IPRO; BRS 1007IPRO; BRS 713IPRO; BRS 7270IPRO; BRS 7180IPRO; BRS1010IPRO; BRS 729IPRO; BRS 7470IPRO; BRS 9180IPRO; BRS 279RR; BRS 360RR; BRS 413RR; BRS 8890RR; BRSMG 760SRR; BRS 9090RR; BRS 740SRR; BRS FAVORITA RR; BRS 333RR; BRS 388RR; BRS 7950RR; BRS 9280RR; BRSMG 750SRR; BRS Sambaiba RR; BRS 359RR; BRS 399RR; BRS 8160RR; BRS 7460RR; BRS 232; BRS 283; BRS 257; BRS 284; BRS 317; BRS 361; BRSMG 800A; BRSGO 8360; BRSGO LUZIANIA; BRS Petala; BRSMG 790A; BRSMG 7525; MG / BR 46 (Conquista); BRS 8381; BRS 217 (Flora); BRS 252 (Serena); BRSMG 810C; BRSMG 68 (Vencedora); BRSGO 7960; BRS 8480; BRSGO Chapadoes; BRS Raimunda; BRS313 (TIETA); BRS Corisco; BRS Barreiras; BRS 314 (Gabriela); BRS Tracaja BRS Perola

The varieties of the above-mentioned plants are not particularly limited as long as they are generally cultivated varieties.

The above-mentioned plants may be plants that can be produced by natural mating, plants that can be generated by mutation, F1 hybrid plants, and transgenic plants (also referred to as genetically modified plants). These plants are generally resistant to herbicides, accumulate toxic substances to pests (also called pest resistance), suppress disease sensitivity (also called disease resistance), increase yield potential, biologically and abiotic. Improved resistance to stress factors, quality changes in products (eg, increase / decrease in content of specific ingredients, changes in composition, improved shelf life or processability), changes in harvest time (eg, very early, early, medium) It has characteristics such as raw, late, and extremely late).

F1 hybrid plants are F1 hybrids obtained by crossing two different strains of varieties and are generally plants with heterotic traits that have better traits than either of their parents. Transgenic plants have characteristics that cannot be easily obtained by cross breeding, mutagenesis, or natural recombination in the natural environment by introducing foreign genes from other organisms such as microorganisms. It is a given plant.

Techniques for producing the above plants include, for example, conventional breeding techniques; genetic recombination techniques; genome breeding techniques; new breeding techniques; genome editing techniques. The conventional breeding technique is a technique for obtaining a plant having desirable properties by mutation or mating. Genetic recombination technology is a technology that imparts new properties to an organism by extracting the target gene (DNA) from one organism (for example, a microorganism) and introducing it into the genome of another target organism, or to a plant. An antisense or RNA interference technique that imparts new or improved properties by silently silencing other genes present. The genomic breeding technique is a technique for improving the efficiency of breeding using genomic information, and includes a DNA marker (also referred to as a genomic marker or a genetic marker) breeding technique and a genomic selection. For example, DNA marker breeding is a method of selecting a progeny having a desired useful trait gene from a large number of mating progeny using a DNA marker, which is a DNA sequence that serves as a marker for the location of a specific useful trait gene on the genome. be. By analyzing the mating progeny using DNA markers when they are young plants, it has the characteristic that the time required for breeding can be effectively shortened.
In addition, genomic selection is a method of creating a prediction formula from the phenotype and genomic information obtained in advance, and predicting the characteristics from the prediction formula and genomic information without evaluating the phenotype, which contributes to the efficiency of breeding. It is a possible technology. New breeding techniques are a general term for breeding techniques that combine molecular biological techniques. For example, cis genesis / intragenesis, oligonucleotide-oriented mutagenesis, RNA-dependent DNA methylation, genome editing, grafting to GM rootstock or scion, reverse breeding, agroinfiltration, seed production technology (Seed Production). Technology, SPT) and other technologies. Genome editing technology is a technology for converting genetic information in a sequence-specific manner, and can delete a base sequence, replace an amino acid sequence, introduce a foreign gene, or the like. Such tools include, for example, zinc-Finger Nucleases (ZFN, ZFNs), TALENs, CRISPR / Cas9, and CRISPER that are capable of sequence-specific DNA cleavage. / Cpf1) and Meganuclease. In addition, there are sequence-specific genome modification techniques such as CAS9 nickase and Target-AID created by modifying the above-mentioned tools.

Examples of the above-mentioned plants include genetically modified crops (http://www.isaaa.org/) on the electronic information site of the INTERNATINAL SERVICE for the ACQUISITION of AGRI-BIOTECH APPLICATIONS, ISAAA. Plants listed in the registration database (GM APPROVAL DATABASE) can be mentioned. More specifically, for example, herbicide-resistant plants, pest-resistant plants, disease-resistant plants, quality-altered products (eg, increase / decrease in component content, change in composition, improvement in storage stability or processability) plants. There are fertile trait-modified plants, abiotic stress-tolerant plants, or trait-modified plants related to growth and yield.

The following are examples of plants that have been endowed with herbicide resistance.
The mechanism of resistance to herbicides, for example, reduces the affinity between the herbicide and its target; rapid metabolism of the herbicide (degradation, modification, etc.) by the expression of an enzyme that inactivates the herbicide; Inhibition of uptake into plants; and inhibition of herbicide transfer into plants.

Plants that have been endowed with herbicide resistance by gene recombination technology include, for example, protoporphyrinogen oxidase (hereinafter abbreviated as PPO) herbicides such as flumioxadin; 4-hydroxyphenylpyruvic acid such as isoxaflutol and mesotrione. Dioxygenase (hereinafter abbreviated as HPPD) inhibitor; imidazolinone herbicide such as imazetapill, sulfonylurea herbicide such as thifensulfuronmethyl and other acetolactic acid synthase (hereinafter abbreviated as ALS) inhibitor; glyphosate and the like 5-Enolpyrvirsikimic acid-3-phosphate synthase (hereinafter abbreviated as EPSPS) inhibitor; Glutamine synthase inhibitor such as gluhocinate; auxin-type herbicide such as 2,4-D, dicamba; Some plants have been endowed with resistance to oxynyl herbicides. Preferred herbicide-tolerant transgenic plants are wheat such as wheat, barley, rye, embuck, canola, sorghum, soybean, corn, cotton, rice, rapeseed, tensai, sugar cane, grapes, lens mane, sunflower, alfalfa, fruit and vegetable. , Nuclear fruits, coffee, cha, strawberry, shiva, tomato, potato, cucumber, lettuce and other vegetables, more preferably wheat such as wheat, barley, rye, embaku, soybean, corn, rice, grapes, tomato, Potatoes and rye.
Specific herbicide-tolerant plants are shown below.
Glyphosate herbicide-resistant plant: Glyphosate-resistant EPSPS gene (CP4 epsps) derived from Agrobacterium tumefaciens strain CP4 and glyphosate N-acetyltransferase gene derived from Bacillus licheniformis. N-Acetyltransferase gene (gat4601 or gat4621), glyphosate oxidase gene (goxv247) from Ochrobacterum anthropi strain LBAA, or EPSPS gene with glyphosate resistance mutation from corn (Zea mays) (Zea mays) Obtained by introducing one or more of mepsps or 2mepsps). The main plants are, for example, alfalfa (Medicago sativa), Argentine canola (Brassica napus), cotton (Gossypium hirsutum L.), creeping bentgrass (Agrostis stolonifera), corn (Zea mays L.) and polish canola (Brassica rapa). Examples include potato (Solanum tuberosum L.), soybean (Glycine max L.), tensai (Beta vulgaris) and wheat (Triticum aestivum). Several glyphosate resistant plants are commercially available. For example, the genetically modified plant introduced with CP4 epsps is a trademark name including "Roundup Ready (registered trademark)", and the genetically modified plant introduced with gat4601 or gat4621 is "Optimum GAT (trademark)", "Optimum (registered trademark)". ) Gly canola "and other genetically modified plants introduced with mepsps or 2mepsps are sold under the brand name of" GlyTol ™ ". More specific glyphosate-tolerant plants include, for example, corn "Roundup Ready ™ Maize", "Roundup Ready ™ 2 Maize", "Agrisure ™ GT", "Agrisure ™ GT / CB /". LL ”,“ Agrisure ™ GT / RW ”,“ Agrisure ™ 3000GT ”,“ YieldGard ™ VT ™ Rootworm ™ RR2 ”and“ YieldGard ™ VT Triple ”; Ready ™ Soybean ”and“ Optimum GAT ™ ”; Wata is“ Roundup Ready ™ Cotton ”,“ Roundup Ready ™ Flex Cotton ”and“ GlyTol ™ ”; Canola is“ Roundup Ready ™. Canola ”and“ Optimum® Gly canola ”; Alfalfa“ Roundup Ready ™ Alfalfa ”; Rice“ Roundup Ready Rice ”; Satoukibi“ Roundup Ready ™ sugar beet ”and“ In Vigor ™ sugar beet ” Wheat is sold under the trade name "Roundup Ready (Trademark) wheat" (Triticum aestivum).
Glufosinate herbicide-resistant plant: Streptomyces hygroscopicus-derived Phosphinothricin N-acetyltransferase (PAT) gene (bar), Streptomyces biridoclo One or more of the PAT gene (pat) derived from Streptomyces viridochromogenes or the synthesized PAT gene (pat syn) derived from the Streptomyces viridochromogenes strain Tu494. Obtained by introducing. The main plants are, for example, Argentine canola (Brassica napus), Chicory (Cichorium intybus) cotton (Gossypium hirsutum L.), corn (Zea mays L.) Polished canola (Brassica rapa), rice (Oryza sativa L.), soybean. (Glycine max L.) and Tensai (Beta vulgaris). Some glufosinate-tolerant plants are commercially available. For example, genetically modified plants introduced with bar or pat are sold under the trade names of "LibertyLink ™", "InVigor ™", or "WideStrike ™". More specific glyphosinate resistant plants are, for example, "Roundup Ready ™ 2", "Liberty Link ™", "Herculex ™ I", "Herculex RW", "Herculex XTRA ™" for corn. , "Agrisure ™ GT / CB / LL", "Agrisure ™ CB / LL / RW" and "Bt10"; Wata is "FiberMax ™ Liberty Link ™"; Rice is "Liberty Link ™" ) Rice ”; Canola is sold under the trade name of“ in Vigor ™ Canola ”; Soybean is sold under the trade name of“ Liberty Link ™ Soybean ”; Satoukibi is sold under the trade name of“ Liberty Link ™ sugar beet ”.
Oxynil herbicide (eg, bromoxynil) resistant plants: Obtained by introducing a nitrilase gene (bxn) from the Klebsiella pneumoniae subsp. Ozaenae. Major plants include, for example, Argentine canola (Brassica napus), cotton (Gossypium hirsutum L.) and tobacco (Nicotiana tabacum L.). Several oxynyl herbicide-tolerant plants are commercially available. For example, it is sold under a trade name including "Navigator (trademark)" or "BXN (trademark)". As a more specific oxynyl herbicide-tolerant plant, for example, cotton is sold under the trade name of "BXN ™ Cotton"; Argentine canola is sold under the trade name of "Navigator ™ Cotton".
ALS herbicide resistant plants: Carnations (Dianthus caryophyllus) introduced with the ALS herbicide resistant ALS gene (surB) derived from tobacco (Nicotiana tabacum) as a selection marker are, for example, "Moondust ™", "Moonshadow ™". , "Moonshade ™", "Moonlite ™", "Moonaqua ™", "Moonvista ™", "Moonique ™", "Moonpearl ™", "Moonberry ™" Alternatively, it is sold under the trade name of "Moonvelvet ™". Flax (Linum usitatissumum L.) introduced with the ALS herbicide-resistant ALS gene (als) derived from Arabidopsis thaliana is sold, for example, under the brand name of "CDC Triffid Flax". Corn (Zea mays L.) resistant to sulfonylurea and imidazolinone herbicides introduced with the ALS gene (zm-hra) resistant to corn-derived ALS herbicides is, for example, the trademark of "Optimum GAT ™". It is sold by name. Soybeans resistant to imidazolinone-based herbicides into which the ALS herbicide-resistant ALS gene (csr1-2) derived from Arabidopsis thaliana have been introduced are sold under the brand name of "Cultivance", for example. Soybeans introduced with the ALS herbicide-resistant ALS gene (gm-hra) derived from soybean (Glycine max) are, for example, trademarks of "Treus ™", "Plenish ™" and "Optimum GAT ™". It is sold by name. In addition, there is a cotton into which the ALS gene (S4-HrA) of ALS herbicide resistance derived from tobacco (Nicotiana tabacum cv. Xanthi) has been introduced.
HPPD herbicide-tolerant plant: Obtained by introducing the HPPD gene (avhppd-03) from Enbac (Avena sativa). For example, soybeans into which the PAT gene (pat) derived from Streptomyces viridochromogenes is introduced at the same time as the above genes are referred to as soybeans resistant to mesotrione and glufosinate in the "Herbicide-tolerant Soybean line". It is sold under the brand name.
2,4-D resistant plant or ACCase herbicide resistant plant: Sphingobium herbicidovorans-derived aryloxyalkanoate dioxygenase gene (aad-1) was introduced 2 Corn resistant to, 4-D or ACCase herbicides is sold, for example, under the trade name "Enlist ™ Maize". Soybeans and cotton resistant to 2,4-D or ACCase herbicides introduced with the allyloxyalkanoate diokigenase gene (aad-12) from Delftia acidovorans are known, for example. It is sold under the trade name of "Enlist (trademark) Soybean".
Dicamba herbicide-tolerant plant: Obtained by introducing the dicamba monooxygenase gene (dmo) from the Stenotrophomonas maltophilia strain DI-6. Soybeans and cotton into which the above genes have been introduced are known. At the same time as the above gene, soybean (Glycine max L.) introduced with the glyphosate-resistant EPSPS gene (CP4 epsps) derived from the Agrobacterium tumefaciens strain CP4 is, for example, "Genuity (registered trademark) Roundup". It is sold under the trade name of "Ready (trademark) 2 Xtend (trademark)".
Further plants with altered resistance to herbicides are widely known, for example, alfalfa, apple, wheat, eucalyptus, flax, grape, corn, rapeseed, pea, potato, rice, tensai, which are resistant to glyphosate. , Sunflower, tobacco, tomato, millet and wheat (see, for example, US5188642, US4940835, US5633435, US5804425, US5627061); corn, cotton, soybean, pea, potato, sunflower, tomato, tobacco, Corn, sorghum and sugar cane (see, eg WO2008 / 051633, US7105724 and US5670454); soybeans, tensai, potatoes, tomatoes and tobacco resistant to gluhosinate (see, eg, US6376754, US5646024, US5561236); 2,4 -D resistant cotton, peppers, apples, tomatoes, sunflowers, tobacco, potatoes, corn, cucumber, wheat, soybeans, sorghum and millets (eg US6153401, US6100446, WO2005 / 107437, US5608147 and US5670454) See); Canola, corn, millet, wheat, cotton, caracina, lettuce, lens bean, melon, awa that are resistant to ALS-inhibiting herbicides (eg, sulfonylurea herbicides or imidazolinone herbicides). , Oat wheat, nata, potato, rice, lime, sorghum, soybean, tensai, sunflower, tobacco, tomato and wheat (see, for example, US5013659, WO2006 / 060634, US4761373, US5304732, US6211438, US6211439 and US6222100), especially imidazolinone. Rice that is resistant to herbicides is known, and specific mutations in the acetohydroxyacid synthase gene (eg, S653N, S654K, A122T, S653 (At) N, S654 (At) K, A122 (At) ) T-bearing rice (see, eg, US2003 / 0217381, WO2005 / 020673); HPPD-inhibiting herbicides (eg, isoxazole-based herbicides such as isoxaflutol; trike such as sulcotrione, mesotrione, etc.) Tons of herbicides; and pyrazole herbicides such as pyrazolineate) or great millet, sugar beet, rice, corn, tobacco, soybean, cotton, rapeseed, sugar beet, wheat and wheat resistant to diketonitrile, a degradation product of isoxaflutor. Potatoes (see, eg, WO2004 / 055191, WO1996 / 38567, WO1997 / 049816 and US6791014); and wheat, soybean, cotton, sugar beet, rapeseed, rice, corn, sorghum, sugar beet and resistant to PPO-inhibiting herbicides. Examples include sugar beet (see, eg, US2002 / 0073443, US2008 / 0052798, Pest Management Science, 61, 2005, 277-285).

Rice "Clearfield (registered trademark) Rice" that is resistant to imidazolinone-based ALS-inhibiting herbicides such as imazetapill and imazamox as plants to which herbicide resistance has been imparted by conventional cultivar improvement technology or genome breeding technology. , Wheat "Clearfield (registered trademark) Wheat", sunflower "Clearfield (registered trademark) Sunflower", lens bean "Clearfield (registered trademark) lentils" and canola "Clearfield (registered trademark) canola" (BASF product); Soybean "STS soybean" resistant to sulfonylurea ALS-inhibiting herbicides such as methyl; corn "SR corn" resistant to acetyl CoA carboxylase inhibitors such as trionoxime herbicides and aryloxyphenoxypropionic acid herbicides (Also known as "Poast Protected® corn"); Sunflower "Express Sun®" resistant to sulfonylurea herbicides such as trivenuron; resistant to acetyl CoA carboxylase inhibitors such as kizarohop Rice "Provisia ™ Rice"; and canola "Triazine Tolerant Canola" resistant to photochemical II inhibitors; sorghum "Igrowth ™" resistant to imidazolinone herbicides.

Sulfonylurea herbicide-resistant canola "SU Canola (registered trademark)" using rapid cultivar development technology (Rapid Trait Development System, RTDS (registered trademark)) as a plant to which herbicide resistance has been imparted by genome editing technology. Can be mentioned. RTDS® corresponds to the introduction of oligonucleotide-oriented mutations in genome editing technology, which is the cleavage of DNA in plants via Gene Repair Oligonucleotide (GRON), a chimeric oligonucleotide of DNA and RNA. It is a technology that can introduce mutations without any. Another example is maize with reduced herbicidal resistance and phytic acid content by deleting the endogenous gene IPK1 with a zinc finger nuclease (see, eg, Nature 459, 437-441 2009); Crisper. Examples include rice that has been conferred herbicide resistance using corn (see, eg, Rice, 7, 5 2014).

Examples of plants to which herbicide resistance has been imparted by the new breeding technique include soybeans in which the properties of the GM rootstock have been imparted to the scion by using the breeding technique using grafting. Specific examples thereof include soybeans (see Weed Technology 2013, 27, 412.) In which non-transgenic soybean scion is imparted with glyphosate resistance using Roundup Ready (registered trademark) soybean having glyphosate resistance as a rootstock. ..

The following are examples of plants that have been endowed with pest resistance.

Examples of plants that have been imparted resistance to maize pests by gene recombination technology include delta-endotoxin, which is an insecticidal protein derived from the soil bacterium Bacillus thuringiensis (hereinafter abbreviated as Bt). Corn (Zea mays L.), soybean (Glycine max L.), cotton (Gossypium hirsutum L.), rice (Oryza sativa L.), poplar (Populus sp.), Tomato (Lycopersicon esculentum) into which the encoding gene has been introduced. , Nas (Solanum melongena) and corn (Saccharum sp.). Delta-endotoxins that confer resistance to lepidopteran pests include, for example, Cry1A, Cry1Ab, modified Cry1Ab (partially missing Cry1Ab), Cry1Ac, Cry1Ab-Ac (hybrid protein fused with Cry1Ab and Cry1Ac), Cry1C, Cry1F, Cry1Fa2 (modified cry1F), moCry1F (modified Cry1F), Cry1A. 105 (hybrid protein fused with Cry1Ab, Cry1Ac, Cry1F), Cry2Ab2, Cry2Ae, Cry9C, Vip3A and Vip3Aa20.
Plants that have been imparted resistance to Coleoptera pests by gene recombination technology include, for example, maize and potatoes into which a gene encoding delta-endotoxin, an insecticidal protein derived from the soil bacterium Bt, has been introduced. .. Delta-endotoxins that impart resistance to Coleoptera pests include, for example, Cry3A, mCry3A (modified Cry3A), Cry3Bb1, Cry34Ab1, Cry35Ab1, Cry6A, Cry6Aa and mCry6Aa (modified Cry6Aa).
As a plant to which resistance to dipteran pests has been imparted by gene recombination technology, for example, corn into which a synthetic gene encoding a hybrid protein eCry3.1Ab, which is a fusion of Cry3A and Cry1Ab derived from the soil bacterium Bt, has been introduced. (Zea mays L.) and cotton (Gossypium hirsutum L.) into which a gene encoding the trypsin inhibitor CpTI derived from corn (Vigna unguiculata) has been introduced. In addition, there are poplars and the like into which a gene encoding API, which is a protease inhibitor protein A derived from arrowhead (Sagittaria sagittifolia), has been introduced, and exhibits resistance to a wide range of pests.
The insecticidal protein that imparts pest resistance to plants includes a hybrid protein of the above insecticidal protein, a partially deleted protein, and a modified protein. Hybrid proteins are made by combining different domains of multiple insecticidal proteins using genetic recombination techniques, with Cry1Ab-Ac and Cry1A. 105 etc. are known. As a protein lacking a part, Cry1Ab or the like lacking a part of the amino acid sequence is known. As the modified protein, one or more amino acids of the natural delta-endotoxin are substituted, and Cry1Fa2, moCry1F, mCry3A and the like are known. The modified protein also includes the case where a non-naturally occurring proteolytic enzyme recognition sequence is inserted into toxin, for example, Cry3A055 (WO2003 / 018810) in which a cathepsin G-recognition sequence is inserted into Cry3A toxin. See).
A cotton plant (event MON88702) introduced with the modified BT protein Cry51Aa2 (Cry51Aa2.834_16) by genetic engineering technology has been developed by Monsanto, and has been developed by Monsanto. Shows resistance to the order Lygus, such as genus species.
Other insecticidal proteins that impart pest resistance to plants by gene recombination technology include, for example, insecticidal proteins derived from Bacillus cereus or Bacillus popilliae; plant insecticidal proteins Vip1, Vip2. , Vip3 (as subclasses Vip3Aa-Vip3Aj, Vip3Ba, Vip3B and Vip3Ca are known, specifically, for example, Vip3Aa20 and Vip3Aa61 are known) and Vip4; Insecticidal proteins derived from nematode symbiotic (colony-forming) bacteria such as Photorhabdus spp. Or Xenorhabdus spp. Such as Xenorhabdus nematophilus; scorpion toxins, spider toxins. , Toxins produced by animals, including insect-specific neurotoxins such as bee toxins; toxins produced by filamentous fungi such as Streptomycetes toxins; Aglutinin; protease inhibitors such as trypsin inhibitors, serine protease inhibitors, pattatin, cystatin, papain inhibitors; ribosome inactivating proteins (RIP) such as lysine, corn-RIP, abrin, rufin, saporin, bryodin Steroid metabolizing enzymes such as 3-hydroxysteroid oxidase, exdisteroid-UDP-glucosyltransferase, cholesterol oxidase; ecdison inhibitor; HMG-CoA-reductase; ion channel inhibitor such as sodium channel inhibitor and calcium channel inhibitor; Immature hormone esterase; diuretic hormone receptor; stylben synthase; bibenzyl synthase; chitinase; and glucanase.

In addition, plants that have been imparted with pest resistance by introducing one or more insecticidal protein genes are already known, and some plants are commercially available.
Examples of cotton that has been endowed with pest resistance are "Bollgard ™ cotton", "BXN ™ Plus Bollgard ™ Cotton", and "BXN ™ Plus" that express the insecticidal protein Cry1Ac derived from Bt bacteria. "Bollgard ™ Cotton", "JK 1", "Roundup Ready ™ Bollgard ™ Cotton" and "Ingard ™";"Herculex" expressing the insecticidal protein-modified Cry1F (Cry1Fa2) derived from Bt. "I" and "Herculex ™ CB";"VIPCOT ™ Cotton" expressing the insecticidal protein Vip3A derived from Bt bacteria; "Bollgard II (trademark)" expressing the insecticidal proteins Cry1Ac and Cry2Ab derived from Bt bacteria. ) Cotton ”,“ Roundup Ready ™ Bollgard II ™ Cotton ”,“ Roundup Ready ™ Flex ™ Bollgard II ™ Cotton ”and“ Fivermax ™ Liberty Link ™ Bollgard II ™ ) ”;“ Bollgard III® ”and“ Bollgard® III x Roundup Ready ™ Flex ™ ”, which express the insecticidal proteins Cry1Ac, Cry2Ab and Vip3A derived from Bt fungus. "VIPCOT ™ Roundup Ready Flex ™ Cotton" expressing the insecticidal proteins Vip3A and Cry1Ab; "VIPCOT® Cotton" expressing the insecticidal proteins Vip3A and Cry1Ac derived from Bt bacteria; "Wide Strike ™ Cotton", "Wide Strike ™ Roundup Ready ™ Cotton" and "Widestrike ™ Roundup Ready Flex ™ Cotton" expressing the sex proteins Cry1Ac and Cry1F; insecticidal proteins derived from Bt bacteria "TwinLink ™ Cotton" and "Gly" expressing Cry1Ab and Cry2Ae tol ™ x Twinlink ™ ”;“ Widestrike® 3 ”and“ Widestrike ™ x Roundup Ready Flex ™ x VIPCOT ”expressing the insecticidal proteins Cry1Ac, Cry1F and Vip3A derived from Bt bacteria. "Cotton";"Glytol ™ x Twinlink ™ x VIPCOT ™ Cotton" expressing the insecticidal proteins Cry1Ab, Cry2Ae and Vip3A derived from Bt bacteria are commercially available.
Examples of pest-resistant corn include "YieldGard® Rootworm RW", "YieldGard® RW + RR", and "YieldGard® VT" that express the insecticidal protein Cry3Bb1 derived from Bt. "Rootworm ™ RR2" and "MaxGard ™";"YieldGard® VT Triple" and "YieldGard ™ Plus with RR"; Bt expressing the insecticidal proteins Cry3Bb1 and Cry1Ab derived from Bt bacteria. "Bt Xtra (trademark) Maize" expressing the fungal-derived insecticidal protein Cry1Ac; "Yield Gard Plus (registered trademark)" expressing the fungal-derived insecticidal proteins Cry1Ab and Cry3Bb1; Expressed "Bt10", "Liberty Link ™ Yieldgard ™ Maize", "Agrisure ™ GT / CB / LL" and "YieldGard ™ CB + RR"; Bt fungus-derived insecticidal protein Cry1A. "Yield Gard ™ VT Pro ™" and "Genuity ™ VT Double Pro ™" expressing 105 and Cry2Ab2; "Agrisure ™ RW" expressing the insecticidal protein mCry3A derived from Bt. "Agrisure ™ GT / RW";"Starlink ™ Maize" expressing the insecticidal protein Cry9C derived from Bt bacteria; "Yield Gard ™", "Yield Gard ™ expressing the insecticidal protein Cry1Ab derived from Bt bacteria" MaizeGard ™, NaturGard KnockOut ™, Maximizer ™, Roundup Ready ™ YieldGard ™ maize, Agrisure ™ CB / LL and Mavera ™ YieldGard "Mize";"Agrisure®3122" expressing the insecticidal proteins Cry1Ab, Cry1F, modified Cry3A, Cyr34Ab1 and Cyr35Ab1 derived from Bt; "Agrisure (registered) expressing the insecticidal protein Vip3Aa20 derived from Bt. Trademark) Viptera ”;“ Agrisure® Viptera ™ 2100 ”and“ Agrisure® Viptera ™ 3110 ”, which express the insecticidal proteins Vip3Aa20 and Cry1Ab derived from Bt bacterium; "Agrisure® Viptera ™ 3100", "Agrisure ™ Viptera ™ 3111) and" Agrisure ™ Viptera ™ 4 "expressing the proteins Vip3Aa20, Cry1Ab and modified Cry3A; "Agrisure® Viptera ™ 3220" expressing the insecticidal proteins Vip3Aa20, Cry1Ab and modified Cry1F derived from Bt bacteria; expressing the insecticidal protein eCry3.1Ab (chimeric protein of Cry3A-Cry1Ab) derived from Bt bacteria. "Agrisure® Duracade ™"; Bt-derived insecticidal protein eCry3.1Ab (Cry3A-Cry1A) B chimeric protein), modified Cry3A, Cry1Ab and modified Cry1F expressing "Agrisure® Duracade ™ 5122"; insecticidal protein derived from Bt fungus eCry3.1Ab (chimeric protein of Cry3A-Cry1Ab), modified Cry3A , "Agrisure® Duracade ™ 5222" expressing modified Cry1Ab and Vip3A variants; "Herculex ™ RW" expressing the insecticidal proteins Cyr34Ab1 and Cyr35Ab1 derived from Bt fungus; "Herculex XTRA ™" expressing the proteins Cyr34Ab1, Cyr35Ab1 and Cry1F; the insecticidal protein Cry1A. "Genuity® VT Triple Pro ™" expressing 105, Cry2Ab2 and Cry3Bb1; insecticidal proteins derived from Bt bacteria Cry1F, Cry2Ab, Cyr34Ab1, Cyr35Ab1, Cry3Bb1 and Cry1A. "Genuity® SmartStax ™" expressing 105; modified insecticidal proteins derived from Bt bacteria Cry1F, Cry2Ab and Cry1A. "Power Core ™" expressing 105; "Herculex XTRA ™ RR" expressing insecticidal protein modified Cry1F, Cyr34Ab1 and Cyr35Ab1 derived from Bt bacteria; Cry1F, Cyr34Ab1, Cyr35Ab1 modified insecticidal protein derived from Bt bacteria , Cry1Ab and modified Cry3A expressed "Optimum® Intrasect Xtreme"; insecticidal protein derived from Bt fungus "Optimum® Intrasect XTRA" expressing modified Cry1F, Cyr34Ab1, Cyr35Ab1 and Cry1Ab; derived from Bt fungus Examples include "Optimum® TRIsect" expressing the insecticidal protein modified Cry1F and modified Cyr3A, which are commercially available.
Examples of other insecticidal plants include "Atlantic New Leaf ™ potato", "New Leaf ™ Russet Burbank potato", "Lugovskoi plus", which express the insecticidal protein Cry3A derived from Bt fungus. "Elizaveta plus", "Hi-Lite NewLeaf ™ Y potato, Superior NewLeaf ™ potato" and "Shepody NewLeaf ™ Y potato"; rice "hanyou" expressing the insecticidal proteins Cry1Ab and Cry1Ac derived from Bt bacteria 63 ”and“ Huahui-1 ”; soybeans expressing the insecticidal protein Cry1Ac derived from Bt bacteria“ Intacta ™ Roundup Ready ™ 2 Pro ”; potatoes expressing the insecticidal protein Cry1Ac derived from Bt bacteria“ BARI Bt Begun-1, -2, -3 and -4 ", and these are commercially available.
Also, corn "Yield Gard corn root worm", "Yield Gard VT", "Herculex RW", "Herculex Rootworm" and "Agrisure CRW" that are resistant to corn root worms; corn "Yield Gard corn borer" that is resistant to corn borers. , "YieldGard plus", "YieldGard VT Pro", "Agrisure CB / LL", "Agrisure 3000GT", "Hercules I", "Hercules II", "KnockOut", "NatureGard" and "StarLink"; Western Bean Cut Worm , Corn Borer, Black Cut Worm and Fall Army Worm Resistant Corn "Herculex I", "Herculex Xtra", "New Leaf", "New Leaf Y" and "New Leaf Plus"; Resistant to Corn Borer and Corn Root Worm Corn "Yield Gard Plus" with corn; cotton "Bollgard I" and "Bollgard II" resistant to fake American tobacco moth; fake American tobacco moth, cotton ball worm, fall army worm, beat army worm, cabbage looper, soybean looper and pink Wata "Bollgard II", "Wide Strike ™" and "Vip Cot" resistant to ball worms; corn "New Leaf", "New Leaf Y" and "New Leaf Plus" resistant to corn corn; Known eggplants "Bt brinjal", "Dumaguete Long Purple" and "Mara" (see, for example, US5128130) have resistance to cotton ball worms.
Further plants with pest resistance are generally known, such as Sankameiga resistant rice (see, eg, Molecular Breeding, Vol. 18, 2006), No. 1), scaly resistant lettuce (eg, eg). (See US5349124), rice that is resistant to the order Pests (eg, Sesamia infernalis, Parnara guttata, Sesamia infernalis, Kobunomeiga, Rice Case Worm, and Rice Army Worm) (see, eg, WO2001 / 021821). Methods of making such plants are generally known to those of skill in the art and are described, for example, in the publications described above.

Plants that have been granted pest resistance by RNA interference technology include corn pests (eg, corn bowlers, corn ear worms, cut worms such as black cut worms and fall army worms) and corn pests (corn root worms). ) Resistant corn is marketed or developed under the trade names "SmartStax®", "SmartStax® Pro" or "Genuity® SmartStax Pro".

As a plant to which pest resistance has been imparted by conventional variety improvement technology or genome breeding technology, for example, the aphid resistance gene "Rag1 (Resistance to Aphis glycines 1)" gene or "Rag2 (Resistance to Aphis glycines 1)" gene 2) ”Soybeans resistant to soybean aphids (Aphis glycines) (see J. Econ. Entomol., 2015, 108, 326.); Soybeans resistant to soybean cyst nematodes (Heterodera glycines) (Phytopathology). , 2016, 106, 1444.); Wata (J. Nematol., 2009, 41, 140) showing resistance to Nekobu nematode (Meloidogyne incognita); Rice "Kanto BPH1" showing resistance to Tobiirounka; The soybean "Fukuminori" showing resistance can be mentioned.

Plants endowed with these pest resistances are endowed with resistance to any harmful insects (particularly lepidopteran insects, lepidopteran insects, dipteran insects, beetle insects), harmful spiders and harmful nematodes. Has been done. Plants conferred with pest resistance are preferably wheat (eg wheat, barley, lime, embaku), corn, canola, sorghum, soybean, rice, rapeseed, tensai, sugar cane, grapes, lentile, sunflower, alfalfa, etc. Selected from fruit fruits, nuclear fruits, peanuts, coffee, tea, strawberries, turf, vegetables (eg tomatoes, potatoes, cornaceae and lettuce), more preferably soybeans, corn, tomatoes, rice and wheat. It is selected from the species (eg wheat, barley, limewood and embaku), most preferably from soybeans, rice, corn and wheat (eg wheat, barley, limegi and embaku).

The following are examples of plants that have been endowed with disease resistance.

Plants conferred disease resistance by genetic engineering techniques express, for example, so-called "pathogenicity-related proteins" (PRP, see EP0392225) or so-called "antifungal proteins" (AFP, see US6864068). It is a plant that Various antifungal proteins with activity against phytopathogenic fungi have been isolated from specific plant species and have become common knowledge. Examples of such anti-pathogenic substances and plants capable of synthesizing such anti-pathogenic substances are known from, for example, EP0392225, WO1993 / 05153, WO1995 / 33818, and EP0353191. Plants that are resistant to fungicidal pathogens, viral and bacterial pathogens are produced by introducing a disease resistance gene. A large number of resistance genes have been identified and isolated and used to improve disease resistance, such resistance genes include, for example, tobacco mosaic virus (TMV) resistant tobacco plants. N gene introduced into TMV-sensitive tobacco strains (see, eg, US 5571706), Prf gene introduced into plants to obtain enhanced pathogen resistance (see, eg, WO 1998/02545), And the Rps2 gene (see, eg WO 1995/028423) derived from Arabidopsis thaliana, which was used to create resistance to bacterial pathogens such as Pseudomonas syringae. Plants with a systemic acquired resistance response were obtained by introducing a nucleic acid molecule encoding the TIR domain of the N gene (see, eg, US 6630618). Further examples of known resistance genes include the Xa21 gene introduced in many rice varieties (see, eg, US5952485, US5977434, WO1999 / 009151, WO1996 / 022375), for colletotrichum resistance. Rcg1 gene (see, eg, US2006 / 225152), prp1 gene (see, eg, US5859332, WO2008 / 017706), ppv-cp gene that introduces resistance to plumpox virus (see, eg, US PP15,154Ps), P1 gene (see, eg, US5968828), genes such as Blb1, Blb2, Blb3, RB2 and Rpi-vnt1 for introducing resistance to the phytophthora infestans in potatoes (see, eg, US7148397), LRPKml Genes (see, eg WO1999 / 0644600), P1 gene for potatovirus Y resistance (see, eg, US5968828), HA5-1 gene (see, eg, US5877403 and US6046384), potatovirus X (PVX), The PIP gene for introducing broad resistance to viruses such as potato virus Y (PVY) and potato leaf roll virus (PLRV) (see, for example, EP0707069), and NI16 for fungal resistance. Examples include genes, genes such as the ScaM4 and ScaM5 genes (see, eg, US6706952 and EP1018553). Ingen, which is resistant to Bean golden mosaic virus (hereinafter referred to as BGMV), is a plant to which resistance has been imparted by RNA interference technology, and is a double-stranded RNA gene of a replicating protein. By introducing (sense and antisense ac1 gene) and inhibiting the synthesis of replication protein of BGMV, it shows resistance to BGMV. Methods of making such plants are generally known to those of skill in the art and are described, for example, in the publications described above.
Antipathogenic substances that can be expressed by such plants include, for example, ion channel blockers (sodium channel blockers, calcium channel blockers, etc.); viral KP1, KP4 and KP6 toxins; stylben synthase; bibenzyl synthase. Kitinase; Glucanase; So-called "pathogenic related proteins"(PRP; see, eg EP0392225); Antipathogenic substances produced by microorganisms (eg, peptide antibiotics, heterocyclic antibiotics (eg, WO1995 / 033818) See) and protein or polypeptide factors involved in phytopathogen defense (so-called "plant disease resistance genes" described in WO2003 / 000906)).
Antipathogenic substances produced by plants can protect plants from various pathogenic microorganisms such as fungi, viruses and bacteria. Useful plants of increasing interest in connection with the present invention include wheat (eg wheat, barley, lime and embaku), soybeans, corn, rice, rapeseed, nuts, nuclear fruits, peanuts, coffee, tea and strawberries. , Turb; vines and vegetables (eg tomatoes, potatoes), sardines, papayas, melons, lenses and lettuce, more preferably soybeans, tomatoes, rice and wheat (eg wheat, barley, etc.) It is selected from (eg, wheat and barley), most preferably from soybeans, rice and wheat (eg wheat, barley, limewood and embaku).
Plants that are resistant to fungal pathogens include, for example, soybeans that are resistant to soybean rust (Phakopsora pachyrhizi and Phakopsora meibomiae) (see, eg, WO 2008/017706); phytophthora infestans. Fusarium plants such as cotton, tomato, and potato that are resistant to (see, eg, US5859332, US7148397, EP1334979); corn that is resistant to the genus Colletotrichum, such as Colletotrichum graminicola (eg, US2006). (See / 225152); Apples resistant to apple scab (venturia inaequalis) (see, eg WO1999 / 064600); Fusarium spp. Plants resistant to culmorum, fusarium poae, fusarium acuminatum, fusarium equiseti (eg, rice, wheat, barley, lime, corn, embaku, potato, melon, soybean and sorghum) (see, eg, US6646184, EP1477557); See plants such as rice, tobacco, sorghum, sugar cane, potatoes (eg, US5859332, US5689046, US6706952, EP1018553 and US6020129) with a wide range of fungal-killing resistance. ).
Plants that are resistant to bacterial pathogens include, for example, rice that is resistant to xylella fastidiosa (see, eg, US6232528); rice, cotton, that is resistant to bacterial bacterial wilt. Bacteria such as soybeans, potatoes, sorghum, corn, wheat, barley, sugar cane, tomatoes and peppers (see, eg, WO2006 / 42145, US5952485, US5977434, WO1999 / 09151, WO1996 / 22375); against Pseudomonas syringae. Examples include resistant tomatoes (see, eg, Can. J. Plant Path., 1983, 5: 251-255).
Plants that are resistant to viral pathogens include, for example, nuclear fruits that are resistant to plum pox virus (eg, plums, almonds, apricots, potatoes, peaches, nectalins) (eg, US PP15154Ps, EP0626449); Potatoes resistant to potato virus Y (see, for example, US5968828); Potatoes, tomatoes, cucumbers resistant to tomato spotted wilt virus And plants such as legumes (see, eg, EP0626449, US5973135); corn with resistance to the potato streak virus (see, eg, US6040496); papaya ring spot. Potatoes resistant to virus) (see, eg, S5877403, US6046384); potatoes resistant to cucumber mosaic virus (eg, cucumber, melon, watermelon and pumpkin) and potatoes (eg, cucumber, melon, watermelon and pumpkin). For example potatoes, tobacco, tomatoes, eggplants, paprika, capsicum and pepper (see, for example, US6849780); Uri family with resistance to watermelon mosaic virus 2 and zucchini yellow mosaic virus. Plants (eg cucumbers, melons, watermelons and pumpkins) (see, eg US6015942); potatoes with resistance to potato leafroll virus (eg, see US5576202); potato virus X, potatoes Potatoes with widespread resistance to viruses such as virus Y (potato virus Y), potato leafroll virus (see, for example, EP0707069); resistance to the Bean golden mosaic virus. Potatoes with sex (See, for example, Mol Plant Microbe Interact. 2007 Jun; 20 (6): 717-26.).
There are plants that are resistant to antibiotics (eg, kanamycin, neomycin and ampicillin). The naturally occurring bacterial nptII gene expresses enzymes that block the action of the antibiotics kanamycin and neomycin. The ampicillin resistance gene ampR (also known as blaTEM1) is derived from the bacterium Salmonella paratyphi and is used as a marker gene in the transformation of microorganisms and plants. ampR is involved in the synthesis of beta-lactamase, an enzyme that neutralizes antibiotics in the penicillin group, including ampicillin. Plants that are resistant to antibiotics include, for example, potatoes, tomatoes, flax, canola, rapeseed, oilseed rape seeds and corn (eg, Plant Cell Reports, 20, 2001, 610-615, Trends in Plant Science, 11, 2006, 317-319, Plant Molecular Biology, 37, 1998, 287-296, Mol Gen Genet., 257, 1998, 606-13. Plant Cell Reports, 6, 1987, 333-336, Federal Register (USA), Vol. 60, No.113, 1995, p. 31139. Federal Register (USA), Vol. 67, No.226, 2002, p. 70392, Federal Register (USA), Vol. 63, No. 88, 1998, p. 25194, Federal Register (USA), Vol. 60, No. 141, 1995, p. 37870, Canadian Food Inspection Agency, FD / OFB-095-264-A, October 1999, FD / OFB-099-127-A, see October 1999). Preferably, the plant is selected from soybeans, tomatoes and wheat (eg wheat, barley, rye and embaku), most preferably from soybeans and wheat (eg wheat, barley, rye and embaku). To.
Available plants resistant to plant virus diseases include, for example, papaya ringspot virus resistant Papaya ringspot virus "Rainbow", "SunUp" and "Huanong No. 1". "Innate® Hibernate", "Innate® Glaciate" and "Innate® Acclimate"; potato virus Y and / or potato cigars that show resistance to the phytophthora infestans. Examples include the potato "Newleaf ™", which exhibits resistance to viruses (PLRV).

Rice that has been given resistance to powdery mildew (blast) as a plant that has been given disease resistance by conventional variety improvement technology or genome breeding technology; has been given resistance to powdery mildew (sheath blight). Rice; Powdery mildew resistant to leaf rust; Powdery mildew resistant wheat; Black powdery mildew (stem rust) resistant wheat; Powdery mildew-resistant wheat; Leaf blotch-resistant wheat; glume blotch-resistant wheat; Yellow spot disease Wheat imparted resistance to (tan spot); powdery mildew imparted resistance; powdery mildew resistant to dwarf leaf rust; Powdery mildew resistant to net blotch; powdery mildew resistant; powdery mildew resistant to Ramularia disease; resistance to powdery mildew (Anthracnose) Sex-imparted corn; corn resistant to gray leaf spot; corn resistant to Goss's wilt disease; Fusarium stalk Corn resistant to rot); Powdery mildew resistant to Asian soybean rust; Powdery mildew (phytophthora stem and root rot) resistant soybean; Sudden death Soybeans resistant to sudden death syndrome; Pepper resistant to Phytophthora rot; Lettuce resistant to powdery mildew; bacterial Wilt-resistant tomatoes; Gemini virus-resistant tomatoes; powdery mildew (downy mil) Lettuce with resistance to dew); Abranaceae plants such as rapeseed, cabbage, Brussels sprouts, cauliflower, colored green (Borekale), broccoli, etc. with resistance to root-knot disease (clubroot); Resistance to rapeseed, cabbage, Brussels sprouts, cauliflower, colored green (Borekale), broccoli and other Abrana plants; resistance to Fusarium oxysporum f.sp. Melonis-induced melon panama disease (Fusarimu wilt) Examples include sex-imparted melons (see, eg, WO2009 / 000736).

Powdery mildew by deleting the powdery mildew resistance gene (MILDEW RESISTACE LOCUS O, hereafter abbreviated as MLO) using powdery mildew and crisper Casnine as plants that have been imparted disease resistance by genome editing technology. Powdery mildew resistant pankomgi (see, eg, Nat.Biotech., 32,947-951 2014); by deleting the SlMLO1 gene, one of the MLOs, using crisper Casnine. Slmlo1 tomelo resistant to powdery mildew (see, eg, Scientific Reports 7, Article number: 482 2017); White leaf blight by editing the OsSWEET14 gene in rice with taren (see, eg, Scientific Reports 7, Article number: 482 2017). Rice resistant to Xanthomonas oryzae pv. Oryzae, which causes bacterial leaf blight (see Nat.Biotechnol. 30, 390-392 2012); OsERF922 gene in rice using crisper Casnine Rice that is resistant to powdery mildew (blast) by modification (see PLoS ONE 11: e0154027. Doi: 10.1371 / journal.pone.0154027 2016); A cucumber that is resistant to powdery mildew yellow ing virus (CVYV), zucchini yellow mosaic virus (ZYMV), and papaya ringspot virus-type W (PRSV-W) by disrupting the recessive eIF4E (ephalon translation initiator 4E) gene. (See Mol. PlantPathol. 17, 7 1140-1153 2016); Phytophthora stem and root caused by Phytophthora sojae by disrupting the RXLR effector gene (Avr4 / 6) with crisper Casnine. Soy mildew resistant to rot) (Mol Plant Pathol 17 (1) 127 -139 See 2016).

Introducing the Rvi6 (formerly called HcrVf2) gene, which is resistant to apple scab caused by Venturia inaequalis, using cisgenesis as a plant that has been imparted disease resistance by new breeding technology. Apples that are resistant to apple scab (see, for example, Plant Biotech.J., 12, 2-9, 2014); As a sweet cherry (Plant Biotech. J., 12, 1319-), the properties of the sweet cherry (Plant Biotech. J., 12, 1319- 1328 See 2014).

The following are examples of plants with altered product quality.
Product quality modification means the synthesis of modified components or the increase or decrease in the amount of components synthesized as compared to the corresponding wild-type plants. Plants with altered product quality include, for example, modified plants with increased or decreased content of vitamins, amino acids, proteins and starches, various oils, and modified plants with reduced nicotine content.

Plants whose product quality has been modified by gene recombination technology include, for example, the double strand of the S-adenosyl-L-methionine: trans-cafe oil CoA 3-methyl transferase (ccomt) gene derived from alfalfa involved in lignin production. Alfalfa whose lignin content was reduced by RNA interference by introducing a gene that produces RNA; triacylglyceride containing lauric acid by introducing a 12: 0 ACP thioesterase gene derived from Laurier (Umbellularia californica) involved in fatty acid synthesis. Canola with increased content "Laurical ™ Canola"; by introducing a partial gene (gm-fad2-1) of ω-6 desaturase derived from soybean, which is a fatty acid desaturase, the gene expression is suppressed. Soybeans "Plenish ™" and "Treus ™" with increased oleic acid content; genes that produce double-stranded RNA of the acyl-acyl carrier protein thioesterase gene (fatb1-A) derived from soybeans. Soybean "Vistive Gold ™" whose saturated fatty acid content was reduced by introducing a gene that produces a double-stranded RNA of the soybean-derived δ-12 desaturase gene (fad2-1A); Recombinant soybean (Pj. D6D) and stearidonic acid, one of the ω3 fatty acids, produced by introducing the δ-12 desaturase gene (Nc. Fad3) derived from red-spotted mold; Thermococcus bacterium related to starch degradation (Pj. D6D) Cornebacterium glutamicum for the production of the amino acid lysine, a corn "Enogen®" whose bioethanol production has been enhanced by introducing the thermococcales sp.) Heat-resistant alpha-amylase gene (amy797E). )-Derived dihydrodipicolinate synthase gene (cordapA) increased lysine production by introducing corn "Mavera ™ Maize" and "Mavera ™ Yield Gard ™ Maize"; potato-derived starch synthase Introduced the antisense gene gbss of (granule-bound starch synthase enzyme, GBSS) The double chains of the transcription factor genes PhL and R1 that promote the degradation of starch derived from potatoes, which are the potatoes "Amflora ™" and "Starch Potato", in which the amylose content in the starch granules is decreased and the amylopectin content is increased. Introducing the genes pPhL and pR1 that generate RNA suppresses the degradation of starch, and the introduction of the gene asn1 that produces the double-stranded RNA of the gene Asn1 involved in asparagine production suppresses the synthesis of asparagine (a carcinogenic substance by heating). Innate (innate), a gene that produces double-stranded RNA of the polyphenol oxidase gene Ppo5 derived from potatoes, is introduced to suppress the formation of black spots. "Cultivate", "Innate® Generate", "Innate® Accelerate", "Innate® Invigorate", "Innate® Glaciate", "Innate® Acclimate" And "Innate® Hibernate"; tobacco whose nicotine content was reduced by introducing the antisense gene (NtQPT1) of the quinophosphate phosphoribosyltransferase gene QpTase derived from tobacco (Nicotiana tabacum); Β-carotene is produced in embryonic tissue by introducing the carotene desaturase gene (crt1) derived from the phytoen synthase gene (psy) derived from it and the soil bacterium (Erwinia uredovora) synthesizing carotenoid and expressing it specifically in embryo milk. Golden rice, which is a rice that can harvest rice containing vitamin A, can be mentioned. In addition, for example, potatoes and corn with modified amyropectin content (see, eg, US6784338, US2007 / 0261136, WO1997 / 04471); canola, corn, cotton, grapes, cattail with modified oil content. , Catalpa, rice, soybean, rapeseed, wheat, sunflower, niggauri, safflower and vernonia plants (eg US7294759, US7157621, US5850026, US6441278, US5723761, US6380462, US6365802, US6974898, WO2001 / 079499, see US2006 / 0075515 and US7294759); sunflowers with increased amino acid content (see, eg, US6084164); soybeans with reduced allergen content (see, eg, US6864362); corn with reduced nicotine content (see, eg, US6084164). See, for example, US2006 / 0185684, WO2005 / 000352 and WO2007 / 0364636); canola and soybean with increased lysine content (see, eg, Bio / Technology 13, 1995, 577-582); methionine, leucine, isoleucine and / Or corn and soybeans with modified valine composition (see, eg, US6946589, US6905877); soybeans with increased sulfur amino acid content (see, eg, EP0929685, WO1997 / 041239); 3 from Escherichia coli. '-Phosphoadenosine-5'-phosphosulfate reductase (3'-Phosphoadenosine-5'-phosphosulfate reductase) was foliar-specifically expressed to increase methionine content in maize (PNAS, 2017, 114 (43). ), 11386.); Tomatoes with increased free amino acid content (eg, asparagine, aspartic acid, serine, methionine, alanine, histidine and glutamate) (see, eg, US6727411); Corn with increased amino acid content (eg, eg, US6727411). WO 05/077117); potatoes, corn and rice with modified starch content (see, eg, WO 1997/044471 and US7317146). ); Tomatoes, corn, grapes, alfalfa, apples, legumes and peas with modified flavonoid content (see, eg, WO 00/04175); corn, rice, sorghum, cotton with modified phenolic compound content. And soybeans (see, eg, US2008 / 0235829); tomatoes and canolas with increased vitamin A content (see, eg, US6797498, US7348167); tomatoes, canolas, soybeans, wheat, sunflowers with increased vitamin E content. , Rice, corn, corn and lime (see, eg, US7348167, WO2004 / 058934); alfalfa, apple, corn, corn, grape, tomato and pea with modified flavonoid content (see, eg, WO00 / 04175). Can be mentioned. Methods of making such plants are generally known to those of skill in the art and are described, for example, in the publications described above. Preferably, the plant is selected from soybeans, canolas, tomatoes, rice and wheat (eg wheat, barley, rye and barley), most preferably from soybeans, canola, rice, wheat and barley.

Rapeseed "Nexera® Canola" that produces unsaturated omega-9 fatty acids as a plant whose product quality has been modified by conventional variety improvement technology or genome breeding technology; soybean with reduced allergen content "Yumeminori"; Rice for the purpose of modifying to a good taste, for example, rice "Yumepirika" having a reduced amylose content is commercially available. In addition, citrus fruits with modified fruit characteristics (eg, fruit weight, aroma, juiciness and sugar content) by genomic selection are known (see Scientific Reports 7, 4721 2017).

Plants with modified nutrient utilization of plants include, for example, plants with enhanced assimilation or metabolism of nitrogen or phosphorus. Plants with enhanced nitrogen assimilation and nitrogen utilization by gene recombination technology include, for example, canola, corn, wheat, sunflower, rice, tobacco, soybean, cotton, alfalfa, tomato, wheat, potato, tensai, sugar cane and Seek rapeseed (see, for example, WO1995 / 009911, WO1997 / 030163, US6084153, US5955651 and US6864405). Plants with improved phosphorus uptake by genetic recombination techniques include, for example, alfalfa, barley, canola, corn, cotton, tomato, rapeseed, rice, soybean, sugar beet, sugar cane, sunflower, wheat and potato (eg,). See US7417181, US2005 / 0137386). Methods of making such plants are generally known to those of skill in the art and are described, for example, in the publications described above. Preferably, the plant is selected from soybeans, tomatoes and wheat (eg wheat, barley, rye and embaku), most preferably from soybeans, rice, corn and wheat.

Examples of the plant in which the fertility trait or the like has been modified by the gene recombination technique include a plant in which the male sterility and the fertility recovery trait are imparted to the plant. For example, corn and chicory imparted with male sterility by expressing a ribonuclease gene (barnase) derived from Bacillus amyloliquefaciens in anther tapetum cells; DNA adenine methylase gene (dam) derived from Escherichia coli. Introduced corn that was given the male sterility trait by introduction; the alpha-amylase gene (zm-aa1) from the corn that gave the male sterility trait and the ms45 protein gene (ms45) from the corn that gave the fertility recovery trait. Cornola whose fertility traits were controlled by the expression of a ribonuclease-inhibiting protein gene (barstar) derived from Bacillus in anther tapetum cells; Examples thereof include canolas whose fertility traits are regulated by expressing a fungal-derived ribonuclease gene (barnase) and a Bacillus-derived ribonuclease inhibitory protein gene (barstar) that imparts fertility recovery traits. Other plants imparted with fertile traits by gene recombination technology include tomato, rice, mustard greens, wheat, soybean and sunflower (eg, US6720481, US6281348, US5659124, US6399856, US7345222, US7230168, US6072102, EP1135982, WO2001. See / 092544 and WO 1996/040949). Methods of making such plants are generally known to those of skill in the art and are described, for example, in the publications described above. Preferably, the plant is selected from corn, canola, soybean, rice, tomatoes and wheat grains (eg wheat), most preferably from corn, canola, soybean, rice, wheat.

Plants conferred with abiotic stress tolerance are limited to drought, high salt content, high light intensity, high UV irradiation, chemical contamination (eg high heavy metal concentration), low temperature or high temperature, nutrients (ie nitrogen, phosphorus). It is a plant that exhibits increased resistance to abiotic stress conditions such as supply and mass stress (see, eg, WO 2000/004173, WO2007 / 131699, CA2521729 and US2008 / 0229448).

Plants that have been endowed with abiotic stress tolerance by gene recombination technology include, for example, drought-tolerant rice, corn, soybean, sugar cane, alfalfa, wheat, tomato, potato, barley, rapeseed, legume, crow wheat, and sorghum. And cotton (see, eg, WO 2005/048693, WO 2008/002480 and WO 2007/030001); low temperature tolerant corn, soybean, wheat, cotton, rice, rapeseed and alfalfa (see, eg, US4731499 and WO2007 / 112122). High salt resistant rice, cotton, potatoes, soybeans, wheat, barley, limewood, sorghum, alfalfa, grapes, tomatoes, sunflowers and tobacco (see, eg, US7256326, US7034139, WO / 2001/030990). .. There is also a corn "Drought Gard®" (Monsanto product) into which the cold shock protein gene cspB of Bacillus subtilis has been introduced.

As plants to which abiotic stress tolerance has been imparted by conventional variety improvement technology or genome breeding technology, for example, maize having drought tolerance is "Agrisure Artesian (registered trademark)" and "Optimum (registered trademark)". Developed under the trade name of "AQUAmax (registered trademark)".

As a plant to which other characteristics have been imparted, there is a plant whose maturity characteristics have been modified. Modifications of maturation properties include, for example, delayed ripening, delayed softening and premature maturation. As a plant whose maturity characteristics have been modified by gene recombination technology, for example, by introducing the S-adenosylmethion hydrolase gene (sam-K) derived from Escherichia coli Bacterophage T3 related to ethylene production of the plant hormone, shelving can be carried out. Improved melons and tomatoes; a gene lacking part of the tomato-derived ACC synthase gene involved in ethylene production of plant hormones, an ACC deaminase gene derived from Pseudomonas chlororaphis that degrades the ethylene precursor ACC, Shelf by introducing one or more of the gene that produces the double-stranded RNA of the tomato-derived polygalacturonase gene that degrades cell wall pectin, or the tomato-derived ACC oxidase gene that is involved in the production of ethylene. Tomatoes with improved shelf life; Tomatoes with improved shelf life by introducing the gene pg that produces the double-stranded RNA of the polygalacturonase gene derived from tomatoes, "FLAVR SAVR ™" can be mentioned. Other plants whose maturity properties have been altered by gene recombination techniques include, for example, delayed ripening tomatoes, melons, raspberries, strawberries, canmelons, peppers and papayas (eg, US 5767376, US7084321, US6107548). , US5981831, WO1995 / 035387, US 5952546, US 5512466, WO1997 / 001952, WO1992 / 008798 and Plant Cell. 1989, 53-63. See Plant Molecular Biology, 50, 2002). Methods of making such plants are generally known to those of skill in the art and are described, for example, in the publications described above. Preferably, the plants are fruits (eg, tomatoes, vines, melons, papayas, bananas, peppers, raspberries and strawberries); nuclear fruits (eg, cherries, apricots and peaches); fruit fruits (eg, apples and oranges). Pear); as well as selected from citrus fruits (eg, citron, lime, orange, pomegranate, grapefruit, and mandarin), more preferably selected from tomatoes, melons, papayas, vines, apples, bananas, oranges and strawberries. Most preferably, tomatoes, melons and papayas.

As a plant to which other quality modifications have been imparted by gene recombination technology, for example, by introducing a 3-phytase gene (phyA) derived from black mold (Aspergillus niger) which is a degrading enzyme of phytic acid of the plant, it is endogenous. Canola "Phytaseed® Canola" with enhanced degradation of phytic acid; dihydrodoflavonol-4-reductase gene derived from Petunia hybrida, an enzyme that produces the blue pigment delphinidin and its derivatives, and petunia, Carnations "Moondust ™" and "Moonshadow" whose flower color is controlled to be blue by introducing a flavonoid-3', 5'-hydroxylase gene derived from pansy (Viola wittrockiana), salvia (Salvia splendens), or carnation. (Trademark), "Moonshade (Trademark)", "Moonlite (Trademark)", "Moonaqua (Trademark)", "Moonvista (Trademark)", "Moonique (Trademark)", "Moonpearl (Trademark)", "Moonberry (Trademark)" "Moonvelvet ™"; the anthocyanin-5-acyltransferase gene from Torenia sp., The enzyme that produces the blue pigment delphinidin and its derivatives, and the flavonoid-3,5'from pansy. -A rose whose flower color is controlled to blue by introducing a hydroxylase gene; Rice having an immunotolerant effect and a pollinosis alleviating effect by introducing a modified cedar pollen antigen protein gene (7crp); derived from black mold Corn with enhanced degradation of endogenous phytic acid by introducing the 3-phytase gene (phyA); producing high quality fibers with improved fiber micronea, increased fiber strength, length uniformity and color, etc. (See, for example, WO1996 / 26639, US7329802, US6472588 and WO2001 / 17333).

Examples of plants whose traits related to plant growth and yield have been modified include plants with enhanced growth ability. Plants whose growth and yield traits have been modified by gene recombination technology are enhanced by introducing, for example, a gene (bbx32) that encodes a transcription factor that regulates diurnal characteristics derived from Arabidopsis thaliana. High yield is expected as a soybean; the introduction of a transcription factor gene (athb17) belonging to the homeodomain-leucine 14 zipper (HD-Zip) family class II HD-Zip II) derived from Arabidopsis increases the ear weight. As a result, high-yielding corn has been developed.

As a plant whose quality has been modified by genome editing technology, it lacks the IPK1 gene encoding the inositol-1,3,4,5,6-pentakisphosphate 2-kinase, which is an enzyme for phytate biosynthesis, using zinc finger nucleases. Zinc finger corn "ZFN-12 maize" with reduced phytic acid content by loss; browning resistance is imparted by deleting the gene encoding polyphenol oxidase using crisper casnine. Mushrooms (see, for example, Nature., Vol 532, 21 APRIL 2016).

As a plant whose quality has been modified by the new breeding technology, for example, using cisgenesis, the low polyphenol oxidase (enzyme that causes browning) production gene sequence GEN-03 isolated from apples should be introduced into new apple varieties. An apple "Arctic (registered trademark)" that reduces the expression level of polyphenol oxidase and does not brown. Examples thereof include tomatoes obtained by imparting salt resistance to tomatoes of non-transgenic scion using trees (see Physiol Plantarum, 124, 465-475 2005).

In rice, genes showing resistance to many diseases, pests and abiotic stress are known, and resistant varieties into which they have been introduced are being actively produced. Genes that show resistance to disease and abiotic stress in rice include, for example, BPH1, BPH2, BPH3, BPH4, BPH5, BPH6, BPH7, BPH8, BPH9, BPH10, BPH11, BPH12, BPH13, BPH14, BPH15, BPH17. , BPH18, BPH19, BPH20, BPH21, BPH22, BPH23, BPH24, BPH25, BPH26, BPH27, BPH28, BPH29, BPH32, qBPH-12, qBPHR-1, qBPHR-3, qBPHR-8, qBPHR-5-1qBPHR-5 -2 Tobiirounka resistance genes such as qBPHR-11-1 and qBPHR-11-2; Sex genes; Qsbph2b, Qsbph3, Qsbph3b, Qsbph3c, Qsbph3d, Qsbph4, Qsbph8, Qsbph11, Qsbph11d, Qsbph11e, Qsbph11f, Qsbph11g, Qsbph11f, Qsbph11g, Qsbph11f, Qsbph11g, Qsbph11f, Qsbph11g, Qsbph12a, etc. , GLH9, GLH10, GLH11, GLH12, GLH13, GRH1, GRH2, GRH3, GRH4, GRH5, Zlh1, Zlh2, Zlh3, qGRH-4, qGRH-2, qGRH-5, qGRH-6, qGRH-11, qGRH-3 Horizontal resistance genes such as SB; Nikameichu resistance genes such as SB; Pii, PI65, PIZT, PI24, PI29, PI25, Pi-jnw1, PB1, PIQ6, PID3, PI67, PITQ5, PITP, PITQ6, PLM2, PISE3, IPI , PISE1, PI157, PIQ4, PI21, PIA, PIB, PIK, PIKUR1, PIKUR2, PI3, PIF, PIZH, PIR4, PIR7, PI30, PI, PIGD2, PIG, PIGD3, PIGD1, PIZ, PI (, PI18, PIM, PI17, PI20, PI1, PI19, PI5, PISH, PI10, PI9, PI21, PI22, PI44, PI22, PI13, PII, PIB1, PIQ1, PIQ2, PIQ3, PIIS1, PII2, PI62, PI12, IPI3, PI14, PI15 , PI16, PIT, PI11, PI6, PI23, PI14, PI11, PIIS2, PIB2, PI12, PI39, PI40, PITA, PIR2-3, PIR9-2, PIR12-2, PIRF2-1, qRBR-2, qRBR-3 , PI27, PI28, PI26, PIGM, PI47, PI48, PI7, PI56, PI49, PI34, PIKG, PI38, PI32, PI31, PI46, PIX, PIXY, Pita3, PI41, PI42, PI2, PI36, PI37, PIKH, PIKM , PIKP, PI35, PIZ5, PIB2, PI43, PI50, PI51, PID1, PIY1, PIY2, PI55-2, PICO39, PI55-1, PIBH8, PIR7A, PIR7B, PID2, PI33, qBFR4-1, qBFR4-2, qRBR -2, qRBR-3, qRBR-8, qRBR-1-1, qRBR-1-3, qRBR-7-1, qRBR-7-2, qRBR-9-1, qRBR-9-2, qRBR-9 Blast resistance genes such as -3, qRBR-1-2, qRBR-1-4; Striped leaf blight resistance genes such as STVA, STVB, Stvb-i; XA21D, XA, XA40, XA NM, XA8, XA33, XA34, XA35, XA36, XA37, XA7, XA3, XA25, XA28, XA29, XA30, XA31, XA32, XA38, XA39, XA11, XA16, XA17, XA18, XA19, XA20, XA14, XA2, XA12 White leaf blight resistance genes such as XA K, XA A, XA H, XA10, XA23, XA22, XA24, XA21, SERRT13, XA4, XA5, XA13; qSB-2, qSB-3, qSB-7, qSB-11 Blight blight resistance genes such as qSB-9-1; sesame leaf blight resistance genes such as CE; yellow dwarf disease resistance genes such as YDV; black streak dwarf disease resistance genes such as BSV; Amy1A, Amy1C , Amy3A, Amy3B and other high temperature ripening resistance genes; low amylose genes such as dul3, qAC9.3, rsr1, Wx and Wx1-1; AP01, SCM2, Sd1 and other lodging resistance genes; Genes; Low temperature resistance genes such as CTB1, CTB2, qLTG3-1; Dry resistance genes such as Dro1; DEP1, Cn1a, GPS, SPIKE, PTB1, TAWAWA1, WFP, IPA1, Genes related to paddy number or seed shape such as GS3, GS5, GS6, GL3.1, GW2, GW8, qGL3, qSS7, qSW5; genes that regulate photoperiod reactivity such as Hd1, Ghd8, DTH8; FLO4, PDIL1, etc. Endosperm emulsion genes; Lipoxygenase deletion genes such as LOX3 (reducing the odor of old rice); Genes related to amylopectin chain length such as Alk are known. Rice varieties in which one or more of these genes are simultaneously incorporated have been developed or marketed.

For the above-mentioned plants, gene recombination technology, conventional variety improvement technology, genome breeding technology, new breeding technology, genome editing technology, etc. are used, and the above-mentioned abiotic stress resistance, disease resistance, and weeding are used. By crossing lines with two or more species of agent resistance, pest resistance, growth and yield traits, alteration of nutrient utilization, modification of product quality, fertility trait, etc., and plants with similar or different properties. It also includes plants endowed with two or more traits of the parent line.

Commercially available plants conferred resistance to more than one herbicide include, for example, cotton "GlyTol ™ LibertyLink ™" and "GlyTol ™ LibertyLink ™" which are resistant to glyphosate and gluhosinate; Glyphosate-resistant and gluhosinate-resistant corn "Roundup Ready ™ LibertyLink ™ Maize"; gluhosinate-resistant and 2,4-D resistant soybean "Enlist ™ Soybean"; glyphosate- and dicamba-resistant soybeans " Genuity® Roundup Ready ™ 2 Xtend ™ ”; corn and soybean“ Optimum GAT ™ ”with glyphosate and ALS inhibitor resistance; three herbicides glyphosate, gluhosinate and 2,4-D Resistant to recombinant soybeans "Enlist E3 ™" and "Enlist ™ Roundup Ready 2 Yield®"; glyphosate, 2,4-D and allyloxyphenoxypropionic acid-based (FOPs) herbicides. Tolerant to corn "Enlist ™ Roundup Ready® Corn 2"; corn tolerant to glyphosate, 2,4-D and allyloxyphenoxypropionic acid (FOPs) herbicides "Enlist ™ Roundup" Ready® Corn 2 ”; cotton that is resistant to dicamba, glyphosate and gluhosinate“ Bollgard II® XtendFlex ™ Cotton ”; resistant to three herbicides: glyphosate, gluhosinate and 2,4-D. One cotton "Enlist ™ Cotton"; a soybean "Liberty Link® GT27 ™" that is resistant to three herbicides: glyphosate, gluhosinate and HPPD herbicides (eg, isoxaflutol). .. In addition, cotton resistant to both glufosinate and 2,4-D; cotton resistant to both glufosinate and dicamba; corn resistant to both glyphosate and 2,4-D; glyphosate and HPPD herbicides. Soybeans resistant to both; corn resistant to glyphosate, glufosinate, 2,4-D, allyloxyphenoxypropionic acid (FOPs) and cyclohexadione (DIMs) herbicides have also been developed.
Commercially available plants imparted with herbicide resistance and pest resistance include, for example, corn "YieldGard Roundup Ready ™" and "YieldGard Roundup Ready 2 ™" having glyphosate resistance and resistance to corn borer. Corn "Agrisure CB / LL ™" with gluhosinate resistance and corn borer resistance; corn "Yield Gard VT Root worm / RR2 ™" with glyphosate resistance and corn root worm resistance; Corn "Yield Gard VT Triple ™" with resistance to corn root worms and corn bowlers; gluhosinate resistance and corn pest resistance (Cry1F) (eg Western Bean Cut Worm, Corn Bowler, Black Cut Worm and Fall) Corn "Herculex I ™" with resistance to army worms; corn "Yield Gard Corn Rootworm / Roundup Ready 2 ™" with glyphosate resistance and corn root worm resistance; Corn "Agrisure GT / RW ™" with pest resistance (Cry3A) (eg, resistance to Western corn root worms, Northern corn root worms and Mexican corn root worms); Cry34 / 35Ab1) (eg, resistance to Western corn root worms, Northern corn root worms and Mexican corn root worms) and corn "Herculex RW ™"; corn with glyphosate resistance and corn root worm resistance " Yield Gard VT Root worm / RR2 ™; cotton with dicamba resistance, glyphosate resistance, glyphosinate resistance and resistance to corn pests (eg, ball worms and tobacco bad worms, army worms, etc.) There is "Bollgard® 3 XtendFlex®".

Examples of commercially available plants imparted with disease resistance and pest resistance include the potato virus Y resistance and pest resistance potato potato "Hi-Lite New Leaf ™ Y". "Potato", "New Leaf ™ Y Russet Burbank Potato" and "Shepody New Leaf ™ Y Potato"; potato leafroll virus and pest resistant potato "New Leaf ™ Plus" Russet Burbank Potato ".

Commercially available plants endowed with herbicide resistance and product quality modification properties include, for example, the canola "InVigor ™ Canola" endowed with glufosinate resistance and fertility traits; which imparts glufosinate resistance and fertility traits. Corn "In Vigor ™ Maize"; soybean "Vistive Gold ™" with modified glyphosate resistance and modified oil content.

Examples of commercially available plants with three or more traits are glyphosate resistant, gluhosinate resistant and corn pest resistant (Cry1F) (ie against western bean cut worms, corn bowlers, black cut worms and fall army worms). Corn with resistance) "Herculex I / Roundup Ready 2 (trademark)"; Corn with glyphosate resistance, corn root worm resistance and corn bowler resistance "Yield Gard Plus / Roundup Ready 2 (trademark)"; glyphosate resistance, gluhosinate Corn "Agrisure GT / CB / LL ™" with resistance and corn borer resistance; gluhosinate resistance, corn pest resistance (Cry1F) and corn pest resistance (Cry34 / 35Ab1) (ie Western Bean Cut Worm, "Herculex Xtra ™" corn with scaly pests such as corn bowlers, black cut worms and fall army worms and pod pests such as western corn root worms, northern corn root worms and Mexican corn root worms); Agrisure CB / LL / RW (Agrisure CB / LL / RW) corn with gluhosinate resistance, corn borer resistance (Cry1Ab) and corn pest resistance (Cry3A) (ie resistance to western corn root worms, northern corn root worms and Mexican corn root worms). ”; Corn“ Agrisure ™ ”with glyphosate resistance, corn borer resistance (Cry1Ab) and corn pest resistance (Cry3A) (ie resistance to western corn root worms, northern corn root worms and Mexican corn root worms). ) 3000GT "; Corn" Mavera high-value corn "with glyphosate resistance, resistance to corn root worms and European corn bowlers and high lysine traits; European corn bowlers, Southwestern corn bowlers, corn ear worms, fall army worms, black Optimum (registered trademark) Leptra (trademark), a corn that is resistant to pests that damage the above-ground parts of plants such as cut worms and / or western bean worms. ”; Glyphosate resistance, gluhosinate resistance, soybean leaf spot resistance, sudden death Syndrome resistance, south stem canker resistance, phytophthora stem and root rot Resistant, soybean root-knot nematode resistance, stem rot resistance, brown stem rot resistance, soybean cyst nematode resistance, iron Soybean "Credenz® soybean" with improved iron chlorosis and modified chloride sensitivity; cotton "Stoneville®" with multiple herbicide resistance and pest resistance. ) Cotton ”(There are nine varieties of ST5517GLTP, ST4848GLT, ST4949GLT, ST5020GLT, ST5115GLT, ST6182GLT, ST4747GLB2, ST4946GLB2, ST6448GLB2 to respond to the outbreak of weeds and pests in the field in each region). ..

The plants on the market or developed are listed below (A1-A556). The numbers in parentheses mean [plant name, Event Name, Event code, Tradename]. NA also means "no information" or "unavailable information". Many of these plants are registered in the database (GM APPROVAL DATABASE) on the electronic information site (http://www.isaaa.org/) of the INTERNATINAL SERVICE for the ACQUISITION of AGRI-BIOTECH APPLICATIONS, ISAAA. It is listed in.
A1: [Alfalfa, J101, MON-00101-8, Roundup Ready ™ Alfalfa], A2: [Alfalfa, J101 x J163, MON-00101-8 x MON-00163-7, Roundup Ready ™ Alfalfa], A3: [Alfalfa, J163, MON-00163-7, Roundup Ready ™ Alfalfa], A4: [Alfalfa, KK179, MON-00179-5, HarvXtra ™], A5: [Alfalfa, KK179 x J101, MON] -00179-5 x MON-00101-8], A6: [Apple, GD743, OKA-NB001-8, Arctic ™ "Golden Delicious" Apple], A7: [Apple, GS784, OKA-NB002-9, Arctic (Trademark)], A8: [Apple, NF872, OKA-NB003-1, Arctic (Trademark) Fuji Apple], A9: [Argentina Canola, 23-18-17 (Event 18), CGN-89111-8, Laurical ( Trademark) Canola], A10: [Argentina Canola, 23-198 (Event 23), CGN-89465-2, Laurical ™ Canola], A11: [Argentina Canola, 61061, DP-061061-7], A12: [ Argentine Canola, 73496, DP-073496-4, Optimum® Gly canola], A13: [Argentina Canola, 73496 x RF3, DP-073496-4 x ACS-BN003-6, NA], A14: [Argentina Canola] , GT200 (RT200), MON-89249-2, Roundup Ready ™ Canola], A15: [Argentina Canola, GT73 (RT73), MON-00073-7, Roundup Ready ™ Canola], A16: [Argentina Canola] , HCN10 (Topas 19/2), NA, Liberty Link ™ Independence ™], A17: [Argentina Canola, HCN28 (T45), ACS-BN008-2, InVigor ( Canola], A18: [Argentina Canola, HCN28 x MON88302, ACS-BN008-2 x MON-88302-9, InVigor ™ x TruFlex ™ Roundup Ready ™ Canola], A19: [Argentina Canola, HCN92 (Topas 19/2), ACS-BN007-1, Liberty Link ™ Innovator ™], A20: [Argentina Canola, HCN92 x MON88302, ACS-BN007-1 x MON-88302-9, Liberty Link ( Innovator ™ x TruFlex ™ Canola], A21: [Argentina Canola, MON88302, MON-88302-9, TruFlex ™ Roundup Ready ™ Canola], A22: [Argentina Canola] , MON88302 x MS8 x RF3, MON-88302-9 x ACS-BN005-8 x ACS-BN003-6, InVigor ™ x TruFlex ™ Roundup Ready ™ Canola], A23: [Argentina Canola, MON88302 x RF3, MON-88302-9 x ACS-BN003-6, NA], A24: [Argentina Canola, MPS961, NA, Phytaseed ™ Canola], A25: [Argentina Canola, MPS962, NA, Phytaseed ™ Canola] , A26: [Argentina Canola, MPS963, NA, Phytaseed ™ Canola], A27: [Argentina Canola, MPS964, NA, Phytaseed ™ Canola], A28: [Argentina Canola, MPS965, NA, Phytaseed ™ Canola] ], A29: [Argentina Canola, MS1 (B91-4), ACS-BN004-7, InVigor ™ Canola], A30: [Argentina Canola, MS1 x MON88302, ACS-BN004-7 x MON-88302-9, InVigor ™ x Tr uFlex ™ Roundup Ready ™ Canola], A31: [Argentina Canola, MS1 x RF1 (PGS1), ACS-BN004-7 x ACS-BN001-4, InVigor ™ Canola], A32: [Argentina Canola, MS1 x RF1 (PGS2), ACS-BN004-7 x ACS-BN002-5, InVigor ™ Canola], A33: [Argentina Canola, MS1 x RF3, ACS-BN004-7 x ACS-BN003-6, InVigor ( Trademark) Canola], A34: [Argentina Canola, MS8, ACS-BN005-8, InVigor ™ Canola], A35: [Argentina Canola, MS8 x MON88302, ACS-BN005-8 x MON-88302-9, InVigor ( Trademark) x TruFlex ™ Roundup Ready ™ Canola], A36: [Argentina Canola, MS8 x RF3, ACS-BN005-8 x ACS-BN003-6, InVigor ™ Canola], A37: [Argentina Canola, MS8 x RF3 x GT73 (RT73), ACS-BN005-8 x ACS-BN003-6 x MON-00073-7, NA], A38: [Argentina Canola, OXY-235, ACS-BN011-5, Navigator ™ Canola], A39: [Argentina Canola, PHY14, NA, NA], A40: [Argentina Canola, PHY23, NA, NA], A41: [Argentina Canola, PHY35, NA, NA], A42: [Argentina Canola, PHY36, NA, NA], A43: [Argentina Canola, RF1 (B93-101), ACS-BN001-4, InVigor ™ Canola], A44: [Argentina Canola, RF1 x MON88302, CS-BN001-4 x MON-88302 -9, InVigor ™ x TruFlex ™ Roundup Ready ™ Canola], A45: [Argentina Canola, RF2 (B94-2), ACS-BN002-5, InVigo r ™ Canola], A46: [Argentina Canola, RF2 x MON88302, ACS-BN002-5 x MON-88302-9, InVigor ™ x TruFlex ™ Roundup Ready ™ Canola], A47: [Argentina Canola, RF3, ACS-BN003-6, InVigor ™ Canola], A48: [Mame, EMBRAPA5.1, EMB-PV051-1, NA], A49: [Carnation, 11 (7442), FLO-07442-4 , Moondust ™], A50: [Carnation, 11363 (1363A), FLO-11363-1, Moonshadow ™], A51: [Carnation, 1226A (11226), FLO-11226-8, Moonshade ™] , A52: [Carnation, 123.2.2 (40619), FLO-40619-7, Moonshade ™], A53: [Carnation, 123.2.38 (40644), FLO-40644-4, Moonlite ™], A54 : [Carnation, 123.8.12, FLO-40689-6, Moonaqua ™], A55: [Carnation, 123.8.8 (40685), FLO-40685-1, Moonvista ™], A56: [Carnation, 1351A (11351), FLO-11351-7, Moonshade ™], A57: [Carnation, 1400A (11400), FLO-11400-2, Moonshade ™], A58: [Carnation, 15, FLO-00015-2 , Moondust ™], A59: [Carnation, 16, FLO-00016-3, Moondust ™], A60: [Carnation, 19907, IFD-19907-9, Moonique ™], A61: [Carnation, 25947, IFD-25947-1, Moonpearl ™], A62: [Carnation, 25958, IFD-25958-3, Moonberry ™], A63: [Carnation, 26407, IFD-26407-2, Moonvelvet ™] ], A64: [Carnation, 4, FLO-00004-9, Moondust ™], A65: [Carnation, 66, FLO-00066-8, NA] A66: [Carnation, 959A (11959), FLO-11959-3, Moonshade ™], A67: [Carnation, 988A (11988), FLO-11988-7 , Moonshade ™], A68: [Chikori, RM3-3, NA, SeedLink ™], A69: [Chikori, RM3-4, NA, SeedLink ™], A70: [Chikori, RM3-6, NA, SeedLink (Trademark)], A71: [Wata, 19-51a, DD-01951A-7, NA], A72: [Wata, 281-26-236, DAS-24236-5, NA], A73: [Wata] , 281-24-236 x 3006-210-23 (MX B-13), DAS-24236-5 x DAS-21023-5, WideStrike ™ Cotton], A74: [Wata, 281-24-236 x 3006 -210-23 x COT102 x 81910, DAS-24236-5 x DAS-21023-5 x SYN-IR102-7 x DAS-81910-7, NA], A75: [Wata, 3006-210-23, DAS-21023 -5, NA], A76: [Wata, 3006-210-23 x 281-24-236 x MON1445, DAS-21023-5 x DAS-24236-5 x MON-01445-2, WideStrike ™ Roundup Ready ™ ) Cotton], A77: [Wata, 3006-210-23 x 281-24-236 x MON88913, DAS-21023-5 x DAS-24236-5 x NAMON-88913-8, Widestrike ™ Roundup ReadyFlex ™ Cotton ], A78: [Wata, 3006-210-23 x 281-24-236 x MON88913 x COT102, DAS-21023-5 x DAS-24236-5 x MON-88913-8 x SYN-IR102-7, Widestrike ™ ) Roundup ReadyFlex ™ Cotton], A79: [Wata, 31707, NA, BXN ™ Plus Bollgard ™ Cotton], A80: [Wata, 31803, NA, BXN ™ Plu sBollgard ™ Cotton], A81: [Wata, 31807 x 31808, NA, NA], A82: [Wata, 31807, NA, BXN ™ Plus Bollgard ™ Cotton], A83: [Wata, 31808, NA, BXN ™ PlusBollgard ™ Cotton], A84: [Wata, 42317, NA, BXN ™ PlusBollgard ™ Cotton], A85: [Wata, 81910, DAS-81910-7, NA], A86: [ Wata, BNLA-601, NA, NA], A87: [Wata, BXN10211 (10211), BXN-10211-9, NA], A88: [Wata, BXN10215 (10215), BXN-10215-4NA, BXN ™) Cotton], A89: [Wat, BXN102 Wata 22 (10222), BXN-10222-2, BXN ™ Cotton], A90: [Wat, BXN10224 (10224), BXN-10224-4NA, BXN ™ Cotton] , A91: [Wata, COT102 (IR102), SYN-IR102-7, VIPCOT ™ Cotton], A92: [Wata, COT102 x COT67B, SYN-IR102-7NA x NASYN-IR67B-1, VIPCOT ™ Cotton ], A93: [Wata, COT102 x COT67B x MON88913, SYN-IR102-7NA x NASYN-IR67B-1NA x NAMON-88913-8, VIPCOT ™ RoundupReadyFle x ™ Cotton], A94: [Wata, COT102 x MON15985, SYN-IR102-7NA x NAMON-15985-7, Bollgard® III], A95: [Wata, COT102 x MON15985 x MON88913, SYN-IR102-7NA x NAMON-15985-7NA x NAMON-88913-8 , Bollgard® III x Roundup Ready® Fle x ™], A96: [Wata, COT102 x MON15985 x MON88913 x MON88701, SYN-IR102-7NA x NAMON-15985-7NA x NAMON-88913-8NA x NAMONNA88701-3, NA], A97: [Wata, COT67B (IR67B), SYN-IR67B-1, NA], A98: [Wata, Event1, NA, JK1], A99: [Wata, GFMCry1A, GTL-GFM311- 7, NA], A100: [Wata, GHB119, BCS-GH005-8, NA], A101: [Wata, GHB614, BCS-GH002-5, GlyTol ™], A102: [Wata, GHB614 x LLCotton25, BCS -GH002-5NA x NAACS-GH001-3, GlyTol ™ LibertyLink ™], A103: [Wata, GHB614 x LLCotton25 x MON15985, BCS-GH002-5NA x NAACS-GH001-3NA x NAMON-15985-7, NA], A104: [Wata, GHB614 x MON15985, BCS-GH002-5NA x NAMON-15985, NA], A105: [Wata, GHB614 x T304-40 x GHB119, BCS-GH002-5NA x NABCS-GH004-7NA x NABCS-GH005-8, Glytol ™ x Twinlink ™], A106: [Wata, GHB614 x T304-40 x GHB119 x COT102, BCS-GH002-5NA x NABCS-GH004-7NA x NABCS-GH005-8NA x NASYN-IR102-7, Glytol ™ x Twinlink ™ x VIPCOT ™ Cotton], A107: [Wata, GK12, NA, NA], A108: [Wata, LLCotton25, ACS-GH001-3NA, Fiberma x (Trademark) LibertyLink (Trademark)], A109: [Wata, LLCotton25 x MON15985, ACS-GH001-3NA x NAMON-15985-7, Fiberma x (Trademark) LibertyLink (Trademark) Bollgard II (Trademark)], A110: [Wata, MLS9124, NA, NA], A111: [Wata, MON1076, MON-89924-2, Bollgard ™ Cotton], A112: [Wata, MON1445, MON-01445-2, Roundup Ready ™ C otton], A113: [Wata, MON15985, MON-15985-7, BollgardII ™ Cotton], A114: [Wata, MON15985 x MON1445, MON-15985-7NA x NAMON-01445-2, Roundup Ready ™ BollgardII (Trademark) Cotton], A115: [Wata, MON1698, MON-89383-1, Roundup Ready ™ Cotton], A116: [Wata, MON531, MON-00531-6, Bollgard ™ Cotton, Ingard ™], A117: [Wata, MON531 x MON1445, MON-0531-6NA x NAMON-01445-2, Roundup Ready ™ Bollgard ™ Cotton], A118: [Wata, MON757, MON-00757-7, Bollgard ™ Cotton] ], A119: [Wat, MON88701, MONNA88701-3, NA], A120: [Wat, MON88701 x MON88913, MONNA88701-3NA x NAMON-88913-8, NA], A121: [Wat, MON88701 x MON88913 x MON15985, MONNA88701 -3NA x NAMON-88913-8NA x NAMON-15985-7, Bollgard II (R) XtendFlex (Trademark) Cotton], A122: [Wata, MON88913, MON-88913-8, Roundup Ready (Trademark) Flex (Trademark) Cotton ], A123: [Wata, MON88913 x MON15985, MON-88913-8NA x NAMON-15985-7, Roundup Ready (Trademark) Flex (Trademark) Bollgard II (Trademark) Cotton], A124: [Wata, NgweChi6Bt, NA, NgweChi6Bt], A125: [Wat, SGK321, NA, NA], A126: [Wat, T303-3, BCS-GH003-6, NA], A127: [Wat, T304-40, BCS-GH004-7, NA], A128: [Wata, T304-40 x GHB119, BCS-GH004-7NA x NABCS-GH005-8, TwinLink ™ Cotton], A1 29: [Creeping Bent Glass, ASR368, SMG-36800-2, NA], A130: [Eggplant, BtBrinjalEventEE1, BtBrinjalEventEE1, BARIBtBegun-1, -2, -3and-4], A131: [Eucalyptus, H421, H421, GM Eucalyptus ], A132: [Ama, FP967 (CDCTriffid), CDC-FL001-2, CDCTriffidFla x], A133: [Lentils, RH44, RH44, Clearfield®
lentil], A134: [Corn, 32138, DP-32138-132138, 2138SPTmaintainer], A135: [Corn, 3272, SYN-E3272-5, Enogen ™], A136: [Corn, 3272 x Bt11, SYN-E3272] -5 x SYN-BT011-1, NA], A137: [Corn, 3272 x Bt11 x GA21, SYN-E3272-5 x SYN-BT011-1 x MON-00021-9, NA], A138: [Corn, 3272 x Bt11 x MIR604, SYN-E3272-5 x SYN-BT011-1 x SYN-IR604-5, NA], A139: [Corn, 3272 x BT11 x MIR604 x GA21, SYN-E3272-5 x SYN-BT011-1 x SYN-IR604-5 x MON-00021-9, NA], A140: [Corn, 3272 x Bt11 x MIR604 x TC1507 x 5307 x GA21, SYN-E3272-5 x SYN-BT011-1 x SYN-IR604-5 x DAS-01507-1 x SYN-05307-1 x MON-00021-9, NA], A141: [Corn, 3272 x GA21, SYN-E3272-5 x MON-00021-9, NA], A142: [Corn , 3272 x MIR604, SYN-E3272-5 x SYN-IR604-5, NA], A143: [Corn, 3272 x MIR604 x GA21, SYN-E3272-5 x SYN-IR604-5 x MON-00021-9, NA ], A144: Corn, 33121, DP-033121-3, NA], A145: [Corn, 4114, DP-004114-3, NA], A146: [Corn, 5307, SYN-05307-1, Agrisure® ) Duracade ™], A147: [Corn, 5307 x GA21, SYN-05307-1 x MON-00021-9, NA], A148: [Corn, 5307 x MIR604 x Bt11 x TC1507 x GA21, SYN-05307- 1 x SYN-IR604- 5 x SYN-BT011-1 x DAS-01507-1 x MON-00021-9, Agrisure® Duracade ™ 5122], A149: [Corn, 5307 x MIR604 x Bt11 x TC1507 x GA21 x MIR162, SYN -05307-1 x SYN-IR604-5 x SYN-BT011-1 x DAS-01507-1 x MON-00021-9 x SYN-IR162-4, Agrisure® Duracade ™ 5222], A150: [ Corn, 59122, DAS-59122-7, Hercule x ™ RW], A151: [Corn, 59122 x DAS40278, DAS-59122-7 x DAS-40278-9, NA], A152: [Corn, 59122 x GA21 , DAS-59122-7 x MON-00021-9, NA], A153: [Corn, 59122 x MIR604, DAS-59122-7 x SYN-IR604-5, NA], A154: [Corn, 59122 x MIR604 x GA21 , DAS-59122-7 x SYN-IR604-5 x MON-00021-9, NA], A155: [Corn, 59122 x MIR604 x TC1507, DAS-59122-7 x SYN-IR604-5 x DAS-01507-1 , NA], A156: [Corn, 59122 x MIR604 x TC1507 x GA21, DAS-59122-7 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, NA], A157: [Corn, 59122 x MON810, DAS-59122-7 x MON-00810-6, NA], A158: [Corn, 59122 x MON810 x MIR604, DAS-59122-7 x MON-00810-6 x SYN-IR604-5, NA], A159: [Corn, 59122 x MON810 x NK603, DAS-59122-7 x MON-00810-6 x MON-00603-6, NA], A160: [Corn, 59122 x MON810 x NK603 x MIR604, DA] S-59122-7 x MON-00810-6 x MON-00603-6 x SYN-IR604-5, NA], A161: [Corn, 59122 x MON88017, DAS-59122-7 x MON-88017-3, NA] , A162: [Corn, 59122 x MON88017 x DAS40278, DAS-59122-7 x MON-88017-3 x DAS-40278-9, NA], A163: [Corn, 59122 x NK603, DAS-59122-7 x MON- 00603-6, Herculex ™ RWRoundupReady ™ 2], A164: [Corn, 59122 x NK603 x MIR604, DAS-59122-7 x MON-00603-6 x SYN-IR604-5, NA], A165: [ Corn, 59122 x TC1507 x GA21, DAS-59122-7 x DAS-01507-1 x MON-00021-9, NA], A166: [Corn, 676, PH-000676-7, NA], A167: [Corn, 678, PH-000678-9, NA], A168: [Corn, 680, PH-000680-2, NA], A169: [Corn, 98140, DP-098140-6, Optimum GAT ™], A170: [ Corn, 98140 x 59122, DP-098140-6 x DAS-59122-7, NA], A171: [Corn, 98140 x TC1507, DP-098140-6 x DAS-01507-1, NA], A172: [Corn, 98140 x TC1507 x 59122, DP-098140-6 x DAS-01507-1 x DAS-59122-7, NA], A173: [Corn, Bt10, NA, Bt10], A174: [Corn, Bt11 (X 4334CBR, X) 4734CBR), SYN-BT011-1, Agrisure ™ CB / LL], A175: [Corn, Bt11 x 5307, SYN-BT011-1 x SYN-05307-1, NA], A176: [Corn, Bt11 x 5307] x GA21, SYN-BT011-1 x SYN-05307-1 x MON-00021-9, NA], A177: [Corn, Bt11 x 59122, SYN-BT011-1 x DAS-59122-7, NA], A178: [Corn, Bt11 x 59122 x GA21, SYN-BT011-1 x DAS-59122-7 x MON-00021-9, NA], A179: [Corn, Bt11 x 59122 x MIR604, SYN-BT011-1 x DAS-59122-7 x SYN-IR604-5, NA], A180: [Corn, Bt11 x 59122 x MIR604 x GA21, SYN-BT011-1 x DAS-59122-7 x SYN-IR604-5 x MON-00021-9, NA], A181: [Corn, Bt11 x 59122 x MIR604 x TC1507 , SYN-BT011-1 x DAS-59122-7 x SYN-IR604-5 x DAS-01507-1, NA], A182: [Corn, BT11 x 59122 x MIR604 x TC1507 x GA21, SYN-BT011-1 x DAS -59122-7 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, Agrisure® 3122], A183: [Corn, Bt11 x 59122 x TC1507, SYN-BT011-1 x DAS- 59122-7 x DAS-01507-1, NA], A184: [Corn, Bt11 x 59122 x TC1507 x GA21, SYN-BT011-1 x DAS-59122-7 x DAS-01507-1 x MON-00021-9, NA], A185: [Corn, Bt11 x GA21, SYN-BT011-1 x MON-00021-9, Agrisure ™ GT / CB / LL], A186: [Corn, Bt11 x MIR162, SYN-BT011-1 x SYN-IR162-4, Agrisure® Viptera ™ 2100], A187: [corn, Bt11 x MIR162 x 5307, SYN-BT011-1 x SYN-IR162-4 x SYN-05307-1, NA], A188: [Corn, Bt 11 x MIR162 x 5307 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-05307-1 x MON-00021-9, NA], A189: [Corn, Bt11 x MIR162 x GA21, SYN-BT011- 1 x SYN-IR162-4 x MON-00021-9, Agrisure® Viptera ™ 3110], A190: [Corn, BT11 x MIR162 x MIR604, SYN-BT011-1 x SYN-IR162-4 x SYN -IR604-5, Agrisure® Viptera ™ 3100], A191: [Corn, BT11 x MIR162 x MIR604 x 5307, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x SYN- 05307-1, NA], A192: [Corn, Bt11 x MIR162 x MIR604 x 5307 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x SYN-05307-1 x MON-00021- 9, NA], A193: [Corn, Bt11 x MIR162 x MIR604 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x MON-00021-9, Agrisure® Viptera ™ ) 3111, Agrisure® Viptera ™ 4], A194: [Corn, Bt11 x MIR162 x MIR604 x MON89034 x 5307 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x MON-89034-3 x SYN-05307-1 x MON-00021-9, NA], A195: [Corn, BT11 x MIR162 x MIR604 x TC1507, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604- 5 x DAS-01507-1, NA], A196: [Corn, BT11 x MIR162 x MIR604 x TC1507 x 5307, SYN-BT011-1 x SYN-IR162- 4 x SYN-IR604-5 x DAS-01507-1 x SYN-05307-1, NA], A197: [Corn, Bt11 x MIR162 x MIR604 x TC1507 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, NA], A198: [Corn, Bt11 x MIR162 x MON89034, SYN-BT011-1 x SYN-IR162-4 x MON-89034-3, NA], A199: [Corn, Bt11 x MIR162 x MON89034 x GA21, SYN-BT011-1 x SYN-IR162-4 x MON-89034-3 x MON-00021-9, NA], A200: [Corn, Bt11 x MIR162 x TC1507, SYN-BT011-1 x SYN-IR162-4 x DAS-01507-1, NA], A201: [Corn, Bt11 x MIR162 x TC1507 x 5307, SYN-BT011-1 x SYN-IR162-4 x DAS-01507-1 x SYN-05307-1, NA], A202: [Corn, Bt11 x MIR162 x TC1507 x 5307 x GA21, SYN-BT011-1 x SYN-IR162-4 x DAS-01507-1 x SYN- 05307-1 x MON-00021-9, NA], A203: [Corn, Bt11 x MIR162 x TC1507 x GA21, SYN-BT011-1 x SYN-IR162-4 x DAS-01507-1 x MON-00021-9, Agrisure ™ Viptera3220], A204: [Corn, Bt11 x MIR604, SYN-BT011-1 x SYN-IR604-5, Agrisure ™ CB / LL / RW], A205: [Corn, Bt11 x MIR604 x 5307, SYN-BT011-1 x SYN-IR604-5 x SYN-05307-1, NA], A206: [Corn, Bt11 x MIR604 x 5307 x GA21, SYN-BT011-1 x SYN-IR604- 5 x SYN-05307-1 x MON-00021-9, NA], A207: [Corn, BT11 x MIR604 x GA21, SYN-BT011-1 x SYN-IR604-5 x MON-00021-9, Agrisure ™ 3000GT], A208: [Corn, Bt11 x MIR604 x TC1507, SYN-BT011-1 x SYN-IR604-5 x DAS-01507-1, NA], A209: [Corn, Bt11 x MIR604 x TC1507 x 5307, SYN- BT011-1 x SYN-IR604-5 x DAS-01507-1 x SYN-05307-1, NA], A210: [Corn, Bt11 x MIR604 x TC1507 x GA21, SYN-BT011-1 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, NA], A211: [Corn, Bt11 x MON89034, SYN-BT011-1 x MON-89034-3, NA], A212: [Corn, Bt11 x MON89034 x GA21, SYN-BT011-1 x MON-89034-3 x MON-00021-9, NA], A213: [Corn, Bt11 x TC1507, SYN-BT011-1 x DAS-01507-1, NA], A214: [Corn, Bt11 x TC1507 x 5307, SYN-BT011-1 x DAS-01507-1 x SYN-05307-1, NA], A215: [Corn, Bt11 x TC1507 x 5307 x GA21, SYN-BT011-1 x DAS-01507- 1 x SYN-05307-1 x MON-00021-9, NA], A216: [Corn, Bt11 x TC1507 x GA21, SYN-BT011-1 x DAS-01507-1 x MON-00021-9, NA], A217 : [Corn, Bt176 (176), SYN-EV176-9, NaturGardKnockOut ™, Max imizer ™], A218: [Corn, BVLA430101, NA, NA], A219: [Corn, CBH-351, ACS -ZM004-3, Starlink ™ Maize], A220: [Corn, DAS40278, DAS-40278-9, Enlist ™ Maize], A221: [Corn, DAS40278 x NK603, DAS-40278-9 x MON-00603-6, NA] , A222: [Corn, DBT418, DKB-89614-9, Bt X tra ™ Maize], A223: [Corn, DLL25 (B16), DKB-89790-5, NA], A224: [Corn, GA21, MON] -00021-9, Roundup Ready ™ Maize, Agrisure ™ GT], A225: [Corn, GA21 x MON810, MON-00021-9 x MON-00810-6, Roundup Ready ™ Yield Gard ™ maize], A226: [Corn, GA21 x T25, MON-00021-9 x ACS-ZM003-2, NA], A227: [Corn, HCEM485, HCEM485, NA], A228: [Corn, LY038, REN-00038-3, Mavera ™ Maize], A229: [Corn, LY038 x MON810, REN-00038-3 x MON-00810-6, Mavera ™ YieldGard ™ Maize], A230: [Corn, MIR162, SYN-IR162-4 , Agrisure ™ Viptera], A231: [Corn, MIR162 x 5307, SYN-IR162-4 x SYN-05307-1, NA], A232: [Corn, MIR162 x 5307 x GA21, SYN-IR162-4 x SYN -05307-1 x MON-00021-9, NA], A233: [Corn, MIR162 x GA21, SYN-IR162-4 x MON-00021-9, NA], A234: [Corn, MIR162 x MIR604, SYN-IR162 -4 x SYN-IR604-5, NA], A235: [Corn, MIR162 x MIR604 x 5307, SYN-IR162-4 x SYN-IR604-5 x SYN-05307-1, NA], A236: [Corn, MIR162 x MIR604 x 5307 x GA21, SYN-IR162-4 x SYN-IR604-5 x SYN-05307-1 x MON-00021-9, NA], A237: [Corn, MIR162 x MIR604 x GA21, SYN-IR162-4 x SYN-IR604-5 x MON-00021-9, NA], A238: [Corn, MIR162 x MIR604 x TC1507 x 5307, SYN-IR162-4 x SYN-IR604-5 x DAS-01507-1 x SYN-05307 -1, NA], A239: [Corn, MIR162 x MIR604 x TC1507 x 5307 x GA21, SYN-IR162-4 x SYN-IR604-5 x DAS-01507-1 x SYN-05307-1 x MON-00021-9 , NA], A240: [Corn, MIR162 x MIR604 x TC1507 x GA21, SYN-IR162-4 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, NA], A241: [Corn, MIR162 x MON89034, SYN-IR162-4 x MON-89034-3, NA], A242: [Corn, MIR162 x MON89034 x GA21, SYN-IR162-4 x MON-89034-3 x MON-00021-9, NA], A243: [Corn, MIR162 x NK603, SYN-IR162-4 x MON-00603-6, NA], A244: [Corn, MIR162 x TC1507, SYN-IR162-4 x DAS-01507-1, NA], A245: [Corn, MIR162 x TC1507 x 5307, SYN-IR162-4 x DAS-01507-1 x SYN-05307-1, NA], A246: [Corn, MIR162 x TC1507 x
5307 x GA21, SYN-IR162-4 x DAS-01507-1 x SYN-05307-1 x MON-00021-9, NA], A247: [Corn, MIR162 x TC1507 x GA21, SYN-IR162-4 x DAS- 01507-1 x MON-00021-9, NA], A248: [Corn, MIR604, SYN-IR604-5, Agrisure ™ RW], A249: [Corn, MIR604 x 5307, SYN-IR604-5 x SYN- 05307-1, NA], A250: [Corn, MIR604 x 5307 x GA21, SYN-IR604-5 x SYN-05307-1 x MON-00021-9, NA], A251: [Corn, MIR604 x GA21, SYN- IR604-5 x MON-00021-9, Agrisure ™ GT / RW], A252: [Corn, MIR604 x NK603, SYN-IR604-5 x MON-00603-6, NA], A253: [Corn, MIR604 x TC1507, SYN-IR604-5 x DAS-01507-1, Optimum® TRIsect ™], A254: [Corn, MIR604 x TC1507 x 5307, SYN-IR604-5 x DAS-01507-1 x SYN- 05307-1, NA], A255: [Corn, MIR604 x TC1507 x 5307 x GA21, SYN-IR604-5 x TC1507 x SYN-05307-1 x MON-00021-9, NA], A256: [Corn, MIR604 x TC1507 x GA21, SYN-IR604-5 x TC1507 x MON-00021-9, NA], A257: [Corn, MON801 (MON80100), MON801, NA], A258: [Corn, MON802, MON-80200-7, NA ], A259: [Corn, MON809, PH-MON-809-2, NA], A260: [Corn, MON810, MON-00810-6, YieldGard ™, MaizeGard ™], A261: [Corn, MON810 x MIR162, M ON-00810-6 x SYN-IR162-4, NA], A262: [Corn, MON810 x MIR162 x NK603, MON-00810-6 x SYN-IR162-4 x MON-00603-6, NA], A263: [ Corn, MON810 x MIR604, MON-00810-6 x SYN-IR604-5, NA], A264: [Corn, MON810 x MON88017, MON-00810-6 x MON-88017-3, YieldGard ™ VT Triple], A265 : [Corn, MON810 x NK603 x MIR604, MON-00810-6 x MON-00603-6 x SYN-IR604-5, NA], A266: [Corn, MON832, NA, Roundup Ready ™ Maize], A267: [ Corn, MON863, MON-00863-5, YieldGard ™ Rootworm RW, MaxGard ™], A268: [Corn, MON863 x MON810, MON-00863-5 x MON-00810-6, YieldGard ™ Plus] , A269: [Corn, MON863 x MON810 x NK603, MON-00603-6 x MON-00810-6 x MON-00863-5, YieldGard ™ PluswithRR], A270: [Corn, MON863 x NK603, MON-00863- 5 x MON-00603-6, YieldGard ™ RW + RR], A271: [Corn, MON87403, MON87403-1, NA], A272: [Corn, MON87411, MON-87411-9, NA], A273: [ Corn, MON87419, MON87419-8, NA], A274: [Corn, MON87427, MON-87427-7, Roundup Ready ™ Maize], A275: [Corn, MON87427 x 59122, MON-87427-7 x DAS-59122- 7, NA], A276: [corn, MON87427 x MON88017, MON-87427-7 x MON-88017-3, NA], A277: [Tomoroko Shi, MON87427 x MON88017 x 59122, MON-87427-7 x MON-88017-3 x DAS-59122-7, NA], A278: [Corn, MON87427 x MON89034, MON-87427-7 x MON-89034-3, NA], A279: [Corn, MON87427 x MON89034 x 59122, MON-87427-7 x MON-89034-3 x DAS-59122-7, NA], A280: [Corn, MON87427 x MON89034 x MON88017, MON-87427- 7 x MON-89034-3 x MON-88017-3, NA], A281: [Corn, MON87427 x MON89034 x MON88017 x 59122, MON-87427-7 x MON-89034-3 x MON-88017-3 x 59122, NA], A282: [Corn, MON87427 x MON89034 x NK603, MON-87427-7 x MON-89034-3 x MON-00603-6, NA], A283: [Corn, MON87427 x MON89034 x TC1507, MON-87427- 7 x MON-89034-3 x DAS-01507-1, NA], A284: [Corn, MON87427 x MON89034 x TC1507 x 59122, MON-87427-7 x MON-89034-3 x DAS-01507-1 x DAS- 59122-7, NA], A285: [Corn, MON87427 x MON89034 x TC1507 x MON87411 x 59122, MON-87427-7 x MON-89034-3 x DAS-01507-1 x MON-87411-9 x DAS-59122- 7, NA], A286: [Corn, MON87427 x MON89034 x TC1507 x MON88017, MON-87427-7 x MON-89034-3 x DAS-01507-1 x MON-88017-3, NA], A287: [Corn, MON87427 x MON89034 x MIR162 x NK603, MON-87427-7 x MON-89034-3 x SYN-IR162-4 x MON-00603-6, NA], A288: [Corn, MON87427 x MON89034 x TC1507 x MON88017 x 59122, MON-87427-7 x MON-89034-3 x DAS- 01507-1 x MON-88017-3 x DAS-59122-7, NA], A289: [Corn, MON87427 x NK603, MON-87427-7 x MON-00603-6, NA], A290: [Corn, MON87427 x TC1507, MON-87427-7 x DAS-01507-1, NA], A291: [Corn, MON87427 x TC1507 x 59122, MON-87427-7 x DAS-01507-1 x DAS-59122-7, NA], A292 : [Corn, MON87427 x TC1507 x MON88017, MON-87427-7 x DAS-01507-1 x MON-88017-3, NA], A293: [Corn, MON87427 x TC1507 x MON88017 x 59122, MON-87427-7 x DAS-01507-1 x MON-88017-3 x DAS-59122-7, NA], A294: [Corn, MON87460, MON-87460-4, Genuity® DroughtGard ™], A295: [Corn, MON87460 x MON88017, MON-87460-4 x MON-88017-3, NA], A296: [Corn, MON87460 x MON89034 x MON88017, MON-87460-4 x MON-89034-3 x MON-88017-3, NA] , A297: [Corn, MON87460 x MON89034 x NK603, MON-87460-4 x MON-89034-3 x MON-00603-6, NA], A298: [Corn, MON87460 x NK603, MON-87460-4 x MON- 00603-6, NA], A299: [Corn, MON88017, MON-88017-3, YieldGard ™ VT ™ Rootworm ™ ) RR2], A300: [Corn, MON88017 x DAS40278, MON-88017-3 x DAS-40278-9, NA], A301: [Corn, MON89034, MON-89034-3, YieldGard ™ VTPro ™] , A302: [Corn, MON89034 x 59122, MON-89034-3 x DAS-59122-7, NA], A303: [Corn, MON89034 x 59122 x DAS40278, MON-89034-3 x DAS-59122-7 x DAS- 40278-9, NA], A304: [Corn, MON89034 x 59122 x MON88017, MON-89034-3 x DAS-59122-7 x MON-88017-3, NA], A305: [Corn, MON89034 x 59122 x MON88017 x DAS40278, MON-89034-3 x DAS-59122-7 x MON-88017-3 x DAS-40278-9, NA], A306: [Corn, MON89034 x DAS40278, MON-89034-3 x DAS-40278-9, NA], A307: [Corn, MON89034 x MON87460, MON-89034-3 x MON-87460-4, NA], A308: [Corn, MON89034 x MON88017, MON-89034-3 x MON-88017-3, Genuity ( Registered Trademark) VTTriplePro ™], A309: [Corn, MON89034 x MON88017 x DAS40278, MON-89034-3 x MON-88017-3 x DAS-40278-9, NA], A310: [Corn, MON89034 x NK603, MON-89034-3 x MON-00603-6, Genuity® VTDoublePro ™], A311: [Corn, MON89034 x NK603 x DAS40278, MON-89034-3 x MON-00603-6 x DAS-40278- 9, NA], A312: [Corn, MON89034 x TC1507, MON-89034-3 x DAS-01507-1, NA ], A313: [Corn, MON89034 x TC1507 x 59122, MON-89034-3 x DAS-01507-1 x DAS-59122-7, NA], A314: [Corn, MON89034 x TC1507 x 59122 x DAS40278, MON-89034 -3 x DAS-01507-1 x DAS-59122-7 x DAS-40278-9, NA], A315: [Corn, MON89034 x TC1507 x DAS40278, MON-89034-3 x DAS-01507-1 x DAS-40278 -9, NA], A316: [Corn, MON89034 x TC1507 x MON88017, MON-89034-3 x DAS-01507-1 x MON-88017-3, NA], A317: [Corn, MON89034 x TC1507 x MON88017 x 59122 , MON-89034-3 x DAS-01507-1 x MON-88017-3 x DAS-59122-7, Genuity® SmartSta x ™], A318: [Corn, MON89034 x TC1507 x MON88017 x 59122 x DAS40278, MON-89034-3 x DAS-01507-1 x MON-88017-3 x DAS-59122-7 x DAS-40278-9, NA], A319: [Corn, MON89034 x TC1507 x MON88017 x DAS40278, MON- 89034-3 x DAS-01507-1 x MON-88017-3 x DAS-59122-7 x DAS-40278-9, NA], A320: [Corn, MON89034 x TC1507 x NK603, MON-89034-3 x DAS- 01507-1 x MON-00603-6, PowerCore ™], A321: [Corn, MON89034 x TC1507 x NK603 x DAS40278, MON-89034-3 x DAS-01507-1 x MON-00603-6 x DAS-40278 -9, NA], A322: [Corn, MON89034 x TC1507 x NK603 x MIR162, MON-89034-3 x DAS-01507-1 x MON-00603-6 x SYN-IR162-4, NA], A323: [Corn, MON89034 x TC1507 x NK603 x MIR162 x DAS40278, MON-89034-3 x DAS-01507-1 x MON-00603-6 x SYN-IR162-4 x DAS-40278-9, PowerCore ™ x MIR162 x Enlist ™], A324: [Corn, MON89034 x GA21, MON-89034- 3 x MON-00021-9, NA], A325: [Corn, MS3, ACS-ZM001-9, InVigor ™ Maize], A326: [Corn, MS6, ACS-ZM005-4, InVigor ™ Maize] , A327: [Corn, MZHG0JG, SYN-000JG-2, NA], A328: [Corn, MZIR098, SYN-00098-3, NA], A329: [Corn, NK603, MON-00603-6, Roundup Ready ™ 2Maize], A330: [Corn, NK603 x MON810 x 4114 x MIR604, MON-00603-6 x MON-00810-6 x DP004114-3 x SYN-IR604-4, NA], A331: [Corn, NK603 x MON810, MON-00603-6 x MON-00810-6, YieldGard ™ CB + RR], A332: [Corn, NK603 x T25, MON-00603-6 x ACS-ZM003-2, Roundup Ready ™ LibertyLink ™ Maize], A333: [Corn, T14, ACS-ZM002-1, LibertyLink ™ Maize], A334: [Corn, T25, ACS-ZM003-2, LibertyLink ™ Maize], A335: [Corn, T25 x MON810, ACS-ZM003-2 x MON-00810-6, LibertyLink ™ Yieldgard ™ Maize], A336: [Corn, TC1507, DAS-01507-1, Herc ule x ™ I, Hercule x CB], A337: [Corn, TC1507 x 59122 x MON810 x MIR604 x NK603, DAS-01507-1 x DAS-59122-7 x MON-00810-6 x SYN- IR604-5 x MON-00603-6, Optimum ™ Intrasect X treme], A338: [Corn, TC1507 x MON810 x MIR604 x NK603, DAS-01507-1 x MON-00810-6 x SYN-IR604-5 x MON-00603-6, NA], A339: [Corn, TC1507 x 5307, DAS-01507-1 x SYN-05307-1, NA], A340: [Corn, TC1507 x 5307 x GA21, DAS-01507-1 x SYN-05307-1 x MON-00021-9, NA], A341: [Corn, TC1507 x 59122, DAS-01507-1 x DAS-59122-7, Hercule x X TRA ™], A342: [Corn, TC1507 x 59122 x DAS40278, DAS-01507-1 x DAS-59122-7 x DAS-40278-9, NA], A343: [Corn, TC1507 x 59122 x MON810, DAS-01507-1 x DAS-59122-7 x MON-00810-6, Optimum® AcreMa x® tra], A344: [Corn, TC1507 x 59122 x MON810 x MIR604, DAS-01507-1 x DAS-59122-7 x MON-00810- 6 x SYN-IR604-5, Optimum® AcreMa x® Treme], A345: [Corn, TC1507 x 59122 x MON810 x NK603, DAS-01507-1 x DAS-59122-7 x MON- 00810-6 x MON-00603-6, Optimum ™ Intrasect X TRA], A346: [Corn, TC1507 x 59122 x MON88017, DAS-01507-1 x DAS-59122-7 x MON-88017-3, NA], A347: [Corn, TC1507 x 59122 x MON88017 x DAS40278, DAS-01507-1 x DAS-59122-7 x MON-88017-3 x DAS-40278-9, NA], A348 : [Corn, TC1507 x 59122 x NK603, DAS-01507-1 x DAS-59122-7 x MON-00603-6, Hercule x X TRA ™ RR], A349: [Corn, TC1507 x 59122 x NK603 x MIR604 , DAS-01507-1 x DAS-59122-7 x MON-00603-6 x SYN-IR604-5, NA], A350: [Corn, TC1507 x DAS40278, DAS-01507-1 x DAS-40278-9, NA ], A351: [Corn, TC1507 x GA21, DAS-01507-1 x MON-00021-9, NA], A352: [Corn, TC1507 x MIR162 x NK603, DAS-01507-1 x SYN-IR162-4 x MON -00603-6, Optimum® Leptra ™], A353: [Corn, TC1507 x MIR604 x NK603, DAS-01507-1 x SYN-IR604-5 x MON-00603-6, Optimum ™ TRIsect ], A354: [Corn, TC1507 x MON810, DAS-01507-1 x MON-00, NA], A355: [Corn, TC1507 x MON810 x MIR162, DAS-01507-1 x MON-00810-6 x SYN-IR162 -4, NA], A356: [Corn, TC1507 x MON810 x MIR162 x NK603, DAS-01507-1 x MON-0
0810-6 x SYN-IR162-4 x MON-00603-6, NA], A357: [Corn, TC1507 x MON810 x MIR604, DAS-01507-1 x MON-00810-6 x SYN-IR604-5, NA] , A358: [Corn, TC1507 x MON810 x NK603, DAS-01507-1 x MON-00810-6 x MON-00603-6, Optimum ™ Intrasect], A359: [Corn, TC1507 x MON810 x NK603 x MIR604, DAS-01507-1 x MON-00810-6 x MON-00603-6 x SYN-IR604-5, NA], A360: [Corn, TC1507 x MON88017, DAS-01507-1 x MON-88017-3, NA] , A361: [Corn, TC1507 x MON88017 x DAS40278, DAS-01507-1 x MON-88017-3 x DAS-40278-9, NA], A362: [Corn, TC1507 x NK603, DAS-01507-1 x MON- 00603-6, Hercule x ™ IRR], A363: [Corn, TC1507 x NK603 x DAS40278, DAS-01507-1 x MON-00603-6 x DAS-40278-9, NA], A364: [Corn, TC6275] , DAS-06275-8, NA], A365: [corn, VCO-01981-5, VCO-01981-5, NA], A366: [corn, DK404SR, DK404SR, NA], A367: [corn, EXP1910IT, EXP1910IT , NA], A368: [Melon, MelonA, NA, NA], A369: [Melon, MelonB, NA, NA], A370: [Papaya, 55-1, CUH-CP551-8, Rainbow, SunUp], A371: [Papaya, 63-1, CUH-CP631-7, NA], A372: [Papaya, HuanongNo.1, NA, HuanongNo.1], A373: [Papaya, X17-2, UFL-X17CP-6, NA], A374: [Petunia-CHS, NA, NA], A375: [Plum, C-5, ARS-PLMC5-6, NA], A376: [Polished Canola, HCR-1, NA, NA], A377: [Polished Canola, ZSR500, NA, Hysyn101RR Roundup-Ready ™] , A378: [Polished Canola, ZSR502, NA, Hysyn101RR Roundup-Ready ™], A379: [Polished Canola, ZSR503, NA, Hysyn101RR Roundup-Ready ™], A380: [Poplar, Btpoplar, poplar12 (Populusnigra), NA , NA], A381: [Potato, Hybridpoplarclone741, NA, NA], A382: [Potato, 1210amk, NA, Lugovskoiplus], A383: [Potato, 2904 / 1kgs, NA, Elizavetaplus], A384: [Potato, AM04-1020] , BPS-A1020-5, StarchPotato], A385: [Potato, ATBT04-27, NMK-89367-8, AtlanticNewLeaf ™ potato], A386: [Potato, ATBT04-30, NMK-89613-2, AtlanticNewLeaf ™ ) Potato], A387: [Potato, ATBT04-31, NMK-89170-9, AtlanticNewLeaf ™ potato], A388: [Potato, ATBT04-36, NMK-89279-1, AtlanticNewLeaf ™ potato], A389: [Potato, ATBT04-6, NMK-89761-6, AtlanticNewLeaf ™ potato], A390: [Potato, BT06, NMK-89812-3, NewLeaf ™ Russet Burbankpotato], A391: [Potato, BT10, NMK-89175 -5, NewLeaf ™ RussetBurbankpotato], A392: [Potato, BT12, NMK-89601-8, NewLeaf ™ RussetBurbankpotato], A393: [Potato, BT16, NMK-89167-6, NewLeaf ™ RussetBurbankpotato], A394: [Potato, BT1 7, NMK-89593-9, NewLeaf ™ RussetBurbankpotato], A395: [Potato, BT18, NMK-89906-7, NewLeaf ™ RussetBurbankpotato], A396: [Potato, BT23, NMK-89675-1, NewLeaf ( (Potato) RussetBurbankpotato], A397: [Potato, E12, SPS-00E12-8, Innate® Cultivate], A398: [Potato, E24, SPS-00E24-2, NA], A399: [Potato, EH92-527] -1, BPS-25271EH92-527-1-9, Amflora ™], A400: [Potato, F10, SPS-00F10-7, Innate® Generate], A401: [Potato, F37, SPS-00F37] -7, NA], A402: [Potato, G11, SPS-00G11-9, NA], A403: [Potato, H37, SPS-00H37-9, NA], A404: [Potato, H50, SPS-00H50-4] , NA], A405: [Potato, HLMT15-15, NA, Hi-LiteNewLeaf ™ Ypotato], A406: [Potato, HLMT15-3, NA, Hi-LiteNewLeaf ™ Ypotato], A407: [Potato, HLMT15 -46, NA, Hi-LiteNewLeaf ™ Ypotato], A408: [Potato, J3, SPS-000J3-4, Innate® Accelerate], A409: [Potato, J55, SPS-00J55-2, NA] , A410: [Potato, J78, SPS-00J78-7, NA], A411: [Potato, RBMT15-101, NMK-89653-6, New Leaf ™ YRussetBurbankpotato], A412: [Potato, RBMT21-129, NMK- 89684-1, NewLeaf ™ PlusRussetBurbankpotato], A413: [Potato, RBMT21-152, NA, NewLeaf ™ PlusRussetBurbankpotato], A414: [Potato, RBMT21-350, NMK-89185-6, NewLeaf (Potato) PlusRussetBurbankpotato], A415: [Potato, RBMT22-082, NMK-89896-6, NewLeaf ™ PlusRussetBurbankpotato], A416: [Potato, RBMT22-186, NA, NewLeaf ™ PlusRussetBurbankpotato], A417: [Potato] , RBMT22-238, NA, NewLeaf ™ PlusRussetBurbankpotato], A418: [Potato, RBMT22-262, NA, NewLeaf ™ PlusRussetBurbankpotato], A419: [Potato, SEMT15-02, NMK-89935-9, ShepodyNewLeaf ™ ) Ypotato], A420: [Potato, SEMT15-07, NA, ShepodyNewLeaf ™ Ypotato], A421: [Potato, SEMT15-15, NMK-89930-4, ShepodyNewLeaf ™ Ypotato], A422: [Potato, SPBT02 -5, NMK-89576-1, SuperiorNewLeaf ™ potato], A423: [Potato, SPBT02-7, NMK-89724-5, SuperiorNewLeaf ™ potato], A424: [Potato, TIC-AR233-5, TIC -AR233-5, NA], A425: [Potato, V11, SPS-00V11-6, Innate® Invigorate], A426: [Potato, W8, SPS-000W8-4, Innate® Glaciate], A427: [Potato, X 17, SPS-00 X 17-5, Innate® Acclimate], A428: [Potato, Y9, SPS-000Y9-7, Innate® Hibernate], A429: [Rice, 7Crp # 10, NA, NA], A430: [Rice, GMShanyou63, NA, BTShanyou63], A431: [Rice, Huahui-1 / TT51-1, NA, Huahui-1], A432: [Rice, LLRICE06, ACS- OS001-4, LibertyLink (trademark) rice], A433: [Rice, LLRICE601, BCS-O S003-7, LibertyLink (trademark) rice], A434: [rice, LLRICE62, ACS-OS002-5, LibertyLink (trademark) rice], A435: [rice, Tarommolaii + cry1Ab, NA, NA], A436: [rice, CL121 x CL141 x CF X 51, CL121 x CL141 x CF X 51, Clearfield® Rice], A437: [Rice, IMINTA-1 x IMINTA-4, IMINTA-1 x IMINTA-4, Clearfield® Rice], A438: [Rice, PWC16, PWC16, NA], A439: [Rose, WKS82 / 130-4-1, IFD-52401-4, NA], A440: [Rose, WKS92 / 130-9-1, IFD-52901-9, NA], A441: [Soybean, 260-05 (G94-1, G94-19, G168), DD-026005-3, NA], A442: [Soybean, A2704-12, ACS-GM005 -3, LibertyLink ™ soybean], A443: [Soybean, A2704-21, ACS-GM004-2, LibertyLink ™ soybean], A444: [Soybean, A5547-127, ACS-GM006-4, LibertyLink ™ ) Soybean], A445: [Soybean, A5547-35, ACS-GM008-6, LibertyLink ™ soybean], A446: [Soybean, CV127, BPS-CV127-9, Culture], A447: [Soybean, DAS44406-6 , DAS-44406-6, NA], A448: [Soybean, DAS68416-4, DAS-68416-4, Enlist ™ Soybean], A449: [Soybean, DAS68416-4 x MON89788, DAS-68416-4 x MON -89788-1, NA], A450: [Soybean, DAS81419, DAS-81419-2, NA], A451: [Soybean, DAS81419 x DAS44406-6, DAS-81419-2 x DAS-44406-6, NA], A452: [Soybean, DP305423, DP-305423-1, Treus ™ or Plenish ™], A453: [Soybean, DP30 5423 x GTS40-3-2, DP-305423-1 x MON-04032-6, NA], A454: [Soybean, DP356043, DP-356043-5, OptimumGAT ™], A455: [Soybean, FG72 (FG072) -2, FG072-3), MST-FG072-3, NA], A456: [Soybean, FG72 x A5547-127, MST-FG072-3 x ACS-GM006-4, Liberty Link (registered trademark) GT27 (trademark) ], A457: [Soybean, GTS40-3-2 (40-3-2), MON-04032-6, Roundup Ready (trademark) soybean], A458: [Soybean, GU262, ACS-GM003-1, LibertyLink (trademark)) soybean], A459: [Soybean, IND-00410-5, IND-00410-5, VerdecaHB4Soybean], A460: [Soybean, MON87701, MON-87701-2, NA], A461: [Soybean, MON87701 x MON89788, MON- 87701-2 x MON-89788-1, Intacta ™ Roundup Ready ™ 2Pro], A462: [Soybean, MON87705, MON-87705-6, VistiveGold ™], A463: [Soybean, MON87705 x MON87708, MON -87705-6 x MON-87708-9, NA], A464: [Soybean, MON87705 x MON87708 x MON89788, MON-87705-6 x MON-87708-9 x MON-89788-1, NA], A465: Soybean, MON87705 x MON89788, MON-87705-6 x MON-89788-1, NA], A466: [Soybean, MON87708, MON-87708-9, Genuity (registered trademark) Roundup Ready (trademark) 2 X tend (trademark)], A467 : [Soybean, MON87708 x MON89788, MON-87708-9 x MON-89788-1, Roundup Ready 2 X tend®], A468: [Soybean, MON87712, MON-87712-4, NA], A469: [ Soybean, MON87751, MON-87751-7, NA], A470: [Soybean, MON87751 x MON87701 x MON87708 x MON89788, MON-87751-7 x MON-87701-2 x MON87708 x MON89788, NA], A471: [Soybean, MON87769, MON87769-7, NA], A472: [Soybean , MON87769 x MON89788, MON-87769-7 x MON-89788-1, NA], A473: [Soybean, MON89788, MON-89788-1, Genuity® Roundup Ready 2 Yield ™], A474: [ Soybean, SYHT0H2, SYN-000H2-5, Herbicide-tolerantSoybeanline], A475: [Soybean, W62, ACS-GM002-9, LibertyLink ™ soybean], A476: [Soybean, W98, ACS-GM001-8, LibertyLink ( Trademarks) soybean], A477: [Soybean, OT96-15, OT96-15, NA], A478: [Cucurbita pepo, CZW3, SEM-0CZW3-2, NA], A479: [Pepo pumpkin (Cucurbita pepo), ZW20 , SEM-0ZW20-7, NA], A480: [Tensai, GTSB77 (T9100152), SY-GTSB77-8, InVigor ™ sugarbeet], A481: [Tensai, H7-1, KM-000H71-4, Roundup Ready] (Soybean) sugarbeet], A482: [Tensai, T120-7, ACS-BV001-3, LibertyLink (trademark) sugarbeet], A483: [Soybean, CTB141175 / 01-A, CTB141175 / 01-A, NA], A484: [Soybeans, NXI-1T, NXI-1T, NA], A485: [Soybeans, NXI-4T, NXI-4T, NA], A486: [Soybeans, NXI-6T, NXI-6T, NA], A487: [Sunflower , X81359, X81359, Clearfield® Sunflower], A488: [Sweet Pepper, PK-SP01, X81359, NA], A489: [Tobacco, C / F / 93 / 08-02, NA, NA], A490: [Tobacco, Vect or21-41, NA, NA], A491: [Tomato, 1345-4, NA, NA], A492: [Tomato, 35-1-N, NA, NA], A493: [Tomato, 5345, NA, NA] , A494: [Tomato, 8338, CGN-89322-3, NA], A495: [Tomato, B, SYN-0000B-6, NA], A496: [Tomato, Da, SYN-000DA-9, NA], A497 : [Tomato, DaDongNo9, NA, NA], A498: [Tomato, F (1401F, h38F, 11013F, 7913F), SYN-0000F-1, FLAVRSAVR ™], A499: [Tomato, FLAVRSAVR, CGN-89564- 2, FLAVRSAVR ™], A500: [Tomato, HuafanNo1, NA, NA], A501: [Tomato, PK-TM8805R (8805R), NA, NA], A502: [Wheat, MON71800, MON-71800-3, Roundup Ready ™ wheat], A503: [Wheat, AP205CL, AP205CL, Clearfield® Wheat], A504: [Wheat, AP602CL, AP602CL, Clearfield® Wheat], A505: [Wheat, BW255-2 x BW238-3, BW255-2 x BW238-3, Clearfield® Wheat], A506: [Wheat, BW7, BW7, Clearfield® Wheat], A507: [Wheat, Teal11A, Teal11A, Clearfield® ) Wheat], A508: [Wheat, SWP965001, SWP965001, NA], A509: [Corn, NA, NA, Agrisure Artesian (trademark)], A510: [Corn, NA, NA, Optimum (registered trademark) AQUAmax (registered trademark) )], A511: [Canola, NA, NA, SU canola®], A512: [Canola, NA, NA, Nexera® Canola], A513: [Soda, NA, NA, STS soybean], A514: "Corn, NA, NA, SR corn", A514: "Sunflower, NA, NA, ExpressSun (registered trademark)", A515: [Rice, NA, NA, Golden rice], A 516: [Corn, NA, NA, Poast Protected® corn], A517: [Sunflower, NA, NA, ExpressSun®], A518: [Rice, NA, NA, Provisia® Rice], A519: [Canola, NA, NA, Triazinon Tolerant Canola], A520: [Corn, NA, NA, SmartStax® Pro], A521: [Soybean, NA, NA, Credenz® soybean], A522: [Corn, TC1507 x 59122, DAS-01507-1 x DAS-59122-7, Optimum® AcreMax® 1], A523: [Corn, 4114 x MON810 x MIR604, DP-00
4114-3 x MON-00810-6 x SYN-IR604-5, Qrome ™], A524: [Wata, NA, NA, Stoneville® Cotton ST5517GLTP], A525: [Wata, NA, NA, Stoneville (Registered Trademark) Cotton ST4848GLT], A526: [Wata, NA, NA, Stoneville® Cotton ST4949GLT], A527: [Wata, NA, NA, Stoneville® Cotton ST5020GLT], A528: [Wata, NA , NA, Stoneville® Cotton ST5115GLT], A529: [Wata, NA, NA, Stoneville® Cotton ST6182GLT], A530: [Wata, NA, NA, Stoneville® Cotton ST4747GLB2], A531: [Wata, NA, NA, Stoneville® Cotton ST4946GLB2], A532: [Wata, NA, NA, Stoneville® Cotton ST6448GLB2], A533: [Soda, NA, NA, Enlist E3®], A534: [Soybean, NA, NA, Enlist ™ Roundup Ready 2 Yield®], A535: [Corn, NA, NA, Enlist ™ Roundup Ready® Corn 2], A536: [Corn 2] , NA, NA, Smartstax® Enlist ™], A537: [Corn, NA, NA, Powercore® Enlist ™], A538: [Wata, NA, NA, Enlist ™ Cotton ], A539: [Wata, NA, NA, Bollgard® 3 XtendFlex®], A540: [Corn, NA, NA, SmartStax® RIB Complete® Corn], A541: [Corn, NA, NA, VT Double PRO® RIB Complete® Corn], A542: [Corn, NA, NA, VT Double PRO® Corn], A543: [Corn, NA, NA , Genuity® ) VT Triple PRO® RIB Complete Corn], A544: [Corn, NA, NA, Trecepta® Corn], A545: [Sodium, NA, NA, Fukuminori], A546: [Sodium, NA, NA, Dream Minori], A547: [Corn, NA, NA, ZFN-12 maize], A548: [Rice, NA, NA, Yumepirika], A549: [Rice NA, NA, Kanto BPH1], A550: [Wata, NA, MON88702, NA], A551: [Sodium, DP305423 x MON87708, DP-305423-1 x MON-87708-9, NA], A552: [Sodium, DP305423 x MON87708 x MON89788, DP-305423-1 x MON- 87708-9 x MON-89788-1, NA], A553: [Sodium, DP305423 x MON89788, DP-305423-1 x MON-89788-1, NA], A554: [Wata, 3006-210-23 x 281- 24-236 x MON88913 x COT102 x 81910, DAS-21023-5 x DAS-24236-5 x MON-88913-8 x SYN-IR102-7], A555: [Wata, GHB811, BCS-GH811-4, NA] , A556: [Sorgham, NA, NA, Igrowth ™].

In the present invention, the composition B can be applied to the above-mentioned modified plants A1 to A556 or the cultivated area thereof. When the composition B is applied to the above-mentioned plants, it is more preferable to apply the composition B to its seeds and vegetative reproduction organs.

Composition B can effectively control a wide range of targets in grain fields, vegetable fields, flower fields, orchards or non-agricultural lands where normal cultivated or no-till cultivated.

When the composition B is applied to sugar cane, in the cultivation of sugar cane, a sugar cane stalk fragment cut so as to have one node may be used, or the size of the sugar cane stalk fragment is 2 cm or more. 15 cm, preferably 3 cm to 8 cm may be used. Cultivation techniques for sugarcane using such stem fragments are known (WO09 / 000398, WO09 / 00399, WO09 / 000400, WO09 / 00401, WO09 / 00402), and are carried out under the trade name of Prene (registered trademark). To.

When the composition B is applied to rice, it may be applied to a nursery, a paddy field, or a rice seed. The above-mentioned nursery area includes a nursery box, a nursery tray for paddy rice, a nursery bed and a nursery (a nursery bed used by dividing a part of a paddy field).

When the composition B is applied to the nursery box, the application time is not particularly limited as long as it is the seedling raising period from sowing of rice to transplantation. The time for treating the composition B into the nursery box at the time of sowing may be not only on the day of sowing but also on any day from a few days before sowing to a few days after sowing. Examples of the method of applying from several days before to several days after sowing include pre-sowing bed soil mixing treatment, pre-sowing pre-sowing soil mixing treatment, sowing pre-soil covering treatment, sowing soil covering post-treatment, and greening period treatment. In the case of pre-sowing bed soil mixing treatment or pre-sowing pre-sowing soil covering treatment, treatment may be performed from 6 months before sowing to the day of sowing, and usually treatment is performed from 1 month before sowing to the day of sowing. The time for processing the composition B into the nursery box at the time of transplanting may be not only on the day of transplanting but also on any day from several days before transplanting to the day of transplanting. Examples of the method of application from several days before transplantation to the day of transplantation include 10-day pre-transplantation treatment, 7-day pre-transplantation treatment, 3-day pre-transplantation treatment, pre-transplantation treatment, pre-transplantation treatment, same-day transplantation treatment, and simultaneous transplantation treatment. A few days before sowing, granules containing one or more components having bactericidal activity selected from group (b) and group (j) are subjected to pre-sowing bed soil mixing treatment or pre-sowing pre-sowing soil covering treatment, and then the composition. B may be applied. As a method of applying the composition B after applying the granule containing one or more components having bactericidal activity selected from the group (b) and the group (j) several days before sowing, the soil covering pretreatment at the time of sowing is used. , Post-sowing soil cover treatment, greening stage treatment, 10-day transplantation treatment, 7-day transplantation treatment, 3-day transplantation treatment, pre-transplantation treatment, same-day transplantation treatment, and simultaneous transplantation treatment. The period from sowing to transplantation is for young seedlings (seedlings with leaf age of 0.8 to less than 2.0 leaves without incomplete leaves without leaf blades, generally 1.5 leaf stage). Seedlings before and after), juveniles (seedlings with leaf age of 2.0 to less than 3.0 leaves when not including incomplete leaves without leaf blades, generally 2.5 leaf stage Seedlings before and after), middle seedlings (seedlings with leaf age of 3.0 to less than 4.0 leaves when not including incomplete leaves without leaf blades, generally 3.5 leaf stage Seedlings before and after) or adult seedlings (seedlings with leaf age of 4.0 to 5.0 leaves when not including incomplete leaves without leaf blades, generally around 4.5 leaf stage The seedling raising period varies depending on which of the seedlings is used, and the seedling raising period varies depending on the weather conditions and the like, but the composition B can be applied in any case.
Examples of the method for treating the composition B into the nursery box include a method of spraying a kneaded granule or a sand-coated granule on the nursery box, and a method of irrigating the nursery box with the solution of the composition B. The seedling raising medium is not particularly limited as long as it is a soil for raising rice seedlings, and a seedling raising mat other than the soil may be used. The seedlings to which the composition B is applied may be cultivated by pool seedling raising.
When the composition B is applied to a seedling raising box, it may be a rice seedling raising box in which rice seeds are sown at a low density and raised, or a rice seedling raising box in which rice seeds are sown at a high density and raised. You may. The amount of rice seeds sown per seedling box varies depending on whether the seedlings are seedlings, seedlings, middle seedlings or adult seedlings, but the dried rice seeds (sometimes called dry paddy) before soaking. The weight may be 60 to 400 g, preferably 70 to 300 g. Normally, the sowing amount of rice seeds per seedling box is generally 130 to 300 g as the weight of dry paddy for seedlings, and generally 100 as the weight of dry paddy for medium seedlings. It is ~ 130 g.

The amount of rice seeds sown in a seedling raising box (width about 60 cm, length about 30 cm) is 230 to 300 g per seedling raising box as the weight of dry paddy, and the number of stems of one rice plant to be transplanted to paddy fields is customary. A cultivation method is known in which the number of seedling raising boxes used per cultivation area is reduced by increasing the number of seedlings to 3 to 5 as in the case of transplant cultivation. The cultivation method (hereinafter, may be referred to as Method A) is described in, for example, "Plant Protection" November 2019 issue, Vol. 73, No. 11 (ISSN 0037-4091). When the seeding amount of dry rice seedlings is 250 to 300 g per seedling raising box, the conventional seeding amount of dried rice seedlings is 100 to 150 g per seedling raising box, so that the seedlings are sown at high density. Called.
When the composition B is used for the rice cultivated by transplantation, the composition B may be used for the rice cultivated by the method A. The planting density (number of crops planted per unit area) of the rice cultivated by the method A is not particularly limited. The rice may be cultivated at the conventional planting density, or may be sparsely cultivated. Here, when transplanting using a rice transplanter, the planting density of rice cultivated at the conventional planting density is usually 18 to 22 plants per 1 m ² (30 cm between rows, 15 to 18 cm between plants). On the other hand, the sparsely planted rice has a planting density of 11 to 15 plants per 1 m ² (30 cm between rows and 23 to 30 cm between plants). The number of stems per planted rice plant is usually 3 to 5, regardless of whether the rice is cultivated at the conventional planting density or sparsely planted.

When the composition B is used for rice cultivated by the method A, the composition B may be applied to a nursery box. When the composition B is applied to the nursery box, the time of application to the nursery box is not particularly limited as long as it is the period from the time of sowing of rice to the time of transplantation. The time for treating the composition B into the nursery box at the time of sowing may be not only on the day of sowing but also on any day from a few days before to a few days after sowing. Examples of the method of applying from several days before to several days after sowing include pre-sowing bed soil mixing treatment, pre-sowing pre-sowing soil mixing treatment, sowing pre-soil covering treatment, sowing soil covering post-treatment, and greening period treatment. Further, the time for treating the composition A into the nursery box at the time of transplanting may be not only on the day of transplanting but also on any day from several days before transplanting to the day of transplanting. Examples of the method of application from several days before transplantation to the day of transplantation include 10-day pre-transplantation treatment, 7-day pre-transplantation treatment, 3-day pre-transplantation treatment, pre-transplantation treatment, pre-transplantation treatment, same-day transplantation treatment, and simultaneous transplantation treatment.

When the composition B is applied to paddy fields, it may be used for rice cultivated by transplantation or rice cultivated by direct sowing. The method of applying to paddy fields is not particularly limited, and examples thereof include a method of applying composition B to rice foliage, a method of applying to paddy soil, and a method of applying to the water surface of a flooded paddy field. Be done. Further, by treating a chemical solution such as an emulsion or flowable at the inflow source of water into a paddy field such as a water outlet or an irrigation device, it can be applied labor-savingly with the supply of water. The time of application to the foliage of rice may be any time from the seedling raising period to the harvest. The pharmaceuticals to be used include pharmaceuticals that are applied as they are, such as powders and fine granules, and flowables, dry flowables, wettable powders, granule wettable powders, SE agents, water solvents, granule water solvents, liquids, and micros. Examples thereof include formulations such as emulsions, EWs, oils, surfing agents and emulsions that are diluted and sprayed. The spraying equipment may be any equipment that is normally used, such as hand-cranked spreaders, power spreaders, punkle sprayers, manned aircraft (manned helicopters, etc.), unmanned aerial vehicles (radio-controlled helicopters, drones, etc.), tractors, planters, etc. can. Further, the composition of the invention may be sprayed by hand without using a spraying device.

As a method of applying the composition B to the paddy soil, a method of treating the entire surface of the paddy soil (total treatment), a method of treating the groove provided when sowing rice (sowing groove treatment), and 0 directly under the rice seeds. Examples thereof include a method of treating to 10 cm, a method of treating rice strains or seeds in the vicinity of streaks or dots (side-strand treatment), and the like.

When the composition B is applied to paddy soil, it can be applied at the same time as agricultural materials such as paste fertilizer and granular fertilizer, or it can be applied by mixing with these agricultural materials. The time to apply the composition B may be before sowing or before transplanting, at the same time as sowing or transplanting, or immediately after sowing or immediately after transplanting. As a specific application method, for example, a method of treating the composition B and fertilizer together in the vicinity of rice seedlings at the time of transplanting rice can be mentioned. The composition B and the fertilizer may be mixed and used immediately before application, or may be applied separately and simultaneously. The place of application is not particularly limited as long as it is near the seedlings, but it may be a place where the seedlings are planted, or a place several to ten and several centimeters away from the seedlings, for example, the seedlings. These include 15 cm directly below (deep fertilization), 3-5 cm directly below seeds or seedlings, and 9-15 cm (two-stage fertilization).

When it is applied at the same time as seeding or transplanting, it may be applied using an attachment attached to the seeding machine or the transplanting machine, or may be applied by other methods. In the case of full-scale treatment, the period from sowing or transplanting to water injection, the mid-drying period, or the intermittent irrigation period may be used. When the composition B is used, the soil surface of the paddy field may be dry, or the soil surface may be moist but not flooded (water depth 0 cm). When applied to the surface of a flooded paddy field, it may be applied at any time during the period from sowing or transplanting to harvesting, as long as the water depth is maintained by normal rice management.

When composition B is used for direct sowing of rice, the surface of rice seeds is coated with iron powder (iron oxide powder, reduced iron powder, atomized iron powder, electrolytic iron powder, etc.), calcium peroxide, molybdenum, molybdenum compound, etc. It may have been processed. These dressings can be used alone or mixed in any ratio, and if necessary, supplements such as gypsum and montmorillonite for the purpose of increasing the amount and improving the adhesion to rice seeds. The agent can be added. A mixture of calcium peroxide, gypsum and mineral powder is available as a commercial product, and examples thereof include Calper powder granule 16 (manufactured by Hodoya UPL Co., Ltd.). Here, the rice seed means a rice seed in a state before sowing in soil such as a paddy field.

When the composition B is treated into rice seeds, the rice seeds can be sown directly in dry fields, wet fields and paddy fields, or can be sown and cultivated in a nursery box. Examples of the paddy field include paddy fields that are flooded or flooded. A paddy field that is in a flooded state is a paddy field that has been cultivated, filled with water, puddled, etc., and then further flooded as necessary. A paddy field in a flooded state means a paddy field in which the water content is maintained at the same level as the flooded state and the soil surface is exposed by performing a waterfall treatment or the like from the flooded state. The composition B can be powdered on rice seeds, the rice seeds before sprouting can be immersed in a solution containing the composition B, or the solution containing the composition B on the rice seeds after sprouting. Can also be sprayed. Further, in any of the treatment methods, the composition B may contain one or more phytotoxicity-reducing components selected from the group (d).

The sowing machine used for sowing rice is not particularly limited as long as it is a sowing machine generally used for direct sowing cultivation of rice such as paddy rice and land rice, but for example, the direct sowing machine for iron coating NDS-6 (Tetsumaki-chan, (Made by Kubota Co., Ltd.), Direct seeding machine for iron coating NDS-8 (Tetsumaki-chan, manufactured by Kubota Co., Ltd.), EP4-TC (Cute Tetsumaki-chan, manufactured by Kubota Co., Ltd.), Multipurpose work machine RG6 (Manufactured by Yanmar Co., Ltd.), multipurpose working machine RG8 (manufactured by Yanmar Co., Ltd.), high-precision seeding machine PZV60 (manufactured by Iseki Agricultural Machinery Co., Ltd.) and high-precision seeding machine PZV80 (manufactured by Iseki Agricultural Machinery Co., Ltd.).

Iron or an oxide thereof (hereinafter, iron and its oxide are referred to as a coating material A) as a covering material for treating rice seeds is preferably in the form of powder. Examples of the powdery covering material A include reduced iron powder, atomized iron powder, electrolytic iron powder and iron oxide powder, which are available as commercial products. Further, two or more of these can be mixed and used. In the present invention, it is preferable to use reduced iron powder and / or iron oxide powder. The iron powder obtained by reducing iron oxide or iron salt with hydrogen or the like is reduced iron powder, and the iron powder obtained by injecting a high-pressure water jet of 8 to 20 MPa into the flow of molten iron is atomized iron powder or sulfuric acid. Iron powder obtained by precipitating iron from a solution such as iron by electrolysis to obtain electrolytic iron flakes, crushing them with a rod mill or a vibration mill and baking them is called electrolytic iron powder. Further, iron oxide is an oxide of iron having an oxidation number of II and / or III. The particle size of the coating material A used in the present invention is not particularly limited, but it is preferable to adjust the particle size to 10 to 100 μm before use. Examples of the coating material A available as a commercially available product include DAE1K iron powder (manufactured by DOWA IP Creation Co., Ltd.), DSP317 iron powder (manufactured by DOWA IP Creation Co., Ltd.), and the like. Examples include agricultural iron powder (manufactured by Daitetsu Kogyo Co., Ltd.), agricultural iron powder (manufactured by Tetsugen Co., Ltd.) and hematite (manufactured by DOWA IP Creation Co., Ltd.).

When the composition B is treated into rice seeds, it may be mixed with gypsum. For example, when treating rice seeds with the composition B and the dressing A, gypsum may be used as an auxiliary agent. The gypsum may be powdered calcium sulfate 1/2 hydrate (CaSO _4.1 / 2H ₂ O), and the gypsum is commercially available, for example, KTS-1. (Manufactured by Yoshino Gypsum Sales Co., Ltd.) and KTS-25 (manufactured by Yoshino Gypsum Sales Co., Ltd.) can be mentioned. Further, a mixture of the dressing A and the calcined gypsum may be used, and such a mixture is available as a commercially available product, and examples thereof include DAE1K mix (manufactured by DOWA IP Creation Co., Ltd.).

The rice seed powder coating treatment using the covering material A can take various forms, but usually, a known method as a rice seed powder coating treatment method using iron powder (“Iron coating flooded direct sowing manual 2010”, independent It will be carried out in the same manner as ISBN978-4-903078-05-2, March 2010, Agricultural and Food Industry Technology Research Organization. Specifically, the dried rice seeds before germination are immersed in water (sometimes called soaking seeds), drained, and then the rice seeds are powdered with a dressing A and, if necessary, gypsum. do. The order of treatment of the dressing A and the gypsum may be any first, and the mixture of the dressing A and the gypsum may be treated at the same time. After performing these treatments, if necessary, after powdering with gypsum as a finishing touch, it is usually placed on a woven cloth or the like laid on a flat surface and dried in the shade.

The amount of the dressing A used for the rice seeds is usually 100 to 2000 g for the dressing A with respect to the dry weight of the rice seeds of 1000 g. Further, the amount of gypsum when powdered with gypsum is usually 5 to 100 g with respect to a dry weight of 1000 g of rice seeds, and the amount of gypsum when further powdered with gypsum is used as a finishing touch. The amount is usually 0 to 50 g with respect to 1000 g of dry weight of rice seeds.

As the calcium peroxide, a powder prepared by preparing calcium peroxide alone into a powder having a particle size of 10 to 150 μm can be used, but if necessary, a composition in which mineral powder such as montmorillonite or calcined gypsum is mixed as an auxiliary material. Can also be used. Such a calcium peroxide-containing composition is available as a commercially available product, and examples thereof include Calper powder granules 16 (manufactured by Hodoya UPL Co., Ltd.).

Although various forms of rice seed powder coating treatment using calcium peroxide can be taken, usually, a method known as a method for powder coating treatment of rice seeds using calcium peroxide (Japanese Patent Laid-Open No. 61-015805) and It is performed by the same operation. Specifically, the dried rice seeds before germination are immersed in water (sometimes called soaking), drained, and then the rice seeds are powdered with calcium peroxide powder or a calcium peroxide-containing composition. .. After performing these treatments, usually, they are placed on a non-woven mat mat or the like laid on a flat surface and dried in the shade.

The amount of calcium peroxide or calcium peroxide-containing composition used for rice seeds is usually 100 to 1000 g in terms of calcium peroxide alone with respect to 1000 g of dry weight of rice seeds.

Examples of molybdenum and molybdenum compounds include molybdenum alone, molybdenum oxide, molybdenum acid and its salt, molybdrine acid and its salt, and molybdenum silicic acid and its salt. Examples of the salt of molybdate include calcium molybdate, magnesium molybdate, ammonium molybdate, sodium molybdate, and potassium molybdate. Examples of the molybdophosphate include ammonium molybdrinate, sodium molybdrine, and potassium molybdrine. Such molybdenum and molybdenum compounds are available as commercial products, and examples thereof include molybdenum trioxide (Nippon Inorganic Chemical Industry Co., Ltd.).

Treatment of rice seeds using molybdenum and molybdenum compounds can take various forms, but is usually carried out by the same operation as a known method (WO2011 / 093341) as a method for treating rice seeds using molybdenum and molybdenum compounds. .. Specifically, it is fixed to the surface of rice seeds using an adhesive such as polyvinyl alcohol, prepared in a solution and immersed in the rice seeds, and mixed with a coating material containing iron powder and / or calcium peroxide. An operation such as powdering rice seeds can be mentioned.

In particular, "Bengara molybdenum coating" is known in which molybdenum compounds such as molybdenum trioxide, iron oxide powder (sometimes called vengara powder), and water-resistant polyvinyl alcohol are mixed and treated into rice seeds (Yoshitaka Hara). 2013. Improvement of Rice Seedling Establishment on Sulfate-Applied Submerged Soil by Seed Coating with Poorly Soluble Molybdenum Compounds. Plant Prod. Sci. 16 (3): 271-275), the method is also preferably used in the present invention.

The amount of molybdenum and molybdenum compound used for rice seeds is usually 0.01 to 10 mol in terms of molybdenum with respect to 1000 g of dry weight of rice seeds.

Examples of the combination with the present compound or the composition A coating material for treating rice seeds include the following.
SX + iron oxide powder, SX + reduced iron powder, SX + iron oxide powder + reduced iron powder, SX + calcium peroxide, SX + molybdenum compound, SX + molybdenum compound + iron oxide powder, SX + molybdenum trioxide, SX + molybdenum trioxide + iron oxide powder, SX + iron oxide powder + roasted gypsum, SX + reduced iron powder + roasted gypsum, SX + iron oxide powder + reduced iron powder + roasted gypsum, SX + calcium peroxide + roasted gypsum, composition A + iron oxide powder, composition A + reduced iron powder, Composition A + iron oxide powder + reduced iron powder, composition A + calcium peroxide, composition A + molybdenum compound, composition A + molybdenum compound + iron oxide powder, composition A + molybdenum trioxide, composition A + molybdenum trioxide + iron oxide Powder, composition A + iron oxide powder + roasted gypsum, composition A + reduced iron powder + roasted gypsum, composition A + iron oxide powder + reduced iron powder + roasted gypsum, composition A + calcium peroxide + roasted gypsum.
Here, as the main component contained in the composition A, in particular, isothianyl, flametopil, impylfluxam, etaboxam, benomyl, oxolinic acid, clothianidin, fenitrothion, cartap hydrochloride, oxazosulfyl, tetraniliprole, and chroma. Lantraniliprole, cyantraniliprole, triflumesopyrim, flupyrimin and ethiprol are preferred.

The order of treatment of the above combination of rice seeds may be such that the rice seeds are treated with the present compound or the composition A and then the coating material is treated, or the rice seeds are treated with the covering material and then the present compound or the composition. A may be treated, or the compound or composition A and the coating material may be treated at the same time. Here, when the composition A is treated, the order of treatment of the present compound and the present component and the coating material contained in the composition A may be the order of the present compound, the present component, and the covering material, or the present compound, The order of the coating material and the present component may be used, the order of the main component, the present compound and the covering material may be used, or the order of the main component, the covering material and the present compound may be used. , The order of the present compound and the present component, or the order of the coating material, the present component and the present compound. Alternatively, the rice seeds may be treated with the present compound, the present component and the dressing at the same time.

When the composition B is applied to rice, the sprouting of rice seeds may be carried out by immersing the rice seeds in water or by keeping the rice seeds in a wet state after being soaked in water. The wet state means a state in which a part or all of the surface of the rice seed after being immersed in water can come into contact with the outside air and retain the water content of the rice seed. For example, in the wet state, the rice seeds after being soaked in water are covered with a breathable material such as rice straw or cloth, and then water is sprinkled over the coated material as needed, or the rice seeds are soaked in water. It is realized by accommodating rice seeds as they are in the material of the net-like body or the bag-like body used at the time of.

When the composition B is used for rice, fertilizer can also be used in combination. Examples of such fertilizers include Rakuichi (registered trademark, Sumitomo Chemical Co., Ltd.), Sumishort (registered trademark, Sumitomo Chemical Co., Ltd.) and Super SR Coat (registered trademark, Sumitomo Chemical Co., Ltd.). When fertilizer is used in combination, fertilizer may be applied to the entire surface of rice cultivated soil before sowing, or to the entire surface of rice cultivated soil after sowing or during the seedling raising period. In addition, fertilizer may be applied in a groove shape along the rows to be sown at the time of sowing (sometimes referred to as side row fertilization).

When the composition B is applied to rice, whether it is applied to a nursery, a paddy field or a seed, disinfected seeds can be used to control seed-borne diseases and pests. Specifically, groups (a) and groups (a) and groups such as prochloraz, triflumizole, pefrazoate, oxolinic acid, ipconazole, fludioxonyl, casgamicin-hydrochloride, cupric hydroxide, basic copper chloride, phenothione, cartap hydrochloride and the like (a) and groups ( b) One or more insecticide and fungicide components selected from b), or Trichoderma atroviride SKT-1 strain, Talaromyces flavus SAY-Y-94-01 strain, Pseudomonas sp. CAB-02 strain, Bacillus symplex CGF2856 Seeds that have been soaked, smeared or powdered with one or more components of a fungicide material selected from the group (j) such as strains can be used.

Applying one or more of cartap hydrochloride and metaaldehyde to paddy fields before sowing rice, before transplanting rice, after sowing rice, or after transplanting rice is effective for apple snails and apple snails. Can be controlled. In addition, weeds generated in paddy fields can be controlled by treating one or more components having herbicidal activity selected from the group (i) and the group (j). The time to apply the above-mentioned component having herbicidal activity is not particularly limited as long as the phytotoxicity to rice by the component having herbicidal activity does not pose a problem.

Examples of one or more herbicidal active ingredients selected from the group (i) that can be used in paddy fields include azimsulfuron, bensulfuron-methyl, chlorimuron-ethyl, and cyclosulfam. Ron (cyclosulfamuron), ethoxysulfuron (ethoxysulfuron), flucetosulfuron, halosulfuron-methyl, imazosulfuron (imazosulfuron), orthosulfuron (orthosulfuron) Luflon ethyl (pyrazosulfuron-ethyl), sinosulfuron, metsulfuron-methyl, metazosulfuron, methazosulfuron, ventiocarbiperibrate (benthiocarb), molite (molate) ), Swep, butachlor, pretilachlor, tenylchlor (theny1ch1or), simethryn, dimethametrin, dimethametrin, methyldimeron (methyl) Set (flufenacet), clomeprop, naproanilide, bromobutide, daimuron, cumyllon, cumyllon, ethobenzanrid, etobenzandi, etobenzandi (Carfentrazone-ethyl), fenchlorazole-ethyl, isoxadiphen-ethyl, fentrazamide, chromaz one), maleic hydrazide, pyridate, oxadylomefone, cinmethylin, benfuresate, benzodiazone, oxadiazone, oxadiazone, oxadiazone. Butyl (cyhalophop-butyl), cafenstrol, iffencarbazone, pyrimisulfan (pyriminobac-methy1), bisbilibac-sodium (bispyribac-sodium), pyrimisulfan (pyrimisulfan) ), Pyribenzoxim, pyriftalid, indanofan, ACN, benzobicyclon, tefuryltriione, methotriione Dalapon (da1apon), chlorthiamid, penoxyslam, anilophos, bensulide, butamiphos, butamiphos, fenoxasulfone, fenoxasulfone (Pyrazoxyfen), imazamethabenza, imazamethabenzamethyl (imazamethabenza-methyl), imazamox, imazamoxammonium salt (imazamamimasimium) ), Imazapyr, imazaquin, imazethepyr, pendimethalin, fenoxaprop-eth yl), phenoxaprop-P-ethyl, metamihop, pyraclonil, quinchlorac, 2,4-D and its salts, MCP and its salts, MCPA and its salts. , MCPB and its salts, Piperophos, fluoxypyr, cyclopyrimorate, benzobicyclon, florpyrauxifen, fluorpyrauxifen-furxifen Examples thereof include taxtomin A and tetflupyrolimet.

The rice in which the composition B can be used refers to Oryza sativa, Oryza graberrima, which are cultivated species among the annual plants of the genus Oryza, and hybrids thereof, and is any of Japonica, Javanica, and Indica. It may be any of glutinous rice, glutinous rice, liquor rice, and feed rice. The rice varieties are not particularly limited, and may be varieties produced by mating or may be varieties produced by genetic recombination technology, as exemplified by the above-mentioned plant varieties. When applied to varieties with resistance to pests, it can be a particularly labor-saving control method. Further, it may be a multi-line in which a plurality of varieties incorporating different resistance genes are mixed and cultivated.

When the composition B is applied to a place where rice seedlings are raised, the application rate of the composition B is usually 5000 g or less, preferably 1000 g or less, per 10a of the sowing area (cultivation area), and is contained in the composition B. The total amount of the compound or the composition A is usually 1000 g or less, preferably 500 g or less. The total amount of the present compound or the composition A contained in the composition B per 1 m ² of the place where the rice seedlings are raised is usually 0.05 to 1000 g, preferably 0.5 to 200 g.

When the composition B is applied to a seedling raising box of rice, the application rate of the composition B is the total amount of the present compound or the composition A contained in the composition B, and one seedling raising box (width about 60 cm, length about 30 cm). It is usually 0.1 to 35 g, preferably 0.2 to 20 g.

In the composition A containing one or more kinds of herbicidal activity components selected from the group (i) and the group (j) and one or more kinds of drug damage reducing components selected from the group (d), all the active ingredients are 1 It may be contained in one preparation, it may be a plurality of preparations consisting of a preparation containing one active ingredient and a preparation containing a plurality of active ingredients, or all the active ingredients may be separate preparations. good. For example, before and after planting seeds or plant reproductive organs treated with one or more chemical damage reducing components selected from the group (d) into the soil, the components having herbicidal activity selected from the groups (i) and the group (j) are added to the soil. Then, the method of applying the compound to a pest, a habitat of the pest, a plant or soil can be mentioned. In that case, a commercially available seed or plant reproductive organ treated with one or more phytotoxicity-reducing ingredients selected from the group (d) may be purchased and used.

The composition A containing one or more herbicide-active components selected from the group (i) and (j) and one or more plant growth-regulating components selected from the group (c) contains all the active ingredients. It may be contained in one preparation, or it may be a plurality of preparations consisting of a preparation containing one active ingredient and a preparation containing a plurality of active ingredients, or all the active ingredients are separate preparations. May be good. When applying multiple formulations, they may be applied to pests, pest habitats, plants or soil at the same time or at different times. For example, before and after planting seeds or plant reproductive organs treated with one or more kinds of plant growth-regulating components selected from group (c) into soil, components having herbicidal activity selected from group (i) and group (j) are used. Examples thereof include a method of treating the soil and then applying the compound to a pest, a habitat of the pest, a plant or the soil. In that case, a commercially available seed or plant reproductive organ treated with one or more kinds of plant growth regulating components selected from the group (c) may be purchased and used.

In the composition A containing one or more ingredients having herbicidal activity selected from the group (i) and the group (j), all the active ingredients may be contained in one formulation, or one active ingredient may be contained. It may be a plurality of preparations including a preparation containing a plurality of active ingredients and a preparation containing a plurality of active ingredients, or all the active ingredients may be separate preparations. When applying multiple formulations, they may be applied to pests, pest habitats, plants or soil at the same time or at different times. Examples of the application time of the component having herbicidal activity include the following.

When treating one or more components having herbicidal activity selected from group (i) and group (j) before sowing seeds or planting vegetative reproductive organs or seedlings, treatment of the components having herbicidal activity. The timing is from 50 days before sowing or planting to just before sowing or planting, preferably from 30 days before sowing or planting to just before sowing or planting, and more preferably from 20 days before sowing or planting. Until just before, more preferably from 10 days before sowing or planting to just before sowing or planting.

When treating one or more herbicidal components selected from group (i) and group (j) after sowing seeds or planting vegetative reproduction organs or seedlings, the treatment timing of the herbicidal component Is preferably from immediately after sowing or planting to 50 days after sowing or planting, and more preferably from immediately after sowing or planting to 3 days after sowing or planting.

At the same time as sowing seeds or planting vegetative reproduction organs or seedlings, one or more components selected from group (i) and group (j) can also be treated.

When one or more components having herbicidal activity selected from group (i) and group (j) are treated after soybean seeds are sown, the treatment time of the component having herbicidal activity is, for example, flowering before soybean germination. The period is mentioned. Among the periods from before the emergence of soybean to the flowering stage, preferably between the period before the emergence of the soybean and the period of 6 compound leaves, and more preferably between the period before the emergence of the soybean and the period of 3 compound leaves.

When treating one or more components having herbicidal activity selected from group (i) and group (j) after sowing corn seeds, the treatment time of the component having herbicidal activity is, for example, from before germination to the 12-leaf stage. During, preferably between pre-emergence and the 8-leaf stage, and more preferably between pre-embodiment and the 6-leaf stage. The leaf age of corn is determined by the Leaf Color Method.

When treating one or more components having herbicidal activity selected from group (i) and group (j) before sowing cotton seeds, the treatment time of the component having herbicidal activity is from 50 days before sowing to immediately before sowing. During, preferably between 30 days before sowing and immediately before sowing, and more preferably between 20 days before sowing and immediately before sowing. When treating one or more components having herbicidal activity selected from group (i) and group (j) after sowing cotton seeds, the treatment time of the component having herbicidal activity is from immediately after sowing to 70 days after sowing. Between, preferably from 30 days after sowing to 50 days after sowing, for example, from before the emergence of cotton to the flowering period, preferably from the beginning of wooding to the base of the stem of cotton, 20 cm from the base. Between.

When treating one or more components having herbicidal activity selected from group (i) and group (j) before planting sugarcane, the treatment time of the component having herbicidal activity is from 40 days before to immediately before the planting date. During, preferably between 30 days before and immediately before the planting date, and more preferably between 20 days before and immediately before the planting date. When treating one or more components having herbicidal activity selected from group (i) and group (j) after planting sugarcane, the treatment time of the component having herbicidal activity is from immediately after planting to 40 days after planting. It is preferably from immediately after planting to 20 days after sowing or planting, and more preferably from immediately after planting to 10 days after planting.

One or more main components selected from this compound and group (i), or groups (a) to group (j) excluding this compound and one or more main components selected from group (i) and group (i). By applying one or more of the above-selected components to plants to which herbicide resistance has been imparted by some method, a high "plant growth improving effect" can be obtained effectively and labor-savingly. Here, the "plant growth improving effect" means that the plant yield is increased as a result by controlling insect damage, disease, weed damage, etc. of the plant.

Specifically, an imidazolinone-based herbicide such as this compound and imazapill, or an imidazolinone-based herbicide such as this compound and imazapill is added to a plant to which imidazolinone-based herbicide resistance is imparted, for example, Clearfield (registered trademark) canola. , And one or more of these components selected from groups (a) to (j) can be applied at the same time or at different times to improve the growth of Clearfield canola.

Further, the compound and glyphosate, or the compound, glyphosate and group (a) to group (j) are selected from plants to which glyphosate resistance has been imparted, for example, RoundupReady (registered trademark) cotton and RoundupReady2 soybean (registered trademark). This ingredient of seeds or more can be applied at the same time or at different times to improve the growth of RoundupReady cotton and RoundupReady2 soybean.

In addition, the compound and glufosinate, or the compound, glufosinate and one or more of the present components selected from the group (a) to the group (j) are added to a plant to which glufosinate resistance is imparted, for example, LibertyLink (registered trademark) maize. By applying at the same time or at different times, the growth of Liberty Link maize can be improved.

One or more of the main components selected from the above group (i) include flumioxadin, sulfentrazone, saflufenacyl, oxyfluolphen, homesaphen, homesaphen sodium, gluhosinate ammonium salt, chlorimronethyl, and chloranthrum. Methyl, pyroxasulfone, imazetapillammonium salt, metribudin, 2,4-D, 2,4-D butothyl ester, 2,4-D dimethylammonium salt, 2,4-D diolamine salt, 2,4 -D ethylhexyl ester, 2,4-D isoctyl ester, 2,4-D isopropylammonium salt, 2,4-D sodium salt, 2,4-D triisopropanolamine salt, 2,4-D choline salt, dicamba , Dicamba diglycolamine salt, dicamba dimethylammonium salt, dicamba isopropylammonium salt, dicamba potassium salt, dicamba sodium salt, dicambacholine salt, methotrion, tembotrion, isoxaflutol and amethrin are preferred.

The compound or composition A can control harmful arthropods such as harmful insects and mites, harmful mollusks, harmful nematodes and harmful protozoa. Specifically, for example, the following can be mentioned.

Hemiptera: Himetobiunka (Laodelphax striatellus), Tobiirounka (Nilaparvata lugens), Sejirounka (Sogatella furcifera), Cornunka (Peregrinus maidis), Kitownka (Javesella pellucida) Leafhopper (Delphacidae); Leafhopper (Nephotettix cincticeps), Leafhopper (Nephotettix virescens), Leafhopper (Nephotettix nigropictus), Leafhopper (Recilia dorsalis), Leafhopper (Recilia dorsalis), Leafhopper (Recilia dorsalis) , Cicadellidae such as Dalbulus maidis, Cofana spectra, Amrasca biguttula biguttula; Aphrophoridae such as Philaenus spumarius; Mahanaridae; Leafhopper (Cercopidae); leafhopper (Aphis fabae), soybean aphid (Aphis glycines), cotton aphid (Aphis gossypii), European apple aphid (Aphis pomi), leafhopper (Aphis spiraecola) Myzus persicae), wheat aphid (Brachycaudus helichrysi), leafhopper aphid (Brevicoryne brassicae), rosy apple aphid (Dysaphis plantaginea), leafhopper aphid (Lipaphis erysimi), tulip aphid (Macrosiphum) Aphididae (Aulacorthum solani), Lettuce aphid (Nasonovia ribisnigri), Wheat aphid (Rhopalosiphum padi), Corn aphid (Rhopalosiphum maidis), Mikankuro aphid (Toxoptera citricida), Momokofuki aphid (Hyalop) sacchari), aphid (Tetraneura nigriabdominalis), aphid (Ceratovacuna lanigera), apple aphid (Eriosoma lanigerum), English grain aphid (Sitobion avenae), etc. , Phylloxera devastatrix, Phylloxera notabilis, Southern Phylloxera russelae, etc. Aphididae (Phylloxeridae); Adelges tsugae, Adelges tsugae , Aphrastasia pectinatae and other aphids (Adelgidae); rice aphids (Scotinophara lurida), black paddy bugs (Scotinophara coarctata), blue-spotted aphids (Nezara antennata) Aphididae (Eysarcoris lewisi), Aphididae (Eysarcoris ventralis), Aphididae (Eysarcoris annamita), Aphididae (Halyomorpha halys), Minamia okamemushi (Nezara viridula) Tink bug (Piezodorus guildinii), O Ebalus pugnax, Dichelops melacanthus and other stink bugs (Pentatomidae); Scaptocoris castanea and other stink bugs (Cydnidae); Diaspididae (Alydidae); Diaspididae (Coreidae) such as the stink bug (Cletus punctiger) and the stink bug (Leptoglossus australis); Stink bugs (Lygaeidae) such as the American stink bug (Blissus leucopterus); Trigonotylus caelestialium, Stenotus rubrovittatus, Stenotus rubrovittatus, etc. Diaspididae (Miridae); Onsitsukonajirami (Trialeurodes vaporariorum), Tobacco konajirami (Bemisia tabaci), Mikankonajirami (Dialeurodes citri), Mikantogekonajirami (Aleurocanthus spiniferus) ) Etc. Aleyrodidae; Abgrallaspis cyanophylli, Aonidiella aurantii, Diaspidiotus perniciosus, Pseudaulacaspis pentagona, Pseudaulacaspis pentagona Diaspididae such as stink bug (Unaspis citri) (Diaspididae); Scale insect family (Coccidae) such as Ruby scale insect (Ceroplastes rubens); Watafuki scale insect family (Margarodidae); ), Black scale insect (Phenacoccus solenopsis), Fuji scale insect (Planococcus kraunhiae), Scale insect (Pseudococcus comstocki), Mikan scale insect (Planococcus citri), Gahaniko scale insect (Pseudococcus cal) Scale insects (Pseudococcidae) such as tuttlemely bug (Brevennia rehi); ), Psyllidae such as Cacopsylla pyricola; Corythucha ciliata, Corythucha marmorata, Stephanitis nashi, Stephanitis pyrioides, etc. (Cimex lectularius), scale insects (Cimex hemipterus), etc. (Cimicidae); Quesada gigas, etc. (Cicadidae); Brazilian scale insects (Triatoma infestans), scale insects (Triatoma rubrofasciata), Triatoma rubrofasciata prolixus) etc. Reduviidae.

Lepidoptera: Chilo suppressalis, Chilo polychrysus, Scirpophaga innotata, Scirpophaga incertulas, Rupela albina, Cnaphalocrocis medinalis Ineha Casino Meiga (Marasmia exigua), Watanomeiga (Notarcha derogata), Awanomeiga (Ostrinia furnacalis), European Corn Borer (Ostrinia nubilalis), Hymadalanomeiga (Hellula undalis), Monki Chronomeiga (Herpetogramma luctu) , Rice case worm (Nymphula depunctalis), Sugar cane bowler (Diatraea saccharalis), Eggplant fruit bowler (Leucinodes orbonalis), Crambidae; Pyralidae such as Euzophera batangensis and Cadra cautella; Spodoptera litura, Spodoptera exigua, Awayoto (Mythimna separata), Awayoto (Mythimna separata) inferens, Spodoptera mauritia, Naranga aenescens, Spodoptera frugiperda, Spodoptera exempta, Spodoptera cosmioides, Semitropical army worm (Spodoptera eridania), Tamana Heliothis spp., Soybean looper (Chrysodeixis includens), Trichoplusia spp., Heliothis virescens, etc. Helicoverpa armigera), Helicoverpa zea and other genus Helicoverpa spp. ); Piieridae such as Pieris rapae; Nashihimeshinkui (Grapholita molesta), Sumomohimeshinkui (Grapholita dimorpha), Mamesinkaiga (Leguminivora glycinivorella), Azukisayamushiga (Matsumuraeses azukivora) ), Adoxophyes honmai, Homona magnanima, Archips fuscocupreanus, Cydia pomonella, Tetramoera schistaceana, Bean shootbora (Epinot) Tortrix moths such as fruit bowler (Citripestis sagittiferella) and European grape wine moss (Lobesia botrana); Family (Carposin) idae; Coffee leaf minor (Leucoptera coffeella), Momohamogriga (Lyonetia clerkella), Ginmonhamogriga (Lyonetia prunifoliella), Lymantria dispar (Lymantria dispar), etc. Euproctis spp. Etc. Euproctis spp. Etc. Euproctis spp. Etc. Euproctis spp. (Lymantriidae); Konaga (Plutella xylostella) etc. ), Lymantria operculella, Tuta absoluta, etc., Gelechiidae; Hyphantria cunea, etc., Arctiidae; Giant sugar cane boler (Telchin licus), etc. (Cossidae) such as (Cossus insularis); Tea tussock moth (Geometridae) such as Ascotis selenaria; (Stathmopodidae); Lymantria disparaceae (Sphingidae) such as Acherontia lachesis; Tea tussock moth (Nokona feralis), Synanthedon hector, Synanthedon tenuis, etc. Lymantria (Hesperiidae); Lymantria (Tinea translucens), Tea tussock moth (Tineola bisselliella), etc. eidae).

Thrips (Thysanoptera): Mikankiiro thrips (Frankliniella occidentalis), Minamikiiro thrips (Thrips palmi), Chanokiiro thrips (Scirtothrips dorsalis), Negia thrips (Thrips tabaci) , Thripidae such as Echinothrips americanus, Scirtothrips perseae; Thripidae such as Haplothrips aculeatus.

Diptera: Anthomyiidae such as Delia platura, Delia antiqua, Pegomya cunicularia; Agromyzidae such as Tetanops myopaeformis. Agromyzidae (Agromyza oryzae), Tomato leafminer (Liriomyza sativae), Agromyzidae (Liriomyza trifolii), Agromyzidae (Chromatomyia horticola), Agromyzidae (Agromyzidae); Bactrocera cucurbitae, Mikankomi fly (Bactrocera dorsalis), Nasumi fly (Bactrocera latifrons), Olive mibae (Bactrocera oleae), Quisland mibae (Bactrocera tryoni), Chichukai mibae (Ceratitis capitata) ) Etc. Fruit fly (Tephritidae); Rice leafminer (Hydrellia griseola), Fruit fly (Hydrellia philippina), Fruit fly (Hydrellia sasakii), etc. Fruit fly (Ephydridae); Agromyzidae (Drosophila melanogaster) and other fruit flies (Drosophilidae); Agromyzidae (Megaselia spiracularis) and other fruit flies (Phoridae); Agromyzidae (Sciaridae); Agromyzidae (Mayetiola destr) Anopheles mosquitoes (Cecidomyiidae) such as uctor, Aneseolia oryzae; Diopsidae such as Diopsis macrophthalma; Anopheles palpalis, Glossina morsitans, etc. Anopheles (Simuliidae); Anopheles subfamily (Phlebotominae); Anopheles mosquito (Tipula aino), Common Crane Fly (Tipula oleracea), European Anopheles (Tipula paludosa), etc. pipiens pallens), Anopheles mosquito (Culex tritaeniorhynchus), Anopheles mosquito (Culex pipiens f. aegypti), Anopheles sinensis, Anopheles gambiae, Anopheles stephensi, Anopheles coluzzii, Anopheles albimanus, Anopheles sundaicus, Anopheles arabiensis, Anopheles arabiensis Anopheles mosquitoes (Prosimulium yezoensis), Anopheles mosquitoes (Simulidae); Anopheles mosquitoes (Tabanidae); Ansca domestica, Ansca domestica ), Sashi Flies (Stomoxys calcitrans), Nosashi flies (Haematobia irritans), etc. Houseflies (Muscidae); Blowflies (Calliphoridae); Flesh flies (Sarcophagidae); Chironomidae; Fannidae.

Coleoptera: Diabrotica spp. For example, Western corn root worm (Diabrotica virgifera virgifera), Southern corn root worm (Diabrotica undecimpunctata howardi), Northern corn root worm (Diabrotica barberi), Mexican corn root worm. (Diabrotica virgifera zeae), banded cucumber beetle (Diabrotica balteata), cucumber beetle (Diabrotica speciosa), beetle leaf beetle (Cerotoma trifurcata), beetle beetle (Oulema melanopus) (Phyllotreta striolata), cabbage free beetle (Phyllotreta cruciferae), western black free beetle (Phyllotreta pusilla), cabbage stem free beetle (Psylliodes chrysocephala), hop free beetle (Psylliodes punctulata), hop-free beetle (Psylliodes punctulata), Colorado beetle (Leptano) ), Grape Collaspis brunnea, Chaetocnema pulicaria, Chaetocnema confinis, Epitrix cucumeris, Dicladispa armigera, Southern corn leaf Chrysomelidae such as Laccoptera quadrimaculata, Epitrix hirtipennis; Stenolophus lecontei, Clivina impressifrons, etc. Ganebuibui (Anomala cuprea), Himekogane (Anomala rufocuprea), Anomala albopilosa, Japanese beetle (Popillia japonica), Nagachacogane (Heptophylla picea), European chacogane (Heptophylla picea), European chacogane (Rhizotrogus majalis) .), Phyllophaga spp. Such as June beetle (Phyllophaga crinita), Diloboderus spp. Such as Diloboderus spp. Anthriibidae; Anomala albopilus (Cylas formicarius) and other Japanese beetles (Aponidae); Brazilian beetle (Zabrotes subfasciatus) and other Japanese beetles (Bruchidae); Hampei, etc. Scolytidae; Anomala albopilosa (Euscepes postfasciatus), Anomala albopilosa (Hypera postica), Anomala albopilosa (Sitophilus zeamais), Anomala albopilosa (Sitophilus oryzae), Japanese beetle (Sitophilus oryzae), Granaria , Japanese beetle (Lissorhoptrus oryzophilus), Japanese beetle (Rhabdoscelus lineaticollis), Japanese beetle (Anthonomus grandis), Japanese beetle (Sphenophorus venatus), Southern cornville bug (Sphenophorus callosus) Cane Weeville (Sphenophorus) Levis, Scepticus griseus, Scepticus uniformis, Aracanthus mourei, etc., Aracanthus spp., Cotton root beetle (Eutinobothrus brasiliensis), etc. Tribolium castaneum, click beetle (Tribolium confusum), click beetle (Alphitobius diaperinus), etc. Click beetles (Bostrychidae) such as Rhizopertha dominica; Click beetles (Ptinidae); Click beetles (Anoplophora malasiaca), Migdolus fryanus, Click beetles (Aromia bungii), etc. Melanotus okinawensis, Click beetle (Agriotes fuscicollis), Click beetle (Melanotus legatus), Click beetle (Anchastus spp.), Conoderus spp., Ctenicera spp. Click beetles (Elateridae) such as spp.), Aeolus spp.; Curculionidae (Staphylinidae) such as Paederus fuscipes; Click beetles (Dermestidae) such as click beetles (Trogoderma granarium); Tobacco click beetles (Lasiode) rma serricorne), drugstore beetle (Stegobium paniceum) and other beetles (Anobiidae); red beetle (Cryptolestes ferrugineus) and other beetles (Laemophloeidae); Sap beetle family (Nitidulidae) such as beetle (Brassicogethes aeneus).

Orthoptera: Orthoptera: Locusta migratoria, Morocco tobibatta (Dociostaurus maroccanus), Australian Tobibatta (Chortoicetes terminifera), Akatobibatta (Nomadacris septemfasciata), Brown Locust (Locustana pardalina), Locustana pardalina Locust (Calliptamus italicus), differential glass hopper (Melanoplus differentialis), two-striped glass hopper (Melanoplus bivittatus), migretry glass hopper (Melanoplus sanguinipes), red legged glass hopper (Melanoplus femurrubrum), clear winged glass hopper (Camnula pellucida) Orthoptera locust (Schistocerca gregaria), Yellow wing locust (Gastrimargus musicus), Superslotted locust (Austracris guttulosa), Kobaneinago (Oxya yezoensis), Hanenagainago (Oxya japonica), Taiwan locust (Patanga) ); Orthoptera (Gryllotalpidae) such as Kera (Gryllotalpa orientalis); Orthoptera (Gryllidae) such as European locust (Acheta domestica), Emma locust (Teleogryllus emma);

Hymenoptera: Hymenoptera (Athalia rosae), Japanese ant (Athalia japonica) and other Hymenoptera (Tenthredinidae); Fire ants (Solenopsis invicta), Red imported fire ants (Solenopsis geminata) and other Tofusiali sp Hymenoptera (Atta spp.), Hymenoptera (Acromyrmex spp.), Sashihari (Paraponera clavata), Luriari (Ochetellus glaber), Fire ants (Monomorium pharaonis), Argentine ants (Linepithe) , Black imported fire ants (Formica japonica), Amime ants (Pristomyrmex punctutus), Red imported fire ants (Pheidole noda), Red imported fire ants (Pheidole megacephala), Black imported fire ants (Camponotus japonicus), Muneakao ants (Camponotus obscuripes), etc. Red imported fire ants (Pogonomyrmex occidentalis) and other genus Hymenoptera (Pogonomyrmex spp.), Red imported fire ants (Wasmania auropunctata) and other genus Hymenoptera (Wasmania spp.) ), Hymenoptera (Vespa simillima), Hymenoptera (Vespa analis), Red imported fire ant (Vespa velutina), Hymenoptera (Polistes jokahamae), etc. Bethylidae.

Cockroaches (Blattodea): Termites (Blattella germanica) and other termites (Ectobiidae); termites (Periplaneta fuliginosa), termites (Periplaneta americana), termites (Periplaneta australasiae), termites (Periplaneta australasiae), termites (Periplaneta australasiae) Cockroaches (Blattidae) such as Blatta orientalis; Yamato termites (Reticulitermes speratus), termites (Coptotermes formosanus), American termites (Incisitermes minor), termites (Cryptotermes minor), termites (Cryptotermes domesticus), termites (Odontotermes) Neotermes koshunensis, Satsuma termites (Glyptotermes satsumensis), Nakajima termites (Glyptotermes nakajimai), Catan termites (Glyptotermes fuscus), Ooshiro ants (Hodotermopsis sjostedti), Cockroaches termites (Hodotermopsis sjostedti) Termites such as miyatakei), termites (Reticulitermes kanmonensis), termites (Nasutitermes takasagoensis), termites (Pericapritermes nitobei), termites (Sinocapritermes mushae), and Cornitermes cumulans.

Fleas (Siphonaptera): Human fleas (Pulex irritans), cat fleas (Ctenocephalides felis), dog fleas (Ctenocephalides canis), keops fleas (Xenopsylla cheopis), chicken fleas (Echidnophaga gallinacea), etc. Hectopsyllidae such as penetrans); Ceratophyllidae such as European flea (Nosopsyllus fasciatus).

Psocodae: Primate body lice (Pediculidae) such as head lice (Pediculus humanus capitis); Pubic lice (Pthiridae) such as head lice (Pthirus pubis); Haematopinidae); Primate body lice (Linognathus vituli), pubic lice (Linognathus vituli), pubic lice (Linognathus ovillus), pubic lice (Solenopotes capillatus), etc. Bovicoliidae such as Werneckiella spp.; Trichodectes canis, Trichodectidae such as Felicola subrostratus; Primatebody lice (Menopon gallinae), primate body lice (Menopon gallinae) ), Trinoton spp. And other pubic lice (Menoponidae); Cummingsia spp. And other pubic lice (Trimenoponidae); Konachatate (Trogium pulsatorium) and other pubic lice (Trogiidae) Primate body lice (Liposcelis corrodens), Primate body lice (Liposcelis bostrychophila), Head lice (Liposcelis pearmani), Head lice (Liposcelis entomophila), etc.

Thysanura: Lepismatidae such as Ctenolepisma villosa and Lepisma saccharina.

Acari: Nami spider mite (Tetranychus urticae), Kanzawa spider mite (Tetranychus kanzawai), Mitsuyubinami spider mite (Tetranychus evansi), Panonychus citri, Panonychus ulmi, Panonychus ulmi, Panonychus ulmi ); Aculops pelekassi, Phyllocoptruta citri, Aculops lycopersici, Calacarus carinatus, Acaphylla theavagrans Aculus schlechtendali), Aceria diospyri, Aceria tosichella, Shevtchenkella sp., Etc. Eriophyidae; Family (Tenuipalpidae); Tetranychus vulgaris (Tuckerellidae);
Haemaphysalis longicornis, Haemaphysalis flava, Haemaphysalis japonica, Haemaphysalis campanulata, American dog tick (Dermacentor variabilis), Taiwan tick tick (Dermacentor variabilis), Taiwan tick tick (Dermacentor) ), Dermacentor reticulatus, Yamato tick (Ixodes ovatus), Schultz tick (Ixodes persulcatus), Black leg tick (Ixodes scapularis), Western black tick (Ixodes pacificus), Ixodes holocyclus, Ixodes ricinus , Gulf coast tick (Amblyomma maculatum), Ousima tick (Rhipicephalus microplus), Cattle tick (Rhipicephalus annulatus), Rhipicephalus sanguineus, Rhipicephalus appendiculatus, Rhipicephalus appendiculatus, Rhipicephalus appendiculatus, Rhipicephalus appendiculatus, Rhipicephalus decoloratus, etc. Ornithodoros hermsi, Ornithodoros turicata, etc. Ixodidae (Argasidae), Kenagakonadani (Tyrophagus putrescentiae), Horensoukenagakonadani (Tyrophagus similis), etc. ); Hosotsumedani (Cheyletus eruditus), Kuwagatatsumedani (Cheyletus malaccensis), Minamitsumedani (Chelacaropsis) Cheyletidae such as moorei, Cheyletiella yasguri; Cheyletidae; Psoroptes ovis, Psoroptes equi, Knemidocoptes mutans, Otodectes cynotis ), Etc. (Psoroptidae); Nekoshosenkouhizendani (Notoedres cati), Nezumishosenkouhizendani (Notoedres muris), Senkouhizendani (Sarcoptes scabiei), etc. (Listrophoridae); Cheyletidae (Dermanyssidae) such as Wakumo (Dermanyssus gallinae); Cheyletidae (Ornithonyssus sylviarum), Cheyletidae (Ornithonyssus bacoti), etc. Varroidae), itch mite (Demodex canis), itch mite (Demodex cati) and other itch mite (Demodicidae), itch mite (Leptotrombidium akamushi), itch mite (Leptotrombidium pallidum), itch mite (Leptotrombidium pallidum) Trombiculidae).

Spiders (Araneae): Cheiracanthium japonicum and other spiders (Eutichuridae); Latrodectus hasseltii and other spiders (Theridiidae).
Polydesmida: Polydesmida (Paradoxosomatidae) such as Polydesmida (Oxidus gracilis) and Polydesmida (Nedyopus tambanus).
Isopoda: Armadillidium vulgare and other armadillidium vulgare.
Chilopoda: Centipede family (Scutigeridae) such as Thereuonema hilgendorfi; Scolopendridae (Scolopendra subspinipes) such as Scolopendra subspinipes; Issun tho polys rugosus (Bothropolys rugosus).
Gastropoda: Pond snails (Limacidae) such as Keelback slug (Limax marginatus), Keelback slug (Limax flavus); Snail family (Ampullariidae); Mono-Aragai family (Lymnaeidae) such as Austropeplea ollula.

Nematoda: Aphelenchoididae such as Aphelenchoides besseyi; Pratylenchus coffeae, Pratylenchus brachyurus, Pratylenchus sylenchus neg Lenks family (Pratylenchidae); Javanese root-knot nematode (Meloidogyne javanica), Root-knot nematode (Meloidogyne incognita), guava root-knot nematodes (Meloidogyne enterolobii), Kitanekobu nematode (Meloidogyne hapla), Root-knot nematode (Meloidogyne hapla) Globodera rostochiensis, Heteroderidae such as Root-knot nematode (Globodera pallida); Hoplolaimidae such as Rothelenchulus reniformis; Anguinidae); Tylenchulidae such as Tylenchulus semipenetrans; Longidoridae such as Xiphinema index; Trichodoridae; Bursaphelenchus x Aferenx family (Parasitaphelenchidae).

Eucoccidiorida: Eimeria tenella, Eimeria acervulina, Eimeria necatrix, Eimeria brunetti, Eimeria maxima, Eimeria maxima (Eimeria mivati), Eimeria mitis, Eimeria precox, Eimeria hagani, Eimeria meleagrimitis, Eimeria adenoides, Eimeria adenoides Eimeria gallopovonis, Eimeria bovis, Eimeria zuernii, Eimeria auburnensis, Eimeria auburnensis, Eimeria ellipsoidalis, Eimeria arlipsoidalis Eimeria ovina, Eimeria parva, Eimeria debliecki, Eimeria scabra, Eimeria stiedai, Eimeria perforans, Eimeria perforans (Eimeria magna), Eimeria media, Eimeria irresidua, Eimeria piriformis, Eimeria neoleporis, Eimeria intenstinalis, Eimeria intenstinalis Eimeria matsubayashii, Isospora alamataensis, Isospo ra anseris), Isospora bigemina, Isospora bronchocelae, Isospora heydorni, Isospora mandari, Isospora mandari, Isospora mejiro (Isospora mejiro) ), Isospora rara, Isospora thibetana, Isospora canis, Isospora ohioensis, Isospora felis, Isospora felis, Isospora felis, Isospora felis ), Isospora suis, etc. Eimeriidae.

Intraspecies mutations are not limited to the above-mentioned harmful insects, harmful arthropods such as harmful mites, harmful mollusks, harmful nematodes and harmful protozoans. That is, harmful arthropods, mollusks, and harmful animals that are less sensitive (also referred to as resistant) to specific insecticides, acaricides, mollusks, nematodes and protozoa. Also includes nematodes and harmful protozoa. Examples of the insecticide, the acaricide, the mollusc, the nematode and the protozoan include groups a1 to a26.
Group a1: Group 1A carbamate-based and Group 1B organic phosphorus-based compounds classified by the acetylcholinesterase inhibitor IRAC, such as alanycarb, aldicarb, bendiocarb, benfuracarb, buttocarboxy. Butocarboxim, butoxycarboxim, carbaryl (NAC), carbofuran, carbosulfan, ethiofencarb, fenobucarb (BPMC), formethanate, fratiocarb furathiocarb, isoprocarb (MIPC), methiocarb, methomyl, methoxychlor, metolcarb, oxamyl, pyrimicarb, promecarb, propoxur: PHC ), Thiodicarb, thiofanox, triazamate, trimethacarb, xylylcarb; acephate, azamethiphos, azinphos-ethyl, azinphos-ethyl, azinphos-ethyl methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, cowaphos, cyanophos: CYAP , Demeton, demeton-S-methyl, diazinon, dichlorvos (DDVP), dicrotophos, dimethate (d) imethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenchlorphos, fenitrothion (MEP) ), Fenitrothion (MPP), fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl-O- (methoxyaminothiophosphoryl) salicylate , Isoxathion, malathion, mecarbam, methamidophos, methidathion (DMTP), mevinphos, monocrotophos, naled (BRP), omethoate. , Oxydemeton-methyl, parathion, parathion-methyl, phenthoate (PAP), phorate, phosalone, phosmet (PMP), phosphamidon ), Phoxim, pyrimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyrazophos, pyridaphenthion, pyridaphenthion, quinalphos (sulfotep), sulprofos, tebupirimfos, temephos, terbufos, tetrachlorvi A group consisting of nphos, thiometon, toxaphene, triazophos, trichlorfon (DEP) and vamidothion.
Group a2: Group 2A cyclic diene organochlorine and group 2B phenylpyrazole compounds of action classification by GABAergic chlorine ion channel blocker IRAC, such as chlordane, endosulfan, dieldrin, ethiprole. ), Fipronil and flufiprole, pyriprole.
Group a3: Group 3A cypermethrin system and group 3B of action classification by sodium channel modulator IRAC, for example, acrinathrin, allethrin, bifenthrin, kappa-bifenthrin, bioallethrin, Bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin , Cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, sigma- cypermethrin, cyphenothrin, deltamethrin, empentthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucitrinate flucythrinate, flumethrin, fluvalinate, tau-fluvalinate, halfenprox, heptafluthrin, imiprothrin, kadethrin, mepermethrin me ), Momfluorothrin, permethrin, phenothrin, prallethrin, pyrethrins, resmethrin, cypermethrin Lafluthrin, tefluthrin, kappa-tefluthrin, tetramethrin, tetramethylfluthrin, tralomethrin, transfluthrin, benfluthrin, benfluthrin A group consisting of flufenoprox, flumethrin, furamethrin, metofluthrin, profluthrin and dimefluthrin, and DDT.
Group a4: Group of action classifications by nicotinic acetylcholine receptor competitive modulator IRAC 4A neonicotinoids, 4B nicotines, 4C butenolides, 4D sulfoximines and 4E mesoionics such as acetamiprid, clothianidin, Dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam, flupyradifurone, sulfaxaflor, sulfoxaflor, cycloxaprid, cycloxaprid A group consisting of dicloromezotiaz and flupyrimin.
Group a5: Group 5 of action classification by nicotinic acetylcholine receptor allosteric modulator IRAC A group consisting of spinosad systems, for example spinosad and spine toram.
Group a6: Glutamic acid-operated chlorine ion channel Allosteric modulator Group of action classification by IRAC 6 Abamectin-based, milbemycin-based, for example, abamectin, emamectin-benzoate, lepimectin, milbemectin , Dimadectin, doramectin, eprinomectin, ivermectin, latideectin, selamectin, milbemycin D, moxidectin and nemadectin. ..
Group a7: Group 7A juvenile hormone analogs of action classification by juvenile hormone mimic IRAC, group 7B phenoxycarb and 7C pyriproxyfen, eg hydroprene, kinoprene, methoprene, phenoxycarb ( A group consisting of fenoxycarb) and pyriproxyfen.
Group a8: Group 9 of the action classification by the chordotonal organ TRPV channel modulator IRAC A group consisting of pyridineazomethine derivatives such as Pymetrozine and Pyrifluquinazon.
Group a9: Group 11A Bacillus thuringensis, Group 11B Bacillus thuringiensis, for example, Bacillus sphaericus, Bacillus thuringensis BD # 32 strain (Bacillus) thuringiensis strain BD # 32), Bacillus thuringiensis strain AQ52), Bacillus thuringiensis subsp. Aizawai strain ABTS-1857, Bacillus thuringiensis subsp. Aizawai strain ABTS-1857. Subspecies HD-1 strain (Bacillus thuringiensis subsp. Kurstaki strain HD-1), Bacillus thuringiensis subsp. Kurstaki strain BMP123, Bacillus thuringiensis subspecies NB176 strain (Bacillus) thuringiensis subsp. Tenebriosis strain NB176), Bacillus thuringiensis var. Israelensis, Bacillus thuringiensis var. Aegypti, Bacillus thuringiensis var. Aegypti, Bacillus thuringiensis var. Aegypti, Bacillus thuringiensis var. thuringiensis var. Colmeri), Bacillus thuringiensis var. Darmstadiensis, Bacillus thuringiensis var. Dendrolimus, Bacillus thuringiensis var. Dendrolimus th . galleriae), Bacillus thuringiensi variant (Bacillus thuringiensi) s var. Japonensis), Bacillus thuringiensis subsp. Morrisoni, Bacillus thuringiensis var. San diego, Bacillus thuringiensis subsp. Morrisoni MPPL002 strain Bacillus thuringiensis subsp. Thuringiensis strain MPPL002), Bacillus thuringiensis 7216 variant (Bacillus thuringiensis var. 7216), Bacillus thuringiensis T36 variant (Bacillus thuringiensis var. (For example, Cry1A, Cry1Ab, modified Cry1Ab (partially missing Cry1Ab), Cry1Ac, Cry1Ab-Ac (hybrid protein fused with Cry1Ab and Cry1Ac), Cry1C, Cry1F, Cry1Fa2 (modified cry1F), moCry1F (Modified Cry1F), Cry1A. 105 (hybrid protein fused with Cry1Ab, Cry1Ac, Cry1F), Cry2Ab2, Cry2Ae, Cry9C, Vip3A, Vip3Aa20), delta-endotoxin conferring resistance to Coleoptera insects (eg Cry3A, mCry3A (modified Cry3A), Cry3B) , Cry34Ab1, Cry35Ab1), and delta-endotoxins (eg, Cry1A, Cry4A, Cry4B, Cry11A) that have insecticidal activity against the family Coleoptera.
Group a10: A group consisting of group 13 of the action classification by the oxidative phosphorylation uncoupler IRAC that disturbs the proton gradient, for example, chlorfenapyr and sulfluramid.
Group a11: Group 14 of the action classification by the nicotinic acetylcholine receptor channel blocker IRAC Neristoxin analogs such as bensultap, cartap, cartap hydrochloride, thiocyclam, thiosultap. A group consisting of thiosultap-disodium and thiosultap-monosodium.
Group a12: Group 15 benzoylurea and Group 16 buprofezins for classification of action by the chitin biosynthesis inhibitor IRAC, such as bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron ( flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflubenzuron and triflumuron bu.
Group a13: Group 17 of the action classification by the molting inhibitor IRAC, for example, a group consisting of cyromazine.
Group a14: Group 18 of the action classification by the molting hormone (ecdysone) receptor agonist IRAC 18 diacylhydrazines, such as chromafenozide, halofenozide, methoxyfenozide and tebufenozide.
Group a15: A group consisting of group 22A oxadiadin and group 22B semicarpazones, such as indoxacarb and metaflumizone, in the classification of action by voltage-gated sodium channel blocker IRAC.
Group a16: Group 23 of action classification by acetyl-CoA carboxylase inhibitor IRAC A group consisting of tetrolic acid, tetramic acid derivatives such as spirodiclofen, spiromesifen and spirotetramat.
Group a17: Group 28 diamides of action classification by ryanodine receptor modulator IRAC, eg, chlorantraniliprole, cyantraniliprole, cycloniliprole, flubendiamide, A group consisting of tetraniliprole, cyhalodiamide and tetrachlorantraniliprole.
Group a18: Group 29 of the action classification by the chordotonal organ modulator IRAC, for example, a group consisting of Flonicamid.
Group a19: Group 10 of the action classification by the mite growth inhibitor IRAC, for example, a group consisting of etoxozole, clofentezine, and hexathiazox.
Group a20: A group consisting of group 19 of the action classification by the octopamine receptor agonist IRAC, for example, amitraz.
Group a21: Group 24 of the action classification by the mitochondrial electron transport chain complex IV inhibitor IRAC, for example, a group consisting of phosphine.
Group a22: A group consisting of isoxazoline compounds such as afoxolaner, fluralaner, sarolaner, and lotilaner.
Group a23: A group consisting of group 12 of the action classification by the mitochondrial ATP synthase inhibitor IRAC, for example, diafenthiuron.
Group a24: A group consisting of group 20 of the action classification by the mitochondrial electron transport chain complex III inhibitor IRAC, for example, acequinocyl and bifenazate.
Group a25: Mitochondrial electron transport chain complex I inhibitor (METI)
Group 21 of the action classification by IRAC, for example, a group consisting of pyridaben and fenpyroximate.
Group a26: A group consisting of azadiractin and pyridalyl.

Factors contributing to the decrease in susceptibility include [1] amino acid substitution of target protein, [2] decrease in target protein, [3] enhancement of metabolism, [4] decrease in skin permeability, and [5] excretion function by membrane transporter. Increased. In [1], the target protein may have one or more amino acid substitutions. The enhancement of metabolism in [3] means an increase in the activity of metabolic enzymes (also referred to as detoxification degrading enzymes) such as cytochrome P450, carboxylesterase and glutathion-S-transferase. .. In addition, as factors of decreased sensitivity, [1] amino acid substitution of target protein, [2] decrease of target protein, [3] enhancement of metabolism, [4] decrease in skin permeability, [5] excretion function by membrane transporter You may have any one or more of the enhancements.

Examples of harmful arthropods such as harmful insects, harmful mites, harmful mollusks and harmful nematodes with reduced susceptibility include the following.
Hemiptera with reduced sensitivity to one or more compounds selected from group a2;
Hemiptera with reduced sensitivity to one or more compounds selected from group a4;
Hemiptera with reduced sensitivity to one or more compounds selected from group a8;
Hemiptera with reduced sensitivity to one or more compounds selected from group a12;
Hemiptera with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
Hemiptera with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a8;
Hemiptera with reduced susceptibility to one or more compounds selected from group a2 and buprofezin belonging to group a12;
Hemiptera with reduced sensitivity to one or more compounds selected from group a4 and one or more compounds selected from group a8;
Hemiptera with reduced susceptibility to one or more compounds selected from group a4 and buprofezin belonging to group a12;
Hemiptera with reduced susceptibility to one or more compounds selected from group a8 and buprofezin belonging to group a12;
Hemiptera with reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a4, and one or more compounds selected from group a8;
One or more compounds selected from group a2, one or more compounds selected from group a4, and Hemiptera with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a2, one or more compounds selected from group a8, and Hemiptera with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a4, one or more compounds selected from group a8, and Hemiptera with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a2, one or more compounds selected from group a4, one or more compounds selected from group a8, and Hemiptera with reduced sensitivity to buprofezin belonging to group a12;
Delphacidae with reduced sensitivity to one or more compounds selected from group a2;
Delphacidae with reduced sensitivity to one or more compounds selected from group a4;
Delphacidae with reduced sensitivity to one or more compounds selected from group a8;
Delphacidae with reduced sensitivity to one or more compounds selected from group a12;
Delphacidae with reduced susceptibility to one or more compounds selected from group a2 and one or more compounds selected from group a4;
Delphacidae with reduced susceptibility to one or more compounds selected from group a2 and pimetrodin belonging to group a8;
Delphacidae with reduced susceptibility to one or more compounds selected from group a2 and buprofezin belonging to group a12;
Delphacidae with reduced susceptibility to one or more compounds selected from group a4 and pimetrodin belonging to group a8;
Delphacidae with reduced susceptibility to one or more compounds selected from group a4 and buprofezin belonging to group a12;
Delphacidae with reduced susceptibility to one or more compounds selected from group a2, one or more compounds selected from group a4, and pimetrodin belonging to group a8;
Delphacidae with reduced susceptibility to one or more compounds selected from group a2, one or more compounds selected from group a4, and buprofezin belonging to group a12;
Delphacidae with reduced susceptibility to one or more compounds selected from group a2, pimetrodin belonging to group a8, and buprofezin belonging to group a12;
Delphacidae with reduced susceptibility to one or more compounds selected from group a4, pimetrodin belonging to group a8, and buprofezin belonging to group a12;
Delphacidae with reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a4, pimetrodin belonging to group a8, and buprofezin belonging to group a12;
Brown planthopper, brown planthopper, or brown planthopper with reduced sensitivity to one or more compounds selected from group a2;
Brown planthopper, brown planthopper, or brown planthopper with reduced sensitivity to one or more compounds selected from group a4;
Brown planthopper, brown planthopper, or brown planthopper with reduced sensitivity to one or more compounds selected from group a8;
Brown planthopper, brown planthopper, or brown planthopper with reduced sensitivity to one or more compounds selected from group a12;
A brown planthopper, a brown planthopper, or a brown planthopper with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
One or more compounds selected from group a2, and brown planthoppers, brown planthoppers, or brown planthoppers with reduced susceptibility to pimetrodin belonging to group a8;
One or more compounds selected from group a2, and brown planthopper, brown planthopper, or brown planthopper with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a4, and brown planthoppers, brown planthoppers, or brown planthoppers with reduced susceptibility to pimetrodin belonging to group a8;
One or more compounds selected from group a4, and brown planthopper, brown planthopper, or brown planthopper with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a2, one or more compounds selected from group a4, and brown planthoppers, sedile planthoppers, or brown planthoppers with reduced susceptibility to pimetrodin belonging to group a8;
One or more compounds selected from group a2, one or more compounds selected from group a4, and brown planthopper, brown planthopper, or brown planthopper with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a2, a brown planthopper, a brown planthopper, or a brown planthopper with reduced sensitivity to pimetrodin belonging to group a8 and buprofezin belonging to group a12;
One or more compounds selected from group a4, a brown planthopper, a brown planthopper, or a brown planthopper with reduced sensitivity to pimetrodin belonging to group a8 and buprofezin belonging to group a12;
One or more compounds selected from group a2, one or more compounds selected from group a4, pimetrodin belonging to group a8, and brown planthopper, sedirounka, or himetobiunka with reduced sensitivity to buprofezin belonging to group a12;
Aphididae with reduced sensitivity to one or more compounds selected from group a3;
Aphididae with reduced sensitivity to one or more compounds selected from group a8;
Aphididae with reduced susceptibility to one or more compounds selected from group a3 and one or more compounds selected from group a4;
Aphididae with reduced susceptibility to one or more compounds selected from group a3 and one or more compounds selected from group a8;
Aphididae with reduced susceptibility to one or more compounds selected from group a4 and one or more compounds selected from group a8;
Aphididae with reduced sensitivity to one or more compounds selected from group a3, one or more compounds selected from group a4, and one or more compounds selected from group a8;
Myzus persicae with reduced sensitivity to one or more compounds selected from group a1;
Aphis gossypii or Myzus persicae with reduced sensitivity to one or more compounds selected from group a3;
Aphis gossypii or Myzus persicae with reduced sensitivity to one or more compounds selected from group a4;
Aphis gossypii or Myzus persicae with reduced sensitivity to one or more compounds selected from group a8;
Aphis gossypii or Myzus persicae with reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a4;
Aphis gossypii or Myzus persicae with reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a8;
Aphis gossypii or Myzus persicae with reduced sensitivity to one or more compounds selected from group a4 and one or more compounds selected from group a8;
Aphis gossypii or Myzus persicae with reduced sensitivity to one or more compounds selected from group a3, one or more compounds selected from group a4, and one or more compounds selected from group a8; selected from group a3. Tobacco aphids with reduced sensitivity to one or more compounds;
Tobacco whiteflies with reduced sensitivity to one or more compounds selected from group a4;
Myzus persicae with reduced sensitivity to one or more compounds selected from group a1;
Aphis gossypii with reduced sensitivity to carbamate compounds selected from group a1 and / or organophosphorus compounds selected from group a1;
Malathion, chlorpyrifos, diazinon, phenocarb, carbofuran, ethiprol, fipronil, fulfiplol, etofenprox, dinotefuran, imidacloprid, nitenpyram, sulfoxaflor, thiacloprid, thiamethoxam, pimetrodin, and / or buprofezin;
Sedirounka with reduced sensitivity to isoprocarb, chlorpyrifos, imidacloprid, and / or buprofezin;
Amrasca biguttula biguttula with reduced sensitivity to imidacloprid, thiamethoxam, acetamiprid, thiacloprid, clothianidin, and / or dinotefuran;
Aphis gossypii with reduced sensitivity to pyrimicurves and / or organophosphorus compounds selected from group a1;
Lettuce aphids with reduced susceptibility to pyrimicurves, methomyl, acephate, dieldrins, and / or endosulfan;
English grain afid with reduced sensitivity to lambdasihalothrin;
One or more compounds selected from group a4, bifenthrins, and / or greenhouse whiteflies with reduced susceptibility to spiromesiphen;
Tobacco whiteflies with reduced susceptibility to pyrimiphosmethyl, prophenofos, endosulfan, fipronil, lambdasihalothrin, bifenthrin, alphacypermethrin, cartap, buprofezin, spiromethifen, chloranthraniliprol, diafentiurone, and / or azadirachtin;
Chlorpyrifos, bifenthrin, cypermethrin, acetamiprid, imidacloprid, thiamethoxam, nitenpyram, and / or diaphorina citri with reduced sensitivity to chlorfenapyr;
Brown stink bugs with reduced sensitivity to monocrotophos, methamidophos, acephate, endosulfan, betacifluthrin, and / or imidacloprid;
Lepidoptera with reduced sensitivity to one or more compounds selected from group a14;
Lepidoptera with reduced sensitivity to one or more compounds selected from group a15;
Lepidoptera with reduced sensitivity to one or more compounds selected from group a17;
Lepidoptera with reduced sensitivity to one or more compounds selected from group a14 and one or more compounds selected from group a17;
Diamondback moth with reduced sensitivity to one or more compounds selected from group a15;
Diamondback moth with reduced sensitivity to one or more compounds selected from group a17;
Kobunomeiga with reduced sensitivity to one or more compounds selected from group a14;
Kobunomeiga with reduced sensitivity to one or more compounds selected from group a17;
Kobunomeiga with reduced sensitivity to one or more compounds selected from group a14 and one or more compounds selected from group a17;
Fake corn earworms with reduced susceptibility to one or more compounds selected from group a3;
Helicoverpa armigera with reduced sensitivity to one or more compounds selected from group a9;
Corn earworms with reduced sensitivity to one or more compounds selected from group a9;
Chahamaki with reduced sensitivity to one or more compounds selected from group a14;
Chahamaki with reduced sensitivity to one or more compounds selected from group a17;
Chanokokakumonhamaki with reduced sensitivity to one or more compounds selected from group a14; Chanokokakumonhamaki with reduced sensitivity to one or more compounds selected from group a17; , And Chanokokakumonhamaki with reduced sensitivity to one or more compounds selected from group a17;
Diamondback moth with reduced sensitivity to one or more compounds selected from group a3;
Tuta absoluta with reduced sensitivity to one or more compounds selected from group a17;
Chilo suppressalis with reduced sensitivity to endosulfan, fipronil, and / or thiosultap monosodium salts;
European corn bowler with reduced susceptibility to deltamethrin and / or lambda sihalotrin;
Sugar cane bowler with reduced sensitivity to the delta-endotoxins Cry1Ab and / or Cry1Ac;
Eggplant fruit bowler with reduced sensitivity to profenophos, carbaryl, chlorpyrifos, endosulfan, deltamethrin, and / or fenvalerate;
Prophenofus, chlorpyrifos, quinalphos, hoxim, triazophos, mesomil, thiodicalve, endosulfane, fipronil, cypermethrin, deltamethrin, beta-cypermethrin, spinosad, abamectin, emamectin benzoate, ruphenurone, diflubenzlone, methoxyphenodide, and / or Reduced Hasmonyoto; Chlorpyrifos, Deltamethrin, Cypermethrin, Spinosad, Abamectin, Emamectin benzoate, Ruphenuron, Indoxacarb, and / or Shiroichimodiyoto with reduced sensitivity to methoxyphenozide;
Spodoptera frugiperda with reduced sensitivity to the delta-endotoxins Cry1Ab, Cry1Ac, Cry2Ab2, Cry2Ae, and / or Cry1F;
Fake corn earworms with reduced susceptibility to sulprophos, profenophos, monocrotophos, parathionmethyl, thiodicalve, methomyl, toxaphene, endosulfan, cypermethrin, deltamethrin, DDT, and / or spinosad;
Helicoverpa armigera, chlorpyrifos, profenophos, methomyl, thiodicalve, toxaphene, endosulfan, fenvalerate, deltamethrin, cypermethrin, DDT, indoxacarb, and / or reduced sensitivity to chloranthraniliprol;
Corn earworms with reduced sensitivity to parathionmethyl, cypermethrin, endosulfan, and / or DDT;
Lambda sihalotrid, thiacloprid, and / or codedling moss with reduced sensitivity to methoxyphenozide;
European grape wine moss with reduced susceptibility to deltamethrin and / or indoxacarb;
Reduced sensitivity to methomyl, dieldrin, permethrin, fipronil, spinosad, abamectin, emamectin benzoate, the delta-endotoxins Cry1C, ruphenuron, indoxacarb, chloranthraniliprol, flubendiamide, and / or diafentiurone. Konaga;
Thrips with reduced sensitivity to one or more compounds selected from group a2;
Thrips with reduced sensitivity to one or more compounds selected from group a3;
Thrips with reduced sensitivity to one or more compounds selected from group a4;
Thrips with reduced sensitivity to one or more compounds selected from group a9;
Thrips with reduced sensitivity to one or more compounds selected from group a17;
Welsh onion thrips with reduced sensitivity to one or more compounds selected from group a3;
Welsh onion thrips with reduced susceptibility to profenophos, chlorpyrifos, deltamethrin and / or lambda sihalotrin;
Methiocarb, Mesomil, Bendiocarb, Holmethanate, Carbofran, Malathion, Chlorpyriphos, Diazinon, Metamidhos, Dimethote, Dichlorvos, Acephate, Metidathione, Toxaphene, Endosulfane, Fipronil, Acrinathrin, Alphacypermethrin, Bifenthrin, Deltamethrin, Esphenthrin Taufluvalinate, cypermethrin, fenvalerate, cypermethrin, imidacloprid, spinosad, spinetram, abamectin, diazinonphene, and / or dichlorvos with reduced susceptibility to cyantranilprol;
Diptera with reduced sensitivity to one or more compounds selected from group a2;
Diptera with reduced sensitivity to one or more compounds selected from group a3;
Diptera with reduced sensitivity to one or more compounds selected from group a4;
Diptera with reduced sensitivity to one or more compounds selected from group a9;
Diptera with reduced sensitivity to one or more compounds selected from group a17;
Tomato leafminer with reduced sensitivity to permethrin and / or fenvalerate;
Methamidophos, parathionmethyl, pyrazophos, demeton, chlorpyrifos, triazophos, permethrin, cypermethrin, DDT, spinosad, abamectin, and / or reduced sensitivity to cyromazine;
Coleoptera with reduced sensitivity to one or more compounds selected from group a2;
Coleoptera with reduced sensitivity to one or more compounds selected from group a3;
Coleoptera with reduced sensitivity to one or more compounds selected from group a4;
Coleoptera with reduced sensitivity to one or more compounds selected from group a9;
Coleoptera with reduced sensitivity to one or more compounds selected from group a17;
Coleoptera with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a2;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a3;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a4;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a9;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a17;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
Inedro worms with reduced sensitivity to one or more compounds selected from group a2;
Inedro worms with reduced sensitivity to one or more compounds selected from group a4;
Inedro worms with reduced susceptibility to one or more compounds selected from group a2 and one or more compounds selected from group a4;
The genus Diablotica with reduced sensitivity to one or more compounds selected from group a2;
The genus Diablotica with reduced sensitivity to one or more compounds selected from group a3;
The genus Diablotica with reduced sensitivity to one or more compounds selected from group a4;
The genus Diablotica with reduced sensitivity to one or more compounds selected from group a9;
The genus Diablotica with reduced sensitivity to one or more compounds selected from group a17;
Western corn root worms with reduced sensitivity to one or more compounds selected from group a2;
Western corn root worms with reduced sensitivity to one or more compounds selected from group a3;
Western corn root worms with reduced sensitivity to one or more compounds selected from group a4;
Western corn root worms with reduced sensitivity to one or more compounds selected from group a9;
Western corn root worms with reduced sensitivity to one or more compounds selected from group a17;
Western corn root worms with reduced sensitivity to one or more compounds selected from group a2;
Western corn root worms with reduced sensitivity to one or more compounds selected from group a3;
Southern corn root worms with reduced sensitivity to one or more compounds selected from group a4;
Southern corn root worms with reduced sensitivity to one or more compounds selected from group a9;
Southern corn root worms with reduced sensitivity to one or more compounds selected from group a17;
Northern corn root worms with reduced sensitivity to one or more compounds selected from group a2;
Northern corn root worms with reduced sensitivity to one or more compounds selected from group a3;
Northern corn root worms with reduced sensitivity to one or more compounds selected from group a4;
Northern corn root worms with reduced sensitivity to one or more compounds selected from group a9;
Northern corn root worms with reduced sensitivity to one or more compounds selected from group a17;
Cuca bit beetle with reduced sensitivity to one or more compounds selected from group a2;
Cuca bit beetle with reduced sensitivity to one or more compounds selected from group a3;
Cuca bit beetle with reduced sensitivity to one or more compounds selected from group a4;
Cuca bit beetle with reduced sensitivity to one or more compounds selected from group a9;
Cuca bit beetle with reduced sensitivity to one or more compounds selected from group a17;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a2;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a3;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a4;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a11;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a17;
Reduced susceptibility to one or more compounds selected from group a3;
Reduced susceptibility to one or more compounds selected from group a4;
Reduced susceptibility to one or more compounds selected from group a17;
Cabbage-free beetle with reduced sensitivity to one or more compounds selected from group a3;
Cabbage-free beetle with reduced sensitivity to one or more compounds selected from group a4;
Cabbage-free beetle with reduced sensitivity to one or more compounds selected from group a17;
Western black free beetle with reduced sensitivity to one or more compounds selected from group a3;
Western black free beetle with reduced sensitivity to one or more compounds selected from group a4;
Western black free beetle with reduced sensitivity to one or more compounds selected from group a17;
Cabbage stem free beetle with reduced sensitivity to one or more compounds selected from group a3;
Cabbage stem free beetle with reduced sensitivity to one or more compounds selected from group a4;
Cabbage stem free beetle with reduced sensitivity to one or more compounds selected from group a17;
Hop-free beetle with reduced sensitivity to one or more compounds selected from group a3;
Hop-free beetle with reduced sensitivity to one or more compounds selected from group a4;
Hop-free beetle with reduced sensitivity to one or more compounds selected from group a17;
Curculionidae with reduced sensitivity to one or more compounds selected from group a2;
Curculionidae with reduced sensitivity to one or more compounds selected from group a4;
Curculionidae with reduced susceptibility to one or more compounds selected from group a2 and one or more compounds selected from group a4;
Lissorhoptrus chinensis with reduced sensitivity to one or more compounds selected from group a2;
Lissorhoptrus vulgaris with reduced sensitivity to one or more compounds selected from group a4;
Lissorhoptrus chinensis with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
Click beetles with reduced sensitivity to one or more compounds selected from group a2;
Click beetles with reduced sensitivity to one or more compounds selected from group a3;
Click beetles with reduced sensitivity to one or more compounds selected from group a4;
Click beetles with reduced sensitivity to one or more compounds selected from group a2;
Click beetles with reduced sensitivity to one or more compounds selected from group a3;
Click beetles with reduced sensitivity to one or more compounds selected from group a4;
Click beetles with reduced sensitivity to one or more compounds selected from group a2;
Click beetles with reduced sensitivity to one or more compounds selected from group a3;
Click beetles with reduced sensitivity to one or more compounds selected from group a4;
Melanotus vulgaris with reduced sensitivity to one or more compounds selected from group a2;
Melanotus vulgaris with reduced sensitivity to one or more compounds selected from group a3;
Melanotus vulgaris with reduced sensitivity to one or more compounds selected from group a4;
Click beetles with reduced sensitivity to one or more compounds selected from group a2;
Click beetles with reduced sensitivity to one or more compounds selected from group a3;
Click beetles with reduced sensitivity to one or more compounds selected from group a4;
The genus Conoderus with reduced sensitivity to one or more compounds selected from group a2;
The genus Conoderus with reduced sensitivity to one or more compounds selected from group a3;
The genus Conoderus with reduced sensitivity to one or more compounds selected from group a4;
The genus Ctenicera with reduced susceptibility to one or more compounds selected from group a2;
The genus Ctenicera with reduced susceptibility to one or more compounds selected from group a3;
The genus Ctenicera with reduced susceptibility to one or more compounds selected from group a4;
The genus Limonius with reduced sensitivity to one or more compounds selected from group a2;
The genus Limonius with reduced sensitivity to one or more compounds selected from group a3;
The genus Limonius with reduced sensitivity to one or more compounds selected from group a4;
Aeolus genus with reduced sensitivity to one or more compounds selected from group a2;
The genus Aeolus with reduced sensitivity to one or more compounds selected from group a3;
Aeolus genus with reduced sensitivity to one or more compounds selected from group a4;
Cabbage stem free beetle with reduced sensitivity to lambda sihalotrin;
Colorado potato beetle with reduced sensitivity to carbosulfane, carbofuran, phosalone, chlorpyrifos, azinephosmethyl, cyhalothrin, lambda sihalothrin, deltamethrin, permethrin, imidacloprid, dinotefuran, clothianidin, thiacloprid, thiamethoxam, and / or nitenpyram;
Phosalone, Lambda cypermethrin, cypermethrin, alpha cypermethrin, zeta cypermethrin, bifenthrin, beta-cypermethrin, deltamethrin, esfenvalerate, taufluvalinate, and / or acetamiprid-reduced blossom beetle;
Reduced susceptibility to one or more compounds selected from group a2;
Reduced susceptibility to one or more compounds selected from group a3;
Reduced susceptibility to one or more compounds selected from group a4;
Reduced susceptibility to one or more compounds selected from group a9;
Reduced sensitivity to one or more compounds selected from group a17;
One or more compounds selected from group a19, bifenthrin, abamectin, milbemectin, acequinosyl and / or reduced susceptibility to biphenacet;
Panonychus ulnaris with reduced susceptibility to fenpropatrin, spirodiclofen, clofentezine, hexitiazox, pyridaben, and / or fenpyroximate;
Bed bugs with reduced sensitivity to one or more compounds selected from group a1;
Bed bugs with reduced sensitivity to one or more compounds selected from group a2;
Bed bugs with reduced sensitivity to one or more compounds selected from group a3;
Bed bugs with reduced sensitivity to one or more compounds selected from group a4;
Bed bugs with reduced sensitivity to one or more compounds selected from group a5;
Bed bugs with reduced sensitivity to one or more compounds selected from group a10;
Bendiocarb, diazinon, dichlorbos, phenothrin, phenothrin, malathion, propoxil, dildoline, fipronil, allethrin, bifenthrin, cypermethrin, beta-cypermethrin, lambda cypermethrin, cypermethrin, alpha permethrin, deltamethrin, esphenvalerate Prox, permethrin, phenothrin, pyrethrin, tetramethrin, DDT, acetamiprid, dinotefuran, imidacloprid, thiamethoxam, spinosad, and / or chlorphenapill-reduced tocodylami;
Nettite bed bugs with reduced sensitivity to one or more compounds selected from group a1;
Nettite bed bugs with reduced sensitivity to one or more compounds selected from group a2;
Nettite bed bugs with reduced sensitivity to one or more compounds selected from group a3;
Nettite bed bugs with reduced sensitivity to one or more compounds selected from group a4;
Nettite bed bugs with reduced sensitivity to one or more compounds selected from group a10;
Bendiocarb, Diazinon, Fenitrothion, Phenocalve, Malathion, Propoxul, Dildoline, Fipronil, Allethrin, Bifenthrin, Cypermethrin, Lambda cypermethrin, Cypermethrin, Alphasipermethrin, Deltamethrin, Esfenvalerate, Etofenprox, Permethrin, DD Nettite codylami with reduced sensitivity to imidacloprid and / or chlorphenapir;
Houseflies with reduced sensitivity to one or more compounds selected from group a1;
Houseflies with reduced sensitivity to one or more compounds selected from group a2;
Houseflies with reduced sensitivity to one or more compounds selected from group a3;
Houseflies with reduced sensitivity to one or more compounds selected from group a4;
Houseflies with reduced sensitivity to one or more compounds selected from group a5;
Houseflies with reduced sensitivity to one or more compounds selected from group a6;
Houseflies with reduced sensitivity to one or more compounds selected from group a7;
Houseflies with reduced sensitivity to one or more compounds selected from group a11;
Houseflies with reduced sensitivity to one or more compounds selected from group a12;
Houseflies with reduced sensitivity to one or more compounds selected from group a13;
Houseflies with reduced sensitivity to one or more compounds selected from group a14;
Houseflies with reduced sensitivity to one or more compounds selected from group a15;
Azamethifos, Adinphosmethyl, Chlorpyrifos, Chlorpyrifosmethyl, Diazinon, Dichlorvos, Dimethrinto, Fenchlorphos, Fenitrothion, Metrifonate, , Bifenthrin, Cifluthrin, Beta-Siflutrin, Lambda Sihalosrin, Cipermethrin, Betasipermetrin, Ciphenothrin, Deltamethrin, Esfenvalerate, Phenothrin, Pyrethrin, Resmethrin, DDT, Acetamiprid, Dinotefuran, Imidacloprid Abamectin, emamectin benzoate, metoprene, pyriproxyfen, cartap, diflubenzron, ruphenuron, triflumuron, silomadin, methoxyphenothrin, and / or reduced sensitivity to indoxacarb;
Simulium damnosum with reduced sensitivity to one or more compounds selected from group a1;
Simulium damnosum with reduced sensitivity to one or more compounds selected from group a3;
Culex pipiens with reduced sensitivity to one or more compounds selected from group a2;
Culex pipiens with reduced sensitivity to one or more compounds selected from group a3;
Culex pipiens with reduced susceptibility to bifenthrin, beta-cyfluthrin, lambda cypermethrin, cypermethrin, deltamethrin, permethrin, and / or resmethrin;
Underground mosquitoes with reduced sensitivity to one or more compounds selected from group a3;
Underground mosquitoes with reduced susceptibility to deltamethrin, etofenprox, permethrin, and / or phenothrin;
Culex quinquefatus with reduced sensitivity to one or more compounds selected from group a1;
Culex quinquefatus with reduced sensitivity to one or more compounds selected from group a3;
Culex quinquefatus with reduced susceptibility to temefos, bifenthrin, beta-cyfluthrin, lambdasihalothrin, cypermethrin, deltamethrin, permethrin, and / or resmethrin;
Aedes aegypti with reduced sensitivity to one or more compounds selected from group a1;
Aedes aegypti with reduced sensitivity to one or more compounds selected from group a3;
Aedes aegypti with reduced sensitivity to one or more compounds selected from group a7;
Aedes aegypti with reduced sensitivity to one or more compounds selected from group a9;
Chlorpyriphos, dichlorvos, fenitrothion, fenitrothion, malathion, pyrimiphosmethyl, propoxur, temefos, allethrin, bifenthrin, cypermethrin, lambdasihalothrin, cypermethrin, alphasipermethrin, deltamethrin, etofenprox, permethrin, phenothrin, DT Desensitized Nettai Shimaka;
Aedes aegypti with reduced susceptibility to the delta-endotoxins Cry4A and Cry4B;
Anopheles gambiel with reduced sensitivity to one or more compounds selected from group a1;
Anopheles gambiel with reduced sensitivity to one or more compounds selected from group a2;
Anopheles gambiel with reduced sensitivity to one or more compounds selected from group a3;
Anopheles gambiel with reduced susceptibility to bendiocarb, fenitrothion, pyrimiphosmethyl, dildrin, lambdasihalothrin, deltamethrin, permethrin, and / or DDT;
Anopheles coluzzii with reduced sensitivity to one or more compounds selected from group a1;
Anopheles coluzzii with reduced sensitivity to one or more compounds selected from group a2;
Anopheles coluzzii with reduced sensitivity to one or more compounds selected from group a3;
Anopheles coluzzii;
Anopheles arabiensis with reduced sensitivity to one or more compounds selected from group a1;
Anopheles arabiensis with reduced sensitivity to one or more compounds selected from group a2;
Anopheles arabiensis with reduced sensitivity to one or more compounds selected from group a3;
Anopheles arabiensis;
Anopheles funestus with reduced sensitivity to one or more compounds selected from group a2;
Anopheles funestus with reduced sensitivity to one or more compounds selected from group a3;
Anopheles funestus;
Red flour beetle with reduced sensitivity to one or more compounds selected from group a1;
Red flour beetle with reduced sensitivity to one or more compounds selected from group a3;
Red flour beetle with reduced sensitivity to one or more compounds selected from group a5;
Red flour beetle with reduced sensitivity to one or more compounds selected from group a21;
Carbaryl, Chlorpyrifos, Chlorpyrifos Methyl, Cyanophos, Diazinon, Dichlorvos, Fenitrothion, Malathion, Hoxim, Pyrimiphosmethyl, Promecarb, Propoxul, Temephos, Tetrachlorbinphos, Bioresmethrin, Cyfluthrin, Sihalothrin, Cypermethrin, Deltamethrin, D. , Spinosad, and / or chlorpyrifos with reduced sensitivity to phosphin;
German cockroach with reduced sensitivity to one or more compounds selected from group a1;
German cockroach with reduced sensitivity to one or more compounds selected from group a2;
German cockroach with reduced sensitivity to one or more compounds selected from group a3;
German cockroach with reduced sensitivity to one or more compounds selected from group a4;
German cockroach with reduced sensitivity to one or more compounds selected from group a6;
Chlorpyrifos, malathion, propoxul, fipronil, beta-cyfluthrin, cypermethrin, deltamethrin, permethrin, pyrethrin, DDT, imidacloprid, and / or abamectin-reduced chabanegokiburi;
Cat fleas with reduced sensitivity to one or more compounds selected from group a1;
Cat fleas with reduced sensitivity to one or more compounds selected from group a2;
Cat fleas with reduced sensitivity to one or more compounds selected from group a3;
Cat fleas with reduced sensitivity to one or more compounds selected from group a4;
Cat fleas with reduced sensitivity to one or more compounds selected from group a5;
Reduced sensitivity to bendiocarb, carbaryl, chlorpyrifos, chlorpyrifos, diazinon, fenthion, isofenphos, propetumphos, propoxil, malathion, fipronil, cypermethrin, cypermethrin, fluvalinate, permethrin, pyrethrin, imidacloprid, and / or spinosad. Cat flea;
American dog tick with reduced sensitivity to one or more compounds selected from group a3;
American dog tick with reduced sensitivity to DDT;
Reduced sensitivity to one or more compounds selected from group a1;
Reduced sensitivity to one or more compounds selected from group a2;
Reduced sensitivity to one or more compounds selected from group a3;
Reduced sensitivity to one or more compounds selected from group a6;
Reduced sensitivity to one or more compounds selected from group a20;
Rhipicephalus vulgaris, chlorpyrifos, coumaphos, fipronil, pyriprol, cypermethrin, deltamethrin, flumethrin, permethrin, ivermectin, and / or amitraz;
A brown dog tick with reduced sensitivity to one or more compounds selected from group a1;
A brown dog tick with reduced sensitivity to one or more compounds selected from group a3;
A brown dog tick with reduced sensitivity to one or more compounds selected from group a20;
A brown dog tick that is less sensitive to permethrin and / or amitraz;

Examples of harmful arthropods, harmful mollusks and harmful nematodes whose susceptibility is reduced by amino acid substitution of the target protein include the following.
Aphis gossypii with an amino acid substitution of R81T in the β subunit of the nicotinic acetylcholine receptor;
Myzus persicae with an amino acid substitution of R81T in the β subunit of the nicotinic acetylcholine receptor;
Diamondback moth with amino acid substitution of G4946E on ryanodine receptor;
Diamondback moth with amino acid substitutions of F1845Y or V1848I on sodium channels;
Sedirounka with A2'N amino acid substitutions on GABAergic chlorine ion channels;
Aphis gossypii with amino acid substitutions of S431F and / or A302S in acetylcholinesterase;
Bemisia tabaci with amino acid substitutions of L925I and / or T929V on voltage-gated sodium channels; Myzus persicae with amino acid substitutions of S431F on acetylcholine esterase;
Myzus persica with amino acid substitutions of L1014F, M918T, and / or TL932F in voltage-gated sodium channels;
Myzus persica with amino acid substitutions of A302S and / or A302G in GABAergic chloride ion channels;
Western flower thrips with amino acid substitutions of L1014F and / or M918T in voltage-gated sodium channels;
Western flower thrips with an amino acid substitution of G275E on the α6 subunit of the nicotinic acetylcholine receptor;
Corn earworms with amino acid substitutions of L1029H, V421M, V421A, V421G and / or I951V in voltage-gated sodium channels;
Fake corn earworms with amino acid substitutions of L1029H, D1561V, E1565G, and / or V421M in voltage-gated sodium channels;
Colorado potato beetle with amino acid substitutions of R30K, S291G, and / or I392T for acetylcholinesterase;
Colorado potato beetle with L1014F amino acid substitution in voltage-gated sodium channels;
Sedirounka with S298P amino acid substitution in acetylcholinesterase type 1;
Nami spider mites having an amino acid substitution of G323D on the GluCl1 subunit of the glutamate receptor;
Nami spider mites having an amino acid substitution of G326E on the GluCl3 subunit of the glutamate receptor;
Welsh onion thrips with amino acid substitutions of M918T, M918L, T929I, V1010A, and / or L1014F in voltage-gated sodium channels;
Greenhouse whitefly with amino acid substitutions of L925I and / or T929I in voltage-gated sodium channels;
Tuta absoluta with amino acid substitutions on the ryanodine receptor G4903V, G4903E, I4746T, and / or I4746M;
Brown planthopper with amino acid substitution of A301S in GABAergic chloride ion channel;
Brown planthopper with amino acid substitution of Y151S at α1 and α3 subunits of nicotinic acetylcholine receptor;
European corn borer with L1014F amino acid substitution in voltage-gated sodium channels;
Panonychus ulnaris with an amino acid substitution of F1538I in voltage-gated sodium channels;
Cabbage stem free beetle with L1014F amino acid substitution in voltage-gated sodium channels;
English grain aid with L1014F amino acid substitution in voltage-gated sodium channels;
Diamondback moth with amino acid substitutions for A282S, A282G, and / or A302S in GABAergic chloride channels;
Diamondback moth with M918I, T929I, and / or L1014F amino acid substitutions on voltage-gated sodium channels;
Bed bugs with amino acid substitutions of V419L, L925I, and / or I936F in the α subunit of voltage-gated sodium channels;
Houseflies with amino acid substitutions of V180L, V260L, G262A, G262V, G342A, G342V, G365A, F327Y, F407Y, and / or G445A on acetylcholinesterase;
Houseflies with amino acid substitutions of M918T, L1014F and / or L1014H in the α subunit of voltage-gated sodium channels;
Housefly with amino acid substitution of A302S in GABAergic chloride ion channel;
Culex pipiens with amino acid substitutions of L1014F and / or L1014S in voltage-gated sodium channels;
Culex pipiens with amino acid substitution of A302S in GABAergic chloride ion channel;
Underground mosquitoes with amino acid substitutions of L1014F and / or L1014S in voltage-gated sodium channels;
Culex quinquefa with amino acid substitutions of L1014F and / or L1014S in voltage-gated sodium channels;
Culex quinquefa with G119S amino acid substitution in acetylcholinesterase;
Aedes aegypti with amino acid substitutions of V410L, G923V, L982W, S989P, I1011M, I1011V, V1016I, V1016G, T1520I, F1534C, and / or D1763Y in voltage-gated sodium channels;
Anopheles gambie with amino acid substitutions of L1014S and / or N1575Y in voltage-gated sodium channels;
Anopheles gambie with amino acid substitution of G119S for acetylcholinesterase;
Anopheles coluzzii with L1014F and / or N1575Y amino acid substitutions on voltage-gated sodium channels;
Anopheles arabiensis with L1014F amino acid substitutions on voltage-gated sodium channels;
Anopheles funestus with amino acid substitutions of A296S, V327I in GABAergic chloride ion channels;
Red flour beetle with amino acid substitution of A302S in GABAergic chloride ion channel;
German cockroaches with amino acid substitutions of D58G, E434K, C764R, L933F, and / or P1880L in voltage-gated sodium channels;
German cockroach with amino acid substitution of A302S in GABAergic chloride ion channel;
Cat fleas with amino acid substitutions of T929V and / or L1014F in voltage-gated sodium channels;
Cat fleas with A302S amino acid substitutions on GABAergic chloride ion channels;
Rhipicephalus has an amino acid substitution of C190A and / or F1550I in voltage-gated sodium channels.

Examples of harmful arthropods such as harmful insects, harmful mites, harmful mollusks and harmful nematodes whose susceptibility is reduced due to a decrease in the target protein include the following.
Houseflies with reduced expression of the α2 subunit of the nicotinic acetylcholine receptor.

Factors for increasing the activity of the metabolic enzyme include, for example, overexpression of the metabolic enzyme gene (also referred to as quantitative variation) and improvement of affinity with the drug by amino acid substitution of the metabolic enzyme (also referred to as qualitative variation). It may have one or more factors for increasing the activity of these metabolic enzymes.

Examples of harmful arthropods such as harmful insects, harmful mites, harmful soft animals and harmful nematodes whose activity of the metabolic enzyme is increased due to overexpression of the metabolic enzyme gene include the following.
Brown planthopper overexpressing CYP6ER1 (a type of cytochrome P450 gene);
Amrasca biguttula biguttula overexpressing the glutathione-S-transferase gene;
Aphis gossypii overexpressing the cytochrome P450 monooxygenase gene;
Tobacco whitefly overexpressing CYP6CM1 (a type of cytochrome P450-dependent monooxygenase gene);
Tobacco whitefly overexpressing cytochrome P450-dependent monoxygenase gene;
Chilo suppressalis overexpressing the carboxylesterase gene and / or the microsomal-O-demethylase gene;
Codling moss overexpressing the glutathion-S-transferase gene and / or the cytochrome P450 monooxygenase gene;
Sugar cane bowler with reduced expression of 3 aminopeptidases N genes (DsAPN1, DsAPN2, and DsAPN3) and / or DsCAD1 (one of the cadherin genes);
Agromyzidae overexpressing the cytochrome P450 gene;
Blossom beetle overexpressing cytochrome P450 gene;
Myzus persicae overexpressing CYP6CY3 (a type of cytochrome P450 gene);
Myzus persicae overexpressing the E4 gene, a type of carboxylesterases, and / or the FE4 gene, a type of carboxylesterases;
Lettuce aphid overexpressing the esterase gene;
Lettuce aphid overexpressing the glutathione S-transferases gene;
Brown stink bug with overexpressed esterase gene;
A brown tinku bug in which the gene for EST-2, a cholinesterase, and / or the gene for EST-4, a cholinesterase, is overexpressed;
Western flower thrips overexpressing the esterase gene;
Western flower thrips overexpressing the cytochrome P450 monooxygenase gene;
Western flower thrips overexpressing the glutathione S-transferases gene;
Helicoverpa armigera expressing CYP337B3 (a type of cytochrome P450 gene);
Helicoverpa armigera overexpressing the cytochrome P450 monooxygenases gene;
Helicoverpa armigera overexpressing the glutathione S-transferases gene;
Helicoverpa armigera overexpressing the esterase gene;
Fake corn earworm overexpressing glutathione-S-transferase gene;
Fake corn earworm overexpressing the esterase gene;
Fake corn earworm overexpressing cytochrome P450 gene;
Colorado potato beetle overexpressing the glutathione-S-transferase gene;
Colorado potato beetle overexpressing the esterase gene;
Colorado potato beetle overexpressing cytochrome P450 gene;
Nami spider mite overexpressing TuGSTd14 (a type of glutathione-S-transferase gene);
Greenhouse whitefly overexpressing CYP6CM1 (a type of cytochrome P450 gene);
Red flour beetle overexpressing cytochrome P450 gene;
Brown planthopper with reduced expression of CYP6AY1 (a type of cytochrome P450 gene);
Brown planthopper overexpressing the carboxylesterases gene;
Brown planthopper overexpressing the gene for Nl-EST1, a type of carboxylesterases;
Brown planthopper overexpressing CYP6ER1, CYP6AY1, and / or CYP6FU1 (a type of cytochrome P450 gene);
European corn bowler overexpressing cytochrome P450 monooxygenase gene;
European corn bowler overexpressing the glutathion-S-transferase gene;
An apple spider mite overexpressing the cytochrome P450-dependent monoxygenase gene;
Cabbage stem free beetle overexpressing cytochrome P450 gene;
Bed bugs overexpressing CYP397A1, CYP398A1, CYP6DN1, CYP4CM1, and / or CYP400A1 (all of which are cytochrome P450 genes);
Bed bugs overexpressing CE3959 and / or CE21331 (both are one of the carboxylesterases genes);
Bed bugs overexpressing S1 (a type of glutathione-S-transferase gene);
Housefly overexpressing CYP6A1, CYP6A5v1, CYP6A5v2, CYP6A36, CYP6A40, CYP6D1, CYP6D1v1, CYP6D3, CYP6D8, CYP6G2, and / or CYP6G4 (all of which are cytochrome P450 genes);
Culex quinquefatus overexpressing CYP9M10, CYP6AA7 and / or CYP4H34 (both are cytochrome P450 genes);
Aedes aegypti overexpressing the esterase gene;
Aedes aegypti overexpressing the glutathione-S-transferase gene;
Aedes aegypti overexpressing CYP4D24, CYP6BB2, CYP6F3, CYP6M11, CYP6N12, and / or CYP9M6 (all of which are cytochrome P450 genes);
Aedes aegypti overexpressing the carboxylesterase gene;
Anopheles gambiensis overexpressing CYP4P16, CYP4P17, CYP6P3, CYP6Z1, CYP12F1 and / or CYP325A3 (all of which are cytochrome P450 genes);
Anopheles gambiensis overexpressing GSTE2 (a type of glutathione-S-transferase gene);
Anopheles gambiensis overexpressing PX13A and / or PX13B (both are one of the peroxidase genes);
Anopheles gambiensis overexpressing the esterase gene;
Anopheles arabiensis overexpressing CYP6P4 (a type of cytochrome P450 gene);
Anopheles arabiensis overexpressing the carboxylesterase gene;
Anopheles arabiensis overexpressing the beta-esterases gene;
Anopheles funestus overexpressing CYP6P4 and / or CYP6P9 (both are cytochrome P450 genes);
Red flour beetle overexpressing CYP6BQ9 (a type of cytochrome P450 gene);
Red flour beetle overexpressing glutathione-S-transferase gene;
Red flour beetle overexpressing Epsilon (a type of glutathione-S-transferase gene);
German cockroach overexpressing CYP4G19 (a type of cytochrome P450 gene).

Examples of harmful arthropods such as harmful insects, harmful mites, harmful mollusks and harmful nematodes whose activity of the metabolic enzyme is increased by improving the affinity with the drug by substituting the amino acid of the metabolic enzyme include the following. ..
Brown planthopper with CYP6ER1vA (a variant of CYP6ER1) with amino acid substitutions for T318S, A375Δ and A376G;
Brown planthopper with CYP6ER1vB (a variant of CYP6ER1) with amino acid substitutions of T318S and A377Δ;
Housefly with carboxyesterase with amino acid substitutions of W251L and / or W251S;
Red flour beetle with dihydrolipoamide dehydrogenase with amino acid substitutions of P45S and / or G131S.

As harmful arthropods such as harmful insects, harmful mites, harmful mollusks and harmful nematodes having multiple factors for increasing the activity of metabolic enzymes, for example, by having CYP6ER1vA and CYP6ER1vB in addition to overexpression of CYP6ER1. Examples include brown planthoppers, which are less sensitive to imidacloprid.

Examples of the harmful insects, harmful arthropods such as harmful mites, harmful mollusks and harmful nematodes whose susceptibility is reduced due to the decrease in skin permeability include the following.
Helicoverpa armigera with reduced sensitivity to pyrethroids (eg, cypermethrin, esfenvalerate, etc.) due to reduced cuticular penetration of the drug;
Bed bugs with reduced susceptibility to pyrethroids (such as beta-cyfluthrin) due to overexpression of C2, C10, and / or C13 (all of which are presumed epidermal protein genes).

Examples of harmful arthropods, harmful mollusks and harmful nematodes whose susceptibility has decreased due to the enhancement of the excretion function by the membrane transporter include the following.
Bed bugs overexpressing the ABC transporter genes Abc8, Abc9, Abc10 and / or Abc11.

The compound and composition A can also be used to protect plants from plant diseases caused by insect-borne viruses or insect-borne bacteria.

Examples of insect-borne viruses include the following.
Rice tungro spherical virus, Rice tungro bacilliform virus, Rice grassy stunt virus, Rice ragged stunt virus, Rice striped leaf blight virus (Rice ragged stunt virus) Rice stripe virus, Rice black streaked dwarf virus, Southern rice black-streaked dwarf virus, Rice gall dwarf virus, Rice hoja blanca virus, Rice yellow stunt virus, Rice yellow mottle virus, Rice dwarf virus, Northern cereal mosaic virus, Barley yellow dwarf virus , Barley mild mosaic virus, Barley yellow dwarf virus-PAV, Cereal yellow dwarf virus-RPS, Wheat yellow leaf virus , Oat sterile dwarf virus, Wheat streak mosaic virus, Maize dwarf mosaic virus, Maize stripe virus, Maize chlorotic mottle virus, Maize chlorotic dwarf virus, Maize rayado fino virus, Sugarcane mosaic virus, Fiji disease virus, Sugarcane yellow leaf virus, Soybean mild mosaic virus , Sotetsu necrotic stunt virus, Soybean dwarf virus, Milk vetch dwarf virus, Soybean mosaic virus, Alfalfa mosaic virus , Bean yellow mosaic virus, Bean common mosaic virus, Southern bean mosaic virus, Peanut stunt virus, Broad bean wilt virus 1), soramame wilt virus 2 (Broad bean wilt virus 2), soramame eso mosaic virus (Broad bean necrosis virus), soramame leaf vein yellowing virus (Broad bean yellow vein virus), clover leaf vein yellowing virus ( Clover yellow vein virus), Peanut mottle virus, Tobacco streak virus, Bean pod mottle virus, Cowpea chlorotic mottle virus, Mung bean yellow mosaic virus, Soybean crinkle leaf virus, tomato bleaching virus (Tomato chlorosis virus), Tomato spotted wilt virus, Tomato yellow leaf curl virus, Tomato aspermy virus, Tomato infectious chlorosis virus (Tomato) infectious chlorosis virus, potato leafroll virus, potato virus Y, melon yellowing virus (Mel) on yellow spot virus, Melon necrotic spot virus, Watermelon mosaic virus, Cucumber mosaic virus, Zucchini yellow mosaic virus, Cub mosaic virus (Turnip mosaic virus), Turnip yellow mosaic virus, Cauliflower mosaic virus, Lettuce mosaic virus, Celery mosaic virus, Beet mosaic virus, Cucurbit chlorotic yellows virus, Capsicum chlorosis virus, Beet pseudo yellows virus, Leak yellow stripe virus ), Onion yellow dwarf virus, Sweet potato feathery mottle virus, Sweet potato shukuyo mosaic virus, Strawberry mottle virus, Strawberry mild yellow edge Virus (Strawberry mild yellow edge virus), Strawberry pseudo mild yellow edge virus, Strawberry crinkle virus, Strawberry vein banding virus, Ume ring pattern virus (Strawberry vein banding virus) plum pox virus), Chrysanthemum stem necrosis vir us), Impatiens necrotic spot virus, Iris yellow spot virus, Lily mottle virus, Lily symptomless virus, Tulip mosaic virus virus) etc.

Examples of insect-borne bacteria include the following.
Rice phytoplasma (Candidatus Phytoplasma oryzae), Candidatus Phytoplasma asteris, Maize bushy stunt phytoplasma, Candidatus Liberbacter asiaticus, Candidatus Liberbacter asiaticus, Candidatus Liberbacter africanus Type (Candidatus Liberbacter americanus), Phytoplasma (Xylella fastidiosa), etc.

The compound and the composition A also have an feeding damage suppressing effect, a repellent effect, an egg laying suppressing effect, an infertility effect, a next-generation production suppressing effect, a mating behavior inhibiting effect, a molting inhibiting effect, and an emergence inhibiting effect. As a result, crops can be protected from damage caused by harmful arthropods such as harmful insects and mites, harmful mollusks, harmful nematodes and harmful protozoans.

When the composition A contains one or more components having bactericidal activity selected from the group (b) and the group (j) as the main component, fungi, oomycete, and Phytomyxea ), Plant diseases caused by phytopathogenic microorganisms such as bacteria can be controlled. Fungi include, for example, Ascomycota, Basidiomycota, Blasocladiomycota, Chytridiomycota, Mucoromycota and Oldiomycota. Specifically, for example, the following may be mentioned. The numbers in parentheses indicate the scientific names of the phytopathogenic microorganisms that cause each disease.

Rice diseases: blast (Pyricularia oryzae), sesame leaf blight (Cochliobolus miyabeanus), blight (Rhizoctonia solani), bakanae (Gibberella fujikuroi), yellowing dwarf disease (Sclerophthora macrospora), rhizoctonia and Epicoccum nigrum, Trichoderma viride, Rhizopus oryzae, Pseudo-spot blight (Waitea circinata), Ceratobasidium setariae, Thanatephorus cucumeris));
Wheat diseases: Udonko disease (Blumeria graminis), Fusarium head blight (Fusarium graminearum, Fusarium avenaceum, Fusarium culmorum, Microdochium nivale), Yellow rust (Puccinia striiformis), Fusarium head blight (Puccinia graminis), Fusarium head blight (Puccinia graminis) ), Fusarium head blight (Microdochium nivale, Microdochium majus), Typhula incarnata, Typhula ishikariensis, Ustilago tritici, Tilletia caries, Tilletia controversa (Pseudocercosporella herpotrichoides), leaf blight (Septoria tritici), Fusarium (Stagonospora nodorum), yellow spot (Pyrenophora tritici-repentis), seedling blight (Rhizoctonia solani), blight (Gaeumannomyces graminis) , Pyricularia graminis-tritici;
Diseases of barley: Blumeria graminis, Fusarium graminearum, Fusarium avenaceum, Fusarium culmorum, Microdochium nivale, Puccinia striiformis, Puccinia graminis, Puccinia graminis hordei), bare scab (Ustilago nuda), cloud disease (Rhynchosporium secalis), net spot disease (Pyrenophora teres), spot disease (Cochliobolus sativus), foliar disease (Pyrenophora graminea), Ramularia collo-cygni ), Rhizoctonia solani;
Corn diseases: rust (Puccinia sorghi), southern rust (Puccinia polysora), soot scab (Setosphaeria turcica), tropical rust (Physopella zeae), sesame leaf blight (Cochliobolus heterostrophus), charcoal hum graminicola ), Gray leaf spot disease (Cercospora zeae-maydis), Brown spot disease (Kabatiella zeae), Faeosphaeria maydis, Diplodia disease (Stenocarpella maydis, Stenocarpella macrospora), Stokelot disease (Fusarium graminearum,) Fusarium verticilioides, Colletotrichum graminicola), Black ear disease (Ustilago maydis), Physoderma maydis, tar spot disease (Phyllachora maydis);
Diseases of cotton: anthrax (Colletotrichum gossypii), mildew (Ramularia areola), black spot disease (Alternaria macrospora, Alternaria gossypii), Black root rot disease (Thielaviopsis basicola);
Coffee diseases: rust (Hemileia vastatrix), leaf spot disease (Cercospora coffeicola);
Diseases of rapeseed: sclerotinia sclerotiorum, Alternaria brassicae, Phoma lingam, light leaf spot disease (Pyrenopeziza brassicae);
Diseases of sugar cane: Rust (Puccinia melanocephela, Puccinia kuehnii), Ustilago scitaminea;
Sunflower disease: rust (Puccinia helianthi), downy mildew (Plasmopara halstedii);
Phytophthora diseases: black spot disease (Diaporthe citri), scab (Elsinoe fawcetti), green mold (Penicillium digitatum), blue mold (Penicillium italicum), plague (Phytophthora parasitica, Phytophthora citrophthora), aspergillus (Aspergillus) ;
Apple diseases: Monilinia mali, Valsa ceratosperma, Podosphaera leucotricha, Alternaria alternata apple pathotype, Venturia inaequalis, Glomerella ul acutatum), brown spot disease (Diplocarpon mali), ring-spot disease (Botryosphaeria berengeriana), plague (Phytophtora cactorum), gymnosporangium (Gymnosporangium juniperi-virginianae, Gymnosporangium yamadae);
Pear diseases: Black spot disease (Venturia nashicola, Venturia pirina), Black spot disease (Alternaria alternata Japanese pear pathotype), Gymnosporangium haraeanum;
Diseases of peach: Monilinia fructicola, Cladosporium carpophilum, Phomopsis sp., Taphrina deformans;
Grape diseases: black rot (Elsinoe ampelina), late rot (Glomerella cingulata, Colletotrichum acutatum), powdery mildew (Uncinula necator), rust (Phakopsora ampelopsidis), black rot (Guignardia bidwellii), downy mildew (Guignardia bidwellii) Plasmopara viticola);
Diseases of oysters: anthrax (Gloeosporium kaki, Colletotrichum acutatum), leaf litter (Cercospora kaki, Mycosphaerella nawae);
Fig Disease: Rust (Phakopsora nishidana);
Diseases of uris: Colletotrichum lagenarium, Sphaerotheca fuliginea, Didymella bryoniae, Corynespora cassiicola, Fusarium oxysporum, Downy mildew (Pseudoperonospora) ), Epidemic (Phytophthora capsici), Didymella baldness (Pythium sp.);
Diseases of tomatoes: Alternaria solani, Cladosporium fulvum, Pseudocercospora fuligena, Phytophthora infestans, Powdery mildew;
Eggplant disease: brown spot disease (Phomopsis vexans), powdery mildew (Erysiphe cichoracearum);
Diseases of Brassicaceae vegetables: black spot (Alternaria japonica), white spot (Cercosporella brassicae), root-knot disease (Plasmodiophora brassicae), downy mildew (Peronospora parasitica), white rust (Albugo candida);
Welsh onion disease: rust (Puccinia allii);
Diseases of soybeans: purpura kikuchii, Elsinoe glycines, Diaporthe phaseolorum var. Sojae, Phakopsora pachyrhizi, Corynespora cassiicola, Colletotrichum , Colletotrichum truncatum), leaf rot (Rhizoctonia solani), brown spot disease (Septoria glycines), spot disease (Cercospora sojina), mycorrhizal disease (Sclerotinia sclerotiorum), udon disease (Microsphaera diffusa), stem plague (Phytophthora sojae) , Sticky disease (Peronospora manshurica), Sudden death (Fusarium virguliforme), Black root rot (Calonectria ilicicola), Diaporthe / Phomopsis complex (Diaporthe longicolla);
Common bean diseases: Sclerotinia sclerotiorum, Uromyces appendiculatus, Phaeoisariopsis griseola, Colletotrichum lindemuthianum, Fusarium solani;
Diseases of peanuts: black astringent disease (Cercospora personata), brown spot disease (Cercospora arachidicola), white silk disease (Sclerotium rolfsii), black root rot (Calonectria ilicicola);
Pea diseases: powdery mildew (Erysiphe pisi), root rot (Fusarium solani);
Potato diseases: summer plague (Alternaria solani), plague (Phytophthora infestans), scarlet rot (Phytophthora erythroseptica), powdery scab (Spongospora subterranea f. Sp. Subterranea), verticillium albo- dahliae, Verticillium nigrescens), dry rot (Fusarium solani), cancerous disease (Synchytrium endobioticum);
Strawberry disease: powdery mildew (Sphaerotheca humuli);
Diseases of tea: Exobasidium reticulatum, Elsinoe leucospila, Pestalotiopsis sp., Colletotrichum theae-sinensis;
Tobacco diseases: Gymnosporangium (Alternaria longipes), anthrax (Colletotrichum tabacum), downy mildew (Peronospora tabacina), plague (Phytophthora nicotianae);
Diseases of sugar beet: brown spot disease (Cercospora beticola), leaf rot (Thanatephorus cucumeris), root rot (Thanatephorus cucumeris), black root disease (Aphanomyces cochlioides), rust (Uromyces betae);
Rose disease: scab (Diplocarpon rosae), powdery mildew (Sphaerotheca pannosa);
Chrysanthemum disease: brown spot disease (Septoria chrysanthemi-indici), white rust disease (Puccinia horiana);
Onion diseases: Botrytis cinerea, Botrytis byssoidea, Botrytis cinerea, Botrytis allii, Botrytis cinerea;
Diseases of various crops: Botrytis cinerea, Sclerotinia sclerotiorum, Sclerotinia sclerotiorum, Pythium aphanidermatum, Pythium irregulare, Pythium ultimum;
Radish disease: Black spot disease (Alternaria brassicicola);
Diseases of Shiva: Dollarspot disease (Sclerotinia homoeocarpa), Brown patch disease, Large patch disease (Rhizoctonia solani), Red burn disease (Pythium aphanidermatum);
Banana disease: Black sigatoka (Mycosphaerella fijiensis, Mycosphaerella musicola);
Diseases of lentils: Ascochyta disease (Ascochyta lentis);
Chickpea disease: Ascochyta disease (Ascochyta rabiei);
Pepper disease: Anthrax (Colletotrichum scovillei);
Mango disease: anthrax (Colletotrichum acutatum);
Diseases of fruit trees: Rosellinia necatrix, Helicobasidium mompa;
Diseases of fruits such as apples and pears after harvest: Mucor piriformis;
Seed or early growth diseases caused by Aspergillus, Penicillium, Fusarium, Gibberella, Tricoderma, Thielaviopsis, Rhizopus, Mucor, Corticium, Phoma, Rhizoctonia, Diplodia, etc.;
Viral diseases: Big vane disease of lettuce transmitted by Olpidium brassicae, viral diseases of various crops transmitted by the genus Polymyxa (eg Polymyxa betae and Polymyxa graminis);
Diseases caused by bacteria: Bacterial disease of seedlings of rice (Burkholderia plantarii), browning of rice seedlings (Pantoea ananatis), bacterial leaf blight of rice (Xanthomonas oryzae pv. Oryzae.), Spot bacterial disease of cucumber (Pseudomonas syringae pv. Lachrymans), Ralstonia solanacearum, Xanthomonas citri, Erwinia carotovora, Streptomyces scabiei, corn Goss's wilt Diseases (Clavibacter michiganensis), Xylella fastidiosa such as grapes, olives and peaches, and root cancer of rose family plants such as apples, peaches and cherries (Agrobacterium tumefaciens).

Intraspecies mutations of the above phytopathogenic microorganisms are not particularly limited. That is, those having reduced sensitivity (also referred to as showing resistance) to a specific fungicide are also included. The decrease in susceptibility may be due to a mutation at the target site (point mutation) or a factor other than the point mutation (non-point mutation). Regarding point mutations, mutations in the open reading frame of the protein that correspond to the amino acid sequence of the protein result in amino acid substitutions in the protein at the target site, deletion of the suppressor sequence in the promoter region, or enhancers. It includes those in which the protein at the target site is overexpressed due to mutations such as sequence amplification and increase in the number of gene copies. Examples of the non-point mutation include an enhancement of the excretion function of the bactericidal agent that has flowed into the cell to the outside of the cell by an ABC transporter, an MFS transporter, or the like. In addition, detoxification by metabolism of fungicides can be mentioned.

The specific fungicides described above include, for example, nucleic acid synthesis inhibitors (eg, phenylamide fungicides, acyl amino acid fungicides, DNA topoisomerase type II fungicides), filamentous division and cell division inhibitors (eg, for example. MBC fungicides, N-phenylcarbamate fungicides), respiratory inhibitors (eg, QoI fungicides, QiI fungicides, SDHI fungicides), amino acid synthesis and protein synthesis inhibitors (eg, anilinopyrimidine-based fungicides), Signal transmission inhibitors (eg, phenylpyrrole fungicides, dicarboxyimide fungicides), lipid synthesis and cell membrane synthesis inhibitors (eg, phosphorothiolate fungicides, dithiorane fungicides, aromatic hydrocarbon fungicides, etc. Complex aromatic fungicides, carbamate fungicides, sterol biosynthesis inhibitors (eg, triazole-based DMI fungicides, hydroxyanilide fungicides, aminopyrazolinone fungicides), cell wall synthesis inhibitors (eg, triazole-based fungicides) , Polyoxine fungicides, carboxylic acid amide fungicides), melanin synthesis inhibitors (eg, MBI-R fungicides, MBI-D fungicides, MBI-P fungicides), and other fungicides (eg, cyanoacetamide). Oxym-based bactericides, phenylacetamide-based bactericides) can be mentioned.

Examples of the amino acid substitution at the target site include the following. Also, although each amino acid substitution is shown in a typical organism, the position of the protein from the N-terminal side may differ depending on the individual organism. Each amino acid substitution shown below includes an orthodox amino acid substitution in an individual organism.
Cytochrome b: G143A, F129L, G137R, A126T, Y132C, C133Y, G137V, G137A, G137S, M139V, T145F, T145R, T145S, T145C, T145L, T145Y, I147V, T148M, T148V, T148L, T148I, T148T, N , N256I, N256S, E272D, E272G, E272Q, W273L, W273F, Y274S, Y274F, L275F, L275S, L275T, F278L, Y279C, Y279S, L295F, M295L, M295V, L299F, I17F, S20L / T, Q22E / T, I26 , W30C, N31K, G33A, S34L, S35I, G37C / D / S / V / A, L198F, L201S, E203-DE-V204, M221Q / E, F225S / L, K228M / I / P, or G232D;
Cyp51 protein to A311G, A379G, A381G, A410T, A61V, D107V, D134G, D282E, D411N, E297K, F120L, F219S, F449S, F489L, F495I, G138C / R / S, G312A, G412A, G432S, G434C, G448S / Δ, G462A, G464S, G484S, G510C, G54E / K / R / V / W, G54W, H147Y, H303Y, H399P, I145F, I330T, I381V / Δ, I471T, I475T, K142R, K143E, K147Q, K175N, K197N , L50S, L98H, M145L, M220K / I / T / V, M288L, N125I, N178S, N22D, N284H, N513K, P216L, P384S, P394L, Q141H, Q88H, R467K, S188N, S208T, S297T, S405F, S508T, S509T , S524T, S52T, S79T, T289A, T440A, T454P, T469S, V101F, V136A / C / G, V490L, Y121F, V130A, Y131F / H, Y132F / H / N, Y134F, Y134F, Y136F, Y137F, Y140F / H , Y145F, Y431C, Y459C / D / N / S / P / Δ, Y461D / H / S / G / L / N / Δ, Y463D / H / N, Y491H, S259F, G476S or Y68N;
β-tubulin: H6L / Y, Y50C / N / S, Q134K, A165V, E198A / D / G / K / L / Q / V, F200Y, M257L, F167Y, Q73R, L240F, Q8L, C165Y, M233I, C239S , I258V or T351I;
SdhB: H277R / Y, P225H / F / L / T, N230I, H272L / R / V / Y, H278Y / R, H249L / N / Y, H273Y, N225I / T, T268I / A, I269V, H242R, H257L, N224T or T253I;
SdhC: H134R, P80H / L, A85V, S73P, T90I, I86F, N88S, H154Y / R, K49E, R64K, N75S, G79R, S135R, N87S, H153R, H146R, I29V, N33T, N34T, T79I / N, W80S, A84V, N86K / S / A, G90R, R151T / S, H152R, I161S, G169D, G171D, H151R, I87F or I88F;
SdhD: H133R, H132R, S89P, G109V, D124E / N, H134R, G138V, D145G, I50F, M114V or D129E;
OS-1 (Shk1): E753K, G420D, I365N / R / S, V368F, Q369H / P, N373S, T447S, F267L, L290S, T765R, Q777R, T489I, E599K or G736Y;
ERG27: S9G, F26S, P57A, T63I, G170R, V192I, L195F, N196T, A210G, I232M, P238S / Δ, P250S, P269L, P298Δ, V309M, A314V, S336C, V365A, E368D, N369D, E375K, A378T, L400 S, Y408S, F412I / S / V / C, A461S or R496T;
RPA190: F382Y, P980S or V1476G;
ORP1: L733W, G700V, S768I / F / K / Y, G769W, G770A / I / P / V / L, G818 / F819Δ, N837I / F / Y / Δ, G839W, P861H, L863W / F or I877F / Y;
CesA3: Q1077K, G1105S / V / W / A or V1109L / M

In addition, the following are examples of phytopathogenic microorganisms and their host plants whose susceptibility to fungicides has decreased due to overexpression of the Cyp51 gene. Wheat Septoria tritici (Reference: Pest Management Science. 2012. 68 (7) .1034-1040), Barley Rhynchosporium secalis (Reference: Molecular Bilogy and Evolution. 2014. 31 (7) .1793-1802) Phakopsora pachyrhizi (reference: Pest Management Science. 2014. 70 (3) .378-388), Venturia inaequalis of apple (reference: Phytopathology. 2016. 106 (6) .562-571), Penicillium digitatum of wheat (reference) References: Applied and Environmental Microbiology. 2000. 66 (8) .3421-3426).

The phytopathogenic microorganisms that can be controlled by the composition A containing the present compound and one or more components having bactericidal activity selected from the group (b) and the group (j) as the main component are subjected to the above amino acid substitution. You may have more than one. In this case, the plurality of amino acid substitutions may be the same protein or different proteins. Further, it may have a plurality of non-point mutations and point mutations. For example, phytopathogenic microorganisms that cause amino acid substitutions of G143A, F129L and G137R in chitochrome b; phytopathogenic microorganisms having an amino acid substitution of G143A in chitochrome b and an amino acid substitution of A311G in Cyp51; G143A and in chitochrome b. A phytopathogenic microorganism having an amino acid substitution of F129L and an amino acid substitution of A311G in Cyp51; an amino acid substitution of G143A and F129L in chitochrome b and an amino acid substitution of H6L / Y in β-tubulin. Further, there are phytopathogenic microorganisms in which the Cyp51 gene is overexpressed.

Examples of phytopathogenic microorganisms having a point mutation include the following.
Alternaria alternata with an amino acid substitution of G143A in cytochrome b;
Alternaria arborescens with an amino acid substitution of G143A in cytochrome b;
Alternaria solani with an amino acid substitution of F129L in cytochrome b;
Alternaria tomato with an amino acid substitution of G143A in cytochrome b;
Botryotinia fuckeliana with G143A amino acid substitution in cytochrome b;
Glomerella graminicola with an amino acid substitution of G143A in cytochrome b;
Corynespora cassiicola with an amino acid substitution of G143A in cytochrome b;
Cercospora beticola with an amino acid substitution of G143A in cytochrome b;
Cercospora sojina with an amino acid substitution of G143A in cytochrome b;
Cladosporium carpophilum with an amino acid substitution of G143A in cytochrome b;
Cladosporium fulvum with an amino acid substitution of F129L in cytochrome b;
Colletotrichum graminicola with an amino acid substitution of G143A in cytochrome b;
Glomerella cingulata with an amino acid substitution of G143A in cytochrome b;
Blumeria graminis f. Sp. Hordei with a G143A amino acid substitution in cytochrome b;
Blumeria graminis f. Sp. Tritici with a G143A amino acid substitution in cytochrome b;
Parastagonospora nodorum with G143A amino acid substitution in cytochrome b;
Monographella nivalis with an amino acid substitution of G143A in cytochrome b;
Microdochium majus, nivale with an amino acid substitution of G143A in cytochrome b;
Mycosphaerella fijiensis with an amino acid substitution of G143A in cytochrome b;
Didymella rabiei with an amino acid substitution of G143A in cytochrome b;
Phakopsora pachyrhizi with an amino acid substitution of F129L in cytochrome b;
Plasmopara viticola with an amino acid substitution of F129L or G143A in cytochrome b;
Pleospora allii with an amino acid substitution of G143A in cytochrome b;
Podosphaera fusca with an amino acid substitution of G143A in cytochrome b;
Podosphaera xanthii with an amino acid substitution of G143A in cytochrome b;
Pseudoperonospora cubensis with G143A amino acid substitution in cytochrome b;
Magnaporthe oryzae with an amino acid substitution of F129L or G143A in cytochrome b;
Pyrenophora teres with an amino acid substitution of F129L in cytochrome b;
Pyrenophora tritici-repentis with amino acid substitutions of F129L, G137R or G143A in cytochrome b;
Pythium aphanidermatum with an amino acid substitution of F129L in cytochrome b;
Thanatephorus cucumeris with an amino acid substitution of F129L or G143A in cytochrome b;
Ramularia collo-cygni with an amino acid substitution of G143A in cytochrome b;
Rhynchosporium secalis with an amino acid substitution of G143A in cytochrome b;
Rhizoctonia solani with an amino acid substitution of F129L in cytochrome b;
Zymoseptoria tritici with an amino acid substitution of F129L, G137R or G143A in cytochrome b;
Erysiphe necator with G143A amino acid substitution in cytochrome b;
Venturia inaequalis with an amino acid substitution of G143A in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of I147V in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of L275F in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of Y279C in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of Y279S in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of M295L in cytochrome b;
Puccinia horiana with N256S amino acid substitution in cytochrome b;
Puccinia horiana with an amino acid substitution of L299F in cytochrome b;
Fungi and oomycota with an amino acid substitution of L299F in cytochrome b;
Fungi and oomycota with an amino acid substitution of A126T in cytochrome b;
Fungi and oomycota with a Y132C amino acid substitution in cytochrome b;
Fungi and oomycota with a C133Y amino acid substitution in cytochrome b;
Fungi and oomycota with G137V amino acid substitutions in cytochrome b;
Fungi and oomycota with G137A amino acid substitutions in cytochrome b;
Fungi and oomycota with G137S amino acid substitutions in cytochrome b;
Fungi and oomycota with an amino acid substitution of M139V in cytochrome b;
Fungi and oomycota with an amino acid substitution of T145F in cytochrome b;
Fungi and oomycota with an amino acid substitution of T145R in cytochrome b;
Fungi and oomycota with an amino acid substitution of T145S in cytochrome b;
Fungi and oomycota with a T145C amino acid substitution in cytochrome b;
Fungi and oomycota with a T145L amino acid substitution in cytochrome b;
Fungi and oomycota with a T145Y amino acid substitution in cytochrome b;
Fungi and oomycota with a T148M amino acid substitution in cytochrome b;
Fungi and oomycota with a T148V amino acid substitution in cytochrome b;
Fungi and oomycota with a T148L amino acid substitution in cytochrome b;
Fungi and oomycota with an amino acid substitution of T148I in cytochrome b;
Fungi and oomycota with a T148T amino acid substitution in cytochrome b;
Fungi and oomycota with an amino acid substitution of N256Y in cytochrome b;
Fungi and oomycota with an amino acid substitution of N256K in cytochrome b;
Fungi and oomycota with an amino acid substitution of N256I in cytochrome b;
Fungi and oomycota with an amino acid substitution of N256S in cytochrome b;
Fungi and oomycota with an amino acid substitution of E272D in cytochrome b;
Fungi and oomycota with an amino acid substitution of E272G in cytochrome b;
Fungi and oomycota with an amino acid substitution of E272Q in cytochrome b;
Fungi and oomycota with a W273L amino acid substitution in cytochrome b;
Fungi and oomycota with an amino acid substitution of W273F in cytochrome b;
Fungi and oomycota with the amino acid substitution of Y274S in cytochrome b;
Fungi and oomycota with an amino acid substitution of Y274F in cytochrome b;
Fungi and oomycota having the amino acid substitution of L275S in cytochrome b;
Fungi and oomycota with an amino acid substitution of L275T in cytochrome b;
Fungi and oomycetes with F278L amino acid substitutions in chitochrome b; fungi and oomycetes with L295F amino acid substitutions in chitochrome b;
Fungi and oomycota with an amino acid substitution of M295V in chitochrome b; Plasmopora viticola with an amino acid substitution of S34L, L201S or E203-DE-V204 in chitochrome b;
Zymoseptoria tritici with a G37V amino acid substitution in cytochrome b;
Ajellomyces capsulatus with an amino acid substitution of Y136F in Cyp51;
Aspergillus flavus with amino acid substitutions of Y132N, K197N, D282E, M288L, T469S, H399P, D411N or T454P on Cyp51;
Cyp51 with N22D, S52T, G54E / K / R / V / W, Y68N, Q88H, L98H, V101F, Y121F, N125I, G138C / R / S, Q141H, H147Y, P216L, F219S, M220K / I / T / V, Aspergillus fumigatus with amino acid substitutions of T289A, S297T, P394L, Y431C, G432S, G434C, T440A, G448S, Y491H or F495I;
Aspergillus parasiticus with a G54W amino acid substitution in Cyp51;
Candida albicans with amino acid substitutions of A61V, Y132F / H, K143E, S405F, F449S, G464S, R467K or I471T on Cyp51;
Cercospora beticola with an amino acid substitution of E297K, I330T or P384S on Cyp51;
Blumeria graminis f. Sp. Hordei with amino acid substitutions of Y136F, K147Q or S509T on Cyp51;
Blumeria graminis f. Sp. Tritici with amino acid substitutions of S79T, Y136F, or K175N on Cyp51;
Filobasidiella neoformans with amino acid substitutions of Y145F or G484S in Cyp51;
Monilinia fructicola, with a Y136F amino acid substitution on Cyp51,
Mycosphaerella fijiensis with amino acid substitutions of Y136F, A313G, A381G, Y461D, G462A or Y463D / H / N on Cyp51;
Phakopsora pachyrhizi with amino acid substitutions of F120L, V130A, Y131F / H, K142R, I145F or I475T on Cyp51;
Puccinia triticina with amino acid substitution of Y134F in Cyp51;
Puccinia striiformis with an amino acid substitution of Y134F in Cyp51;
Pyrenophora teres with an amino acid substitution of F489L on Cyp51;
Pyrenopeziza brassicae with S508T amino acid substitution in Cyp51;
Saccharomyces cerevisiae with a Y140F / H amino acid substitution in Cyp51;
Cyp51 with L50S, D107V, D134G, V136A / C / G, Y137F, M145L, N178S, S188N, S208T, N284H, H303Y, A311G, G312A, A379G, I381V / Δ, A410T, G412A, Y459C / D / N / S / Zymoseptoria tritici with amino acid substitutions of P / Δ, G460D / Δ, Y461D / H / S / G / L / N / Δ, V490L, G510C, N513K, S259F, G476S or S524T;
Erysiphe necator with amino acid substitution of Y136F in Cyp51;
Emericella nidulans with amino acid substitutions of H6L / Y, Y50N / S, Q134K, A165V, E198D / K / Q, F200Y or M257L in β-tubulin;
Botryotinia fuckeliana with E198A / G / K / V or F200Y amino acid substitutions in β-tubulin;
Cochliobolus heterostrophus with an amino acid substitution of F167Y in β-tubulin;
Cercospora beticola with an amino acid substitution of F167Y or E198A in β-tubulin;
Gibberella fujikuroi with amino acid substitutions of Y50N, E198V or F200Y in β-tubulin;
Gibberella zeae with amino acid substitutions of Y50C, Q73R, F167Y, E198K / L / Q or F200Y in β-tubulin;
Helminthosporium solani with an E198A / Q amino acid substitution in β-tubulin;
Hypomyces odoratus with a Y50C amino acid substitution in β-tubulin;
Parastagonospora nodorum with H6Y amino acid substitution in β-tubulin;
Monilinia fructicola with H6Y or E198A / K amino acid substitutions in β-tubulin;
Monilinia laxa with L240F amino acid substitution in β-tubulin;
Microdochium majus, nivale with an amino acid substitution of E198A in β-tubulin;
Mycosphaerella fijiensis with E198A amino acid substitution in β-tubulin;
Neurospora crassa with F167Y or E198G amino acid substitutions in β-tubulin;
Penicillium aurantiogriseum with an amino acid substitution of E198A / K or F200Y in β-tubulin;
Penicillium expansum with F167Y or E198A / K / V amino acid substitutions in β-tubulin;
Penicillium italicum with an amino acid substitution of E198K or F200Y in β-tubulin;
Pyrenopeziza brassicae with L240F amino acid substitution in β-tubulin;
Rhynchosporium secalis with E198G / K or F200Y amino acid substitutions on β-tubulin;
Sclerotinia homoeocarpa with an amino acid substitution of E198A / K in β-tubulin;
Sclerotinia sclerotiorum with an amino acid substitution of E198A in β-tubulin;
Zymoseptoria tritici with E198A / G amino acid substitution in β-tubulin;
Venturia inaequalis with E198A / K, F200Y or L240F amino acid substitutions in β-tubulin;
Phytophthora sojae with amino acid substitutions of Q8L, C165Y, C239S or I258V in β-tubulin;
Botrytis cinerea with an amino acid substitution of M233I or T351I in β-tubulin;
Alternaria alternata with H277R / Y amino acid substitution in SdhB;
Alternaria solani, with an amino acid substitution of H277R / Y in SdhB,
Botryotinia fuckeliana with P225H / F / L / T, N230I or H272L / R / V / Y amino acid substitutions in SdhB;
Corynespora cassiicola with H278Y / R amino acid substitution in SdhB;
Stagonosporopsis cucurbitacearum with H277R / Y amino acid substitution in SdhB;
Eurotium oryzae with H249 L / N / Y amino acid substitution in SdhB;
Pyrenophora teres with H277Y amino acid substitution in SdhB;
Ramularia collo-cygni with an amino acid substitution of N224T in SdhB;
Sclerotinia sclerotiorum with H273Y amino acid substitution in SdhB;
Zymoseptoria tritici with N225I / T, H273Y, T268I / A or I269V amino acid substitutions in SdhB;
Erysiphe necator with H242R amino acid substitution in SdhB;
Ustilago maydis with an amino acid substitution of H257L in SdhB;
Venturia inaequalis with an amino acid substitution of T253I in SdhB;
Alternaria alternata with H134R amino acid substitution in SdhC;
Botryotinia fuckeliana with P80H / L or A85V amino acid substitutions in SdhC;
Corynespora cassiicola with S73P amino acid substitution in SdhC;
Eurotium oryzae with T90I amino acid substitution in SdhC;
Phakopsora pachyrhizi with amino acid substitutions of I86F, N88S or H154Y / R in SdhC;
Pyrenophora teres with amino acid substitutions of K49E, R64K, N75S, G79R, H134R or S135R in SdhC;
Ramularia collo-cygni with N87S, H146R, G171D or H153R amino acid substitutions in SdhC;
Sclerotinia sclerotiorum with H146R amino acid substitution in SdhC;
Zymoseptoria tritici with amino acid substitutions of I29V, N33T, N34T, T79I / N, W80S, A84V, N86K / S / A, G90R, R151T / S, H152R or I161S in SdhC;
Erysiphe necator with G169D amino acid substitution in SdhC;
Venturia inaequalis with H151R amino acid substitution in SdhC;
Puccinia horiana with I88F amino acid substitution in SdhC;
Puccinia hordei with an amino acid substitution of I87F in SdhC;
Alternaria alternata with H133R amino acid substitution in SdhD;
Alternaria solani with H133R amino acid substitution in SdhD;
Botryotinia fuckeliana with H132R amino acid substitution in SdhD;
Corynespora cassiicola with S89P or G109V amino acid substitutions in SdhD;
Eurotium oryzae with an amino acid substitution of D124E in SdhD;
Pyrenophora teres with amino acid substitutions of D124E / N, H134R, G138V or D145G in SdhD;
Sclerotinia sclerotiorum with H132R amino acid substitution in SdhD;
Zymoseptoria tritici with amino acid substitutions for I50F, M114V or D129E in SdhD;
Phytophthora capsici with an amino acid substitution of Q1077K or V1109L / M in CesA3;
Phytophthora drechsleri with V1109L amino acid substitution on CesA3;
Phytophthora infestans with amino acid substitutions of G1105A / V or V1109L on CesA3;
Plasmopara viticola with G1105S / V amino acid substitution in CesA3;
Pseudoperonospora cubensis with G1105V / W amino acid substitution in CesA3;
Alternaria brassicicola with E753K amino acid substitution in OS-1 (Shk1);
Alternaria longipes with G420D amino acid substitutions in OS-1 (Shk1);
Botryotinia fuckeliana with amino acid substitutions of I365N / R / S, V368F, Q369H / P, N373S or T447S on OS-1 (Shk1);
Pleospora allii with F267L, L290S, T765R or Q777R amino acid substitutions in OS-1 (Shk1);
Sclerotinia sclerotiorum with T489I, E599 K or G736Y amino acid substitutions in OS-1 (Shk1);
ERG27 with S9G, F26S, P57A, T63I, G170R, V192I, L195F, N196T, A210G, I232M, P238S / Δ, P250S, P269L, P298Δ, V309M, A314V, S336C, V365A, E368D, N369D, E375K, A378T, L400 Botryotinia fuckeliana with amino acid substitutions for S, Y408S, F412I / S / V / C, A461S or R496T.
Phytophthora infestans with F382Y, P980S or V1476G amino acid substitutions in RPA190;
Pythium spp with an amino acid substitution of F382Y, P980S or V1476G on RPA190;
ORP1 has amino acid substitutions of L733W, S768I / F / K / Y, G770A / I / P / V / L, G818 / F819Δ, N837I / F / Y / Δ, G839W, P861H, L863W / F or I877F / Y. Phytophthora infestans ；
Phytophthora sojae with amino acid substitutions of L733W, S768F / Y, G770V, N837F / Y / Δ, G839W, P861H, L863W or I877Y in ORP1;
Phytophthora capsici with an amino acid substitution of G700V or G769W in ORP1;
Plasmopara viticola with an amino acid substitution of G770A / I / P / V / L, N837I / F / Y / Δ, or L863W / F in ORP1;
Pseudoperonospora cubensis with G700A / I / P / V / L, N767I / F / Y / Δ or L793W / F amino acid substitutions in ORP1;
Plasmopara viticola with G1105S amino acid substitution in CesA3;
Pseudoperonospora cubensis with a G1105 V / W amino acid substitution in CesA3.

Zymoseptoria tritici means the same species as Septoria tritici. Also, Microsphaera diffusa means the same species as Erysiphe diffusa.

When the present compound or the composition A contains one or more components having bactericidal activity selected from the group (b) and the group (j) as the main component, it is suitable for fungal diseases occurring on the surface or inside of the lumber. It can also be used.

Rice diseases: blast (Pyricularia oryzae), sesame leaf blight (Cochliobolus miyabeanus), blight (Rhizoctonia solani), bakanae disease (Gibberella fujikuroi), yellowing dwarf disease (Sclerophthora macrospora), scab and scab Epicoccum nigrum, Trichoderma viride, Rhizopus oryzae;
Wheat diseases: Udonko disease (Blumeria graminis), Fusarium head blight (Fusarium graminearum, Fusarium avenaceum, Fusarium culmorum, Microdochium nivale), Yellow rust (Puccinia striiformis), Fusarium head blight (Puccinia graminis), Fusarium head blight (Puccinia graminis) ), Fusarium head blight (Microdochium nivale, Microdochium majus), Typhula incarnata, Typhula ishikariensis, Ustilago tritici, Tilletia caries, Tilletia controversa (Pseudocercosporella herpotrichoides), leaf blight (Septoria tritici), Fusarium (Stagonospora nodorum), yellow spot (Pyrenophora tritici-repentis), seedling blight (Rhizoctonia solani), blight (Gaeumannomyces graminis) , Pyricularia graminis-tritici;
Diseases of barley: Blumeria graminis, Fusarium graminearum, Fusarium avenaceum, Fusarium culmorum, Microdochium nivale, Puccinia striiformis, Puccinia graminis, Puccinia graminis hordei), bare scab (Ustilago nuda), cloud disease (Rhynchosporium secalis), net spot disease (Pyrenophora teres), spot disease (Cochliobolus sativus), foliar disease (Pyrenophora graminea), Ramularia collo-cygni ), Rhizoctonia solani;
Corn diseases: rust (Puccinia sorghi), southern rust (Puccinia polysora), soot scab (Setosphaeria turcica), tropical rust (Physopella zeae), sesame leaf blight (Cochliobolus heterostrophus), charcoal hum graminicola ), Gray leaf spot disease (Cercospora zeae-maydis), Brown spot disease (Kabatiella zeae), Faeosphaeria maydis, Diplodia disease (Stenocarpella maydis, Stenocarpella macrospora), Stokelot disease (Fusarium graminearum,) Fusarium verticilioides, Colletotrichum graminicola), Black ear disease (Ustilago maydis), Physoderma maydis;
Diseases of cotton: anthrax (Colletotrichum gossypii), mildew (Ramularia areola), black spot disease (Alternaria macrospora, Alternaria gossypii), Black root rot disease (Thielaviopsis basicola);
Coffee diseases: rust (Hemileia vastatrix), leaf spot disease (Cercospora coffeicola);
Diseases of rapeseed: sclerotinia sclerotiorum, Alternaria brassicae, Phoma lingam, light leaf spot disease (Pyrenopeziza brassicae);
Diseases of sugar cane: Rust (Puccinia melanocephela, Puccinia kuehnii), Ustilago scitaminea;
Sunflower disease: rust (Puccinia helianthi), downy mildew (Plasmopara halstedii);
Phytophthora diseases: black spot disease (Diaporthe citri), scab (Elsinoe fawcetti), green mold (Penicillium digitatum), blue mold (Penicillium italicum), plague (Phytophthora parasitica, Phytophthora citrophthora), aspergillus (Aspergillus) ;
Apple diseases: Monilinia mali, Valsa ceratosperma, Podosphaera leucotricha, Alternaria alternata apple pathotype, Venturia inaequalis, Glomerella ul acutatum), brown spot disease (Diplocarpon mali), ring-spot disease (Botryosphaeria berengeriana), plague (Phytophtora cactorum), gymnosporangium (Gymnosporangium juniperi-virginianae, Gymnosporangium yamadae);
Pear diseases: Black spot disease (Venturia nashicola, Venturia pirina), Black spot disease (Alternaria alternata Japanese pear pathotype), Gymnosporangium haraeanum;
Diseases of peach: Monilinia fructicola, Cladosporium carpophilum, Phomopsis sp., Taphrina deformans;
Grape diseases: black rot (Elsinoe ampelina), late rot (Glomerella cingulata, Colletotrichum acutatum), powdery mildew (Uncinula necator), rust (Phakopsora ampelopsidis), black rot (Guignardia bidwellii), downy mildew (Guignardia bidwellii) Plasmopara viticola);
Diseases of oysters: anthrax (Gloeosporium kaki, Colletotrichum acutatum), leaf litter (Cercospora kaki, Mycosphaerella nawae);
Fig Disease: Rust (Phakopsora nishidana);
Diseases of uris: Colletotrichum lagenarium, Sphaerotheca fuliginea, Didymella bryoniae, Corynespora cassiicola, Fusarium oxysporum, Downy mildew (Pseudoperonospora) ), Epidemic (Phytophthora capsici), Didymella baldness (Pythium sp.);
Diseases of tomatoes: Alternaria solani, Cladosporium fulvum, Pseudocercospora fuligena, Phytophthora infestans, Powdery mildew;
Eggplant disease: brown spot disease (Phomopsis vexans), powdery mildew (Erysiphe cichoracearum);
Diseases of Brassicaceae vegetables: black spot (Alternaria japonica), white spot (Cercosporella brassicae), root-knot disease (Plasmodiophora brassicae), downy mildew (Peronospora parasitica), white rust (Albugo candida);
Welsh onion disease: rust (Puccinia allii);
Diseases of soybeans: purpura kikuchii, Elsinoe glycines, Diaporthe phaseolorum var. Sojae, Phakopsora pachyrhizi, Corynespora cassiicola, Colletotrichum , Colletotrichum truncatum), leaf rot (Rhizoctonia solani), brown spot disease (Septoria glycines), spot disease (Cercospora sojina), mycorrhizal disease (Sclerotinia sclerotiorum), udon disease (Microsphaera diffusa), stem plague (Phytophthora sojae) , Sticky disease (Peronospora manshurica), Sudden death (Fusarium virguliforme), Black root rot (Calonectria ilicicola), Diaporthe / Phomopsis complex (Diaporthe longicolla);
Common bean diseases: Sclerotinia sclerotiorum, Uromyces appendiculatus, Phaeoisariopsis griseola, Colletotrichum lindemuthianum, Fusarium solani;
Diseases of peanuts: black astringent disease (Cercospora personata), brown spot disease (Cercospora arachidicola), white silk disease (Sclerotium rolfsii), black root rot (Calonectria ilicicola);
Pea diseases: powdery mildew (Erysiphe pisi), root rot (Fusarium solani);
Potato diseases: summer plague (Alternaria solani), plague (Phytophthora infestans), scarlet rot (Phytophthora erythroseptica), powdery scab (Spongospora subterranea f. Sp. Subterranea), verticillium albo- dahliae, Verticillium nigrescens), dry rot (Fusarium solani), cancerous disease (Synchytrium endobioticum);
Strawberry disease: powdery mildew (Sphaerotheca humuli);
Diseases of tea: Exobasidium reticulatum, Elsinoe leucospila, Pestalotiopsis sp., Colletotrichum theae-sinensis;
Tobacco diseases: Gymnosporangium (Alternaria longipes), anthrax (Colletotrichum tabacum), downy mildew (Peronospora tabacina), plague (Phytophthora nicotianae);
Diseases of sugar beet: brown spot disease (Cercospora beticola), leaf rot (Thanatephorus cucumeris), root rot (Thanatephorus cucumeris), black root disease (Aphanomyces cochlioides), rust (Uromyces betae);
Rose disease: scab (Diplocarpon rosae), powdery mildew (Sphaerotheca pannosa);
Chrysanthemum disease: brown spot disease (Septoria chrysanthemi-indici), white rust disease (Puccinia horiana);
Onion diseases: Botrytis cinerea, Botrytis byssoidea, Botrytis cinerea, Botrytis allii, Botrytis cinerea;
Diseases of various crops: Botrytis cinerea, Sclerotinia sclerotiorum,
Seedling blight (Pythium aphanidermatum, Pythium irregulare, Pythium ultimum);
Radish disease: Black spot disease (Alternaria brassicicola);
Diseases of Shiva: Dollarspot disease (Sclerotinia homoeocarpa), Brown patch disease, Large patch disease (Rhizoctonia solani), Red burn disease (Pythium aphanidermatum);
Banana disease: Black sigatoka (Mycosphaerella fijiensis, Mycosphaerella musicola);
Diseases of lentils: Ascochyta disease (Ascochyta lentis);
Chickpea disease: Ascochyta disease (Ascochyta rabiei);
Pepper disease: Anthrax (Colletotrichum scovillei);
Mango disease: anthrax (Colletotrichum acutatum);
Diseases of fruit trees: Rosellinia necatrix, Helicobasidium mompa;
Diseases of fruits such as apples and pears after harvest: Mucor piriformis;
Seed or early growth diseases caused by Aspergillus, Penicillium, Fusarium, Gibberella, Tricoderma, Thielaviopsis, Rhizopus, Mucor, Corticium, Phoma, Rhizoctonia, Diplodia, etc.;
Viral diseases: Big vane disease of lettuce transmitted by Olpidium brassicae, viral diseases of various crops transmitted by the genus Polymyxa (eg Polymyxa betae and Polymyxa graminis);
Bacterial-induced diseases: rice seedling bacterial plantarii, cucumber spot bacterial disease (Pseudomonas syringae pv. Lachrymans), eggplant wilt disease (Ralstonia solanacearum), citrus scab (Xanthomonas citri) ), Erwinia carotovora, Streptomyces scabiei, Goss's wilt disease in corn (Clavibacter michiganensis), Xylella fastidiosa such as grapes, olives and peaches, apples, peaches and cherry blossoms. Agrobacterium tumefaciens, etc. of rose family plants.

Intraspecies mutations of the above phytopathogenic microorganisms are not particularly limited. That is, those having reduced sensitivity (also referred to as showing resistance) to a specific fungicide are also included. The decrease in susceptibility may be due to a mutation at the target site (point mutation) or a factor other than the point mutation (non-point mutation). Regarding point mutations, mutations in the open reading frame of the protein that correspond to the amino acid sequence of the protein result in amino acid substitutions in the protein at the target site, deletion of the suppressor sequence in the promoter region, or enhancers. It includes those in which the protein at the target site is overexpressed due to mutations such as sequence amplification and increase in the number of gene copies. Examples of the non-point mutation include an enhancement of the excretion function of the bactericidal agent that has flowed into the cell to the outside of the cell by an ABC transporter, an MFS transporter, or the like. In addition, detoxification by metabolism of fungicides can be mentioned.

The specific fungicides described above include, for example, nucleic acid synthesis inhibitors (eg, phenylamide fungicides, acyl amino acid fungicides, DNA topoisomerase type II fungicides), filamentous division and cell division inhibitors (eg, for example. MBC fungicides, N-phenylcarbamate fungicides), respiratory inhibitors (eg, QoI fungicides, QiI fungicides, SDHI fungicides), amino acid synthesis and protein synthesis inhibitors (eg, anilinopyrimidine-based fungicides), Signal transmission inhibitors (eg, phenylpyrrole fungicides, dicarboxyimide fungicides), lipid synthesis and cell membrane synthesis inhibitors (eg, phosphorothiolate fungicides, dithiorane fungicides, aromatic hydrocarbon fungicides, etc. Complex aromatic fungicides, carbamate fungicides, sterol biosynthesis inhibitors (eg, triazole-based DMI fungicides, hydroxyanilide fungicides, aminopyrazolinone fungicides), cell wall synthesis inhibitors (eg, triazole-based fungicides) , Polyoxine fungicides, carboxylic acid amide fungicides), melanin synthesis inhibitors (eg, MBI-R fungicides, MBI-D fungicides, MBI-P fungicides), and other fungicides (eg, cyanoacetamide). Oxym-based bactericides, phenylacetamide-based bactericides) can be mentioned.

Examples of the amino acid substitution at the target site include the following.
Cytochrome b: G143A, F129L, G137R, I147V, Y279C, Y279S, M295L, A126T, Y132C, C133Y, G137V, G137A, G137S, M139V, T145F, T145R, T145S, T145C, T145L, T145Y, T148M, T148V , T148T, N256Y, N256K, N256I, E272D, E272G, E272Q, W273L, W273F, Y274S, Y274F, L275F, L275S, L275T, L295F
Or L299F, I17F, S20L / T, Q22E / T, I26L, W30C, N31K, G33A, S34L, S35I, G37C / D / S / V / A, L198F, L201S, E203-DE-V204, M221Q / E, F225S / L, K228M / I / P, G232D or N256S;
Cyp51 protein to A311G, A379G, A381G, A410T, A61V, D107V, D134G, D282E, D411N, E297K, F120L, F219S, F449S, F489L, F495I, G138C / R / S, G312A, G412A, G432S, G434C, G448S / Δ, G462A, G464S, G484S, G510C, G54E / K / R / V / W, G54W, H147Y, H303Y, H399P, I145F, I330T, I381V / Δ, I471T, I475T, K142R, K143E, K147Q, K175N, K197N , L50S, L98H, M145L, M220K / I / T / V, M288L, N125I, N178S, N22D, N284H, N513K, P216L, P384S, P394L, Q141H, Q88H, R467K, S188N, S208T, S297T, S405F, S508T, S509T , S524T, S52T, S79T, T289A, T440A, T454P, T469S, V101F, V136A / C / G, V490L, Y121F, Y131F / H, Y132F / H / N, Y134F, Y134F, Y136F, Y137F, Y140F / H, Y145F , Y431C, Y459C / D / N / S / P / Δ, Y461D / H / S / G / L / N / Δ, Y463D / H / N, Y491H, S259F, G476S or Y68N;
β-tubulin: H6L / Y, Y50C / N / S, Q134K, A165V, E198A / D / G / K / L / Q / V, F200Y, M257L, F167Y, Q73R, L240F, Q8L, C165Y, M233I, C239S , I258V or T351I;
SdhB: H277R / Y, P225H / F / L / T, N230I, H272L / R / V / Y, H278Y / R, H249L / N / Y, H273Y, N225I / T, T268I / A, I269V, H242R, H257L, N224T or T253I;
SdhC: H134R, P80H / L, A85V, S73P, T90I, I86F, N88S, H154Y / R, K49E, R64K, N75S, G79R, S135R, N87S, H153R, H146R, I29V, N33T, N34T, T79I / N, W80S, A84V, N86K / S / A, G90R, R151T / S, H152R, I161S, G169D, G171D or H151R;
SdhD: H133R, H132R, S89P, G109V, D124E / N, H134R, G138V, D145G, I50F, M114V or D129E;
OS-1 (Shk1): E753K, G420D, I365N / R / S, V368F, Q369H / P, N373S, T447S, F267L, L290S, T765R, Q777R, T489I, E599K or G736Y;
ERG27: S9G, F26S, P57A, T63I, G170R, V192I, L195F, N196T, A210G, I232M, P238S / Δ, P250S, P269L, P298Δ, V309M, A314V, S336C, V365A, E368D, N369D, E375K, A378T, L400 S, Y408S, F412I / S / V / C, A461S or R496T;
RPA190: F382Y, P980S or V1476G;
ORP1: L733W, G700V, S768I / F / K / Y, G769W, G770A / I / P / V / L, G818 / F819Δ, N837I / F / Y / Δ, G839W, P861H, L863W / F or I877F / Y;
CesA3: Q1077K, G1105S / V / W / A or V1109L / M

In addition, the following are examples of phytopathogenic microorganisms and their host plants whose susceptibility to fungicides has decreased due to overexpression of the Cyp51 gene. Wheat Septoria tritici (Reference: Pest Management Science. 2012. 68 (7) .1034-1040), Barley Rhynchosporium secalis (Reference: Molecular Bilogy and Evolution. 2014. 31 (7) .1793-1802) Phakopsora pachyrhizi (reference: Pest Management Science. 2014. 70 (3) .378-388), Venturia inaequalis of apple (reference: Phytopathology. 2016. 106 (6) .562-571), Penicillium digitatum of wheat (reference) References: Applied and Environmental Microbiology. 2000. 66 (8) .3421-3426).

The phytopathogenic microorganism that can be controlled by the present compound and the composition A may have a plurality of the above amino acid substitutions. In this case, the plurality of amino acid substitutions may be the same protein or different proteins. Further, it may have a plurality of non-point mutations and point mutations. For example, phytopathogenic microorganisms that cause amino acid substitutions of G143A, F129L and G137R in chitochrome b; phytopathogenic microorganisms having an amino acid substitution of G143A in chitochrome b and an amino acid substitution of A311G in Cyp51; G143A and in chitochrome b. A phytopathogenic microorganism having an amino acid substitution of F129L and an amino acid substitution of A311G in Cyp51; an amino acid substitution of G143A and F129L in chitochrome b and an amino acid substitution of H6L / Y in β-tubulin. Further, there are phytopathogenic microorganisms in which the Cyp51 gene is overexpressed.

Examples of phytopathogenic microorganisms having a point mutation include the following.
Alternaria alternata with an amino acid substitution of G143A in cytochrome b;
Alternaria arborescens with an amino acid substitution of G143A in cytochrome b;
Alternaria solani with an amino acid substitution of F129L in cytochrome b;
Alternaria tomato with an amino acid substitution of G143A in cytochrome b;
Botryotinia fuckeliana with G143A amino acid substitution in cytochrome b;
Glomerella graminicola with an amino acid substitution of G143A in cytochrome b;
Corynespora cassiicola with an amino acid substitution of G143A in cytochrome b;
Cercospora beticola with an amino acid substitution of G143A in cytochrome b;
Cercospora sojina with an amino acid substitution of G143A in cytochrome b;
Cladosporium carpophilum with an amino acid substitution of G143A in cytochrome b;
Cladosporium fulvum with an amino acid substitution of F129L in cytochrome b;
Colletotrichum graminicola with an amino acid substitution of G143A in cytochrome b;
Glomerella cingulata with an amino acid substitution of G143A in cytochrome b;
Blumeria graminis f. Sp. Hordei with a G143A amino acid substitution in cytochrome b;
Blumeria graminis f. Sp. Tritici with a G143A amino acid substitution in cytochrome b;
Parastagonospora nodorum with G143A amino acid substitution in cytochrome b;
Monographella nivalis with an amino acid substitution of G143A in cytochrome b;
Microdochium majus, nivale with an amino acid substitution of G143A in cytochrome b;
Mycosphaerella fijiensis with an amino acid substitution of G143A in cytochrome b;
Didymella rabiei with an amino acid substitution of G143A in cytochrome b;
Phakopsora pachyrhizi with an amino acid substitution of F129L in cytochrome b;
Plasmopara viticola with an amino acid substitution of F129L or G143A in cytochrome b;
Pleospora allii with an amino acid substitution of G143A in cytochrome b;
Podosphaera fusca with an amino acid substitution of G143A in cytochrome b;
Podosphaera xanthii with an amino acid substitution of G143A in cytochrome b;
Pseudoperonospora cubensis with G143A amino acid substitution in cytochrome b;
Magnaporthe oryzae with an amino acid substitution of F129L or G143A in cytochrome b;
Pyrenophora teres with an amino acid substitution of F129L in cytochrome b;
Pyrenophora tritici-repentis with amino acid substitutions of F129L, G137R or G143A in cytochrome b;
Pythium aphanidermatum with an amino acid substitution of F129L in cytochrome b;
Thanatephorus cucumeris with an amino acid substitution of F129L or G143A in cytochrome b;
Ramularia collo-cygni with an amino acid substitution of G143A in cytochrome b;
Rhynchosporium secalis with an amino acid substitution of G143A in cytochrome b;
Rhizoctonia solani with an amino acid substitution of F129L in cytochrome b;
Zymoseptoria tritici with an amino acid substitution of F129L, G137R or G143A in cytochrome b;
Erysiphe necator with G143A amino acid substitution in cytochrome b;
Venturia inaequalis with an amino acid substitution of G143A in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of I147V in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of L275F in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of Y279C in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of Y279S in cytochrome b;
Saccharomyces cerevisiae with an amino acid substitution of M295L in cytochrome b;
Puccinia horiana with N256S amino acid substitution in cytochrome b;
Puccinia horiana with an amino acid substitution of L299F in cytochrome b;
Fungi and oomycota with an amino acid substitution of L299F in cytochrome b;
Fungi and oomycota with an amino acid substitution of A126T in cytochrome b;
Fungi and oomycota with a Y132C amino acid substitution in cytochrome b;
Fungi and oomycota with a C133Y amino acid substitution in cytochrome b;
Fungi and oomycota with G137V amino acid substitutions in cytochrome b;
Fungi and oomycota with G137A amino acid substitutions in cytochrome b;
Fungi and oomycota with G137S amino acid substitutions in cytochrome b;
Fungi and oomycota with an amino acid substitution of M139V in cytochrome b;
Fungi and oomycota with an amino acid substitution of T145F in cytochrome b;
Fungi and oomycota with an amino acid substitution of T145R in cytochrome b;
Fungi and oomycota with an amino acid substitution of T145S in cytochrome b;
Fungi and oomycota with a T145C amino acid substitution in cytochrome b;
Fungi and oomycota with a T145L amino acid substitution in cytochrome b;
Fungi and oomycota with a T145Y amino acid substitution in cytochrome b;
Fungi and oomycota with a T148M amino acid substitution in cytochrome b;
Fungi and oomycota with a T148V amino acid substitution in cytochrome b;
Fungi and oomycota with a T148L amino acid substitution in cytochrome b;
Fungi and oomycota with an amino acid substitution of T148I in cytochrome b;
Fungi and oomycota with a T148T amino acid substitution in cytochrome b;
Fungi and oomycota with an amino acid substitution of N256Y in cytochrome b;
Fungi and oomycota with an amino acid substitution of N256K in cytochrome b;
Fungi and oomycota with an amino acid substitution of N256I in cytochrome b;
Fungi and oomycota with an amino acid substitution of E272D in cytochrome b;
Fungi and oomycota with an amino acid substitution of E272G in cytochrome b;
Fungi and oomycota with an amino acid substitution of E272Q in cytochrome b;
Fungi and oomycota with a W273L amino acid substitution in cytochrome b;
Fungi and oomycota with an amino acid substitution of W273F in cytochrome b;
Fungi and oomycota with the amino acid substitution of Y274S in cytochrome b;
Fungi and oomycota with an amino acid substitution of Y274F in cytochrome b;
Fungi and oomycota having the amino acid substitution of L275S in cytochrome b;
Fungi and oomycota with an amino acid substitution of L275T in cytochrome b;
Fungi and oomycota with an amino acid substitution of L295F in cytochrome b;
Plasmopora viticola with an amino acid substitution of S34L, L201S or E203-DE-V204 in cytochrome b;
Zymoseptoria tritici with a G37V amino acid substitution in cytochrome b;
Ajellomyces capsulatus with an amino acid substitution of Y136F in Cyp51;
Aspergillus flavus with amino acid substitutions of Y132N, K197N, D282E, M288L, T469S, H399P, D411N or T454P on Cyp51;
Cyp51 with N22D, S52T, G54E / K / R / V / W, Y68N, Q88H, L98H, V101F, Y121F, N125I, G138C / R / S, Q141H, H147Y, P216L, F219S, M220K / I / T / V, Aspergillus fumigatus with amino acid substitutions of T289A, S297T, P394L, Y431C, G432S, G434C, T440A, G448S, Y491H or F495I;
Aspergillus parasiticus with a G54W amino acid substitution in Cyp51;
Candida albicans with amino acid substitutions of A61V, Y132F / H, K143E, S405F, F449S, G464S, R467K or I471T on Cyp51;
Cercospora beticola with an amino acid substitution of E297K, I330T or P384S on Cyp51;
Blumeria graminis f. Sp. Hordei with amino acid substitutions of Y136F, K147Q or S509T on Cyp51;
Blumeria graminis f. Sp. Tritici with amino acid substitutions of S79T, Y136F, or K175N on Cyp51;
Filobasidiella neoformans with amino acid substitutions of Y145F or G484S in Cyp51;
Monilinia fructicola, with a Y136F amino acid substitution on Cyp51,
Mycosphaerella fijiensis with amino acid substitutions of Y136F, A313G, A381G, Y461D, G462A or Y463D / H / N on Cyp51;
Phakopsora pachyrhizi with amino acid substitutions of F120L, Y131F / H, K142R, I145F or I475T on Cyp51;
Puccinia triticina with amino acid substitution of Y134F in Cyp51;
Pyrenophora teres with an amino acid substitution of F489L on Cyp51;
Pyrenopeziza brassicae with S508T amino acid substitution in Cyp51;
Saccharomyces cerevisiae with a Y140F / H amino acid substitution in Cyp51;
Cyp51 with L50S, D107V, D134G, V136A / C / G, Y137F, M145L, N178S, S188N, S208T, N284H, H303Y, A311G, G312A, A379G, I381V / Δ, A410T, G412A, Y459C / D / N / S / Zymoseptoria tritici with amino acid substitutions of P / Δ, G460D / Δ, Y461D / H / S / G / L / N / Δ, V490L, G510C, N513K, S259F, G476S or S524T;
Erysiphe necator with amino acid substitution of Y136F in Cyp51;
Emericella nidulans with amino acid substitutions of H6L / Y, Y50N / S, Q134K, A165V, E198D / K / Q, F200Y or M257L in β-tubulin;
Botryotinia fuckeliana with E198A / G / K / V or F200Y amino acid substitutions in β-tubulin;
Cochliobolus heterostrophus with an amino acid substitution of F167Y in β-tubulin;
Cercospora beticola with an amino acid substitution of F167Y or E198A in β-tubulin;
Gibberella fujikuroi with amino acid substitutions of Y50N, E198V or F200Y in β-tubulin;
Gibberella zeae with amino acid substitutions of Y50C, Q73R, F167Y, E198K / L / Q or F200Y in β-tubulin;
Helminthosporium solani with an E198A / Q amino acid substitution in β-tubulin;
Hypomyces odoratus with a Y50C amino acid substitution in β-tubulin;
Parastagonospora nodorum with H6Y amino acid substitution in β-tubulin;
Monilinia fructicola with H6Y or E198A / K amino acid substitutions in β-tubulin;
Monilinia laxa with L240F amino acid substitution in β-tubulin;
Microdochium majus, nivale with an amino acid substitution of E198A in β-tubulin;
Mycosphaerella fijiensis with E198A amino acid substitution in β-tubulin;
Neurospora crassa with F167Y or E198G amino acid substitutions in β-tubulin;
Penicillium aurantiogriseum with an amino acid substitution of E198A / K or F200Y in β-tubulin;
Penicillium expansum with F167Y or E198A / K / V amino acid substitutions in β-tubulin;
Penicillium italicum with an amino acid substitution of E198K or F200Y in β-tubulin;
Pyrenopeziza brassicae with L240F amino acid substitution in β-tubulin;
Rhynchosporium secalis with E198G / K or F200Y amino acid substitutions on β-tubulin;
Sclerotinia homoeocarpa with an amino acid substitution of E198A / K in β-tubulin;
Sclerotinia sclerotiorum with an amino acid substitution of E198A in β-tubulin;
Zymoseptoria tritici with E198A / G amino acid substitution in β-tubulin;
Venturia inaequalis with E198A / K, F200Y or L240F amino acid substitutions in β-tubulin;
Phytophthora sojae with amino acid substitutions of Q8L, C165Y, C239S or I258V in β-tubulin;
Botrytis cinerea with an amino acid substitution of M233I or T351I in β-tubulin;
Alternaria alternata with H277R / Y amino acid substitution in SdhB;
Alternaria solani, with an amino acid substitution of H277R / Y in SdhB,
Botryotinia fuckeliana with P225H / F / L / T, N230I or H272L / R / V / Y amino acid substitutions in SdhB;
Corynespora cassiicola with H278Y / R amino acid substitution in SdhB;
Stagonosporopsis cucurbitacearum with H277R / Y amino acid substitution in SdhB;
Eurotium oryzae with H249 L / N / Y amino acid substitution in SdhB;
Pyrenophora teres with H277Y amino acid substitution in SdhB;
Ramularia collo-cygni with an amino acid substitution of N224T in SdhB;
Sclerotinia sclerotiorum with H273Y amino acid substitution in SdhB;
Zymoseptoria tritici with N225I / T, H273Y, T268I / A or I269V amino acid substitutions in SdhB;
Erysiphe necator with H242R amino acid substitution in SdhB;
Ustilago maydis with an amino acid substitution of H257L in SdhB;
Venturia inaequalis with an amino acid substitution of T253I in SdhB;
Alternaria alternata with H134R amino acid substitution in SdhC;
Botryotinia fuckeliana with P80H / L or A85V amino acid substitutions in SdhC;
Corynespora cassiicola with S73P amino acid substitution in SdhC;
Eurotium oryzae with T90I amino acid substitution in SdhC;
Phakopsora pachyrhizi with amino acid substitutions of I86F, N88S or H154Y / R in SdhC;
Pyrenophora teres with amino acid substitutions of K49E, R64K, N75S, G79R, H134R or S135R in SdhC;
Ramularia collo-cygni with N87S, H146R, G171D or H153R amino acid substitutions in SdhC;
Sclerotinia sclerotiorum with H146R amino acid substitution in SdhC;
Zymoseptoria tritici with amino acid substitutions of I29V, N33T, N34T, T79I / N, W80S, A84V, N86K / S / A, G90R, R151T / S, H152R or I161S in SdhC;
Erysiphe necator with G169D amino acid substitution in SdhC;
Venturia inaequalis with H151R amino acid substitution in SdhC;
Alternaria alternata with H133R amino acid substitution in SdhD;
Alternaria solani with H133R amino acid substitution in SdhD;
Botryotinia fuckeliana with H132R amino acid substitution in SdhD;
Corynespora cassiicola with S89P or G109V amino acid substitutions in SdhD;
Eurotium oryzae with an amino acid substitution of D124E in SdhD;
Pyrenophora teres with amino acid substitutions of D124E / N, H134R, G138V or D145G in SdhD;
Sclerotinia sclerotiorum with H132R amino acid substitution in SdhD;
Zymoseptoria tritici with amino acid substitutions for I50F, M114V or D129E in SdhD;
Phytophthora capsici with an amino acid substitution of Q1077K or V1109L / M in CesA3;
Phytophthora drechsleri with V1109L amino acid substitution on CesA3;
Phytophthora infestans with amino acid substitutions of G1105A / V or V1109L on CesA3;
Plasmopara viticola with G1105S / V amino acid substitution in CesA3;
Pseudoperonospora cubensis with G1105V / W amino acid substitution in CesA3;
Alternaria brassicicola with E753K amino acid substitution in OS-1 (Shk1);
Alternaria longipes with G420D amino acid substitutions in OS-1 (Shk1);
Botryotinia fuckeliana with amino acid substitutions of I365N / R / S, V368F, Q369H / P, N373S or T447S on OS-1 (Shk1);
Pleospora allii with F267L, L290S, T765R or Q777R amino acid substitutions in OS-1 (Shk1);
Sclerotinia sclerotiorum with T489I, E599 K or G736Y amino acid substitutions in OS-1 (Shk1);
ERG27 with S9G, F26S, P57A, T63I, G170R, V192I, L195F, N196T, A210G, I232M, P238S / Δ, P250S, P269L, P298Δ, V309M, A314V, S336C, V365A, E368D, N369D, E375K, A378T, L400 Botryotinia fuckeliana with amino acid substitutions for S, Y408S, F412I / S / V / C, A461S or R496T.
Phytophthora infestans with F382Y, P980S or V1476G amino acid substitutions in RPA190;
Pythium spp with an amino acid substitution of F382Y, P980S or V1476G on RPA190;
ORP1 has amino acid substitutions of L733W, S768I / F / K / Y, G770A / I / P / V / L, G818 / F819Δ, N837I / F / Y / Δ, G839W, P861H, L863W / F or I877F / Y. Phytophthora infestans ；
Phytophthora sojae with amino acid substitutions of L733W, S768F / Y, G770V, N837F / Y / Δ, G839W, P861H, L863W or I877Y in ORP1;
Phytophthora capsici with an amino acid substitution of G700V or G769W in ORP1;
Plasmopara viticola with an amino acid substitution of G770A / I / P / V / L, N837I / F / Y / Δ, or L863W / F in ORP1;
Pseudoperonospora cubensis with G700A / I / P / V / L, N767I / F / Y / Δ or L793W / F amino acid substitutions in ORP1;
Plasmopara viticola with G1105S amino acid substitution in CesA3;
Pseudoperonospora cubensis with a G1105 V / W amino acid substitution in CesA3.

Zymoseptoria tritici means the same species as Septoria tritici. Also, Microsphaera diffusa means the same species as Erysiphe diffusa.

When the composition A contains one or more components having bactericidal activity selected from the group (b) and the group (j) as the main component, it also resists fungal diseases occurring on the surface or inside of the lumber. Can be used.

The composition A can also control weeds when the present component contains one or more components having herbicidal activity selected from the group (i) and the group (j). The weed in the present invention means a plant whose growth is not desirable in the place. Examples of weeds include the following.

Urticaceae Weeds (Urticaceae): Small Nettle (Urtica urens)
Polygonaceae: Polygonum convolvulus, Polygonum lapathifolium, Polygonum pensylvanicum, Polygonum persicaria, Polygonum longisetum, Prostrate knotweed (Polygonum longisetum), Prostrate knotweed (Polygonum longisetum), Prostrate knotweed (Polygonum longisetum) , Knotweed (Polygonum cuspidatum), Prostrate knotweed (Rumex japonicus), Prostrate knotweed (Rumex crispus), Prostrate knotweed (Rumex obtusifolius), Swiva (Rumex acetosa)
Portulacaceae: Portulaca oleracea
Caryophyllaceae: Chickweed (Stellaria media), Bovine chickweed (Stellaria aquatica), Mouse-ears (Cerastium holosteoides), Sticky mouse (Cerastium glomeratum), Sticky mouse (Spergula arvensis), Silene
Molluginaceae (Molluginaceae): Molluginaceae (Mollugo verticillata)
Goosefoot (Chenopodiaceae): White goosefoot (Chenopodium album), Mexican tea (Chenopodium ambrosioides), Bassia scoparia (Kochia scoparia), Noharahijiki (Salsola kali), Atriplex spp.

Amaranthaceae: Amaranthus retroflexus, Amaranthus viridis, Amaranthus lividus, Amaranthus spinosus, Amaranthus spinosus, Amaranthus hybridus, Amaranthus hybridus, Amaranthus hybridus Amaranthus patulus, Amaranthus tuberculatus = Amaranthus rudis = Amaranthus tamariscinus, Amaranthus blitoides, Amaranthus deflexus, Amaranthus deflexus, Amaranthus quitensis (Amaranthus) ), Sanguinaria (Alternanthera tenella)
Poppyaceae weeds (Papaveraceae): Poppy (Papaver rhoeas), Papaver dubium, Prickly poppy (Argemone mexicana)
Brassicaceae: Brassicaceae: Raphanus raphanistrum, Raphanus sativus, Sinapis arvensis, Capsella bursa-pastoris, Brassica juncea, Brassica napus (Descurainia pinnata), yellowcresses (Rorippa islandica), yellowcresses (Rorippa sylvestris), yellowcresses (Thlaspi arvense), yellowcresses (Myagrum rugosum), yellowcresses (Lepidium virginicum), Karakusana.
Capparaceae: Cleome affinis

Legumes (Fabaceae): Aeschynomene indica, Aeschynomene rudis, Sesbania exaltata, Cassia obtusifolia, Cassia occidentalis, Desmo adscendens), Desmodium illinoense, Trifolium repens, Pueraria lobata, Vicia angustifolia, Indigofera hirsuta, Indigofera hirsuta, Indigofera trxylensis tr Vigna sinensis)
Oxalidaceae: Oxalis corniculata, Oxalis stricta, Oxalis oxyptera
Geraniaceae: American geranium (Geranium carolinense), Dutch stork (Erodium cicutarium)
Spurges (Euphorbiaceae): Spurges (Euphorbia helioscopia), Spurges (Euphorbia maculata), Spurges (Euphorbia humistrata), Hagiso (Euphorbia esula), Acalypha australis (Euphorbia esula), Acalypha australis (Euphorbia esula) (Acalypha australis), Troton glandulosus, Croton lobatus, Phyllanthus corcovadensis, Spurges (Ricinus communis)

Malvaceae: Velvetleaf (Abutilon theophrasti), Sida rhombifolia, Sida cordifolia, Sida spinosa, Sida glaziovii, Sida santaremnsis ), Sida cordifolia (Hibiscus trionum), Nishikiaoi (Anoda cristata), Enokiaoi (Malvastrum coromandelianum)
Evening Primrose (Onagraceae): Ludwigia epilobioides, Ludwigia octovalvis, Ludwigia decurrens, Evening Primrose (Oenothera biennis), Evening Primrose (Oenothera lacini)
Sterculiaceae (Sterculiaceae): Kobanbanoki (Waltheria indica)
Violaceae: Makibasumire (Viola arvensis), Wild Pansy (Viola tricolor)
Cucurbitaceae: Bur-cucumber (Sicyos angulatus), wild cucumber (Echinocystis lobata), wild bitter melon (Momordica charantia)
Lythraceae: Lythraceae: Ammannia multiflora, Ammannia auriculata, Ammannia coccinea, Lythrum salicaria, Rotala indica
Elatinaceae: Elatine triandra, Elatine californica

Umbelliferae weeds (Apiaceae): Auction (Oenanthe javanica), wild carrot (Daucus carota), hemlock (Conium maculatum)
Araliaceae: Hydrocotyle sibthorpioides, Brazilian Hydrocotyle ranunculoides
Hornwort weed (Ceratophyllaceae): Coontail (Ceratophyllum demersum)
Cabombaceae (Cabombaceae): Cabomba caroliniana
Watermilloils (Haloragaceae): Parrot's feather (Myriophyllum aquaticum), Watermilfoils (Myriophyllum verticillatum), Watermilfoils (Myriophyllum spicatum, Myriophyllum heterophyllum, etc.)
Soapberry weed (Sapindaceae): Balloon vine (Cardiospermum halicacabum)
Primulaceae: Scarlet pimpernel (Anagallis arvensis)
Asclepiadaceae: Milkweed (Asclepias syriaca), Honeyweed Milkweed (Ampelamus albidus)
Rubiaceae: Rubiaceae: Galium aparine, Galium spurium var. Echinospermon, Spermacoce latifolia, Richardia brasiliensis, Wingedfars buttonweed

Convolvulaceae: Asagao (Ipomoea nil), American Asagao (Ipomoea hederacea), Malva Asagao (Ipomoea purpurea), Malva American Asagao (Ipomoea hederacea var. , Ipomoea acuminata, Ipomoea hederifolia, Ipomoea coccinea, Ipomoea quamoclit, Ipomoea quamoclit, Ipomoea grandifolia, Ipomoea grandifolia , Ipomoea (Convolvulus arvensis), Kohilgao (Calystegia hederacea), Hirugao (Calystegia japonica), Tsutanoha hirugao (Merremia hederacea), Hairy Wood Rose (Merremia aegyptia), Roadside Wood Rose (Merremia cissoides), Okina folia
Boraginaceae: Forget-me-not (Myosotis arvensis)
Labiatae weeds (Lamiaceae): Red deadnettle (Lamium purpureum), Henbit deadnettle (Lamium amplexicaule), Leonotis nepetaefolia, Hyptis suaveolens, Hyptis suaveolens, Hyptis lophanta, Hyptis lophanta

Solanaceae Weeds (Solanaceae): Nightshade (Datura stramonium), Nightshade (Solanum nigrum), Nightshade (Solanum americanum), American nightshade (Solanum ptycanthum), Nightshade (Solanum sarrachoides), Tomato dama , Kingin Nasubi (Solanum aculeatissimum), Wild Tomato (Solanum sisymbriifolium), Warnasbi (Solanum carolinense), Nightshade (Physalis angulata), Smooth Grand Cherry (Physalis subglabrata), Osennari (Nicandra physalodes)
Figworts (Scrophulariaceae): Frasabasou (Veronica hederaefolia), Persian speedwell (Veronica persica), Corn speedwell (Veronica arvensis), Azena (Lindernia procumbens), American Azena (Lindernia dubia), American water hyssop (Lindernia dubia) (Dopatrium junceum), Water Hyssop (Gratiola japonica)
Plantainaceae: Plantain (Plantago asiatica), Plantain (Plantago lanceolata), Plantain (Plantago major), Plantain (Callitriche palustris)

Asteraceae: Asteraceae: Xanthium pensylvanicum, Xanthium occidentale, Xanthium italicum, Helianthus annuus, Matricaria chamomilla, Matricaria chamomilla, Matricaria chamomilla ), Oroshagiku (Matricaria matricarioides), Yomogi (Artemisia princeps), Moxa vulgaris (Artemisia vulgaris), Chinese Magwart (Artemisia verlotorum), Seitaka Awadachisou (Solidago altissima), Seiyota ragweed (Taraxacum offic) (Galinsoga parviflora), sowthistle (Senecio vulgaris), Senecio brasiliensis, Senecio grisebachii, Conyza bonariensis, ragweed (Conyza bonariensis), ragweed (Conyza smatrensis), horseweed (Conyza smatrensis) , Kwamodoki (Ambrosia trifida), Taukogi (Bidens tripartita), Kosendangusa (Bidens pilosa), American Sendangusa (Bidens frondosa), Bidens subalternans, Seiyotoge Azami (Cirsium arvense) Sealybum marianum, Carduus nutans, Lactuca serriola, Sonchus oleraceus, Sonchus asper, Wedelia glauc a), Perforate Blackfoot (Melampodium perfoliatum), Usbenignana (Emilia sonchifolia), Shiozakisou (Tagetes minuta), Paracres (Blainvillea latifolia), Tridax procumbens, Jerba Porosa (Porophyllum ruderale), Paraghyllum ruderale ), Bristoli Starbar (Acanthospermum hispidum), Fusengazura (Cardiospermum halicacabum), Ageratum conyzoides, Common Bone Set (Eupatorium perfoliatum), Dandoborogiku (Erechtites hieracifolia), American Everlasting (Gamochaeta) Gnaphalium spicatum), Jaegeria hirta, Tridax procumbens (Parthenium hysterophorus), Menamomi (Siegesbeckia orientalis), Soliva sessilis, False daisy (Eclipta prostrata), False daisy (Eclipta prostrata), False daisy (Eclipta prostrata), False daisy (Eclipta prostrata)

Water-plantain weeds (Alismataceae): Sagittaria pygmaea, Sagittaria trifolia, Sagittaria sagittifolia, Sagittaria montevidensis, Sagittaria montevidensis, Sagittaria montevidensis, Sagittaria trifolia aquatica)
Limnocharitaceae (Limnocharitaceae): Limnocharis flava
Hydrocharitaceae: Frogbit (Limnobium spongia), Waterthymes (Hydrilla verticillata), Common water nymph (Najas guadalupensis)
Araceae: Pistia stratiotes
Lemnaceae: Duckweed (Lemna aoukikusa, Lemna paucicostata, Lemna aequinoctialis), Spirodela polyrhiza, Spirodela spp.
Potamogetonaceae: Potamogeton distinctus, Pondweeds (Potamogeton crispus, Potamogeton illinoensis, Stickenia pectinata, etc.)
Liliaceae: Wild onion (Allium canadense), Wild garlic (Allium vineale), Nobile (Allium macrostemon)
Pontederiaceae: Eichhornia crassipes, Heteranthera limosa, Monochoria korsakowii, Monochoria vaginalis
Commelinaaceae: Commelina communis, Commelina benghalensis, Commelina erecta, Murdannia keisak

Poaceae: Echinochloa crus-galli, Echinochloa oryzicola, Echinochloa crus-galli var. Formosensis, late watergrass (Echinochloa oryzoides), Echinochloa colon (Echinochloa crus-pavonis), Enocologsa (Setaria viridis), Aquinoenocologsa (Setaria faberi), Kinenocoro (Setaria glauca), American Enocologsa (Setaria geniculata), Barnyardgrass (Digitaria ciliaris), Large club grass (Digitaria sanguinalis) (Digitaria horizontalis), Barnyardgrass (Digitaria insularis), Barnyardgrass (Eleusine indica), Barnyardgrass (Poa annua), Poa trivialis, Nagahagusa (Poa pratensis), Barnyardgrass (Poa pratensis), Barnyardgrass (Alopecurus) Avena fatua, Sorghum halepense, Sorghum vulgare, Agropyron repens, Lolium multiflorum, Lolium perenne, catharus, catharus Aegilops cylindrica ), Silkybe Apera spica-venti, Panicum dichotomiflorum, Panicum texanum, Panicum maximum, Brachiaria platyphylla, Brachiaria platyphylla, Brachiaria ruziziensis, Alexander grass Glass (Brachiaria decumbens), Parisade glass (Brachiaria brizantha), Columbia grass (Brachiaria humidicola), Cenchrus echinatus, Cenchrus pauciflorus, Eriochloa villosa, Pennisetum setosum ), Chloris virgata, Eragrostis pilosa, Rhynchelytrum repens, Dactyloctenium aegyptium, Ischaemum rugosum, Ischaemum rugosum, Chigozasa (Isachne globosa) notatum), Coastal Sandpass Palm (Paspalum maritimum), Crowngrass (Paspalum distichum), Kikuyugrass (Pennisetum clandestinum), Hosobachikarashiba (Pennisetum setosum), Tsunoaiashi (Rottboellia cochinchinensis), Azegaya (Lottboellia cochinchinensis) Itoazegaya (Leptochloa filiformis), Amazon sprungle top (Leptochloa panicoides), Ashikaki (Leersia japonica), Sayanukagusa (Leersia sayanuka), Ezonosayanukagusa (Leersia oryzo) ides), Glyceria leptorrhiza, Glyceria acutiflora, Glyceria maxima, Agrostis gigantea, Agrostis stolonifera, Agrostis stolonifera, Glyceria, Cynodon d ophiuroides), Festuca arundinacea, Festuca rubra, Imperata cylindrica, Misscanthus sinensis, Panicum virgatum, Zoysia japonica

Nutsedges (Cyperaceae): Nutsedges (Cyperus microiria), Nutsedges (Cyperus iria), Nutsedges (Cyperus compressus), Nutsedges (Cyperus difformis), Nutsedges (Cyperus difformis), Nutsedges (Cyperus flaccidus) (Cyperus odoratus), Nutsedge (Cyperus serotinus), Nutsedge (Cyperus rotundus), Nutsedge (Cyperus esculentus), Nutsedge (Kyllinga gracillima), Nutsedge (Kyllinga brevifolia), Hiderico (Fimbrista brevifolia) acicularis, Eleocharis kuroguwai, Schoenoplectiella hotarui, Schoenoplectiella juncoides, Schoenoplectiella wallichii, Schoenoplectiella wallichii, Schoenoplectiella mucronatus, Schoenoplectiella mucronatus triqueter), nutsedge (Bolboschoenus koshevnikovii), nutsedge (Bolboschoenus fluviatilis)
Equisetaceae: Equisetum arvense, Equisetum palustre
Salvinia natans: Salvinia natans
Azolla pinnata: Azolla japonica, Azolla pinnata
Marsilea quadrifolia (Marsileaceae): Marsilea quadrifolia
Others: Filamentous algae (Pithophora, Cladophora), moss, liverworts, hornworts, cyanobacteria, ferns, perennial crops (fruits, stones, berries, berries, citrus fruits, hops, grapes, etc.) Sucker.

Intraspecific variation is not particularly limited for the above weeds. That is, those having reduced sensitivity to a specific herbicide (also referred to as exhibiting resistance) are also included. The decrease in susceptibility may be due to a mutation at the target site (point mutation) or a factor other than the point mutation (non-point mutation). Regarding point mutations, mutations in the open reading frame of the protein that correspond to the amino acid sequence of the protein cause amino acid substitutions in the protein at the target site, deletion of the suppressor sequence in the promoter region, and enhancer sequences. This includes proteins in which the protein at the target site is overexpressed due to mutations such as amplification of the gene or an increase in the number of copies of the gene. Non-acting point mutations include metabolic enhancement, absorption deficiency, migration deficiency, and extrasystem excretion. Factors that enhance metabolism include those with increased activity of metabolic enzymes such as cytochrome P450 monooxygenase, arylacylamidase, esterase, and glutathione S-transferase. Out-of-system discharge includes transport to vacuoles by ABC transporters.

Examples of the amino acid substitution at the target site include the following. ALS: A122T, A122V, A122Y, P197S, P197H, P197T, P197R, P197L, P197Q, P197A, P197I, A205V, A205F, D376E, R377H, W574L, W574G, W574M, S653T, S653N, S653I, G654E or G654D
ACCase: I1781L, I1781V, I1781T, W1999C, W1999L, A2004V, W2027C, I2041N, I2041V, D2078G or C2088R, G2096R;
PPX2: G210Δ, R98L, R98M, R98G, R98H, G399A;
EPSP: T102I, P106S, P106A or P106L.

The weed that can be controlled by the composition A containing one or more components having herbicidal activity selected from the group (i) and the group (j) as the present component may have a plurality of the above amino acid substitutions. .. In this case, the plurality of amino acid substitutions may be the same protein or different proteins. Further, it may have a plurality of non-point mutations and point mutations.

Examples of weeds having a point mutation include the following.
Amaranthus palmeri with amino acid substitutions of G210Δ, R98M, R98G or G399A in PPX2;
Water hemp with amino acid substitutions of G210Δ, R98M, R98G or G399A on PPX2;
Ragweed with R98L amino acid substitution in PPX2;
PPX2 with an amino acid substitution of R98H;
Goosegrass with an amino acid substitution of T102I, P106S, P106A or P106L in EPSP;
EPSP with amino acid substitutions of T102I, P106S, P106A or P106L;
Japanese pampas grass having an amino acid substitution of T102I, P106S, P106A or P106L in EPSP;
Water hemp with amino acid substitutions of T102I, P106S, P106A or P106L on EPSP;
Kohimebier having an amino acid substitution of T102I, P106S, P106A or P106L in EPSP.

Amaranthus palmeri, water hemp and ragweed, which have the above-mentioned point mutations in PPX2, show resistance to PPO inhibitors such as lactophen, homesaphen, and flumioxazine.

Examples of weeds having the above-mentioned amino acid substitutions include glyphosate-resistant goosegrass, Festuca perensis, Boumugi, Miscanthus sinensis, Roughfruit amarckii, and Kohimebier having amino acid substitutions of T102I and P106S.

In addition, other weeds include the following.
Amaranthus palmeri, water hemp, scoparia, which became less sensitive to glyphosate due to overexpression of the EPSP gene;
Resistant horseweed, erigeron sumatren, and erigeron bonarien that are less sensitive to glyphosate involving ABC transporters.

Hereinafter, the present invention will be described in more detail with reference to production examples, reference production examples, composition examples, pharmaceutical examples, application examples, test examples, etc., but the present invention is not limited to these examples.

In the present specification, Me represents a methyl group, Et represents an ethyl group, Pr represents a propyl group, i-Pr represents an isopropyl group, t-Bu represents a tert-butyl group, and C ₂ F ₅ Represents a perfluoroethyl group, c-Pr represents a cyclopropyl group, Bn represents a benzyl group, Ph represents a phenyl group, Py2 represents a 2-pyridyl group, Py3 represents a 3-pyridyl group, and Py4. Represents a 4-pyridyl group. If c-Pr, Ph, Py2, Py3, and Py4 have substituents, the substituents are listed before the symbol along with the substitution position. For example, 1-CN-c-Pr represents a 1-cyanocyclopropyl group, 3,4-F ₂ -Ph represents a 3,4-difluorophenyl group, and 2-C ₂ F ₅ -Ph represents 2-( Perfluoroethyl) phenyl group, 4-SO ₂ CF ₃ -Ph represents 4- (trifluoromethanesulfonyl) phenyl group, 3,4- (OCF ₃ ) ₂ -Ph represents 3,4-bis (trifluoromethoxy) ) Represents a phenyl group, 3-SCF ₃ -4-OCF ₃ -Ph represents a 3-[(trifluoromethyl) thio] -4- (trifluoromethoxy) phenyl group, 4-CF ₃ -Py2 represents a 4- Represents a (trifluoromethyl) -2-pyridyl group.

First, a production example of this compound is shown.

When the physical properties of the compound were measured by liquid chromatography / mass spectrometry (hereinafter referred to as LCMS), the measured molecular ion value [M + H] ⁺ or [MH] ^-and the retention time (hereinafter referred to as RT). Write). The conditions for liquid chromatography (hereinafter referred to as LC) are as follows.

[LC condition]
Column: L-column2 ODS, inner diameter 4.6 mm, length 30 mm, particle diameter 3 μm (Chemicals Evaluation and Research Institute)
UV measurement wavelength: 254 nm
Mobile phase: Solution A: 0.1% formic acid aqueous solution, Solution B: 0.1% formic acid acetonitrile Flow rate: 2.0 mL / min Gradient conditions: Liquid is sent at the concentration gradient described in [Table LC1].

[Table LC1]

中間体１：¹H-NMR (CDCl₃) δ: 9.39 (1H, s), 8.52 (1H, s), 8.07 (2H, d), 7.79 (2H, d), 7.57 (1H, d), 7.47 (1H, d), 2.75 (2H, q), 1.24 (3H, t). Reference manufacturing example 1
6-bromo-3- (ethylthio) imidazole [1,2-a] pyridin-2-amine (hereinafter referred to as intermediate Z) 1.1 g and THF 8 mL produced by the method described in WO2018 / 052136. To the mixture of, 0.83 g of 4- (trifluoromethyl) benzoyl chloride was added, 1.1 mL of triethylamine was added, and the mixture was stirred at room temperature for 30 minutes. Water was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 1.4 g of Intermediate 1 represented by the following formula.

Intermediate 1: ¹ H-NMR (CDCl ₃ ) δ: 9.39 (1H, s), 8.52 (1H, s), 8.07 (2H, d), 7.79 (2H, d), 7.57 (1H, d), 7.47 (1H, d), 2.75 (2H, q), 1.24 (3H, t).

中間体２：¹H-NMR (CDCl₃) δ: 8.56-8.53 (2H, m), 8.24 (1H, s), 8.10 (1H, d), 7.87 (1H, d), 7.60 (1H, t), 7.54 (1H, d), 7.39 (1H, d), 2.77 (2H, q), 1.25 (3H, t). Reference manufacturing example 2
Intermediate Z 6.12 g, 3- (trifluoromethylthio) benzoic acid 5.0 g, 4- (dimethylamino) pyridine 0.55 g, pyridine 50 mL, and 1-ethyl-3- [3- (dimethylamino) propyl] carbodiimide A mixture of 6.47 g of hydrochloride was stirred at 100 ° C. for 2 hours. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 6.57 g of Intermediate 2 represented by the following formula.

Intermediate 2: ¹ H-NMR (CDCl ₃ ) δ: 8.56-8.53 (2H, m), 8.24 (1H, s), 8.10 (1H, d), 7.87 (1H, d), 7.60 (1H, t) , 7.54 (1H, d), 7.39 (1H, d), 2.77 (2H, q), 1.25 (3H, t).

で示される化合物において、Ａ²、Ａ³、Ａ⁴、Ａ⁵、Ｇ⁴及びＲ^3bの組合せが［表Ａ－１］に記載のいずれかの組合せである化合物。 Reference manufacturing example 2-1
Reference The compounds manufactured according to Production Example 2 and their physical property values are shown below.
Equation (A-1)

A compound in which the combination of A ² , A ³ , A ⁴ , A ⁵ , G ⁴ and R ^3b is any combination shown in [Table A-1].

中間体３：¹H-NMR (CDCl₃) δ: 8.56 (1H, s), 8.38 (1H, s), 8.23 (1H, s), 8.09 (1H, t), 7.89 (1H, d), 7.85-7.40 (3H, m), 2.78 (2H, q), 1.18 (3H, t).
中間体４：¹H-NMR (CDCl₃) δ: 8.63-8.61 (2H, m), 8.23 (1H, s), 8.08 (1H, d), 7.87 (1H, d), 7.75-7.48 (3H, m), 2.76 (2H, q), 1.19 (3H, t).
中間体５：¹H-NMR (CDCl₃) δ: 8.62 (1H, s), 8.53 (1H, d), 8.34 (1H, d), 7.76-7.46 (3H, m), 7.31-7.29 (1H, m), 2.64 (2H, q), 1.19 (3H, t).
中間体６：¹H-NMR (CDCl₃) δ: 8.53 (1H, s), 8.34 (1H, s), 7.99 (2H, d), 7.80 (2H, d), 7.56 (1H, d), 7.39 (1H, d), 2.75 (2H, q), 1.24 (3H, t).
中間体７： ¹H-NMR (CDCl₃) δ: 8.57 (1H, s), 8.44 (1H, s), 7.99 (2H, d), 7.79 (2H, d), 7.70-7.42 (2H, m), 2.73 (2H, q), 1.23 (3H, t).
中間体８： ¹H-NMR (CDCl₃) δ: 8.53 (1H, s), 8.36 (1H, s), 8.12-8.09 (1H, m), 7.84 (2H, d), 7.68 (2H, d), 6.92-6.90 (1H, m), 3.22 (2H, q), 1.32 (3H, t).
中間体１２：¹H-NMR (CDCl₃) δ: 8.52 (1H, s), 8.45 (1H, s), 8.29 (1H, s), 7.91-7.88 (2H, m), 7.52 (1H, d), 7.37 (1H, d), 7.25-7.20 (1H, m), 2.75 (2H, q), 1.23 (3H, t).
中間体１３：¹H-NMR (CDCl₃) δ: 8.53 (1H, s), 8.34 (1H, s), 7.84 (2H, d), 7.69 (2H, d), 7.56 (1H, d), 7.35 (1H, d), 2.75 (2H, q), 1.24 (3H, t).
中間体１４：¹H-NMR (CDCl₃) δ: 8.56 (1H, s), 8.35 (1H, s), 7.95 (2H, d), 7.65 (1H, d), 7.54 (2H, d), 7.35 (1H, d), 2.76 (2H, q), 1.23 (3H, t).
中間体１５：¹H-NMR (CDCl₃) δ: 8.63 (1H, s), 8.44 (1H, s), 7.97 (2H, d), 7.61 (1H, d), 7.51 (2H, d), 7.31 (1H, d), 4.48-4.36 (2H, m), 2.75 (2H, q), 1.19 (3H, t).
中間体１６：¹H-NMR (CDCl₃) δ: 8.63 (1H, s), 8.54 (1H, s), 8.07 (2H, d), 7.82 (2H, d), 7.55 (1H, d), 7.40 (1H, d), 2.76 (2H, q), 1.17 (3H, t).
中間体１７：¹H-NMR (CDCl₃) δ: 8.65 (1H, s), 8.41-8.37 (2H, m), 8.09 (1H, s), 7.92 (1H, s), 7.51 (1H, d), 7.45 (1H, d), 2.78 (2H, q), 1.25 (3H, t).
中間体１８：¹H-NMR (CDCl₃) δ: 8.54 (1H, s), 8.43-8.41 (2H, m), 8.11 (1H, s), 7.93-7.87 (1H, m), 7.53 (1H, d), 7.41 (1H, d), 2.77 (2H, q), 1.26 (3H, t).
中間体１９：¹H-NMR (CDCl₃) δ: 8.70-8.46 (1H, m), 8.64 (1H, s), 8.28 (1H, s), 8.12 (1H, s), 7.96 (1H, s), 7.54-7.48 (1H, m), 7.45-7.38 (1H, m), 2.77 (2H, q), 1.24 (3H, t).
中間体２０：¹H-NMR (CDCl₃) δ: 8.63 (1H, s), 8.27-8.22 (1H, m), 7.99 (2H, d), 7.87 (1H, t), 7.53-7.48 (1H, m), 7.44 (1H, d), 2.75 (2H, q), 1.24 (3H, t).
中間体２１：¹H-NMR (CDCl₃) δ: 9.05-9.04 (1H, m), 8.87 (1H, d), 8.64-8.62 (1H, m), 8.45-8.40 (2H, m), 7.51 (1H, dd), 7.44 (1H, d), 2.75 (2H, q), 1.24 (3H, t).
中間体２２：¹H-NMR (CDCl₃) δ: 8.64-8.61 (1H, m), 8.31-8.26 (1H, m), 7.82-7.78 (2H, m), 7.57 (1H, t), 7.50 (1H, dd), 7.44 (1H, d), 2.75 (2H, q), 1.33-1.19 (3H, m).
中間体２３：¹H-NMR (CDCl₃) δ: 8.55-8.54 (1H, m), 8.21 (1H, s), 7.63-7.56 (3H, m), 7.41 (1H, d), 7.20 (1H, d), 2.77 (2H, q), 1.26 (3H, t).
中間体２４：¹H-NMR (CDCl₃) δ: 8.54 (1H, s), 8.43 (1H, s), 7.85-7.82 (3H, m), 7.56 (1H, d), 7.42 (1H, d), 2.77 (2H, q), 1.25 (3H, t).
中間体２５：¹H-NMR (CDCl₃) δ: 8.53-8.53 (1H, m), 8.30 (1H, s), 7.86-7.81 (1H, m), 7.72-7.70 (1H, m), 7.56 (1H, d), 7.40 (1H, d), 7.35-7.28 (1H, m), 2.75 (2H, q), 1.24 (3H, t). [Table A-1]

Intermediate 3: ¹ H-NMR (CDCl ₃ ) δ: 8.56 (1H, s), 8.38 (1H, s), 8.23 (1H, s), 8.09 (1H, t), 7.89 (1H, d), 7.85 -7.40 (3H, m), 2.78 (2H, q), 1.18 (3H, t).
Intermediate 4: ¹ H-NMR (CDCl ₃ ) δ: 8.63-8.61 (2H, m), 8.23 (1H, s), 8.08 (1H, d), 7.87 (1H, d), 7.75-7.48 (3H, d) m), 2.76 (2H, q), 1.19 (3H, t).
Intermediate 5: ¹ H-NMR (CDCl ₃ ) δ: 8.62 (1H, s), 8.53 (1H, d), 8.34 (1H, d), 7.76-7.46 (3H, m), 7.31-7.29 (1H, m), 2.64 (2H, q), 1.19 (3H, t).
Intermediate 6: ¹ H-NMR (CDCl ₃ ) δ: 8.53 (1H, s), 8.34 (1H, s), 7.99 (2H, d), 7.80 (2H, d), 7.56 (1H, d), 7.39 (1H, d), 2.75 (2H, q), 1.24 (3H, t).
Intermediate 7: ¹ H-NMR (CDCl ₃ ) δ: 8.57 (1H, s), 8.44 (1H, s), 7.99 (2H, d), 7.79 (2H, d), 7.70-7.42 (2H, m) , 2.73 (2H, q), 1.23 (3H, t).
Intermediate 8: ¹ H-NMR (CDCl ₃ ) δ: 8.53 (1H, s), 8.36 (1H, s), 8.12-8.09 (1H, m), 7.84 (2H, d), 7.68 (2H, d) , 6.92-6.90 (1H, m), 3.22 (2H, q), 1.32 (3H, t).
Intermediate 12: ¹ H-NMR (CDCl ₃ ) δ: 8.52 (1H, s), 8.45 (1H, s), 8.29 (1H, s), 7.91-7.88 (2H, m), 7.52 (1H, d) , 7.37 (1H, d), 7.25-7.20 (1H, m), 2.75 (2H, q), 1.23 (3H, t).
Intermediate 13: ¹ H-NMR (CDCl ₃ ) δ: 8.53 (1H, s), 8.34 (1H, s), 7.84 (2H, d), 7.69 (2H, d), 7.56 (1H, d), 7.35 (1H, d), 2.75 (2H, q), 1.24 (3H, t).
Intermediate 14: ¹ H-NMR (CDCl ₃ ) δ: 8.56 (1H, s), 8.35 (1H, s), 7.95 (2H, d), 7.65 (1H, d), 7.54 (2H, d), 7.35 (1H, d), 2.76 (2H, q), 1.23 (3H, t).
Intermediate 15: ¹ H-NMR (CDCl ₃ ) δ: 8.63 (1H, s), 8.44 (1H, s), 7.97 (2H, d), 7.61 (1H, d), 7.51 (2H, d), 7.31 (1H, d), 4.48-4.36 (2H, m), 2.75 (2H, q), 1.19 (3H, t).
Intermediate 16: ¹ H-NMR (CDCl ₃ ) δ: 8.63 (1H, s), 8.54 (1H, s), 8.07 (2H, d), 7.82 (2H, d), 7.55 (1H, d), 7.40 (1H, d), 2.76 (2H, q), 1.17 (3H, t).
Intermediate 17: ¹ H-NMR (CDCl ₃ ) δ: 8.65 (1H, s), 8.41-8.37 (2H, m), 8.09 (1H, s), 7.92 (1H, s), 7.51 (1H, d) , 7.45 (1H, d), 2.78 (2H, q), 1.25 (3H, t).
Intermediate 18: ¹ H-NMR (CDCl ₃ ) δ: 8.54 (1H, s), 8.43-8.41 (2H, m), 8.11 (1H, s), 7.93-7.87 (1H, m), 7.53 (1H, d), 7.41 (1H, d), 2.77 (2H, q), 1.26 (3H, t).
Intermediate 19: ¹ H-NMR (CDCl ₃ ) δ: 8.70-8.46 (1H, m), 8.64 (1H, s), 8.28 (1H, s), 8.12 (1H, s), 7.96 (1H, s) , 7.54-7.48 (1H, m), 7.45-7.38 (1H, m), 2.77 (2H, q), 1.24 (3H, t).
Intermediate 20: ¹ H-NMR (CDCl ₃ ) δ: 8.63 (1H, s), 8.27-8.22 (1H, m), 7.99 (2H, d), 7.87 (1H, t), 7.53-7.48 (1H, t) m), 7.44 (1H, d), 2.75 (2H, q), 1.24 (3H, t).
Intermediate 21: ¹ H-NMR (CDCl ₃ ) δ: 9.05-9.04 (1H, m), 8.87 (1H, d), 8.64-8.62 (1H, m), 8.45-8.40 (2H, m), 7.51 ( 1H, dd), 7.44 (1H, d), 2.75 (2H, q), 1.24 (3H, t).
Intermediate 22: ¹ H-NMR (CDCl ₃ ) δ: 8.64-8.61 (1H, m), 8.31-8.26 (1H, m), 7.82-7.78 (2H, m), 7.57 (1H, t), 7.50 ( 1H, dd), 7.44 (1H, d), 2.75 (2H, q), 1.33-1.19 (3H, m).
Intermediate 23: ¹ H-NMR (CDCl ₃ ) δ: 8.55-8.54 (1H, m), 8.21 (1H, s), 7.63-7.56 (3H, m), 7.41 (1H, d), 7.20 (1H, 1H, d), 2.77 (2H, q), 1.26 (3H, t).
Intermediate 24: ¹ H-NMR (CDCl ₃ ) δ: 8.54 (1H, s), 8.43 (1H, s), 7.85-7.82 (3H, m), 7.56 (1H, d), 7.42 (1H, d) , 2.77 (2H, q), 1.25 (3H, t).
Intermediate 25: ¹ H-NMR (CDCl ₃ ) δ: 8.53-8.53 (1H, m), 8.30 (1H, s), 7.86-7.81 (1H, m), 7.72-7.70 (1H, m), 7.56 ( 1H, d), 7.40 (1H, d), 7.35-7.28 (1H, m), 2.75 (2H, q), 1.24 (3H, t).

In the compound represented by the formula (A-1), the combination of A ² , A ³ , A ⁴ , A ⁵ , G ⁴ and R ^3b is any combination shown in [Table AA-1].

中間体４１：¹H-NMR (CDCl₃) δ: 8.63 (1H, s), 8.34 (1H, s), 8.06 (2H, d), 7.79 (2H, d), 7.47 (2H, dd), 2.74 (2H, q), 1.23 (3H, t).
中間体４３：¹H-NMR (CDCl₃) δ: 10.48 (1H, s), 8.88 (1H, d), 8.59 (1H, s), 8.53 (1H, d), 7.75 (1H, d), 7.60 (1H, d), 7.37 (1H, dd), 2.74 (2H, q), 1.24 (3H, t).
中間体４４：¹H-NMR (CDCl₃) δ: 10.48 (1H, s), 8.58-8.53 (2H, m), 8.15 (1H, t), 7.90 (1H, d), 7.59 (1H, d), 7.39-7.35 (1H, m), 2.73 (2H, q), 1.27 (3H, t).
中間体４５：¹H-NMR (CDCl₃) δ: 10.49 (1H, s), 8.88 (1H, d), 8.64-8.60 (2H, m), 7.75 (1H, dd), 7.50-7.49 (2H, m), 2.74 (2H, q), 1.24 (3H, t).
中間体４６：¹H-NMR (DMSO-D₆) δ: 10.79 (1H, s), 8.92 (1H, s), 8.36 (1H, dd), 8.10-8.07 (1H, m), 7.86 (1H, d), 7.69 (1H, dd), 7.58 (1H, t), 2.81 (2H, q), 1.08 (3H, t).
中間体４７：¹H-NMR (CDCl₃)δ: 8.65-8.64 (1H, m), 8.45-8.43 (2H, m), 8.14 (1H, s), 7.51 (1H, dd), 7.42 (1H, dd), 4.34 (1H, br s), 2.77 (2H, q), 1.24 (3H, t).
中間体４８：LCMS: ４９３[M+H]⁺, RT =1.897分
中間体５０：¹H-NMR (DMSO-D₆) δ: 10.62 (1H, s), 8.76 (1H, s), 8.02 (2H, d), 7.63 (3H, d), 7.56 (1H, dd), 2.77 (2H, q), 1.08 (3H, t).
中間体５１：¹H-NMR (DMSO-D₆) δ: 10.66 (1H, s), 8.76-8.76 (1H, m), 8.04-8.04 (1H, m), 7.97 (1H, d), 7.71-7.70 (1H, m), 7.65-7.55 (3H, m), 2.77 (2H, q), 1.08 (3H, t).
中間体５２：¹H-NMR (CDCl₃) δ: 8.63-8.62 (1H, m), 8.37 (1H, br s), 8.08 (2H, d), 7.77 (2H, d), 7.52-7.44 (2H, m), 2.74 (2H, q), 1.24 (3H, t)
中間体５３：¹H-NMR (CDCl₃) δ: 8.64-8.63 (1H, m), 8.26-8.25 (1H, m), 8.21-8.20 (3H, m), 7.52-7.42 (2H, m), 2.75 (2H, q), 1.24 (3H, t)
中間体５４：¹H-NMR (DMSO-D₆) δ: 10.66 (1H, s), 8.76 (1H, d), 8.13 (2H, d), 7.64 (1H, d), 7.58-7.54 (3H, m), 2.77 (2H, q), 1.08 (3H, t).
中間体５５：¹H-NMR (DMSO-D₆) δ: 10.75 (1H, s), 8.77 (1H, d), 8.06 (1H, d), 7.94 (1H, s), 7.71 (1H, t), 7.66-7.64 (2H, m), 7.57 (1H, dd), 2.78 (2H, q), 1.08 (3H, t).
中間体５６：¹H-NMR (DMSO-D₆) δ: 10.56 (1H, s), 8.76 (1H, d), 8.08 (2H, d), 7.63 (1H, d), 7.56 (1H, dd), 7.40 (1H, t), 7.33 (2H, d), 2.77 (2H, q), 1.08 (3H, t).
中間体５７：¹H-NMR (DMSO-D₆) δ: 10.64 (1H, s), 8.77 (1H, s), 7.90 (1H, d), 7.78 (1H, s), 7.65-7.53 (3H, m), 7.44 (1H, d), 7.35 (1H, t), 2.78 (2H, q), 1.10-1.06 (3H, m).
中間体５８：¹H-NMR (DMSO-D₆) δ: 10.90 (1H, s), 8.93 (1H, s), 8.20 (2H, d), 7.95 (2H, d), 7.86 (1H, d), 7.70 (1H, dd), 2.81 (2H, q), 1.09 (3H, t).
中間体５９：¹H-NMR (DMSO-D₆) δ: 10.91 (1H, s), 8.93 (1H, s), 8.20 (2H, d), 7.95 (2H, d), 7.86 (1H, d), 7.70 (1H, d), 2.81 (2H, q), 1.09 (3H, t).
中間体６０：¹H-NMR (DMSO-D₆) δ: 10.79 (1H, s), 8.73 (1H, dd), 8.19 (2H, d), 7.94 (2H, d), 7.70 (1H, dd), 7.50 (1H, dd), 2.78 (2H, q), 1.08 (3H, t).
中間体６１：¹H-NMR (DMSO-D₆) δ: 10.75 (1H, s), 8.73 (1H, dd), 8.10 (2H, d), 7.90 (2H, d), 7.70 (1H, dd), 7.50 (1H, dd), 2.77 (2H, q), 1.08 (3H, t).
中間体６２：¹H-NMR (CDCl₃) δ: 8.79-8.77 (1H, m), 8.48-8.44 (1H, br m), 8.41-8.39 (2H, m), 8.10 (1H, s), 7.75 (1H, d), 7.51-7.49 (1H, m), 2.81 (2H, q), 1.27 (3H, t).
中間体６３：¹H-NMR (CDCl₃) δ: 8.63-8.62 (1H, m), 8.25-8.19 (1H, br s), 7.61 (2H, t), 7.53-7.43 (2H, m), 2.74 (2H, q), 1.23 (3H, t).
中間体６４：¹H-NMR (CDCl₃) δ: 8.64-8.63 (1H, m), 8.57-8.54 (1H, br s), 7.56-7.56 (2H, m), 7.51-7.40 (2H, m), 7.12-7.11 (1H, m),6.79-6.42 (2H, m),2.75 (2H, q), 1.24 (3H, t).
中間体６５：¹H-NMR (CDCl₃) δ: 8.63-8.62 (1H, m), 8.56-8.53 (1H, br s), 8.08-8.08 (1H, m), 7.87-7.84 (1H, m), 7.51-7.39 (2H, m), 7.35 (1H, d),6.81-6.45 (1H, m),2.74 (2H, q), 1.23 (3H, t).
中間体６６：¹H-NMR (CDCl₃) δ: 8.63-8.63 (1H, m), 8.41-8.38 (1H, br s), 8.05 (2H, d), 7.91 (2H, d), 7.52-7.43 (2H, m), 2.74 (2H, q), 1.23 (3H, t). [Table AA-1]

Intermediate 41: ¹ H-NMR (CDCl ₃ ) δ: 8.63 (1H, s), 8.34 (1H, s), 8.06 (2H, d), 7.79 (2H, d), 7.47 (2H, dd), 2.74 (2H, q), 1.23 (3H, t).
Intermediate 43: ¹ H-NMR (CDCl ₃ ) δ: 10.48 (1H, s), 8.88 (1H, d), 8.59 (1H, s), 8.53 (1H, d), 7.75 (1H, d), 7.60 (1H, d), 7.37 (1H, dd), 2.74 (2H, q), 1.24 (3H, t).
Intermediate 44: ¹ H-NMR (CDCl ₃ ) δ: 10.48 (1H, s), 8.58-8.53 (2H, m), 8.15 (1H, t), 7.90 (1H, d), 7.59 (1H, d) , 7.39-7.35 (1H, m), 2.73 (2H, q), 1.27 (3H, t).
Intermediate 45: ¹ H-NMR (CDCl ₃ ) δ: 10.49 (1H, s), 8.88 (1H, d), 8.64-8.60 (2H, m), 7.75 (1H, dd), 7.50-7.49 (2H, m), 2.74 (2H, q), 1.24 (3H, t).
Intermediate 46: ¹ H-NMR (DMSO-D ₆ ) δ: 10.79 (1H, s), 8.92 (1H, s), 8.36 (1H, dd), 8.10-8.07 (1H, m), 7.86 (1H, d), 7.69 (1H, dd), 7.58 (1H, t), 2.81 (2H, q), 1.08 (3H, t).
Intermediate 47: ¹ H-NMR (CDCl ₃ ) δ: 8.65-8.64 (1H, m), 8.45-8.43 (2H, m), 8.14 (1H, s), 7.51 (1H, dd), 7.42 (1H, dd), 4.34 (1H, br s), 2.77 (2H, q), 1.24 (3H, t).
Intermediate 48: LCMS: 493 [M + H] ⁺ , RT = 1.897 minutes Intermediate 50: ¹ H-NMR (DMSO-D ₆ ) δ: 10.62 (1H, s), 8.76 (1H, s), 8.02 ( 2H, d), 7.63 (3H, d), 7.56 (1H, dd), 2.77 (2H, q), 1.08 (3H, t).
Intermediate 51: ¹ H-NMR (DMSO-D ₆ ) δ: 10.66 (1H, s), 8.76-8.76 (1H, m), 8.04-8.04 (1H, m), 7.97 (1H, d), 7.71- 7.70 (1H, m), 7.65-7.55 (3H, m), 2.77 (2H, q), 1.08 (3H, t).
Intermediate 52: ¹ H-NMR (CDCl ₃ ) δ: 8.63-8.62 (1H, m), 8.37 (1H, br s), 8.08 (2H, d), 7.77 (2H, d), 7.52-7.44 (2H) , m), 2.74 (2H, q), 1.24 (3H, t)
Intermediate 53: ¹ H-NMR (CDCl ₃ ) δ: 8.64-8.63 (1H, m), 8.26-8.25 (1H, m), 8.21-8.20 (3H, m), 7.52-7.42 (2H, m), 2.75 (2H, q), 1.24 (3H, t)
Intermediate 54: ¹ H-NMR (DMSO-D ₆ ) δ: 10.66 (1H, s), 8.76 (1H, d), 8.13 (2H, d), 7.64 (1H, d), 7.58-7.54 (3H, d) m), 2.77 (2H, q), 1.08 (3H, t).
Intermediate 55: ¹ H-NMR (DMSO-D ₆ ) δ: 10.75 (1H, s), 8.77 (1H, d), 8.06 (1H, d), 7.94 (1H, s), 7.71 (1H, t) , 7.66-7.64 (2H, m), 7.57 (1H, dd), 2.78 (2H, q), 1.08 (3H, t).
Intermediate 56: ¹ H-NMR (DMSO-D ₆ ) δ: 10.56 (1H, s), 8.76 (1H, d), 8.08 (2H, d), 7.63 (1H, d), 7.56 (1H, dd) , 7.40 (1H, t), 7.33 (2H, d), 2.77 (2H, q), 1.08 (3H, t).
Intermediate 57: ¹ H-NMR (DMSO-D ₆ ) δ: 10.64 (1H, s), 8.77 (1H, s), 7.90 (1H, d), 7.78 (1H, s), 7.65-7.53 (3H, s) m), 7.44 (1H, d), 7.35 (1H, t), 2.78 (2H, q), 1.10-1.06 (3H, m).
Intermediate 58: ¹ H-NMR (DMSO-D ₆ ) δ: 10.90 (1H, s), 8.93 (1H, s), 8.20 (2H, d), 7.95 (2H, d), 7.86 (1H, d) , 7.70 (1H, dd), 2.81 (2H, q), 1.09 (3H, t).
Intermediate 59: ¹ H-NMR (DMSO-D ₆ ) δ: 10.91 (1H, s), 8.93 (1H, s), 8.20 (2H, d), 7.95 (2H, d), 7.86 (1H, d) , 7.70 (1H, d), 2.81 (2H, q), 1.09 (3H, t).
Intermediate 60: ¹ H-NMR (DMSO-D ₆ ) δ: 10.79 (1H, s), 8.73 (1H, dd), 8.19 (2H, d), 7.94 (2H, d), 7.70 (1H, dd) , 7.50 (1H, dd), 2.78 (2H, q), 1.08 (3H, t).
Intermediate 61: ¹ H-NMR (DMSO-D ₆ ) δ: 10.75 (1H, s), 8.73 (1H, dd), 8.10 (2H, d), 7.90 (2H, d), 7.70 (1H, dd) , 7.50 (1H, dd), 2.77 (2H, q), 1.08 (3H, t).
Intermediate 62: ¹ H-NMR (CDCl ₃ ) δ: 8.79-8.77 (1H, m), 8.48-8.44 (1H, br m), 8.41-8.39 (2H, m), 8.10 (1H, s), 7.75 (1H, d), 7.51-7.49 (1H, m), 2.81 (2H, q), 1.27 (3H, t).
Intermediate 63: ¹ H-NMR (CDCl ₃ ) δ: 8.63-8.62 (1H, m), 8.25-8.19 (1H, br s), 7.61 (2H, t), 7.53-7.43 (2H, m), 2.74 (2H, q), 1.23 (3H, t).
Intermediate 64: ¹ H-NMR (CDCl ₃ ) δ: 8.64-8.63 (1H, m), 8.57-8.54 (1H, br s), 7.56-7.56 (2H, m), 7.51-7.40 (2H, m) , 7.12-7.11 (1H, m), 6.79-6.42 (2H, m), 2.75 (2H, q), 1.24 (3H, t).
Intermediate 65: ¹ H-NMR (CDCl ₃ ) δ: 8.63-8.62 (1H, m), 8.56-8.53 (1H, br s), 8.08-8.08 (1H, m), 7.87-7.84 (1H, m) , 7.51-7.39 (2H, m), 7.35 (1H, d), 6.81-6.45 (1H, m), 2.74 (2H, q), 1.23 (3H, t).
Intermediate 66: ¹ H-NMR (CDCl ₃ ) δ: 8.63-8.63 (1H, m), 8.41-8.38 (1H, br s), 8.05 (2H, d), 7.91 (2H, d), 7.52-7.43 (2H, m), 2.74 (2H, q), 1.23 (3H, t).

中間体２６：¹H-NMR (CDCl₃) δ: 9.83 (1H, s), 8.78 (1H, s), 8.10 (2H, d), 7.82 (2H, d), 7.74 (1H, d), 7.60 (1H, d), 3.32 (2H, q), 1.36 (3H, t). Reference manufacturing example 3
To a mixture of 500 mg of Intermediate 1 and 5 mL of chloroform, 830 mg of mCPBA (purity 70%, containing 30% water) was added under ice-cooling, and the mixture was stirred at room temperature for 2 hours. A saturated aqueous sodium hydrogen carbonate solution and an aqueous sodium thiosulfate solution were sequentially added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 260 mg of Intermediate 26.

Intermediate 26: ¹ H-NMR (CDCl ₃ ) δ: 9.83 (1H, s), 8.78 (1H, s), 8.10 (2H, d), 7.82 (2H, d), 7.74 (1H, d), 7.60 (1H, d), 3.32 (2H, q), 1.36 (3H, t).

で示される化合物において、Ａ²、Ａ³、Ａ⁴、Ａ⁵及びＲ^3bの組合せが［表Ａ－２］に記載のいずれかの組合せである化合物。 Reference manufacturing example 3-1
Reference The compounds manufactured according to Production Example 3 and their physical property values are shown below.
Equation (A-2)

A compound in which the combination of A ² , A ³ , A ⁴ , A ⁵ and R ^3b is any combination shown in [Table A-2].

中間体２７：¹H-NMR (CDCl₃) δ: 9.78 (1H, s), 8.80-8.76 (1H, m), 8.27 (1H, s), 8.07 (1H, d), 7.89 (1H, d), 7.72 (1H, d), 7.64-7.57 (2H, m), 3.33 (2H, q), 1.36 (3H, t).
中間体２８：¹H-NMR (CDCl₃) δ: 9.80 (1H, s), 8.77 (1H, s), 8.02 (2H, d), 7.81 (2H, d), 7.72 (1H, d), 7.59 (1H, d), 3.32 (2H, q), 1.36 (3H, t).
中間体２９：¹H-NMR (CDCl₃) δ: 10.09 (1H, s), 8.84-8.82 (1H, m), 8.36 (1H, t), 7.73 (1H, d), 7.61-7.58 (2H, m), 7.49 (1H, d), 3.32 (2H, q), 1.37 (3H, t).
中間体４２：¹H-NMR (CDCl₃) δ: 9.83 (1H, s), 8.86 (1H, s), 8.10 (2H, d), 7.80 (2H, d), 7.71 (1H, dd), 7.62 (1H, d), 3.31 (2H, q), 1.36 (3H, t). [Table A-2]

Intermediate 27: ¹ H-NMR (CDCl ₃ ) δ: 9.78 (1H, s), 8.80-8.76 (1H, m), 8.27 (1H, s), 8.07 (1H, d), 7.89 (1H, d) , 7.72 (1H, d), 7.64-7.57 (2H, m), 3.33 (2H, q), 1.36 (3H, t).
Intermediate 28: ¹ H-NMR (CDCl ₃ ) δ: 9.80 (1H, s), 8.77 (1H, s), 8.02 (2H, d), 7.81 (2H, d), 7.72 (1H, d), 7.59 (1H, d), 3.32 (2H, q), 1.36 (3H, t).
Intermediate 29: ¹ H-NMR (CDCl ₃ ) δ: 10.09 (1H, s), 8.84-8.82 (1H, m), 8.36 (1H, t), 7.73 (1H, d), 7.61-7.58 (2H, m), 7.49 (1H, d), 3.32 (2H, q), 1.37 (3H, t).
Intermediate 42: ¹ H-NMR (CDCl ₃ ) δ: 9.83 (1H, s), 8.86 (1H, s), 8.10 (2H, d), 7.80 (2H, d), 7.71 (1H, dd), 7.62 (1H, d), 3.31 (2H, q), 1.36 (3H, t).

中間体３０：¹H-NMR (DMSO-D₆) δ: 11.98 (1H, br s), 8.10 (1H, d), 7.54 (1H, d), 7.37 (1H, s). Reference manufacturing example 4
A mixture of 1.52 g of triphosgene and 15 mL of THF was added dropwise to a mixture of 3.00 g of 4- (trifluoromethyl) anthranilic acid and 22 mL of THF under ice-cooling. The resulting mixture was stirred at room temperature for 4 hours. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain 3.30 g of Intermediate 30 represented by the following formula.

Intermediate 30: ¹ H-NMR (DMSO-D ₆ ) δ: 11.98 (1H, br s), 8.10 (1H, d), 7.54 (1H, d), 7.37 (1H, s).

中間体３１：¹H-NMR (DMSO-D₆) δ: 9.92 (1H, s), 5.83 (1H, d), 5.80-5.77 (1H, m), 5.26 (1H, d). Reference manufacturing example 4-1
Reference The compounds manufactured according to Production Example 4 and their physical property values are shown below.

Intermediate 31: ¹ H-NMR (DMSO-D ₆ ) δ: 9.92 (1H, s), 5.83 (1H, d), 5.80-5.77 (1H, m), 5.26 (1H, d).

中間体３２：¹H-NMR (CDCl₃) δ: 8.54 (1H, dd), 8.35 (1H, s), 7.67 (1H, d), 7.60 (1H, dd), 7.41 (1H, dd), 7.00 (1H, s), 6.98 (1H, d), 5.95 (2H, br s), 2.75 (2H, q), 1.27 (3H, t). Reference manufacturing example 5
To a mixture of 300 mg of intermediate Z and 4 mL of THF, 2.2 mL of potassium bis (trimethylsilyl) amide (1 mol / L THF solution) was added dropwise at −78 ° C. under a nitrogen atmosphere, and the mixture was stirred for 30 minutes. A mixture of 254 mg of Intermediate 30 and 4 mL of THF was added to the obtained mixture, and the mixture was stirred at room temperature for 30 minutes. A saturated aqueous solution of ammonium chloride was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. Hexane was added to the obtained residue, and the precipitated solid was filtered. The obtained solid was washed with hexane and dried under reduced pressure to obtain 491 mg of Intermediate 32 represented by the following formula.

Intermediate 32: ¹ H-NMR (CDCl ₃ ) δ: 8.54 (1H, dd), 8.35 (1H, s), 7.67 (1H, d), 7.60 (1H, dd), 7.41 (1H, dd), 7.00 (1H, s), 6.98 (1H, d), 5.95 (2H, br s), 2.75 (2H, q), 1.27 (3H, t).

中間体３３：¹H-NMR (CDCl₃) δ: 8.53-8.53 (1H, m), 8.33 (1H, s), 7.80 (1H, s), 7.57 (1H, d), 7.50 (1H, dd), 7.39 (1H, dd), 6.78 (1H, d), 6.14 (2H, s), 2.74 (2H, q), 1.26 (3H, t). Reference manufacturing example 5-1
Reference The compounds manufactured according to Production Example 5 and their physical property values are shown below.

Intermediate 33: ¹ H-NMR (CDCl ₃ ) δ: 8.53-8.53 (1H, m), 8.33 (1H, s), 7.80 (1H, s), 7.57 (1H, d), 7.50 (1H, dd) , 7.39 (1H, dd), 6.78 (1H, d), 6.14 (2H, s), 2.74 (2H, q), 1.26 (3H, t).

中間体３４：¹H-NMR (CDCl₃) δ: 8.61-8.60 (1H, m), 8.28 (1H, s), 7.56 (1H, d), 7.50-7.44 (2H, m), 6.57-6.54 (2H, m), 5.96 (2H, s), 2.71 (2H, q), 1.23 (3H, t).

Intermediate 34: ¹ H-NMR (CDCl ₃ ) δ: 8.61-8.60 (1H, m), 8.28 (1H, s), 7.56 (1H, d), 7.50-7.44 (2H, m), 6.57-6.54 ( 2H, m), 5.96 (2H, s), 2.71 (2H, q), 1.23 (3H, t).

中間体３５：¹H-NMR (CDCl₃) δ: 8.65 (1H, dd), 8.51 (1H, d), 8.20 (1H, s), 8.08 (1H, d), 7.77 (1H, dd), 7.61 (1H, dd), 7.50 (1H, dd), 2.77 (2H, q), 1.18 (3H, t). Reference manufacturing example 6
A mixture of 491 mg of Intermediate 32 and 11 mL of triethyl orthoformate was stirred at 100 ° C. for 1 hour. The resulting mixture was allowed to cool to room temperature and concentrated under reduced pressure. The obtained solid was washed with hexane to obtain 447 mg of Intermediate 35 represented by the following formula.

Intermediate 35: ¹ H-NMR (CDCl ₃ ) δ: 8.65 (1H, dd), 8.51 (1H, d), 8.20 (1H, s), 8.08 (1H, d), 7.77 (1H, dd), 7.61 (1H, dd), 7.50 (1H, dd), 2.77 (2H, q), 1.18 (3H, t).

中間体３６：¹H-NMR (CDCl₃) δ: 8.69-8.67 (1H, m), 8.65-8.64 (1H, m), 8.22 (1H, s), 8.03 (1H, dd), 7.92-7.90 (1H, m), 7.61 (1H, dd), 7.52-7.49 (1H, m), 2.78 (2H, q), 1.19 (3H, t). Reference manufacturing example 6-1
Reference The compounds manufactured according to Production Example 6 and their physical property values are shown below.

Intermediate 36: ¹ H-NMR (CDCl ₃ ) δ: 8.69-8.67 (1H, m), 8.65-8.64 (1H, m), 8.22 (1H, s), 8.03 (1H, dd), 7.92-7.90 ( 1H, m), 7.61 (1H, dd), 7.52-7.49 (1H, m), 2.78 (2H, q), 1.19 (3H, t).

中間体３７：¹H-NMR (CDCl₃) δ: 8.76-8.74 (1H, m), 8.22-8.20 (1H, m), 8.14 (1H, s), 7.85 (1H, d), 7.66 (1H, dd), 7.61 (1H, dd), 7.49 (1H, d), 2.77 (2H, q), 1.19 (3H, t).

Intermediate 37: ¹ H-NMR (CDCl ₃ ) δ: 8.76-8.74 (1H, m), 8.22-8.20 (1H, m), 8.14 (1H, s), 7.85 (1H, d), 7.66 (1H, 1H, dd), 7.61 (1H, dd), 7.49 (1H, d), 2.77 (2H, q), 1.19 (3H, t).

中間体３８：¹H-NMR (CDCl₃) δ: 9.06 (1H, dd), 8.47 (1H, d), 8.26 (1H, s), 8.09 (1H, d), 7.78 (1H, dd), 7.73 (1H, dd), 7.68 (1H, dd), 3.56 (2H, q), 1.46 (3H, t). Reference manufacturing example 7
Reference The compounds manufactured according to Production Example 3 and their physical property values are shown below.

Intermediate 38: ¹ H-NMR (CDCl ₃ ) δ: 9.06 (1H, dd), 8.47 (1H, d), 8.26 (1H, s), 8.09 (1H, d), 7.78 (1H, dd), 7.73 (1H, dd), 7.68 (1H, dd), 3.56 (2H, q), 1.46 (3H, t).

中間体３９：¹H-NMR (CDCl₃) δ: 9.06-9.05 (1H, m), 8.64-8.63 (1H, m), 8.28 (1H, s), 8.04 (1H, dd), 7.93-7.91 (1H, m), 7.73 (1H, dd), 7.69 (1H, dd), 3.59 (2H, q), 1.47 (3H, t).

Intermediate 39: ¹ H-NMR (CDCl ₃ ) δ: 9.06-9.05 (1H, m), 8.64-8.63 (1H, m), 8.28 (1H, s), 8.04 (1H, dd), 7.93-7.91 ( 1H, m), 7.73 (1H, dd), 7.69 (1H, dd), 3.59 (2H, q), 1.47 (3H, t).

中間体４０：¹H-NMR (CDCl₃) δ: 9.14 (1H, dd), 8.20 (1H, s), 8.17-8.15 (1H, m), 7.85 (1H, d), 7.79 (1H, dd), 7.67-7.65 (1H, m), 7.60 (1H, dd), 3.57 (2H, q), 1.46 (3H, t).

Intermediate 40: ¹ H-NMR (CDCl ₃ ) δ: 9.14 (1H, dd), 8.20 (1H, s), 8.17-8.15 (1H, m), 7.85 (1H, d), 7.79 (1H, dd) , 7.67-7.65 (1H, m), 7.60 (1H, dd), 3.57 (2H, q), 1.46 (3H, t).

本化合物１：¹H-NMR (CDCl₃) δ: 8.30 (1H, s), 7.56 (2H, d), 7.50 (1H, d), 7.44-7.38 (3H, m), 3.55 (3H, s), 2.40 (2H, q), 1.10 (3H, t). Production Example 1
To a mixture of 1.2 g of Intermediate 1, 0.88 g of cesium carbonate and 6 mL of DMF, 0.51 mL of methyl iodide was added under ice-cooling, and the mixture was stirred at room temperature for 2 hours. Water was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel chromatography (hexane: ethyl acetate = 1: 1) to obtain 810 mg of this compound 1.

This compound 1: ¹ H-NMR (CDCl ₃ ) δ: 8.30 (1H, s), 7.56 (2H, d), 7.50 (1H, d), 7.44-7.38 (3H, m), 3.55 (3H, s) , 2.40 (2H, q), 1.10 (3H, t).

で示される化合物において、Ａ²、Ａ³、Ａ⁴、Ａ⁵、Ｇ⁴、Ｒ¹、Ｒ^3b及びｎの組合せが［表Ｂ－１］に記載のいずれかの組合せである化合物。 Production Example 1-1
The compounds produced according to Production Example 1 and their physical property values are shown below.
Equation (B-1)

A compound in which the combination of A ² , A ³ , A ⁴ , A ⁵ , G ⁴ , R ¹ , R ^3b and n is any combination shown in [Table B-1].

本化合物２：¹H-NMR (CDCl₃) δ: 8.30 (1H, s), 7.70-7.66 (2H, m), 7.56-7.49 (2H, m), 7.41 (1H, d), 7.29-7.27 (1H, m), 3.58 (3H, s), 2.38 (2H, q), 1.11 (3H, t).
本化合物３：¹H-NMR (CDCl₃) δ: 8.30 (1H, d), 7.71-7.66 (2H, m), 7.55-7.50 (2H, m), 7.41 (1H, d), 7.29-7.27 (1H, m), 4.10 (2H, q), 2.31 (2H, q), 1.34 (3H, t), 1.11 (3H, t).
本化合物４：¹H-NMR (CDCl₃) δ: 8.51 (1H, s), 7.72-7.69 (2H, m), 7.61 (1H, s), 7.53 (1H, d), 7.48 (1H, d), 7.31-7.30 (1H, m), 3.59 (3H, s), 2.39 (2H, q), 1.11 (3H, t).
本化合物５：¹H-NMR (CDCl₃) δ: 8.19 (1H, s), 7.69-7.66 (2H, m), 7.56-7.51 (2H, m), 7.29-7.27 (2H, m), 3.56 (3H, s), 2.37 (2H, q), 1.10 (3H, t).
本化合物６：¹H-NMR (CDCl₃) δ: 8.61 (1H, s), 8.52 (1H, s), 7.68-7.66 (2H, m), 7.54 (1H, d), 7.28-7.25 (1H, m), 3.59 (3H, s), 2.38 (2H, q), 1.10 (3H, t).
本化合物７：¹H-NMR (CDCl₃) δ: 8.31 (1H, s), 7.53-7.41 (6H, m), 3.56 (3H, s), 2.32 (2H, q), 1.10 (3H, t).
本化合物８：¹H-NMR (CDCl₃) δ: 8.31 (1H, s), 7.55-7.40 (6H, m), 4.08 (2H, q), 2.23 (2H, q), 1.32 (3H, t), 1.10 (3H, t).
本化合物９：¹H-NMR (CDCl₃) δ: 8.39 (1H, s), 7.53-7.36 (6H, m), 3.53 (3H, s), 2.29 (2H, q), 1.07 (3H, t).
本化合物１０：¹H-NMR (CDCl₃) δ: 8.51-8.50 (1H, m), 8.07 (1H, d), 7.41-7.36 (4H, m), 6.95-6.93 (1H, m), 3.39 (3H, s), 3.17 (2H, q), 1.27 (3H, t).
本化合物１５：¹H-NMR (CDCl₃) δ: 8.31 (1H, s), 7.90-7.87 (1H, m), 7.56 (1H, d), 7.51 (1H, d), 7.39 (1H, d), 7.31 (1H, d), 6.84 (1H, t), 3.52 (3H, s), 2.37 (2H, q), 1.12 (3H, t).
本化合物１６：¹H-NMR (CDCl₃) δ: 8.31 (1H, s), 7.50 (1H, d), 7.40 (1H, d), 7.32-7.28 (4H, m), 3.53 (3H, s), 2.40 (2H, q), 1.11 (3H, t).
本化合物１７：¹H-NMR (CDCl₃) δ: 8.23 (1H, s), 7.57 (1H, d), 7.51 (2H, d), 7.32 (1H, d), 7.00 (2H, d), 3.55 (3H, s), 2.34 (2H, q), 1.10 (3H, t).
本化合物１８：¹H-NMR (CDCl₃) δ: 8.22 (1H, s), 7.56 (1H, d), 7.45 (2H, d), 7.30 (1H, d), 6.70 (2H, d), 4.28-4.26 (2H, m), 3.54 (3H, s), 2.37 (2H, q), 1.10 (3H, t).
本化合物１９：¹H-NMR (CDCl₃) δ: 8.30 (1H, s), 7.53-7.46 (6H, m), 3.56 (3H, s), 2.47 (2H, q), 1.13 (3H, t).
本化合物２０：¹H-NMR (CDCl₃) δ: 8.38 (1H, s), 7.90-7.87 (2H, m), 7.71 (1H, s), 7.52 (1H, d), 7.38 (1H, d), 3.57 (3H, s), 2.46 (2H, q), 1.11 (3H, t).
本化合物２１：¹H-NMR (CDCl₃) δ: 8.29 (1H, s), 7.91-7.87 (2H, m), 7.74 (1H, s), 7.50 (1H, d), 7.42 (1H, d), 3.56 (3H, s), 2.51 (2H, q), 1.13 (3H, t).
本化合物２２：¹H-NMR (CDCl₃) δ: 8.41 (1H, t), 7.80 (1H, s), 7.60 (2H, d), 7.52 (1H, dd), 7.38 (1H, d), 3.54 (3H, s), 2.46 (2H, q), 1.12 (3H, t).
本化合物２３：¹H-NMR (CDCl₃) δ: 8.45-8.43 (1H, m), 7.54-7.50 (4H, m), 7.39 (1H, d), 3.51 (3H, s), 2.46 (2H, q), 1.13 (3H, t).
本化合物２４：¹H-NMR (CDCl₃) δ: 8.50 (1H, d), 8.41 (1H, dd), 8.34 (1H, d), 8.06 (1H, t), 7.54-7.51 (1H, m), 7.38 (1H, dd), 3.55 (3H, s), 2.47 (2H, q), 1.13 (3H, t).
本化合物２５：¹H-NMR (CDCl₃) δ: 8.44-8.43 (1H, m), 7.52 (1H, dd), 7.39 (1H, d), 7.34-7.32 (2H, m), 7.22-7.20 (1H, m), 3.51 (3H, s), 2.46 (2H, q), 1.13 (3H, t).
本化合物２６：¹H-NMR (CDCl₃) δ: 8.32 (1H, s), 7.50 (1H, d), 7.42 (1H, d), 7.21-7.19 (1H, m), 7.05-7.05 (1H, m), 6.83-6.81 (1H, m), 3.54 (3H, s), 2.46 (2H, q), 1.12 (3H, t).
本化合物２７：¹H-NMR (CDCl₃) δ: 8.33 (1H, s), 7.51 (1H, d), 7.42-7.36 (3H, m), 7.25 (1H, d), 3.55 (3H, s), 2.52 (2H, q), 1.14 (3H, t).
本化合物２８：¹H-NMR (CDCl₃) δ: 8.31 (1H, s), 7.49 (1H, d), 7.40 (1H, d), 7.35-7.32 (1H, m), 7.16-7.12 (1H, m), 6.91-6.88 (1H, m), 3.51 (3H, s), 2.43 (2H, q), 1.11 (3H, t).
本化合物３２：¹H-NMR (CDCl₃) δ: 8.82 (1H, s), 7.88-7.41 (6H, m), 3.53-3.43 (5H, m), 1.38-1.20 (3H, m).
本化合物３３：¹H-NMR (CDCl₃) δ: 8.97 (1H, s), 7.84-7.39 (6H, m), 4.08-3.86 (2H, m), 3.61-3.36 (2H, m), 1.35-1.17 (6H, m).
本化合物３８：¹H-NMR (CDCl₃) δ: 8.92-8.84 (1H, s), 7.75-7.55 (6H, m), 3.56-3.31 (5H, m), 1.42-1.26 (3H, m).
本化合物４４：¹H-NMR (CDCl₃) δ: 9.00 (1H, s), 7.84-7.40 (5H, m), 3.61-3.48 (2H, m), 3.40 (3H, s), 1.49-1.39 (3H, m). [Table B-1]

This compound 2: ¹ H-NMR (CDCl ₃ ) δ: 8.30 (1H, s), 7.70-7.66 (2H, m), 7.56-7.49 (2H, m), 7.41 (1H, d), 7.29-7.27 ( 1H, m), 3.58 (3H, s), 2.38 (2H, q), 1.11 (3H, t).
This compound 3: ¹ H-NMR (CDCl ₃ ) δ: 8.30 (1H, d), 7.71-7.66 (2H, m), 7.55-7.50 (2H, m), 7.41 (1H, d), 7.29-7.27 ( 1H, m), 4.10 (2H, q), 2.31 (2H, q), 1.34 (3H, t), 1.11 (3H, t).
This compound 4: ¹ H-NMR (CDCl ₃ ) δ: 8.51 (1H, s), 7.72-7.69 (2H, m), 7.61 (1H, s), 7.53 (1H, d), 7.48 (1H, d) , 7.31-7.30 (1H, m), 3.59 (3H, s), 2.39 (2H, q), 1.11 (3H, t).
This compound 5: ¹ H-NMR (CDCl ₃ ) δ: 8.19 (1H, s), 7.69-7.66 (2H, m), 7.56-7.51 (2H, m), 7.29-7.27 (2H, m), 3.56 ( 3H, s), 2.37 (2H, q), 1.10 (3H, t).
This compound 6: ¹ H-NMR (CDCl ₃ ) δ: 8.61 (1H, s), 8.52 (1H, s), 7.68-7.66 (2H, m), 7.54 (1H, d), 7.28-7.25 (1H, m), 3.59 (3H, s), 2.38 (2H, q), 1.10 (3H, t).
This compound 7: ¹ H-NMR (CDCl ₃ ) δ: 8.31 (1H, s), 7.53-7.41 (6H, m), 3.56 (3H, s), 2.32 (2H, q), 1.10 (3H, t) ..
This compound 8: ¹ H-NMR (CDCl ₃ ) δ: 8.31 (1H, s), 7.55-7.40 (6H, m), 4.08 (2H, q), 2.23 (2H, q), 1.32 (3H, t) , 1.10 (3H, t).
This compound 9: ¹ H-NMR (CDCl ₃ ) δ: 8.39 (1H, s), 7.53-7.36 (6H, m), 3.53 (3H, s), 2.29 (2H, q), 1.07 (3H, t) ..
This compound 10: ¹ H-NMR (CDCl ₃ ) δ: 8.51-8.50 (1H, m), 8.07 (1H, d), 7.41-7.36 (4H, m), 6.95-6.93 (1H, m), 3.39 ( 3H, s), 3.17 (2H, q), 1.27 (3H, t).
This compound 15: ¹ H-NMR (CDCl ₃ ) δ: 8.31 (1H, s), 7.90-7.87 (1H, m), 7.56 (1H, d), 7.51 (1H, d), 7.39 (1H, d) , 7.31 (1H, d), 6.84 (1H, t), 3.52 (3H, s), 2.37 (2H, q), 1.12 (3H, t).
This compound 16: ¹ H-NMR (CDCl ₃ ) δ: 8.31 (1H, s), 7.50 (1H, d), 7.40 (1H, d), 7.32-7.28 (4H, m), 3.53 (3H, s) , 2.40 (2H, q), 1.11 (3H, t).
This compound 17: ¹ H-NMR (CDCl ₃ ) δ: 8.23 (1H, s), 7.57 (1H, d), 7.51 (2H, d), 7.32 (1H, d), 7.00 (2H, d), 3.55 (3H, s), 2.34 (2H, q), 1.10 (3H, t).
This compound 18: ¹ H-NMR (CDCl ₃ ) δ: 8.22 (1H, s), 7.56 (1H, d), 7.45 (2H, d), 7.30 (1H, d), 6.70 (2H, d), 4.28 -4.26 (2H, m), 3.54 (3H, s), 2.37 (2H, q), 1.10 (3H, t).
This compound 19: ¹ H-NMR (CDCl ₃ ) δ: 8.30 (1H, s), 7.53-7.46 (6H, m), 3.56 (3H, s), 2.47 (2H, q), 1.13 (3H, t) ..
This compound 20: ¹ H-NMR (CDCl ₃ ) δ: 8.38 (1H, s), 7.90-7.87 (2H, m), 7.71 (1H, s), 7.52 (1H, d), 7.38 (1H, d) , 3.57 (3H, s), 2.46 (2H, q), 1.11 (3H, t).
This compound 21: ¹ H-NMR (CDCl ₃ ) δ: 8.29 (1H, s), 7.91-7.87 (2H, m), 7.74 (1H, s), 7.50 (1H, d), 7.42 (1H, d) , 3.56 (3H, s), 2.51 (2H, q), 1.13 (3H, t).
This compound 22: ¹ H-NMR (CDCl ₃ ) δ: 8.41 (1H, t), 7.80 (1H, s), 7.60 (2H, d), 7.52 (1H, dd), 7.38 (1H, d), 3.54 (3H, s), 2.46 (2H, q), 1.12 (3H, t).
This compound 23: ¹ H-NMR (CDCl ₃ ) δ: 8.45-8.43 (1H, m), 7.54-7.50 (4H, m), 7.39 (1H, d), 3.51 (3H, s), 2.46 (2H, q), 1.13 (3H, t).
This compound 24: ¹ H-NMR (CDCl ₃ ) δ: 8.50 (1H, d), 8.41 (1H, dd), 8.34 (1H, d), 8.06 (1H, t), 7.54-7.51 (1H, m) , 7.38 (1H, dd), 3.55 (3H, s), 2.47 (2H, q), 1.13 (3H, t).
This compound 25: ¹ H-NMR (CDCl ₃ ) δ: 8.44-8.43 (1H, m), 7.52 (1H, dd), 7.39 (1H, d), 7.34-7.32 (2H, m), 7.22-7.20 ( 1H, m), 3.51 (3H, s), 2.46 (2H, q), 1.13 (3H, t).
This compound 26: ¹ H-NMR (CDCl ₃ ) δ: 8.32 (1H, s), 7.50 (1H, d), 7.42 (1H, d), 7.21-7.19 (1H, m), 7.05-7.05 (1H, m) m), 6.83-6.81 (1H, m), 3.54 (3H, s), 2.46 (2H, q), 1.12 (3H, t).
This compound 27: ¹ H-NMR (CDCl ₃ ) δ: 8.33 (1H, s), 7.51 (1H, d), 7.42-7.36 (3H, m), 7.25 (1H, d), 3.55 (3H, s) , 2.52 (2H, q), 1.14 (3H, t).
This compound 28: ¹ H-NMR (CDCl ₃ ) δ: 8.31 (1H, s), 7.49 (1H, d), 7.40 (1H, d), 7.35-7.32 (1H, m), 7.16-7.12 (1H, m), 6.91-6.88 (1H, m), 3.51 (3H, s), 2.43 (2H, q), 1.11 (3H, t).
This compound 32: ¹ H-NMR (CDCl ₃ ) δ: 8.82 (1H, s), 7.88-7.41 (6H, m), 3.53-3.43 (5H, m), 1.38-1.20 (3H, m).
This compound 33: ¹ H-NMR (CDCl ₃ ) δ: 8.97 (1H, s), 7.84-7.39 (6H, m), 4.08-3.86 (2H, m), 3.61-3.36 (2H, m), 1.35- 1.17 (6H, m).
This compound 38: ¹ H-NMR (CDCl ₃ ) δ: 8.92-8.84 (1H, s), 7.75-7.55 (6H, m), 3.56-3.31 (5H, m), 1.42-1.26 (3H, m).
This compound 44: ¹ H-NMR (CDCl ₃ ) δ: 9.00 (1H, s), 7.84-7.40 (5H, m), 3.61-3.48 (2H, m), 3.40 (3H, s), 1.49-1.39 ( 3H, m).

In the compound represented by the formula (B-1), the combination of A ² , A ³ , A ⁴ , A ⁵ , G ⁴ , R ¹ , R ^3b and n is any combination shown in [Table C-1]. The compound that is.

本化合物６４：¹H-NMR (CDCl₃) δ: 8.40 (1H, s), 7.56 (2H, d), 7.51 (1H, dd), 7.45-7.35 (3H, m), 3.55 (3H, s), 2.39 (2H, q), 1.10 (3H, t).
本化合物６５：¹H-NMR (CDCl₃) δ: 8.98 (1H, s), 7.88-7.49 (6H, m), 3.50-3.40 (5H, m), 1.35 (3H, t).
本化合物６７：¹H-NMR (CDCl₃) δ: 8.36 (1H, s), 8.28 (1H, s), 8.14 (1H, s), 7.44-7.31 (3H, m), 3.62 (3H, s), 2.57 (2H, q), 1.15 (3H, t).
本化合物６８：¹H-NMR (CDCl₃) δ: 8.43 (1H, s), 8.17 (1H, d), 7.90 (1H, t), 7.50 (1H, d), 7.32-7.29 (2H, m), 3.64 (3H, s), 2.65 (2H, q), 1.22 (3H, t).
本化合物７３：¹H-NMR (CDCl₃) δ: 8.47 (1H, s), 8.32-8.26 (1H, m), 8.14 (1H, s), 7.45 (1H, d), 7.35 (1H, d), 7.31 (1H, d), 3.62 (3H, s), 2.57 (2H, q), 1.15 (3H, t).
本化合物７５：¹H-NMR (CDCl₃) δ: 8.55 (1H, s), 7.78 (1H, dd), 7.71 (1H, d), 7.49 (1H, dd), 7.30-7.27 (1H, m), 6.84 (1H, t), 3.54 (3H, s), 2.46 (2H, q), 1.13 (3H, t).
本化合物７６：¹H-NMR (CDCl₃) δ: 8.41 (1H, s), 7.99 (1H, s), 7.78 (1H, s), 7.62 (1H, s), 7.52 (1H, dd), 7.39 (1H, dd), 3.53 (3H, s), 2.46 (2H, q), 1.12 (3H, t).
本化合物７７：LCMS:５０７[M+H]⁺, RT = 1.97 分
本化合物７８：¹H-NMR (CDCl₃) δ: 8.42-8.41 (1H, m), 7.91-7.89 (2H, m), 7.80-7.78 (1H, m), 7.60-7.57 (1H, m), 7.43-7.40 (1H, m), 4.95 (2H, s), 2.60 (2H, q), 1.18 (3H, t).
本化合物８３：¹H-NMR (CDCl₃) δ: 8.40-8.40 (1H, m), 7.50-7.47 (1H, m), 7.42-7.38 (3H, m), 6.64 (2H, d), 3.72 (3H, s), 3.53 (3H, s), 2.31 (2H, q), 1.07 (3H, t).
本化合物８４：¹H-NMR (CDCl₃) δ: 8.41-8.40 (1H, m), 7.53-7.49 (1H, m), 7.39-7.36 (3H, m), 7.13-7.10 (2H, m), 3.52 (3H, s), 2.38 (2H, q), 1.09 (3H, t).
本化合物８５：¹H-NMR (CDCl₃) δ: 8.41-8.40 (1H, m), 7.54-7.49 (2H, m), 7.40-7.37 (1H, m), 7.23-7.20 (2H, m), 7.06-7.02 (1H, m), 3.52 (3H, s), 2.37 (2H, q), 1.11 (3H, t).
本化合物８６：¹H-NMR (CDCl₃) δ: 8.41-8.40 (1H, m), 7.59-7.57 (2H, m), 7.53-7.51 (1H, m), 7.41-7.37 (3H, m), 3.55 (3H, s), 2.32 (2H, q), 1.08 (3H, t).
本化合物８７：¹H-NMR (CDCl₃) δ: 8.38-8.37 (1H, m), 7.71-7.70 (1H, m), 7.64-7.62 (1H, m), 7.52-7.45 (2H, m), 7.39-7.29 (2H, m), 3.56 (3H, s), 2.37 (2H, q), 1.08 (3H, t).
本化合物８９：¹H-NMR (CDCl₃) δ: 8.45-8.43 (1H, m), 7.89-7.88 (1H, m), 7.73-7.73 (2H, m), 7.54-7.51 (1H, m), 7.41-7.38 (1H, m), 3.50 (3H, s), 2.45 (2H, q), 1.14 (3H, t).
本化合物９０：¹H-NMR (CDCl₃) δ: 8.31 (1H, dd), 7.51-7.48 (3H, m), 7.40 (1H, dd), 6.99 (2H, d), 3.53 (3H, s), 2.33 (2H, q), 1.08 (3H, t).
本化合物９１：¹H-NMR (DMSO-D₆) δ: 8.58 (1H, s), 7.67 (1H, d), 7.60 (1H, d), 7.39 (2H, d), 7.31 (1H, s), 7.09 (1H, s), 3.41 (3H, s), 2.43 (2H, q), 0.96 (3H, t).
本化合物９２：¹H-NMR (DMSO-D₆) δ: 8.59 (1H, s), 7.67 (1H, d), 7.58 (1H, d), 7.35 (2H, d), 7.22 (1H, t), 6.99 (2H, d), 3.38 (3H, s), 2.41 (2H, q), 0.96 (3H, t).
本化合物９３：¹H-NMR (DMSO-D₆) δ: 8.58 (1H, s), 7.66 (1H, d), 7.58 (1H, d), 7.26 (1H, t), 7.16 (1H, d), 7.11-7.04 (2H, m), 7.07 (1H, t), 3.39 (3H, s), 2.42 (2H, q), 0.96 (3H, t).
本化合物１０２：¹H-NMR (DMSO-D₆) δ: 8.72 (1H, s), 7.89 (1H, d), 7.72 (1H, dd), 7.56 (2H, d), 7.43 (2H, dt), 3.43 (3H, s), 2.42 (2H, q), 0.98 (3H, t).
本化合物１０３：¹H-NMR (CDCl₃) δ: 8.20 (1H, s), 7.56-7.42 (5H, m), 7.31 (1H, ｍ), 3.54 (3H, s), 2.29 (2H, q), 1.08 (3H, t).
本化合物１０４：¹H-NMR (DMSO-D₆) δ: 8.56 (1H, s), 7.73 (1H, t), 7.54 (3H, dt), 7.42 (2H, t), 3.41 (3H, s), 2.37 (2H, q), 0.96 (3H, t).
本化合物１０５：¹H-NMR (DMSO-D₆) δ: 8.56 (1H, s), 7.73 (1H, t), 7.56-7.52 (3H, m), 7.43-7.42 (2H, m), 3.41 (3H, s), 2.37 (2H, q), 0.96 (3H, t).
本化合物１０６：¹H-NMR (CDCl₃) δ: 8.31-8.27 (1H, m),7.57-7.31 (6H, m), 4.06 (2H, q), 2.33 (2H, q), 1.32 (3H, t), 1.10 (3H, t).
本化合物１０７：¹H-NMR (CDCl₃) δ: 8.31-8.28 (1H, m), 7.59-7.38 (6H, m), 3.92 (2H, d), 2.33 (2H, q), 1.26-1.17 (1H, m), 1.10 (3H, t), 0.45-0.43 (2H, m), 0.24-0.23 (2H, m).
本化合物１０８：¹H-NMR (CDCl₃) δ: 8.33-8.32 (1H, m), 7.60-7.44 (6H, m), 4.93 (2H, s), 2.52 (2H, q), 1.16 (3H, t).
本化合物１１３：¹H-NMR (CDCl₃) δ: 8.40-8.39 (1H, m), 7.80-7.78 (1H, m), 7.62-7.59 (1H, m), 7.54-7.51 (2H, m), 7.40-7.38 (1H, m), 7.25 (1H, t), 3.54 (3H, s), 2.45 (2H, q), 1.12 (3H, t).
本化合物１１４：¹H-NMR (CDCl₃) δ: 8.52-8.51 (1H, m), 7.90-7.88 (2H, m), 7.73-7.70 (2H, m), 7.51-7.49 (1H, m), 3.59 (3H, s), 2.50 (2H, q), 1.13 (3H, t).
本化合物１１５：¹H-NMR (CDCl₃) δ: 7.90 (2H, s), 7.70 (1H, s), 7.66 (1H, d), 7.49 (1H, d), 7.13 (1H, dd), 3.83 (3H, s), 3.57 (3H, s), 2.45 (2H, q), 1.11 (3H, t).
本化合物１１６：¹H-NMR (DMSO-D₆) δ: 8.59-8.58 (1H, m), 7.68-7.57 (2H, m), 7.32-7.26 (4H, m), 3.39 (3H, s), 2.48-2.43 (2H, q), 0.97 (3H, t).
本化合物１１７：¹H-NMR (DMSO-D₆) δ: 8.60-8.60 (1H, m), 7.69-7.58 (2H, m), 7.37-7.35 (2H, m), 7.22-7.14 (2H, m),3.39 (3H, s), 2.49-2.43 (2H, q), 0.96 (3H, t).
本化合物１１８：¹H-NMR (CDCl₃) δ: 8.45-8.44 (1H, m), 7.55-7.52 (1H, m), 7.41-7.38 (1H, m), 7.12-7.08 (2H, m), 3.51 (3H, s), 2.49 (2H, q), 1.13 (3H, t).
本化合物１１９：¹H-NMR (CDCl₃) δ: 8.18-8.16 (1H, m), 7.58-7.20 (11H, m), 5.27 (2H, s), 1.68-1.66 (2H, m), 0.81 (3H, t).
本化合物１２０：¹H-NMR (CDCl₃) δ: 8.52-8.51 (1H, m), 8.49-8.47 (1H, m), 8.17-8.16 (1H, m), 7.97-7.95 (1H, m),7.59-7.51 (3H, m),7.42-7.40 (3H, m), 7.26-7.24 (1H, m),5.27 (2H, s), 1.76 (2H, q), 0.84 (3H, t).
本化合物１２１：¹H-NMR (CDCl₃) δ: 8.42-8.41 (1H, m), 7.53-7.37 (2H, m), 7.08-7.07 (2H, m), 6.78-6.76 (1H, m),6.53-6.17 (2H, m), 3.53 (3H, s), 2.42 (2H, q), 1.11 (3H, t).
本化合物１２２：¹H-NMR (CDCl₃) δ: 8.43-8.42 (1H, m), 7.66-7.65 (1H, m), 7.54-7.51 (2H, m), 6.95-6.93 (1H, m),6.64-6.28 (2H, m),3.52 (3H, s), 2.41 (2H, q), 1.11 (3H, t).
本化合物１２３：¹H-NMR (CDCl₃) δ: 8.42-8.42 (1H, m), 7.55-7.51 (5H, m), 7.40-7.38 (1H, m), 3.54 (3H, s), 2.40 (2H, q), 1.10 (3H, t).
本化合物１２４：LCMS:６１８[M+H]⁺, RT = 2.40 分 [Table C-1]

This compound 64: ¹ H-NMR (CDCl ₃ ) δ: 8.40 (1H, s), 7.56 (2H, d), 7.51 (1H, dd), 7.45-7.35 (3H, m), 3.55 (3H, s) , 2.39 (2H, q), 1.10 (3H, t).
This compound 65: ¹ H-NMR (CDCl ₃ ) δ: 8.98 (1H, s), 7.88-7.49 (6H, m), 3.50-3.40 (5H, m), 1.35 (3H, t).
This compound 67: ¹ H-NMR (CDCl ₃ ) δ: 8.36 (1H, s), 8.28 (1H, s), 8.14 (1H, s), 7.44-7.31 (3H, m), 3.62 (3H, s) , 2.57 (2H, q), 1.15 (3H, t).
This compound 68: ¹ H-NMR (CDCl ₃ ) δ: 8.43 (1H, s), 8.17 (1H, d), 7.90 (1H, t), 7.50 (1H, d), 7.32-7.29 (2H, m) , 3.64 (3H, s), 2.65 (2H, q), 1.22 (3H, t).
This compound 73: ¹ H-NMR (CDCl ₃ ) δ: 8.47 (1H, s), 8.32-8.26 (1H, m), 8.14 (1H, s), 7.45 (1H, d), 7.35 (1H, d) , 7.31 (1H, d), 3.62 (3H, s), 2.57 (2H, q), 1.15 (3H, t).
This compound 75: ¹ H-NMR (CDCl ₃ ) δ: 8.55 (1H, s), 7.78 (1H, dd), 7.71 (1H, d), 7.49 (1H, dd), 7.30-7.27 (1H, m) , 6.84 (1H, t), 3.54 (3H, s), 2.46 (2H, q), 1.13 (3H, t).
This compound 76: ¹ H-NMR (CDCl ₃ ) δ: 8.41 (1H, s), 7.99 (1H, s), 7.78 (1H, s), 7.62 (1H, s), 7.52 (1H, dd), 7.39 (1H, dd), 3.53 (3H, s), 2.46 (2H, q), 1.12 (3H, t).
Compound 77: LCMS: 507 [M + H] ⁺ , RT = 1.97 Compound 78: ¹ H-NMR (CDCl ₃ ) δ: 8.42-8.41 (1H, m), 7.91-7.89 (2H, m), 7.80-7.78 (1H, m), 7.60-7.57 (1H, m), 7.43-7.40 (1H, m), 4.95 (2H, s), 2.60 (2H, q), 1.18 (3H, t).
This compound 83: ¹ H-NMR (CDCl ₃ ) δ: 8.40-8.40 (1H, m), 7.50-7.47 (1H, m), 7.42-7.38 (3H, m), 6.64 (2H, d), 3.72 ( 3H, s), 3.53 (3H, s), 2.31 (2H, q), 1.07 (3H, t).
This compound 84: ¹ H-NMR (CDCl ₃ ) δ: 8.41-8.40 (1H, m), 7.53-7.49 (1H, m), 7.39-7.36 (3H, m), 7.13-7.10 (2H, m), 3.52 (3H, s), 2.38 (2H, q), 1.09 (3H, t).
This compound 85: ¹ H-NMR (CDCl ₃ ) δ: 8.41-8.40 (1H, m), 7.54-7.49 (2H, m), 7.40-7.37 (1H, m), 7.23-7.20 (2H, m), 7.06-7.02 (1H, m), 3.52 (3H, s), 2.37 (2H, q), 1.11 (3H, t).
This compound 86: ¹ H-NMR (CDCl ₃ ) δ: 8.41-8.40 (1H, m), 7.59-7.57 (2H, m), 7.53-7.51 (1H, m), 7.41-7.37 (3H, m), 3.55 (3H, s), 2.32 (2H, q), 1.08 (3H, t).
This compound 87: ¹ H-NMR (CDCl ₃ ) δ: 8.38-8.37 (1H, m), 7.71-7.70 (1H, m), 7.64-7.62 (1H, m), 7.52-7.45 (2H, m), 7.39-7.29 (2H, m), 3.56 (3H, s), 2.37 (2H, q), 1.08 (3H, t).
This compound 89: ¹ H-NMR (CDCl ₃ ) δ: 8.45-8.43 (1H, m), 7.89-7.88 (1H, m), 7.73-7.73 (2H, m), 7.54-7.51 (1H, m), 7.41-7.38 (1H, m), 3.50 (3H, s), 2.45 (2H, q), 1.14 (3H, t).
This compound 90: ¹ H-NMR (CDCl ₃ ) δ: 8.31 (1H, dd), 7.51-7.48 (3H, m), 7.40 (1H, dd), 6.99 (2H, d), 3.53 (3H, s) , 2.33 (2H, q), 1.08 (3H, t).
This compound 91: ¹ H-NMR (DMSO-D ₆ ) δ: 8.58 (1H, s), 7.67 (1H, d), 7.60 (1H, d), 7.39 (2H, d), 7.31 (1H, s) , 7.09 (1H, s), 3.41 (3H, s), 2.43 (2H, q), 0.96 (3H, t).
This compound 92: ¹ H-NMR (DMSO-D ₆ ) δ: 8.59 (1H, s), 7.67 (1H, d), 7.58 (1H, d), 7.35 (2H, d), 7.22 (1H, t) , 6.99 (2H, d), 3.38 (3H, s), 2.41 (2H, q), 0.96 (3H, t).
This compound 93: ¹ H-NMR (DMSO-D ₆ ) δ: 8.58 (1H, s), 7.66 (1H, d), 7.58 (1H, d), 7.26 (1H, t), 7.16 (1H, d) , 7.11-7.04 (2H, m), 7.07 (1H, t), 3.39 (3H, s), 2.42 (2H, q), 0.96 (3H, t).
This compound 102: ¹ H-NMR (DMSO-D ₆ ) δ: 8.72 (1H, s), 7.89 (1H, d), 7.72 (1H, dd), 7.56 (2H, d), 7.43 (2H, dt) , 3.43 (3H, s), 2.42 (2H, q), 0.98 (3H, t).
This compound 103: ¹ H-NMR (CDCl ₃ ) δ: 8.20 (1H, s), 7.56-7.42 (5H, m), 7.31 (1H, m), 3.54 (3H, s), 2.29 (2H, q) , 1.08 (3H, t).
This compound 104: ¹ H-NMR (DMSO-D ₆ ) δ: 8.56 (1H, s), 7.73 (1H, t), 7.54 (3H, dt), 7.42 (2H, t), 3.41 (3H, s) , 2.37 (2H, q), 0.96 (3H, t).
This compound 105: ¹ H-NMR (DMSO-D ₆ ) δ: 8.56 (1H, s), 7.73 (1H, t), 7.56-7.52 (3H, m), 7.43-7.42 (2H, m), 3.41 ( 3H, s), 2.37 (2H, q), 0.96 (3H, t).
This compound 106: ¹ H-NMR (CDCl ₃ ) δ: 8.31-8.27 (1H, m), 7.57-7.31 (6H, m), 4.06 (2H, q), 2.33 (2H, q), 1.32 (3H, m) t), 1.10 (3H, t).
This compound 107: ¹ H-NMR (CDCl ₃ ) δ: 8.31-8.28 (1H, m), 7.59-7.38 (6H, m), 3.92 (2H, d), 2.33 (2H, q), 1.26-1.17 ( 1H, m), 1.10 (3H, t), 0.45-0.43 (2H, m), 0.24-0.23 (2H, m).
This compound 108: ¹ H-NMR (CDCl ₃ ) δ: 8.33-8.32 (1H, m), 7.60-7.44 (6H, m), 4.93 (2H, s), 2.52 (2H, q), 1.16 (3H, m) t).
This compound 113: ¹ H-NMR (CDCl ₃ ) δ: 8.40-8.39 (1H, m), 7.80-7.78 (1H, m), 7.62-7.59 (1H, m), 7.54-7.51 (2H, m), 7.40-7.38 (1H, m), 7.25 (1H, t), 3.54 (3H, s), 2.45 (2H, q), 1.12 (3H, t).
This compound 114: ¹ H-NMR (CDCl ₃ ) δ: 8.52-8.51 (1H, m), 7.90-7.88 (2H, m), 7.73-7.70 (2H, m), 7.51-7.49 (1H, m), 3.59 (3H, s), 2.50 (2H, q), 1.13 (3H, t).
This compound 115: ¹ H-NMR (CDCl ₃ ) δ: 7.90 (2H, s), 7.70 (1H, s), 7.66 (1H, d), 7.49 (1H, d), 7.13 (1H, dd), 3.83 (3H, s), 3.57 (3H, s), 2.45 (2H, q), 1.11 (3H, t).
This compound 116: ¹ H-NMR (DMSO-D ₆ ) δ: 8.59-8.58 (1H, m), 7.68-7.57 (2H, m), 7.32-7.26 (4H, m), 3.39 (3H, s), 2.48-2.43 (2H, q), 0.97 (3H, t).
This compound 117: ¹ H-NMR (DMSO-D ₆ ) δ: 8.60-8.60 (1H, m), 7.69-7.58 (2H, m), 7.37-7.35 (2H, m), 7.22-7.14 (2H, m) ), 3.39 (3H, s), 2.49-2.43 (2H, q), 0.96 (3H, t).
This compound 118: ¹ H-NMR (CDCl ₃ ) δ: 8.45-8.44 (1H, m), 7.55-7.52 (1H, m), 7.41-7.38 (1H, m), 7.12-7.08 (2H, m), 3.51 (3H, s), 2.49 (2H, q), 1.13 (3H, t).
This compound 119: ¹ H-NMR (CDCl ₃ ) δ: 8.18-8.16 (1H, m), 7.58-7.20 (11H, m), 5.27 (2H, s), 1.68-1.66 (2H, m), 0.81 ( 3H, t).
This compound 120: ¹ H-NMR (CDCl ₃ ) δ: 8.52-8.51 (1H, m), 8.49-8.47 (1H, m), 8.17-8.16 (1H, m), 7.97-7.95 (1H, m), 7.59-7.51 (3H, m), 7.42-7.40 (3H, m), 7.26-7.24 (1H, m), 5.27 (2H, s), 1.76 (2H, q), 0.84 (3H, t).
This compound 121: ¹ H-NMR (CDCl ₃ ) δ: 8.42-8.41 (1H, m), 7.53-7.37 (2H, m), 7.08-7.07 (2H, m), 6.78-6.76 (1H, m), 6.53-6.17 (2H, m), 3.53 (3H, s), 2.42 (2H, q), 1.11 (3H, t).
Compound 122: ¹ H-NMR (CDCl ₃ ) δ: 8.43-8.42 (1H, m), 7.66-7.65 (1H, m), 7.54-7.51 (2H, m), 6.95-6.93 (1H, m), 6.64-6.28 (2H, m), 3.52 (3H, s), 2.41 (2H, q), 1.11 (3H, t).
This compound 123: ¹ H-NMR (CDCl ₃ ) δ: 8.42-8.42 (1H, m), 7.55-7.51 (5H, m), 7.40-7.38 (1H, m), 3.54 (3H, s), 2.40 ( 2H, q), 1.10 (3H, t).
This compound 124: LCMS: 618 [M + H] ⁺ , RT = 2.40 minutes

で示される化合物において、Ａ²、Ａ³、Ａ⁴、Ａ⁵、Ｇ⁴、Ｒ¹、Ｒ^3b及びｎの組合せが［表Ｂ－２］及び［表Ｂ－３］に記載のいずれかの組合せである化合物。 Production Example 1-2
Reference The compounds manufactured according to Production Example 3 and their physical property values are shown below.
Equation (B-2)

In the compound represented by, the combination of A ² , A ³ , A ⁴ , A ⁵ , G ⁴ , R ¹ , R ^3b and n is any one of those shown in [Table B-2] and [Table B-3]. A compound that is a combination.

[Table B-2]

本化合物２９：¹H-NMR (CDCl₃) δ: 8.99 (1H, s), 7.84 (1H, s), 7.77 (1H, s), 7.67-7.60 (2H, m), 7.47 (1H, d), 3.53 (3H, s), 3.48-3.33 (1H, m), 2.90-2.40 (1H, m), 1.41-1.30 (3H, m).
本化合物３０：¹H-NMR (CDCl₃) δ: 9.00 (1H, s), 7.62 (1H, dq), 7.46 (1H, dd), 7.40-7.30 (3H, m), 3.59-3.33 (4H, m), 2.95-2.43 (1H, m), 1.43-1.32 (3H, m).
本化合物３１：¹H-NMR (CDCl₃) δ: 8.90 (1H, s), 7.84-7.51 (6H, m), 3.71-3.22 (5H, m), 1.42-1.29 (3H, m).
本化合物３５：¹H-NMR (CDCl₃) δ: 9.10 (1H, s), 7.98 (1H, d), 7.90-7.67 (5H, m), 3.56-3.34 (5H, m), 1.40-1.36 (3H, m).
本化合物３６：¹H-NMR (CDCl₃) δ: 8.77 (1H, s), 7.82 (1H, d), 7.73-7.42 (5H, m), 3.60-3.19 (5H, m), 1.30-1.26 (3H, m).
本化合物３９：¹H-NMR (CDCl₃) δ: 8.95 (1H, s), 7.71-7.65 (5H, m), 7.50 (1H, d), 3.61-3.27 (5H, m), 1.43-1.17 (3H, m).
本化合物４５：¹H-NMR (CDCl₃) δ: 8.89 (1H, s), 7.99-7.50 (6H, m), 3.58-3.26 (5H, m), 1.44-1.30 (3H, m).
本化合物４７：¹H-NMR (CDCl₃) δ: 8.81 (1H, s), 7.69-7.68 (4H, m), 7.51 (1H, d), 7.26-7.25 (1H, m), 3.57-3.34 (5H, m), 1.38-1.33 (3H, m).
本化合物４８：¹H-NMR (CDCl₃) δ: 8.81 (1H, s), 7.64-7.53 (5H, m), 6.98-6.93 (1H, m), 4.39-4.37 (2H, m), 3.47-3.40 (5H, m), 1.31-1.30 (3H, m).
本化合物４９：¹H-NMR (CDCl₃) δ: 8.89 (1H, s), 7.78-7.67 (6H, m), 3.46-3.31 (5H, m), 1.38-1.35 (3H, m).
本化合物５０：¹H-NMR (CDCl₃) δ: 8.92 (1H, s), 8.13-7.76 (3H, m), 7.71 (1H, d), 7.50 (1H, d), 3.58-2.91 (5H, m), 1.46-1.28 (3H, m).
本化合物５３：¹H-NMR (CDCl₃) δ: 9.04-8.92 (1H, m), 7.80-7.59 (4H, m), 7.51 (1H, dd), 3.59-3.16 (5H, m), 1.29-1.23 (3H, m).
本化合物５４：¹H-NMR (CDCl₃) δ: 9.07-8.43 (3H, m), 8.14-8.11 (1H, m), 7.72 (1H, dd), 7.51 (1H, dd), 3.79-2.63 (5H, m), 1.45-1.24 (3H, m).
本化合物５５：¹H-NMR (CDCl₃) δ: 9.05-8.87 (1H, m), 7.70 (1H, dd), 7.55-7.36 (4H, m), 3.66-2.79 (5H, m), 1.45-1.32 (3H, m).
本化合物６６：¹H-NMR (CDCl₃) δ: 8.87 (1H, s), 8.05-7.37 (6H, m), 3.51-3.43 (5H, m), 1.29 (3H, t).
本化合物６９：¹H-NMR (CDCl₃) δ: 9.17 (1H, s), 8.45-8.21 (2H, m), 7.72-7.43 (3H, m), 3.69 (3H, s), 3.58-3.39 (2H, m), 1.52-1.40 (3H, m).
本化合物７０：¹H-NMR (CDCl₃) δ: 8.96 (1H, s), 7.97-7.92 (2H, m), 7.87 (1H, s), 7.63 (1H, d), 7.46 (1H, d), 3.60-3.29 (5H, m), 1.30 (3H, t).
本化合物７１：¹H-NMR (CDCl₃) δ: 8.72 (1H, s), 8.63 (1H, s), 8.53 (1H, s), 7.92 (1H, s), 7.41 (1H, dd), 7.23 (1H, dd), 3.15 (2H, br s), 2.47 (3H, br s), 1.05 (3H, d).
本化合物７２：¹H-NMR (CDCl₃) δ: 9.10-8.63 (3H, br m), 8.21 (1H, s), 7.72 (1H, dd), 7.51 (1H, dd), 3.58-2.76 (5H, br m), 1.57-1.54 (3H, br m).
本化合物７４：¹H-NMR (CDCl₃) δ: 9.17 (1H, s), 8.40-7.92 (2H, m), 7.64-7.31 (3H, m), 3.64-3.28 (5H, m), 1.42-1.30 (3H, m).
本化合物７９：LCMS:４９５[M+H]⁺, RT ＝1.68 分
本化合物８０：LCMS:６３１[M+H]⁺, RT = 2.07 分
本化合物８１：¹H-NMR (DMSO-D₆)δ: 8.85 (1H, s), 7.80 (1H, d), 7.73 (1H, dd), 7.68 (2H, d), 7.50 (2H, d), 3.52-3.41 (5H, m), 1.10 (3H, t).
本化合物８２：¹H-NMR (DMSO-D₆)δ: 8.84 (1H, s), 7.80 (1H, dd), 7.74-7.71 (3H, m), 7.58 (2H, d), 3.52-3.40 (5H, m), 1.10 (3H, t).
本化合物８８：LCMS:５８８[M+H]⁺, RT = 2.03 分
本化合物９４：LCMS:４９０[M+H]⁺, RT = 1.78 分
本化合物９５：LCMS:４９０[M+H]⁺, RT = 1.79 分
本化合物９７：¹H-NMR (CDCl₃) δ: 9.02-9.00 (1H, m), 8.08-8.06 (1H, m), 7.82-7.77 (2H, m), 7.64-7.61 (1H, m), 7.48-7.45 (1H, m), 3.51 (3H, s), 3.49-3.37 (2H, br m), 1.41 (3H, t).
本化合物９８：LCMS:４７２[M+H]⁺, RT = 1.62 分
本化合物９９：LCMS:４７２[M+H]⁺, RT = 1.62 分
本化合物１００：LCMS:４８８[M+H]⁺, RT = 1.78 分
本化合物１０１：LCMS:４８８[M+H]⁺, RT = 1.78 分
本化合物１０９：LCMS:５０４[M+H]⁺, RT = 1.98 分
本化合物１１０：LCMS:５３２[M+H]⁺, RT = 2.07 分
本化合物１１１：LCMS:５１７[M+H]⁺, RT = 1.91 分
本化合物１１２：¹H-NMR (CDCl₃) δ: 9.13 (1H, s), 8.40 (1H, d), 8.07 (1H, t), 7.71-7.58 (2H, m), 7.53-7.45 (1H, m), 3.72 (3H, s), 3.42-3.23 (2H, m), 1.49 (3H, t).
本化合物１２５：LCMS:５４８[M+H]⁺, RT = 2.13 分
本化合物１２６：LCMS:６２０[M+H]⁺, RT = 2.16 分
本化合物１２７：LCMS:６４６[M+H]⁺, RT = 2.24 分
本化合物１２８：LCMS:６５０[M+H]⁺, RT = 2.23 分
本化合物１２９：¹H-NMR (DMSO-D₆) δ: 8.94 (1H, br s), 8.07 (1H, d), 7.97 (1H, d), 7.73-7.63 (4H, m), 3.40 (3H, s), 3.36-3.33 (2H, br m), 1.19-1.12 (3H, br m).
本化合物１３０：¹H-NMR (DMSO-D₆) δ: 8.70 (1H, br s), 7.91 (1H, d), 7.79-7.76 (1H, m), 7.71-7.63 (4H, m), 3.42-3.31 (2H, br m), 3.38 (3H, s), 1.19-1.08 (3H, br m).
本化合物１３１：¹H-NMR (DMSO-D₆) δ: 8.83 (1H, br s), 7.81-7.71 (2H, m), 7.42-7.36 (4H, m), 3.50-3.41 (5H, m), 1.10 (3H, t).
本化合物１３２：¹H-NMR (DMSO-D₆) δ: 8.83 (1H, br s), 7.81-7.70 (4H, m), 7.14 (2H, d), 3.51-3.40 (5H, m), 1.10 (3H, t).
本化合物１３３：¹H-NMR (DMSO-D₆) δ: 8.91 (1H, br s), 7.88-7.78 (4H, m), 7.36 (1H, d), 7.16 (1H, t), 3.57-3.47 (5H, m), 1.19 (3H, t).
本化合物１３４：¹H-NMR (DMSO-D₆) δ: 8.94 (1H, s), 8.07 (1H, d), 7.97 (1H, dd), 7.69-7.54 (4H, br m), 3.39 (3H, s), 3.38-3.38 (2H, m), 1.19-1.08 (3H, br m).
本化合物１３５：LCMS:５６６[M+H]⁺, RT = 2.15 分
本化合物１３６：LCMS:５８３[M+H]⁺, RT = 1.66 分
本化合物１３７：LCMS:６０２[M+H]⁺, RT = 1.90 分
本化合物１３８：LCMS:５５４[M+H]⁺, RT = 1.81 分
本化合物１３９：LCMS:５９６[M+H]⁺, RT = 1.95 分
本化合物１４０：LCMS:４５６[M+H]⁺, RT = 1.85 分
本化合物１４１：LCMS:５４８[M+H]⁺, RT = 1.87 分
本化合物１４２：¹H-NMR (DMSO-D₆) δ: 8.85 (1H, br s), 7.82-7.72 (2H, m), 7.50-7.47 (2H, m), 7.33 (1H, t), 7.24 (1H, d), 3.52-3.41 (5H, m), 1.12 (3H, t).
本化合物１４３：LCMS:４５６[M+H]⁺, RT = 1.79 分 [Table B-3]

This compound 29: ¹ H-NMR (CDCl ₃ ) δ: 8.99 (1H, s), 7.84 (1H, s), 7.77 (1H, s), 7.67-7.60 (2H, m), 7.47 (1H, d) , 3.53 (3H, s), 3.48-3.33 (1H, m), 2.90-2.40 (1H, m), 1.41-1.30 (3H, m).
This compound 30: ¹ H-NMR (CDCl ₃ ) δ: 9.00 (1H, s), 7.62 (1H, dq), 7.46 (1H, dd), 7.40-7.30 (3H, m), 3.59-3.33 (4H, m), 2.95-2.43 (1H, m), 1.43-1.32 (3H, m).
This compound 31: ¹ H-NMR (CDCl ₃ ) δ: 8.90 (1H, s), 7.84-7.51 (6H, m), 3.71-3.22 (5H, m), 1.42-1.29 (3H, m).
This compound 35: ¹ H-NMR (CDCl ₃ ) δ: 9.10 (1H, s), 7.98 (1H, d), 7.90-7.67 (5H, m), 3.56-3.34 (5H, m), 1.40-1.36 ( 3H, m).
This compound 36: ¹ H-NMR (CDCl ₃ ) δ: 8.77 (1H, s), 7.82 (1H, d), 7.73-7.42 (5H, m), 3.60-3.19 (5H, m), 1.30-1.26 ( 3H, m).
This compound 39: ¹ H-NMR (CDCl ₃ ) δ: 8.95 (1H, s), 7.71-7.65 (5H, m), 7.50 (1H, d), 3.61-3.27 (5H, m), 1.43-1.17 ( 3H, m).
This compound 45: ¹ H-NMR (CDCl ₃ ) δ: 8.89 (1H, s), 7.99-7.50 (6H, m), 3.58-3.26 (5H, m), 1.44-1.30 (3H, m).
This compound 47: ¹ H-NMR (CDCl ₃ ) δ: 8.81 (1H, s), 7.69-7.68 (4H, m), 7.51 (1H, d), 7.26-7.25 (1H, m), 3.57-3.34 ( 5H, m), 1.38-1.33 (3H, m).
This compound 48: ¹ H-NMR (CDCl ₃ ) δ: 8.81 (1H, s), 7.64-7.53 (5H, m), 6.98-6.93 (1H, m), 4.39-4.37 (2H, m), 3.47- 3.40 (5H, m), 1.31-1.30 (3H, m).
This compound 49: ¹ H-NMR (CDCl ₃ ) δ: 8.89 (1H, s), 7.78-7.67 (6H, m), 3.46-3.31 (5H, m), 1.38-1.35 (3H, m).
This compound 50: ¹ H-NMR (CDCl ₃ ) δ: 8.92 (1H, s), 8.13-7.76 (3H, m), 7.71 (1H, d), 7.50 (1H, d), 3.58-2.91 (5H, m), 1.46-1.28 (3H, m).
This compound 53: ¹ H-NMR (CDCl ₃ ) δ: 9.04-8.92 (1H, m), 7.80-7.59 (4H, m), 7.51 (1H, dd), 3.59-3.16 (5H, m), 1.29- 1.23 (3H, m).
This compound 54: ¹ H-NMR (CDCl ₃ ) δ: 9.07-8.43 (3H, m), 8.14-8.11 (1H, m), 7.72 (1H, dd), 7.51 (1H, dd), 3.79-2.63 ( 5H, m), 1.45-1.24 (3H, m).
This compound 55: ¹ H-NMR (CDCl ₃ ) δ: 9.05-8.87 (1H, m), 7.70 (1H, dd), 7.55-7.36 (4H, m), 3.66-2.79 (5H, m), 1.45- 1.32 (3H, m).
This compound 66: ¹ H-NMR (CDCl ₃ ) δ: 8.87 (1H, s), 8.05-7.37 (6H, m), 3.51-3.43 (5H, m), 1.29 (3H, t).
This compound 69: ¹ H-NMR (CDCl ₃ ) δ: 9.17 (1H, s), 8.45-8.21 (2H, m), 7.72-7.43 (3H, m), 3.69 (3H, s), 3.58-3.39 ( 2H, m), 1.52-1.40 (3H, m).
This compound 70: ¹ H-NMR (CDCl ₃ ) δ: 8.96 (1H, s), 7.97-7.92 (2H, m), 7.87 (1H, s), 7.63 (1H, d), 7.46 (1H, d) , 3.60-3.29 (5H, m), 1.30 (3H, t).
This compound 71: ¹ H-NMR (CDCl ₃ ) δ: 8.72 (1H, s), 8.63 (1H, s), 8.53 (1H, s), 7.92 (1H, s), 7.41 (1H, dd), 7.23 (1H, dd), 3.15 (2H, br s), 2.47 (3H, br s), 1.05 (3H, d).
This compound 72: ¹ H-NMR (CDCl ₃ ) δ: 9.10-8.63 (3H, br m), 8.21 (1H, s), 7.72 (1H, dd), 7.51 (1H, dd), 3.58-2.76 (5H) , br m), 1.57-1.54 (3H, br m).
This compound 74: ¹ H-NMR (CDCl ₃ ) δ: 9.17 (1H, s), 8.40-7.92 (2H, m), 7.64-7.31 (3H, m), 3.64-3.28 (5H, m), 1.42- 1.30 (3H, m).
This compound 79: LCMS: 495 [M + H] ⁺ , RT = 1.68 union compound 80: LCMS: 631 [M + H] ⁺ , RT = 2.07 Union compound 81: ¹ H-NMR (DMSO-D ₆ ) δ: 8.85 (1H, s), 7.80 (1H, d), 7.73 (1H, dd), 7.68 (2H, d), 7.50 (2H, d), 3.52-3.41 (5H, m), 1.10 (3H, t).
This compound 82: ¹ H-NMR (DMSO-D ₆ ) δ: 8.84 (1H, s), 7.80 (1H, dd), 7.74-7.71 (3H, m), 7.58 (2H, d), 3.52-3.40 ( 5H, m), 1.10 (3H, t).
Compound 88: LCMS: 588 [M + H] ⁺ , RT = 2.03 Compound 94: LCMS: 490 [M + H] ⁺ , RT = 1.78 Compound 95: LCMS: 490 [M + H] ⁺ , RT = 1.79 Minute compound 97: ¹ H-NMR (CDCl ₃ ) δ: 9.02-9.00 (1H, m), 8.08-8.06 (1H, m), 7.82-7.77 (2H, m), 7.64-7.61 (1H) , m), 7.48-7.45 (1H, m), 3.51 (3H, s), 3.49-3.37 (2H, br m), 1.41 (3H, t).
Compound 98: LCMS: 472 [M + H] ⁺ , RT = 1.62 Compound 99: LCMS: 472 [M + H] ⁺ , RT = 1.62 Compound 100: LCMS: 488 [M + H] ⁺ , RT = 1.78 Minutes Compound 101: LCMS: 488 [M + H] ⁺ , RT = 1.78 Minutes Compound 109: LCMS: 504 [M + H] ⁺ , RT = 1.98 Minutes Compound 110: LCMS: 532 [M + H] ⁺ , RT = 2.07 Split compound 111: LCMS: 517 [M + H] ⁺ , RT = 1.91 Split compound 112: ¹ H-NMR (CDCl ₃ ) δ: 9.13 (1H, s), 8.40 (1H) , d), 8.07 (1H, t), 7.71-7.58 (2H, m), 7.53-7.45 (1H, m), 3.72 (3H, s), 3.42-3.23 (2H, m), 1.49 (3H, t) ).
Compound 125: LCMS: 548 [M + H] ⁺ , RT = 2.13 Compound 126: LCMS: 620 [M + H] ⁺ , RT = 2.16 Compound 127: LCMS: 646 [M + H] ⁺ , RT = 2.24 Branch compound 128: LCMS: 650 [M + H] ⁺ , RT = 2.23 Branch compound 129: ¹ H-NMR (DMSO-D ₆ ) δ: 8.94 (1H, br s), 8.07 (1H, d), 7.97 (1H, d), 7.73-7.63 (4H, m), 3.40 (3H, s), 3.36-3.33 (2H, br m), 1.19-1.12 (3H, br m).
This compound 130: ¹ H-NMR (DMSO-D ₆ ) δ: 8.70 (1H, br s), 7.91 (1H, d), 7.79-7.76 (1H, m), 7.71-7.63 (4H, m), 3.42 -3.31 (2H, br m), 3.38 (3H, s), 1.19-1.08 (3H, br m).
This compound 131: ¹ H-NMR (DMSO-D ₆ ) δ: 8.83 (1H, br s), 7.81-7.71 (2H, m), 7.42-7.36 (4H, m), 3.50-3.41 (5H, m) , 1.10 (3H, t).
This compound 132: ¹ H-NMR (DMSO-D ₆ ) δ: 8.83 (1H, br s), 7.81-7.70 (4H, m), 7.14 (2H, d), 3.51-3.40 (5H, m), 1.10 (3H, t).
This compound 133: ¹ H-NMR (DMSO-D ₆ ) δ: 8.91 (1H, br s), 7.88-7.78 (4H, m), 7.36 (1H, d), 7.16 (1H, t), 3.57-3.47 (5H, m), 1.19 (3H, t).
This compound 134: ¹ H-NMR (DMSO-D ₆ ) δ: 8.94 (1H, s), 8.07 (1H, d), 7.97 (1H, dd), 7.69-7.54 (4H, br m), 3.39 (3H) , s), 3.38-3.38 (2H, m), 1.19-1.08 (3H, br m).
Compound 135: LCMS: 566 [M + H] ⁺ , RT = 2.15 Compound 136: LCMS: 583 [M + H] ⁺ , RT = 1.66 Compound 137: LCMS: 602 [M + H] ⁺ , RT = 1.90 Minutes Compound 138: LCMS: 554 [M + H] ⁺ , RT = 1.81 Minutes Compound 139: LCMS: 596 [M + H] ⁺ , RT = 1.95 Minutes Compound 140: LCMS: 456 [M + H] ⁺ , RT = 1.85 fractional compound 141: LCMS: 548 [M + H] ⁺ , RT = 1.87 fractional compound 142: ¹ H-NMR (DMSO-D ₆ ) δ: 8.85 (1H, br s), 7.82-7.72 (2H, m), 7.50-7.47 (2H, m), 7.33 (1H, t), 7.24 (1H, d), 3.52-3.41 (5H, m), 1.12 (3H, t).
This compound 143: LCMS: 456 [M + H] ⁺ , RT = 1.79 minutes

本化合物３４：LCMS: ５５０[M+H]⁺, RT = 2.16 分 Manufacturing example 2
A mixture of 370 mg of Intermediate 2, 580 mg of cesium carbonate, 200 μL of 2-iodopropane and 10 mL of DMF was stirred at 50 ° C. for 8 hours. Water was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. Chloroform (5 mL) was added to the obtained residue, 400 mg of mCPBA (purity 70%, containing 30% water) was added under ice-cooling, and the mixture was stirred at room temperature for 2 hours. A saturated aqueous sodium hydrogen carbonate solution and an aqueous sodium thiosulfate solution were sequentially added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 110 mg of this compound 34.

Compound 34: LCMS: 550 [M + H] ⁺ , RT = 2.16 minutes

本化合物５９：¹H-NMR (CDCl₃) δ: 9.02-9.01 (1H, m), 8.13 (1H, d), 7.59-7.56 (2H, m), 7.18 (1H, d), 7.08 (1H, s), 5.19 (2H, d), 4.77 (1H, br s), 3.64 (2H, q), 1.45 (3H, t). Production example 3
To a mixture of 300 mg of Intermediate 38 and 6 mL of THF was sequentially added 45 mg of sodium borohydride and 0.5 mL of methanol under ice-cooling, and the mixture was stirred at room temperature for 2 hours. Water was added to the obtained mixture under ice-cooling, and the precipitated solid was filtered. The obtained solid was washed with water and dried under reduced pressure to obtain 240 mg of the present compound 59 represented by the following formula.

This compound 59: ¹ H-NMR (CDCl ₃ ) δ: 9.02-9.01 (1H, m), 8.13 (1H, d), 7.59-7.56 (2H, m), 7.18 (1H, d), 7.08 (1H, d) s), 5.19 (2H, d), 4.77 (1H, br s), 3.64 (2H, q), 1.45 (3H, t).

本化合物６０：¹H-NMR (CDCl₃) δ: 9.01-9.01 (1H, m), 8.28 (1H, s), 7.57-7.54 (3H, m), 6.83 (1H, d), 5.21 (2H, d), 5.01 (1H, br s), 3.67 (2H, q), 1.47 (3H, t). Production Example 3-1
The compounds produced according to Production Example 3 and their physical property values are shown below.

This compound 60: ¹ H-NMR (CDCl ₃ ) δ: 9.01-9.01 (1H, m), 8.28 (1H, s), 7.57-7.54 (3H, m), 6.83 (1H, d), 5.21 (2H, d), 5.01 (1H, br s), 3.67 (2H, q), 1.47 (3H, t).

本化合物６１：¹H-NMR (CDCl₃) δ: 9.09-9.09 (1H, m), 7.87 (1H, d), 7.67 (1H, dd), 7.45 (1H, dd), 7.23-7.20 (1H, m), 6.81 (1H, d), 5.14 (2H, d), 4.80 (1H, br s), 3.65 (2H, q), 1.47-1.43 (3H, m).

This compound 61: ¹ H-NMR (CDCl ₃ ) δ: 9.09-9.09 (1H, m), 7.87 (1H, d), 7.67 (1H, dd), 7.45 (1H, dd), 7.23-7.20 (1H, dd) m), 6.81 (1H, d), 5.14 (2H, d), 4.80 (1H, br s), 3.65 (2H, q), 1.47-1.43 (3H, m).

本化合物６２：¹H-NMR (CDCl₃) δ: 9.01 (1H, s), 8.30 (1H, d), 7.67 (1H, d), 7.59-7.56 (2H, m), 6.84 (1H, d), 5.07 (2H, s), 3.69 (2H, q), 3.07 (3H, s), 1.48 (3H, t). Production example 4
To a mixture of 150 mg of the present compound 60 and 3 mL of DMF, 0.2 mL of methyl iodide and 83 mg of potassium carbonate were sequentially added at room temperature, and the mixture was stirred at 80 ° C. for 16 hours. The resulting mixture was allowed to cool to room temperature and water was added. The precipitated solid was filtered, the obtained solid was washed with water, and dried under reduced pressure to obtain 102 mg of the present compound 62 represented by the following formula.

This compound 62: ¹ H-NMR (CDCl ₃ ) δ: 9.01 (1H, s), 8.30 (1H, d), 7.67 (1H, d), 7.59-7.56 (2H, m), 6.84 (1H, d) , 5.07 (2H, s), 3.69 (2H, q), 3.07 (3H, s), 1.48 (3H, t).

本化合物６３：¹H-NMR (CDCl₃) δ: 9.01 (1H, s), 8.31 (1H, d), 7.64 (1H, d), 7.58-7.57 (2H, m), 6.89 (1H, d), 5.14 (2H, s), 3.68 (2H, q), 3.57 (2H, q), 1.47 (3H, t), 1.28 (3H, t). Production Example 4-1
The compounds produced according to Production Example 4 and their physical property values are shown below.

This compound 63: ¹ H-NMR (CDCl ₃ ) δ: 9.01 (1H, s), 8.31 (1H, d), 7.64 (1H, d), 7.58-7.57 (2H, m), 6.89 (1H, d) , 5.14 (2H, s), 3.68 (2H, q), 3.57 (2H, q), 1.47 (3H, t), 1.28 (3H, t).

本化合物１１：¹H-NMR (CDCl₃) δ: 7.95 (1H, s), 7.51-7.50 (3H, m), 7.42 (2H, d), 7.07 (1H, d), 3.54 (3H, s), 2.26 (2H, q), 1.94-1.91 (1H, m), 1.27 (3H, t), 1.02-1.00 (2H, m), 0.73-0.70 (2H, m). Production Example 5
0.49 g of this compound 7, cyclopropylboronic acid 260 mg, [1,1'-bis (diphenylphosphino) ferrocene] dichloropalladium (II) 150 mg, tripotassium phosphate 640 mg, toluene 4 mL, and water 0.4 mL. The mixture was stirred at 110 ° C. for 2 hours. The obtained mixture was allowed to cool to room temperature, water was added, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel chromatography (ethyl acetate: hexane = 1: 1) to obtain 400 mg of the present compound 11 represented by the following formula.

This compound 11: ¹ H-NMR (CDCl ₃ ) δ: 7.95 (1H, s), 7.51-7.50 (3H, m), 7.42 (2H, d), 7.07 (1H, d), 3.54 (3H, s) , 2.26 (2H, q), 1.94-1.91 (1H, m), 1.27 (3H, t), 1.02-1.00 (2H, m), 0.73-0.70 (2H, m).

本化合物１２：¹H-NMR (CDCl₃) δ: 8.28 (1H, s), 7.68 (1H, d), 7.57-7.50 (5H, m), 7.44 (2H, d), 7.20-7.16 (2H, m), 3.58 (3H, s), 2.31 (2H, d), 1.09 (3H, t). Production Example 5-1
The compounds produced according to Production Example 5 and their physical property values are shown below.

This compound 12: ¹ H-NMR (CDCl ₃ ) δ: 8.28 (1H, s), 7.68 (1H, d), 7.57-7.50 (5H, m), 7.44 (2H, d), 7.20-7.16 (2H, d) m), 3.58 (3H, s), 2.31 (2H, d), 1.09 (3H, t).

本化合物１３：¹H-NMR (CDCl₃) δ: 8.84 (1H, s), 8.68 (1H, d), 8.36 (1H, s), 7.89-7.86 (1H, m), 7.73 (1H, d), 7.59-7.53 (3H, m), 7.46-7.42 (3H, m), 3.58 (3H, s), 2.32 (2H, q), 1.10 (3H, t).

This compound 13: ¹ H-NMR (CDCl ₃ ) δ: 8.84 (1H, s), 8.68 (1H, d), 8.36 (1H, s), 7.89-7.86 (1H, m), 7.73 (1H, d) , 7.59-7.53 (3H, m), 7.46-7.42 (3H, m), 3.58 (3H, s), 2.32 (2H, q), 1.10 (3H, t).

Next, examples of the present compound produced according to any of the production examples described in Examples and the production methods described in the present specification are shown below.

で示される化合物（以下、化合物（Ｌ－１）と記す）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1と記す）。 Equation (L-1)

In the compound represented by (hereinafter referred to as compound (L-1)), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is. , [Table L1] to [Table L11], which is a compound which is any of the substituents (hereinafter referred to as compound group SX1).

化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX2と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX3と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX4と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX5と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX6と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX7と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX8と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX9と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX10と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX11と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX12と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX13と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX14と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX15と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX16と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX17と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX18と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX19と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX20と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX21と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX22と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX23と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX24と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX25と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX26と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX27と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX28と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX29と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX30と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX31と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX32と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX33と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX34と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX35と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX36と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX37と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX38と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX39と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX40と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX41と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX42と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX43と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX44と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX45と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX46と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX47と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX48と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX49と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX50と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX51と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX52と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX53と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX54と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX55と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX56と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX57と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX58と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX59と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX60と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX61と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX62と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX63と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX64と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX65と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX66と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX67と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX68と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX69と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX70と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX71と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX72と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX73と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX74と記す）。
化合物（Ｌ－１）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX75と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX76と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX77と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX78と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX79と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX80と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX81と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX82と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX83と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX84と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX85と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX86と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX87と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX88と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX89と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX90と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX91と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX92と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX93と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX94と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX95と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX96と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX97と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX98と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX99と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX100と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX101と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX102と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX103と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX104と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX105と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX106と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX107と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX108と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX109と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX110と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX111と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX112と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX113と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX114と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX115と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX116と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX117と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX118と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX119と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX120と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX121と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX122と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX123と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX124と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX125と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX126と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX127と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX128と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX129と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX130と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX131と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX132と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX133と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX134と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX135と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX136と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX137と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX138と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX139と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX140と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX141と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX142と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX143と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX144と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX145と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX146と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX147と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX148と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX149と記す）。
化合物（Ｌ－１）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX150と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX151と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX152と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX153と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX154と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX155と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX156と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX157と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX158と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX159と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX160と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX161と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX162と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX163と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX164と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX165と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX166と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX167と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX168と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX169と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX170と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX171と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX172と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX173と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX174と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX175と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX176と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX177と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX178と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX179と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX180と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX181と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX182と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX183と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX184と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX185と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX186と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX187と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX188と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX189と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX190と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX191と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX192と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX193と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX194と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX195と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX196と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX197と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX198と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX199と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX200と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX201と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX202と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX203と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX204と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX205と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX206と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX207と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX208と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX209と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX210と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX211と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX212と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX213と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX214と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX215と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX216と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX217と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX218と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX219と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX220と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX221と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX222と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX223と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX224と記す）。
化合物（Ｌ－１）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX225と記す）。

In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX2).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX3).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX4).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX5).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX6).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX7).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX8).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX9).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX10).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX11).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX12).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX13).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX14).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX15).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX16).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX17).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX18).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX19).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX20).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX21).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX22).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX23).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX24).
In compound (L-1), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX25).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX26).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX27).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX28).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX29).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX30).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX31).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX32).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX33).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX34).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX35).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX36).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX37).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX38).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX39).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX40).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX41).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX42).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX43).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX44).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX45).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX46).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX47).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX48).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX49).
In compound (L-1), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX50).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX51).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX52).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX53).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX54).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX55).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX56).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX57).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX58).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX59).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX60).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX61).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX62).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX63).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX64).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX65).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX66).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX67).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX68).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX69).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX70).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX71).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX72).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX73).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX74).
In compound (L-1), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX75).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX76).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX77).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX78).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX79).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX80).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX81).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX82).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX83).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX84).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX85).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX86).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX87).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX88).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX89).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX90).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX91).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX92).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX93).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX94).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX95).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX96).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX97).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX98).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX99).
In compound (L-1), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX100).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX101).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX102).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX103).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX104).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX105).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX106).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX107).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX108).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX109).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX110).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX111).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX112).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX113).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX114).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX115).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX116).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX117).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX118).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX119).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX120).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX121).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX122).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX123).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX124).
In compound (L-1), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX125).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX126).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX127).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX128).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX129).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX130).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX131).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX132).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX133).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX134).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX135).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX136).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX137).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX138).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX139).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX140).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX141).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX142).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX143).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX144).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX145).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX146).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX147).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX148).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX149).
In compound (L-1), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX150).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX151).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX152).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX153).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX154).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX155).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX156).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX157).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX158).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX159).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX160).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX161).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX162).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX163).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX164).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX165).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX166).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX167).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX168).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX169).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX170).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX171).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX172).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX173).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX174).
In compound (L-1), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX175).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX176).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX177).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX178).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX179).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX180).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX181).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX182).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX183).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX184).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX185).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX186).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX187).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX188).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX189).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX190).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX191).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX192).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX193).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX194).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX195).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX196).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX197).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX198).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX199).
In compound (L-1), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX200).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX201).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX202).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX203).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX204).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX205).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX206).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX207).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX208).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX209).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX210).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX211).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX212).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX213).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX214).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX215).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX216).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX217).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX218).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX219).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX220).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX221).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX222).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX223).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX224).
In compound (L-1), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX225).

In compound (L-1), n is 0, R ¹ is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, R ^3c is a hydrogen atom, and R ^3b is. , [Table L12] to [Table L14], a compound which is any of the substituents (hereinafter referred to as compound group SX226).

In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX227).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX228).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX229).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX230).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX231).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX232).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX233).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX234).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX235).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX236).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX237).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX238).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX239).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX240).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX241).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX242).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX243).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX244).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX245).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX246).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX247).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX248).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX249).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX250).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX251).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX252).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX253).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX254).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX255).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX256).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX257).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX258).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX259).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX260).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX261).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX262).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX263).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX264).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX265).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX266).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX267).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX268).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX269).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX270).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX271).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX272).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX273).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX274).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX275).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX276).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX277).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX278).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX279).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX280).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX281).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX282).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX283).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX284).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX285).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX286).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX287).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX288).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX289).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX290).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX291).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX292).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX293).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX294).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX295).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX296).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX297).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX298).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX299).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX300).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX301).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX302).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX303).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX304).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX305).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX306).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX307).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX308).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX309).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX310).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX311).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX312).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX313).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX314).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX315).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX316).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX317).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX318).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX319).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX320).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX321).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX322).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX323).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX324).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX325).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX326).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX327).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX328).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX329).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX330).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX331).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX332).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX333).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX334).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX335).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX336).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX337).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX338).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX339).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX340).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX341).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX342).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX343).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX344).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX345).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX346).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX347).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX348).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX349).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX350).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX351).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX352).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX353).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX354).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX355).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX356).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX357).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX358).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX359).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX360).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX361).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX362).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX363).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX364).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX365).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX366).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX367).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX368).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX369).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX370).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX371).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX372).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX373).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX374).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX375).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX376).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX377).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX378).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX379).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX380).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX381).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX382).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX383).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX384).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX385).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX386).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX387).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX388).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX389).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX390).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX391).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX392).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX393).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX394).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX395).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX396).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX397).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX398).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX399).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX400).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX401).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX402).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX403).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX404).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX405).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX406).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX407).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX408).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX409).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX410).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX411).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX412).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX413).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX414).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX415).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX416).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX417).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX418).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX419).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX420).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX421).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX422).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX423).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX424).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX425).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX426).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX427).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX428).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX429).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX430).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX431).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX432).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX433).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX434).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX435).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX436).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX437).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX438).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX439).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX440).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX441).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX442).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX443).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX444).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX445).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX446).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX447).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX448).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX449).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX450).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX451).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX452).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX453).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX454).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX455).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX456).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX457).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX458).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX459).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX460).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX461).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX462).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX463).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX464).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX465).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX466).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX467).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX468).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX469).
In compound (L-1), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX470).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX471).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX472).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX473).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX474).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX475).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX476).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX477).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX478).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX479).
In compound (L-1), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX480).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX481).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX482).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX483).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX484).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX485).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX486).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX487).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX488).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX489).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX490).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX491).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX492).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX493).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX494).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX495).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX496).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX497).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX498).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX499).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX500).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX501).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX502).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX503).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX504).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX505).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX506).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX507).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX508).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX509).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX510).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX511).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX512).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX513).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX514).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX515).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX516).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX517).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX518).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX519).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX520).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX521).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX522).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX523).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX524).
In compound (L-1), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX525).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX526).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX527).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX528).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX529).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX530).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX531).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX532).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX533).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX534).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX535).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX536).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX537).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX538).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX539).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX540).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX541).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX542).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX543).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX544).
In compound (L-1), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX545).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX546).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX547).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX548).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX549).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX550).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX551).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX552).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX553).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX554).
In compound (L-1), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX555).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX556).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX557).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX558).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX559).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX560).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX561).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX562).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX563).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX564).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX565).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX566).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX567).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX568).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX569).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX570).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX571).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX572).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX573).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX574).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX575).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX576).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX577).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX578).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX579).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX580).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX581).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX582).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX583).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX584).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX585).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX586).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX587).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX588).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX589).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX590).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX591).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX592).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX593).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX594).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX595).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX596).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX597).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX598).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX599).
In compound (L-1), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX600).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX601).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX602).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX603).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX604).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX605).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX606).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX607).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX608).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX609).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX610).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX611).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX612).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX613).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX614).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX615).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX616).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX617).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX618).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX619).
In compound (L-1), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX620).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX621).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX622).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX623).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX624).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX625).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX626).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX627).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX628).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX629).
In compound (L-1), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX630).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX631).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX632).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX633).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX634).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX635).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX636).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX637).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX638).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX639).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX640).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX641).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX642).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX643).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX644).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX645).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX646).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX647).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX648).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX649).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX650).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX651).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX652).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX653).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX654).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX655).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX656).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX657).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX658).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX659).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX660).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX661).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX662).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX663).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX664).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX665).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX666).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX667).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX668).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX669).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX670).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX671).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX672).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX673).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX674).
In compound (L-1), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX675).

で示される化合物（以下、化合物（Ｌ－２）と記す）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX676と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX677と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX678と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX679と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX680と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX681と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX682と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX683と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX684と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX685と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX686と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX687と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX688と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX689と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX690と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX691と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX692と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX693と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX694と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX695と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX696と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX697と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX698と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX699と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX700と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX701と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX702と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX703と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX704と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX705と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX706と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX707と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX708と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX709と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX710と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX711と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX712と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX713と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX714と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX715と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX716と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX717と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX718と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX719と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX720と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX721と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX722と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX723と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX724と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX725と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX726と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX727と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX728と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX729と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX730と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX731と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX732と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX733と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX734と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX735と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX736と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX737と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX738と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX739と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX740と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX741と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX742と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX743と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX744と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX745と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX746と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX747と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX748と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX749と記す）。
化合物（Ｌ－２）において、ｎが０であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX750と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX751と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX752と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX753と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX754と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX755と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX756と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX757と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX758と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX759と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX760と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX761と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX762と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX763と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX764と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX765と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX766と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX767と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX768と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX769と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX770と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX771と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX772と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX773と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX774と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX775と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX776と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX777と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX778と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX779と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX780と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX781と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX782と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX783と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX784と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX785と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX786と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX787と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX788と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX789と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX790と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX791と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX792と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX793と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX794と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX795と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX796と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX797と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX798と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX799と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX800と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX801と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX802と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX803と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX804と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX805と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX806と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX807と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX808と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX809と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX810と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX811と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX812と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX813と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX814と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX815と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX816と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX817と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX818と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX819と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX820と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX821と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX822と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX823と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX824と記す）。
化合物（Ｌ－２）において、ｎが１であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX825と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX826と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX827と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX828と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX829と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX830と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX831と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX832と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX833と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX834と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX835と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX836と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX837と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX838と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX839と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX840と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX841と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX842と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX843と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX844と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX845と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX846と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX847と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX848と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX849と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX850と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX851と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX852と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX853と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX854と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX855と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX856と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX857と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX858と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX859と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX860と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX861と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX862と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX863と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX864と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX865と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX866と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX867と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX868と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX869と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX870と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX871と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX872と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX873と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX874と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX875と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX876と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX877と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX878と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX879と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが水素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX880と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX881と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX882と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX883と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX884と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが塩素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX885と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX886と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX887と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX888と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX889と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cが臭素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX890と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX891と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX892と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX893と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX894と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがヨウ素原子であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX895と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが水素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX896と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが塩素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX897と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bが臭素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX898と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがヨウ素原子であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX899と記す）。
化合物（Ｌ－２）において、ｎが２であり、Ｒ¹がイソプロピル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^3cがＣＦ₃であり、Ｔが［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX900と記す）。 Equation (L-2)

In the compound represented by (hereinafter referred to as compound (L-2)), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is. A compound which is any of the substituents shown in [Table L1] to [Table L11] (hereinafter referred to as compound group SX676).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX677).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX678).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX679).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX680).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX681).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX682).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX683).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX684).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX685).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX686).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX687).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX688).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX689).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX690).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX691).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX692).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX693).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX694).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX695).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX696).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX697).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX698).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX699).
In compound (L-2), n is 0, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX700).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX701).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX702).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX703).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX704).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX705).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX706).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX707).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX708).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX709).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX710).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX711).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX712).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX713).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX714).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX715).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX716).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX717).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX718).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX719).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX720).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX721).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX722).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX723).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX724).
In compound (L-2), n is 0, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX725).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX726).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX727).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX728).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX729).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX730).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX731).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX732).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX733).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX734).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX735).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX736).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX737).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX738).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX739).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX740).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX741).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX742).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX743).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX744).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX745).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX746).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX747).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX748).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX749).
In compound (L-2), n is 0, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX750).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX751).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX752).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX753).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX754).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX755).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX756).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX757).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX758).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX759).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX760).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX761).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX762).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX763).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX764).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX765).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX766).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX767).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX768).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX769).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX770).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX771).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX772).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX773).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX774).
In compound (L-2), n is 1, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX775).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX776).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX777).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX778).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX779).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX780).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX781).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX782).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX783).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX784).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX785).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX786).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX787).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX788).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX789).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX790).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX791).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX792).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX793).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX794).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX795).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX796).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX797).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX798).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX799).
In compound (L-2), n is 1, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX800).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX801).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX802).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX803).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX804).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX805).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX806).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX807).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX808).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX809).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX810).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX811).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX812).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX813).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX814).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX815).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX816).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX817).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX818).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX819).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX820).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX821).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX822).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX823).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX824).
In compound (L-2), n is 1, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX825).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX826).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX827).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX828).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX829).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX830).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX831).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX832).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX833).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX834).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX835).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX836).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX837).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX838).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX839).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX840).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX841).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX842).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX843).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX844).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX845).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX846).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX847).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX848).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX849).
In compound (L-2), n is 2, R ¹ is a methyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX850).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX851).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX852).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX853).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX854).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX855).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX856).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX857).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX858).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX859).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX860).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX861).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX862).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX863).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX864).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX865).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX866).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX867).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX868).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX869).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX870).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX871).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX872).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX873).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX874).
In compound (L-2), n is 2, R ¹ is an ethyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX875).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX876).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX877).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX878).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX879).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a hydrogen atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX880).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX881).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX882).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX883).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX884).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a chlorine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX885).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX886).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX887).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX888).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX889).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is a bromine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX890).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX891).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX892).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX893).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX894).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is an iodine atom, and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX895).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a hydrogen atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX896).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a chlorine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX897).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is a bromine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX898).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is an iodine atom, R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX899).
In compound (L-2), n is 2, R ¹ is an isopropyl group, R ^3b is CF ₃ , R ^3c is CF ₃ , and T is in [Table L1] to [Table L11]. A compound that is any of the above-mentioned substituents (hereinafter referred to as compound group SX900).

In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX901).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX902).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX903).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX904).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX905).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX906).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX907).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX908).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX909).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX910).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX911).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX912).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX913).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX914).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX915).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX916).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX917).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX918).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX919).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX920).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX921).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX922).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX923).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX924).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX925).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX926).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX927).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX928).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX929).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX930).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX931).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX932).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX933).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX934).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX935).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX936).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX937).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX938).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX939).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX940).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX941).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX942).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX943).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX944).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX945).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX946).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX947).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX948).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX949).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX950).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX951).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX952).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX953).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX954).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX955).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX956).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX957).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX958).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX959).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX960).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX961).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX962).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX963).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX964).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX965).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX966).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX967).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX968).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX969).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX970).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX971).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX972).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX973).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX974).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX975).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX976).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX977).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX978).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX979).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX980).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX981).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX982).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX983).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX984).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX985).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX986).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX987).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX988).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX989).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX990).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX991).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX992).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX993).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX994).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX995).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX996).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX997).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX998).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX999).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1000).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1001).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1002).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1003).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1004).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1005).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1006).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1007).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1008).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1009).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1010).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1011).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1012).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1013).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1014).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1015).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1016).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1017).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1018).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1019).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1020).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1021).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1022).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1023).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1024).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1025).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1026).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1027).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1028).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1029).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1030).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1031).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1032).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1033).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1034).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1035).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1036).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1037).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1038).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1039).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1040).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1041).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1042).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1043).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1044).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1045).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1046).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1047).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1048).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1049).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1050).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1051).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1052).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1053).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1054).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1055).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1056).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1057).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1058).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1059).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1060).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1061).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1062).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1063).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1064).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1065).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1066).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1067).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1068).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1069).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1070).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1071).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1072).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1073).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1074).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1075).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1076).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1077).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1078).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1079).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1080).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1081).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1082).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1083).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1084).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1085).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1086).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1087).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1088).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1089).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1090).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1091).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1092).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1093).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1094).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1095).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1096).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1097).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1098).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1099).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1100).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1101).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1102).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1103).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1104).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1105).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1106).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1107).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1108).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1109).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1110).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1111).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1112).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1113).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1114).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1115).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1116).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1117).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1118).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1119).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1120).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1121).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1122).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1123).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1124).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1125).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1126).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1127).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1128).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1129).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1130).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1131).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1132).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1133).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1134).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1135).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1136).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1137).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1138).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1139).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1140).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1141).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1142).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1143).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1144).
In compound (L-2), n is 0 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1145).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1146).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1147).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1148).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1149).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1150).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1151).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1152).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1153).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1154).
In compound (L-2), n is 0 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1155).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1156).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1157).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1158).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1159).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1160).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1161).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1162).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1163).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1164).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1165).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1166).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1167).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1168).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1169).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1170).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1171).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1172).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1173).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1174).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1175).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1176).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1177).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1178).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1179).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1180).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1181).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1182).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1183).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1184).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1185).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1186).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1187).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1188).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1189).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1190).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1191).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1192).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1193).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1194).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1195).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1196).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1197).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1198).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1199).
In compound (L-2), n is 0 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1200).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1201).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1202).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1203).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1204).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1205).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1206).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1207).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1208).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1209).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1210).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1211).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1212).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1213).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1214).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1215).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1216).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1217).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1218).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1219).
In compound (L-2), n is 1 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1220).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1221).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1222).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1223).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1224).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1225).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1226).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1227).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1228).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1229).
In compound (L-2), n is 1 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1230).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1231).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1232).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1233).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1234).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1235).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1236).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1237).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1238).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1239).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1240).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1241).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1242).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1243).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1244).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1245).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1246).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1247).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1248).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1249).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1250).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1251).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1252).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1253).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1254).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1255).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1256).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1257).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1258).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1259).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1260).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1261).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1262).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1263).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1264).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1265).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1266).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1267).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1268).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1269).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1270).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1271).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1272).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1273).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1274).
In compound (L-2), n is 1 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1275).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1276).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1277).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1278).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1279).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1280).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1281).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1282).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1283).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1284).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1285).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1286).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1287).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1288).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1289).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1290).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1291).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1292).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1293).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1294).
In compound (L-2), n is 2 and R ¹ Is an ethyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1295).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1296).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1297).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1298).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1299).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 3-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1300).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1301).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1302).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1303).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1304).
In compound (L-2), n is 2 and R ¹ Is an isopropyl group, T is a 4-[(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1305).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1306).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1307).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1308).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1309).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethoxy) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1310).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1311).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1312).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1313).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1314).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 4- (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1315).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1316).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1317).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1318).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1319).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1320).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1321).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1322).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1323).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1324).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1325).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1326).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1327).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1328).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1329).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,4-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1330).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1331).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1332).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1333).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1334).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis [(trifluoromethyl) thio] phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1335).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1336).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1337).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1338).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1339).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1340).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1341).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1342).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1343).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1344).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3,5-bis (trifluoromethyl) phenyl group, and R ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1345).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a hydrogen atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1346).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a chlorine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1347).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is a bromine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1348).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is an iodine atom, R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1349).
In compound (L-2), n is 2 and R ¹ Is a methyl group, T is a 3-fluoro-5- (trifluoromethoxy) phenyl group, and R is. ^3b Is CF ₃ And R ^3c Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1350).

で示される化合物（以下、化合物（Ｌ－３）と記す）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1351と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bが塩素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1352と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bが臭素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1353と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1354と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1355と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1356と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bが塩素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1357と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bが臭素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1358と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1359と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1360と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1361と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bが塩素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1362と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bが臭素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1363と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1364と記す）。
化合物（Ｌ－３）において、ｎが０であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1365と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1366と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bが塩素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1367と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bが臭素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1368と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1369と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1370と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1371と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bが塩素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1372と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bが臭素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1373と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1374と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1375と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1376と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bが塩素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1377と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bが臭素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1378と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1379と記す）。
化合物（Ｌ－３）において、ｎが１であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1380と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1381と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bが塩素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1382と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bが臭素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1383と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1384と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がメチル基であり、Ｒ²がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1385と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1386と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bが塩素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1387と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bが臭素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1388と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1389と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がプロパルギル基であり、Ｒ²がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1390と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bが水素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1391と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bが塩素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1392と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bが臭素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1393と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1394と記す）。
化合物（Ｌ－３）において、ｎが２であり、Ｒ¹がシクロプロピルメチル基であり、Ｒ²がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｔが、［表Ｌ１］～［表Ｌ１１］に記載のいずれかの置換基である化合物（以下、化合物群SX1395と記す）。 Equation (L-3)

In the compound represented by (hereinafter referred to as compound (L-3)), n is 0, R ¹ is a methyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is. , [Table L1] to [Table L11], a compound which is any of the substituents (hereinafter referred to as compound group SX1351).
In compound (L-3), n is 0, R ¹ is a methyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1352).
In compound (L-3), n is 0, R ¹ is a methyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1353).
In compound (L-3), n is 0, R ¹ is a methyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1354).
In compound (L-3), n is 0, R ¹ is a methyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1355).
In compound (L-3), n is 0, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1356).
In compound (L-3), n is 0, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1357).
In compound (L-3), n is 0, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1358).
In compound (L-3), n is 0, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1359).
In compound (L-3), n is 0, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1360).
In compound (L-3), n is 0, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1361).
In compound (L-3), n is 0, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1362).
In compound (L-3), n is 0, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1363).
In compound (L-3), n is 0, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1364).
In compound (L-3), n is 0, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1365).
In compound (L-3), n is 1, R ¹ is a methyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1366).
In compound (L-3), n is 1, R ¹ is a methyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1367).
In compound (L-3), n is 1, R ¹ is a methyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1368).
In compound (L-3), n is 1, R ¹ is a methyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1369).
In compound (L-3), n is 1, R ¹ is a methyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1370).
In compound (L-3), n is 1, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1371).
In compound (L-3), n is 1, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1372).
In compound (L-3), n is 1, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1373).
In compound (L-3), n is 1, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1374).
In compound (L-3), n is 1, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1375).
In compound (L-3), n is 1, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1376).
In compound (L-3), n is 1, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1377).
In compound (L-3), n is 1, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1378).
In compound (L-3), n is 1, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1379).
In compound (L-3), n is 1, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1380).
In compound (L-3), n is 2, R ¹ is a methyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1381).
In compound (L-3), n is 2, R ¹ is a methyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1382).
In compound (L-3), n is 2, R ¹ is a methyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1383).
In compound (L-3), n is 2, R ¹ is a methyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1384).
In compound (L-3), n is 2, R ¹ is a methyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1385).
In compound (L-3), n is 2, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1386).
In compound (L-3), n is 2, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1387).
In compound (L-3), n is 2, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1388).
In compound (L-3), n is 2, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1389).
In compound (L-3), n is 2, R ¹ is a propargyl group, R ² is an ethyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1390).
In compound (L-3), n is 2, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1391).
In compound (L-3), n is 2, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1392).
In compound (L-3), n is 2, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1393).
In compound (L-3), n is 2, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1394).
In compound (L-3), n is 2, R ¹ is a cyclopropylmethyl group, R ² is an ethyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L1]. A compound which is any of the substituents described in [L11] (hereinafter referred to as compound group SX1395).

In compound (L-3), n is 0, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1840).
In compound (L-3), n is 0, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1841).
In compound (L-3), n is 0, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1842).
In compound (L-3), n is 0, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1843).
In compound (L-3), n is 0, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1844).
In compound (L-3), n is 1, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1845).
In compound (L-3), n is 1, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1846).
In compound (L-3), n is 1, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1847).
In compound (L-3), n is 1, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1848).
In compound (L-3), n is 1, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1849).
In compound (L-3), n is 2, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1850).
In compound (L-3), n is 2, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1851).
In compound (L-3), n is 2, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1852).
In compound (L-3), n is 2, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1853).
In compound (L-3), n is 2, R ¹ is a hydrogen atom, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1854).
In compound (L-3), n is 0, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1855).
In compound (L-3), n is 0, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1856).
In compound (L-3), n is 0, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1857).
In compound (L-3), n is 0, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1858).
In compound (L-3), n is 0, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1859).
In compound (L-3), n is 1, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1860).
In compound (L-3), n is 1, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1861).
In compound (L-3), n is 1, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1862).
In compound (L-3), n is 1, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1863).
In compound (L-3), n is 1, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1864).
In compound (L-3), n is 2, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1865).
In compound (L-3), n is 2, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1866).
In compound (L-3), n is 2, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1867).
In compound (L-3), n is 2, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1868).
In compound (L-3), n is 2, R ¹ is a benzyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1869).
In compound (L-3), n is 0, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1870).
In compound (L-3), n is 0, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1871).
In compound (L-3), n is 0, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1872).
In compound (L-3), n is 0, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1873).
In compound (L-3), n is 0, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1874).
In compound (L-3), n is 1, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1875).
In compound (L-3), n is 1, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1876).
In compound (L-3), n is 1, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1877).
In compound (L-3), n is 1, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1878).
In compound (L-3), n is 1, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1879).
In compound (L-3), n is 2, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1880).
In compound (L-3), n is 2, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1881).
In compound (L-3), n is 2, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1882).
In compound (L-3), n is 2, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1883).
In compound (L-3), n is 2, R ¹ is a cyanomethyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. A compound that is any of the substituents described in (hereinafter referred to as compound group SX1884).
In compound (L-3), n is 0, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1885).
In compound (L-3), n is 0, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1886).
In compound (L-3), n is 0, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1887).
In compound (L-3), n is 0, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1888).
In compound (L-3), n is 0, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1889).
In compound (L-3), n is 1, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1890).
In compound (L-3), n is 1, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1891).
In compound (L-3), n is 1, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1892).
In compound (L-3), n is 1, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1893).
In compound (L-3), n is 1, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1894).
In compound (L-3), n is 2, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1895).
In compound (L-3), n is 2, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1896).
In compound (L-3), n is 2, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1897).
In compound (L-3), n is 2, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1898).
In compound (L-3), n is 2, R ¹ is an ethoxymethyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [Table L11]. ], Which is any of the substituents (hereinafter referred to as compound group SX1899).
In compound (L-3), n is 0, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1900).
In compound (L-3), n is 0, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1901).
In compound (L-3), n is 0, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1902).
In compound (L-3), n is 0, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1903).
In compound (L-3), n is 0, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1904).
In compound (L-3), n is 1, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1905).
In compound (L-3), n is 1, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1906).
In compound (L-3), n is 1, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1907).
In compound (L-3), n is 1, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1908).
In compound (L-3), n is 1, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1909).
In compound (L-3), n is 2, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is a hydrogen atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1910).
In compound (L-3), n is 2, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is a chlorine atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1911).
In compound (L-3), n is 2, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is a bromine atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1912).
In compound (L-3), n is 2, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is an iodine atom, and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1913).
In compound (L-3), n is 2, R ¹ is a 3-pyridylmethyl group, R ² is a methyl group, R ^3b is CF ₃ , and T is [Table L1] to [ A compound which is any of the substituents shown in [Table L11] (hereinafter referred to as compound group SX1914).

で示される化合物（以下、化合物（Ｌ－４）と記す）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが水素原子であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1396と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが水素原子であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1397と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1398と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが水素原子であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1399と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが水素原子であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1400と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが水素原子であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1401と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが水素原子であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1402と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがフッ素原子であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1403と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがフッ素原子であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1404と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがフッ素原子であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1405と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがフッ素原子であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1406と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがフッ素原子であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1407と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがフッ素原子であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1408と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがフッ素原子であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1409と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが塩素原子であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1410と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが塩素原子であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1411と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが塩素原子であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1412と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが塩素原子であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1413と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが塩素原子であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1414と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが塩素原子であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1415と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bが塩素原子であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1416と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1417と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1418と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1419と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1420と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1421と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1422と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1423と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1424と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1425と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1426と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1427と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1428と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1429と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1430と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1431と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1432と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1433と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1434と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1435と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1436と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵が水素原子であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1437と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが水素原子であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1438と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが水素原子であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1439と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1440と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが水素原子であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1441と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが水素原子であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1442と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが水素原子であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1443と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが水素原子であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1444と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがフッ素原子であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1445と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがフッ素原子であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1446と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがフッ素原子であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1447と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがフッ素原子であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1448と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがフッ素原子であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1449と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがフッ素原子であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1450と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがフッ素原子であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1451と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが塩素原子であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1452と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが塩素原子であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1453と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが塩素原子であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1454と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが塩素原子であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1455と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが塩素原子であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1456と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが塩素原子であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1457と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bが塩素原子であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1458と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1459と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1460と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1461と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1462と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1463と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1464と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがヨウ素原子であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1465と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1466と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1467と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1468と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1469と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1470と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1471と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＣＦ₃であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1472と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cが水素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1473と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cがフッ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1474と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cが塩素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1475と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cが臭素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1476と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cがヨウ素原子であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1477と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cがＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1478と記す）。
化合物（Ｌ－４）において、Ｒ⁴⁵がメチル基であり、Ｒ^4bがＯＣＦ₃であり、Ｒ^4cがＯＣＦ₃であり、Ｒ^3bが［表Ｌ１２］～［表Ｌ１４］に記載のいずれかの置換基である化合物（以下、化合物群SX1479と記す）。 Equation (L-4)

In the compound represented by (hereinafter referred to as compound (L-4)), R ⁴⁵ is a hydrogen atom, R ^4b is a hydrogen atom, R ^4c is a hydrogen atom, and R ^3b is [Table L12] to. A compound which is any of the substituents shown in [Table L14] (hereinafter referred to as compound group SX1396).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a hydrogen atom, R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1397).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a hydrogen atom, R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1398).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a hydrogen atom, R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1399).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a hydrogen atom, R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1400).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a hydrogen atom, R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1401).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a hydrogen atom, R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1402).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a fluorine atom, R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1403).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a fluorine atom, R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1404).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a fluorine atom, R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1405).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a fluorine atom, R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1406).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a fluorine atom, R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1407).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a fluorine atom, R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1408).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a fluorine atom, R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1409).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a chlorine atom, R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1410).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a chlorine atom, R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1411).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a chlorine atom, R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1412).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a chlorine atom, R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1413).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a chlorine atom, R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1414).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a chlorine atom, R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1415).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is a chlorine atom, R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1416).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is an iodine atom, R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1417).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is an iodine atom, R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1418).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is an iodine atom, R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1419).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is an iodine atom, R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1420).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is an iodine atom, R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1421).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is an iodine atom, R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1422).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is an iodine atom, R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1423).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is CF ₃ , R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1424).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is CF ₃ , R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1425).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is CF ₃ , R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1426).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is CF ₃ , R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1427).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is CF ₃ , R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1428).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is CF ₃ , R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1429).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is CF ₃ , R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1430).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is OCF ₃ , R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1431).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is OCF ₃ , R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1432).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is OCF ₃ , R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1433).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is OCF ₃ , R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1434).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is OCF ₃ , R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1435).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is OCF ₃ , R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1436).
In compound (L-4), R ⁴⁵ is a hydrogen atom, R ^4b is OCF ₃ , R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1437).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a hydrogen atom, R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1438).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a hydrogen atom, R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1439).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a hydrogen atom, R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1440).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a hydrogen atom, R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1441).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a hydrogen atom, R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1442).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a hydrogen atom, R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1443).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a hydrogen atom, R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1444).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a fluorine atom, R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1445).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a fluorine atom, R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1446).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a fluorine atom, R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1447).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a fluorine atom, R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1448).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a fluorine atom, R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1449).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a fluorine atom, R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1450).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a fluorine atom, R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1451).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a chlorine atom, R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1452).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a chlorine atom, R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1453).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a chlorine atom, R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1454).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a chlorine atom, R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1455).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a chlorine atom, R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1456).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a chlorine atom, R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1457).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is a chlorine atom, R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1458).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is an iodine atom, R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1459).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is an iodine atom, R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1460).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is an iodine atom, R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1461).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is an iodine atom, R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1462).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is an iodine atom, R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1463).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is an iodine atom, R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1464).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is an iodine atom, R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1465).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is CF ₃ , R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1466).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is CF ₃ , R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1467).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is CF ₃ , R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1468).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is CF ₃ , R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1469).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is CF ₃ , R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1470).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is CF ₃ , R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1471).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is CF ₃ , R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1472).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is OCF ₃ , R ^4c is a hydrogen atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1473).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is OCF ₃ , R ^4c is a fluorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1474).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is OCF ₃ , R ^4c is a chlorine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1475).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is OCF ₃ , R ^4c is a bromine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1476).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is OCF ₃ , R ^4c is an iodine atom, and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1477).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is OCF ₃ , R ^4c is CF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1478).
In compound (L-4), R ⁴⁵ is a methyl group, R ^4b is OCF ₃ , R ^4c is OCF ₃ , and R ^3b is any of those described in [Table L12] to [Table L14]. A compound that is a substituent (hereinafter referred to as compound group SX1479).

In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a hydrogen atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1915).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a hydrogen atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1916).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a fluorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1917).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a fluorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1918).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a chlorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1919).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a chlorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1920).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is an iodine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1921).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is an iodine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1922).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is CF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1923).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is CF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1924).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is OCF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1925).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is OCF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1926).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a bromine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1927).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a bromine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1928).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is OCF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1929).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is OCF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1930).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is CF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1931).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is CF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1932).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a bromine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1933).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a bromine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1934).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a bromine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1935).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a bromine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1936).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a bromine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1937).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a bromine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1938).
In compound (L-4), R ^{45 45} Is a hydrogen atom, R ^4b Is a bromine atom, R ^4c Is OCF ₃ And R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1939).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1940).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1941).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1942).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1943).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1944).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1945).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1946).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is an iodine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1947).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₂ H and R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1948).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is CF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1949).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1950).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1951).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1952).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a bromine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1953).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is OCF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1954).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is OCF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1955).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is CF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1956).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is CF ₂ H and R ^4c Is CF ₂ H and R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1957).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a bromine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1958).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a bromine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1959).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a bromine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1960).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a bromine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1961).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a bromine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1962).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a bromine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1963).
In compound (L-4), R ^{45 45} Is a methyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1964).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a hydrogen atom, R ^4c Is a hydrogen atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1965).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a hydrogen atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1966).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a hydrogen atom, R ^4c Is a chlorine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1967).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a hydrogen atom, R ^4c Is a bromine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1968).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a hydrogen atom, R ^4c Is an iodine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1969).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1970).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1971).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a fluorine atom, R ^4c Is a hydrogen atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1972).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a fluorine atom, R ^4c Is a fluorine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1973).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a fluorine atom, R ^4c Is a chlorine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1974).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a fluorine atom, R ^4c Is a bromine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1975).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a fluorine atom, R ^4c Is an iodine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1976).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1977).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₃ And R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1978).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a chlorine atom, R ^4c Is a hydrogen atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1979).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a chlorine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1980).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a chlorine atom, R ^4c Is a chlorine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1981).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a chlorine atom, R ^4c Is a bromine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1982).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a chlorine atom, R ^4c Is an iodine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1983).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₃ And R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1984).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₃ And R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1985).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is an iodine atom, R ^4c Is a hydrogen atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1986).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is an iodine atom, R ^4c Is a fluorine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1987).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is an iodine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1988).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is an iodine atom, R ^4c Is a bromine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1989).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is an iodine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1990).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is an iodine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX1991).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₃ And R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1992).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₃ And R ^4c Is a hydrogen atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1993).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₃ And R ^4c Is a fluorine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1994).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1995).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1996).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₃ And R ^4c Is an iodine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1997).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1998).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX1999).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₃ And R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2000).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₃ And R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2001).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2002).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2003).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₃ And R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2004).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2005).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2006).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2007).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2008).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2009).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2010).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2011).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2012).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2013).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is an iodine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2014).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2015).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2016).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2017).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter referred to as compound group SX2018).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2019).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a bromine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2020).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2021).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is OCF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2022).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2023).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is CF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2024).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a bromine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2025).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a bromine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2026).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a bromine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2027).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a bromine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2028).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a bromine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2029).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a bromine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2030).
In compound (L-4), R ^{45 45} Is an ethyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2031).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is a hydrogen atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2032).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a hydrogen atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2033).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a hydrogen atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2034).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a hydrogen atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2035).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a hydrogen atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2036).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2037).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2038).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a fluorine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2039).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a fluorine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2040).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a fluorine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2041).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is a fluorine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2042).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is a fluorine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2043).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is a fluorine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2044).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2045).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a chlorine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2046).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a chlorine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2047).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a chlorine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2048).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a chlorine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2049).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a chlorine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2050).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2051).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2052).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is an iodine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2053).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is an iodine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2054).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is an iodine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2055).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is an iodine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2056).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is an iodine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2057).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is an iodine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2058).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2059).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₃ And R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2060).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₃ And R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2061).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2062).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2063).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₃ And R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2064).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2065).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2066).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is OCF ₃ And R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2067).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is OCF ₃ And R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2068).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is OCF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2069).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is OCF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2070).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is OCF ₃ And R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2071).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2072).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2073).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2074).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2075).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2076).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2077).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is a chlorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2078).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is a chlorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2079).
In compound (L-4), R ^{45 45} Is a benzyl group and R ^4b Is an iodine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2080).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is an iodine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2081).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2082).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2083).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2084).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2085).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2086).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a bromine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2087).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is OCF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2088).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is OCF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2089).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2090).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is CF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2091).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a bromine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2092).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a bromine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2093).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a bromine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2094).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a bromine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2095).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a bromine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2096).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a bromine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2097).
In compound (L-4), R ^{45 45} Is a benzyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2098).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a hydrogen atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2099).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a hydrogen atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2100).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a hydrogen atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2101).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a hydrogen atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2102).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a hydrogen atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2103).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2104).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2105).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a fluorine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2106).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a fluorine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2107).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a fluorine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2108).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a fluorine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2109).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a fluorine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2110).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2111).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2112).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a chlorine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2113).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a chlorine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2114).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a chlorine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2115).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a chlorine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2116).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a chlorine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2117).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2118).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2119).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is an iodine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2120).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is an iodine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2121).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is an iodine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2122).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is an iodine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2123).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is an iodine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2124).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is an iodine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2125).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2126).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₃ And R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2127).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₃ And R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2128).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2129).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2130).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₃ And R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2131).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2132).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2133).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₃ And R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2134).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₃ And R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2135).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2136).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2137).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₃ And R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2138).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2139).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2140).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2141).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2142).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2143).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2144).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2145).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2146).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2147).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is an iodine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2148).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2149).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2150).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2151).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2152).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2153).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a bromine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2154).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2155).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is OCF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2156).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2157).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is CF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2158).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a bromine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2159).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a bromine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2160).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a bromine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2161).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a bromine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2162).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a bromine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2163).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a bromine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2164).
In compound (L-4), R ^{45 45} Is a 3-pyridylmethyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2165).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a hydrogen atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2166).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a hydrogen atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2167).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a hydrogen atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2168).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a hydrogen atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2169).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a hydrogen atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2170).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2171).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₃ And R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2172).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a fluorine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2173).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a fluorine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2174).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a fluorine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2175).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a fluorine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2176).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a fluorine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2177).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2178).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2179).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a chlorine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2180).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a chlorine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2181).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a chlorine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2182).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a chlorine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2183).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a chlorine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2184).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2185).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2186).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is an iodine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2187).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is an iodine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2188).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is an iodine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2189).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is an iodine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2190).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is an iodine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2191).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is an iodine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2192).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2193).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₃ And R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2194).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₃ And R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2195).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2196).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2197).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₃ And R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2198).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2199).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2200).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₃ And R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2201).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₃ And R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2202).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2203).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2204).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₃ And R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2205).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2206).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2207).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2208).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2209).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2210).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2211).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2212).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2213).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2214).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is an iodine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2215).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2216).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2217).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2218).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2219).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2220).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a bromine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2221).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2222).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is OCF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2223).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2224).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is CF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2225).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a bromine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2226).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a bromine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2227).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a bromine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2228).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a bromine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2229).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a bromine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2230).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a bromine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2231).
In compound (L-4), R ^{45 45} Is an ethoxymethyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2232).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a hydrogen atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2233).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a hydrogen atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2234).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a hydrogen atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2235).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a hydrogen atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2236).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a hydrogen atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2237).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2238).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2239).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a fluorine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2240).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a fluorine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2241).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a fluorine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2242).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a fluorine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2243).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a fluorine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2244).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2245).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2246).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a chlorine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2247).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a chlorine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2248).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a chlorine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2249).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a chlorine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2250).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a chlorine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2251).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2252).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2253).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is an iodine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2254).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is an iodine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2255).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is an iodine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2256).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is an iodine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2257).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is an iodine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2258).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is an iodine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2259).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2260).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₃ And R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2261).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₃ And R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2262).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2263).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2264).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₃ And R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2265).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2266).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₃ And R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2267).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₃ And R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2268).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₃ And R ^4c Is a fluorine atom, R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2269).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₃ And R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2270).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₃ And R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2271).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₃ And R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2272).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2273).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2274).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a hydrogen atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2275).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a hydrogen atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2276).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a fluorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2277).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a fluorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2278).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a chlorine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2279).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a chlorine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2280).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is an iodine atom, R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2281).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is an iodine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2282).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2283).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2284).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₃ And R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2285).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₃ And R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2286).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₂ H and R ^3b However, the compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2287).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a bromine atom, R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2288).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2289).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is OCF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2290).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₂ H and R ^4c Is OCF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2291).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is CF ₂ H and R ^4c Is CF ₂ H and R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2292).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a bromine atom, R ^4c Is a hydrogen atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2293).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a bromine atom, R ^4c Is a fluorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2294).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a bromine atom, R ^4c Is a chlorine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2295).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a bromine atom, R ^4c Is a bromine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2296).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a bromine atom, R ^4c Is an iodine atom, R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2297).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a bromine atom, R ^4c Is CF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2298).
In compound (L-4), R ^{45 45} Is a cyanomethyl group, R ^4b Is a bromine atom, R ^4c Is OCF ₃ And R ^3b Is a compound which is any of the substituents described in [Table L12] to [Table L14] (hereinafter, referred to as compound group SX2299).

で示される化合物（以下、化合物（Ｌ－５）と記す）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4bが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1480と記す）。

Equation (L-5)

In the compound represented by (hereinafter referred to as compound (L-5)), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, and R ^3b . Is a hydrogen atom and R ^4b is any of the substituents shown in [Table L15] to [Table L16] (hereinafter referred to as compound group SX1480).

In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1481).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1482).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1483).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1484).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1485).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1486).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1487).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1488).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1489).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1490).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1491).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1492).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1493).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1494).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1495).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1496).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1497).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1498).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1499).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1500).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1501).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1502).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1503).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1504).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1505).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1506).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1507).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1508).
In compound (L-5), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1509).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1510).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1511).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1512).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1513).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1514).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1515).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1516).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1517).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1518).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1519).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1520).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1521).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1522).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1523).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1524).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1525).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1526).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1527).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1528).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1529).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1530).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1531).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1532).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1533).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1534).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1535).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1536).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1537).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1538).
In compound (L-5), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1539).
In the compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1540).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1541).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1542).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1543).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1544).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1545).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1546).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1547).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1548).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1549).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1550).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1551).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1552).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1553).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1554).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1555).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1556).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1557).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1558).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1559).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1560).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1561).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1562).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1563).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1564).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1565).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1566).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1567).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1568).
In compound (L-5), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1569).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1570).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1571).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1572).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1573).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1574).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1575).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1576).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1577).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1578).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1579).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1580).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1581).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1582).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1583).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1584).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1585).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1586).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1587).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1588).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1589).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1590).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1591).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1592).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1593).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1594).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1595).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1596).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1597).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1598).
In compound (L-5), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1599).
In the compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1600).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1601).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1602).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1603).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1604).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1605).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1606).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1607).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1608).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1609).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1610).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1611).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1612).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1613).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1614).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1615).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1616).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1617).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1618).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1619).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1620).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1621).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1622).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1623).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1624).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1625).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1626).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1627).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1628).
In compound (L-5), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1629).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1630).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1631).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1632).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1633).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1634).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1635).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1636).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1637).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1638).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1639).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1640).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1641).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1642).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1643).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1644).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1645).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1646).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1647).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1648).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1649).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1650).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1651).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1652).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1653).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1654).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1655).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1656).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1657).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1658).
In compound (L-5), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4b is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1659).

で示される化合物（以下、化合物（Ｌ－６）と記す）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1660と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1661と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1662と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1663と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1664と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1665と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1666と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1667と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1668と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1669と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1670と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1671と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1672と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1673と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1674と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1675と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1676と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1677と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1678と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1679と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1680と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1681と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1682と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1683と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1684と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1685と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1686と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1687と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1688と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1689と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1690と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1691と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1692と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1693と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1694と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1695と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1696と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1697と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1698と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1699と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1700と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1701と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1702と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1703と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1704と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1705と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1706と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1707と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1708と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1709と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1710と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1711と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1712と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1713と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1714と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1715と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1716と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1717と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1718と記す）。
化合物（Ｌ－６）において、ｎが０であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1719と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1720と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1721と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1722と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1723と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1724と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1725と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1726と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1727と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1728と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1729と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1730と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1731と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1732と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1733と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1734と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1735と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1736と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1737と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1738と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1739と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1740と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1741と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1742と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1743と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1744と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1745と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1746と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1747と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1748と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1749と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1750と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1751と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1752と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1753と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1754と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1755と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1756と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1757と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1758と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1759と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1760と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1761と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1762と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1763と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1764と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1765と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1766と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1767と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1768と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1769と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1770と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1771と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1772と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1773と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1774と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1775と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1776と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1777と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1778と記す）。
化合物（Ｌ－６）において、ｎが１であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1779と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1780と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1781と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1782と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1783と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1784と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1785と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1786と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1787と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1788と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1789と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1790と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1791と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1792と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1793と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1794と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1795と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1796と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1797と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1798と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1799と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1800と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1801と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1802と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1803と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1804と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1805と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1806と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1807と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1808と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹が水素原子であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1809と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1810と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1811と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1812と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1813と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1814と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1815と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1816と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1817と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1818と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1819と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1820と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1821と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1822と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1823と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²が水素原子であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1824と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1825と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1826と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1827と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1828と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵が水素原子であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1829と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1830と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1831と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1832と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1833と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がメチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1834と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが水素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1835と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがフッ素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1836と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが塩素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1837と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bが臭素原子であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1838と記す）。
化合物（Ｌ－６）において、ｎが２であり、Ｒ⁴¹がメチル基であり、Ｒ⁴²がメチル基であり、Ｒ⁴⁵がエチル基であり、Ｒ^3bがＣＦ₃であり、Ｒ^4cが［表Ｌ１５］～［表Ｌ１６］に記載のいずれかの置換基である化合物（以下、化合物群SX1839と記す）。
。 Equation (L-6)

In the compound represented by (hereinafter referred to as compound (L-6)), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, and R ^3b . Is a hydrogen atom and R ^4c is any of the substituents shown in [Table L15] to [Table L16] (hereinafter referred to as compound group SX1660).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1661).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1662).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1663).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1664).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1665).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1666).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1667).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1668).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1669).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1670).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1671).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1672).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1673).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1674).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1675).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1676).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1677).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1678).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1679).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1680).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1681).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1682).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1683).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1684).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1685).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1686).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1687).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1688).
In compound (L-6), n is 0, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1689).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1690).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1691).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1692).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1693).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1694).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1695).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1696).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1697).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1698).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1699).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1700).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1701).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1702).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1703).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1704).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1705).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1706).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1707).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1708).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1709).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1710).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1711).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1712).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1713).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1714).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1715).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1716).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1717).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1718).
In compound (L-6), n is 0, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1719).
In the compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1720).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1721).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1722).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1723).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1724).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1725).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1726).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1727).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1728).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1729).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1730).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1731).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1732).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1733).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1734).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1735).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1736).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1737).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1738).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1739).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1740).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1741).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1742).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1743).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1744).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1745).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1746).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1747).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1748).
In compound (L-6), n is 1, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1749).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1750).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1751).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1752).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1753).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1754).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1755).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1756).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1757).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1758).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1759).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1760).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1761).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1762).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1763).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1764).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1765).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1766).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1767).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1768).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1769).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1770).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1771).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1772).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1773).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1774).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1775).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1776).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1777).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1778).
In compound (L-6), n is 1, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1779).
In the compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^{4 c} is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1780).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1781).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1782).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1783).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^{4 c} is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1784).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1785).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1786).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1787).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1788).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1789).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1790).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1791).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1792).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1793).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1794).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1795).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1796).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1797).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1798).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1799).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1800).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1801).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1802).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1803).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1804).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1805).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1806).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1807).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1808).
In compound (L-6), n is 2, R ⁴¹ is a hydrogen atom, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1809).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1810).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1811).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1812).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1813).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1814).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1815).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1816).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1817).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1818).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1819).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1820).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1821).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1822).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1823).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a hydrogen atom, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1824).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1825).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1826).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1827).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1828).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a hydrogen atom, R ^3b is CF ₃ , and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1829).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1830).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1831).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1832).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1833).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is a methyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1834).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a hydrogen atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1835).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a fluorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1836).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a chlorine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1837).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is a bromine atom, and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1838).
In compound (L-6), n is 2, R ⁴¹ is a methyl group, R ⁴² is a methyl group, R ⁴⁵ is an ethyl group, R ^3b is CF ₃ and R ^4c is [ A compound which is any of the substituents shown in Tables L15] to [Table L16] (hereinafter referred to as compound group SX1839).
..

Examples of the composition A include the following.

In Group 1, the combination of SX and this ingredient is any combination of the following "2 active ingredient list", and is composed of composition A consisting of 2 parts of SX and 0.5 parts of this ingredient. ..

In the "2 Active Ingredient List", for example, SX + spinetram means a combination of SX and spinetram.

"2 Active ingredient list":
SX + spinnetram, SX + clothianidin, SX + triflumezopyrim, SX + isothianil, SX + flametopill, SX + impilfluxam, SX + orythastrobin, SX + fusalide, SX + validamycin A, SX + ferlimzone, SX + azoxy Strobin.

In Group 2, the combination of SX and this ingredient is any combination of the above "2 active ingredient list", and is composed of composition A consisting of 2 parts of SX and 1.5 parts of this ingredient. ..
In Group 3, the combination of SX and this ingredient is any combination of the above "2 active ingredient list", and is composed of a composition A composed of 1 part of SX and 1 part of this ingredient.
In Group 4, the combination of SX and this ingredient is any combination of the above-mentioned "2 active ingredient list", and is composed of a composition A composed of 1 part of SX and 2 parts of this ingredient.
In Group 5, the combination of SX and this ingredient is any combination of the above "2 active ingredient list", and is composed of composition A consisting of 2 parts of SX and 7 parts of this ingredient.
In Group 6, the combination of SX and this ingredient is any combination of the above-mentioned "2 active ingredient list", and is composed of composition A consisting of 1 part of SX and 5 parts of this ingredient.
In Group 7, the combination of SX and this ingredient is any combination of the above-mentioned "2 active ingredient list", and is composed of composition A consisting of 1 part of SX and 15 parts of this ingredient.
In Group 8, the combination of SX and this ingredient is any combination of the above-mentioned "2 active ingredient list", and is composed of composition A composed of 1 part of SX and 3 parts of this ingredient.
In Group 9, the combination of SX and this ingredient is any combination of the above "2 active ingredient list", and is composed of composition A consisting of 5 parts of SX and 6.6 parts of this ingredient. ..
In group 10, the combination of SX and this component is any combination of the above "2 active ingredient list", and is composed of 1 part of SX and 4 parts of composition A consisting of this component.
In Group 11, the combination of SX and this ingredient is any combination of the above "2 active ingredient list", and is composed of composition A consisting of 5 parts of SX and 8 parts of this ingredient.

In group 12, the combination of SX, this component 1 and this component 2 is any combination of the following "3 active ingredient list", and 2 parts of SX, 0.5 parts of this component 1 and 1.5. It is composed of the composition A composed of the main component 2 of the portion.

In the "3 active ingredient list", for example, SX + spinetram + clothianidin means a combination of SX, spinetram and clothianidin, and this component 1 is spinetram and this component 2 is clothianidin.

"3 Active Ingredient List":
SX + Spinetram + Crossianidin,
SX + Spinetram + Triflumezopyrim,
SX + Spinetram + Isothianil,
SX + Spinetram + Dicrobench Azox,
SX + Spinetram + Torpro Calve,
SX + Spinetram + Flametopill,
SX + Spinetram + Impilfluxam,
SX + Spinetram + Orythastrobin,
SX + clothianidin + triflumezopyrim,
SX + clothianidin + isothianil,
SX + clothianidin + diclobenazox,
SX + clothianidin + tolprocarb,
SX + clothianidin + flametopill,
SX + clothianidin + impilfluxam,
SX + clothianidin + orisastrobin,
SX + Triflumezopyrim + Isothianil,
SX + Triflumezopyrim + Diclobenazox,
SX + Triflumezopyrim + Torprocarb,
SX + Triflumezopyrim + Flametopil,
SX + Triflumezopyrim + Impilfluxam,
SX + Triflumezopyrim + Orysustrobin,
SX + Isothianil + Flametopil,
SX + isothianil + impilfluxam,
SX + Dicrobench Azox + Flametopill,
SX + diclobenazox + impilfluxam,
SX + Torprocarb + Flametopil,
SX + Torprocarb + Impilfluxam,
SX + clothianidin + fusalide,
SX + clothianidin + validamycin A,
SX + Fusalide + Validamycin A,
SX + Felimzon + Fusalide,
SX + Fusalide + Felimzon,
SX + Fusalide + Validamycin A,
SX + chlorantraniliprol + clothianidin,
SX + chlorantraniliprol + imidacloprid,
SX + Chlorantraniliprol + Thiamethoxam,
SX + chlorantraniliprol + thiacloprid,
SX + chlorantraniliprol + full pyraziflon,
SX + Chlorantraniliprol + Triflumezopyrim,
SX + chlorantraniliprol + flupyrimin,
SX + chlorantraniliprol + brofuranilide,
SX + chlorantraniliprol + tefluthrin,
SX + chlorantraniliprol + bifenthrin,
SX + cyantraniliprole + clothianidin,
SX + Cyantraniliprole + Imidacloprid,
SX + Cyantraniliprole + Thiamethoxam,
SX + Cyantraniliprole + Thiacloprid,
SX + Cyantraniliprole + Full Pyradiflon,
SX + Cyantraniliprole + Triflumezopyrim,
SX + Cyantraniliprole + Flupyrimin,
SX + Cyantraniliprole + Brofuranilide,
SX + Cyantraniliprole + Tefluthrin,
SX + Cyantraniliprole + Bifenthrin,
SX + tetraniliprol + clothianidin,
SX + Tetraniliprol + imidacloprid,
SX + Tetraniliprol + Thiamethoxam,
SX + Tetraniliprol + Thiacloprid,
SX + Tetra Niliprol + Full Pyraziflon,
SX + Tetraniliprol + Triflumezopyrim,
SX + Tetraniliprol + Flupyrimin,
SX + Tetraniliprol + Brofuranilide,
SX + Tetraniliprol + Tefluthrin,
SX + Tetraniliprol + Bifenthrin,
SX + clothianidin + brofuranilide,
SX + clothianidin + tefluthrin,
SX + clothianidin + bifenthrin,
SX + imidacloprid + brofuranilide,
SX + imidacloprid + tefluthrin,
SX + thiamethoxam + bifenthrin,
SX + thiamethoxam + brofuranilide,
SX + thiamethoxam + tefluthrin,
SX + thiamethoxam + bifenthrin,
SX + thiacloprid + brofuranilide,
SX + thiacloprid + tefluthrin,
SX + thiacloprid + bifenthrin,
SX + full pyraziflon + brofuranilide,
SX + full pyraziflon + tefluthrin,
SX + full pyraziflon + bifenthrin,
SX + Triflumezopyrim + Brofuranilide,
SX + Triflumezopyrim + Tefluthrin,
SX + Triflumezopyrim + Bifenthrin,
SX + flupyrimin + brofuranilide,
SX + flupyrimin + tefluthrin,
SX + flupyrimin + bifenthrin,
SX + Bacillus firmus strain I-1582 + clothianidin,
SX + Bacillus firmus strain I-1582 + imidacloprid,
SX + Bacillus firmus strain I-1582 + Thiamethoxam,
SX + Bacillus firmus strain I-1582 + thiacloprid,
SX + Bacillus firmus strain I-1582 + full pyraziflon,
SX + Bacillus firmus strain I-1582 + flupyrimin,
SX + Bacillus firmus strain I-1582 + Triflumezopyrim,
SX + Bacillus firmus strain I-1582 + Chlorantraniliprol,
SX + Bacillus firmus strain I-1582 + Cyantraniliprole,
SX + Bacillus firmus strain I-1582 + Tetraniliprol,
SX + Bacillus firmus strain I-1582 + tefluthrin,
SX + Bacillus firmus strain I-1582 + bifenthrin,
SX + Bacillus firmus strain I-1582 + fipronil,
SX + Bacillus firmus strain I-1582 + Brofuranilide,
SX + Pasteuria nishizawae strain Pn1 + clothianidin,
SX + Pasteuria nishizawae strain Pn1 + imidacloprid,
SX + Pasteuria nishizawae strain Pn1 + Thiamethoxam,
SX + Pasteuria nishizawae strain Pn1 + thiacloprid,
SX + Pasteuria nishizawae strain Pn1 + full pyraziflon,
SX + Pasteuria nishizawae strain Pn1 + flupyrimin,
SX + Pasteuria nishizawae strain Pn1 + Triflumezopyrim,
SX + Pasteuria nishizawae strain Pn1 + chlorantrani lipol,
SX + Pasteuria nishizawae strain Pn1 + Cyantraniliprole,
SX + Pasteuria nishizawae strain Pn1 + Tetra niliprol,
SX + Pasteuria nishizawae strain Pn1 + tefluthrin,
SX + Pasteuria nishizawae strain Pn1 + bifenthrin,
SX + Pasteuria nishizawae strain Pn1 + fipronil,
SX + Pasteuria nishizawae strain Pn1 + Brofuranilide,
SX + Bradyrhizobium japonicum strain TA-11 + clothianidin,
SX + Bradyrhizobium japonicum strain TA-11 + imidacloprid,
SX + Bradyrhizobium japonicum strain TA-11 + Thiamethoxam,
SX + Bradyrhizobium japonicum strain TA-11 + thiacloprid,
SX + Bradyrhizobium japonicum strain TA-11 + full pyraziflon,
SX + Bradyrhizobium japonicum strain TA-11 + flupyrimin,
SX + Bradyrhizobium japonicum strain TA-11 + Triflumezopyrim,
SX + Bradyrhizobium japonicum strain TA-11 + chlorantraniliprol,
SX + Bradyrhizobium japonicum strain TA-11 + Cyantraniliprole,
SX + Bradyrhizobium japonicum strain TA-11 + Tetraniliprol,
SX + Bradyrhizobium japonicum strain TA-11 + tefluthrin,
SX + Bradyrhizobium japonicum strain TA-11 + bifenthrin,
SX + Bradyrhizobium japonicum strain TA-11 + fipronil,
SX + Bradyrhizobium japonicum strain TA-11 + Bradyrhizobium,
SX + Bacillus thuringiensis strain EX297512 + clothianidin,
SX + Bacillus thuringiensis strain EX297512 + imidacloprid,
SX + Bacillus thuringiensis strain EX297512 + Thiamethoxam,
SX + Bacillus thuringiensis strain EX297512 + thiacloprid,
SX + Bacillus thuringiensis strain EX297512 + full pyraziflon,
SX + Bacillus thuringiensis strain EX297512 + flupyrimin,
SX + Bacillus thuringiensis strain EX297512 + Triflumezopyrim,
SX + Bacillus thuringiensis strain EX297512 + chlorantraniliprol,
SX + Bacillus thuringiensis strain EX297512 + Cyantraniliprole,
SX + Bacillus thuringiensis strain EX297512 + Tetraniliprol,
SX + Bacillus thuringiensis strain EX297512 + tefluthrin,
SX + Bacillus thuringiensis strain EX297512 + bifenthrin,
SX + Bacillus thuringiensis strain EX297512 + fipronil,
SX + Bacillus thuringiensis strain EX297512 + Brofuranilide,
SX + Penicillium bilaiae + clothianidin,
SX + Penicillium bilaiae + imidacloprid,
SX + Penicillium bilaiae + Thiamethoxam,
SX + Penicillium bilaiae + thiacloprid,
SX + Penicillium bilaiae + full pyraziflon,
SX + Penicillium bilaiae + full pyrimine,
SX + Penicillium bilaiae + Triflumezopyrim,
SX + Penicillium bilaiae + Chlorantran Liprol,
SX + Penicillium bilaiae + Cyantraniliprole,
SX + Penicillium bilaiae + Tetrani Liprol,
SX + Penicillium bilaiae + tefluthrin,
SX + Penicillium bilaiae + bifenthrin,
SX + Penicillium bilaiae + fipronil,
SX + Penicillium bilaiae + Brofuranilide,
SX + Sinorhizobium meliloti + clothianidin,
SX + Sinorhizobium meliloti + imidacloprid,
SX + Sinorhizobium meliloti + Thiamethoxam,
SX + Sinorhizobium meliloti + thiacloprid,
SX + Sinorhizobium meliloti + full pyraziflon,
SX + Sinorhizobium meliloti + flupyrimin,
SX + Sinorhizobium meliloti + Triflumezopyrim,
SX + Sinorhizobium meliloti + chlorantrani lipol,
SX + Sinorhizobium meliloti + Cyantraniliprole,
SX + Sinorhizobium meliloti + Tetraniliprol,
SX + Sinorhizobium meliloti + tefluthrin,
SX + Sinorhizobium meliloti + bifenthrin,
SX + Sinorhizobium meliloti + fipronil,
SX + Sinorhizobium meliloti + Brofuranilide,
SX + Rhizobium leguminosarum + clothianidin,
SX + Rhizobium leguminosarum + imidacloprid,
SX + Rhizobium leguminosarum + thiamethoxam,
SX + Rhizobium leguminosarum + thiacloprid,
SX + Rhizobium leguminosarum + full pyraziflon,
SX + Rhizobium leguminosarum + flupyrimin,
SX + Rhizobium leguminosarum + Triflumezopyrim,
SX + Rhizobium leguminosarum + chlorantrani riprol,
SX + Rhizobium leguminosarum + Cyantraniliprole,
SX + Rhizobium leguminosarum + Tetrani Liprol,
SX + Rhizobium leguminosarum + tefluthrin,
SX + Rhizobium leguminosarum + bifenthrin,
SX + Rhizobium leguminosarum + fipronil,
SX + Rhizobium leguminosarum + brofuranilide,
SX + full azaindlizine + clothianidin,
SX + Full Azain Indolizine + Imidacloprid,
SX + Full Azain Indolizine + Thiamethoxam,
SX + Full Azain Indolizine + Thiacloprid,
SX + Full Azain Indolizine + Full Pyraziflon,
SX + fluazindolizine + flupyrimin,
SX + full azine indolizine + triflumezopyrim,
SX + Full Azain Indolizine + Chlorantran Liprol,
SX + Full Azain Indolizine + Cyantraniliprole,
SX + Full Azin Indolizine + Tetraniliprol,
SX + Full Azin Indolizine + Tefluthrin,
SX + Full Azain Indolizine + Bifenthrin,
SX + full azine indolizine + fipronil,
SX + Full Azain Indolizine + Brofuranilide,
SX + thioxazaphen + clothianidin,
SX + tioxazaphen + imidacloprid,
SX + thioxazaphen + thiamethoxam,
SX + thioxazaphen + thiacloprid,
SX + thioxazaphen + flupyraziflon,
SX + thioxazaphen + flupyrimin,
SX + thioxazaphen + triflumezopyrim,
SX + thioxazaphen + chlorantraniliprol,
SX + Thioxazaphen + Cyantraniliprole,
SX + thioxazaphen + tetraniliprol,
SX + thioxazaphen + tefluthrin,
SX + tioxazaphen + bifenthrin,
SX + tioxazaphen + fipronil,
SX + thioxazaphen + brofuranilide,
SX + fluene sulfone + clothianidin,
SX + fluene sulfone + imidacloprid,
SX + Fluensulfone + Thiamethoxam,
SX + fluene sulfone + thiacloprid,
SX + Fluensulfone + Flupyraziflon,
SX + fluene sulfone + flupyrimin,
SX + fluene sulfone + triflumezopyrim,
SX + Fluensulfone + Chlorantraniliprol,
SX + fluene sulfone + cyantraniliprole,
SX + fluene sulfone + tetraniliprol,
SX + fluene sulfone + tefluthrin,
SX + fluene sulfone + bifenthrin,
SX + fluene sulfone + fipronil,
SX + Fluensulfone + Brofuranilide,
SX + abamectin + clothianidin,
SX + abamectin + imidacloprid,
SX + abamectin + thiamethoxam,
SX + abamectin + thiacloprid,
SX + abamectin + fulpyraziflon,
SX + abamectin + flupyrimin,
SX + abamectin + triflumezopyrim,
SX + abamectin + chloranthraniliprol,
SX + abamectin + cyantraniliprole,
SX + abamectin + tetraniliprol,
SX + abamectin + tefluthrin,
SX + abamectin + bifenthrin,
SX + abamectin + fipronil,
SX + abamectin + brofuranilide,
SX + fluopirum + clothianidin,
SX + full opirum + imidacloprid,
SX + Full Opirum + Thiamethoxam,
SX + full opirum + thiacloprid,
SX + Full Opirum + Full Pilaziflon,
SX + fluopirum + flupyrimin,
SX + fluopirum + triflumezopyrim,
SX + Full Opirum + Chlorantrani Liprol,
SX + Full Opirum + Cyantraniliprole,
SX + Fluopirum + Tetraniliprol,
SX + Fluopirum + Tefluthrin,
SX + fluopirum + bifenthrin,
SX + fluopirum + fipronil,
SX + Full Opirum + Brofuranilide,
SX + Bacillus amyloliquefaciens + Trichoderma virens,
SX + Penicillium bilaiae + Bradyrhizobium japonicum,
SX + Penicillium bilaiae + Mesorhizobium ciceri,
SX + Bradyrhizobium japonicum + lipochitooligosaccharide,
SX + fluopirum + mefentrifluconazole,
SX + fluopyram + methyltetraprowl,
SX + fluopirum + pigiflumethofen,
SX + fluopirum + isoflusiplum,
SX + fluopyram + aminopyriphen,
SX + Full Opirum + Mankozeb,
SX + Full Opirum + Carbendazim,
SX + Full Opirum + Picaru Butra Zox,
SX + fluopyram + fluoxapiproline,
SX + Fluazin Indolizine + Mefentrifluconazole,
SX + fluazindolizine + methyltetraprowl,
SX + fluazindolizine + pidiflumethofen,
SX + fluazin indolizine + isoflusiplum,
SX + fluazindolizine + aminopyriphen,
SX + Full Azain Indolizine + Mancozeb,
SX + Full Azain Indolizine + Carbendazim,
SX + Full Azain Indolizine + Picaru Butra Zox,
SX + Fluazin Indolizine + Fluoxapiproline,
SX + fluene sulfone + mefentrifluconazole,
SX + fluene sulfone + methyltetraprowl,
SX + fluene sulfone + pidiflumethofen,
SX + fluene sulfone + isoflusiplum,
SX + fluene sulfone + aminopyriphen,
SX + Fluensulfone + Mancozeb,
SX + Fluensulfone + Carbendazim,
SX + fluene sulfone + picaru butrazox,
SX + fluene sulfone + fluoxapiproline,
SX + tioxazaphen + mefentrifluconazole,
SX + thioxazaphen + methyltetraprowl,
SX + thioxazaphen + pidiflumethofen,
SX + tioxazaphen + isoflusiplum,
SX + thioxazaphen + aminopyriphen,
SX + tioxazaphen + mancozeb,
SX + tioxazaphen + carbendazim,
SX + thioxazaphen + picaru butrazox,
SX + thioxazaphen + fluoxapiproline,
SX ＋ Bacillus firmus strain I-1582 ＋ Mefentrifluconazole,
SX ＋ Bacillus firmus strain I-1582 ＋ Methyltetraprowl,
SX ＋ Bacillus firmus strain I-1582 ＋ Pigiflumethofen,
SX ＋ Bacillus firmus strain I-1582 ＋ Isoflusiplum,
SX ＋ Bacillus firmus strain I-1582 ＋ Aminopyrifen,
SX ＋ Bacillus firmus strain I-1582 ＋ Mankozeb,
SX ＋ Bacillus firmus strain I-1582 ＋ Carbendazim,
SX ＋ Bacillus firmus strain I-1582 ＋ Picaru Butrazox,
SX ＋ Bacillus firmus strain I-1582 ＋ Fluoxapiproline,
SX ＋ Pasteuria nishizawae strain Pn1 ＋ Mefentrifluconazole,
SX ＋ Pasteuria nishizawae strain Pn1 ＋ Methyltetraprowl,
SX ＋ Pasteuria nishizawae strain Pn1 ＋ Pigiflumethofen,
SX ＋ Pasteuria nishizawae strain Pn1 ＋ Isoflusiplum,
SX ＋ Pasteuria nishizawae strain Pn1 ＋ Aminopyrifen,
SX ＋ Pasteuria nishizawae strain Pn1 ＋ Mankozeb,
SX ＋ Pasteuria nishizawae strain Pn1 ＋ Carbendazim,
SX ＋ Pasteuria nishizawae strain Pn1 ＋ Picaru Butra Zox,
SX ＋ Pasteuria nishizawae strain Pn1 ＋ Fluoxapiproline.

In group 13, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 2 parts of SX, 0.5 part of this component 1 and 2 parts. It is composed of the composition A composed of the present component 2.
In group 14, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 2 parts of SX, 0.5 part of this component 1 and 4 parts. It is composed of the composition A composed of the present component 2.
In group 15, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 2 parts of SX, 0.5 part of this component 1 and 7 parts. It is composed of the composition A composed of the present component 2.
In group 16, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 2 parts of SX, 1.5 parts of this component 1 and 2 parts. It is composed of the composition A composed of the present component 2.
In group 17, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 2 parts of SX, 1.5 parts of this component 1 and 4 parts. It is composed of the composition A composed of the present component 2.
In group 18, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 2 parts of SX, 1.5 parts of this component 1 and 7 parts. It is composed of the composition A composed of the present component 2.
In group 19, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 2 parts of SX, 2 parts of this component 1 and 2.5 parts. It is composed of the composition A composed of the present component 2.
In group 20, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 1 part of SX, 1 part of this component 1 and 2 parts of this component. It is composed of the composition A composed of 2.
In group 21, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 0.1 part of SX, 0.5 part of this component 1 and 1 It is composed of composition A composed of .5 parts of this component 2.
In group 22, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 0.1 part of SX, 0.5 part of this component 1 and 0. . Consists of composition A consisting of 3 parts of this component 2.
In group 23, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 0.1 part of SX, 2 parts of this component 1 and 1.5. It is composed of the composition A composed of the main component 2 of the portion.
In group 24, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 5 parts of SX, 6.6 parts of this component 1 and 20 parts. It is composed of the composition A composed of the present component 2.
In group 25, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 5 parts of SX, 6.6 parts of this component 1 and 5 parts. It is composed of the composition A composed of the present component 2.
In group 26, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 5 parts of SX, 6.6 parts of this component 1 and 8 parts. It is composed of the composition A composed of the present component 2.
In group 27, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 1 part of SX, 1 part of this component 1 and 1 part of this component. It is composed of the composition A composed of 2.
In group 28, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 1 part of SX, 1 part of this component 1 and 10 parts of this component. It is composed of the composition A composed of 2.
In group 29, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 1 part of SX, 10 parts of this component 1 and 1 part of this component. It is composed of the composition A composed of 2.
In group 30, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 1 part of SX, 10 parts of this component 1 and 10 parts of this component. It is composed of the composition A composed of 2.
In group 31, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 10 parts of SX, 1 part of this component 1 and 1 part of this component. It is composed of the composition A composed of 2.
In group 32, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 10 parts of SX, 1 part of this component 1 and 10 parts of this component. It is composed of the composition A composed of 2.
In group 33, the combination of SX, this component 1 and this component 2 is any combination of the above "3 active ingredient list", and 10 parts of SX, 10 parts of this component 1 and 1 part of this component. It is composed of the composition A composed of 2.

In group 34, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the following "4 active ingredient list", and 2 parts of SX and 0.5 part of this component 1 , 1.5 parts of the main component 2 and 2 parts of the main component 3 of the composition A.

In the "4 active ingredient list", for example, SX + spinnetram + clothianidin + isothianyl means a combination of SX, spinetram, clothianidin and isothianil, and this component 1 is spinetram, this component 2 is clothianidin, and this component. 3 is isothianil.

"4 Active Ingredient List":
SX + spinnetram + clothianidin + isothianil,
SX + spinnetram + clothianidin + diclobenazox,
SX + spine tram + clothianidin + tolprocarb,
SX + spinnetram + clothianidin + flametopill,
SX + spinnetram + clothianidin + impilfluxam,
SX + Spinetram + Triflumezopyrim + Isothianil,
SX + Spinetram + Triflumezopyrim + Diclobenazox,
SX + Spinetram + Triflumezopyrim + Torprocarb,
SX + Spinetram + Triflumezopyrim + Flametopil,
SX + spinnetram + triflumezopyrim + impilfluxam,
SX + Spinetram + Isothianil + Flametopill,
SX + Spinetram + Isothianil + Impilfluxam,
SX + Spinetram + Diclobenazox + Flametopill,
SX + Spinetram + Diclobenazox + Impilfluxam,
SX + Spinetram + Torprocarb + Flametopill,
SX + Spinetram + Torprocarb + Impilfluxam,
SX + Spinetram + Torprocarb + Simeconazole,
SX + clothianidin + isothianil + flametopil,
SX + clothianidin + isothianil + impilfluxam,
SX + clothianidin + diclobenazox + flametopill,
SX + clothianidin + diclobenazox + impilfluxam,
SX + clothianidin + tolprocarb + flametopill,
SX + clothianidin + tolprocarb + impilfluxam,
SX + clothianidin + tolprocarb + simeconazole,
SX + clothianidin + ferlimzone + fusalide,
SX + clothianidin + fusalide + validamycin A,
SX + Felimzon + Fusalide + Validamycin A,
SX + clothianidin + fusalide + validamycin A,
SX + clothianidin + fusalide + ferlimzone.

In group 35, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 2 parts of SX and 0.5 part of this component 1 , 1.5 parts of the main component 2 and 4 parts of the main component 3 of the composition A.
In group 36, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 2 parts of SX and 0.5 part of this component 1 It is composed of a composition A composed of two parts of the main component 2 and two parts of the main component 3.
In group 37, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 2 parts of SX and 0.5 part of this component 1 It is composed of a composition A composed of two parts of the main component 2 and four parts of the main component 3.
In group 38, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 2 parts of SX and 1.5 parts of this component 1 It is composed of a composition A composed of two parts of the main component 2 and two parts of the main component 3.
In group 39, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 2 parts of SX and 1.5 parts of this component 1 It is composed of a composition A composed of two parts of the main component 2 and four parts of the main component 3.
In group 40, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 0.1 part of SX and 0.5 part of this book. It is composed of a composition A composed of 1 and 2 parts of the main component 2 and 1.5 parts of the main component 3.
In group 41, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 0.1 part of SX and 0.5 part of this book. It is composed of the composition A composed of the component 1, 1.5 parts of the main component 2 and 0.3 parts of the main component 3.
In group 42, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 0.1 part of SX and 2 parts of this component 1 , 1.5 parts of the main component 2 and 0.3 parts of the main component 3 of the composition A.
In group 43, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 5 parts of SX and 6.6 parts of this component 1 , 15 parts of the main component 2 and 15 parts of the main component 3 of the composition A.
In group 44, the combination of SX, this component 1, this component 2 and this component 3 is any combination of the above "4 active ingredient list", and 5 parts of SX and 6.6 parts of this component 1 , 20 parts of the main component 2 and 5 parts of the main component 3 of the composition A.

In group 45, the combination of SX, this component 1, this component 2, this component 3 and this component 4 is any combination of the following "5 active ingredient list", and 2 parts of SX, 0.5 part. It is composed of the composition A consisting of the main component 1, 1.5 parts of the main component 2, 2 parts of the main component 3 and 4 parts of the main component 4.

In the "5 Active Ingredient List", for example, SX + spinnetram + clothianidin + isothianyl + flametopill means a combination of SX, spinetram, clothianidin, isothianil and flametopil, where component 1 is spinetram and component 2 is clothianidin. Yes, this ingredient 3 is isothianil and this ingredient 4 is flametopil.

"5 Active Ingredient List":
SX + spinnetram + clothianidin + isothianil + flametopil,
SX + spinnetram + clothianidin + isothianil + impilfluxam,
SX + clothianidin + ferimzone + fusalide + validamycin A,
SX + clothianidin + fusalide + ferlimzone + validamycin A.

In group 46, the combination of SX, this component 1, this component 2, this component 3 and this component 4 is any combination of the above "5 active ingredient list", and 2 parts of SX, 0.5 part. It is composed of the composition A composed of the main component 1, 1.5 parts of the main component 2, 2 parts of the main component 3 and 2 parts of the main component 4.
In group 47, the combination of SX, this component 1, this component 2, this component 3 and this component 4 is any combination of the above "5 active ingredient list", and 0.1 part of SX, 0. It is composed of a composition A consisting of 5 parts of the main ingredient 1, 2 parts of the main ingredient 2, 1.5 parts of the main ingredient 3 and 0.3 parts of the main ingredient 4.
In group 48, the combination of SX, this component 1, this component 2, this component 3 and this component 4 is any combination of the above "5 active ingredient list", and 5 parts of SX, 6.6 parts. It is composed of the composition A consisting of the main component 1, 15 parts of the main component 2, 15 parts of the main component 3 and 5 parts of the main component 4.

In group 1', the combination of SX, this component 1, this component 2, this component 3, this component 4 and this component 5 is any combination of the following "6 active ingredient list", and 1000 copies of SX. It is composed of a composition A consisting of 1 part of the main component 1, 1 part of the main component 2, 1 part of the main component 3, 1 part of the main component 4 and 1 part of the main component 5.

In the "6 Active Ingredient List", for example, SX + methconazole + mandestrobin + fluopirum + fludioxonyl + metalaxyl M means a combination of SX, methconazole, mandestrobin, fluopirum, fludioxonyl and metalaxyl M, and this ingredient 1 is used. It is methconazole, the main component 2 is mandestrobin, the main component 3 is fluopyram, the main component 4 is fludioxonyl, and the main component 5 is metalluxyl M.

"6 Active Ingredient List":
SX + metconazole + mandestrobin + fluopirum + fludioxonyl + metalaxil M,
SX + metconazole + mandestrobin + fluopirum + fludioxonyl + picarubutrazox,
SX + methconazole + mandestrobin + fulopyram + thiophanate-methyl + methanolate-methyl,
SX + metconazole + mandestrobin + fluorium + thiophanate-methyl + picalbutrazox,
SX + metconazole + mandestrobin + fluopirum + thiabendazole + metalaxil M,
SX + metconazole + mandestrobin + fluopirum + thiabendazole + picarubutrazox,
SX + metconazole + mandestrobin + fluopiram + thiuram + metalaxil M,
SX + metconazole + mandestrobin + fluopiram + thiuram + picaru butrazox,
SX + methconazole + mandestrobin + fluopyram + torquelophosmethyl + metalaxyl M,
SX + methconazole + mandestrobin + fluopyram + torquelophosmethyl + picarubutrazox,
SX + methconazole + mandestrobin + fluopyram + boscalid + metalaxil M,
SX + methconazole + mandestrobin + fluopirum + boscalid + picaru butrazox,
SX + metconazole + mandestrobin + fluopyram + aminopyriphen + metalaxil M,
SX + Metoconazole + Mandestrobin + Fluopirum + Aminopyriphen + Picarubutrasox,
SX + metconazole + mandestrobin + fluopyram + mancozeb + metalaxil M,
SX + metconazole + mandestrobin + fluopirum + mancozeb + picarubutrazox,
SX + methconazole + mandestrobin + fluopyram + carbendazim + metalaxil M,
SX + Metoconazole + Mandestrobin + Fluopirum + Carbendazim + Picarubutrazox,
SX + methconazole + mandestrobin + fluxapirokid + fludioxonyl + metalaxil M,
SX + metconazole + mandestrobin + fluxapyroxado + fludioxonyl + picalbutrazox,
SX + methconazole + mandestrobin + fluxapyrokid + thiophanate-methyl + metalaxil M,
SX + metconazole + mandestrobin + fluxapyroxado + thiophanate-methyl + picalbutrazox,
SX + metconazole + mandestrobin + fluxapyroxado + thiabendazole + metalaxil M,
SX + metconazole + mandestrobin + fluxapyroxado + thiabendazole + picarubutrazox,
SX + metconazole + mandestrobin + fluxapyrokid + thiuram + metalaxil M,
SX + metconazole + mandestrobin + fluxapyroxado + thiuram + picarubutrazox,
SX + methconazole + mandestrobin + fluxapyrokid + torculophosmethyl + metalaxil M,
SX + methconazole + mandestrobin + fluxapyroxado + torquelophosmethyl + picarubutrazox,
SX + Metconazole + Mandestrobin + Fluxapirokid + Boscalide + Metalaxil M,
SX + metconazole + mandestrobin + fluxapyroxado + boscalid + picarubutrazox,
SX + methconazole + mandestrobin + fluxapyrokid + aminopyrifene + metalaxil M,
SX + metconazole + mandestrobin + fluxapyroxado + aminopyriphen + picarubutrazox,
SX + methconazole + mandestrobin + fluxapirokid + mancozeb + metalaxil M,
SX + metconazole + mandestrobin + fluxapyroxado + mancozeb + picarubutrazox,
SX + methconazole + mandestrobin + fluxapyrokid + carbendazim + metalaxil M,
SX + methconazole + mandestrobin + fluxapyroxado + carbendazim + picalbutrazox,
SX + metconazole + mandestrobin + boscalide + fludioxonyl + metalaxil M,
SX + metconazole + mandestrobin + boscalid + fludioxonyl + picarubutrazox,
SX + methconazole + mandestrobin + vophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + mandestrobin + boscalide + thiophanate-methyl + picalbutrazox,
SX + metconazole + mandestrobin + boscalid + tiabendazole + metalaxil M,
SX + metconazole + mandestrobin + boscalid + thiabendazole + picaru butrazox,
SX + Metconazole + Mandestrobin + Boscalid + Thiram + Metalaxil M,
SX + Metconazole + Mandestrobin + Boscalid + Thiram + Picaru Butrazox,
SX + Metconazole + Mandestrobin + Boscalide + Torquelophosmethyl + Metalaxyl M,
SX + Metoconazole + Mandestrobin + Boscalide + Torquelophosmethyl + Picarubutrasox,
SX + Metoconazole + Mandestrobin + Boscalid + Boscalid + Metalaxil M,
SX + Metoconazole + Mandestrobin + Boscalid + Boscalid + Picaru Butrazox,
SX + Metoconazole + Mandestrobin + Boscalide + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Mandestrobin + Boscalide + Aminopyriphen + Picarubutrasox,
SX + Metoconazole + Mandestrobin + Boscalid + Mancozeb + Metalaxil M,
SX + metconazole + mandestrobin + boscalid + mancozeb + picaru butrazox,
SX + Metconazole + Mandestrobin + Boscalid + Carbendazim + Metalaxil M,
SX + Metconazole + Mandestrobin + Boscalid + Carbendazim + Picaru Butrazox,
SX + metconazole + mandestrobin + penflufen + fludioxonyl + metalaxil M,
SX + metconazole + mandestrobin + penflufen + fludioxonyl + picarubutrazox,
SX + methconazole + mandestrobin + penfurphene + thiophanate-methyl + methanolate-methyl,
SX + metconazole + mandestrobin + penflufen + thiophanate-methyl + picalbutrazox,
SX + metconazole + mandestrobin + penflufen + thiabendazole + metalaxil M,
SX + metconazole + mandestrobin + penflufen + thiabendazole + picarubutrazox,
SX + metconazole + mandestrobin + penflufen + thiuram + metalaxil M,
SX + metconazole + mandestrobin + penflufen + thiuram + picaru butrazox,
SX + methconazole + mandestrobin + penflufen + torquelophosmethyl + metalaxil M,
SX + Metoconazole + Mandestrobin + Penflufen + Torquelophosmethyl + Picarubutrasox,
SX + Metconazole + Mandestrobin + Penflufen + Boscalid + Metalaxil M,
SX + methconazole + mandestrobin + penflufen + boscalid + picaru butrazox,
SX + metconazole + mandestrobin + penflufen + aminopyriphen + metalaxil M,
SX + metconazole + mandestrobin + penflufen + aminopyriphen + picarubutrazox,
SX + metconazole + mandestrobin + penflufen + mancozeb + metalaxil M,
SX + metconazole + mandestrobin + penflufen + mancozeb + picarubutrazox,
SX + methconazole + mandestrobin + penflufen + carbendazim + metalaxil M,
SX + methconazole + mandestrobin + penflufen + carbendazim + picaru butrazox,
SX + metconazole + mandestrobin + tifluzamide + fludioxonyl + metalaxil M,
SX + metconazole + mandestrobin + tifluzamide + fludioxonyl + picarubutrazox,
SX + methconazole + mandestrobin + thiophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + mandestrobin + tifluzamide + thiophanate-methyl + picalbutrazox,
SX + metconazole + mandestrobin + tibendazole + thiabendazole + metalaxil M,
SX + metconazole + mandestrobin + tifluzamide + thiabendazole + picaru butrazox,
SX + metconazole + mandestrobin + thifruzamide + thiuram + metalaxil M,
SX + metconazole + mandestrobin + thifruzamide + thiuram + picaru butrazox,
SX + methconazole + mandestrobin + tifluzamide + torculophosmethyl + metalaxil M,
SX + metconazole + mandestrobin + tifluzamide + torquelophosmethyl + picarubutrazox,
SX + metconazole + mandestrobin + tifluzamide + boscalid + metalaxil M,
SX + metconazole + mandestrobin + tifluzamide + boscalid + picaru butrazox,
SX + metconazole + mandestrobin + tifluzamide + aminopyridene + metalaxil M,
SX + metconazole + mandestrobin + tifluzamide + aminopyriphen + picarubutrazox,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + metalaxil M,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + picaru butrazox,
SX + metconazole + mandestrobin + tifluzamide + carbendazim + metalaxil M,
SX + methconazole + mandestrobin + tifluzamide + carbendazim + picaru butrazox,
SX + methconazole + mandestrobin + impilfluxam + fludioxonyl + metalaxil M,
SX + methconazole + mandestrobin + impilfluxam + fludioxonyl + picalbutrazox,
SX + methconazole + mandestrobin + impilfluxam + thiophanate-methyl + metalaxil M,
SX + methconazole + mandestrobin + impilfluxam + thiophanate-methyl + picalbutrazox,
SX + methconazole + mandestrobin + impilfluxam + thiabendazole + metalaxil M,
SX + methconazole + mandestrobin + impilfluxam + thiabendazole + picarubutrazox,
SX + methconazole + mandestrobin + impilfluxam + thiuram + metalaxil M,
SX + methconazole + mandestrobin + impilfluxam + thiuram + picaru butrazox,
SX + methconazole + mandestrobin + impilfluxam + torquelophosmethyl + metalaxil M,
SX + methconazole + mandestrobin + impilfluxam + torquelophosmethyl + picarubutrazox,
SX + methconazole + mandestrobin + impilfluxam + boscalid + metalaxil M,
SX + methconazole + mandestrobin + impilfluxam + boscalid + picaru butrazox,
SX + methconazole + mandestrobin + impilfluxam + aminopyridene + metalaxil M,
SX + methconazole + mandestrobin + impilfluxam + aminopyridene + picarubutrazox,
SX + methconazole + mandestrobin + impilfluxam + mancozeb + metalaxil M,
SX + methconazole + mandestrobin + impilfluxam + mancozeb + picarubutrazox,
SX + methconazole + mandestrobin + impilfluxam + carbendazim + metalaxil M,
SX + methconazole + mandestrobin + impilfluxam + carbendazim + picarubutrazox,
SX + metconazole + mandestrobin + sedaxan + fludioxonyl + metalaxil M,
SX + metconazole + mandestrobin + sedaxane + fludioxonyl + picarubutrazox,
SX + methconazole + mandestrobin + sedaxan + thiophanate-methyl + methanolate-methyl,
SX + metconazole + mandestrobin + sedaxane + thiophanate-methyl + picalbutrazox,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + metalaxil M,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + picarubutrazox,
SX + metconazole + mandestrobin + sedaxan + thiuram + metalaxil M,
SX + metconazole + mandestrobin + sedaxan + thiuram + picaru butrazox,
SX + methconazole + mandestrobin + sedaxane + torquelophosmethyl + metalaxyl M,
SX + methconazole + mandestrobin + sedaxane + torquelophosmethyl + picarubutrazox,
SX + metconazole + mandestrobin + sedaxan + boscalid + metalaxil M,
SX + metconazole + mandestrobin + sedaxan + boscalid + picaru butrazox,
SX + metconazole + mandestrobin + sedaxan + aminopyriphen + metalaxil M,
SX + metconazole + mandestrobin + sedaxane + aminopyriphen + picarubutrazox,
SX + metconazole + mandestrobin + sedaxan + mancozeb + metalaxil M,
SX + metconazole + mandestrobin + sedaxane + mancozeb + picarubutrazox,
SX + metconazole + mandestrobin + sedaxan + carbendazim + metalaxil M,
SX + methconazole + mandestrobin + sedaxan + carbendazim + picaru butrazox,
SX + metconazole + mandestrobin + pidiflumethofen + fludioxonyl + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethophene + fludioxonyl + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethophene + thiophanate-methyl + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethophene + thiophanate-methyl + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethophene + thiabendazole + metalaxil M,
SX + metconazole + mandestrobin + pidiflumethophene + thiabendazole + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethophene + thiuram + metalaxil M,
SX + metconazole + mandestrobin + pidiflumethophene + thiuram + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethophene + torquelophosmethyl + metalaxil M,
SX + methconazole + mandestrobin + pidiflumethophene + torquelophosmethyl + picalbutrazox,
SX + methconazole + mandestrobin + pidiflumethophene + boscalide + metalaxil M,
SX + methconazole + mandestrobin + pidiflumethophene + boscalid + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethophene + aminopyridene + metalaxil M,
SX + metconazole + mandestrobin + pidiflumethophene + aminopyriphen + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethophene + mancozeb + metalaxil M,
SX + metconazole + mandestrobin + pidiflumethophene + mancozeb + picalbutrazox,
SX + methconazole + mandestrobin + pidiflumethophene + carbendazim + metalaxil M,
SX + metconazole + mandestrobin + pidiflumethophene + carbendazim + picalbutrazox,
SX + metconazole + mandestrobin + isoflusiplum + fludioxonyl + metalaxil M,
SX + metconazole + mandestrobin + isoflusiplum + fludioxonyl + picarubutrazox,
SX + methconazole + mandestrobin + isofflusiplum + thiophanate-methyl + methanolate-methyl,
SX + metconazole + mandestrobin + isoflusiplum + thiophanate-methyl + picalbutrazox,
SX + metconazole + mandestrobin + isoflusiplum + tiabendazole + metalaxil M,
SX + metconazole + mandestrobin + isoflusiplum + thiabendazole + picarubutrazox,
SX + metconazole + mandestrobin + isoflusiplum + thiuram + metalaxil M,
SX + metconazole + mandestrobin + isoflusiplum + thiuram + picaru butrazox,
SX + Metoconazole + Mandestrobin + Isoflusiplum + Torquelophosmethyl + Metalaxyl M,
SX + metconazole + mandestrobin + isoflusiplum + torquelophosmethyl + picarubutrazox,
SX + metconazole + mandestrobin + isoflusiplum + boscalid + metalaxil M,
SX + methconazole + mandestrobin + isoflusiplum + boscalid + picaru butrazox,
SX + metconazole + mandestrobin + isoflusiplum + aminopyriphen + metalaxil M,
SX + metconazole + mandestrobin + isoflusiplum + aminopyriphen + picarubutrazox,
SX + metconazole + mandestrobin + isoflusiplum + mancozeb + metalaxil M,
SX + metconazole + mandestrobin + isoflusiplum + mancozeb + picarubutrazox,
SX + methconazole + mandestrobin + isoflusiplum + carbendazim + metalaxil M,
SX + methconazole + mandestrobin + isoflusiplum + carbendazim + picaru butrazox,
SX + metconazole + azoxystrobin + fluopyram + fludioxonyl + metalaxil M,
SX + metconazole + azoxystrobin + fluopyram + fludioxonyl + picalbutrazox,
SX + methconazole + azoxystrobin + fluopyram + thiophanate-methyl + metalaxil M,
SX + metconazole + azoxystrobin + fluorium + thiophanate-methyl + picalbutrazox,
SX + metconazole + azoxystrobin + fluorium + thiabendazole + metalaxil M,
SX + metconazole + azoxystrobin + fluopyram + thiabendazole + picalbutrazox,
SX + metconazole + azoxystrobin + fluopyram + thiuram + metalaxil M,
SX + metconazole + azoxystrobin + fluopyram + thiuram + picarubutrazox,
SX + methconazole + azoxystrobin + fluoropyram + torculophosmethyl + metalaxyl M,
SX + methconazole + azoxystrobin + fluopyram + torquelophosmethyl + picarubutrasox,
SX + metconazole + azoxystrobin + fluopyram + boscalide + metalaxil M,
SX + Metoconazole + Azoxystrobin + Fluopirum + Boscalid + Picarubutrasox,
SX + metconazole + azoxystrobin + fluopyram + aminopyridene + metalaxil M,
SX + metconazole + azoxystrobin + fluopyram + aminopyriphen + picalbutrazox,
SX + metconazole + azoxystrobin + fluopyram + mancozeb + metalaxil M,
SX + metconazole + azoxystrobin + fluopyram + mancozeb + picarubutrazox,
SX + metconazole + azoxystrobin + fluopyram + carbendazim + metalaxil M,
SX + methconazole + azoxystrobin + fluopyram + carbendazim + picalbutrazox,
SX + methconazole + azoxystrobin + fluxapirokid + fludioxonyl + metalaxil M,
SX + metconazole + azoxystrobin + fluxapyroxado + fludioxonyl + picalbutrazox,
SX + metconazole + azoxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil M,
SX + metconazole + azoxystrobin + fluxapyroxado + thiophanate-methyl + picalbutrazox,
SX + metconazole + azoxystrobin + fluxapyroxado + thiabendazole + metalaxil M,
SX + metconazole + azoxystrobin + fluxapyroxado + thiabendazole + picalbutrazox,
SX + metconazole + azoxystrobin + fluxapyroxado + thiuram + metalaxil M,
SX + metconazole + azoxystrobin + fluxapyroxado + thiuram + picarubutrazox,
SX + methconazole + azoxystrobin + fluxapyrokid + torculophosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + fluxapyroxado + torquelophosmethyl + picarubutrazox,
SX + methconazole + azoxystrobin + fluxapirokid + boscalide + metalaxil M,
SX + metconazole + azoxystrobin + fluxapyroxado + boscalide + picarubutrazox,
SX + methconazole + azoxystrobin + fluxapyroxado + aminopyrifene + metalaxil M,
SX + metconazole + azoxystrobin + fluxapyroxado + aminopyriphen + picalbutrazox,
SX + metconazole + azoxystrobin + fluxapirokid + mancozeb + metalaxil M,
SX + metconazole + azoxystrobin + fluxapyroxado + mancozeb + picarubutrazox,
SX + methconazole + azoxystrobin + fluxapyroxado + carbendazim + metalaxil M,
SX + metconazole + azoxystrobin + fluxapyroxado + carbendazim + picalbutrazox,
SX + metconazole + azoxystrobin + boscalide + fludioxonyl + metalaxil M,
SX + metconazole + azoxystrobin + boscalide + fludioxonyl + picarubutrasox,
SX + methconazole + azoxystrobin + boscalide + thiophanate-methyl + metalaxil M,
SX + metconazole + azoxystrobin + boscalide + thiophanate-methyl + picalbutrazox,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + metalaxil M,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + picarubutrazox,
SX + metconazole + azoxystrobin + boscalid + thiuram + metalaxil M,
SX + metconazole + azoxystrobin + boscalid + thiuram + picaru butrazox,
SX + Metoconazole + Azoxystrobin + Boscalide + Torquelophosmethyl + Metalaxyl M,
SX + Metoconazole + Azoxystrobin + Boscalide + Torquelophosmethyl + Picarubutrasox,
SX + metconazole + azoxystrobin + boscalid + boscalid + metalaxil M,
SX + Metoconazole + Azoxystrobin + Boscalid + Boscalid + Picarubutrasox,
SX + metconazole + azoxystrobin + boscalide + aminopyridene + metalaxil M,
SX + Metoconazole + Azoxystrobin + Boscalide + Aminopyriphen + Picarubutrasox,
SX + metconazole + azoxystrobin + boscalid + mancozeb + metalaxil M,
SX + metconazole + azoxystrobin + boscalid + mancozeb + picarubutrazox,
SX + methconazole + azoxystrobin + boscalid + carbendazim + metalaxil M,
SX + Metoconazole + Azoxystrobin + Boscalid + Carbendazim + Picarubutrazox,
SX + metconazole + azoxystrobin + penflufen + fludioxonyl + metalaxil M,
SX + metconazole + azoxystrobin + penflufen + fludioxonyl + picalbutrazox,
SX + methconazole + azoxystrobin + penflufen + thiophanate-methyl + metalaxil M,
SX + metconazole + azoxystrobin + penflufen + thiophanate-methyl + picalbutrazox,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + metalaxil M,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + picarubutrazox,
SX + metconazole + azoxystrobin + penflufen + thiuram + metalaxil M,
SX + metconazole + azoxystrobin + penflufen + thiuram + picarubutrazox,
SX + methconazole + azoxystrobin + penflufen + torquelophosmethyl + metalaxyl M,
SX + methconazole + azoxystrobin + penflufen + torquelophosmethyl + picarubutrasox,
SX + metconazole + azoxystrobin + penflufen + boscalide + metalaxil M,
SX + metconazole + azoxystrobin + penflufen + boscalid + picarubutrazox,
SX + metconazole + azoxystrobin + penflufen + aminopyridene + metalaxil M,
SX + metconazole + azoxystrobin + penflufen + aminopyriphen + picarubutrasox,
SX + metconazole + azoxystrobin + penflufen + mancozeb + metalaxil M,
SX + metconazole + azoxystrobin + penflufen + mancozeb + picarubutrazox,
SX + metconazole + azoxystrobin + penflufen + carbendazim + metalaxil M,
SX + methconazole + azoxystrobin + penflufen + carbendazim + picalbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonyl + metalaxil M,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonyl + picalbutrazox,
SX + methconazole + azoxystrobin + tifluzamide + thiophanate-methyl + metalaxil M,
SX + metconazole + azoxystrobin + tifluzamide + thiophanate-methyl + picalbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + thiabendazole + metalaxil M,
SX + metconazole + azoxystrobin + tifluzamide + thiabendazole + picarubutrazox,
SX + metconazole + azoxystrobin + thifluzamide + thiuram + metalaxil M,
SX + methconazole + azoxystrobin + thifluzamide + thiuram + picaru butrazox,
SX + metconazole + azoxystrobin + tifluzamide + torquelophosmethyl + metalaxil M,
SX + metconazole + azoxystrobin + tifluzamide + torquelophosmethyl + picarubutrasox,
SX + metconazole + azoxystrobin + tifluzamide + boscalide + metalaxil M,
SX + metconazole + azoxystrobin + tifluzamide + boscalid + picaru butrazox,
SX + metconazole + azoxystrobin + tifluzamide + aminopyridene + metalaxil M,
SX + metconazole + azoxystrobin + tifluzamide + aminopyriphen + picarubutrazox,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + metalaxil M,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + picarubutrazox,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + metalaxil M,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + picalbutrazox,
SX + methconazole + azoxystrobin + impilfluxam + fludioxonyl + metalaxil M,
SX + methconazole + azoxystrobin + impilfluxam + fludioxonyl + picalbutrazox,
SX + methconazole + azoxystrobin + impilfluxam + thiophanate-methyl + metalaxil M,
SX + methconazole + azoxystrobin + impilfluxam + thiophanate-methyl + picalbutrazox,
SX + methconazole + azoxystrobin + impilfluxam + thiabendazole + metalaxil M,
SX + methconazole + azoxystrobin + impilfluxam + thiabendazole + picarubutrazox,
SX + methconazole + azoxystrobin + impilfluxam + thiuram + metalaxil M,
SX + methconazole + azoxystrobin + impilfluxam + thiuram + picarubutrazox,
SX + methconazole + azoxystrobin + impilfluxam + torquelophosmethyl + metalaxil M,
SX + methconazole + azoxystrobin + impilfluxam + torquelophosmethyl + picarubutrasox,
SX + methconazole + azoxystrobin + impilfluxam + boscalid + metalaxil M,
SX + methconazole + azoxystrobin + impilfluxam + boscalid + picarubutrazox,
SX + methconazole + azoxystrobin + impilfluxam + aminopyridene + metalaxil M,
SX + methconazole + azoxystrobin + impilfluxam + aminopyridene + picalbutrazox,
SX + methconazole + azoxystrobin + impilfluxam + mancozeb + metalaxil M,
SX + methconazole + azoxystrobin + impilfluxam + mancozeb + picarubutrazox,
SX + methconazole + azoxystrobin + impilfluxam + carbendazim + metalaxil M,
SX + methconazole + azoxystrobin + impilfluxam + carbendazim + picalbutrazox,
SX + metconazole + azoxystrobin + sedaxan + fludioxonyl + metalaxil M,
SX + metconazole + azoxystrobin + sedaxane + fludioxonyl + picalbutrazox,
SX + methconazole + azoxystrobin + sedaxan + thiophanate-methyl + metalaxil M,
SX + metconazole + azoxystrobin + sedaxane + thiophanate-methyl + picalbutrazox,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + metalaxil M,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + picarubutrazox,
SX + metconazole + azoxystrobin + sedaxane + thiuram + metalaxil M,
SX + metconazole + azoxystrobin + sedaxan + thiuram + picarubutrazox,
SX + methconazole + azoxystrobin + sedaxane + torquelophosmethyl + metalaxyl M,
SX + methconazole + azoxystrobin + sedaxane + torquelophosmethyl + picarubutrasox,
SX + metconazole + azoxystrobin + sedaxan + boscalide + metalaxil M,
SX + metconazole + azoxystrobin + sedaxane + boscalid + picarubutrazox,
SX + metconazole + azoxystrobin + sedaxan + aminopyridene + metalaxil M,
SX + metconazole + azoxystrobin + sedaxane + aminopyriphen + picalbutrazox,
SX + metconazole + azoxystrobin + sedaxan + mancozeb + metalaxil M,
SX + metconazole + azoxystrobin + sedaxane + mancozeb + picarubutrazox,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + metalaxil M,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethofen + fludioxonyl + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethofen + fludioxonyl + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + thiophanate-methyl + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethophene + thiophanate-methyl + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethofen + thiabendazole + metalaxil M,
SX + metconazole + azoxystrobin + pidiflumethophene + thiabendazole + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + thiuram + metalaxil M,
SX + metconazole + azoxystrobin + pidiflumethophene + thiuram + picalbutrazox,
SX + methconazole + azoxystrobin + pidiflumethophene + torculophosmethyl + metalaxyl M,
SX + methconazole + azoxystrobin + pidiflumethophene + torquelophosmethyl + picalbutrazox,
SX + methconazole + azoxystrobin + pidiflumethophene + boscalide + metalaxil M,
SX + metconazole + azoxystrobin + pidiflumethophene + boscalid + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + aminopyridene + metalaxil M,
SX + metconazole + azoxystrobin + pidiflumethophene + aminopyridene + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + mancozeb + metalaxil M,
SX + metconazole + azoxystrobin + pidiflumethophene + mancozeb + picalbutrazox,
SX + methconazole + azoxystrobin + pidiflumethophene + carbendazim + metalaxil M,
SX + metconazole + azoxystrobin + pidiflumethophene + carbendazim + picalbutrazox,
SX + metconazole + azoxystrobin + isoflusiplum + fludioxonyl + metalaxil M,
SX + metconazole + azoxystrobin + isoflusiplum + fludioxonyl + picarubutrazox,
SX + methconazole + azoxystrobin + isoflusiplum + thiophanate-methyl + metalaxil M,
SX + metconazole + azoxystrobin + isoflusiplum + thiophanate-methyl + picalbutrazox,
SX + metconazole + azoxystrobin + isoflusiplum + thiabendazole + metalaxil M,
SX + metconazole + azoxystrobin + isoflusiplum + thiabendazole + picarubutrazox,
SX + metconazole + azoxystrobin + isoflusiplum + thiuram + metalaxil M,
SX + metconazole + azoxystrobin + isoflusiplum + thiuram + picarubutrazox,
SX + Metoconazole + Azoxystrobin + Isoflusiplum + Torquelophosmethyl + Metalaxyl M,
SX + metconazole + azoxystrobin + isoflusiplum + torquelophosmethyl + picarubutrasox,
SX + metconazole + azoxystrobin + isoflusiplum + boscalide + metalaxil M,
SX + methconazole + azoxystrobin + isoflusiplum + boscalid + picarubutrazox,
SX + metconazole + azoxystrobin + isoflusiplum + aminopyridene + metalaxil M,
SX + metconazole + azoxystrobin + isoflusiplum + aminopyridene + picarubutrazox,
SX + metconazole + azoxystrobin + isoflusiplum + mancozeb + metalaxil M,
SX + metconazole + azoxystrobin + isoflusiplum + mancozeb + picarubutrazox,
SX + methconazole + azoxystrobin + isoflusiplum + carbendazim + metalaxil M,
SX + methconazole + azoxystrobin + isoflusiplum + carbendazim + picarubutrazox,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonyl + metalaxil M,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonyl + picalbutrazox,
SX + methoconazole + fuloxastrobin + fulopyram + thiophanate-methyl + methanolate-M,
SX + metconazole + fluoxastrobin + fluopyram + thiophanate-methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + fluopirum + thiabendazole + metalaxil M,
SX + metconazole + fluoxastrobin + fluopirum + thiabendazole + picarubutrazox,
SX + metconazole + fluoxastrobin + fluopiram + thiuram + metalaxil M,
SX + metconazole + fluoxastrobin + fluopiram + thiuram + picarubutrazox,
SX + methconazole + fluoxastrobin + fluoropyram + turquophosmethyl + metalaxyl M,
SX + methconazole + fluoxastrobin + fluopyram + turquophosmethyl + picarubutrasox,
SX + methconazole + fluoxastrobin + fluopyram + boscalide + metalaxil M,
SX + methconazole + fluoxastrobin + fluopyram + boscalid + picarubutrazox,
SX + metconazole + fluoxastrobin + fluopyram + aminopyriphen + metalaxil M,
SX + metconazole + fluoxastrobin + fluopyram + aminopyriphen + picarubutrasox,
SX + metconazole + fluoxastrobin + fluopyram + mancozeb + metalaxil M,
SX + metconazole + fluoxastrobin + fluopirum + mancozeb + picarubutrazox,
SX + methconazole + fluoxastrobin + fluopyram + carbendazim + metalaxil M,
SX + methconazole + fluoxastrobin + fluopyram + carbendazim + picalbutrazox,
SX + methconazole + fluoxastrobin + fluxapirokid + fludioxonyl + metalaxil M,
SX + metconazole + fluoxastrobin + fluxapyroxado + fludioxonyl + picalbutrazox,
SX + methconazole + fluoxastrobin + fluxapyrokid + thiophanate-methyl + metalaxil M,
SX + metconazole + fluoxastrobin + fluxapyroxado + thiophanate-methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + fluxapyroxado + thiabendazole + metalaxil M,
SX + metconazole + fluoxastrobin + fluxapyroxado + thiabendazole + picalbutrazox,
SX + methconazole + fluoxastrobin + fluxapyrokid + thiuram + metalaxil M,
SX + metconazole + fluoxastrobin + fluxapyroxado + thiuram + picarubutrazox,
SX + methconazole + fluoxastrobin + fluxapyroxado + turquophosmethyl + metalaxil M,
SX + methconazole + fluoxastrobin + fluxapyroxado + torquelophosmethyl + picarubutrazox,
SX + methconazole + fluoxastrobin + fluxapirokid + boscalide + metalaxil M,
SX + methconazole + fluoxastrobin + fluxapyroxado + boscalide + picarubutrazox,
SX + methconazole + fluoxastrobin + fluxapyrokid + aminopyrifene + metalaxil M,
SX + metconazole + fluoxastrobin + fluxapyroxado + aminopyriphen + picarubutrazox,
SX + methconazole + fluoxastrobin + fluxapirokid + mancozeb + metalaxil M,
SX + metconazole + fluoxastrobin + fluxapyroxado + mancozeb + picarubutrazox,
SX + methconazole + fluoxastrobin + fluxapyroxado + carbendazim + metalaxil M,
SX + methconazole + fluoxastrobin + fluxapyroxado + carbendazim + picalbutrazox,
SX + metconazole + fluoxastrobin + boscalide + fludioxonyl + metalaxil M,
SX + metconazole + fluoxastrobin + boscalide + fludioxonyl + picarubutrazox,
SX + methconazole + fluoxastrobin + vophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fluoxastrobin + boscalide + thiophanate-methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + boscalid + tiabendazole + metalaxil M,
SX + metconazole + fluoxastrobin + boscalid + thiabendazole + picarubutrazox,
SX + metconazole + fluoxastrobin + boscalid + thiuram + metalaxil M,
SX + metconazole + fluoxastrobin + boscalid + thiuram + picaru butrazox,
SX + methconazole + fluoxastrobin + boscalide + torquelophosmethyl + metalaxyl M,
SX + methconazole + fluoxastrobin + boscalide + turquophosmethyl + picarubutrazox,
SX + metconazole + fluoxastrobin + boscalid + boscalide + metalaxil M,
SX + metconazole + fluoxastrobin + boscalid + boscalid + picaru butrazox,
SX + metconazole + fluoxastrobin + boscalide + aminopyriphen + metalaxil M,
SX + metconazole + fluoxastrobin + boscalide + aminopyriphen + picarubutrazox,
SX + metconazole + fluoxastrobin + boscalide + mancozeb + metalaxil M,
SX + metconazole + fluoxastrobin + boscalid + mancozeb + picarubutrazox,
SX + methconazole + fluoxastrobin + boscalid + carbendazim + metalaxil M,
SX + methconazole + fluoxastrobin + boscalid + carbendazim + picalbutrazox,
SX + metconazole + fluoxastrobin + penflufen + fludioxonyl + metalaxil M,
SX + metconazole + fluoxastrobin + penflufen + fludioxonyl + picarubutrazox,
SX + methconazole + fluoxastrobin + penfurphene + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fluoxastrobin + penflufen + thiophanate-methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + metalaxil M,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + picarubutrazox,
SX + metconazole + fluoxastrobin + penflufen + thiuram + metalaxil M,
SX + metconazole + fluoxastrobin + penflufen + thiuram + picaru butrazox,
SX + methconazole + fluoxastrobin + penflufen + torquelophosmethyl + metalaxyl M,
SX + methconazole + fluoxastrobin + penflufen + torquelophosmethyl + picarubutrazox,
SX + metconazole + fluoxastrobin + penflufen + boscalide + metalaxil M,
SX + metconazole + fluoxastrobin + penflufen + boscalid + picarubutrazox,
SX + metconazole + fluoxastrobin + penflufen + aminopyriphen + metalaxil M,
SX + metconazole + fluoxastrobin + penflufen + aminopyriphen + picarubutrazox,
SX + metconazole + fluoxastrobin + penflufen + mancozeb + metalaxil M,
SX + metconazole + fluoxastrobin + penflufen + mancozeb + picarubutrazox,
SX + methconazole + fluoxastrobin + penflufen + carbendazim + metalaxil M,
SX + metconazole + fluoxastrobin + penflufen + carbendazim + picalbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonyl + metalaxil M,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonyl + picalbutrazox,
SX + methconazole + fluoxastrobin + thiophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fluoxastrobin + tifluzamide + thiophanate-methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + tibendazole + thiabendazole + metalaxil M,
SX + metconazole + fluoxastrobin + tifluzamide + thiabendazole + picarubutrazox,
SX + metconazole + fluoxastrobin + thifluzamide + thiuram + metalaxil M,
SX + metconazole + fluoxastrobin + thifluzamide + thiuram + picaru butrazox,
SX + methconazole + fluoxastrobin + tyfluzamide + torculophosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + torquelophosmethyl + picarubutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + boscalid + metalaxil M,
SX + metconazole + fluoxastrobin + tifluzamide + boscalid + picaru butrazox,
SX + metconazole + fluoxastrobin + tifluzamide + aminopyridene + metalaxil M,
SX + metconazole + fluoxastrobin + tifluzamide + aminopyriphen + picarubutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + metalaxil M,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + picarubutrazox,
SX + methconazole + fluoxastrobin + tifluzamide + carbendazim + metalaxil M,
SX + methconazole + fluoxastrobin + tifluzamide + carbendazim + picalbutrazox,
SX + methconazole + fluoxastrobin + impilfluxam + fludioxonyl + metalaxil M,
SX + methconazole + fluoxastrobin + impilfluxam + fludioxonyl + picalbutrazox,
SX + methconazole + fluoxastrobin + impilfluxam + thiophanate-methyl + metalaxil M,
SX + methconazole + fluoxastrobin + impilfluxam + thiophanate-methyl + picalbutrazox,
SX + methconazole + fluoxastrobin + impilfluxam + thiabendazole + metalaxil M,
SX + methconazole + fluoxastrobin + impilfluxam + thiabendazole + picarubutrazox,
SX + methconazole + fluoxastrobin + impilfluxam + thiuram + metalaxil M,
SX + methconazole + fluoxastrobin + impilfluxam + thiuram + picarubutrazox,
SX + methconazole + fluoxastrobin + impilfluxam + torquelophosmethyl + metalaxil M,
SX + methconazole + fluoxastrobin + impilfluxam + torquelophosmethyl + picarubutrazox,
SX + methconazole + fluoxastrobin + impilfluxam + boscalide + metalaxil M,
SX + methconazole + fluoxastrobin + impilfluxam + boscalid + picarubutrazox,
SX + methconazole + fluoxastrobin + impilfluxam + aminopyridene + metalaxil M,
SX + methconazole + fluoxastrobin + impilfluxam + aminopyridene + picalbutrazox,
SX + methconazole + fluoxastrobin + impilfluxam + mancozeb + metalaxil M,
SX + methconazole + fluoxastrobin + impilfluxam + mancozeb + picarubutrazox,
SX + methconazole + fluoxastrobin + impilfluxam + carbendazim + metalaxil M,
SX + methconazole + fluoxastrobin + impilfluxam + carbendazim + picalbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonyl + metalaxil M,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonyl + picalbutrazox,
SX + methconazole + fluoxastrobin + sedaxane + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fluoxastrobin + sedaxane + thiophanate-methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + metalaxil M,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + picarubutrazox,
SX + metconazole + fluoxastrobin + sedaxane + thiuram + metalaxil M,
SX + metconazole + fluoxastrobin + sedaxane + thiuram + picarubutrazox,
SX + methconazole + fluoxastrobin + sedaxane + torquelophosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + sedaxane + torquelophosmethyl + picarubutrazox,
SX + methconazole + fluoxastrobin + sedaxan + boscalide + metalaxil M,
SX + metconazole + fluoxastrobin + sedaxane + boscalid + picarubutrazox,
SX + metconazole + fluoxastrobin + sedaxane + aminopyriphen + metalaxil M,
SX + metconazole + fluoxastrobin + sedaxane + aminopyriphen + picalbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + mancozeb + metalaxil M,
SX + metconazole + fluoxastrobin + sedaxane + mancozeb + picarubutrazox,
SX + methconazole + fluoxastrobin + sedaxane + carbendazim + metalaxil M,
SX + methconazole + fluoxastrobin + sedaxane + carbendazim + picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethofen + fludioxonyl + metalaxyl M,
SX + metconazole + fluoxastrobin + pidiflumethofen + fludioxonyl + picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiophanate-methyl + metalaxyl M,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiophanate-methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethofen + thiabendazole + metalaxil M,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiabendazole + picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiuram + metalaxil M,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiuram + picalbutrazox,
SX + methconazole + fluoxastrobin + pidiflumethophene + torculophosmethyl + metalaxyl M,
SX + methconazole + fluoxastrobin + pidiflumethophene + torculophosmethyl + picalbutrazox,
SX + methconazole + fluoxastrobin + pidiflumethofen + boscalide + metalaxil M,
SX + methconazole + fluoxastrobin + pidiflumethophene + boscalid + picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethophene + aminopyridene + metalaxil M,
SX + metconazole + fluoxastrobin + pidiflumethophene + aminopyriphen + picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethofen + mancozeb + metalaxil M,
SX + metconazole + fluoxastrobin + pidiflumethophene + mancozeb + picalbutrazox,
SX + methconazole + fluoxastrobin + pidiflumethofen + carbendazim + metalaxil M,
SX + metconazole + fluoxastrobin + pidiflumethophene + carbendazim + picalbutrazox,
SX + metconazole + fluoxastrobin + isoflusiplum + fludioxonyl + metalaxil M,
SX + metconazole + fluoxastrobin + isoflusiplum + fludioxonyl + picarubutrazox,
SX + methoconazole + fluoxastrobin + isofluate-methyl + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fluoxastrobin + isoflusiplum + thiophanate-methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + isoflusiplum + thiabendazole + metalaxil M,
SX + metconazole + fluoxastrobin + isoflusiplum + thiabendazole + picarubutrazox,
SX + metconazole + fluoxastrobin + isoflusiplum + thiuram + metalaxil M,
SX + metconazole + fluoxastrobin + isoflusiplum + thiuram + picarubutrazox,
SX + methconazole + fluoxastrobin + isoflusiplum + torquelophosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + isoflusiplum + torquelophosmethyl + picarubutrazox,
SX + metconazole + fluoxastrobin + isoflusiplum + boscalide + metalaxil M,
SX + metconazole + fluoxastrobin + isoflusiplum + boscalid + picarubutrazox,
SX + metconazole + fluoxastrobin + isoflusiplum + aminopyridene + metalaxil M,
SX + metconazole + fluoxastrobin + isoflusiplum + aminopyridene + picarubutrazox,
SX + metconazole + fluoxastrobin + isoflusiplum + mancozeb + metalaxil M,
SX + metconazole + fluoxastrobin + isoflusiplum + mancozeb + picarubutrazox,
SX + methconazole + fluoxastrobin + isoflusiplum + carbendazim + metalaxil M,
SX + methconazole + fluoxastrobin + isoflusiplum + carbendazim + picarubutrazox,
SX + metconazole + trifloxystrobin + fluopyram + fludioxonyl + metalaxil M,
SX + metconazole + trifloxystrobin + fluopirum + fludioxonyl + picalbutrazox,
SX + metconazole + trifluoxystrobin + fluopyram + thiophanate-methyl + metalaxil M,
SX + metconazole + trifloxystrobin + fluopyram + thiophanate-methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + fluopirum + thiabendazole + metalaxil M,
SX + metconazole + trifloxystrobin + fluopyram + thiabendazole + picalbutrazox,
SX + methconazole + trifloxystrobin + fluopyram + thiuram + metalaxil M,
SX + methconazole + trifloxystrobin + fluopyram + thiuram + picarubutrazox,
SX + methconazole + trifloxystrobin + fluopyram + torquelophosmethyl + metalaxil M,
SX + methconazole + trifloxystrobin + fluopyram + torquelophosmethyl + picalbutrazox,
SX + Metoconazole + Trifloxystrobin + Fluopirum + Boscalide + Metalaxil M,
SX + Metoconazole + Trifloxystrobin + Fluopirum + Boscalid + Picarubutrasox,
SX + methconazole + trifluoxystrobin + fluopyram + aminopyriphen + metalaxil M,
SX + methconazole + trifloxystrobin + fluopyram + aminopyriphen + picalbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + mancozeb + metalaxil M,
SX + Metoconazole + Trifloxystrobin + Fluopirum + Mancozeb + Picarubutrazox,
SX + methconazole + trifloxystrobin + fluopyram + carbendazim + metalaxil M,
SX + methconazole + trifloxystrobin + fluopyram + carbendazim + picalbutrazox,
SX + methconazole + trifloxystrobin + fluxapyrokid + fludioxonyl + metalaxil M,
SX + metconazole + trifluoxystrobin + fluxapyroxado + fludioxonyl + picalbutrazox,
SX + methconazole + trifloxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil M,
SX + metconazole + trifluoxystrobin + fluxapyroxado + thiophanate-methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + fluxapyroxado + thiabendazole + metalaxil M,
SX + metconazole + trifloxystrobin + fluxapyroxado + thiabendazole + picalbutrazox,
SX + methconazole + trifloxystrobin + fluxapyrokid + thiuram + metalaxil M,
SX + metconazole + trifloxystrobin + fluxapyroxado + thiuram + picalbutrazox,
SX + methconazole + trifloxystrobin + fluxapyroxado + torclophosmethyl + metalaxil M,
SX + methconazole + trifloxystrobin + fluxapyroxado + torculophosmethyl + picarubutrazox,
SX + methconazole + trifloxystrobin + fluxapyrokid + boscalide + metalaxil M,
SX + methconazole + trifluoxystrobin + fluxapyroxado + boscalide + picarubutrazox,
SX + methconazole + trifloxystrobin + fluxapyrokid + aminopyriphen + metalaxil M,
SX + metconazole + trifluoxystrobin + fluxapyroxado + aminopyridene + picalbutrazox,
SX + methconazole + trifloxystrobin + fluxapyrokid + mancozeb + metalaxil M,
SX + metconazole + trifloxystrobin + fluxapyroxado + mancozeb + picarubutrazox,
SX + methconazole + trifloxystrobin + fluxapyroxado + carbendazim + metalaxil M,
SX + methconazole + trifloxystrobin + fluxapyroxado + carbendazim + picalbutrazox,
SX + metconazole + trifloxystrobin + boscalide + fludioxonyl + metalaxil M,
SX + metconazole + trifloxystrobin + boscalide + fludioxonyl + picarubutrazox,
SX + metconazole + trifloxystrobin + boscalide + thiophanate-methyl + metalaxil M,
SX + metconazole + trifloxystrobin + boscalide + thiophanate-methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + boscalid + thiabendazole + metalaxil M,
SX + metconazole + trifloxystrobin + boscalid + thiabendazole + picarubutrazox,
SX + Metoconazole + Trifloxystrobin + Boscalid + Thiram + Metalaxil M,
SX + Metconazole + Trifloxystrobin + Boscalid + Thiram + Picarubutrasox,
SX + Metoconazole + Trifloxystrobin + Boscalide + Torquelophosmethyl + Metalaxil M,
SX + methconazole + trifloxystrobin + boscalide + turquophosmethyl + picarubutrasox,
SX + metconazole + trifloxystrobin + boscalid + boscalid + metalaxil M,
SX + Metoconazole + Trifloxystrobin + Boscalid + Boscalid + Picarubutrasox,
SX + methconazole + trifloxystrobin + boscalide + aminopyriphen + metalaxil M,
SX + methconazole + trifluoxystrobin + boscalide + aminopyriphen + picalbutrazox,
SX + methconazole + trifloxystrobin + boscalid + mancozeb + metalaxil M,
SX + Metoconazole + Trifloxystrobin + Boscalid + Mancozeb + Picarubutrasox,
SX + methconazole + trifloxystrobin + boscalid + carbendazim + metalaxil M,
SX + Metconazole + Trifloxystrobin + Boscalid + Carbendazim + Picarubutrazox,
SX + metconazole + trifloxystrobin + penflufen + fludioxonyl + metalaxil M,
SX + metconazole + trifloxystrobin + penflufen + fludioxonyl + picalbutrazox,
SX + metconazole + trifloxystrobin + penflufen + thiophanate-methyl + metalaxil M,
SX + metconazole + trifloxystrobin + penflufen + thiophanate-methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + metalaxil M,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + picalbutrazox,
SX + metconazole + trifloxystrobin + penflufen + thiuram + metalaxil M,
SX + methconazole + trifloxystrobin + penflufen + thiuram + picaru butrazox,
SX + Metoconazole + Trifloxystrobin + Penflufen + Torquelophosmethyl + Metalaxil M,
SX + methconazole + trifloxystrobin + penflufen + torquelophosmethyl + picarubutrasox,
SX + Metoconazole + Trifloxystrobin + Penflufen + Boscalide + Metalaxil M,
SX + Metoconazole + Trifloxystrobin + Penflufen + Boscalid + Picarubutrasox,
SX + metconazole + trifloxystrobin + penflufen + aminopyriphen + metalaxil M,
SX + metconazole + trifloxystrobin + penflufen + aminopyriphen + picarubutrazox,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + metalaxil M,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + picarubutrazox,
SX + methconazole + trifloxystrobin + penflufen + carbendazim + metalaxil M,
SX + Metoconazole + Trifloxystrobin + Penflufen + Carbendazim + Picarubutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonyl + metalaxil M,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonyl + picarubutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + thiophanate-methyl + metalaxil M,
SX + metconazole + trifloxystrobin + tifluzamide + thiophanate-methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + metalaxil M,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + picarubutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + thiuram + metalaxil M,
SX + metconazole + trifloxystrobin + tifluzamide + thiuram + picaru butrazox,
SX + metconazole + trifloxystrobin + tifluzamide + torquelophosmethyl + metalaxil M,
SX + metconazole + trifloxystrobin + tifluzamide + torquelophosmethyl + picarubutrazox,
SX + methconazole + trifloxystrobin + tifluzamide + boscalide + metalaxil M,
SX + methconazole + trifloxystrobin + tifluzamide + boscalid + picaru butrazox,
SX + metconazole + trifloxystrobin + tifluzamide + aminopyridene + metalaxil M,
SX + metconazole + trifloxystrobin + tifluzamide + aminopyriphen + picarubutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + mancozeb + metalaxil M,
SX + metconazole + trifloxystrobin + tifluzamide + mancozeb + picarubutrazox,
SX + methconazole + trifloxystrobin + tifluzamide + carbendazim + metalaxil M,
SX + methconazole + trifloxystrobin + tifluzamide + carbendazim + picalbutrazox,
SX + methconazole + trifloxystrobin + impilfluxam + fludioxonyl + metalaxil M,
SX + methconazole + trifloxystrobin + impilfluxam + fludioxonyl + picalbutrazox,
SX + methconazole + trifloxystrobin + impilfluxam + thiophanate-methyl + metalaxil M,
SX + methconazole + trifloxystrobin + impilfluxam + thiophanate-methyl + picalbutrazox,
SX + methconazole + trifloxystrobin + impilfluxam + thiabendazole + metalaxil M,
SX + methconazole + trifloxystrobin + impilfluxam + thiabendazole + picarubutrazox,
SX + methconazole + trifloxystrobin + impilfluxam + thiuram + metalaxil M,
SX + methconazole + trifloxystrobin + impilfluxam + thiuram + picarubutrazox,
SX + methconazole + trifloxystrobin + impilfluxam + torquelophosmethyl + metalaxil M,
SX + methconazole + trifloxystrobin + impilfluxam + torquelophosmethyl + picarubutrazox,
SX + methconazole + trifloxystrobin + impilfluxam + boscalid + metalaxil M,
SX + methconazole + trifloxystrobin + impilfluxam + boscalid + picarubutrazox,
SX + methconazole + trifloxystrobin + impilfluxam + aminopyridene + metalaxil M,
SX + methconazole + trifloxystrobin + impilfluxam + aminopyridene + picalbutrazox,
SX + methconazole + trifloxystrobin + impilfluxam + mancozeb + metalaxil M,
SX + methconazole + trifloxystrobin + impilfluxam + mancozeb + picarubutrazox,
SX + methconazole + trifloxystrobin + impilfluxam + carbendazim + metalaxil M,
SX + methconazole + trifloxystrobin + impilfluxam + carbendazim + picalbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonyl + metalaxil M,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonyl + picalbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + thiophanate-methyl + metalaxil M,
SX + metconazole + trifloxystrobin + sedaxane + thiophanate-methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + metalaxil M,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + picalbutrazox,
SX + Metoconazole + Trifloxystrobin + Sedaxan + Thiram + Metalaxil M,
SX + metconazole + trifloxystrobin + sedaxan + thiuram + picarubutrazox,
SX + methconazole + trifloxystrobin + sedaxane + torculophosmethyl + metalaxil M,
SX + methconazole + trifloxystrobin + sedaxane + torculophosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + boscalide + metalaxil M,
SX + methconazole + trifloxystrobin + sedaxane + boscalid + picarubutrazox,
SX + methconazole + trufflextrobin + sedaxane + aminopyriphen + metalaxil M,
SX + metconazole + trifloxystrobin + sedaxane + aminopyriphen + picalbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + mancozeb + metalaxil M,
SX + metconazole + trifloxystrobin + sedaxane + mancozeb + picarubutrazox,
SX + methconazole + trifloxystrobin + sedaxane + carbendazim + metalaxil M,
SX + methconazole + trifloxystrobin + sedaxane + carbendazim + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethofen + fludioxonyl + metalaxil M,
SX + metconazole + trifloxystrobin + pidiflumethofen + fludioxonyl + picalbutrazox,
SX + methconazole + trifloxystrobin + pidiflumethophene + thiophanate-methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethophene + thiophanate-methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethofen + thiabendazole + metalaxil M,
SX + metconazole + trifloxystrobin + pidiflumethophene + thiabendazole + picalbutrazox,
SX + methconazole + trufflextrobin + pidiflumethofen + thiuram + metalaxil M,
SX + metconazole + trifloxystrobin + pidiflumethophene + thiuram + picalbutrazox,
SX + methconazole + trifloxystrobin + pidiflumethophene + torculophosmethyl + metalaxyl M,
SX + methconazole + trifloxystrobin + pidiflumethophene + turquophosmethyl + picalbutrazox,
SX + methconazole + trifloxystrobin + pidiflumethofen + boscalide + metalaxil M,
SX + methconazole + trifloxystrobin + pidiflumethophene + boscalid + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethophene + aminopyridene + metalaxil M,
SX + metconazole + trifloxystrobin + pidiflumethophene + aminopyridene + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethophene + mancozeb + metalaxil M,
SX + metconazole + trifloxystrobin + pidiflumethophene + mancozeb + picalbutrazox,
SX + methconazole + trifloxystrobin + pidiflumethophene + carbendazim + metalaxil M,
SX + metconazole + trifloxystrobin + pidiflumethophene + carbendazim + picalbutrazox,
SX + metconazole + trifloxystrobin + isoflusiplum + fludioxonyl + metalaxil M,
SX + metconazole + trifloxystrobin + isoflusiplum + fludioxonyl + picarubutrazox,
SX + metconazole + trifloxystrobin + isoflusiplum + thiophanate-methyl + metalaxil M,
SX + metconazole + trifloxystrobin + isoflusiplum + thiophanate-methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + isoflusiplum + thiabendazole + metalaxil M,
SX + metconazole + trifloxystrobin + isoflusiplum + thiabendazole + picarubutrazox,
SX + methconazole + trifloxystrobin + isoflusiplum + thiuram + metalaxil M,
SX + metconazole + trifloxystrobin + isoflusiplum + thiuram + picarubutrazox,
SX + Metoconazole + Trifloxystrobin + Isoflusiplum + Torcrophosmethyl + Metalaxyl M,
SX + metconazole + trifloxystrobin + isoflusiplum + torquelophosmethyl + picarubutrazox,
SX + Metoconazole + Trifloxystrobin + Isoflusiplum + Boscalide + Metalaxil M,
SX + metconazole + trifloxystrobin + isoflusiplum + boscalid + picarubutrazox,
SX + metconazole + trifloxystrobin + isoflusiplum + aminopyridene + metalaxil M,
SX + metconazole + trifloxystrobin + isoflusiplum + aminopyridene + picarubutrazox,
SX + metconazole + trifloxystrobin + isoflusiplum + mancozeb + metalaxil M,
SX + metconazole + trifloxystrobin + isoflusiplum + mancozeb + picarubutrazox,
SX + methconazole + trifloxystrobin + isoflusiplum + carbendazim + metalaxil M,
SX + methconazole + trifloxystrobin + isoflusiplum + carbendazim + picalbutrazox,
SX + methconazole + pyracrostrobin + fluopyram + fludioxonyl + metalaxil M,
SX + metconazole + pyracrostrobin + fluopirum + fludioxonyl + picalbutrazox,
SX + methconazole + pyracrostrobin + fluorine + thiophanate-methyl + methanolate-methyl,
SX + metconazole + pyracrostrobin + fluorium + thiophanate-methyl + picalbutrazox,
SX + metconazole + pyracrostrobin + fluopirum + thiabendazole + metalaxil M,
SX + metconazole + pyracrostrobin + fluopirum + thiabendazole + picalbutrazox,
SX + Metconazole + Pyracrostrobin + Fluopiram + Thiram + Metalaxil M,
SX + methconazole + pyracrostrobin + fluopiram + thiuram + picaru butrazox,
SX + Metconazole + Pyracrostrobin + Fluopirum + Torquelophosmethyl + Metalaxyl M,
SX + methconazole + pyracrostrobin + fluopyram + torquelophosmethyl + picalbutrazox,
SX + Metconazole + Pyracrostrobin + Fluopirum + Boscalid + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Boscalid + Picarubutrasox,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Pyraclostrobin + Fluopirum + Aminopyriphen + Picalbutrasox,
SX + Metconazole + Pyracrostrobin + Fluopirum + Mancozeb + Metalaxil M,
SX + metconazole + pyracrostrobin + fluopirum + mancozeb + picarubutrazox,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Carbendazim + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Carbendazim + Picalbutrasox,
SX + methconazole + pyracrostrobin + fluxapyroxado + fludioxonyl + metalaxil M,
SX + metconazole + pyracrostrobin + fluxapyroxado + fludioxonyl + picalbutrazox,
SX + methconazole + pyracrostrobin + fluxapyroxado + thiophanate-methyl + metalaxil M,
SX + metconazole + pyracrostrobin + fluxapyroxado + thiophanate-methyl + picalbutrazox,
SX + metconazole + pyracrostrobin + fluxapyroxado + thiabendazole + metalaxil M,
SX + metconazole + pyracrostrobin + fluxapyroxado + thiabendazole + picalbutrazox,
SX + methconazole + pyracrostrobin + fluxapyroxado + thiuram + metalaxil M,
SX + metconazole + pyracrostrobin + fluxapyroxado + thiuram + picalbutrazox,
SX + methconazole + pyracrostrobin + fluxapyroxado + torquelophosmethyl + metalaxil M,
SX + methconazole + pyracrostrobin + fluxapyroxado + torquelophosmethyl + picalbutrazox,
SX + Metconazole + Pyracrostrobin + Fluxapyrokid + Boscalide + Metalaxil M,
SX + methconazole + pyracrostrobin + fluxapyroxado + boscalid + picalbutrazox,
SX + Metconazole + Pyracrostrobin + Fluxapyroxado + Aminopyriphen + Metalaxil M,
SX + methconazole + pyracrostrobin + fluxapyroxado + aminopyridene + picalbutrazox,
SX + methconazole + pyracrostrobin + fluxapyroxado + mancozeb + metalaxil M,
SX + metconazole + pyracrostrobin + fluxapyroxado + mancozeb + picarubutrazox,
SX + methconazole + pyracrostrobin + fluxapyroxado + carbendazim + metalaxil M,
SX + methconazole + pyracrostrobin + fluxapyroxado + carbendazim + picalbutrazox,
SX + methconazole + pyracrostrobin + boscalid + fludioxonyl + metalaxil M,
SX + metconazole + pyracrostrobin + boscalid + fludioxonyl + picarubutrazox,
SX + methconazole + pyracrostrobin + vophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + pyracrostrobin + boscalide + thiophanate-methyl + picalbutrazox,
SX + metconazole + pyracrostrobin + boscalid + tiabendazole + metalaxil M,
SX + Metoconazole + Pyracrostrobin + Boscalid + Tiabendazole + Picarubutrazox,
SX + Metconazole + Pyracrostrobin + Boscalid + Thiram + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Boscalid + Thiram + Picarubutrasox,
SX + Metoconazole + Pyracrostrobin + Boscalide + Torquelophosmethyl + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Boscalid + Torquelophosmethyl + Picarubutrasox,
SX + Metoconazole + Pyracrostrobin + Boscalid + Boscalid + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Boscalid + Boscalid + Picarubutrasox,
SX + Metoconazole + Pyracrostrobin + Boscalide + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Boscalid + Aminopyriphen + Picarubutrasox,
SX + Metoconazole + Pyracrostrobin + Boscalid + Mancozeb + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Boscalid + Mancozeb + Picarubutrasox,
SX + Metoconazole + Pyracrostrobin + Boscalid + Carbendazim + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Boscalid + Carbendazim + Picarubutrasox,
SX + methconazole + pyracrostrobin + penflufen + fludioxonyl + metalaxil M,
SX + metconazole + pyracrostrobin + penflufen + fludioxonyl + picalbutrazox,
SX + methconazole + pyracrostrobin + penfurphene + thiophanate-methyl + methanolate-methyl,
SX + metconazole + pyracrostrobin + penflufen + thiophanate-methyl + picalbutrazox,
SX + metconazole + pyracrostrobin + penflufen + thiabendazole + metalaxil M,
SX + metconazole + pyracrostrobin + penflufen + thiabendazole + picarubutrazox,
SX + methconazole + pyracrostrobin + penflufen + thiuram + metalaxil M,
SX + methconazole + pyracrostrobin + penflufen + thiuram + picaru butrazox,
SX + Metoconazole + Pyracrostrobin + Penflufen + Torquelophosmethyl + Metalaxyl M,
SX + Metoconazole + Pyracrostrobin + Penflufen + Torquelophosmethyl + Picarubutrasox,
SX + Metoconazole + Pyracrostrobin + Penflufen + Boscalid + Metalaxil M,
SX + methconazole + pyracrostrobin + penflufen + boscalid + picaru butrazox,
SX + methconazole + pyracrostrobin + penflufen + aminopyriphen + metalaxil M,
SX + methconazole + pyracrostrobin + penflufen + aminopyriphen + picarubutrasox,
SX + methconazole + pyracrostrobin + penflufen + mancozeb + metalaxil M,
SX + methconazole + pyracrostrobin + penflufen + mancozeb + picarubutrazox,
SX + Metoconazole + Pyracrostrobin + Penflufen + Carbendazim + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Penflufen + Carbendazim + Picarubutrasox,
SX + metconazole + pyracrostrobin + tifluzamide + fludioxonyl + metalaxil M,
SX + metconazole + pyracrostrobin + tifluzamide + fludioxonyl + picalbutrazox,
SX + methconazole + pyracrostrobin + thiophanate-methyl + methanolate-methyl,
SX + metconazole + pyracrostrobin + tifluzamide + thiophanate-methyl + picalbutrazox,
SX + metconazole + pyracrostrobin + tibendazole + thiabendazole + metalaxil M,
SX + metconazole + pyracrostrobin + tifluzamide + thiabendazole + picarubutrazox,
SX + methconazole + pyracrostrobin + thifruzamide + thiuram + metalaxil M,
SX + methconazole + pyracrostrobin + thifruzamide + thiuram + picaru butrazox,
SX + methconazole + pyracrostrobin + tifluzamide + torquelophosmethyl + metalaxil M,
SX + metconazole + pyracrostrobin + tifluzamide + torquelophosmethyl + picarubutrazox,
SX + methconazole + pyracrostrobin + tifluzamide + boscalid + metalaxil M,
SX + methconazole + pyracrostrobin + tifluzamide + boscalid + picaru butrazox,
SX + metconazole + pyracrostrobin + tifluzamide + aminopyridene + metalaxil M,
SX + metconazole + pyracrostrobin + tifluzamide + aminopyriphen + picarubutrazox,
SX + metconazole + pyracrostrobin + tifluzamide + mancozeb + metalaxil M,
SX + metconazole + pyracrostrobin + tifluzamide + mancozeb + picarubutrazox,
SX + methconazole + pyracrostrobin + tifluzamide + carbendazim + metalaxil M,
SX + methconazole + pyracrostrobin + tifluzamide + carbendazim + picalbutrazox,
SX + methconazole + pyracrostrobin + impilfluxam + fludioxonyl + metalaxil M,
SX + methconazole + pyracrostrobin + impilfluxam + fludioxonyl + picalbutrazox,
SX + methconazole + pyracrostrobin + impilfluxam + thiophanate-methyl + metalaxil M,
SX + methconazole + pyracrostrobin + impilfluxam + thiophanate-methyl + picalbutrazox,
SX + methconazole + pyracrostrobin + impilfluxam + thiabendazole + metalaxil M,
SX + methconazole + pyracrostrobin + impilfluxam + thiabendazole + picalbutrazox,
SX + methconazole + pyracrostrobin + impilfluxam + thiuram + metalaxil M,
SX + methconazole + pyracrostrobin + impilfluxam + thiuram + picarubutrazox,
SX + methconazole + pyracrostrobin + impilfluxam + torquelophosmethyl + metalaxil M,
SX + methconazole + pyracrostrobin + impilfluxam + torquelophosmethyl + picalbutrazox,
SX + methconazole + pyracrostrobin + impilfluxam + boscalid + metalaxil M,
SX + methconazole + pyracrostrobin + impilfluxam + boscalid + picarubutrazox,
SX + methconazole + pyracrostrobin + impilfluxam + aminopyridene + metalaxil M,
SX + methconazole + pyracrostrobin + impilfluxam + aminopyridene + picalbutrazox,
SX + methconazole + pyracrostrobin + impilfluxam + mancozeb + metalaxil M,
SX + methconazole + pyracrostrobin + impilfluxam + mancozeb + picarubutrazox,
SX + methconazole + pyracrostrobin + impilfluxam + carbendazim + metalaxil M,
SX + methconazole + pyracrostrobin + impilfluxam + carbendazim + picalbutrazox,
SX + metconazole + pyracrostrobin + sedaxane + fludioxonyl + metalaxil M,
SX + metconazole + pyracrostrobin + sedaxane + fludioxonyl + picalbutrazox,
SX + methconazole + pyracrostrobin + sedaxane + thiophanate-methyl + methanolate-methyl,
SX + metconazole + pyracrostrobin + sedaxane + thiophanate-methyl + picalbutrazox,
SX + metconazole + pyracrostrobin + sedaxane + thiabendazole + metalaxil M,
SX + metconazole + pyracrostrobin + sedaxane + thiabendazole + picalbutrazox,
SX + metconazole + pyracrostrobin + sedaxan + thiuram + metalaxil M,
SX + methconazole + pyracrostrobin + sedaxan + thiuram + picaru butrazox,
SX + methconazole + pyracrostrobin + sedaxane + torquelophosmethyl + metalaxyl M,
SX + methconazole + pyracrostrobin + sedaxane + torquelophosmethyl + picalbutrazox,
SX + Metoconazole + Pyracrostrobin + Sedaxan + Boscalid + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Sedaxan + Boscalid + Picarubutrasox,
SX + methconazole + pyracrostrobin + sedaxan + aminopyriphen + metalaxil M,
SX + metconazole + pyracrostrobin + sedaxane + aminopyriphen + picalbutrazox,
SX + methconazole + pyracrostrobin + sedaxan + mancozeb + metalaxil M,
SX + metconazole + pyracrostrobin + sedaxane + mancozeb + picarubutrazox,
SX + methconazole + pyracrostrobin + sedaxane + carbendazim + metalaxil M,
SX + Metoconazole + Pyracrostrobin + Sedaxan + Carbendazim + Picalbutrasox,
SX + methconazole + pyracrostrobin + pidiflumethofen + fludioxonyl + metalaxil M,
SX + metconazole + pyracrostrobin + pidiflumethofen + fludioxonyl + picalbutrazox,
SX + metconazole + pyracrostrobin + pidiflumethophene + thiophanate-methyl + metalaxyl M,
SX + metconazole + pyracrostrobin + pidiflumethophene + thiophanate-methyl + picalbutrazox,
SX + metconazole + pyracrostrobin + pidiflumethophene + thiabendazole + metalaxil M,
SX + metconazole + pyracrostrobin + pidiflumethophene + thiabendazole + picalbutrazox,
SX + methconazole + pyracrostrobin + pidiflumethophene + thiuram + metalaxil M,
SX + metconazole + pyracrostrobin + pidiflumethophene + thiuram + picalbutrazox,
SX + Metoconazole + Pyracrostrobin + Pidiflumethofen + Torquelophosmethyl + Metalaxyl M,
SX + Metoconazole + Pyracrostrobin + Pidiflumethofen + Torquelophosmethyl + Picalbutrasox,
SX + Metoconazole + Pyracrostrobin + Pidiflumethofen + Boscalide + Metalaxil M,
SX + Metoconazole + Pyracrostrobin + Pidiflumethofen + Boscalid + Picalbutrazox,
SX + metconazole + pyracrostrobin + pidiflumethophene + aminopyridene + metalaxil M,
SX + metconazole + pyracrostrobin + pidiflumethophene + aminopyridene + picalbutrazox,
SX + metconazole + pyracrostrobin + pidiflumethophene + mancozeb + metalaxil M,
SX + metconazole + pyracrostrobin + pidiflumethophene + mancozeb + picalbutrazox,
SX + methconazole + pyracrostrobin + pidiflumethophene + carbendazim + metalaxil M,
SX + methconazole + pyracrostrobin + pidiflumethophene + carbendazim + picalbutrazox,
SX + methconazole + pyracrostrobin + isoflusiplum + fludioxonyl + metalaxil M,
SX + metconazole + pyracrostrobin + isoflusiplum + fludioxonyl + picarubutrazox,
SX + methconazole + pyracrostrobin + isofflusiplum + thiophanate-methyl + methanolate-methyl,
SX + metconazole + pyracrostrobin + isoflusiplum + thiophanate-methyl + picalbutrazox,
SX + metconazole + pyracrostrobin + isoflusiplum + thiabendazole + metalaxil M,
SX + metconazole + pyracrostrobin + isoflusiplum + thiabendazole + picarubutrazox,
SX + methconazole + pyracrostrobin + isoflusiplum + thiuram + metalaxil M,
SX + methconazole + pyracrostrobin + isoflusiplum + thiuram + picaru butrazox,
SX + Metoconazole + Pyracrostrobin + Isoflusiplum + Torquelophosmethyl + Metalaxyl M,
SX + Metoconazole + Pyracrostrobin + Isoflusiplum + Torquelophosmethyl + Picarubutrasox,
SX + Metoconazole + Pyracrostrobin + Isoflusiplum + Boscalide + Metalaxil M,
SX + methconazole + pyracrostrobin + isoflusiplum + boscalid + picarubutrazox,
SX + methconazole + pyracrostrobin + isoflusiplum + aminopyridene + metalaxil M,
SX + metconazole + pyracrostrobin + isoflusiplum + aminopyriphen + picarubutrasox,
SX + methconazole + pyracrostrobin + isoflusiplum + mancozeb + metalaxil M,
SX + metconazole + pyracrostrobin + isoflusiplum + mancozeb + picarubutrazox,
SX + methconazole + pyracrostrobin + isoflusiplum + carbendazim + metalaxil M,
SX + methconazole + pyracrostrobin + isoflusiplum + carbendazim + picarubutrazox,
SX + metconazole + picoxystrobin + fluopyram + fludioxonyl + metalaxil M,
SX + metconazole + picoxystrobin + fluopyram + fludioxonyl + picalbutrazox,
SX + methconazole + picoxystrobin + fulopyram + thiophanate-methyl + methanolate-M,
SX + metconazole + picoxystrobin + fluorium + thiophanate-methyl + picalbutrazox,
SX + metconazole + picoxystrobin + fluorium + tiabendazole + metalaxil M,
SX + metconazole + picoxystrobin + fluopirum + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + fluopiram + thiuram + metalaxil M,
SX + metconazole + picoxystrobin + fluopyram + thiuram + picalbutrazox,
SX + methconazole + picoxystrobin + fluopyram + torculophosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + torquelophosmethyl + picalbutrazox,
SX + methconazole + picoxystrobin + fluopyram + boscalid + metalaxil M,
SX + methconazole + picoxystrobin + fluopyram + boscalid + picalbutrazox,
SX + metconazole + picoxystrobin + fluopyram + aminopyriphen + metalaxil M,
SX + metconazole + picoxystrobin + fluopyram + aminopyriphen + picalbutrazox,
SX + metconazole + picoxystrobin + fluopyram + mancozeb + metalaxil M,
SX + metconazole + picoxystrobin + fluopyram + mancozeb + picalbutrazox,
SX + methconazole + picoxystrobin + fluopyram + carbendazim + metalaxil M,
SX + methconazole + picoxystrobin + fluopyram + carbendazim + picalbutrazox,
SX + methconazole + picoxystrobin + fluxapyroxado + fludioxonyl + metalaxil M,
SX + metconazole + picoxystrobin + fluxapyroxado + fludioxonyl + picalbutrazox,
SX + methconazole + picoxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil M,
SX + metconazole + picoxystrobin + fluxapyroxado + thiophanate-methyl + picalbutrazox,
SX + metconazole + picoxystrobin + fluxapyroxado + thiabendazole + metalaxil M,
SX + metconazole + picoxystrobin + fluxapyroxado + thiabendazole + picalbutrazox,
SX + methconazole + picoxystrobin + fluxapyroxado + thiuram + metalaxil M,
SX + metconazole + picoxystrobin + fluxapyroxado + thiuram + picalbutrazox,
SX + methconazole + picoxystrobin + fluxapyroxado + torquelophosmethyl + metalaxil M,
SX + methconazole + picoxystrobin + fluxapyroxado + torquelophosmethyl + picalbutrazox,
SX + methconazole + picoxystrobin + fluxapirokid + boscalide + metalaxil M,
SX + methconazole + picoxystrobin + fluxapyroxado + boscalide + picalbutrazox,
SX + methconazole + picoxystrobin + fluxapyroxado + aminopyrifene + metalaxil M,
SX + metconazole + picoxystrobin + fluxapyroxado + aminopyriphen + picalbutrazox,
SX + methconazole + picoxystrobin + fluxapyrokid + mancozeb + metalaxil M,
SX + metconazole + picoxystrobin + fluxapyroxado + mancozeb + picalbutrazox,
SX + methconazole + picoxystrobin + fluxapyroxado + carbendazim + metalaxil M,
SX + methconazole + picoxystrobin + fluxapyroxado + carbendazim + picalbutrazox,
SX + metconazole + picoxystrobin + boscalide + fludioxonyl + metalaxil M,
SX + metconazole + picoxystrobin + boscalid + fludioxonyl + picalbutrazox,
SX + methconazole + picoxystrobin + vophanate + thiophanate-methyl + methanolate-M,
SX + metconazole + picoxystrobin + boscalide + thiophanate-methyl + picalbutrazox,
SX + metconazole + picoxystrobin + boscalid + tiabendazole + metalaxil M,
SX + metconazole + picoxystrobin + boscalid + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + boscalid + thiuram + metalaxil M,
SX + metconazole + picoxystrobin + boscalid + thiuram + picalbutrazox,
SX + methconazole + picoxystrobin + boscalide + torculophosmethyl + metalaxyl M,
SX + methconazole + picoxystrobin + boscalid + torculophosmethyl + picalbutrazox,
SX + Metoconazole + Picoxystrobin + Boscalid + Boscalid + Metalaxil M,
SX + methconazole + picoxystrobin + boscalid + boscalid + picalbutrazox,
SX + methconazole + picoxystrobin + boscalide + aminopyriphen + metalaxil M,
SX + metconazole + picoxystrobin + boscalid + aminopyriphen + picalbutrazox,
SX + metconazole + picoxystrobin + boscalid + mancozeb + metalaxil M,
SX + metconazole + picoxystrobin + boscalid + mancozeb + picalbutrazox,
SX + methconazole + picoxystrobin + boscalid + carbendazim + metalaxil M,
SX + methconazole + picoxystrobin + boscalid + carbendazim + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + fludioxonyl + metalaxil M,
SX + metconazole + picoxystrobin + penflufen + fludioxonyl + picalbutrazox,
SX + methconazole + picoxystrobin + penfurphene + thiophanate-methyl + methanolate-methyl,
SX + metconazole + picoxystrobin + penflufen + thiophanate-methyl + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + metalaxil M,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + thiuram + metalaxil M,
SX + metconazole + picoxystrobin + penflufen + thiuram + picalbutrazox,
SX + methconazole + picoxystrobin + penflufen + torquelophosmethyl + metalaxyl M,
SX + methconazole + picoxystrobin + penflufen + torquelophosmethyl + picalbutrazox,
SX + methconazole + picoxystrobin + penflufen + boscalid + metalaxil M,
SX + methconazole + picoxystrobin + penflufen + boscalid + picalbutrazox,
SX + methconazole + picoxystrobin + penflufen + aminopyriphen + metalaxil M,
SX + metconazole + picoxystrobin + penflufen + aminopyriphen + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + mancozeb + metalaxil M,
SX + metconazole + picoxystrobin + penflufen + mancozeb + picalbutrazox,
SX + methconazole + picoxystrobin + penflufen + carbendazim + metalaxil M,
SX + methconazole + picoxystrobin + penflufen + carbendazim + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + fludioxonyl + metalaxil M,
SX + metconazole + picoxystrobin + tifluzamide + fludioxonyl + picalbutrazox,
SX + methconazole + picoxystrobin + thiophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + picoxystrobin + tifluzamide + thiophanate-methyl + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + thiabendazole + metalaxil M,
SX + metconazole + picoxystrobin + tifluzamide + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + thifruzamide + thiuram + metalaxil M,
SX + metconazole + picoxystrobin + thifluzamide + thiuram + picalbutrazox,
SX + methconazole + picoxystrobin + tifluzamide + torculophosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + torquelophosmethyl + picalbutrazox,
SX + methconazole + picoxystrobin + tifluzamide + boscalid + metalaxil M,
SX + methconazole + picoxystrobin + tifluzamide + boscalid + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + aminopyriphen + metalaxil M,
SX + metconazole + picoxystrobin + tifluzamide + aminopyriphen + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + mancozeb + metalaxil M,
SX + metconazole + picoxystrobin + tifluzamide + mancozeb + picalbutrazox,
SX + methconazole + picoxystrobin + tifluzamide + carbendazim + metalaxil M,
SX + methconazole + picoxystrobin + tifluzamide + carbendazim + picalbutrazox,
SX + methconazole + picoxystrobin + impilfluxam + fludioxonyl + metalaxil M,
SX + methconazole + picoxystrobin + impilfluxam + fludioxonyl + picalbutrazox,
SX + methconazole + picoxystrobin + impilfluxam + thiophanate-methyl + metalaxil M,
SX + methconazole + picoxystrobin + impilfluxam + thiophanate-methyl + picalbutrazox,
SX + methconazole + picoxystrobin + impilfluxam + thiabendazole + metalaxil M,
SX + methconazole + picoxystrobin + impilfluxam + thiabendazole + picalbutrazox,
SX + methconazole + picoxystrobin + impilfluxam + thiuram + metalaxil M,
SX + methconazole + picoxystrobin + impilfluxam + thiuram + picalbutrazox,
SX + methconazole + picoxystrobin + impilfluxam + torquelophosmethyl + metalaxil M,
SX + methconazole + picoxystrobin + impilfluxam + torquelophosmethyl + picalbutrazox,
SX + methconazole + picoxystrobin + impilfluxam + boscalid + metalaxil M,
SX + methconazole + picoxystrobin + impilfluxam + boscalid + picalbutrazox,
SX + methconazole + picoxystrobin + impilfluxam + aminopyridene + metalaxil M,
SX + methconazole + picoxystrobin + impilfluxam + aminopyridene + picalbutrazox,
SX + methconazole + picoxystrobin + impilfluxam + mancozeb + metalaxil M,
SX + methconazole + picoxystrobin + impilfluxam + mancozeb + picalbutrazox,
SX + methconazole + picoxystrobin + impilfluxam + carbendazim + metalaxil M,
SX + methconazole + picoxystrobin + impilfluxam + carbendazim + picalbutrazox,
SX + metconazole + picoxystrobin + sedaxane + fludioxonyl + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + fludioxonyl + picalbutrazox,
SX + methconazole + picoxystrobin + sedaxane + thiophanate-methyl + methanolate-M,
SX + metconazole + picoxystrobin + sedaxane + thiophanate-methyl + picalbutrazox,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + metalaxil M,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + sedaxan + thiuram + metalaxil M,
SX + metconazole + picoxystrobin + sedaxane + thiuram + picalbutrazox,
SX + methconazole + picoxystrobin + sedaxane + torquelophosmethyl + metalaxyl M,
SX + methconazole + picoxystrobin + sedaxane + torquelophosmethyl + picalbutrazox,
SX + methconazole + picoxystrobin + sedaxan + boscalid + metalaxil M,
SX + methconazole + picoxystrobin + sedaxane + boscalid + picalbutrazox,
SX + methconazole + picoxystrobin + sedaxan + aminopyriphen + metalaxil M,
SX + metconazole + picoxystrobin + sedaxane + aminopyriphen + picalbutrazox,
SX + metconazole + picoxystrobin + sedaxan + mancozeb + metalaxil M,
SX + metconazole + picoxystrobin + sedaxane + mancozeb + picalbutrazox,
SX + methconazole + picoxystrobin + sedaxane + carbendazim + metalaxil M,
SX + methconazole + picoxystrobin + sedaxane + carbendazim + picalbutrazox,
SX + methconazole + picoxystrobin + pidiflumethofen + fludioxonyl + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethofen + fludioxonyl + picalbutrazox,
SX + methconazole + picoxystrobin + pidiflumethophene + thiophanate-methyl + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethophene + thiophanate-methyl + picalbutrazox,
SX + metconazole + picoxystrobin + pidiflumethofen + thiabendazole + metalaxil M,
SX + metconazole + picoxystrobin + pidiflumethophene + thiabendazole + picalbutrazox,
SX + methconazole + picoxystrobin + pidiflumethophene + thiuram + metalaxil M,
SX + metconazole + picoxystrobin + pidiflumethophene + thiuram + picalbutrazox,
SX + methconazole + picoxystrobin + pidiflumethophene + torculophosmethyl + metalaxyl M,
SX + methconazole + picoxystrobin + pidiflumethophene + torquelophosmethyl + picalbutrazox,
SX + methconazole + picoxystrobin + pidiflumethophene + boscalide + metalaxil M,
SX + methconazole + picoxystrobin + pidiflumethophene + boscalid + picalbutrazox,
SX + methconazole + picoxystrobin + pidiflumethophene + aminopyridene + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethophene + aminopyridene + picalbutrazox,
SX + methconazole + picoxystrobin + pidiflumethophene + mancozeb + metalaxil M,
SX + metconazole + picoxystrobin + pidiflumethophene + mancozeb + picalbutrazox,
SX + methconazole + picoxystrobin + pidiflumethophene + carbendazim + metalaxil M,
SX + methconazole + picoxystrobin + pidiflumethophene + carbendazim + picalbutrazox,
SX + methconazole + picoxystrobin + isoflusiplum + fludioxonyl + metalaxil M,
SX + metconazole + picoxystrobin + isoflusiplum + fludioxonyl + picalbutrazox,
SX + methconazole + picoxystrobin + isofflusiplum + thiophanate-methyl + methanolate-methyl,
SX + metconazole + picoxystrobin + isoflusiplum + thiophanate-methyl + picalbutrazox,
SX + metconazole + picoxystrobin + isoflusiplum + tiabendazole + metalaxil M,
SX + metconazole + picoxystrobin + isoflusiplum + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + isoflusiplum + thiuram + metalaxil M,
SX + metconazole + picoxystrobin + isoflusiplum + thiuram + picalbutrazox,
SX + methconazole + picoxystrobin + isoflusiplum + torquelophosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + isoflusiplum + torquelophosmethyl + picalbutrazox,
SX + methconazole + picoxystrobin + isoflusiplum + boscalide + metalaxil M,
SX + methconazole + picoxystrobin + isoflusiplum + boscalid + picalbutrazox,
SX + methconazole + picoxystrobin + isoflusiplum + aminopyridene + metalaxil M,
SX + metconazole + picoxystrobin + isoflusiplum + aminopyriphen + picalbutrazox,
SX + methconazole + picoxystrobin + isoflusiplum + mancozeb + metalaxil M,
SX + metconazole + picoxystrobin + isoflusiplum + mancozeb + picalbutrazox,
SX + methconazole + picoxystrobin + isoflusiplum + carbendazim + metalaxil M,
SX + methconazole + picoxystrobin + isoflusiplum + carbendazim + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Fluopirum + Fludioxonyl + Metalaxyl M,
SX + methconazole + methyltetraprowl + fluopyram + fludioxonyl + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Fluopirum + Thiophanate-methyl + Metalaxyl M,
SX + methconazole + methyltetraprowl + fluorium + thiophanate-methyl + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Fluopirum + Tiabendazole + Metalaxil M,
SX + Metconazole + Methyltetraprol + Fluopirum + Tiabendazole + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Fluopiram + Thiram + Metalaxil M,
SX + methconazole + methyltetraprowl + fluopyram + thiuram + picarubutrazox,
SX + Metconazole + Methyltetraprowl + Fluopirum + Torquelophosmethyl + Metalaxyl M,
SX + Metconazole + Methyltetraprowl + Fluopirum + Torquelophosmethyl + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Fluopirum + Boscalide + Metalaxil M,
SX + Metconazole + Methyltetraprowl + Fluopirum + Boscalid + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Fluopirum + Aminopyriphen + Metalaxyl M,
SX + Metconazole + Methyltetraprowl + Fluopirum + Aminopyriphen + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Fluopirum + Mancozeb + Metalaxil M,
SX + methconazole + methyltetraprowl + fluopyram + mancozeb + picarubutrazox,
SX + Metconazole + Methyltetraprowl + Fluopirum + Carbendazim + Metalaxil M,
SX + Metconazole + Methyltetraprol + Fluopirum + Carbendazim + Picalbutrazox,
SX + methconazole + methyltetraprowl + fluxapyroxado + fludioxonyl + metalaxil M,
SX + methconazole + methyltetraprowl + fluxapyroxado + fludioxonyl + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Thiophanate-methyl + Metalaxyl M,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiophanate-methyl + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Tiabendazole + Metalaxil M,
SX + metconazole + methyltetraprol + fluxapyroxado + thiabendazole + picalbutrazox,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiuram + metalaxil M,
SX + methconazole + methyltetraprol + fluxapyroxado + thiuram + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Torquelophosmethyl + Metalaxyl M,
SX + Metoconazole + Methyltetraprowl + Fluxapyroxado + Torquelophosmethyl + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Boscalide + Metalaxil M,
SX + Metconazole + Methyltetraprol + Fluxapyroxado + Boscalide + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Aminopyriphen + Metalaxil M,
SX + methconazole + methyltetraprowl + fluxapyroxado + aminopyridene + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Mancozeb + Metalaxil M,
SX + methconazole + methyltetraprowl + fluxapyroxado + mancozeb + picarubutrazox,
SX + methconazole + methyltetraprowl + fluxapyroxado + carbendazim + metalaxil M,
SX + methconazole + methyltetraprol + fluxapyroxado + carbendazim + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Boscalide + Fludioxonyl + Metalaxyl M,
SX + methconazole + methyltetraprowl + boscalide + fludioxonyl + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Boscalide + Thiophanate-methyl + Metalaxyl M,
SX + Metconazole + Methyltetraprowl + Boscalide + Thiophanate-methyl + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Boscalide + Tiabendazole + Metalaxil M,
SX + Metconazole + Methyltetraprol + Boscalide + Tiabendazole + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Boscalide + Thiram + Metalaxil M,
SX + Metconazole + Methyltetraprol + Boscalid + Thiram + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Boscalide + Torquelophosmethyl + Metalaxyl M,
SX + Metconazole + Methyltetraprowl + Boscalide + Torquelophosmethyl + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Boscalide + Boscalide + Metalaxil M,
SX + Metconazole + Methyltetraprol + Boscalid + Boscalid + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Boscalide + Aminopyriphen + Metalaxil M,
SX + Metconazole + Methyltetraprol + Boscalide + Aminopyriphen + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Boscalide + Mancozeb + Metalaxil M,
SX + Metconazole + Methyltetraprowl + Boscalide + Mancozeb + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Boscalide + Carbendazim + Metalaxil M,
SX + Metconazole + Methyltetraprol + Boscalid + Carbendazim + Picarubutrazox,
SX + methconazole + methyltetraprowl + penflufen + fludioxonyl + metalaxyl M,
SX + methconazole + methyltetraprowl + penflufen + fludioxonyl + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Penflufen + Thiophanate-methyl + Metalaxyl M,
SX + methconazole + methyltetraprowl + penflufen + thiophanate-methyl + picalbutrazox,
SX + metconazole + methyltetraprowl + penflufen + thiabendazole + metalaxil M,
SX + metconazole + methyltetraprowl + penflufen + thiabendazole + picarubutrazox,
SX + Metconazole + Methyltetraprowl + Penflufen + Thiram + Metalaxil M,
SX + methconazole + methyltetraprowl + penflufen + thiuram + picarubutrazox,
SX + Metconazole + Methyltetraprowl + Penflufen + Torquelophosmethyl + Metalaxyl M,
SX + Metconazole + Methyltetraprowl + Penflufen + Torquelophosmethyl + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Penflufen + Boscalide + Metalaxil M,
SX + methconazole + methyltetraprowl + penflufen + boscalid + picarubutrazox,
SX + Metconazole + Methyltetraprowl + Penflufen + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Methyltetraprowl + Penflufen + Aminopyriphen + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Penflufen + Mancozeb + Metalaxil M,
SX + methconazole + methyltetraprowl + penflufen + mancozeb + picarubutrazox,
SX + Metconazole + Methyltetraprowl + Penflufen + Carbendazim + Metalaxil M,
SX + Metconazole + Methyltetraprol + Penflufen + Carbendazim + Picarubutrazox,
SX + methconazole + methyltetraprowl + tifluzamide + fludioxonyl + metalaxil M,
SX + methconazole + methyltetraprowl + tifluzamide + fludioxonyl + picalbutrazox,
SX + methconazole + methyltetraprowl + tifluzamide + thiophanate-methyl + metalaxil M,
SX + methconazole + methyltetraprowl + tifluzamide + thiophanate-methyl + picalbutrazox,
SX + metconazole + methyltetraprowl + tifluzamide + thiabendazole + metalaxil M,
SX + metconazole + methyltetraprol + tifluzamide + thiabendazole + picarubutrazox,
SX + methconazole + methyltetraprowl + thifruzamide + thiuram + metalaxil M,
SX + Metconazole + Methyltetraprol + Thifluzamide + Thiram + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Tifluzamide + Torquelophosmethyl + Metalaxyl M,
SX + Metconazole + Methyltetraprowl + Tifluzamide + Torquelophosmethyl + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Thifluzamide + Boscalide + Metalaxil M,
SX + methconazole + methyltetraprowl + tifluzamide + boscalid + picarubutrazox,
SX + Metconazole + Methyltetraprowl + Thifluzamide + Aminopyriphen + Metalaxil M,
SX + Metconazole + Methyltetraprowl + Tifruzamide + Aminopyriphen + Picarubutrazox,
SX + methconazole + methyltetraprowl + tifluzamide + mancozeb + metalaxil M,
SX + methconazole + methyltetraprowl + tifluzamide + mancozeb + picarubutrazox,
SX + methconazole + methyltetraprowl + tifluzamide + carbendazim + metalaxil M,
SX + methconazole + methyltetraprol + tifluzamide + carbendazim + picalbutrazox,
SX + methconazole + methyltetraprowl + impilfluxam + fludioxonyl + metalaxil M,
SX + methconazole + methyltetraprol + impilfluxam + fludioxonyl + picalbutrazox,
SX + methconazole + methyltetraprowl + impilfluxam + thiophanate-methyl + metalaxil M,
SX + methconazole + methyltetraprol + impilfluxam + thiophanate-methyl + picalbutrazox,
SX + methconazole + methyltetraprowl + impilfluxam + thiabendazole + metalaxil M,
SX + methconazole + methyltetraprol + impilfluxam + thiabendazole + picalbutrazox,
SX + methconazole + methyltetraprowl + impilfluxam + thiuram + metalaxil M,
SX + methconazole + methyltetraprol + impilfluxam + thiuram + picarubutrazox,
SX + Metconazole + Methyltetraprowl + Impilfluxam + Torquelophosmethyl + Metalaxil M,
SX + Metconazole + Methyltetraprol + Impilfluxam + Torquelophosmethyl + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Impilfluxam + Boscalide + Metalaxil M,
SX + methconazole + methyltetraprol + impilfluxam + boscalid + picarubutrazox,
SX + Metconazole + Methyltetraprowl + Impilfluxam + Aminopyriphen + Metalaxil M,
SX + Metconazole + Methyltetraprol + Impilfluxam + Aminopyriphen + Picarubutrazox,
SX + methconazole + methyltetraprowl + impilfluxam + mancozeb + metalaxil M,
SX + methconazole + methyltetraprol + impilfluxam + mancozeb + picarubutrazox,
SX + methconazole + methyltetraprowl + impilfluxam + carbendazim + metalaxil M,
SX + methconazole + methyltetraprol + impilfluxam + carbendazim + picalbutrazox,
SX + methconazole + methyltetraprowl + sedaxane + fludioxonyl + metalaxyl M,
SX + metconazole + methyltetraprol + sedaxane + fludioxonyl + picalbutrazox,
SX + methconazole + methyltetraprowl + sedaxane + thiophanate-methyl + metalaxyl M,
SX + methconazole + methyltetraprowl + sedaxane + thiophanate-methyl + picalbutrazox,
SX + metconazole + methyltetraprowl + sedaxane + thiabendazole + metalaxil M,
SX + metconazole + methyltetraprol + sedaxane + thiabendazole + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Sedaxan + Thiram + Metalaxil M,
SX + Metconazole + Methyltetraprol + Sedaxan + Thiram + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Sedaxane + Torquelophosmethyl + Metalaxyl M,
SX + Metconazole + Methyltetraprol + Sedaxane + Torquelophosmethyl + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Sedaxan + Boscalide + Metalaxil M,
SX + Metconazole + Methyltetraprol + Sedaxan + Boscalid + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Sedaxan + Aminopyriphen + Metalaxyl M,
SX + Metconazole + Methyltetraprol + Sedaxan + Aminopyriphen + Picarubutrasox,
SX + methconazole + methyltetraprowl + sedaxane + mancozeb + metalaxil M,
SX + methconazole + methyltetraprowl + sedaxane + mancozeb + picarubutrazox,
SX + methconazole + methyltetraprowl + sedaxane + carbendazim + metalaxil M,
SX + methconazole + methyltetraprol + sedaxane + carbendazim + picalbutrazox,
SX + methconazole + methyltetraprowl + pidiflumethofen + fludioxonyl + metalaxyl M,
SX + methconazole + methyltetraprowl + pidiflumethofen + fludioxonyl + picalbutrazox,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiophanate-methyl + metalaxyl M,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiophanate-methyl + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Pidiflumethofen + Tiabendazole + Metalaxil M,
SX + metconazole + methyltetraprol + pidiflumethophene + thiabendazole + picalbutrazox,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiuram + metalaxil M,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiuram + picalbutrazox,
SX + Metconazole + Methyltetraprowl + Pidiflumethophene + Torquelophosmethyl + Metalaxyl M,
SX + Metconazole + Methyltetraprowl + Pidiflumethophene + Torquelophosmethyl + Picalbutrazox,
SX + Metconazole + Methyltetraprowl + Pidiflumethofen + Boscalide + Metalaxil M,
SX + Metconazole + Methyltetraprol + Pidiflumethofen + Boscalid + Picalbutrazox,
SX + Metconazole + Methyltetraprowl + Pidiflumethofen + Aminopyriphen + Metalaxil M,
SX + Metconazole + Methyltetraprol + Pidiflumethofen + Aminopyriphen + Picalbutrazox,
SX + Metconazole + Methyltetraprowl + Pidiflumethofen + Mancozeb + Metalaxil M,
SX + methconazole + methyltetraprowl + pidiflumethophene + mancozeb + picalbutrazox,
SX + methconazole + methyltetraprowl + pidiflumethophene + carbendazim + metalaxil M,
SX + Metconazole + Methyltetraprol + Pidiflumethofen + Carbendazim + Picalbutrazox,
SX + methconazole + methyltetraprowl + isoflusiplum + fludioxonyl + metalaxil M,
SX + methconazole + methyltetraprowl + isoflusiplum + fludioxonyl + picalbutrazox,
SX + methconazole + methyltetraprowl + isoflusiplum + thiophanate-methyl + metalaxil M,
SX + Metconazole + Methyltetraplol + Isoflusiplum + Thiophanate-methyl + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Tiabendazole + Metalaxil M,
SX + metconazole + methyltetraprol + isoflusiplum + thiabendazole + picarubutrazox,
SX + methconazole + methyltetraprowl + isoflusiplum + thiuram + metalaxil M,
SX + Metconazole + Methyltetraprol + Isoflusiplum + Thiram + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Torquelophosmethyl + Metalaxyl M,
SX + Metconazole + Methyltetraplol + Isoflusiplum + Torquelophosmethyl + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Boscalide + Metalaxil M,
SX + Metconazole + Methyltetraprol + Isoflusiplum + Boscalid + Picarubutrasox,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Aminopyriphen + Metalaxil M,
SX + Metconazole + Methyltetraplol + Isoflusiplum + Aminopyriphen + Picarubutrazox,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Mancozeb + Metalaxil M,
SX + methconazole + methyltetraprowl + isoflusiplum + mancozeb + picarubutrazox,
SX + methconazole + methyltetraprowl + isoflusiplum + carbendazim + metalaxil M,
SX + methconazole + methyltetraprol + isoflusiplum + carbendazim + picalbutrazox,
SX + methconazole + fempicoxamide + fluopyram + fludioxonyl + metalaxil M,
SX + metconazole + fenpicoxamide + fluopirum + fludioxonyl + picalbutrazox,
SX + methoconazole + fenpicoxamide + fluorium + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fenpicoxamide + fluorium + thiophanate-methyl + picalbutrazox,
SX + metconazole + fempicoxamide + fluorium + thiabendazole + metalaxil M,
SX + metconazole + fenpicoxamide + fluopirum + thiabendazole + picalbutrazox,
SX + metconazole + fempicoxamide + fluopiram + thiuram + metalaxil M,
SX + metconazole + fempicoxamide + fluopyram + thiuram + picarubutrazox,
SX + methconazole + fempicoxamide + fluoropyram + torculophosmethyl + metalaxil M,
SX + methconazole + fenpicoxamide + fluoropyram + torculophosmethyl + picalbutrazox,
SX + methconazole + fempicoxamide + fluopyram + boscalide + metalaxil M,
SX + methconazole + fempicoxamide + fluopyram + boscalid + picarubutrazox,
SX + methconazole + fenpicoxamide + fluopyram + aminopyriphen + metalaxil M,
SX + metconazole + fenpicoxamide + fluopyram + aminopyriphen + picalbutrazox,
SX + metconazole + fempicoxamide + fluopyram + mancozeb + metalaxil M,
SX + metconazole + fempicoxamide + fluopyram + mancozeb + picarubutrazox,
SX + methconazole + fempicoxamide + fluopyram + carbendazim + metalaxil M,
SX + methconazole + fempicoxamide + fluopyram + carbendazim + picalbutrazox,
SX + methconazole + fempicoxamide + fluxapirokid + fludioxonyl + metalaxil M,
SX + metconazole + fenpicoxamide + fluxapyroxado + fludioxonyl + picalbutrazox,
SX + methconazole + fempicoxamide + fluxapyroxado + thiophanate-methyl + metalaxil M,
SX + metconazole + fenpicoxamide + fluxapyroxado + thiophanate-methyl + picalbutrazox,
SX + metconazole + fempicoxamide + fluxapyroxado + thiabendazole + metalaxil M,
SX + metconazole + fenpicoxamide + fluxapyroxado + thiabendazole + picalbutrazox,
SX + methconazole + fempicoxamide + fluxapyroxado + thiuram + metalaxil M,
SX + metconazole + fenpicoxamide + fluxapyroxado + thiuram + picalbutrazox,
SX + methconazole + fempicoxamide + fluxapyroxado + torculophosmethyl + metalaxil M,
SX + methconazole + fenpicoxamide + fluxapyroxado + torquelophosmethyl + picalbutrazox,
SX + Metoconazole + Fempicoxamide + Fluxapirokid + Boscalide + Metalaxil M,
SX + metconazole + fenpicoxamide + fluxapyroxado + boscalide + picalbutrazox,
SX + methconazole + fenpicoxamide + fluxapyrokid + aminopyrifene + metalaxil M,
SX + metconazole + fenpicoxamide + fluxapyroxado + aminopyriphen + picalbutrazox,
SX + methconazole + fempicoxamide + fluxapirokid + mancozeb + metalaxil M,
SX + metconazole + fenpicoxamide + fluxapyroxado + mancozeb + picalbutrazox,
SX + methconazole + fempicoxamide + fluxapyroxado + carbendazim + metalaxil M,
SX + methconazole + fenpicoxamide + fluxapyroxado + carbendazim + picalbutrazox,
SX + metconazole + fempicoxamide + boscalide + fludioxonyl + metalaxil M,
SX + metconazole + fenpicoxamide + boscalide + fludioxonyl + picalbutrazox,
SX + methconazole + fenpicoxamide + vophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fenpicoxamide + boscalide + thiophanate-methyl + picalbutrazox,
SX + metconazole + fempicoxamide + boscalid + thiabendazole + metalaxil M,
SX + metconazole + fenpicoxamide + boscalid + thiabendazole + picalbutrazox,
SX + metconazole + fempicoxamide + boscalid + thiuram + metalaxil M,
SX + metconazole + fempicoxamide + boscalid + thiuram + picalbutrazox,
SX + methconazole + fempicoxamide + boscalide + torculophosmethyl + metalaxil M,
SX + methconazole + fenpicoxamide + boscalide + torculophosmethyl + picalbutrazox,
SX + methconazole + fempicoxamide + boscalid + boscalid + metalaxil Mqzhrhx,
SX + Metoconazole + Fempicoxamide + Boscalid + Boscalid + Picalbutrazox,
SX + methconazole + fenpicoxamide + boscalide + aminopyriphen + metalaxil M,
SX + metconazole + fenpicoxamide + boscalide + aminopyriphen + picalbutrazox,
SX + Metoconazole + Fempicoxamide + Boscalide + Mancozeb + Metalaxil M,
SX + metconazole + fempicoxamide + boscalid + mancozeb + picarubutrazox,
SX + methconazole + fempicoxamide + boscalid + carbendazim + metalaxil M,
SX + methconazole + fempicoxamide + boscalid + carbendazim + picalbutrazox,
SX + metconazole + fenpicoxamide + penflufen + fludioxonyl + metalaxil M,
SX + metconazole + fenpicoxamide + penflufen + fludioxonyl + picalbutrazox,
SX + methconazole + fenpicoxamide + penfurphene + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fenpicoxamide + penflufen + thiophanate-methyl + picalbutrazox,
SX + metconazole + fenpicoxamide + penflufen + thiabendazole + metalaxil M,
SX + metconazole + fenpicoxamide + penflufen + thiabendazole + picalbutrazox,
SX + metconazole + fenpicoxamide + penflufen + thiuram + metalaxil M,
SX + metconazole + fenpicoxamide + penflufen + thiuram + picalbutrazox,
SX + methconazole + fenpicoxamide + penflufen + torculophosmethyl + metalaxil M,
SX + methconazole + fenpicoxamide + penflufen + torquelophosmethyl + picalbutrazox,
SX + methconazole + fenpicoxamide + penflufen + boscalid + metalaxil M,
SX + methconazole + fenpicoxamide + penflufen + boscalid + picalbutrazox,
SX + methconazole + fenpicoxamide + penflufen + aminopyriphen + metalaxil M,
SX + metconazole + fenpicoxamide + penflufen + aminopyriphen + picalbutrazox,
SX + methconazole + fenpicoxamide + penflufen + mancozeb + metalaxil M,
SX + metconazole + fenpicoxamide + penflufen + mancozeb + picarubutrazox,
SX + methconazole + fenpicoxamide + penflufen + carbendazim + metalaxil M,
SX + methconazole + fenpicoxamide + penflufen + carbendazim + picalbutrazox,
SX + methconazole + fenpicoxamide + tifluzamide + fludioxonyl + metalaxil M,
SX + metconazole + fenpicoxamide + tifluzamide + fludioxonyl + picalbutrazox,
SX + methconazole + fenpicoxamide + thiophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fenpicoxamide + tifluzamide + thiophanate-methyl + picalbutrazox,
SX + metconazole + fempicoxamide + tifluzamide + thiabendazole + metalaxil M,
SX + metconazole + fenpicoxamide + tifluzamide + thiabendazole + picalbutrazox,
SX + metconazole + fempicoxamide + thifruzamide + thiuram + metalaxil M,
SX + methconazole + fenpicoxamide + thifluzamide + thiuram + picarubutrazox,
SX + methconazole + fenpicoxamide + tyfluzamide + torculophosmethyl + metalaxil M,
SX + metconazole + fenpicoxamide + tifluzamide + torquelophosmethyl + picalbutrazox,
SX + methconazole + fenpicoxamide + tifluzamide + boscalid + metalaxil M,
SX + methconazole + fenpicoxamide + tifluzamide + boscalid + picarubutrazox,
SX + methconazole + fenpicoxamide + tifluzamide + aminopyriphen + metalaxil M,
SX + metconazole + fenpicoxamide + tifluzamide + aminopyriphen + picalbutrazox,
SX + methconazole + fenpicoxamide + tifluzamide + mancozeb + metalaxil M,
SX + metconazole + fenpicoxamide + tifluzamide + mancozeb + picarubutrazox,
SX + methconazole + fempicoxamide + tifluzamide + carbendazim + metalaxil M,
SX + methconazole + fenpicoxamide + tifluzamide + carbendazim + picalbutrazox,
SX + methconazole + fempicoxamide + impilfluxam + fludioxonyl + metalaxil M,
SX + methconazole + fenpicoxamide + impilfluxam + fludioxonyl + picalbutrazox,
SX + methconazole + fempicoxamide + impilfluxam + thiophanate-methyl + metalaxil M,
SX + methconazole + fenpicoxamide + impilfluxam + thiophanate-methyl + picalbutrazox,
SX + methconazole + fempicoxamide + impilfluxam + thiabendazole + metalaxil M,
SX + methconazole + fenpicoxamide + impilfluxam + thiabendazole + picalbutrazox,
SX + methconazole + fempicoxamide + impilfluxam + thiuram + metalaxil M,
SX + methconazole + fenpicoxamide + impilfluxam + thiuram + picalbutrazox,
SX + methconazole + fempicoxamide + impilfluxam + torquelophosmethyl + metalaxil M,
SX + methconazole + fenpicoxamide + impilfluxam + torquelophosmethyl + picalbutrazox,
SX + methconazole + fempicoxamide + impilfluxam + boscalide + metalaxil M,
SX + methconazole + fenpicoxamide + impilfluxam + boscalid + picalbutrazox,
SX + methconazole + fenpicoxamide + impilfluxam + aminopyridene + metalaxil M,
SX + methconazole + fenpicoxamide + impilfluxam + aminopyriphen + picalbutrazox,
SX + methconazole + fempicoxamide + impilfluxam + mancozeb + metalaxil M,
SX + methconazole + fenpicoxamide + impilfluxam + mancozeb + picalbutrazox,
SX + methconazole + fempicoxamide + impilfluxam + carbendazim + metalaxil M,
SX + methconazole + fenpicoxamide + impilfluxam + carbendazim + picalbutrazox,
SX + metconazole + fempicoxamide + sedaxane + fludioxonyl + metalaxil M,
SX + metconazole + fenpicoxamide + sedaxane + fludioxonyl + picalbutrazox,
SX + methconazole + fenpicoxamide + sedaxane + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fenpicoxamide + sedaxane + thiophanate-methyl + picalbutrazox,
SX + metconazole + fempicoxamide + sedaxane + thiabendazole + metalaxil M,
SX + metconazole + fenpicoxamide + sedaxane + thiabendazole + picalbutrazox,
SX + metconazole + fempicoxamide + sedaxane + thiuram + metalaxil M,
SX + metconazole + fenpicoxamide + sedaxane + thiuram + picalbutrazox,
SX + methconazole + fempicoxamide + sedaxane + torculophosmethyl + metalaxil M,
SX + methconazole + fenpicoxamide + sedaxane + torculophosmethyl + picalbutrazox,
SX + methconazole + fempicoxamide + sedaxane + boscalide + metalaxil M,
SX + metconazole + fempicoxamide + sedaxane + boscalid + picalbutrazox,
SX + methconazole + fenpicoxamide + sedaxane + aminopyriphen + metalaxil M,
SX + metconazole + fenpicoxamide + sedaxane + aminopyriphen + picalbutrazox,
SX + metconazole + fempicoxamide + sedaxane + mancozeb + metalaxil M,
SX + metconazole + fempicoxamide + sedaxane + mancozeb + picarubutrazox,
SX + methconazole + fempicoxamide + sedaxane + carbendazim + metalaxil M,
SX + methconazole + fenpicoxamide + sedaxane + carbendazim + picalbutrazox,
SX + methconazole + fenpicoxamide + pidiflumethophene + fludioxonyl + metalaxil M,
SX + metconazole + fenpicoxamide + pidiflumethophene + fludioxonyl + picalbutrazox,
SX + methconazole + fenpicoxamide + pidiflumethophene + thiophanate-methyl + metalaxil M,
SX + metconazole + fenpicoxamide + pidiflumethophene + thiophanate-methyl + picalbutrazox,
SX + metconazole + fenpicoxamide + pidiflumethophene + thiabendazole + metalaxil M,
SX + metconazole + fenpicoxamide + pidiflumethophene + thiabendazole + picalbutrazox,
SX + methconazole + fenpicoxamide + pidiflumethophene + thiuram + metalaxil M,
SX + metconazole + fenpicoxamide + pidiflumethophene + thiuram + picalbutrazox,
SX + methconazole + fenpicoxamide + pidiflumethophene + torquelophosmethyl + metalaxil M,
SX + methconazole + fenpicoxamide + pidiflumethophene + torquelophosmethyl + picalbutrazox,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Boscalide + Metalaxil M,
SX + methconazole + fenpicoxamide + pidiflumethophene + boscalid + picalbutrazox,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Aminopyriphen + Picalbutrazox,
SX + methconazole + fenpicoxamide + pidiflumethophene + mancozeb + metalaxil M,
SX + metconazole + fenpicoxamide + pidiflumethophene + mancozeb + picalbutrazox,
SX + methconazole + fenpicoxamide + pidiflumethophene + carbendazim + metalaxil M,
SX + methconazole + fenpicoxamide + pidiflumethophene + carbendazim + picalbutrazox,
SX + methconazole + fenpicoxamide + isoflusiplum + fludioxonyl + metalaxil M,
SX + metconazole + fenpicoxamide + isoflusiplum + fludioxonyl + picalbutrazox,
SX + methoconazole + fenpicoxamide + isofrusiplum + thiophanate-methyl + methanolate-methyl,
SX + metconazole + fenpicoxamide + isoflusiplum + thiophanate-methyl + picalbutrazox,
SX + metconazole + fempicoxamide + isoflusiplum + thiabendazole + metalaxil M,
SX + metconazole + fenpicoxamide + isoflusiplum + thiabendazole + picalbutrazox,
SX + metconazole + fempicoxamide + isoflusiplum + thiuram + metalaxil M,
SX + metconazole + fenpicoxamide + isoflusiplum + thiuram + picarubutrazox,
SX + methconazole + fempicoxamide + isoflusiplum + torculophosmethyl + metalaxil M,
SX + methconazole + fenpicoxamide + isoflusiplum + torquelophosmethyl + picalbutrazox,
SX + methconazole + fempicoxamide + isoflusiplum + boscalide + metalaxil M,
SX + methconazole + fenpicoxamide + isoflusiplum + boscalid + picarubutrazox,
SX + methconazole + fenpicoxamide + isoflusiplum + aminopyriphen + metalaxil M,
SX + metconazole + fenpicoxamide + isoflusiplum + aminopyriphen + picalbutrazox,
SX + metconazole + fempicoxamide + isoflusiplum + mancozeb + metalaxil M,
SX + metconazole + fenpicoxamide + isoflusiplum + mancozeb + picarubutrazox,
SX + methconazole + fempicoxamide + isoflusiplum + carbendazim + metalaxil M,
SX + methconazole + fenpicoxamide + isoflusiplum + carbendazim + picalbutrazox,
SX + metconazole + florylpicoxamide + fluoripyram + fludioxonyl + metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Fludioxonyl + Picalbutrazox,
SX + methconazole + florylpicoxamide + fluoripyram + thiophanate-methyl + methanolate-methyl,
SX + metconazole + florylpicoxamide + fluoripyram + thiophanate-methyl + picalbutrazox,
SX + metconazole + florylpicoxamide + fluoripyram + tiabendazole + metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Tiabendazole + Picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Fluopiram + Thiram + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluopiram + Thiram + Picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Torquelophosmethyl + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Torquelophosmethyl + Picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Boscalide + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Boscalid + Picarubutrazox,
SX + methconazole + florylpicoxamide + fluopyram + aminopyriphen + metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Aminopyriphen + Picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Mancozeb + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Mancozeb + Picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Carbendazim + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Carbendazim + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Fluxapirokid + Fludioxonyl + Metalaxil M,
SX + metconazole + florylpicoxamide + fluxapyroxado + fludioxonyl + picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Thiophanate-methyl + Metalaxil M,
SX + metconazole + florylpicoxamide + fluxapyroxado + thiophanate-methyl + picalbutrazox,
SX + metconazole + florylpicoxamide + fluxapyroxado + thiabendazole + metalaxil M,
SX + metconazole + florylpicoxamide + fluxapyroxado + thiabendazole + picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Thiram + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Thiram + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Torquelophosmethyl + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Torquelophosmethyl + Picalbutrazox,
SX + Metconazole + Florylpicoxamide + Fluxapirokid + Boscalide + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Boscalide + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Fluxapyrokid + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Aminopyriphen + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Fluxapirokid + Mancozeb + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Mancozeb + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Carbendazim + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Carbendazim + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Boscalide + Fludioxonyl + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Boscalide + Fludioxonyl + Picalbutrazox,
SX + methconazole + floryl picoxamide + vophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + florylpicoxamide + boscalide + thiophanate-methyl + picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Boscalide + Tiabendazole + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Boscalid + Tiabendazole + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Boscalid + Thiram + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Boscalid + Thiram + Picarubutrazox,
SX + Metconazole + Florylpicoxamide + Boscalide + Torquelophosmethyl + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Boscalide + Torquelophosmethyl + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Boscalid + Boscalid + Metalaxil Mqzhrhx,
SX + Metoconazole + Florylpicoxamide + Boscalid + Boscalid + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Boscalide + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Boscalide + Aminopyriphen + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Boscalid + Mancozeb + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Boscalid + Mancozeb + Picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Boscalide + Carbendazim + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Boscalid + Carbendazim + Picalbutrazox,
SX + methconazole + floryl picoxamide + penflufen + fludioxonyl + metalaxil M,
SX + metconazole + florylpicoxamide + penflufen + fludioxonyl + picalbutrazox,
SX + methconazole + florylpicoxamide + penfurphene + thiophanate-methyl + methanolate-methyl,
SX + metconazole + florylpicoxamide + penflufen + thiophanate-methyl + picalbutrazox,
SX + metconazole + florylpicoxamide + penflufen + thiabendazole + metalaxil M,
SX + metconazole + florylpicoxamide + penflufen + thiabendazole + picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Penflufen + Thiram + Metalaxil M,
SX + methconazole + floryl picoxamide + penflufen + thiuram + picaru butrazox,
SX + Metoconazole + Florylpicoxamide + Penflufen + Torquelophosmethyl + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Penflufen + Torquelophosmethyl + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Penflufen + Boscalide + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Penflufen + Boscalid + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Penflufen + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Penflufen + Aminopyriphen + Picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Penflufen + Mancozeb + Metalaxil M,
SX + metconazole + florylpicoxamide + penflufen + mancozeb + picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Penflufen + Carbendazim + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Penflufen + Carbendazim + Picalbutrazox,
SX + methconazole + floryl picoxamide + tifluzamide + fludioxonyl + metalaxil M,
SX + metconazole + floryl picoxamide + tifluzamide + fludioxonyl + picalbutrazox,
SX + methoconazole + florylpicoxamide + thiophanate + thiophanate-methyl + methanolate-methyl,
SX + metconazole + floryl picoxamide + tifluzamide + thiophanate methyl + picalbutrazox,
SX + metconazole + florylpicoxamide + tifluzamide + thiabendazole + metalaxil M,
SX + metconazole + florylpicoxamide + tifluzamide + thiabendazole + picalbutrazox,
SX + metconazole + florylpicoxamide + thifruzamide + thiuram + metalaxil M,
SX + methconazole + floryl picoxamide + thifluzamide + thiuram + picarubutrazox,
SX + Metconazole + Florylpicoxamide + Tifruzamide + Torquelophosmethyl + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Thifluzamide + Torquelophosmethyl + Picarubutrasox,
SX + Metoconazole + Florylpicoxamide + Thifluzamide + Boscalide + Metalaxil M,
SX + methconazole + floryl picoxamide + tifluzamide + boscarido + picaru butrazox,
SX + methconazole + floryl picoxamide + tifluzamide + aminopyriphen + metalaxil M,
SX + Metoconazole + Florylpicoxamide + Thifluzamide + Aminopyriphen + Picalbutrazox,
SX + methconazole + floryl picoxamide + tifluzamide + mancozeb + metalaxil M,
SX + metconazole + floryl picoxamide + tifluzamide + mancozeb + picarubutrazox,
SX + metconazole + florylpicoxamide + tifluzamide + carbendazim + metalaxil M,
SX + methconazole + floryl picoxamide + tifluzamide + carbendazim + picalbutrazox,
SX + methconazole + florylpicoxamide + impilfluxam + fludioxonyl + metalaxil M,
SX + methconazole + floryl picoxamide + impilfluxam + fludioxonyl + picalbutrazox,
SX + methconazole + florylpicoxamide + impilfluxam + thiophanate-methyl + metalaxil M,
SX + methconazole + florylpicoxamide + impilfluxam + thiophanate-methyl + picalbutrazox,
SX + methconazole + florylpicoxamide + impilfluxam + thiabendazole + metalaxil M,
SX + methconazole + floryl picoxamide + impilfluxam + thiabendazole + picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Impilfluxam + Thiram + Metalaxil M,
SX + methconazole + floryl picoxamide + impilfluxam + thiuram + picalbutrazox,
SX + methconazole + florylpicoxamide + impilfluxam + torquelophosmethyl + metalaxil M,
SX + methconazole + florylpicoxamide + impilfluxam + torquelophosmethyl + picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Impilfluxam + Boscalide + Metalaxil M,
SX + methconazole + floryl picoxamide + impilfluxam + boscalid + picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Impilfluxam + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Impilfluxam + Aminopyriphen + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Impilfluxam + Mancozeb + Metalaxil M,
SX + methconazole + floryl picoxamide + impilfluxam + mancozeb + picarubutrazox,
SX + methconazole + florylpicoxamide + impilfluxam + carbendazim + metalaxil M,
SX + methconazole + floryl picoxamide + impilfluxam + carbendazim + picalbutrazox,
SX + metconazole + florylpicoxamide + sedaxane + fludioxonyl + metalaxil M,
SX + metconazole + florylpicoxamide + sedaxane + fludioxonyl + picalbutrazox,
SX + methconazole + florylpicoxamide + sedaxane + thiophanate-methyl + methanolate-methyl,
SX + metconazole + florylpicoxamide + sedaxane + thiophanate-methyl + picalbutrazox,
SX + metconazole + florylpicoxamide + sedaxane + thiabendazole + metalaxil M,
SX + metconazole + florylpicoxamide + sedaxane + thiabendazole + picalbutrazox,
SX + metconazole + florylpicoxamide + sedaxane + thiuram + metalaxil M,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Thiram + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Sedaxane + Torquelophosmethyl + Metalaxyl M,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Torquelophosmethyl + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Boscalide + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Boscalid + Picalbutrazox,
SX + metconazole + florylpicoxamide + sedaxane + aminopyriphen + metalaxil M,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Aminopyriphen + Picalbutrazox,
SX + metconazole + florylpicoxamide + sedaxane + mancozeb + metalaxil M,
SX + metconazole + florylpicoxamide + sedaxane + mancozeb + picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Carbendazim + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Carbendazim + Picalbutrazox,
SX + metconazole + floryl picoxamide + pidiflumethofen + fludioxonyl + metalaxil M,
SX + metconazole + floryl picoxamide + pidiflumethofen + fludioxonyl + picalbutrazox,
SX + metconazole + florylpicoxamide + pidiflumethophene + thiophanate-methyl + metalaxyl M,
SX + metconazole + floryl picoxamide + pidiflumethophene + thiophanate methyl + picalbutrazox,
SX + metconazole + florylpicoxamide + pidiflumethofen + thiabendazole + metalaxil M,
SX + metconazole + floryl picoxamide + pidiflumethophene + thiabendazole + picalbutrazox,
SX + metconazole + floryl picoxamide + pidiflumethophene + thiuram + metalaxil M,
SX + metconazole + floryl picoxamide + pidiflumethophene + thiuram + picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Torquelophosmethyl + Metalaxyl M,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Torquelophosmethyl + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Boscalide + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Boscalid + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Aminopyriphen + Picalbutrazox,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Mancozeb + Metalaxil M,
SX + metconazole + floryl picoxamide + pidiflumethophene + mancozeb + picalbutrazox,
SX + methconazole + floryl picoxamide + pidiflumethophene + carbendazim + metalaxil M,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Carbendazim + Picalbutrazox,
SX + metconazole + florylpicoxamide + isoflusiplum + fludioxonyl + metalaxil M,
SX + metconazole + floryl picoxamide + isoflusiplum + fludioxonyl + picalbutrazox,
SX + methoconazole + florylpicoxamide + isofrusiplum + thiophanate-methyl + methanolate-methyl,
SX + metconazole + florylpicoxamide + isoflusiplum + thiophanate-methyl + picalbutrazox,
SX + metconazole + florylpicoxamide + isoflusiplum + thiabendazole + metalaxil M,
SX + metconazole + florylpicoxamide + isoflusiplum + thiabendazole + picalbutrazox,
SX + metconazole + florylpicoxamide + isoflusiplum + thiuram + metalaxil M,
SX + methconazole + floryl picoxamide + isoflusiplum + thiuram + picaru butrazox,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Torquelophosmethyl + Metalaxyl M,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Torquelophosmethyl + Picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Boscalide + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Boscalid + Picarubutrazox,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Aminopyriphen + Metalaxil M,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Aminopyriphen + Picalbutrazox,
SX + metconazole + florylpicoxamide + isoflusiplum + mancozeb + metalaxil M,
SX + metconazole + florylpicoxamide + isoflusiplum + mancozeb + picarubutrazox,
SX + metconazole + florylpicoxamide + isoflusiplum + carbendazim + metalaxil M,
SX + methconazole + floryl picoxamide + isoflusiplum + carbendazim + picalbutrazox.

Group 2'is composed of composition A consisting of one part of tebuconazole instead of one part of metconazole contained in each composition of group 1'.
Group 3'composed of composition A consisting of one part of diphenoconazole instead of one part of metconazole contained in each composition of group 1'.
Group 4'consists of composition A consisting of one part of triticonazole instead of one part of metconazole contained in each composition of group 1'.
Group 5'consists of composition A consisting of one part of prothioconazole in place of one part of metconazole contained in each composition of group 1'.
Group 6'composed of composition A consisting of one part of diniconazole instead of one part of metconazole contained in each composition of group 1'.
Group 7'is composed of composition A consisting of one part of diniconazole M instead of one part of metconazole contained in each composition of group 1'.
Group 8'is composed of composition A consisting of one part of ipconazole instead of one part of metconazole contained in each composition of group 1'.
Group 9'is composed of composition A consisting of one part of prochloras instead of one part of metconazole contained in each composition of group 1'.
Group 10'composed of composition A consisting of a portion of flukinconazole instead of a portion of metconazole contained in each composition of group 1'.
Group 11'is composed of composition A consisting of one part of bromconazole instead of one part of metconazole contained in each composition of group 1'.
Group 12'composed of composition A consisting of a portion of mefentrifluconazole instead of a portion of metconazole contained in each composition of group 1'.

In group 13', the combination of SX, this component 1, this component 2, this component 3, this component 4 and this component 5 is any combination of the above "6 active ingredient list", and one part of SX. It is composed of a composition A consisting of 1 part of the main component 1, 1 part of the main component 2, 1 part of the main component 3, 1 part of the main component 4 and 1 part of the main component 5.

Group 14'consists of composition A consisting of one part of tebuconazole in place of one part of metconazole contained in each composition of group 13'.
Group 15'composed of composition A consisting of a portion of diphenoconazole instead of a portion of metconazole contained in each composition of group 13'.
Group 16'consists of composition A consisting of a portion of triticonazole instead of a portion of metconazole contained in each composition of group 13'.
Group 17'consists of composition A consisting of a portion of prothioconazole in place of one portion of metconazole contained in each composition of group 13'.
Group 18'consists of composition A consisting of a portion of diniconazole instead of a portion of metconazole contained in each composition of group 13'.
Group 19'consists of composition A consisting of one part of diniconazole M instead of one part of metconazole contained in each composition of group 13'.
Group 20'consists of composition A consisting of a portion of ipconazole instead of a portion of metconazole contained in each composition of group 13'.
Group 21'consists of composition A consisting of one part of prochloras instead of one part of metconazole contained in each composition of group 13'.
Group 22'consists of composition A consisting of a portion of flukinconazole instead of a portion of metconazole contained in each composition of group 13'.
Group 23'composed of composition A consisting of a portion of bromconazole instead of a portion of metconazole contained in each composition of group 13'.
Group 24'composed of composition A consisting of a portion of mefentrifluconazole instead of a portion of metconazole contained in each composition of group 13'.

Group 25'is from composition A, which is obtained by adding 1000 parts of clothianidin, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil to each of the compositions of groups 1'to 12'. It is composed.
Group 26'comes from Composition A, which comprises 1000 parts of clothianidin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide to each of the compositions of groups 1'to 12'. It is composed.
Group 27'is a composition in which 1000 parts of clothianidin, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 28'from composition A, each of which is a composition of groups 1'to 12', is further supplemented with 1000 parts of clothianidin, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. It is composed.
Group 29'is composed of 1000 parts of clothianidin, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas added to each of the compositions of groups 1'to 12'. It is composed.
Group 30'is from composition A in which 1000 parts of clothianidin, 1000 parts of chlorantraniliplol, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 31'is from composition A in which 1000 parts of clothianidin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 32'is a composition obtained by adding 1000 parts of clothianidin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each of the compositions of groups 1'to 12'. It is composed of A.
Group 33'is composed of 1000 parts of clothianidin, 1000 parts of chlorantraniliplol, 1000 parts of bifenthrin and 1000 parts of fluxametamide added to each of the compositions of groups 1'to 12'. It is composed.
Group 34'is composed of 1000 parts of clothianidin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas added to each of the compositions of groups 1'to 12'. It is composed.
Group 35'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil were added. Will be done.
Group 36'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide were added. Will be done.
Group 37'is a composition A in which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 38'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamid were added. Will be done.
Group 39'consists of composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. Will be done.
Group 40'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil were added. Will be done.
Group 41'composed of Composition A in which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide were added to each of the compositions of groups 1'to 12'. Will be done.
Group 42'has added 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each of the compositions of groups 1'to 12'. Consists of.
Group 43'composed of Composition A, in which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamid were added to each of the compositions of groups 1'to 12'. Will be done.
Group 44'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas were added. Will be done.
Group 45'composed of each composition of groups 1'-12', plus 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil. To.
Group 46'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide were added. To.
Group 47'comes from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram. It is composed.
Group 48'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid were added. To.
Group 49'composed of each composition of groups 1'-12' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. To.
Group 50'composed of each composition of groups 1'-12' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil. To.
Group 51'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide were added. To.
Group 52'is from composition A in which 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 53'composed of each composition of groups 1'-12' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid. To.
Group 54'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas were added. To.
Group 55'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 1'to 12'. It is composed.
Group 56'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 57'is a composition obtained by adding 1000 parts of imidacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram to each of the compositions of groups 1'to 12'. It is composed of A.
Group 58'is composed of 1000 parts of imidacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamide added to each of the compositions of groups 1'to 12'. It is composed.
Group 59'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 1'to 12'. It is composed.
Group 60'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil are added to each of the compositions of groups 1'to 12'. It is composed.
Group 61'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 62'is a composition obtained by adding 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each of the compositions of groups 1'to 12'. It is composed of A.
Group 63'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 64'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 1'to 12'. It is composed.
Group 65'composed of composition A, each of the compositions of groups 1'to 12', further to which 1000 parts imidacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts fipronil were added. Will be done.
Group 66'composed of composition A, each of the compositions of groups 1'to 12', further to which 1000 parts imidacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts brofuranilide were added. Will be done.
Group 67'is a composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 68'composed of each composition of groups 1'-12' with 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamid. Will be done.
Group 69'composed of composition A, each of the compositions of groups 1'to 12', further to which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas were added. Will be done.
Group 70'consists of composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil. Will be done.
Group 71'consists of composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 1'to 12'. Will be done.
Group 72'is a composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 73'composed of Composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamid were added to each of the compositions of groups 1'to 12'. Will be done.
Group 74'composed of composition A, each of the compositions of groups 1'to 12', further to which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas were added. Will be done.
Group 75'composed of each composition of groups 1'-12' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil. To.
Group 76'composed of composition A, each of the compositions of groups 1'to 12', further to which 1000 parts imidacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts brofuranilide were added. To.
Group 77'is from composition A in which 1000 parts imidacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 78'composed of each composition of groups 1'-12' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. To.
Group 79'composed of each composition of groups 1'-12' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. To.
Group 80'composed of each composition of groups 1'-12' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil. To.
Group 81'composed of composition A, each of the compositions of groups 1'to 12', further to which 1000 parts imidacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts brofuranilide were added. To.
Group 82'is from composition A in which 1000 parts imidacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 83'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid were added. To.
Group 84'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas were added. To.
Group 85'is from composition A in which 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts fipronil are added to each of the compositions of groups 1'to 12'. It is composed.
Group 86'is from composition A in which 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts brofuranilide are added to each of the compositions of groups 1'to 12'. It is composed.
Group 87'is a composition obtained by adding 1000 parts of thiamethoxam, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram to each of the compositions of groups 1'to 12'. It is composed of A.
Group 88'comes from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of thiamethoxam, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. It is composed.
Group 89'is composed of 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts ginpropyridas added to each of the compositions of groups 1'to 12'. It is composed.
Group 90'is from composition A in which 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts bifenthrin and 1000 parts fipronil are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 91'is from composition A in which 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts bifenthrin and 1000 parts brofuranilide are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 92'is a composition obtained by adding 1000 parts of thiamethoxam, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each of the compositions of groups 1'to 12'. It is composed of A.
Group 93'is from composition A in which 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts bifenthrin and 1000 parts fluxametamide are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 94'is composed of 1000 parts of thiamethoxam, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas added to each of the compositions of groups 1'to 12'. It is composed.
Group 95'composed of Composition A, each of the compositions of Groups 1'to 12', further comprising 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts fipronil. Will be done.
Group 96'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts brofuranilide were added. Will be done.
Group 97'is a composition A in which 1000 parts of thiamethoxam, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 98'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts fluxametamid were added. Will be done.
Group 99'consists of composition A, which is obtained by adding 1000 parts of thiamethoxam, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas to each of the compositions of groups 1'to 12'. Will be done.
Group 100'composed of composition A, each of the compositions of groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil were added. Will be done.
Group 101'consists of composition A in which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide are added to each of the compositions of groups 1'to 12'. Will be done.
Group 102'is a composition A in which 1000 parts of thiamethoxam, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 103'composed of Composition A in which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fluxametamid were added to each of the compositions of groups 1'to 12'. Will be done.
Group 104'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts ginpropyridas were added. Will be done.
Group 105'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts fipronil were added. To.
Group 106'composed of composition A, each of the compositions of groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts brofuranilide were added. To.
Group 107'is composed of 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts isocycloceram added to each of the compositions of groups 1'to 12'. It is composed.
Group 108'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts fluxametamid were added. To.
Group 109'composed of each composition of groups 1'-12', plus 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts ginpropyridas. To.
Group 110'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts fipronil were added. To.
Group 111'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts brofuranilide were added. To.
Group 112'is from composition A in which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 113'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts fluxametamid were added. To.
Group 114'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts ginpropyridas were added. To.
Group 115'is composed of 1000 parts of thiacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil added to each of the compositions of groups 1'to 12'. It is composed.
Group 116'is from composition A, each of which is a composition of groups 1'to 12', further comprising 1000 parts thiacloprid, 1000 parts chlorantraniliprol, 1000 parts tefluthrin and 1000 parts brofuranilide. It is composed.
Group 117'is a composition obtained by adding 1000 parts of thiacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram to each composition of groups 1'to 12'. It is composed of A.
Group 118'is composed of 1000 parts of thiacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid added to each of the compositions of groups 1'to 12'. It is composed.
Group 119'is from composition A in which 1000 parts thiacloprid, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts ginpropyridas are added to each of the compositions of groups 1'to 12'. It is composed.
Group 120'is from composition A in which 1000 parts of thiacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil are added to each of the compositions of groups 1'to 12'. It is composed.
Group 121'is from composition A in which 1000 parts of thiacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 122'is a composition in which 1000 parts of thiacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 123'is from composition A in which 1000 parts of thiacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 124'is composed of 1000 parts of thiacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas added to each of the compositions of groups 1'to 12'. It is composed.
Group 125'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts fipronil were added. Will be done.
Group 126'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts brofuranilide were added. Will be done.
Group 127'is a composition A in which 1000 parts of thiacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 128'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts fluxametamid were added. Will be done.
Group 129'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts ginpropyridas were added. Will be done.
Group 130'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil were added. Will be done.
Group 131'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide were added. Will be done.
Group 132'is a composition A in which 1000 parts of thiacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 133'composed of Composition A in which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fluxametamid were added to each of the compositions of groups 1'to 12'. Will be done.
Group 134'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts ginpropyridas were added. Will be done.
Group 135'composed of each composition of groups 1'-12' with 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts fipronil. To.
Group 136'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts brofuranilide were added. To.
Group 137'is from composition A in which 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed.
Group 138'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts fluxametamid were added. To.
Group 139'composed of each composition of groups 1'-12', plus 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts ginpropyridas. To.
Group 140'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts fipronil were added. To.
Group 141'composed of Composition A in which 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts brofuranilide were added to each of the compositions of groups 1'to 12'. To.
Group 142'is from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of thiacloprid, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram. It is composed.
Group 143'composed of each composition of groups 1'-12', plus 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts fluxametamid. To.
Group 144'composed of each composition of groups 1'-12', plus 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts ginpropyridas. To.
Group 145'is from composition A in which 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 1'to 12'. It is composed.
Group 146'is from composition A, each of which is a composition of groups 1'to 12', which is further supplemented with 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide. It is composed.
Group 147'is a composition in which 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 148'is from composition A, each of which is a composition of groups 1'to 12', further comprising 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. It is composed.
Group 149'is from composition A, each of which is a composition of groups 1'to 12', which is further supplemented with 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. It is composed.
Group 150'is composed of 1000 parts of flupyraziflon, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil added to each of the compositions of groups 1'to 12'. It is composed.
Group 151'is composed of 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide to each of the compositions of groups 1'to 12'. It is composed.
Group 152'is a composition in which 1000 parts of flupyraziflon, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 153'is from composition A, each of which is a composition of groups 1'to 12', further comprising 1000 parts of flupyraziflon, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid. It is composed.
Group 154'is from composition A, each of which is a composition of groups 1'to 12', which is further supplemented with 1000 parts of flupyraziflon, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. It is composed.
Group 155'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil. Will be done.
Group 156'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide. Will be done.
Group 157'is a composition A in which 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 158'composed of Composition A in which 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamid were added to each of the compositions of groups 1'to 12'. Will be done.
Group 159'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. Will be done.
Group 160'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil were added. Will be done.
Group 161'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide. Will be done.
Group 162'is a composition A in which 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 163'composed of Composition A in which 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamid were added to each of the compositions of groups 1'to 12'. Will be done.
Group 164'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. Will be done.
Group 165'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil. To.
Group 166'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide. To.
Group 167'comes from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of flupyradiflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram. It is composed.
Group 168'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. To.
Group 169'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. To.
Group 170'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil. To.
Group 171'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide. To.
Group 172'is from composition A in which 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are added to each of the compositions of groups 1'to 12'. It is composed.
Group 173'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid. To.
Group 174'composed of each composition of groups 1'-12' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. To.
Group 175'comes from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil. It is composed.
Group 176'is from composition A, each of which is a composition of groups 1'to 12', which is further supplemented with 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide. It is composed.
Group 177'is a composition in which 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 178'comes from Composition A, which comprises 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid to each of the compositions of groups 1'to 12'. It is composed.
Group 179'is from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. It is composed.
Group 180'comes from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil. It is composed.
Group 181'is from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide. It is composed.
Group 182'is a composition in which 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 183'is composed of 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamide added to each of the compositions of groups 1'to 12'. It is composed.
Group 184'is from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. It is composed.
Group 185'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil. Will be done.
Group 186'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide. Will be done.
Group 187'is a composition A in which 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 188'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamid. Will be done.
Group 189'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. Will be done.
Group 190'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil. Will be done.
Group 191'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide. Will be done.
Group 192'is a composition A in which 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 193'composed of Composition A in which 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamid were added to each of the compositions of groups 1'to 12'. Will be done.
Group 194'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. Will be done.
Group 195'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil. To.
Group 196'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide. To.
Group 197'comes from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram. It is composed.
Group 198'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. To.
Group 199'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. To.
Group 200'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil. To.
Group 201'composed of Composition A, each of the compositions of Groups 1'to 12', further to which 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide were added. To.
Group 202'is from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram. It is composed.
Group 203'composed of Composition A in which 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid were added to each of the compositions of groups 1'to 12'. To.
Group 204'composed of each composition of groups 1'-12' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. To.
Group 205'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 206'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 207'added 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram to each composition of groups 1'-12'. It is composed of composition A.
Group 208'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 209'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 210'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 211'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 212'added 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each composition of groups 1'-12'. It is composed of composition A.
Group 213'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamide are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 214'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 215'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 216'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 1'to 12'. Consists of.
Group 217'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each composition of groups 1'to 12'. It is composed of object A.
Group 218'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamid are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 219'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 1'to 12'. Consists of.
Group 220'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 221'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 1'to 12'. Consists of.
Group 222'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each composition of groups 1'to 12'. It is composed of object A.
Group 223'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamide are further added to each of the compositions of groups 1'to 12'. Consists of.
Group 224'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 1'to 12'. Consists of.
Group 225'is from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil. It is composed.
Group 226'is from composition A, in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 1'to 12'. It is composed.
Group 227'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 228'comes from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. It is composed.
Group 229'is from Composition A, in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 1'to 12'. It is composed.
Group 230'is from composition A in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil are added to each of the compositions of groups 1'to 12'. It is composed.
Group 231'is from composition A in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 1'to 12'. It is composed.
Group 232'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 1'to 12'. It is composed of A.
Group 233'is from composition A in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid are added to each of the compositions of groups 1'to 12'. It is composed.
Group 234'is from composition A, each of which is a composition of groups 1'to 12', plus 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. It is composed.

Group 235'is from composition A in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of tefluthrin and 1 part of fipronil are added to each of the compositions of groups 13'to 24'. It is composed.
Group 236'is from composition A, in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of tefluthrin and 1 part of brofuranilide are added to each of the compositions of groups 13'to 24'. It is composed.
Group 237'is a composition obtained by adding 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of tefluthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 238'is from composition A, each of which is a composition of groups 13'to 24', further comprising 1 portion of clothianidin, 1 portion of chloranthraniliprol, 1 portion of tefluthrin and 1 portion of fluxametamid. It is composed.
Group 239'is from composition A in which 1 part clothianidin, 1 part chloranthraniliplol, 1 part tefluthrin and 1 part ginpropyridas are added to each of the compositions of groups 13'to 24'. It is composed.
Group 240'is from composition A in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fipronil are further added to each of the compositions of groups 13'to 24'. It is composed.
Group 241'is from composition A, in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of brofuranilide are added to each of the compositions of groups 13'to 24'. It is composed.
Group 242'is a composition obtained by adding 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 243'is from composition A in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fluxametamid are further added to each of the compositions of groups 13'to 24'. It is composed.
Group 244'is from composition A in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of ginpropyridas are added to each of the compositions of groups 13'to 24'. It is composed.
Group 245'composed of each composition of groups 13'to 24', plus 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fipronil. Will be done.
Group 246'composed of Composition A, each of the compositions of Groups 13'to 24', further to which 1 portion of clothianidin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of brofuranilide were added. Will be done.
Group 247'is a composition A in which 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of isocycloceram are further added to each of the compositions of groups 13'to 24'. Consists of.
Group 248'composed of Composition A in which 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fluxametamid were added to each of the compositions of groups 13'to 24'. Will be done.
Group 249'consists of composition A, each of which is a composition of groups 13'to 24', plus one part of clothianidin, one part of cyantraniliprole, one part of tefluthrin and one part of ginpropyridas. Will be done.
Group 250'consists of composition A in which 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fipronil are added to each of the compositions of groups 13'to 24'. Will be done.
Group 251'composed of Composition A, each of the compositions of Groups 13'to 24', further to which 1 portion of clothianidin, 1 portion of cyantraniliprole, 1 part of bifenthrin and 1 part of brofuranilide were added. Will be done.
Group 252'is a composition A in which 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of isocycloceram are further added to each composition of groups 13'to 24'. Consists of.
Group 253'composed of Composition A in which 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fluxametamid were added to each of the compositions of groups 13'to 24'. Will be done.
Group 254'consists of composition A, each of which is a composition of groups 13'to 24', plus one part of clothianidin, one part of cyantraniliprole, one part of bifenthrin and one part of ginpropyridas. Will be done.
Group 255'composed of each composition of groups 13'to 24', plus 1 part of clothianidin, 1 part of tetraniliprol, 1 part of tefluthrin and 1 part of fipronil. To.
Group 256'composed of Composition A, each of the compositions of Groups 13'to 24', further to which 1 portion of clothianidin, 1 portion of tetraniliprol, 1 portion of tefluthrin and 1 portion of brofuranilide were added. To.
Group 257'is from composition A in which 1 part clothianidin, 1 part tetraniliprol, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. It is composed.
Group 258'composed of Composition A, each of the compositions of Groups 13'to 24', further to which 1 part clothianidin, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid were added. To.
Group 259'composed of each composition of groups 13'to 24', plus 1 part clothianidin, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 260'composed of each composition of groups 13'to 24', plus 1 part of clothianidin, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of fipronil. To.
Group 261'composed of each composition of groups 13'to 24', plus 1 part of clothianidin, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of brofuranilide. To.
Group 262'is from composition A in which 1 part clothianidin, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. It is composed.
Group 263'composed of each composition of groups 13'to 24', plus 1 part of clothianidin, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of fluxametamid. To.
Group 264'composed of each composition of groups 13'to 24', plus 1 part of clothianidin, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of ginpropyridas. To.
Group 265'is from composition A in which 1 part imidacloprid, 1 part chlorantraniliplol, 1 part tefluthrin and 1 part fipronil are added to each of the compositions of groups 13'to 24'. It is composed.
Group 266'is from composition A, in which 1 part imidacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part brofuranilide are added to each of the compositions of groups 13'to 24'. It is composed.
Group 267'is a composition obtained by adding 1 part of imidacloprid, 1 part of chlorantraniliplol, 1 part of tefluthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 268'is from composition A in which 1 part imidacloprid, 1 part chlorantraniliplol, 1 part tefluthrin and 1 part fluxametamid are further added to each of the compositions of groups 13'to 24'. It is composed.
Group 269'is from composition A, each of which is a composition of groups 13'to 24', plus one part of imidacloprid, one part of chlorantraniliprol, one part of tefluthrin and one part of ginpropyridas. It is composed.
Group 270'is from composition A in which 1 part imidacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part fipronil are added to each of the compositions of groups 13'to 24'. It is composed.
Group 271'is from composition A in which 1 part imidacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part brofuranilide are added to each of the compositions of groups 13'to 24'. It is composed.
Group 272'is a composition obtained by adding 1 part of imidacloprid, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 273'is from composition A in which 1 part imidacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part fluxametamid are further added to each composition of groups 13'to 24'. It is composed.
Group 274'comes from composition A, each of which is a composition of groups 13'to 24', plus one part of imidacloprid, one part of chlorantraniliprol, one part of bifenthrin and one part of ginpropyridas. It is composed.
Group 275'composed of each composition of groups 13'-24', plus 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Will be done.
Group 276'composed of composition A, each of the compositions of groups 13'to 24', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Will be done.
Group 277'is a composition A in which 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. Consists of.
Group 278'composed of Composition A, each of the compositions of Groups 13'to 24', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fluxametamid. Will be done.
Group 279'consists of composition A, each of which is a composition of groups 13'to 24', plus 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas. Will be done.
Group 280'consists of composition A, each of which is a composition of groups 13'to 24', plus 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Will be done.
Group 281'composed of composition A, each of the compositions of groups 13'to 24', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Will be done.
Group 282'is a composition A in which 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. Consists of.
Group 283'consists of composition A, each of which is a composition of groups 13'to 24', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fluxametamid. Will be done.
Group 284'composed of composition A, each of the compositions of groups 13'to 24', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part ginpropyridas. Will be done.
Group 285'composed of each composition of groups 13'to 24', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil. To.
Group 286'composed of each composition of groups 13'to 24', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part brofuranilide. To.
Group 287'is from composition A, each of which is a composition of groups 13'to 24', plus one part of imidacloprid, one part of tetraniliprol, one part of tefluthrin and one part of isocycloceram. It is composed.
Group 288'composed of each composition of groups 13'to 24', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid. To.
Group 289'composed of each composition of groups 13'to 24', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 290'is composed of composition A in which 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil are further added to each composition of groups 13'to 24'. To.
Group 291'composed of each composition of groups 13'to 24', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part brofuranilide. To.
Group 292'is from composition A in which 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. It is composed.
Group 293'composed of each composition of groups 13'to 24', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid. To.
Group 294'composed of each composition of groups 13'-24', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part ginpropyridas. To.
Group 295'from each composition of groups 13'-24' is further added with 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fipronil. It is composed.
Group 296'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part brofuranilide are added to each of the compositions of groups 13'to 24'. It is composed.
Group 297'is a composition obtained by adding 1 part thiamethoxam, 1 part chloranthraniliplol, 1 part tefluthrin and 1 part isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 298'is from composition A, each of which is a composition of groups 13'to 24', plus one part of thiamethoxam, one part of chloranthraniliprol, one part of tefluthrin and one part of fluxametamid. It is composed.
Group 299'is from composition A, each of which is a composition of groups 13'to 24', plus one part of thiamethoxam, one part of chloranthraniliprol, one part of tefluthrin and one part of ginpropyridas. It is composed.
Group 300'is from composition A in which 1 part thiamethoxam, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part fipronil are further added to each composition of groups 13'to 24'. It is composed.
Group 301'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part brofuranilide are added to each of the compositions of groups 13'to 24'. It is composed.
Group 302'is a composition obtained by adding 1 part thiamethoxam, 1 part chloranthraniliplol, 1 part bifenthrin and 1 part isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 303'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliplol, 1 part bifenthrin and 1 part fluxametamid are further added to each composition of groups 13'to 24'. It is composed.
Group 304'is from composition A in which 1 part thiamethoxam, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part ginpropyridas are added to each of the compositions of groups 13'to 24'. It is composed.
Group 305'consists of composition A in which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil are added to each of the compositions of groups 13'to 24'. Will be done.
Group 306'consists of composition A, each of which is a composition of groups 13'to 24', further comprising 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Will be done.
Group 307'is a composition A in which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. Consists of.
Group 308'consists of composition A, each of which is a composition of groups 13'to 24', further comprising 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fluxametamid. Will be done.
Group 309'composed of Composition A, each of the compositions of Groups 13'to 24', further comprising 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas. Will be done.
Group 310'consists of composition A in which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil are added to each of the compositions of groups 13'to 24'. Will be done.
Group 311'consists of composition A, each of which is a composition of groups 13'to 24', further comprising 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Will be done.
Group 312'is a composition A in which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. Consists of.
Group 313'composed of Composition A in which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fluxametamid were added to each of the compositions of groups 13'to 24'. Will be done.
Group 314'consists of composition A, each of which is a composition of groups 13'to 24', plus one part of thiamethoxam, one part of cyantraniliprole, one part of bifenthrin and one part of ginpropyridas. Will be done.
Group 315'composed of each composition of groups 13'-24', plus 1 part thiamethoxam, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil. To.
Group 316'composed of each composition of groups 13'to 24', plus 1 part thiamethoxam, 1 part tetraniliprol, 1 part tefluthrin and 1 part brofuranilide. To.
Group 317'is from composition A in which 1 part thiamethoxam, 1 part tetraniliprol, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. It is composed.
Group 318'composed of Composition A, each of the compositions of Groups 13'to 24', in which 1 part thiamethoxam, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid were added. To.
Group 319'composed of each composition of groups 13'-24', plus 1 part thiamethoxam, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 320'composed of each composition of groups 13'to 24', plus 1 part thiamethoxam, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil. To.
Group 321'composed of Composition A, each of the compositions of Groups 13'to 24', further comprising 1 part thiamethoxam, 1 part tetraniliprol, 1 part bifenthrin and 1 part brofuranilide. To.
Group 322'is from composition A in which 1 part thiamethoxam, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. It is composed.
Group 323'is composed of composition A in which 1 part thiamethoxam, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid are further added to each composition of groups 13'to 24'. To.
Group 324'composed of each composition of groups 13'to 24', plus 1 part thiamethoxam, 1 part tetraniliprol, 1 part bifenthrin and 1 part ginpropyridas. To.
Group 325'is from composition A, each of which is a composition of groups 13'to 24', plus one part of thiacloprid, one part of chloranthraniliprol, one part of tefluthrin and one part of fipronil. It is composed.
Group 326'is from composition A, each of which is a composition of groups 13'to 24', in which 1 part thiacloprid, 1 part chlorantraniliprol, 1 part tefluthrin and 1 part brofuranilide are added. It is composed.
Group 327'is a composition obtained by adding 1 part thiacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 328'comes from composition A, each of which is a composition of groups 13'to 24', further comprising 1 part thiacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fluxametamid. It is composed.
Group 329'is from composition A, each of which is a composition of groups 13'to 24', plus one part of thiacloprid, one part of chlorantraniliprol, one part of tefluthrin and one part of ginpropyridas. It is composed.
Group 330'is from composition A in which 1 part thiacloprid, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part fipronil are further added to each composition of groups 13'to 24'. It is composed.
Group 331'is from composition A, each of which is a composition of groups 13'to 24', in which 1 part thiacloprid, 1 part chlorantraniliprol, 1 part bifenthrin and 1 part brofuranilide are added. It is composed.
Group 332'is a composition obtained by adding 1 part thiacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 333'is from composition A, each of which is a composition of groups 13'to 24', further comprising 1 part thiacloprid, 1 part chlorantraniliprol, 1 part bifenthrin and 1 part fluxametamid. It is composed.
Group 334'is from composition A in which 1 part thiacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part ginpropyridas are added to each of the compositions of groups 13'to 24'. It is composed.
Group 335'consists of composition A, each of which is a composition of groups 13'to 24', plus 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Will be done.
Group 336'composed of Composition A, each of the compositions of Groups 13'to 24', further comprising 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Will be done.
Group 337'is a composition A in which 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. Consists of.
Group 338'composed of Composition A in which 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fluxametamid were added to each of the compositions of groups 13'to 24'. Will be done.
Group 339'composed of each composition of groups 13'-24', plus 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas. Will be done.
Group 340'consists of composition A in which 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil are added to each composition of groups 13'to 24'. Will be done.
Group 341'consists of composition A in which 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide are added to each composition of groups 13'to 24'. Will be done.
Group 342'is a composition A in which 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. Consists of.
Group 343'consists of composition A, each of which is a composition of groups 13'to 24', further comprising 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fluxametamid. Will be done.
Group 344'composed of Composition A, each of the compositions of Groups 13'to 24', further comprising 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part ginpropyridas. Will be done.
Group 345'composed of each composition of groups 13'to 24', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil. To.
Group 346'composed of Composition A, each of the compositions of Groups 13'to 24', further comprising 1 part thiacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part brofuranilide. To.
Group 347'comes from composition A, each of which is a composition of groups 13'to 24', plus one part thiacloprid, one part tetraniliprol, one part tefluthrin and one part isocycloceram. It is composed.
Group 348'composed of each composition of groups 13'to 24', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid. To.
Group 349'composed of Composition A, each of the compositions of Groups 13'to 24', further comprising 1 part thiacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 350'composed of each composition of groups 13'to 24', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil. To.
Group 351'is composed of composition A in which 1 part thiacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part brofuranilide are added to each composition of groups 13'to 24'. To.
Group 352'is from composition A in which 1 part thiacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. It is composed.
Group 353'composed of each composition of groups 13'to 24', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid. To.
Group 354'composed of each composition of groups 13'to 24', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part ginpropyridas. To.
Group 355'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyraziflon, one part of chlorantraniliprol, one part of tefluthrin and one part of fipronil. It is composed.
Group 356'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyraziflon, one part of chloranthraniliprol, one part of tefluthrin and one part of brofuranilide. It is composed.
Group 357'is a composition obtained by adding 1 part of flupyraziflon, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 358'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyraziflon, one part of chloranthraniliprol, one part of tefluthrin and one part of fluxametamid. It is composed.
Group 359'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyraziflon, one part of chlorantraniliprol, one part of tefluthrin and one part of ginpropyridas. It is composed.
Group 360'is from composition A in which 1 part flupyraziflon, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part fipronil are further added to each composition of groups 13'to 24'. It is composed.
Group 361'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyraziflon, one part of chlorantraniliplol, one part of bifenthrin and one part of brofuranilide. It is composed.
Group 362'is a composition obtained by adding 1 part of flupyraziflon, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 363'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyraziflon, one part of chlorantraniliplol, one part of bifenthrin and one part of fluxametamid. It is composed.
Group 364'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyraziflon, one part of chlorantraniliprol, one part of bifenthrin and one part of ginpropyridas. It is composed.
Group 365'composed of Composition A, each of the compositions of Groups 13'to 24', in which 1 part flupyraziflon, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil were added. Will be done.
Group 366'composed of Composition A, each of the compositions of Groups 13'to 24', further comprising 1 part flupyraziflon, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Will be done.
Group 367'is a composition A in which 1 part of flupyraziflon, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of isocycloceram are further added to each composition of groups 13'to 24'. Consists of.
Group 368'composed of Composition A, each of the compositions of Groups 13'to 24', further comprising 1 part flupyraziflon, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fluxametamid. Will be done.
Group 369'composed of Composition A, each of the compositions of Groups 13'to 24', in which 1 part flupyraziflon, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas were added. Will be done.
Group 370'consists of composition A in which 1 part of flupyraziflon, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fipronil are added to each of the compositions of groups 13'to 24'. Will be done.
Group 371'consists of composition A, each of which is a composition of groups 13'to 24', plus one part of flupyradiflon, one part of cyantraniliprole, one part of bifenthrin and one part of brofuranilide. Will be done.
Group 372'is a composition A in which 1 part of flupyraziflon, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of isocycloceram are further added to each composition of groups 13'to 24'. Consists of.
Group 373'composed of Composition A, each of the compositions of Groups 13'to 24', further to which 1 part flupyraziflon, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fluxametamid were added. Will be done.
Group 374'composed of composition A, each of the compositions of groups 13'to 24', further comprising 1 part flupyraziflon, 1 part cyantraniliprole, 1 part bifenthrin and 1 part ginpropyridas. Will be done.
Group 375'composed of each composition of groups 13'to 24', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil. To.
Group 376'composed of Composition A, each of the compositions of Groups 13'to 24', in which 1 part flupyraziflon, 1 part tetraniliprol, 1 part tefluthrin and 1 part brofuranilide were added. To.
Group 377'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyradiflon, one part of tetraniliprol, one part of tefluthrin and one part of isocycloceram. It is composed.
Group 378'composed of Composition A, each of the compositions of Groups 13'to 24', further to which 1 part flupyraziflon, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid were added. To.
Group 379'consists of composition A, each of the compositions of groups 13'to 24', in which 1 part flupyraziflon, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas are added. To.
Group 380'composed of each composition of groups 13'to 24', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil. To.
Group 381'consists of composition A, each of which is a composition of groups 13'to 24', plus one part of flupyradiflon, one part of tetraniliprol, one part of bifenthrin and one part of brofuranilide. To.
Group 382'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyradiflon, one part of tetraniliprol, one part of bifenthrin and one part of isocycloceram. It is composed.
Group 383'composed of composition A, each of the compositions of groups 13'to 24', further to which 1 part flupyraziflon, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid were added. To.
Group 384'composed of each composition of groups 13'-24', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part bifenthrin and 1 part ginpropyridas. To.
Group 385'is from composition A, in which 1 part flupyrimin, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fipronil are further added to each of the compositions of groups 13'to 24'. It is composed.
Group 386'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyrimin, one part of chloranthraniliprol, one part of tefluthrin and one part of brofuranilide. It is composed.
Group 387'is a composition obtained by adding 1 part of flupyrimin, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Groups 388'from each composition of groups 13'-24', further added 1 part flupyrimin, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fluxametamid. It is composed.
Group 389'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyrimin, one part of chloranthraniliprol, one part of tefluthrin and one part of ginpropyridas. It is composed.
Group 390'is from composition A in which 1 part flupyrimin, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part fipronil are further added to each composition of groups 13'to 24'. It is composed.
Group 391'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyrimin, one part of chlorantraniliprol, one part of bifenthrin and one part of brofuranilide. It is composed.
Group 392'is a composition obtained by adding 1 part of flupyrimin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 393'is from composition A, each of which is a composition of groups 13'to 24', further to which 1 part flupyrimin, 1 part chlorantraniliprol, 1 part bifenthrin and 1 part fluxametamid are added. It is composed.
Group 394'is from composition A, each of which is a composition of groups 13'to 24', plus one part of flupyrimin, one part of chlorantraniliprol, one part of bifenthrin and one part of ginpropyridas. It is composed.
Group 395'consists of composition A in which 1 part of flupyrimin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fipronil are added to each of the compositions of groups 13'to 24'. Will be done.
Group 396'composed of each composition of groups 13'to 24', plus 1 part flupyrimin, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Will be done.
Group 397'is a composition A in which 1 part of flupyrimin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of isocycloselam are added to each of the compositions of groups 13'to 24'. Consists of.
Group 398'composed of Composition A in which 1 part of flupyrimin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fluxametamid were added to each of the compositions of groups 13'to 24'. Will be done.
Group 399'composed of each composition of groups 13'-24', plus 1 part flupyrimin, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas. Will be done.
Group 400'consists of composition A in which 1 part of flupyrimin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fipronil are added to each of the compositions of groups 13'to 24'. Will be done.
Group 401'consists of composition A in which 1 part of flupyrimin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of brofuranilide are added to each of the compositions of groups 13'to 24'. Will be done.
Group 402'is a composition A in which 1 part of flupyrimin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of isocycloselam are added to each of the compositions of groups 13'to 24'. Consists of.
Group 403'composed of each composition of groups 13'to 24', further composed of composition A in which 1 part of flupyrimin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fluxametamid were added. Will be done.
Group 404'composed of each composition of groups 13'to 24', plus 1 part flupyrimin, 1 part cyantraniliprole, 1 part bifenthrin and 1 part ginpropyridas. Will be done.
Group 405'is composed of composition A in which 1 part of flupyrimin, 1 part of tetraniliprol, 1 part of tefluthrin and 1 part of fipronil are added to each composition of groups 13'to 24'. To.
Group 406'composed of each composition of groups 13'-24' with 1 portion of flupyrimin, 1 portion of tetraniliprol, 1 portion of tefluthrin and 1 portion of brofuranilide. To.
Group 407'is from composition A in which 1 part flupyrimin, 1 part tetraniliprol, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. It is composed.
Group 408'composed of each composition of groups 13'to 24', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid. To.
Group 409'composed of each composition of groups 13'-24', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 410'composed of each composition of groups 13'to 24', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil. To.
Group 411'composed of each composition of groups 13'to 24', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part bifenthrin and 1 part brofuranilide. To.
Group 412'is from composition A in which 1 part flupyrimin, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 13'to 24'. It is composed.
Group 413'composed of each composition of groups 13'to 24', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid. To.
Group 414'is composed of composition A in which 1 part of flupyrimin, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of ginpropyridas are added to each composition of groups 13'to 24'. To.
Group 415'is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of fipronil to each composition of groups 13'to 24'. It is composed of A.
Group 416'is a composition in which 1 part of triflumezopyrim, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of brofuranilide are added to each composition of groups 13'to 24'. It is composed of A.
Group 417'added 1 part triflumezopyrim, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part isocycloceram to each composition of groups 13'-24'. It is composed of composition A.
Group 418'is a composition in which 1 part of triflumezopyrim, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of fluxametamid are further added to each composition of groups 13'to 24'. It is composed of A.
Group 419'is a composition in which 1 part of triflumezopyrim, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of ginpropyridas are added to each of the compositions of groups 13'to 24'. It is composed of A.
Group 420'is a composition in which 1 part of triflumezopyrim, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fipronil are added to each composition of groups 13'to 24'. It is composed of A.
Group 421'is a composition in which 1 part of triflumezopyrim, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of brofuranilide are added to each composition of groups 13'to 24'. It is composed of A.
Group 422'added 1 part triflumezopyrim, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part isocycloceram to each composition of groups 13'-24'. It is composed of composition A.
Group 423'is a composition in which 1 part of triflumezopyrim, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fluxametamid are further added to each composition of groups 13'to 24'. It is composed of A.
Group 424'is a composition in which 1 part of triflumezopyrim, 1 part of chlorantraniliprol, 1 part of bifenthrin and 1 part of ginpropyridas are added to each composition of groups 13'to 24'. It is composed of A.
Group 425'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fipronil are added to each of the compositions of groups 13'to 24'. Consists of.
Group 426'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of brofuranilide are added to each of the compositions of groups 13'to 24'. Consists of.
Group 427'is a composition in which 1 part of triflumesopirium, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of isocycloceram are added to each composition of groups 13'to 24'. It is composed of object A.
Group 428'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fluxametamid are added to each of the compositions of groups 13'to 24'. Consists of.
Group 429'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of ginpropyridas are added to each of the compositions of groups 13'to 24'. Consists of.
Group 430'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fipronil are added to each composition of groups 13'to 24'. Consists of.
Group 431'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of brofuranilide are added to each of the compositions of groups 13'to 24'. Consists of.
Group 432'is a composition in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of isocycloceram are added to each composition of groups 13'to 24'. It is composed of object A.
Group 433'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fluxametamid are added to each of the compositions of groups 13'to 24'. Consists of.
Group 434'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of ginpropyridas are added to each of the compositions of groups 13'to 24'. Consists of.
Group 435'is from composition A, each of which is a composition of groups 13'to 24', plus one part of triflumezopyrim, one part of tetraniliprol, one part of tefluthrin and one part of fipronil. It is composed.
Group 436'is from composition A, each of which is a composition of groups 13'to 24', plus one part of triflumezopyrim, one part of tetraniliprol, one part of tefluthrin and one part of brofuranilide. It is composed.
Group 437'is a composition obtained by adding 1 part of triflumezopyrim, 1 part of tetraniliprol, 1 part of tefluthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 438'is from composition A, each of which is a composition of groups 13'to 24', plus one part of triflumezopyrim, one part of tetraniliprol, one part of tefluthrin and one part of fluxametamid. It is composed.
Group 439'is from composition A, each of which is a composition of groups 13'to 24', plus one part of triflumezopyrim, one part of tetraniliprol, one part of tefluthrin and one part of ginpropyridas. It is composed.
Group 440'is from composition A, each of which is a composition of groups 13'to 24', plus one part of triflumezopyrim, one part of tetraniliprol, one part of bifenthrin and one part of fipronil. It is composed.
Group 441'is from composition A, each of which is a composition of groups 13'to 24', plus one part of triflumezopyrim, one part of tetraniliprol, one part of bifenthrin and one part of brofuranilide. It is composed.
Group 442'is a composition obtained by adding 1 part of triflumezopyrim, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of isocycloceram to each composition of groups 13'to 24'. It is composed of A.
Group 443'is from composition A, each of which is a composition of groups 13'to 24', which is further supplemented with 1 part triflumezopyrim, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid. It is composed.
Group 444'is from composition A, each of which is a composition of groups 13'to 24', plus one part of triflumezopyrim, one part of tetraniliprol, one part of bifenthrin and one part of ginpropyridas. It is composed.

Group 445'is composed of composition A in which 1000 parts of Bacillus subutilis strain QST713 are further added to each composition of groups 25'to 234'.
Group 446'is composed of composition A in which 1000 parts of Agrobactrerium radiobacter strain K84 is further added to each composition of groups 25'to 234'.
Group 447'consists of composition A, which is obtained by adding 1000 parts of Bacillus amyloliquefaciens strain MBI 600 to each composition of groups 25'to 234'.
Group 448'composed of Composition A, in which 1000 parts of Bacillus pumilus strain QST2808 were added to each of the compositions of Groups 25'to 234'.
Group 449'is composed of composition A, which is obtained by adding 1000 parts of Burkholderia cepacia to each composition of groups 25'to 234'.
Group 450'is composed of composition A in which 1000 parts of Gliocladium catenulatum strain J1446 are further added to each composition of groups 25'to 234'.
Group 451'is composed of composition A in which 1000 parts of Pseudomonas chlororaphis strain MA342 are further added to each composition of groups 25'to 234'.
Group 452'is composed of composition A in which 1000 parts of Pseudomonas fluorescens are further added to each composition of groups 25'to 234'.
Group 453'is composed of composition A in which 1000 parts of Pythium oligandrum strain DV74 is further added to each composition of groups 25'to 234'.
Group 454'is composed of composition A in which 1000 parts of Streptomyces griseoviridis strain K61 are further added to each composition of groups 25'to 234'.
Group 455'is composed of composition A in which 1000 parts of Trichoderma gamsii are further added to each composition of groups 25'to 234'.
Group 456'is composed of composition A in which 1000 parts of Trichoderma asperellum is further added to each composition of groups 25'to 234'.
Group 457'is composed of composition A, which is obtained by adding 1000 parts of Trichoderma harzianum strain T-22 to each composition of groups 25'to 234'.
Group 458'is composed of Composition A, which is obtained by adding 1000 parts of Trichoderma virens strain GL-21 to each composition of Groups 25'to 234'.
Group 459'is composed of composition A in which 1000 parts of Streptomyces lydicus strain WYEC108 are further added to each composition of groups 25'to 234'.
Group 460'is composed of composition A in which 1000 parts of Bacillus thuringiensis subsp. Kurstraki strain ABTS-351 are further added to each composition of groups 25'to 234'.
Group 461'is composed of composition A, which is obtained by adding 1000 parts of Bacillus thuringiensis subs. Kurstraki strain MBP123 to each composition of groups 25'to 234'.
Group 462'is composed of composition A, which is obtained by adding 1000 parts of Bacillus thuringiensis subs.aizawai strain ABTS-1857 to each composition of groups 25'to 234'.
Group 463'is composed of composition A in which 1000 parts of Bacillus thuringiensis strain EX297512 are further added to each composition of groups 25'to 234'.
Group 464'is composed of composition A in which 1000 parts of Metarhizium anisopliae strain F52 is further added to each composition of groups 25'to 234'.
Group 465'consists of composition A, which is obtained by adding 1000 parts of Bacillus firmus strain l-1582 to each composition of groups 25'to 234'.
Group 466'is composed of composition A in which 1000 parts of Pasteuria nishizawae strain Pn1 are further added to each composition of groups 25'to 234'.
Group 467'is composed of composition A in which 10000 parts of Bradyrhizobium japonicum strain TA-11 is further added to each composition of groups 25'to 234'.
Group 468'is composed of composition A in which 10,000 parts of Sinorhizobium meliloti are further added to each composition of groups 25'to 234'.
Group 469'is composed of composition A in which 10,000 parts of Rhizobium leguminosarum is further added to each composition of groups 25'to 234'.
Group 470'is composed of composition A in which 10,000 parts of Rhizophagus intraradices strain RTI-801 are further added to each composition of groups 25'to 234'.
Group 471'composed of each composition of groups 25'to 234', plus 10000 parts of Bacillus amylolique faciens and 10000 parts of Trichoderma virens.
Group 472'is composed of composition A in which 10,000 parts of Penicillium bilaiae and 10,000 parts of Bradyrhizobium japonicum are further added to each of the compositions of groups 25'to 234'.
Group 473'is composed of composition A in which 10,000 parts of Penicillium bilaiae and 10,000 parts of Mesorhizobium ciceri are added to each of the compositions of groups 25'to 234'.
Group 474'composed of each composition of groups 25'to 234', plus 10,000 parts of Bradyrhizobium japonicum and 10,000 parts of lipochitooligosaccharide.

Group 475'is composed of composition A, which is obtained by adding a part of Bacillus subutilis strain QST713 to each composition of groups 235'to 444'.
Group 476'is composed of composition A in which a part of Agrobactrerium radiobacter strain K84 is further added to each composition of groups 235'to 444'.
Group 477'consists of Composition A, which is obtained by adding a portion of Bacillus amyloliquefaciens strain MBI 600 to each of the compositions of Groups 235'to 444'.
Group 478'is composed of composition A, which is obtained by adding a part of Bacillus pumilus strain QST2808 to each composition of groups 235'to 444'.
Group 479'is composed of composition A, which is obtained by adding a part of Burkholderia cepacia to each composition of groups 235'to 444'.
Group 480'is composed of composition A, which is obtained by adding a part of Gliocladium catenulatum strain J1446 to each composition of groups 235'to 444'.
Group 481'is composed of composition A, which is obtained by adding a part of Pseudomonas chlororaphis strain MA342 to each composition of groups 235'to 444'.
Group 482'is composed of composition A, which is obtained by adding a part of Pseudomonas fluorescens to each composition of groups 235'to 444'.
Group 483'is composed of composition A, which is obtained by adding a part of Pythium oligandrum strain DV74 to each composition of groups 235'to 444'.
Group 484'is composed of composition A, which is obtained by adding a part of Streptomyces griseoviridis strain K61 to each composition of groups 235'to 444'.
Group 485'is composed of composition A, which is obtained by adding a part of Trichoderma gamsii to each composition of groups 235'to 444'.
Group 486'is composed of composition A, which is obtained by adding a part of Trichoderma asperellum to each composition of groups 235'to 444'.
Group 487'is composed of composition A, which is obtained by adding a part of Trichoderma harzianum strain T-22 to each composition of groups 235'to 444'.
Group 488'is composed of composition A, which is obtained by adding a part of Trichoderma virens strain GL-21 to each composition of groups 235'to 444'.
Group 489'is composed of composition A, which is obtained by adding a part of Streptomyces lydicus strain WYEC108 to each composition of groups 235'to 444'.
Group 490'is composed of composition A, which is obtained by adding a part of Bacillus thuringiensis subsp. Kurstraki strain ABTS-351 to each composition of groups 235'to 444'.
Group 491'is composed of composition A, which is obtained by adding a part of Bacillus thuringiensis subs. Kurstraki strain MBP123 to each composition of groups 235'to 444'.
Group 492'is composed of composition A, which is obtained by adding a part of Bacillus thuringiensis subs.aizawai strain ABTS-1857 to each composition of groups 235'to 444'.
Group 493'is composed of composition A, which is obtained by adding a part of Bacillus thuringiensis strain EX297512 to each composition of groups 235'to 444'.
Group 494'is composed of composition A, which is obtained by adding a part of Metarhizium anisopliae strain F52 to each composition of groups 235'to 444'.
Group 495'consists of Composition A, which is obtained by adding a portion of Bacillus firmus strain l-1582 to each of the compositions of Groups 235'to 444'.
Group 496'is composed of composition A in which a part of Pasteuria nishizawae strain Pn1 is further added to each composition of groups 235'to 444'.
Group 497'is composed of composition A, which is obtained by adding a part of Bradyrhizobium japonicum strain TA-11 to each composition of groups 235'to 444'.
Group 498'is composed of composition A in which a part of Sinorhizobium meliloti is further added to each composition of groups 235'to 444'.
Group 499'is composed of composition A in which a part of Rhizobium leguminosarum is further added to each composition of groups 235'to 444'.
Group 500'is composed of composition A in which a part of Rhizophagus intraradices strain RTI-801 is further added to each composition of groups 235'to 444'.
Group 501'is composed of composition A in which 1 part Bacillus amylolique faciens and 1 part Trichoderma virens are added to each composition of groups 235'to 444'.
Group 502'is composed of composition A, which is obtained by adding 1 part of Penicillium bilaiae and 1 part of Bradyrhizobium japonicum to each composition of groups 235'to 444'.
Group 503'composed of each composition of groups 235'-444', plus one part of Penicillium bilaiae and one part of Mesorhizobium ciceri.
Group 504'is composed of composition A, which is obtained by adding 1 part Bradyrhizobium japonicum and 1 part lipochitooligosaccharide to each composition of groups 235'to 444'.

Group 505'is composed of composition A in which 1000 parts of fluazindolizine is further added to each composition of groups 445'to 474'.
Group 506'is composed of composition A in which 1000 parts of tioxazaphen is further added to each composition of groups 445'to 474'.
Group 507'is composed of composition A in which 1000 parts of fluene sulfone is further added to each composition of groups 445'to 474'.
Group 508'is composed of composition A in which 1000 parts of abamectin is further added to each composition of groups 445'to 474'.
Group 509'is composed of composition A in which 1000 parts of fluopylum is further added to each composition of groups 445'to 474'.
Group 510'is composed of composition A in which 1000 parts of cyclobutrifluram is further added to each composition of groups 445'to 474'.

Group 511'is composed of composition A in which a part of fluazindolizine is further added to each composition of groups 475' to 504'.
Group 512'is composed of composition A in which a part of tioxazaphen is further added to each composition of groups 475' to 504'.
Group 513'is composed of composition A in which a part of fluene sulfone is further added to each composition of groups 475' to 504'.
Group 514'is composed of composition A in which a part of abamectin is further added to each composition of groups 475' to 504'.
Group 515'is composed of composition A in which a portion of fluopylum is further added to each of the compositions of groups 475'to 504'.
Group 516'is composed of composition A in which a portion of cyclobutrifluram is added to each of the compositions of groups 475'to 504'.

In group 517', the combination of SX, this component 1, this component 2, this component 3, this component 4, this component 5 and this component 6 is any combination of the following "7 active ingredient list". A composition consisting of 1000 parts of SX, 1 part of this component 1, 1 part of this component 2, 1 part of this component 3, 1 part of this component 4, 1 part of this component 5 and 1 part of this component 6 It is composed of A.

In the "7 Active Ingredient List", for example, SX + methconazole + mandestrobin + fluopirum + fludioxonyl + metalaxil + etaboxam means a combination of SX, methconazole, mandestrobin, fluopirum, fludioxonyl, metalaxyl and etaboxam, and this ingredient. 1 is metconazole, this component 2 is mandestrobin, this component 3 is fluopyram, this component 4 is fludioxonyl, this component 5 is metalluxyl, and this component 6 is etaboxam.

"7 Active Ingredient List":
SX + metconazole + mandestrobin + fluopyram + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + mandestrobin + fluopyram + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fulopyram + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + metconazole + mandestrobin + fluorium + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + fluorium + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + fluopirum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + mandestrobin + fluopirum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + fluopirum + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + fluopiram + thiuram + metalaxil + etaboxam,
SX + metconazole + mandestrobin + fluopyram + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fluopyram + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + fluopyram + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + fluopyram + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fluopyram + boscalid + metalaxil + etaboxam,
SX + Metoconazole + Mandestrobin + Fluopirum + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Mandestrobin + Fluopirum + Boscalide + Metalaxil + Fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + mandestrobin + fluopyram + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + mancozeb + metalaxil + etaboxam,
SX + metconazole + mandestrobin + fluopyram + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fluopyram + carbendazim + metalaxil + etaboxam,
SX + methconazole + mandestrobin + fluopyram + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + fluopyram + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fluxapirokid + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + fluxapyroxado + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + fluxapyroxado + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + fluxapyroxado + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + fluxapyroxado + thiabendazole + metalaxil + etaboxam,
SX + metconazole + mandestrobin + fluxapyroxado + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + fluxapyroxado + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + thiuram + metalaxil + etaboxam,
SX + metconazole + mandestrobin + fluxapyroxado + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + fluxapyroxado + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + Metconazole + Mandestrobin + Fluxapirokid + Boscalide + Metalaxil + Etaboxam,
SX + methconazole + mandestrobin + fluxapyroxado + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Mandestrobin + Fluxapyroxado + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + mandestrobin + fluxapyrokid + aminopyrifene + metalaxil + etaboxam,
SX + methconazole + mandestrobin + fluxapyroxado + aminopyriphen + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fluxapirokid + mancozeb + metalaxil + etaboxam,
SX + methconazole + mandestrobin + fluxapyroxado + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + carbendazim + metalaxil + etaboxam,
SX + methconazole + mandestrobin + fluxapyroxado + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + fluxapyroxado + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + mandestrobin + boscalide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + boscalide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + vophanate + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + metconazole + mandestrobin + boscalide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + boscalide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + thiabendazole + metalaxil + etaboxam,
SX + metconazole + mandestrobin + boscalid + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + thiabendazole + metalaxil + fluoxapiproline,
SX + Metconazole + Mandestrobin + Boscalid + Thiram + Metalaxil + Etaboxam,
SX + methconazole + mandestrobin + boscalid + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Mandestrobin + Boscalide + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Mandestrobin + Boscalide + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Mandestrobin + Boscalide + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Mandestrobin + Boscalid + Boscalid + Metalaxil + Etaboxam,
SX + Metoconazole + Mandestrobin + Boscalide + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Mandestrobin + Boscalide + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Mandestrobin + Boscalide + Aminopyriphen + Metalaxil + Etaboxam,
SX + metconazole + mandestrobin + boscalide + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + boscalide + aminopyridene + metalaxil + fluoxapiproline,
SX + Metconazole + Mandestrobin + Boscalid + Mancozeb + Metalaxil + Etaboxam,
SX + Metoconazole + Mandestrobin + Boscalide + Mancozeb + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Mandestrobin + Boscalide + Mancozeb + Metalaxil + Fluoxapiproline,
SX + methconazole + mandestrobin + boscalid + carbendazim + metalaxil + etaboxam,
SX + methconazole + mandestrobin + boscalid + carbendazim + metalaxil + oxathiapiproline,
SX + Metoconazole + Mandestrobin + Boscalide + Carbendazim + Metalaxil + Fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + mandestrobin + penflufen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + penfurphene + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + metconazole + mandestrobin + penflufen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + mandestrobin + penflufen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + thiabendazole + metalaxil + fluoxapiproline,
SX + Metconazole + Mandestrobin + Penflufen + Thiram + Metalaxil + Etaboxam,
SX + metconazole + mandestrobin + penflufen + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + penflufen + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + penflufen + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + penflufen + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + penflufen + boscalid + metalaxil + etaboxam,
SX + methconazole + mandestrobin + penflufen + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Mandestrobin + Penflufen + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + mandestrobin + penflufen + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + mandestrobin + penflufen + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + mancozeb + metalaxil + etaboxam,
SX + metconazole + mandestrobin + penflufen + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + penflufen + carbendazim + metalaxil + etaboxam,
SX + methconazole + mandestrobin + penflufen + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + penflufen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + mandestrobin + tifluzamide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + thiophanate-methyl + metholaxyl + etaphanate,
SX + metconazole + mandestrobin + tifluzamide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + tibendazole + thiabendazole + metalaxil + etaboxam,
SX + metconazole + mandestrobin + tifluzamide + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + thifruzamide + thiuram + metalaxil + etaboxam,
SX + metconazole + mandestrobin + thifruzamide + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + thifluzamide + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + tifluzamide + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + tifluzamide + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + boscalid + metalaxil + etaboxam,
SX + methconazole + mandestrobin + tifluzamide + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Mandestrobin + Thifluzamide + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + mandestrobin + tifluzamide + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + mandestrobin + tifluzamide + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + metalaxil + etaboxam,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + tifluzamide + carbendazim + metalaxil + etaboxam,
SX + methconazole + mandestrobin + tifluzamide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + tifluzamide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + impilfluxam + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + impilfluxam + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + impilfluxam + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + impilfluxam + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + impilfluxam + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + impilfluxam + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + impilfluxam + thiabendazole + metalaxil + etaboxam,
SX + methconazole + mandestrobin + impilfluxam + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + impilfluxam + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + impilfluxam + thiuram + metalaxil + etaboxam,
SX + methconazole + mandestrobin + impilfluxam + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + impilfluxam + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + impilfluxam + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + impilfluxam + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + impilfluxam + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + impilfluxam + boscalid + metalaxil + etaboxam,
SX + methconazole + mandestrobin + impilfluxam + boscalid + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + impilfluxam + boscalid + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + impilfluxam + aminopyridene + metalaxil + etaboxam,
SX + methconazole + mandestrobin + impilfluxam + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + impilfluxam + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + impilfluxam + mancozeb + metalaxil + etaboxam,
SX + methconazole + mandestrobin + impilfluxam + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + impilfluxam + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + impilfluxam + carbendazim + metalaxil + etaboxam,
SX + methconazole + mandestrobin + impilfluxam + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + impilfluxam + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxan + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + mandestrobin + sedaxane + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + sedaxan + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + metconazole + mandestrobin + sedaxane + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + metalaxil + etaboxam,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + metalaxil + fluoxapiproline,
SX + Metconazole + Mandestrobin + Sedaxan + Thiram + Metalaxil + Etaboxam,
SX + metconazole + mandestrobin + sedaxan + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxan + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + sedaxane + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + sedaxane + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + sedaxane + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + sedaxan + boscalid + metalaxil + etaboxam,
SX + methconazole + mandestrobin + sedaxane + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + sedaxane + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + sedaxan + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + mandestrobin + sedaxane + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxan + mancozeb + metalaxil + etaboxam,
SX + metconazole + mandestrobin + sedaxane + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + sedaxan + carbendazim + metalaxil + etaboxam,
SX + methconazole + mandestrobin + sedaxane + carbendazim + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofen + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + mandestrobin + pidiflumethofen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + pidiflumethophene + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + mandestrobin + pidiflumethophene + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethophene + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethophene + thiabendazole + metalaxil + etaboxam,
SX + metconazole + mandestrobin + pidiflumethophene + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethophene + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + pidiflumethophene + thiuram + metalaxil + etaboxam,
SX + metconazole + mandestrobin + pidiflumethophene + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethophene + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + pidiflumethophene + torquelophosmethyl + metalaxil + etaboxam,
SX + metconazole + mandestrobin + pidiflumethophene + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethophene + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + pidiflumethophene + boscalid + metalaxil + etaboxam,
SX + methconazole + mandestrobin + pidiflumethophene + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + pidiflumethophene + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + pidiflumethophene + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + mandestrobin + pidiflumethophene + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethophene + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofen + mancozeb + metalaxil + etaboxam,
SX + metconazole + mandestrobin + pidiflumethophene + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethophene + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + pidiflumethophene + carbendazim + metalaxil + etaboxam,
SX + methconazole + mandestrobin + pidiflumethophene + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + pidiflumethophene + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + isoflusiplum + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + mandestrobin + isoflusiplum + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + isoflusiplum + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + isofflusiplum + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + methconazole + mandestrobin + isoflusiplum + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + isoflusiplum + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + isoflusiplum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + mandestrobin + isoflusiplum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + isoflusiplum + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + isoflusiplum + thiuram + metalaxil + etaboxam,
SX + metconazole + mandestrobin + isoflusiplum + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + isoflusiplum + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Mandestrobin + Isoflusiplum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Mandestrobin + Isoflusiplum + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + methconazole + mandestrobin + isoflusiplum + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + isoflusiplum + boscalid + metalaxil + etaboxam,
SX + methconazole + mandestrobin + isoflusiplum + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + isoflusiplum + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + isoflusiplum + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + mandestrobin + isoflusiplum + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + isoflusiplum + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + mandestrobin + isoflusiplum + mancozeb + metalaxil + etaboxam,
SX + methconazole + mandestrobin + isoflusiplum + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + mandestrobin + isoflusiplum + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + mandestrobin + isoflusiplum + carbendazim + metalaxil + etaboxam,
SX + methconazole + mandestrobin + isoflusiplum + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + mandestrobin + isoflusiplum + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluopyram + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiophanate-methyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluorium + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + fluorium + thiabendazole + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluorium + thiabendazole + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Fluopirum + Tiabendazole + Metalaxil + Fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiuram + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluopyram + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + fluopyram + torquelophosmethyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluopyram + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + fluoropyram + torculophosmethyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + boscalid + metalaxil + etaboxam,
SX + Metoconazole + Azoxystrobin + Fluopirum + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Azoxystrobin + Fluopirum + Boscalide + Metalaxil + Fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + aminopyridene + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluopyram + aminopyridene + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Fluopirum + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + mancozeb + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluopyram + mancozeb + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Fluopirum + Mancozeb + Metalaxil + Fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + carbendazim + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluopyram + carbendazim + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Fluopirum + Carbendazim + Metalaxil + Fluoxapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluxapyroxado + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + fluxapyroxado + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + fluxapyroxado + thiabendazole + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluxapyroxado + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + fluxapyroxado + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + thiuram + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluxapyroxado + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + fluxapyroxado + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + fluxapirokid + boscalide + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + fluxapyroxado + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Fluxapyroxado + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + fluxapyroxado + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + fluxapirokid + mancozeb + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + fluxapyroxado + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + fluxapyroxado + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + carbendazim + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + fluxapyroxado + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + fluxapyroxado + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + boscalide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + boscalide + thiophanate-methyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + boscalide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Boscalide + Thiophanate-methyl + Metalaxil + Fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + metalaxil + fluoxapiproline,
SX + Metoconazole + Azoxystrobin + Boscalid + Thiram + Metalaxil + Etaboxam,
SX + metconazole + azoxystrobin + boscalid + thiuram + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Boscalide + Thiram + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Azoxystrobin + Boscalide + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Azoxystrobin + Boscalide + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Azoxystrobin + Boscalide + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Azoxystrobin + Boscalid + Boscalid + Metalaxil + Etaboxam,
SX + Metoconazole + Azoxystrobin + Boscalide + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Azoxystrobin + Boscalide + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Azoxystrobin + Boscalide + Aminopyridene + Metalaxil + Etaboxam,
SX + metconazole + azoxystrobin + boscalide + aminopyridene + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Boscalide + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + mancozeb + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + boscalide + mancozeb + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Boscalide + Mancozeb + Metalaxil + Fluoxapiproline,
SX + methconazole + azoxystrobin + boscalid + carbendazim + metalaxil + etaboxam,
SX + Metoconazole + Azoxystrobin + Boscalide + Carbendazim + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Azoxystrobin + Boscalide + Carbendazim + Metalaxil + Fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + penflufen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + thiophanate-methyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + penflufen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + thiuram + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + penflufen + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + penflufen + torquelophosmethyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + penflufen + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + penflufen + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + boscalid + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + penflufen + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Azoxystrobin + Penflufen + Boscalide + Metalaxil + Fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + aminopyridofen + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + penflufen + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + mancozeb + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + penflufen + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + mancozeb + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + carbendazim + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + penflufen + carbendazim + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + thiophanate-methyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + tifluzamide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + thiabendazole + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + tifluzamide + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + thifluzamide + thiuram + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + thifluzamide + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + thifluzamide + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + tifluzamide + torquelophosmethyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + tifluzamide + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + boscalid + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + tifluzamide + boscalide + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + boscalide + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + aminopyridene + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + tifluzamide + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + impilfluxam + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + impilfluxam + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + impilfluxam + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + impilfluxam + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + impilfluxam + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + impilfluxam + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + impilfluxam + thiabendazole + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + impilfluxam + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + impilfluxam + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + impilfluxam + thiuram + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + impilfluxam + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + impilfluxam + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + impilfluxam + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + impilfluxam + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + impilfluxam + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + impilfluxam + boscalid + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + impilfluxam + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + impilfluxam + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + impilfluxam + aminopyridene + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + impilfluxam + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + impilfluxam + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + impilfluxam + mancozeb + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + impilfluxam + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + impilfluxam + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + impilfluxam + carbendazim + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + impilfluxam + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + impilfluxam + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxan + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + sedaxane + fludioxonyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxan + thiophanate-methyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + sedaxane + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxan + thiuram + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + sedaxane + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + sedaxane + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + sedaxane + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + sedaxane + torquelophosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxan + boscalid + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + sedaxane + boscalide + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + boscalide + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxan + aminopyridene + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + sedaxane + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + aminopyridene + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxan + mancozeb + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + sedaxane + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + mancozeb + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofen + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + pidiflumethofen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethofen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + pidiflumethophene + thiophanate-methyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + pidiflumethophene + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + pidiflumethofen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethofen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + pidiflumethophene + thiuram + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + pidiflumethophene + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethofen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + pidiflumethophene + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + pidiflumethophene + torculophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + pidiflumethofen + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + pidiflumethophene + boscalide + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + pidiflumethophene + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + pidiflumethofen + boscalide + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofen + aminopyridene + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + pidiflumethophene + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofen + mancozeb + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + pidiflumethofen + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethofen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + pidiflumethophene + carbendazim + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + pidiflumethophene + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + pidiflumethofen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + isoflusiplum + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + thiophanate-methyl + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + isoflusiplum + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + isoflusiplum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + thiuram + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + isoflusiplum + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + thiuram + metalaxil + fluoxapiproline,
SX + Metoconazole + Azoxystrobin + Isoflusiplum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Azoxystrobin + Isoflusiplum + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Azoxystrobin + Isoflusiplum + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + boscalid + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + isoflusiplum + boscalide + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + boscalide + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + aminopyridene + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + isoflusiplum + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + mancozeb + metalaxil + etaboxam,
SX + metconazole + azoxystrobin + isoflusiplum + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflusiplum + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + azoxystrobin + isoflusiplum + carbendazim + metalaxil + etaboxam,
SX + methconazole + azoxystrobin + isoflusiplum + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + azoxystrobin + isoflusiplum + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fulopyram + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + fluoxastrobin + fluorium + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluopyram + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopirum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + fluopirum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopirum + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluopiram + thiuram + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + fluopyram + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluoropyram + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluopyram + turquophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluopyram + turquophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluopyram + boscalid + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluopyram + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluopyram + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluopyram + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluopyram + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluopyram + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + mancozeb + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluopyram + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluopyram + carbendazim + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluopyram + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluopyram + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluxapirokid + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluxapyroxado + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluxapyroxado + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluxapyroxado + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + fluxapyroxado + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluxapyroxado + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + thiuram + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + fluxapyroxado + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluxapyroxado + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluxapirokid + boscalide + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluxapyroxado + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + aminopyrifene + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluxapyroxado + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluxapirokid + mancozeb + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluxapyroxado + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + carbendazim + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + fluxapyroxado + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + fluxapyroxado + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalide + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + boscalide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + vophanate + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + fluoxastrobin + boscalide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + boscalide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + boscalid + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + thiuram + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + boscalid + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + boscalid + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + boscalide + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + boscalide + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + boscalide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + boscalid + boscalide + metalaxil + etaboxam,
SX + Metoconazole + Fluxastrobin + Boscalide + Boscalide + Metalaxil + Oxatiapiproline,
SX + methconazole + fluoxastrobin + boscalide + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + boscalide + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + boscalide + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalide + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + mancozeb + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + boscalide + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + boscalide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + boscalid + carbendazim + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + boscalide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + boscalide + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + penflufen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + penfurphene + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + methconazole + fluoxastrobin + penflufen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + penflufen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiuram + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + penflufen + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + penflufen + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + penflufen + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + penflufen + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + penflufen + boscalid + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + penflufen + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + penflufen + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + penflufen + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + penflufen + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + penflufen + mancozeb + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + penflufen + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + penflufen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + penflufen + carbendazim + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + penflufen + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + penflufen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + thiophanate-methyl + metholaxyl + etaphanate,
SX + methconazole + fluoxastrobin + tifluzamide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + tifluzamide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + tibendazole + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + thifruzamide + thiuram + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + thifluzamide + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + thifluzamide + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + tyfluzamide + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + tyfluzamide + torculophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + thyfluzamide + torculophosmethyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + boscalid + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + tifluzamide + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + tifluzamide + boscalide + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + aminopyridene + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + tifluzamide + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + tifluzamide + carbendazim + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + tifluzamide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + tifluzamide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + impilfluxam + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + impilfluxam + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + thiabendazole + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + impilfluxam + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + thiuram + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + impilfluxam + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + impilfluxam + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + boscalid + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + impilfluxam + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + aminopyridene + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + impilfluxam + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + mancozeb + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + impilfluxam + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + carbendazim + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + impilfluxam + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + impilfluxam + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + sedaxan + thiophanate-methyl + methanolate + etaphanate,
SX + methconazole + fluoxastrobin + sedaxane + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + sedaxane + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxan + thiuram + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + sedaxane + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + sedaxane + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + sedaxane + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + sedaxane + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + sedaxan + boscalid + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + sedaxane + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + sedaxane + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + sedaxan + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + sedaxane + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + sedaxane + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxan + mancozeb + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + sedaxane + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + sedaxane + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + sedaxane + carbendazim + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + sedaxane + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + sedaxane + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + pidiflumethofen + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + pidiflumethofen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofen + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofen + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + pidiflumethofen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + pidiflumethofen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + pidiflumethofen + thiuram + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + pidiflumethofen + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + pidiflumethofen + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + pidiflumethofen + torculophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + pidiflumethofen + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + pidiflumethofen + boscalide + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + pidiflumethofen + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + pidiflumethofen + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + pidiflumethofen + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + pidiflumethophene + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethophene + aminopyridene + metalaxil + fluorapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofen + mancozeb + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + pidiflumethofen + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + pidiflumethofen + carbendazim + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + pidiflumethofen + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + pidiflumethofen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflusiplum + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + isoflusiplum + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflusiplum + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + isofluate-methyl + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + fluoxastrobin + isoflusiplum + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + isoflusiplum + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflusiplum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + isoflusiplum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflusiplum + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflusiplum + thiuram + metalaxil + etaboxam,
SX + metconazole + fluoxastrobin + isoflusiplum + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflusiplum + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + isoflusiplum + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + isoflusiplum + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + isoflusiplum + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflusiplum + boscalide + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + isoflusiplum + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + isoflusiplum + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + isoflusiplum + aminopyridene + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + isoflusiplum + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + isoflusiplum + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflusiplum + mancozeb + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + isoflusiplum + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + isoflusiplum + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fluoxastrobin + isoflusiplum + carbendazim + metalaxil + etaboxam,
SX + methconazole + fluoxastrobin + isoflusiplum + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fluoxastrobin + isoflusiplum + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopirum + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + fluopyram + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopirum + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + trifluoxystrobin + fluopyram + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + trifluoxystrobin + fluorium + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + fluopyram + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopirum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + fluopirum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + trifluoxystrobin + fluopirum + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluopyram + thiuram + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + fluopyram + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + fluopyram + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluopyram + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluopyram + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + fluopyram + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + trifluoxystrobin + fluopyram + boscalid + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluopyram + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + fluopyram + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + trifluoxystrobin + fluopyram + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluopyram + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + fluopyram + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + mancozeb + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + fluopyram + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + trifluoxystrobin + fluopyram + carbendazim + metalaxil + etaboxam,
SX + methconazole + trifluoxystrobin + fluopyram + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + fluopyram + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluxapyroxado + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluxapyroxado + thiabendazole + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + fluxapyroxado + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluxapyroxado + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + thiuram + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluxapyroxado + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluxapyroxado + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluxapyrokid + boscalide + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluxapyroxado + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + fluxapyroxado + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluxapyroxado + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluxapyrokid + mancozeb + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluxapyroxado + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + fluxapyroxado + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + carbendazim + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + fluxapyroxado + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + fluxapyroxado + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalide + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + boscalide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + trifluoxystrobin + boscalide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + trifluoxystrobin + boscalide + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + boscalide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + boscalide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalid + thiabendazole + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + boscalid + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + boscalide + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + boscalid + thiuram + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + boscalid + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + boscalide + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + boscalide + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + boscalide + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + boscalide + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + trifluoxystrobin + boscalid + boscalid + metalaxil + etaboxam,
SX + methconazole + trifluoxystrobin + boscalid + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + boscalide + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + boscalide + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + boscalide + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + boscalide + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + boscalid + mancozeb + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + boscalide + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + boscalide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + boscalid + carbendazim + metalaxil + etaboxam,
SX + methconazole + trifluoxystrobin + boscalide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + boscalide + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + penflufen + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + penflufen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + penflufen + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + penflufen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + penflufen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + penflufen + thiuram + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + penflufen + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + penflufen + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + penflufen + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + penflufen + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + penflufen + boscalid + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + penflufen + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + penflufen + boscalide + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + penflufen + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + penflufen + aminopyriphen + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + penflufen + carbendazim + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + penflufen + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + penflufen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + tifluzamide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + tifluzamide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + tifluzamide + thiuram + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + tifluzamide + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + tifluzamide + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + tifluzamide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + tifluzamide + boscalid + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + tifluzamide + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + tifluzamide + boscalide + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + aminopyridene + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + tifluzamide + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + mancozeb + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + tifluzamide + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + tifluzamide + carbendazim + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + tifluzamide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + tifluzamide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + impilfluxam + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + impilfluxam + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + thiabendazole + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + impilfluxam + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + thiuram + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + impilfluxam + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + impilfluxam + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + boscalid + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + impilfluxam + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + aminopyridene + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + impilfluxam + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + mancozeb + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + impilfluxam + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + carbendazim + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + impilfluxam + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + impilfluxam + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + sedaxane + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxan + thiuram + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + sedaxane + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + sedaxane + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + sedaxane + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + sedaxane + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + sedaxane + boscalid + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + sedaxane + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + sedaxane + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + trufflextrobin + sedaxane + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + sedaxane + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + trifluoxystrobin + sedaxane + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + mancozeb + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + sedaxane + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + trifluoxystrobin + sedaxane + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + sedaxane + carbendazim + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + sedaxane + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + sedaxane + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + pidiflumethofen + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + pidiflumethophene + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + pidiflumethofen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + pidiflumethofen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + thiuram + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + pidiflumethofen + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + pidiflumethofen + torculophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + boscalide + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + pidiflumethofen + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + pidiflumethophene + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + mancozeb + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + pidiflumethofen + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + trifluoxystrobin + pidiflumethofen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + pidiflumethophene + carbendazim + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + pidiflumethofen + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + pidiflumethofen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + isoflusiplum + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + isoflusiplum + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + isoflusiplum + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + trifloxystrobin + isoflusiplum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + trifloxystrobin + isoflusiplum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflusiplum + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + thiuram + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + isoflusiplum + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflusiplum + thiuram + metalaxil + fluoxapiproline,
SX + Metoconazole + Trifloxystrobin + Isoflusiplum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + methconazole + trifloxystrobin + isoflusiplum + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + boscalide + metalaxil + etaboxam,
SX + Metoconazole + Trifloxystrobin + Isoflusiplum + Boscalide + Metalaxil + Oxatiapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + aminopyridene + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + isoflusiplum + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + mancozeb + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + isoflusiplum + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + carbendazim + metalaxil + etaboxam,
SX + methconazole + trifloxystrobin + isoflusiplum + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + trifloxystrobin + isoflusiplum + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + fluopyram + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + fluorium + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluopyram + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + pyraclothtrobin + fulopyram + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + pyracrostrobin + fluorium + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluorium + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + pyracrostrobin + fluopirum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + fluorium + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + fluopirum + thiabendazole + metalaxil + fluoxapiproline,
SX + Metconazole + Pyracrostrobin + Fluopiram + Thiram + Metalaxil + Etaboxam,
SX + methconazole + pyracrostrobin + fluopyram + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluopyram + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Pyracrostrobin + Fluopirum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + methconazole + pyracrostrobin + fluopyram + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluopyram + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Boscalid + Metalaxil + Etaboxam,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Aminopyriphen + Metalaxil + Etaboxam,
SX + metconazole + pyracrostrobin + fluorium + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluopyram + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + fluopyram + mancozeb + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + fluopyram + mancozeb + metalaxil + oxathiapiproline,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Mancozeb + Metalaxil + Fluoxapiproline,
SX + methconazole + pyracrostrobin + fluopyram + carbendazim + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + fluopyram + carbendazim + metalaxil + oxathiapiproline,
SX + Metoconazole + Pyracrostrobin + Fluopirum + Carbendazim + Metalaxil + Fluoxapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + fluxapyroxado + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + fluxapyroxado + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + pyracrostrobin + fluxapyroxado + thiabendazole + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + fluxapyroxado + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + fluxapyroxado + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + thiuram + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + fluxapyroxado + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Pyracrostrobin + Fluxapyroxado + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + methconazole + pyracrostrobin + fluxapyroxado + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + Metconazole + Pyracrostrobin + Fluxapyrokid + Boscalide + Metalaxil + Etaboxam,
SX + methconazole + pyracrostrobin + fluxapyroxado + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Pyracrostrobin + Fluxapyroxado + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Pyracrostrobin + Fluxapyroxado + Aminopyriphen + Metalaxil + Etaboxam,
SX + methconazole + pyracrostrobin + fluxapyroxado + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + mancozeb + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + fluxapyroxado + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + carbendazim + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + fluxapyroxado + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + fluxapyroxado + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + boscalid + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + boscalide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + boscalide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + pyraclothtrobin + vophanate + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + pyracrostrobin + boscalide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + Metoconazole + Pyracrostrobin + Boscalide + Thiophanate-methyl + Metalaxil + Fluoxapiproline,
SX + metconazole + pyracrostrobin + boscalid + thiabendazole + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + boscalid + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + boscalid + thiabendazole + metalaxil + fluoxapiproline,
SX + Metconazole + Pyracrostrobin + Boscalid + Thiram + Metalaxil + Etaboxam,
SX + Metoconazole + Pyracrostrobin + Boscalid + Thiram + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Pyracrostrobin + Boscalid + Thiram + Metalaxil + Fluoxapiproline,
SX + Metconazole + Pyracrostrobin + Boscalide + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Pyracrostrobin + Boscalide + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Pyracrostrobin + Boscalide + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Pyracrostrobin + Boscalid + Boscalid + Metalaxil + Etaboxam,
SX + Metoconazole + Pyracrostrobin + Boscalid + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Pyracrostrobin + Boscalid + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Pyracrostrobin + Boscalid + Aminopyriphen + Metalaxil + Etaboxam,
SX + metconazole + pyracrostrobin + boscalide + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + boscalide + aminopyridene + metalaxil + fluoxapiproline,
SX + Metconazole + Pyracrostrobin + Boscalid + Mancozeb + Metalaxil + Etaboxam,
SX + methconazole + pyracrostrobin + boscalid + mancozeb + metalaxil + oxathiapiproline,
SX + Metoconazole + Pyracrostrobin + Boscalide + Mancozeb + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Pyracrostrobin + Boscalid + Carbendazim + Metalaxil + Etaboxam,
SX + Metoconazole + Pyracrostrobin + Boscalid + Carbendazim + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Pyracrostrobin + Boscalid + Carbendazim + Metalaxil + Fluoxapiproline,
SX + methconazole + pyracrostrobin + penflufen + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + penflufen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + penflufen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + penfurphene + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + methconazole + pyracrostrobin + penflufen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + penflufen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + pyracrostrobin + penflufen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + penflufen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + penflufen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + penflufen + thiuram + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + penflufen + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + penflufen + thiuram + metalaxil + fluoxapiproline,
SX + Metoconazole + Pyracrostrobin + Penflufen + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + methconazole + pyracrostrobin + penflufen + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + penflufen + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + Metoconazole + Pyracrostrobin + Penflufen + Boscalid + Metalaxil + Etaboxam,
SX + methconazole + pyracrostrobin + penflufen + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Pyracrostrobin + Penflufen + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + pyracrostrobin + penflufen + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + penflufen + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + penflufen + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + penflufen + mancozeb + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + penflufen + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + penflufen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + penflufen + carbendazim + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + penflufen + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + penflufen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + pyracrostrobin + tifluzamide + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + tifluzamide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + tifluzamide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + methconazole + pyracrostrobin + tifluzamide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + pyracrostrobin + tibendazole + thiabendazole + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + tifluzamide + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + tifluzamide + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + thifruzamide + thiuram + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + thifruzamide + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + thifluzamide + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + tifluzamide + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + boscalid + metalaxil + etaboxam,
SX + Metoconazole + Pyracrostrobin + Thifluzamide + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Pyracrostrobin + Thifluzamide + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + tifluzamide + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + mancozeb + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + tifluzamide + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + carbendazim + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + tifluzamide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + tifluzamide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + impilfluxam + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + impilfluxam + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + thiabendazole + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + impilfluxam + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + thiuram + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + impilfluxam + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + impilfluxam + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + boscalid + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + impilfluxam + boscalid + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + aminopyridene + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + impilfluxam + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + mancozeb + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + impilfluxam + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + carbendazim + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + impilfluxam + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + impilfluxam + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + pyracrostrobin + sedaxan + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + sedaxane + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + sedaxane + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + pyraclothtrobin + sedaxan + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + pyracrostrobin + sedaxane + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + sedaxane + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + pyracrostrobin + sedaxane + thiabendazole + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + sedaxane + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + sedaxane + thiabendazole + metalaxil + fluoxapiproline,
SX + Metconazole + Pyracrostrobin + Sedaxan + Thiram + Metalaxil + Etaboxam,
SX + metconazole + pyracrostrobin + sedaxan + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + sedaxan + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + sedaxane + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + sedaxane + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + sedaxane + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + sedaxan + boscalid + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + sedaxane + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Pyracrostrobin + Sedaxan + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + pyracrostrobin + sedaxan + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + sedaxane + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + sedaxane + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + sedaxan + mancozeb + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + sedaxane + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + sedaxane + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + sedaxan + carbendazim + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + sedaxane + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + sedaxane + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + pidiflumethofen + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + pidiflumethofen + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + pidiflumethofen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + pidiflumethophene + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + pidiflumethophene + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + pidiflumethofen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + pyracrostrobin + pidiflumethofen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + pidiflumethofen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + pidiflumethofen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + pidiflumethofen + thiuram + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + pidiflumethofen + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + pidiflumethofen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + pidiflumethophene + torculophosmethyl + metalaxil + etaboxam,
SX + Metoconazole + Pyracrostrobin + Pidiflumethofen + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + methconazole + pyracrostrobin + pidiflumethophene + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + pidiflumethofen + boscalid + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + pidiflumethofen + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Pyracrostrobin + Pidiflumethofen + Boscalide + Metalaxil + Fluoxapiproline,
SX + metconazole + pyracrostrobin + pidiflumethofen + aminopyridene + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + pidiflumethophene + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + pidiflumethophene + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + pidiflumethofen + mancozeb + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + pidiflumethofen + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + pidiflumethofen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + pidiflumethophene + carbendazim + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + pidiflumethophene + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + pidiflumethophene + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + isoflusiplum + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + pyraclothtrobin + isofulsiplum + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + methconazole + pyracrostrobin + isoflusiplum + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + pyracrostrobin + isoflusiplum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + pyracrostrobin + isoflusiplum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + pyracrostrobin + isoflusiplum + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + thiuram + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + isoflusiplum + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + thiuram + metalaxil + fluoxapiproline,
SX + Metoconazole + Pyracrostrobin + Isoflusiplum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Pyracrostrobin + Isoflusiplum + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + boscalid + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + isoflusiplum + boscalide + metalaxil + oxathiapiproline,
SX + Metoconazole + Pyracrostrobin + Isoflusiplum + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + aminopyridene + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + isoflusiplum + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + mancozeb + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + isoflusiplum + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + carbendazim + metalaxil + etaboxam,
SX + methconazole + pyracrostrobin + isoflusiplum + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + pyracrostrobin + isoflusiplum + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + fluorium + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + fluorium + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fulopyram + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + picoxystrobin + fluorium + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluorium + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopirum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + fluorium + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopirum + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopiram + thiuram + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + fluorium + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluopyram + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluopyram + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluoropyram + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluopyram + boscalid + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluopyram + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluopyram + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluopyram + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + fluorium + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluorium + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + mancozeb + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluopyram + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluopyram + carbendazim + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluopyram + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluopyram + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluxapyroxado + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + fluxapyroxado + thiabendazole + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + fluxapyroxado + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + fluxapyroxado + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + thiuram + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluxapyroxado + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluxapyroxado + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluxapirokid + boscalide + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluxapyroxado + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + aminopyrifene + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluxapyroxado + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluxapyrokid + mancozeb + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluxapyroxado + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + carbendazim + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + fluxapyroxado + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + fluxapyroxado + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalide + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + boscalide + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + boscalide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + vophanate + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + picoxystrobin + boscalide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + boscalide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + thiabendazole + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + boscalid + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + boscalid + thiuram + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + boscalid + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + boscalide + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + boscalide + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + boscalide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + boscalid + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + boscalid + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + boscalid + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + boscalide + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + boscalide + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalide + aminopyridene + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + mancozeb + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + boscalide + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + boscalide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + boscalid + carbendazim + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + boscalid + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + boscalide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + penflufen + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + penflufen + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + penflufen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + penfurphene + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + methconazole + picoxystrobin + penflufen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + penflufen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + penflufen + thiuram + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + penflufen + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + penflufen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + penflufen + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + penflufen + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + penflufen + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + penflufen + boscalid + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + penflufen + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + penflufen + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + penflufen + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + penflufen + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + penflufen + mancozeb + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + penflufen + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + penflufen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + penflufen + carbendazim + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + penflufen + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + penflufen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + tifluzamide + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + tifluzamide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + methconazole + picoxystrobin + tifluzamide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + tifluzamide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + tibendazole + thiabendazole + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + tifluzamide + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + thifruzamide + thiuram + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + thifluzamide + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + thifluzamide + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + tifluzamide + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + tifluzamide + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + tifluzamide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + tifluzamide + boscalid + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + tifluzamide + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + tifluzamide + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + tifluzamide + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + tifluzamide + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + tifluzamide + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + tifluzamide + mancozeb + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + tifluzamide + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + tifluzamide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + tifluzamide + carbendazim + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + tifluzamide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + tifluzamide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + impilfluxam + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + impilfluxam + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + impilfluxam + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + impilfluxam + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + impilfluxam + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + impilfluxam + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + impilfluxam + thiabendazole + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + impilfluxam + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + impilfluxam + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + impilfluxam + thiuram + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + impilfluxam + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + impilfluxam + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + impilfluxam + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + impilfluxam + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + impilfluxam + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + impilfluxam + boscalid + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + impilfluxam + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + impilfluxam + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + impilfluxam + aminopyridene + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + impilfluxam + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + impilfluxam + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + impilfluxam + mancozeb + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + impilfluxam + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + impilfluxam + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + impilfluxam + carbendazim + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + impilfluxam + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + impilfluxam + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxan + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + sedaxane + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + sedaxan + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + methconazole + picoxystrobin + sedaxane + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + sedaxane + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + sedaxan + thiuram + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + sedaxan + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxan + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + sedaxane + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + sedaxane + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + sedaxane + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + sedaxan + boscalid + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + sedaxane + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + sedaxane + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + sedaxan + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + sedaxane + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + sedaxane + aminopyridene + metalaxyl + fluoxapiproline,
SX + methconazole + picoxystrobin + sedaxan + mancozeb + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + sedaxane + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + sedaxan + carbendazim + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + sedaxane + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + sedaxane + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + pidiflumethofen + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + pidiflumethofen + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + pidiflumethofen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + pidiflumethophene + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethofen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + pidiflumethofen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethofen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + thiuram + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + pidiflumethophene + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + pidiflumethofen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + pidiflumethophene + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + boscarido + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + pidiflumethophene + boscarido + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + pidiflumethofen + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + aminopyridene + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + pidiflumethophene + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + pidiflumethofen + mancozeb + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + pidiflumethofen + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + pidiflumethofen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + carbendazim + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + pidiflumethophene + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + pidiflumethophene + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + isoflusiplum + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + isofrusiplum + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + methconazole + picoxystrobin + isoflusiplum + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + picoxystrobin + isoflusiplum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + picoxystrobin + isoflusiplum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflusiplum + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + thiuram + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + isoflusiplum + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + isoflusiplum + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + boscalid + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + isoflusiplum + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + aminopyridene + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + isoflusiplum + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + mancozeb + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + isoflusiplum + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + carbendazim + metalaxil + etaboxam,
SX + methconazole + picoxystrobin + isoflusiplum + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + picoxystrobin + isoflusiplum + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + fluorium + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + fluorium + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + fluorium + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + fluorium + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + fluorium + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Thiophanate-methyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Tiabendazole + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + fluorium + thiabendazole + metalaxil + oxathiapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Tiabendazole + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluopiram + Thiram + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + fluorium + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + fluopyram + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprowl + Fluopirum + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Boscalide + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprowl + Fluopirum + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Aminopyriphen + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprol + Fluopirum + Aminopyriphen + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprol + Fluopirum + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Mancozeb + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + fluopyram + mancozeb + metalaxil + oxathiapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Mancozeb + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluopirum + Carbendazim + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + fluopyram + carbendazim + metalaxil + oxathiapiproline,
SX + Metconazole + Methyltetraprol + Fluopirum + Carbendazim + Metalaxil + Fluoxapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + fluxapyroxado + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiabendazole + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiuram + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Boscalide + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + fluxapyroxado + boscalide + metalaxil + oxathiapiproline,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Aminopyriphen + Metalaxil + Etaboxam,
SX + Metoconazole + Methyltetraprol + Fluxapyroxado + Aminopyriphen + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Methyltetraprol + Fluxapyroxado + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Fluxapyroxado + Mancozeb + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + fluxapyroxado + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + carbendazim + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + fluxapyroxado + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + fluxapyroxado + carbendazim + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Fludioxonyl + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + boscalide + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + boscalide + fludioxonyl + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Thiophanate-methyl + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprowl + Boscalide + Thiophanate-methyl + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Thiophanate-methyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Tiabendazole + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprol + Boscalide + Tiabendazole + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprol + Boscalide + Tiabendazole + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Boscalid + Thiram + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprol + Boscalide + Thiram + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprol + Boscalide + Thiram + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprowl + Boscalide + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Boscalide + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprol + Boscalide + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Aminopyriphen + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprol + Boscalide + Aminopyriphen + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprol + Boscalide + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Mancozeb + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + boscalide + mancozeb + metalaxil + oxathiapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Mancozeb + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Boscalide + Carbendazim + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprol + Boscalide + Carbendazim + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprol + Boscalide + Carbendazim + Metalaxil + Fluoxapiproline,
SX + methconazole + methyltetraprowl + penflufen + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + penflufen + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + penflufen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + penflufen + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + penflufen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + penflufen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + methyltetraprowl + penflufen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + methyltetraprowl + penflufen + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + penflufen + thiabendazole + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Penflufen + Thiram + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + penflufen + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + penflufen + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Penflufen + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprowl + Penflufen + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Penflufen + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Penflufen + Boscalide + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + penflufen + boscalide + metalaxil + oxathiapiproline,
SX + Metconazole + Methyltetraprowl + Penflufen + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Penflufen + Aminopyriphen + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + penflufen + aminopyriphen + metalaxil + oxathiapiproline,
SX + Metoconazole + Methyltetraprol + Penflufen + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Penflufen + Mancozeb + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + penflufen + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + penflufen + mancozeb + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Penflufen + Carbendazim + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + penflufen + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + penflufen + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + tifluzamide + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + tifluzamide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + methyltetraprowl + tifluzamide + thiabendazole + metalaxil + etaboxam,
SX + metconazole + methyltetraprowl + tifluzamide + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + thiuram + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + tifluzamide + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + torquelophosmethyl + metalaxil + etaboxam,
SX + Metconazole + Methyltetraprowl + Tyfluzamide + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Thifluzamide + Boscalide + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + tifluzamide + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + boscalide + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Thifluzamide + Aminopyriphen + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + tifluzamide + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + mancozeb + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + tifluzamide + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + carbendazim + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + tifluzamide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + tifluzamide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + impilfluxam + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + impilfluxam + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + thiabendazole + metalaxil + etaboxam,
SX + methconazole + methyltetraprol + impilfluxam + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + thiuram + metalaxil + etaboxam,
SX + methconazole + methyltetraprol + impilfluxam + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + impilfluxam + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Impilfluxam + Boscalide + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprol + Impilfluxam + Boscalide + Metalaxil + Oxatiapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + aminopyriphen + metalaxil + etaboxam,
SX + Metconazole + Methyltetraprol + Impilfluxam + Aminopyriphen + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Methyltetraprol + Impilfluxam + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + mancozeb + metalaxil + etaboxam,
SX + methconazole + methyltetraprol + impilfluxam + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + carbendazim + metalaxil + etaboxam,
SX + methconazole + methyltetraprol + impilfluxam + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + impilfluxam + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + sedaxane + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + sedaxane + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + sedaxane + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + sedaxane + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + sedaxane + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + sedaxane + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + methyltetraprowl + sedaxane + thiabendazole + metalaxil + etaboxam,
SX + metconazole + methyltetraprol + sedaxane + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + methyltetraprowl + sedaxane + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + sedaxane + thiuram + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + sedaxane + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + sedaxane + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Sedaxane + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraplol + Sedaxane + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Sedaxane + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Sedaxan + Boscalide + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + sedaxane + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + sedaxane + boscalide + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Sedaxan + Aminopyriphen + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + sedaxane + aminopyridene + metalaxil + oxathiapiproline,
SX + Metoconazole + Methyltetraprol + Sedaxane + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + methconazole + methyltetraprowl + sedaxane + mancozeb + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + sedaxane + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + sedaxane + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + sedaxane + carbendazim + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + sedaxane + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + sedaxane + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + pidiflumethofen + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + pidiflumethofen + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + pidiflumethofen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiabendazole + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + pidiflumethofen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiuram + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + pidiflumethophene + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + pidiflumethofen + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Pidiflumethophene + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprol + Pidiflumethophene + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Pidiflumethophene + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Pidiflumethofen + Boscalide + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + pidiflumethophene + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + pidiflumethofen + boscalide + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Pidiflumethofen + Aminopyriphen + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraprol + Pidiflumethofen + Aminopyriphen + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Methyltetraprol + Pidiflumethofen + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Pidiflumethofen + Mancozeb + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + pidiflumethophene + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + pidiflumethophene + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + pidiflumethophene + carbendazim + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + pidiflumethophene + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + pidiflumethophene + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + isoflusiplum + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + isoflusiplum + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + thiabendazole + metalaxil + etaboxam,
SX + Metconazole + Methyltetraplol + Isoflusiplum + Thiabendazole + Metalaxil + Oxatiapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + thiuram + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + isoflusiplum + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metconazole + Methyltetraplol + Isoflusiplum + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Boscalide + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprowl + isoflusiplum + boscalide + metalaxil + oxathiapiproline,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metconazole + Methyltetraprowl + Isoflusiplum + Aminopyriphen + Metalaxil + Etaboxam,
SX + methconazole + methyltetraprol + isoflusiplum + aminopyridene + metalaxil + oxathiapiproline,
SX + Metoconazole + Methyltetraprol + Isoflusiplum + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + mancozeb + metalaxil + etaboxam,
SX + methconazole + methyltetraprowl + isoflusiplum + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + carbendazim + metalaxil + etaboxam,
SX + Metconazole + Methyltetraplol + Isoflusiplum + Carbendazim + Metalaxil + Oxatiapiproline,
SX + methconazole + methyltetraprowl + isoflusiplum + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + fluopyram + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + fluopyram + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + fluopyram + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + fluorium + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + methconazole + fempicoxamide + fluorium + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluorium + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + fluopirum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + fluorium + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + fluopirum + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + fluopiram + thiuram + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + fluorium + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + fluopyram + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Fempicoxamide + Fluopirum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + methconazole + fempicoxamide + fluopyram + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluoropyram + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluopyram + boscalid + metalaxil + etaboxam,
SX + Metoconazole + Fempicoxamide + Fluopirum + Boscalide + Metalaxil + Oxatiapiproline,
SX + methconazole + fempicoxamide + fluopyram + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + fluopyram + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + fluorium + aminopyriphen + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluopirum + aminopyriphen + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluopyram + mancozeb + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + fluopyram + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + fluopyram + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluopyram + carbendazim + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + fluopyram + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluopyram + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluxapirokid + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + fluxapyroxado + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + fluxapyroxado + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + fluxapyroxado + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + fluxapyroxado + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + fluxapyroxado + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + thiuram + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + fluxapyroxado + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + fluxapyroxado + torculophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluxapirokid + boscalide + metalaxil + etaboxam,
SX + Metoconazole + Fempicoxamide + Fluxapyroxado + Boscalide + Metalaxil + Oxatiapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + fluxapyrokid + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + fluxapyroxado + aminopyriphen + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + fluxapyroxado + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluxapyrokid + mancozeb + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + fluxapyroxado + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + carbendazim + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + fluxapyroxado + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + fluxapyroxado + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + boscalide + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + boscalide + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + boscalide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + vophanate + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + fempicoxamide + boscalide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + boscalide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + boscalid + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + boscalid + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + boscalid + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + boscalid + thiuram + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + boscalid + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + boscalid + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Fempicoxamide + Boscalide + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Fempicoxamide + Boscalide + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Fempicoxamide + Boscalide + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Fempicoxamide + Boscalid + Boscalid + Metalaxil + Etaboxam,
SX + Metoconazole + Fempicoxamide + Boscalide + Boscalide + Metalaxil + Oxatiapiproline,
SX + methconazole + fempicoxamide + boscalide + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + boscalide + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + boscalide + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + boscalide + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + boscalid + mancozeb + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + boscalide + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + boscalide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + boscalid + carbendazim + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + boscalide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + boscalide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + penflufen + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fenpicoxamide + penflufen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fenpicoxamide + penflufen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + penfurphene + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + methconazole + fenpicoxamide + penflufen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + penflufen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fenpicoxamide + penflufen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fenpicoxamide + penflufen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fenpicoxamide + penflufen + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fenpicoxamide + penflufen + thiuram + metalaxil + etaboxam,
SX + metconazole + fenpicoxamide + penflufen + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fenpicoxamide + penflufen + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + penflufen + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + penflufen + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + penflufen + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + penflufen + boscalid + metalaxil + etaboxam,
SX + Metoconazole + Fempicoxamide + Penflufen + Boscalide + Metalaxil + Oxatiapiproline,
SX + methconazole + fenpicoxamide + penflufen + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + penflufen + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + penflufen + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + fenpicoxamide + penflufen + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + penflufen + mancozeb + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + penflufen + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + fenpicoxamide + penflufen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + penflufen + carbendazim + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + penflufen + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + penflufen + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + tifluzamide + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + tifluzamide + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + tifluzamide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + thiophanate-methyl + metholaxyl + etaphanate,
SX + methconazole + fempicoxamide + tifluzamide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + tifluzamide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + tifluzamide + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + tifluzamide + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + tifluzamide + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + thifruzamide + thiuram + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + thifluzamide + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + thifluzamide + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + tyfluzamide + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + tyfluzamide + torculophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + tyfluzamide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + tifluzamide + boscalid + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + tifluzamide + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + tifluzamide + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + tifluzamide + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + tifluzamide + aminopyriphen + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + tifluzamide + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + tifluzamide + mancozeb + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + tifluzamide + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + tifluzamide + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + tifluzamide + carbendazim + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + tifluzamide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + tifluzamide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + impilfluxam + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + impilfluxam + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + impilfluxam + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + impilfluxam + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + impilfluxam + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + impilfluxam + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + impilfluxam + thiabendazole + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + impilfluxam + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + impilfluxam + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + impilfluxam + thiuram + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + impilfluxam + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + impilfluxam + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + impilfluxam + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + impilfluxam + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + impilfluxam + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + impilfluxam + boscalid + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + impilfluxam + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + impilfluxam + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + impilfluxam + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + impilfluxam + aminopyriphen + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + impilfluxam + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + impilfluxam + mancozeb + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + impilfluxam + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + impilfluxam + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + impilfluxam + carbendazim + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + impilfluxam + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + impilfluxam + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + sedaxan + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + sedaxane + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + sedaxane + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + sedaxan + thiophanate-methyl + metalluxyl + etaphanate-methyl,
SX + methconazole + fempicoxamide + sedaxane + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + sedaxane + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + sedaxane + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + sedaxane + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + sedaxane + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + sedaxan + thiuram + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + sedaxane + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + sedaxane + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + sedaxane + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + sedaxane + torculophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + sedaxane + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + sedaxan + boscalid + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + sedaxane + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + sedaxane + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + sedaxan + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + sedaxane + aminopyridene + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + sedaxane + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + sedaxane + mancozeb + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + sedaxane + mancozeb + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + sedaxane + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + sedaxane + carbendazim + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + sedaxane + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + sedaxane + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + pidiflumethophene + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + pidiflumethophene + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fenpicoxamide + pidiflumethophene + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fenpicoxamide + pidiflumethophene + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fenpicoxamide + pidiflumethophene + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + thiuram + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + pidiflumethophene + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + thiuram + metalaxil + fluoxapiproline,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + methconazole + fenpicoxamide + pidiflumethophene + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Boscalide + Metalaxil + Etaboxam,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Aminopyriphen + Metalaxil + Etaboxam,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Aminopyriphen + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Fenpicoxamide + Pidiflumethofen + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + mancozeb + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + pidiflumethophene + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + carbendazim + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + pidiflumethophene + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + pidiflumethophene + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + isoflusiplum + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + isofrusiplum + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + methconazole + fempicoxamide + isoflusiplum + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + isoflusiplum + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + isoflusiplum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + isoflusiplum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + isoflusiplum + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + fempicoxamide + isoflusiplum + thiuram + metalaxil + etaboxam,
SX + metconazole + fempicoxamide + isoflusiplum + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + fempicoxamide + isoflusiplum + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + torculophosmethyl + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + isoflusiplum + torculophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + torculophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + boscalide + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + isoflusiplum + boscalide + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + boscalide + metalaxil + fluoxapiproline,
SX + methconazole + fenpicoxamide + isoflusiplum + aminopyriphen + metalaxil + etaboxam,
SX + methconazole + fenpicoxamide + isoflusiplum + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + fenpicoxamide + isoflusiplum + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + mancozeb + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + isoflusiplum + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + carbendazim + metalaxil + etaboxam,
SX + methconazole + fempicoxamide + isoflusiplum + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + fempicoxamide + isoflusiplum + carbendazim + metalaxil + fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Fludioxonyl + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Fludioxonyl + Metalaxil + Oxatiapiproline,
SX + metconazole + florylpicoxamide + fluoripyram + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + floryl picoxamide + fluoripyram + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Thiophanate-methyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Thiophanate-methyl + Metalaxil + Fluoxapiproline,
SX + metconazole + florylpicoxamide + fluoripyram + thiabendazole + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + fluoripyram + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + fluoripyram + thiabendazole + metalaxil + fluoxapiproline,
SX + Metconazole + Florylpicoxamide + Fluopiram + Thiram + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluopiram + Thiram + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopiram + Thiram + Metalaxil + Fluoxapiproline,
SX + Metconazole + Florylpicoxamide + Fluopirum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Florylpicoxamide + Fluopirum + Boscalid + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Aminopyriphen + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Aminopyriphen + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Mancozeb + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Mancozeb + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Mancozeb + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Carbendazim + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Carbendazim + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluopirum + Carbendazim + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Fludioxonyl + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Fludioxonyl + Metalaxil + Oxatiapiproline,
SX + methconazole + florylpicoxamide + fluxapyroxado + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + fluxapyroxado + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + fluxapyroxado + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + fluxapyroxado + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + fluxapyroxado + thiabendazole + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + fluxapyroxado + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + fluxapyroxado + thiabendazole + metalaxil + fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Thiram + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Thiram + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Thiram + Metalaxil + Fluxapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metconazole + Florylpicoxamide + Fluxapirokid + Boscalide + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Boscalide + Metalaxil + Fluxapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyrokid + Aminopyriphen + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Aminopyridene + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Aminopyridene + Metalaxil + Fluxapiproline,
SX + Metconazole + Florylpicoxamide + Fluxapirokid + Mancozeb + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Mancozeb + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Mancozeb + Metalaxil + Fluxapiproline,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Carbendazim + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Fluxapyroxado + Carbendazim + Metalaxil + Oxatiapiproline,
SX + methconazole + florylpicoxamide + fluxapyroxado + carbendazim + metalaxil + fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Fludioxonyl + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Boscalide + Fludioxonyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Fludioxonyl + Metalaxil + Fluoxapiproline,
SX + methconazole + floryl picoxamide + vophanate + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + Metoconazole + Florylpicoxamide + Boscalide + Thiophanate-methyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Thiophanate-methyl + Metalaxil + Fluoxapiproline,
SX + metconazole + florylpicoxamide + boscalid + thiabendazole + metalaxil + etaboxam,
SX + Metoconazole + Florylpicoxamide + Boscalide + Tiabendazole + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Tiabendazole + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalid + Thiram + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Boscalide + Thiram + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Thiram + Metalaxil + Fluoxapiproline,
SX + Metconazole + Florylpicoxamide + Boscalide + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Boscalide + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalid + Boscalid + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Boscalide + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Aminopyriphen + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Boscalide + Aminopyriphen + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalid + Mancozeb + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Boscalide + Mancozeb + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Mancozeb + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalid + Carbendazim + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Boscalide + Carbendazim + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Boscalide + Carbendazim + Metalaxil + Fluoxapiproline,
SX + metconazole + florylpicoxamide + penflufen + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + penflufen + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + penflufen + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + floryl picoxamide + penfurphene + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + methconazole + florylpicoxamide + penflufen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + penflufen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + penflufen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + penflufen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + penflufen + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + penflufen + thiuram + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + penflufen + thiuram + metalaxil + oxathiapiproline,
SX + Metoconazole + Florylpicoxamide + Penflufen + Thiram + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Penflufen + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Penflufen + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Penflufen + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Penflufen + Boscalid + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Penflufen + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Penflufen + Boscalide + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Penflufen + Aminopyriphen + Metalaxil + Etaboxam,
SX + metconazole + florylpicoxamide + penflufen + aminopyridene + metalaxil + oxathiapiproline,
SX + Metoconazole + Florylpicoxamide + Penflufen + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + methconazole + florylpicoxamide + penflufen + mancozeb + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + penflufen + mancozeb + metalaxil + oxathiapiproline,
SX + Metoconazole + Florylpicoxamide + Penflufen + Mancozeb + Metalaxil + Fluoxapiproline,
SX + methconazole + florylpicoxamide + penflufen + carbendazim + metalaxil + etaboxam,
SX + Metoconazole + Florylpicoxamide + Penflufen + Carbendazim + Metalaxil + Oxatiapiproline,
SX + methconazole + florylpicoxamide + penflufen + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + tifluzamide + fludioxonyl + metalaxil + etaboxam,
SX + Metoconazole + Florylpicoxamide + Thifluzamide + Fludioxonyl + Metalaxil + Oxatiapiproline,
SX + methconazole + florylpicoxamide + tifluzamide + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + floryl picoxamide + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + methconazole + florylpicoxamide + tifluzamide + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + tifluzamide + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + tibendazole + thiabendazole + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + tifluzamide + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + tifluzamide + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + thifruzamide + thiuram + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + thifruzamide + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + thifruzamide + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Florylpicoxamide + Tifruzamide + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Thifluzamide + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + methconazole + florylpicoxamide + tifluzamide + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + methconazole + floryl picoxamide + tifluzamide + boscarido + metalaxil + etaboxam,
SX + Metoconazole + Florylpicoxamide + Thifluzamide + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Thifluzamide + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + florylpicoxamide + tifluzamide + aminopyridene + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + tifluzamide + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + tifluzamide + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + tifluzamide + mancozeb + metalaxil + etaboxam,
SX + Metoconazole + Florylpicoxamide + Thifluzamide + Mancozeb + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Thifluzamide + Mancozeb + Metalaxil + Fluoxapiproline,
SX + methconazole + florylpicoxamide + tifluzamide + carbendazim + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + tifluzamide + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + tifluzamide + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + fludioxonyl + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + impilfluxam + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + thiophanate-methyl + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + impilfluxam + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + thiabendazole + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + impilfluxam + thiabendazole + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + thiuram + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + impilfluxam + thiuram + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + impilfluxam + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + torquelophosmethyl + metalaxil + fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Impilfluxam + Boscalid + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Impilfluxam + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Impilfluxam + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + aminopyridene + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + impilfluxam + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + mancozeb + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + impilfluxam + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + carbendazim + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + impilfluxam + carbendazim + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + impilfluxam + carbendazim + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + sedaxan + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + sedaxane + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + sedaxane + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + floryl picoxamide + sedaxan + thiophanate-methyl + methanolate + etaphanate-methyl,
SX + methconazole + florylpicoxamide + sedaxane + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + sedaxane + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + sedaxane + thiabendazole + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + sedaxane + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + sedaxane + thiabendazole + metalaxil + fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Thiram + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Thiram + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Thiram + Metalaxil + Fluoxapiproline,
SX + methconazole + florylpicoxamide + sedaxane + torquelophosmethyl + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + sedaxane + torquelophosmethyl + metalaxil + oxathiapiproline,
SX + Metoconazole + Florylpicoxamide + Sedaxane + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Boscalide + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Boscalide + Metalaxil + Fluoxapiproline,
SX + methconazole + florylpicoxamide + sedaxan + aminopyriphen + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + sedaxane + aminopyridene + metalaxil + oxathiapiproline,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Aminopyriphen + Metalaxil + Fluoxapiproline,
SX + metconazole + florylpicoxamide + sedaxane + mancozeb + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + sedaxane + mancozeb + metalaxil + oxathiapiproline,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Mancozeb + Metalaxil + Fluoxapiproline,
SX + methconazole + florylpicoxamide + sedaxane + carbendazim + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + sedaxane + carbendazim + metalaxil + oxathiapiproline,
SX + Metoconazole + Florylpicoxamide + Sedaxan + Carbendazim + Metalaxil + Fluoxapiproline,
SX + methconazole + floryl picoxamide + pidiflumethofen + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + floryl picoxamide + pidiflumethofen + fludioxonyl + metalaxil + oxathiapiproline,
SX + methconazole + floryl picoxamide + pidiflumethofen + fludioxonyl + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + pidiflumethofen + thiophanate-methyl + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + pidiflumethofen + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + pidiflumethofen + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + pidiflumethofen + thiabendazole + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + pidiflumethofen + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + pidiflumethofen + thiabendazole + metalaxil + fluoxapiproline,
SX + methconazole + floryl picoxamide + pidiflumethophene + thiuram + metalaxil + etaboxam,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Thiram + Metalaxil + Oxatiapiproline,
SX + metconazole + floryl picoxamide + pidiflumethophene + thiuram + metalaxil + fluoxapiproline,
SX + methconazole + floryl picoxamide + pidiflumethophene + turquophosmethyl + metalaxil + etaboxam,
SX + methconazole + floryl picoxamide + pidiflumethophene + torculophosmethyl + metalaxil + oxathiapiproline,
SX + methconazole + floryl picoxamide + pidiflumethophene + torculophosmethyl + metalaxil + fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Boscalide + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Boscalide + Metalaxil + Fluoxapiproline,
SX + metconazole + florylpicoxamide + pidiflumethofen + aminopyridene + metalaxil + etaboxam,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Aminopyridene + Metalaxil + Oxatiapiproline,
SX + metconazole + floryl picoxamide + pidiflumethophene + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + pidiflumethofen + mancozeb + metalaxil + etaboxam,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Mancozeb + Metalaxil + Oxatiapiproline,
SX + metconazole + florylpicoxamide + pidiflumethofen + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + floryl picoxamide + pidiflumethophene + carbendazim + metalaxil + etaboxam,
SX + Metoconazole + Florylpicoxamide + Pidiflumethofen + Carbendazim + Metalaxil + Oxatiapiproline,
SX + methconazole + floryl picoxamide + pidiflumethophene + carbendazim + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + isoflusiplum + fludioxonyl + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + isoflusiplum + fludioxonyl + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + isoflusiplum + fludioxonyl + metalaxil + fluoxapiproline,
SX + methconazole + floryl picoxamide + isoflcyplum + thiophanate-methyl + metholaxyl + etaphanate-methyl,
SX + methconazole + florylpicoxamide + isoflusiplum + thiophanate-methyl + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + isoflusiplum + thiophanate-methyl + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + isoflusiplum + thiabendazole + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + isoflusiplum + thiabendazole + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + isoflusiplum + thiabendazole + metalaxil + fluoxapiproline,
SX + metconazole + florylpicoxamide + isoflusiplum + thiuram + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + isoflusiplum + thiuram + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + isoflusiplum + thiuram + metalaxil + fluoxapiproline,
SX + Metconazole + Florylpicoxamide + Isoflusiplum + Torquelophosmethyl + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Torquelophosmethyl + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Torquelophosmethyl + Metalaxil + Fluoxapiproline,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Boscalide + Metalaxil + Etaboxam,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Boscalide + Metalaxil + Oxatiapiproline,
SX + Metoconazole + Florylpicoxamide + Isoflusiplum + Boscalide + Metalaxil + Fluoxapiproline,
SX + metconazole + florylpicoxamide + isoflusiplum + aminopyridene + metalaxil + etaboxam,
SX + metconazole + florylpicoxamide + isoflusiplum + aminopyridene + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + isoflusiplum + aminopyridene + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + isoflusiplum + mancozeb + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + isoflusiplum + mancozeb + metalaxil + oxathiapiproline,
SX + methconazole + florylpicoxamide + isoflusiplum + mancozeb + metalaxil + fluoxapiproline,
SX + methconazole + florylpicoxamide + isoflusiplum + carbendazim + metalaxil + etaboxam,
SX + methconazole + florylpicoxamide + isoflusiplum + carbendazim + metalaxil + oxathiapiproline,
SX + metconazole + florylpicoxamide + isoflusiplum + carbendazim + metalaxil + fluoxapiproline.

Group 518'consists of composition A consisting of one part of tebuconazole in place of one part of methconazole contained in each composition of group 517'.
Group 519'composed of composition A consisting of a portion of diphenoconazole instead of a portion of metconazole contained in each composition of group 517'.
Group 520'is composed of composition A consisting of one part of triticonazole instead of one part of metconazole contained in each composition of group 517'.
Group 521'composed of composition A consisting of one part of prothioconazole in place of one part of metconazole contained in each composition of group 517'.
Group 522'is composed of composition A consisting of one part of diniconazole instead of one part of metconazole contained in each composition of group 517'.
Group 523'is composed of composition A consisting of one part of diniconazole M instead of one part of metconazole contained in each composition of group 517'.
Group 524'composed of composition A consisting of one part of ipconazole in place of one part of metconazole contained in each composition of group 517'.
Group 525'consists of composition A consisting of one part of prochloras instead of one part of methconazole contained in each composition of group 517'.
Group 526'consists of composition A consisting of one part of flukinconazole in place of one part of metconazole contained in each composition of group 517'.
Group 527'consists of composition A consisting of one part of bromconazole in place of one part of metconazole contained in each composition of group 517'.
Group 528'consists of composition A consisting of a portion of mefentrifluconazole instead of a portion of metconazole contained in each composition of group 517'.

In group 529', the combination of SX, this component 1, this component 2, this component 3, this component 4, this component 5 and this component 6 is any combination of the above "7 active ingredient list". A composition consisting of 1 part SX, 1 part main component 1, 1 part main component 2, 1 part main component 3, 1 part main component 4, 1 part main component 5 and 1 part main component 6 It is composed of A.

Group 530'consists of composition A consisting of one part of tebuconazole in place of one part of metconazole contained in each composition of group 529'.
Group 531'composed of composition A consisting of a portion of diphenoconazole instead of a portion of metconazole contained in each composition of group 529'.
Group 532'is composed of composition A consisting of one part of triticonazole instead of one part of metconazole contained in each composition of group 529'.
Group 533'is composed of composition A consisting of one part of prothioconazole in place of one part of metconazole contained in each composition of group 529'.
Group 534'consists of composition A consisting of one part of diniconazole in place of one part of metconazole contained in each composition of group 529'.
Group 535'composed of composition A consisting of one part of diniconazole M instead of one part of metconazole contained in each composition of group 529'.
Group 536'consists of composition A consisting of one part of ipconazole in place of one part of metconazole contained in each composition of group 529'.
Group 537'is composed of composition A consisting of one part of prochloras instead of one part of metconazole contained in each composition of group 529'.
Group 538'consists of composition A consisting of one part of flukinconazole in place of one part of metconazole contained in each composition of group 529'.
Group 539'consists of composition A consisting of a portion of bromconazole instead of a portion of metconazole contained in each composition of group 529'.
Group 540'composed of composition A consisting of a portion of mefentrifluconazole instead of a portion of metconazole contained in each composition of group 529'.

Group 541'is from composition A in which 1000 parts of clothianidin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. It is composed.
Group 542'is from composition A in which 1000 parts of clothianidin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 517'to 528'. It is composed.
Group 543'is a composition in which 1000 parts of clothianidin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 517'to 528'. It is composed of A.
Group 544'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of clothianidin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamide have been added. It is composed.
Group 545'is from Composition A, in which 1000 parts of clothianidin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 517'to 528'. It is composed.
Group 546'is from composition A in which 1000 parts of clothianidin, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. It is composed.
Group 547'from each composition of groups 517' to 528' is further added with 1000 parts of clothianidin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide. It is composed.
Group 548'is a composition obtained by adding 1000 parts of clothianidin, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each of the compositions of groups 517'to 528'. It is composed of A.
Group 549'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of clothianidin, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamide have been added. It is composed.
Group 550'from each composition of groups 517'-528' from composition A further comprising 1000 parts of clothianidin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. It is composed.
Group 551'consists of composition A in which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. Will be done.
Group 552'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide were added. Will be done.
Group 553'is a composition A in which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 517'to 528'. Consists of.
Group 554'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamid were added. Will be done.
Group 555'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas were added. Will be done.
Group 556'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil were added. Will be done.
Group 557'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide were added. Will be done.
Group 558'is a composition A in which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 517'to 528'. Consists of.
Group 559'consists of Composition A in which 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamide are further added to each of the compositions of groups 517'to 528'. Will be done.
Group 560'composed of each composition of groups 517'to 528', plus 1000 parts of clothianidin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. Will be done.
Group 561'composed of each composition of groups 517'-528' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil. To.
Group 562'composed of each composition of groups 517'-528' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide. To.
Group 563'is from composition A in which 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are added to each of the compositions of groups 517'to 528'. It is composed.
Group 564'composed of each composition of groups 517'-528' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. To.
Group 565'composed of each composition of groups 517'-528' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. To.
Group 566'composed of each composition of groups 517'-528' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil. To.
Group 567'composed of each composition of groups 517'-528' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide. To.
Group 568'comes from Composition A, which comprises 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each of the compositions of groups 517'to 528'. It is composed.
Group 569'composed of each composition of groups 517'-528' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid. To.
Group 570'composed of each composition of groups 517'-528' with 1000 parts of clothianidin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. To.
Group 571'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. It is composed.
Group 572'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 517'to 528'. It is composed.
Group 573'is a composition obtained by adding 1000 parts of imidacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram to each composition of groups 517' to 528'. It is composed of A.
Group 574'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid have been added. It is composed.
Group 575'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas have been added. It is composed.
Group 576'is from composition A in which 1000 parts imidacloprid, 1000 parts chloranthraniliprol, 1000 parts bifenthrin and 1000 parts fipronil are added to each of the compositions of groups 517'to 528'. It is composed.
Group 577'is from composition A in which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 517'to 528'. It is composed.
Group 578'is a composition obtained by adding 1000 parts of imidacloprid, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each composition of groups 517' to 528'. It is composed of A.
Group 579'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid are added. It is composed.
Group 580'is from composition A, each of which is a composition of groups 517'to 528', to which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas are added. It is composed.
Group 581'consists of composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. Will be done.
Group 582'composed of each composition of groups 517'-528', further composed of composition A containing 1000 parts imidacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts brofuranilide. Will be done.
Group 583'is a composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each composition of groups 517' to 528'. Consists of.
Group 584'composed of each composition of groups 517'-528', further composed of composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamid were added. Will be done.
Group 585'consists of composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas are added. Will be done.
Group 586'composed of each composition of groups 517'-528' with 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil. Will be done.
Group 587'composed of each composition of groups 517'-528' with 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide. Will be done.
Group 588'is a composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 517'to 528'. Consists of.
Group 589'composed of each composition of groups 517'-528' with 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamid. Will be done.
Group 590'composed of each composition of groups 517'-528', plus 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. Will be done.
Group 591'is composed of composition A in which 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. To.
Group 592'composed of each composition of groups 517'-528', plus 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide. To.
Group 593'is from composition A in which 1000 parts imidacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts isocycloceram are added to each of the compositions of groups 517'to 528'. It is composed.
Group 594'composed of each composition of groups 517'-528' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. To.
Group 595'composed of each composition of groups 517'-528' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. To.
Group 596'composed of each composition of groups 517'-528' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil. To.
Group 597'composed of each composition of groups 517'-528' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide. To.
Group 598'comes from Composition A, which comprises 1000 parts imidacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts isocycloceram to each of the compositions in groups 517'to 528'. It is composed.
Group 599'composed of each composition of groups 517'-528' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid. To.
Group 600'composed of each composition of groups 517'-528' with 1000 parts of imidacloprid, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. To.
Group 601'is from composition A in which 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts fipronil are added to each of the compositions of groups 517'to 528'. It is composed.
Group 602'is from composition A in which 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts brofuranilide are added to each of the compositions of groups 517'to 528'. It is composed.
Group 603'is a composition obtained by adding 1000 parts of thiamethoxam, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram to each composition of groups 517'to 528'. It is composed of A.
Group 604'is from composition A, each of which is a composition of groups 517'to 528', further comprising 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts fluxametamide. It is composed.
Group 605'is from composition A, each of which is a composition of groups 517'to 528', plus 1000 parts of thiamethoxam, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. It is composed.
Group 606'is from composition A in which 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts bifenthrin and 1000 parts fipronil are added to each of the compositions of groups 517'to 528'. It is composed.
Group 607'comes from composition A, each of which is a composition of groups 517'to 528', further comprising 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts bifenthrin and 1000 parts brofuranilide. It is composed.
Group 608'is a composition obtained by adding 1000 parts of thiamethoxam, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each composition of groups 517' to 528'. It is composed of A.
Group 609'from each composition of groups 517'-528' from composition A further comprising 1000 parts thiamethoxam, 1000 parts chloranthraniliprol, 1000 parts bifenthrin and 1000 parts fluxametamide. It is composed.
Group 610'is from composition A, each of which is a composition of groups 517'to 528', plus 1000 parts of thiamethoxam, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. It is composed.
Group 611'consists of composition A, each of which is a composition of groups 517'to 528', to which 1000 parts of thiamethoxam, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil are added. Will be done.
Group 612'composed of composition A, each of the compositions of groups 517'to 528', further to which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts brofuranilide were added. Will be done.
Group 613'is a composition A in which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts isocycloceram are further added to each composition of groups 517'to 528'. Consists of.
Group 614'consists of composition A, each of which is a composition of groups 517'to 528', further comprising 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts fluxametamide. Will be done.
Group 615'composed of each composition of groups 517'-528', plus 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts ginpropyridas. Will be done.
Group 616'composed of each composition of groups 517' to 528', plus 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Will be done.
Group 617'consists of composition A, each of which is a composition of groups 517'to 528', further comprising 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Will be done.
Group 618'is a composition A in which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts isocycloceram are further added to each composition of groups 517'to 528'. Consists of.
Group 619'composed of composition A, each of the compositions of groups 517'to 528', further to which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fluxametamide were added. Will be done.
Group 620'composed of each composition of groups 517'-528', plus 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts ginpropyridas. Will be done.
Group 621'composed of each composition of groups 517'-528' with 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts fipronil. To.
Group 622'consists of composition A, each of which is a composition of groups 517'to 528', further comprising 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts brofuranilide. To.
Group 623'is from composition A in which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts isocycloceram are added to each of the compositions of groups 517'to 528'. It is composed.
Group 624'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts fluxametamide were added. To.
Group 625'composed of each composition of groups 517'-528', plus 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts ginpropyridas. To.
Group 626'composed of each composition of groups 517'to 528', plus 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts fipronil. To.
Group 627'composed of each composition of groups 517'-528', plus 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts brofuranilide. To.
Group 628'comes from Composition A, which comprises 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts isocycloceram to each of the compositions in groups 517'to 528'. It is composed.
Group 629'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts fluxametamid were added. To.
Group 630'composed of each composition of groups 517'-528', plus 1000 parts thiamethoxam, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts ginpropyridas. To.
Group 631'is from composition A in which 1000 parts thiacloprid, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts fipronil are added to each of the compositions of groups 517'to 528'. It is composed.
Group 632'is from composition A in which 1000 parts thiacloprid, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts brofuranilide are added to each of the compositions of groups 517'to 528'. It is composed.
Group 633'is a composition obtained by adding 1000 parts of thiacloprid, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram to each composition of groups 517' to 528'. It is composed of A.
Group 634'from composition A, each of which is a composition of groups 517'to 528', further comprising 1000 parts thiacloprid, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts fluxametamid. It is composed.
Group 635'from each composition of groups 517'-528' from composition A further comprising 1000 parts thiacloprid, 1000 parts chloranthraniliprol, 1000 parts tefluthrin and 1000 parts ginpropyridas. It is composed.
Group 636'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts thiacloprid, 1000 parts chloranthraniliprol, 1000 parts bifenthrin and 1000 parts fipronil have been added. It is composed.
Group 637'from each composition of groups 517'-528' from composition A further comprising 1000 parts thiacloprid, 1000 parts chlorantraniliprol, 1000 parts bifenthrin and 1000 parts brofuranilide. It is composed.
Group 638'is a composition obtained by adding 1000 parts of thiacloprid, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each composition of groups 517' to 528'. It is composed of A.
Group 639'is from composition A in which 1000 parts of thiacloprid, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid are further added to each of the compositions of groups 517'to 528'. It is composed.
Group 640'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts thiacloprid, 1000 parts chloranthraniliprol, 1000 parts bifenthrin and 1000 parts ginpropyridas have been added. It is composed.
Group 641'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts fipronil were added. Will be done.
Group 642'composed of each composition of groups 517'-528', plus 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts brofuranilide. Will be done.
Group 643'is a composition A in which 1000 parts of thiacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 517'to 528'. Consists of.
Group 644'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts fluxametamid were added. Will be done.
Group 645'composed of each composition of groups 517'-528', plus 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts ginpropyridas. Will be done.
Group 646'composed of Composition A in which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil were added to each of the compositions of groups 517'to 528'. Will be done.
Group 647'composed of composition A, each of the compositions of groups 517'to 528', further to which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide were added. Will be done.
Group 648'is a composition A in which 1000 parts of thiacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each composition of groups 517'to 528'. Consists of.
Group 649'consists of composition A in which 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fluxametamid are added to each of the compositions of groups 517'to 528'. Will be done.
Group 650'composed of each composition of groups 517'-528', plus 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts ginpropyridas. Will be done.
Group 651'is composed of composition A in which 1000 parts of thiacloprid, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. To.
Group 652'composed of composition A, each of the compositions of groups 517'to 528', further to which 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts brofuranilide were added. To.
Group 653'is from composition A in which 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts isocycloceram are added to each of the compositions of groups 517'to 528'. It is composed.
Group 654'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts fluxametamid were added. To.
Group 655'composed of each composition of groups 517'-528', plus 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts tefluthrin and 1000 parts ginpropyridas. To.
Group 656'composed of each composition of groups 517'-528', plus 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts fipronil. To.
Group 657'composed of each composition of groups 517'-528', plus 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts brofuranilide. To.
Group 658'comes from composition A, each of which is a composition of groups 517'-528', plus 1000 parts of thiacloprid, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram. It is composed.
Group 659'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts fluxametamid were added. To.
Group 660'composed of each composition of groups 517'-528', plus 1000 parts thiacloprid, 1000 parts tetraniliprol, 1000 parts bifenthrin and 1000 parts ginpropyridas. To.
Group 661'is from composition A, each of which is a composition of groups 517'to 528', to which 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are added. It is composed.
Group 662'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide have been added. It is composed.
Group 663'is a composition in which 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each composition of groups 517'to 528'. It is composed of A.
Group 664'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid have been added. It is composed.
Group 665'comes from composition A, each of which is a composition of groups 517'to 528', plus 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. It is composed.
Group 666'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyraziflon, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil have been added. It is composed.
Group 667'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyraziflon, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added. It is composed.
Group 668'is a composition obtained by adding 1000 parts of flupyraziflon, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each of the compositions of groups 517'to 528'. It is composed of A.
Group 669'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyraziflon, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid have been added. It is composed.
Group 670'is from composition A, each of which is a composition of groups 517'to 528', which is further supplemented with 1000 parts of flupyraziflon, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. It is composed.
Group 671'composed of each composition of groups 517'-528' with 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil. Will be done.
Group 672'composed of each composition of groups 517'to 528', plus 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide. Will be done.
Group 673'is a composition A in which 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are added to each of the compositions of groups 517'to 528'. Consists of.
Group 674'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamid were added. Will be done.
Group 675'composed of each composition of groups 517'-528', plus 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. Will be done.
Group 676'composed of each composition of groups 517'-528' with 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil. Will be done.
Group 677'composed of each composition of groups 517'to 528' with 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide. Will be done.
Group 678'is a composition A in which 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are added to each of the compositions of groups 517'to 528'. Consists of.
Group 679'composed of each composition of groups 517'to 528' with 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamide. Will be done.
Group 680'composed of each composition of groups 517'-528', plus 1000 parts of flupyraziflon, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. Will be done.
Group 681'composed of each composition of groups 517'-528' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil. To.
Group 682'composed of each composition of groups 517'-528' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide. To.
Group 683'is from composition A in which 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are added to each of the compositions of groups 517'to 528'. It is composed.
Group 684'composed of each composition of groups 517'-528' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. To.
Group 685'composed of each composition of groups 517'-528' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. To.
Group 686'composed of each composition of groups 517'-528' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil. To.
Group 687'composed of each composition of groups 517'-528' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide. To.
Group 688'is from composition A in which 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are added to each of the compositions of groups 517'to 528'. It is composed.
Group 689'composed of each composition of groups 517'-528' with 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid. To.
Group 690'composed of each composition of groups 517'-528', plus 1000 parts of flupyraziflon, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. To.
Group 691'is from composition A in which 1000 parts of flupyrimin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. It is composed.
Group 692'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyrimin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added. It is composed.
Group 693'is a composition obtained by adding 1000 parts of flupyrimin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram to each composition of groups 517'to 528'. It is composed of A.
Group 694'is from composition A in which 1000 parts of flupyrimin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid are further added to each of the compositions of groups 517'to 528'. It is composed.
Group 695'comes from composition A, each of which is a composition of groups 517'to 528', plus 1000 parts of flupyrimin, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. It is composed.
Group 696'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil have been added. It is composed.
Group 697'is composed of the respective compositions of groups 517'to 528' from composition A further comprising 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide. It is composed.
Group 698'is a composition in which 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each composition of groups 517'to 528'. It is composed of A.
Group 699'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid have been added. It is composed.
Group 700'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyrimin, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas are added. It is composed.
Group 701'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil. Will be done.
Group 702'consists of composition A, each of which is a composition of groups 517'to 528', to which 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added. Will be done.
Group 703'is a composition A in which 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are added to each of the compositions of groups 517'to 528'. Consists of.
Group 704'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamid were added. Will be done.
Group 705'composed of each composition of groups 517'-528', plus 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. Will be done.
Group 706'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil. Will be done.
Group 707'composed of Composition A, each of the compositions of Groups 517'to 528', further to which 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide were added. Will be done.
Group 708'is a composition A in which 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each of the compositions of groups 517'to 528'. Consists of.
Group 709'consists of composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamid are added. Will be done.
Group 710'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. Will be done.
Group 711'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil. To.
Group 712'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide. To.
Group 713'is from composition A in which 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are added to each of the compositions of groups 517'to 528'. It is composed.
Group 714'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid. To.
Group 715'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas. To.
Group 716'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil. To.
Group 717'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide. To.
Group 718'is from composition A in which 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are added to each of the compositions of groups 517'to 528'. It is composed.
Group 719'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid. To.
Group 720'composed of each composition of groups 517'-528' with 1000 parts of flupyrimin, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas. To.
Group 721'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are further added to each composition of groups 517' to 528'. It is composed of A.
Group 722'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 517'to 528'. It is composed of A.
Group 723'added 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram to each composition of groups 517'-528'. It is composed of composition A.
Group 724'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid are further added to each of the compositions of groups 517'to 528'. It is composed of A.
Group 725'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 517'to 528'. It is composed of A.
Group 726'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of groups 517'to 528'. It is composed of A.
Group 727'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each composition of groups 517'to 528'. It is composed of A.
Group 728'added 1000 parts of triflumezopyrim, 1000 parts of chloranthraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram to each composition of groups 517'-528'. It is composed of composition A.
Group 729'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid are further added to each of the compositions of groups 517'to 528'. It is composed of A.
Group 730'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 517'to 528'. It is composed of A.
Group 731'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. Consists of.
Group 732'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 517'to 528'. Consists of.
Group 733'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each composition of groups 517'to 528'. It is composed of object A.
Group 734'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fluxametamide are further added to each of the compositions of groups 517'to 528'. Consists of.
Group 735'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 517'to 528'. Consists of.
Group 736'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. Consists of.
Group 737'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 517'to 528'. Consists of.
Group 738'composed of each composition of groups 517'-528' with 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of isocycloceram. It is composed of object A.
Group 739'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fluxametamide are further added to each of the compositions of groups 517'to 528'. Consists of.
Group 740'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 517'to 528'. Consists of.
Group 741'is from composition A in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of groups 517'to 528'. It is composed.
Group 742'is from composition A in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 517'to 528'. It is composed.
Group 743'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of isocycloceram are further added to each composition of groups 517'to 528'. It is composed of A.
Group 744'is from composition A in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of fluxametamid are added to each of the compositions of groups 517'to 528'. It is composed.
Group 745'is from composition A, each of which is a composition of groups 517'to 528', to which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of tefluthrin and 1000 parts of ginpropyridas are added. It is composed.
Group 746'is from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of triflumesopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fipronil have been added. It is composed.
Group 747'comes from composition A, each of which is a composition of groups 517'to 528', further to which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added. It is composed.
Group 748'is a composition in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of isocycloceram are further added to each composition of groups 517'to 528'. It is composed of A.
Group 749'is from composition A, each of which is a composition of groups 517'to 528', which is further supplemented with 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of fluxametamid. It is composed.
Group 750'is from composition A in which 1000 parts of triflumezopyrim, 1000 parts of tetraniliprol, 1000 parts of bifenthrin and 1000 parts of ginpropyridas are added to each of the compositions of groups 517'to 528'. It is composed.

Group 751'is from composition A in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of tefluthrin and 1 part of fipronil are added to each of the compositions of groups 529'to 540'. It is composed.
Group 752'is from composition A in which 1 part of clothianidin, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of brofuranilide are added to each of the compositions of groups 529'to 540'. It is composed.
Group 753'is a composition obtained by adding 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of tefluthrin and 1 part of isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Groups 754'from each composition of groups 529' to 540' from composition A further comprising 1 part clothianidin, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fluxametamid. It is composed.
Group 755'is from Composition A, in which 1 portion of clothianidin, 1 portion of chlorantraniliplol, 1 portion of tefluthrin and 1 portion of ginpropyridas are added to each of the compositions of groups 529'to 540'. It is composed.
Group 756'is from composition A in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fipronil are added to each of the compositions of groups 529'to 540'. It is composed.
Group 757'from each composition of groups 529' to 540' is further added with one portion of clothianidin, one portion of chlorantraniliplol, one portion of bifenthrin and one portion of brofuranilide. It is composed.
Group 758'is a composition obtained by adding 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 759'is from Composition A, in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fluxametamid are added to each of the compositions of groups 529'to 540'. It is composed.
Group 760'is from composition A in which 1 part of clothianidin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of ginpropyridas are added to each of the compositions of groups 529'to 540'. It is composed.
Group 761'composed of composition A, each of the compositions of groups 529'to 540', further to which 1 part clothianidin, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil were added. Will be done.
Group 762'composed of Composition A, each of the compositions of Groups 529'to 540', further to which 1 portion of clothianidin, 1 portion of cyantraniliprole, 1 part of tefluthrin and 1 part of brofuranilide were added. Will be done.
Group 763'is a composition A in which 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of isocycloceram are further added to each composition of groups 529'to 540'. Consists of.
Group 764'composed of Composition A in which 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fluxametamid were added to each of the compositions of groups 529'to 540'. Will be done.
Group 765'composed of each composition of groups 529' to 540', plus 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of ginpropyridas. Will be done.
Group 766'composed of each composition of groups 529' to 540', plus 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fipronil. Will be done.
Group 767'composed of each composition of groups 529' to 540', plus 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of brofuranilide. Will be done.
Group 768'is a composition A in which 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of isocycloceram are further added to each composition of groups 529'to 540'. Consists of.
Group 769'composed of Composition A in which 1 part of clothianidin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fluxametamid were added to each of the compositions of groups 529'to 540'. Will be done.
Group 770'consists of composition A, each of which is a composition of groups 529'to 540', further to which 1 portion of clothianidin, 1 portion of cyantraniliprole, 1 part of bifenthrin and 1 part of ginpropyridas are added. Will be done.
Group 771'composed of each composition of groups 529'to 540', plus 1 part clothianidin, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil. To.
Group 772'is composed of composition A in which 1 part of clothianidin, 1 part of tetraniliprol, 1 part of tefluthrin and 1 part of brofuranilide are added to each composition of groups 529'to 540'. To.
Group 773'is from composition A in which 1 part clothianidin, 1 part tetraniliprol, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. It is composed.
Group 774'is composed of composition A in which 1 part of clothianidin, 1 part of tetraniliprol, 1 part of tefluthrin and 1 part of fluxametamid are added to each composition of groups 529'to 540'. To.
Group 775'composed of each composition of groups 529'-540', plus 1 portion of clothianidin, 1 portion of tetraniliprol, 1 portion of tefluthrin and 1 portion of ginpropyridas. To.
Group 776'composed of each composition of groups 529' to 540', plus 1 part clothianidin, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil. To.
Group 777'composed of each composition of groups 529'to 540', plus 1 portion of clothianidin, 1 portion of tetraniliprol, 1 portion of bifenthrin and 1 portion of brofuranilide. To.
Group 778'is from composition A in which 1 part clothianidin, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. It is composed.
Group 779'composed of Composition A, each of the compositions of Groups 529'to 540', further to which 1 part clothianidin, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid were added. To.
Group 780'composed of each composition of groups 529' to 540', plus 1 portion of clothianidin, 1 portion of tetraniliprol, 1 portion of bifenthrin and 1 portion of ginpropyridas. To.
Group 781'is from composition A in which 1 part imidacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fipronil are added to each of the compositions of groups 529'to 540'. It is composed.
Group 782'is from composition A in which 1 part imidacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part brofuranilide are added to each composition of groups 529'to 540'. It is composed.
Group 783'is a composition obtained by adding 1 part imidacloprid, 1 part chlorantraniliplol, 1 part tefluthrin and 1 part isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 784'from each composition of groups 529' to 540' from composition A further comprising 1 part imidacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fluxametamid. It is composed.
Group 785'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 part imidacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part ginpropyridas. It is composed.
Group 786'is from composition A in which 1 part imidacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part fipronil are added to each composition of groups 529'to 540'. It is composed.
Group 787'is from composition A in which 1 part imidacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part brofuranilide are added to each composition of groups 529'to 540'. It is composed.
Group 788'is a composition obtained by adding 1 part imidacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 789'is from composition A in which 1 part imidacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part fluxametamid are further added to each composition of groups 529'to 540'. It is composed.
Group 790'is from composition A in which 1 part imidacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part ginpropyridas are added to each of the compositions of groups 529'to 540'. It is composed.
Group 791'consists of composition A in which 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil are added to each composition of groups 529'to 540'. Will be done.
Group 792'composed of composition A, each of the compositions of groups 529'to 540', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Will be done.
Group 793'is a composition A in which 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part isocycloceram are added to each composition of groups 529'to 540'. Consists of.
Group 794'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fluxametamid. Will be done.
Group 795'composed of each composition of groups 529' to 540', plus 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas. Will be done.
Group 796'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Will be done.
Group 797'consists of composition A in which 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide are added to each composition of groups 529'to 540'. Will be done.
Group 798'is a composition A in which 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part isocycloceram are added to each composition of groups 529'to 540'. Consists of.
Group 799'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fluxametamid. Will be done.
Group 800'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part ginpropyridas. Will be done.
Group 801'composed of each composition of groups 529'to 540', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil. To.
Group 802'composed of each composition of groups 529'to 540', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part brofuranilide. To.
Group 803'is from composition A in which 1 part imidacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. It is composed.
Group 804'composed of each composition of groups 529'to 540', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid. To.
Group 805'composed of each composition of groups 529' to 540', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 806'is composed of composition A in which 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil are added to each composition of groups 529'to 540'. To.
Group 807'composed of each composition of groups 529'to 540', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part brofuranilide. To.
Group 808'is from composition A in which 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. It is composed.
Group 809'is composed of composition A in which 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid are further added to each composition of groups 529'to 540'. To.
Group 810'composed of each composition of groups 529' to 540', plus 1 part imidacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part ginpropyridas. To.
Group 811'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fipronil are added to each composition of groups 529'to 540'. It is composed.
Group 812'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part brofuranilide are added to each of the compositions of groups 529'to 540'. It is composed.
Group 813'is a composition obtained by adding 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 814'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fluxametamid are further added to each composition of groups 529'to 540'. It is composed.
Group 815'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part ginpropyridas are added to each of the compositions of groups 529'to 540'. It is composed.
Group 816'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part fipronil are added to each composition of groups 529'to 540'. It is composed.
Group 817'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part brofuranilide are added to each composition of groups 529'to 540'. It is composed.
Group 818'is a composition obtained by adding 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 819'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part fluxametamid are further added to each composition of groups 529'to 540'. It is composed.
Group 820'is from composition A in which 1 part thiamethoxam, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part ginpropyridas are added to each composition of groups 529'to 540'. It is composed.
Group 821'consists of composition A in which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil are added to each composition of groups 529'to 540'. Will be done.
Group 822'consists of composition A, each of which is a composition of groups 529'to 540', to which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide are added. Will be done.
Group 823'is a composition A in which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. Consists of.
Group 824'composed of Composition A, each of the compositions of Groups 529'to 540', further to which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fluxametamid were added. Will be done.
Group 825'composed of each composition of groups 529' to 540', plus 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas. Will be done.
Group 826'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Will be done.
Group 827'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Will be done.
Group 828'is a composition A in which 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. Consists of.
Group 829'consists of composition A, each of which is a composition of groups 529'to 540', further to which is added 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fluxametamid. Will be done.
Group 830'composed of each composition of groups 529' to 540', plus 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part ginpropyridas. Will be done.
Group 831'composed of each composition of groups 529'to 540', plus 1 part thiamethoxam, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil. To.
Group 832'consists of composition A, each of which is a composition of groups 529'to 540', plus one part thiamethoxam, one part tetraniliprol, one part tefluthrin and one part brofuranilide. To.
Group 833'from composition A, each of the compositions of groups 529'-540', further comprising 1 part thiamethoxam, 1 part tetraniliprol, 1 part tefluthrin and 1 part isocycloceram. It is composed.
Group 834'composed of Composition A, each of the compositions of Groups 529'to 540', further comprising 1 part thiamethoxam, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid. To.
Group 835'composed of each composition of groups 529'to 540', plus 1 part thiamethoxam, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 836'composed of each composition of groups 529'to 540', plus 1 part thiamethoxam, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil. To.
Group 837'composed of Composition A, each of the compositions of Groups 529'to 540', further comprising 1 portion thiamethoxam, 1 portion tetraniliprol, 1 portion bifenthrin and 1 portion brofuranilide. To.
Group 838'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 part thiamethoxam, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram. It is composed.
Group 839'composed of Composition A, each of the compositions of Groups 529'to 540', further comprising 1 part thiamethoxam, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid. To.
Group 840'composed of each composition of groups 529' to 540', plus 1 part thiamethoxam, 1 part tetraniliprol, 1 part bifenthrin and 1 part ginpropyridas. To.
Group 841'is from composition A in which 1 part thiacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fipronil are added to each composition of groups 529'to 540'. It is composed.
Group 842'is from composition A in which 1 part thiacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part brofuranilide are added to each composition of groups 529'to 540'. It is composed.
Group 843'is a composition obtained by adding 1 part thiacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 844'from composition A, each of which is a composition of groups 529'to 540', further comprising 1 part thiacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fluxametamid. It is composed.
Group 845'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 part thiacloprid, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part ginpropyridas. It is composed.
Group 846'is from composition A in which 1 part thiacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part fipronil are further added to each composition of groups 529'to 540'. It is composed.
Group 847'is from composition A in which 1 part thiacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part brofuranilide are added to each composition of groups 529'to 540'. It is composed.
Group 848'is a composition obtained by adding 1 part thiacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 849'is from composition A in which 1 part thiacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part fluxametamid are further added to each composition of groups 529'to 540'. It is composed.
Group 850'is from composition A in which 1 part thiacloprid, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part ginpropyridas are added to each composition of groups 529'to 540'. It is composed.
Group 851'composed of each composition of groups 529' to 540', plus 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Will be done.
Group 852'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Will be done.
Group 853'is a composition A in which 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. Consists of.
Group 854'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fluxametamid. Will be done.
Group 855'composed of each composition of groups 529' to 540', plus 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas. Will be done.
Group 856'composed of Composition A, each of the compositions of Groups 529'to 540', further comprising 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Will be done.
Group 857'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Will be done.
Group 858'is a composition A in which 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. Consists of.
Group 859'consists of composition A, each of which is a composition of groups 529'to 540', further to which is added 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fluxametamid. Will be done.
Group 860'composed of each composition of groups 529' to 540', plus 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part ginpropyridas. Will be done.
Group 861'is composed of composition A in which 1 part thiacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil are added to each composition of groups 529'to 540'. To.
Group 862'composed of each composition of groups 529' to 540', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part brofuranilide. To.
Group 863'is from composition A in which 1 part thiacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. It is composed.
Group 864'composed of each composition of groups 529'to 540', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid. To.
Group 865'composed of each composition of groups 529' to 540', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 866'composed of each composition of groups 529'to 540', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil. To.
Group 867'composed of Composition A, each of the compositions of Groups 529'to 540', further comprising 1 portion thiacloprid, 1 portion tetraniliprol, 1 portion bifenthrin and 1 portion brofuranilide. To.
Group 868'is from composition A in which 1 part thiacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. It is composed.
Group 869'composed of Composition A, each of the compositions of Groups 529'to 540', further comprising 1 part thiacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid. To.
Group 870'composed of each composition of groups 529'-540', plus 1 part thiacloprid, 1 part tetraniliprol, 1 part bifenthrin and 1 part ginpropyridas. To.
Group 871'is from composition A, each of which is a composition of groups 529'to 540', plus one part of flupyraziflon, one part of chloranthraniliprol, one part of tefluthrin and one part of fipronil. It is composed.
Group 872'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 part flupyraziflon, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part brofuranilide. It is composed.
Group 873'is a composition obtained by adding 1 part of flupyraziflon, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 874'is from composition A, each of which is a composition of groups 529'to 540', to which 1 part flupyraziflon, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part fluxametamid are added. It is composed.
Group 875'is from composition A, each of which is a composition of groups 529'to 540', plus one part of flupyraziflon, one part of chlorantraniliprol, one part of tefluthrin and one part of ginpropyridas. It is composed.
Group 876'is from composition A in which 1 part of flupyraziflon, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fipronil are added to each of the compositions of groups 529'to 540'. It is composed.
Group 877'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 portion of flupyraziflon, 1 portion of chlorantraniliplol, 1 portion of bifenthrin and 1 portion of brofuranilide. It is composed.
Group 878'is a composition obtained by adding 1 part of flupyraziflon, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 879'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 portion of flupyraziflon, 1 portion of chlorantraniliplol, 1 portion of bifenthrin and 1 portion of fluxametamid. It is composed.
Group 880'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 portion of flupyraziflon, 1 portion of chlorantraniliplol, 1 portion of bifenthrin and 1 portion of ginpropyridas. It is composed.
Group 881'consists of composition A, which is obtained by adding 1 part of flupyraziflon, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fipronil to each composition of groups 529'to 540'. Will be done.
Group 882'composed of Composition A, each of the compositions of Groups 529'to 540', further to which 1 part flupyraziflon, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide were added. Will be done.
Group 883'is a composition A in which 1 part of flupyraziflon, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of isocycloceram are added to each of the compositions of groups 529'to 540'. Consists of.
Group 884'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part flupyraziflon, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fluxametamid. Will be done.
Group 885'composed of each composition of groups 529' to 540', plus 1 part flupyraziflon, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas. Will be done.
Group 886'composed of each composition of groups 529' to 540', plus 1 part flupyraziflon, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Will be done.
Group 887'composed of composition A, each of the compositions of groups 529'to 540', further comprising 1 part flupyraziflon, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Will be done.
Group 888'is a composition A in which 1 part of flupyraziflon, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of isocycloceram are added to each composition of groups 529'to 540'. Consists of.
Group 889'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part flupyraziflon, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fluxametamid. Will be done.
Group 890'composed of each composition of groups 529' to 540', plus 1 part flupyraziflon, 1 part cyantraniliprole, 1 part bifenthrin and 1 part ginpropyridas. Will be done.
Group 891'composed of each composition of groups 529' to 540', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil. To.
Group 892'composed of each composition of groups 529' to 540', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part tefluthrin and 1 part brofuranilide. To.
Group 893'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 part flupyraziflon, 1 part tetraniliprol, 1 part tefluthrin and 1 part isocycloceram. It is composed.
Group 894'composed of Composition A, each of the compositions of Groups 529'to 540', further to which 1 part flupyraziflon, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid were added. To.
Group 895'composed of each composition of groups 529'-540', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 896'composed of each composition of groups 529' to 540', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil. To.
Group 897'composed of each composition of groups 529'-540', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part bifenthrin and 1 part brofuranilide. To.
Group 898'is composed of the respective compositions of groups 529'to 540' from composition A further comprising 1 part flupyraziflon, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram. It is composed.
Group 899'composed of each composition of groups 529' to 540', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part bifenthrin and 1 part fluxametamid. To.
Group 900'composed of each composition of groups 529' to 540', plus 1 part flupyraziflon, 1 part tetraniliprol, 1 part bifenthrin and 1 part ginpropyridas. To.
Group 901'is from composition A in which 1 part of flupyrimin, 1 part of chlorantraniliplol, 1 part of tefluthrin and 1 part of fipronil are added to each of the compositions of groups 529'to 540'. It is composed.
Group 902'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 part flupyrimin, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part brofuranilide. It is composed.
Group 903'is a composition obtained by adding 1 part of flupyrimin, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 904'is from composition A in which 1 part of flupyrimin, 1 part of chlorantraniliplol, 1 part of tefluthrin and 1 part of fluxametamid are added to each of the compositions of groups 529'to 540'. It is composed.
Group 905'is from composition A in which 1 part of flupyrimin, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of ginpropyridas are added to each of the compositions of groups 529'to 540'. It is composed.
Group 906'is from composition A in which 1 part flupyrimin, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part fipronil are further added to each composition of groups 529'to 540'. It is composed.
Group 907'is from composition A in which 1 part flupyrimin, 1 part chlorantraniliplol, 1 part bifenthrin and 1 part brofuranilide are added to each composition of groups 529'to 540'. It is composed.
Group 908'is a composition obtained by adding 1 part of flupyrimin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 909'is from composition A in which 1 part of flupyrimin, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fluxametamid are further added to each composition of groups 529'to 540'. It is composed.
Group 910'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 portion of flupyrimin, 1 portion of chlorantraniliprol, 1 portion of bifenthrin and 1 portion of ginpropyridas. It is composed.
Group 911'composed of each composition of groups 529' to 540', plus 1 part flupyrimin, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Will be done.
Group 912'composed of each composition of groups 529' to 540', plus 1 part flupyrimin, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Will be done.
Group 913'is a composition A in which 1 part of flupyrimin, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of isocycloceram are added to each composition of groups 529'to 540'. Consists of.
Group 914'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part flupyrimin, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fluxametamid. Will be done.
Group 915'composed of each composition of groups 529' to 540', plus 1 part flupyrimin, 1 part cyantraniliprole, 1 part tefluthrin and 1 part ginpropyridas. Will be done.
Group 916'composed of each composition of groups 529' to 540', plus 1 part flupyrimin, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Will be done.
Group 917'composed of each composition of groups 529' to 540', plus 1 part flupyrimin, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Will be done.
Group 918'is a composition A in which 1 part of flupyrimin, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of isocycloceram are added to each composition of groups 529'to 540'. Consists of.
Group 919'consists of composition A, each of which is a composition of groups 529'to 540', further comprising 1 part flupyrimin, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fluxametamid. Will be done.
Group 920'composed of each composition of groups 529' to 540', plus 1 part flupyrimin, 1 part cyantraniliprole, 1 part bifenthrin and 1 part ginpropyridas. Will be done.
Group 921'composed of each composition of groups 529' to 540', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil. To.
Group 922'composed of each composition of groups 529'-540', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part tefluthrin and 1 part brofuranilide. To.
Group 923'is from composition A in which 1 part flupyrimin, 1 part tetraniliprol, 1 part tefluthrin and 1 part isocycloceram are further added to each composition of groups 529'to 540'. It is composed.
Group 924'composed of each composition of groups 529'to 540', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part tefluthrin and 1 part fluxametamid. To.
Group 925'composed of each composition of groups 529'-540', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part tefluthrin and 1 part ginpropyridas. To.
Group 926'composed of each composition of groups 529'-540', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part bifenthrin and 1 part fipronil. To.
Group 927'composed of each composition of groups 529'to 540', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part bifenthrin and 1 part brofuranilide. To.
Group 928'is from composition A, each of which is a composition of groups 529'to 540', further to which 1 part flupyrimin, 1 part tetraniliprol, 1 part bifenthrin and 1 part isocycloceram have been added. It is composed.
Group 929'is composed of composition A in which 1 part of flupyrimin, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of fluxametamid are added to each composition of groups 529'to 540'. To.
Group 930'composed of each composition of groups 529' to 540', plus 1 part flupyrimin, 1 part tetraniliprol, 1 part bifenthrin and 1 part ginpropyridas. To.
Group 931'is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of fipronil to each composition of groups 529'to 540'. It is composed of A.
Group 932'is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of brofuranilide to each composition of groups 529'to 540'. It is composed of A.
Group 933'added 1 part triflumezopyrim, 1 part chloranthraniliprol, 1 part tefluthrin and 1 part isocycloceram to each composition of groups 529'to 540'. It is composed of composition A.
Group 934'is a composition in which 1 part of triflumezopyrim, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of fluxametamid are further added to each composition of groups 529'to 540'. It is composed of A.
Group 935'is a composition in which 1 part of triflumezopyrim, 1 part of chloranthraniliprol, 1 part of tefluthrin and 1 part of ginpropyridas are added to each composition of groups 529'to 540'. It is composed of A.
Group 936'is a composition in which 1 part of triflumezopyrim, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fipronil are added to each composition of groups 529'to 540'. It is composed of A.
Group 937'is a composition in which 1 part of triflumezopyrim, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of brofuranilide are added to each composition of groups 529'to 540'. It is composed of A.
Group 938'added 1 part triflumezopyrim, 1 part chloranthraniliprol, 1 part bifenthrin and 1 part isocycloceram to each composition of groups 529'to 540'. It is composed of composition A.
Group 939'is a composition in which 1 part of triflumezopyrim, 1 part of chlorantraniliplol, 1 part of bifenthrin and 1 part of fluxametamid are further added to each composition of groups 529'to 540'. It is composed of A.
Group 940'is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chloranthraniliprol, 1 part of bifenthrin and 1 part of ginpropyridas to each composition of groups 529'to 540'. It is composed of A.
Group 941'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fipronil are added to each composition of groups 529'to 540'. Consists of.
Group 942'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of brofuranilide are added to each composition of groups 529'to 540'. Consists of.
Group 943'is a composition in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of isocycloceram are added to each composition of groups 529'to 540'. It is composed of object A.
Group 944'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of fluxametamid are added to each of the compositions of groups 529'to 540'. Consists of.
Group 945'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of tefluthrin and 1 part of ginpropyridas are added to each of the compositions of groups 529'to 540'. Consists of.
Group 946'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fipronil are added to each composition of groups 529'to 540'. Consists of.
Group 947'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of brofuranilide are added to each composition of groups 529'to 540'. Consists of.
Group 948'composed of each composition of groups 529' to 540' with 1 portion of triflumezopyrim, 1 portion of cyantraniliprole, 1 portion of bifenthrin and 1 portion of isocycloceram. It is composed of object A.
Group 949'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of fluxametamid are added to each of the compositions of groups 529'to 540'. Consists of.
Group 950'is a composition A in which 1 part of triflumezopyrim, 1 part of cyantraniliprole, 1 part of bifenthrin and 1 part of ginpropyridas are added to each of the compositions of groups 529'to 540'. Consists of.
Group 951'is from composition A, each of which is a composition of groups 529'to 540', further to which 1 part triflumesopyrim, 1 part tetraniliprol, 1 part tefluthrin and 1 part fipronil have been added. It is composed.
Group 952'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 portion of triflumesopyrim, 1 portion of tetraniliprol, 1 portion of tefluthrin and 1 portion of brofuranilide. It is composed.
Group 953'is a composition obtained by adding 1 part of triflumezopyrim, 1 part of tetraniliprol, 1 part of tefluthrin and 1 part of isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 954'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 portion of triflumesopyrium, 1 portion of tetraniliprol, 1 portion of tefluthrin and 1 portion of fluxametamid. It is composed.
Group 955'is from composition A, each of which is a composition of groups 529'to 540', plus one part of triflumezopyrim, one part of tetraniliprol, one part of tefluthrin and one part of ginpropyridas. It is composed.
Group 956'is from composition A in which 1 part of triflumezopyrim, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of fipronil are added to each composition of groups 529'to 540'. It is composed.
Group 957'is from composition A in which 1 part of triflumezopyrim, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of brofuranilide are added to each composition of groups 529'to 540'. It is composed.
Group 958'is a composition obtained by adding 1 part of triflumezopyrim, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of isocycloceram to each composition of groups 529'to 540'. It is composed of A.
Group 959'is from Composition A, in which 1 part of triflumesopyrim, 1 part of tetraniliprol, 1 part of bifenthrin and 1 part of fluxametamid are added to each of the compositions of groups 529'to 540'. It is composed.
Group 960'is from composition A, each of which is a composition of groups 529'to 540', further comprising 1 portion of triflumezopyrim, 1 portion of tetraniliprol, 1 portion of bifenthrin and 1 portion of ginpropyridas. It is composed.

Group 961'is composed of composition A in which 1000 parts of Bacillus subutilis strain QST713 are further added to each composition of groups 541'to 750'.
Group 962'is composed of composition A in which 1000 parts of Agrobactrerium radiobacter strain K84 is further added to each composition of groups 541'to 750'.
Group 963'is composed of composition A, which is obtained by adding 1000 parts of Bacillus amyloliquefaciens strain MBI 600 to each composition of groups 541'to 750'.
Group 964'is composed of composition A in which 1000 parts of Bacillus pumilus strain QST2808 are further added to each composition of groups 541'to 750'.
Group 965'is composed of composition A in which 1000 parts of Burkholderia cepacia are further added to each composition of groups 541'to 750'.
Group 966'consists of Composition A, which is obtained by adding 1000 parts of Gliocladium catenulatum strain J1446 to each of the compositions of Groups 541'to 750'.
Group 967'is composed of composition A in which 1000 parts of Pseudomonas chlororaphis strain MA342 are further added to each composition of groups 541'to 750'.
Group 968'is composed of composition A in which 1000 parts of Pseudomonas fluorescens are further added to each composition of groups 541'to 750'.
Group 969'is composed of composition A in which 1000 parts of Pythium oligandrum strain DV74 is further added to each composition of groups 541'to 750'.
Group 970'is composed of composition A in which 1000 parts of Streptomyces griseoviridis strain K61 are further added to each composition of groups 541'to 750'.
Group 971'is composed of composition A in which 1000 parts of Trichoderma gamsii are further added to each composition of groups 541'to 750'.
Group 972'is composed of composition A in which 1000 parts of Trichoderma asperellum is further added to each composition of groups 541'to 750'.
Group 973'is composed of composition A in which 1000 parts of Trichoderma harzianum strain T-22 is further added to each composition of groups 541'to 750'.
Group 974'is composed of composition A in which 1000 parts of Trichoderma virens strain GL-21 is further added to each composition of groups 541'to 750'.
Group 975'is composed of composition A in which 1000 parts of Streptomyces lydicus strain WYEC108 are further added to each composition of groups 541'to 750'.
Group 976'is composed of composition A in which 1000 parts of Bacillus thuringiensis subsp. Kurstraki strain ABTS-351 are further added to each composition of groups 541'to 750'.
Group 977'consists of composition A, which is obtained by adding 1000 parts of Bacillus thuringiensis subs. Kurstraki strain MBP123 to each composition of groups 541'to 750'.
Group 978'consists of composition A, which is obtained by adding 1000 parts of Bacillus thuringiensis subs.aizawai strain ABTS-1857 to each composition of groups 541'to 750'.
Group 979'is composed of composition A in which 1000 parts of Bacillus thuringiensis strain EX297512 are further added to each composition of groups 541'to 750'.
Group 980'is composed of composition A in which 1000 parts of Metarhizium anisopliae strain F52 is further added to each composition of groups 541'to 750'.
Group 981'is composed of composition A in which 1000 parts of Bacillus firmus strain l-1582 are further added to each composition of groups 541'to 750'.
Group 982'is composed of composition A in which 1000 parts of Pasteuria nishizawae strain Pn1 are further added to each composition of groups 541'to 750'.
Group 983'is composed of composition A in which 10000 parts of Bradyrhizobium japonicum strain TA-11 is further added to each composition of groups 541'to 750'.
Group 984'is composed of composition A in which 10,000 parts of Sinorhizobium meliloti are further added to each composition of groups 541'to 750'.
Group 985'is composed of composition A in which 10,000 parts of Rhizobium leguminosarum is further added to each composition of groups 541'to 750'.
Group 986'is composed of composition A in which 10,000 parts of Rhizophagus intraradices strain RTI-801 are further added to each composition of groups 541'to 750'.
Group 987'consists of each composition of groups 541'to 750', plus 10000 parts of Bacillus amylolique faciens and 10000 parts of Trichoderma virens.
Group 988'composed of each composition of groups 541'to 750', plus 10,000 parts of Penicillium bilaiae and 10,000 parts of Bradyrhizobium japonicum.
Group 989'is composed of composition A in which 10,000 parts of Penicillium bilaiae and 10,000 parts of Mesorhizobium ciceri are added to each of the compositions of groups 541'to 750'.
Group 990'is composed of composition A in which 10,000 parts of Bradyrhizobium japonicum and 10,000 parts of lipochitooligosaccharide are added to each of the compositions of groups 541'to 750'.

Group 991'is composed of composition A, which is obtained by adding a part of Bacillus subutilis strain QST713 to each composition of groups 751'to 960'.
Group 992'is composed of composition A in which a part of Agrobactrerium radiobacter strain K84 is further added to each composition of groups 751'to 960'.
Group 993'is composed of composition A, which is obtained by adding a part of Bacillus amyloliquefaciens strain MBI 600 to each composition of groups 751'to 960'.
Group 994'is composed of composition A, which is obtained by adding a part of Bacillus pumilus strain QST2808 to each composition of groups 751'to 960'.
Group 995'is composed of composition A, which is obtained by adding a part of Burkholderia cepacia to each composition of groups 751'to 960'.
Group 996'is composed of composition A, which is obtained by adding a part of Gliocladium catenulatum strain J1446 to each composition of groups 751'to 960'.
Group 997'is composed of composition A, which is obtained by adding a part of Pseudomonas chlororaphis strain MA342 to each composition of groups 751'to 960'.
Group 998'is composed of composition A in which a part of Pseudomonas fluorescens is further added to each composition of groups 751'to 960'.
Group 999'is composed of composition A in which a part of Pythium oligandrum strain DV74 is further added to each composition of groups 751'to 960'.
Group 1000'is composed of composition A, which is obtained by adding a part of Streptomyces griseoviridis strain K61 to each composition of groups 751'to 960'.
Group 1001'is composed of composition A, which is obtained by adding a part of Trichoderma gamsii to each composition of groups 751'to 960'.
Group 1002'is composed of composition A in which a part of Trichoderma asperellum is further added to each composition of groups 751'to 960'.
Group 1003'is composed of composition A, which is obtained by adding a part of Trichoderma harzianum strain T-22 to each composition of groups 751'to 960'.
Group 1004'is composed of composition A in which a part of Trichoderma virens strain GL-21 is further added to each composition of groups 751'to 960'.
Group 1005'is composed of composition A in which a part of Streptomyces lydicus strain WYEC108 is further added to each composition of groups 751'to 960'.
Group 1006'is composed of composition A, which is obtained by adding a part of Bacillus thuringiensis subsp. Kurstraki strain ABTS-351 to each composition of groups 751'to 960'.
Group 1007'is composed of composition A, which is obtained by adding a part of Bacillus thuringiensis subs. Kurstraki strain MBP123 to each composition of groups 751'to 960'.
Group 10008'is composed of composition A, which is obtained by adding a part of Bacillus thuringiensis subs.aizawai strain ABTS-1857 to each composition of groups 751'to 960'.
Group 1009'is composed of composition A, which is obtained by adding a part of Bacillus thuringiensis strain EX297512 to each composition of groups 751'to 960'.
Group 1010'is composed of composition A, which is obtained by adding a part of Metarhizium anisopliae strain F52 to each composition of groups 751'to 960'.
Group 1011'is composed of composition A, which is obtained by adding a part of Bacillus firmus strain l-1582 to each composition of groups 751'to 960'.
Group 1012'is composed of composition A in which a part of Pasteuria nishizawae strain Pn1 is further added to each composition of groups 751'to 960'.
Group 1013'is composed of composition A, which is obtained by adding a part of Bradyrhizobium japonicum strain TA-11 to each composition of groups 751'to 960'.
Group 1014'is composed of composition A in which a part of Sinorhizobium meliloti is further added to each composition of groups 751'to 960'.
Group 1015'is composed of composition A in which a part of Rhizobium leguminosarum is further added to each composition of groups 751'to 960'.
Group 1016'is composed of composition A in which a part of Rhizophagus intraradices strain RTI-801 is further added to each composition of groups 751'to 960'.
Group 1017'composed of each composition of groups 751'to 960', plus one part of Bacillus amylolique faciens and one part of Trichoderma virens.
Group 1018'is composed of composition A in which 1 part of Penicillium bilaiae and 1 part of Bradyrhizobium japonicum are added to each of the compositions of groups 751'to 960'.
Group 1019'is composed of composition A in which 1 part of Penicillium bilaiae and 1 part of Mesorhizobium ciceri are added to each composition of groups 751'to 960'.
Group 1020'is composed of composition A, which is obtained by adding 1 part of Bradyrhizobium japonicum and 1 part of lipochitooligosaccharide to each composition of groups 751'to 960'.

Group 1021'is composed of composition A in which 1000 parts of fluazindolizine is further added to each composition of groups 961'to 990'.
Group 1022'is composed of composition A in which 1000 parts of tioxazaphen is further added to each composition of groups 961'to 990'.
Group 1023'is composed of composition A in which 1000 parts of fluene sulfone is further added to each composition of groups 961'to 990'.
Group 1024'is composed of composition A in which 1000 parts of abamectin is further added to each composition of groups 961'to 990'.
Group 1025'is composed of composition A in which 1000 parts of fluopylum is further added to each composition of groups 961'to 990'.
Group 1026'is composed of composition A in which 1000 parts of cyclobutrifluram is further added to each composition of groups 961'to 990'.

Group 1027'is composed of composition A, which is obtained by adding a part of fluazindolizine to each composition of groups 991'to 1020'.
Group 1028'is composed of composition A in which a part of tioxazaphen is further added to each composition of groups 991'to 1020'.
Group 1029'is composed of composition A in which a part of fluene sulfone is further added to each composition of groups 991' to 1020'.
Group 1030'is composed of composition A in which a part of abamectin is further added to each composition of groups 991'to 1020'.
Group 1031'is composed of composition A in which a part of fluopylum is further added to each composition of groups 991'to 1020'.
Group 1032'is composed of composition A in which a portion of cyclobutriflulam is added to each of the compositions of groups 991'to 1020'.

Next, an example of the pharmaceutical product is shown. In addition, a part represents a weight part. The abbreviation for MX means any one composition A selected from groups 1-48 and groups 1'to 1032'.

Pharmaceutical example 1
The pharmaceutical product is prepared by mixing 35 parts of a mixture of polyoxyethylene alkyl ether sulfate ammonium salt and silica (weight ratio 1: 1), 10 parts of SX or MX, and 55 parts of water, and finely grinding the mixture by a wet grinding method. obtain.

Pharmaceutical example 2
A pharmaceutical product is obtained by pulverizing and mixing 50 parts of SX or MX, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and 45 parts of silica.

Pharmaceutical example 3
The preparation is prepared by mixing 5 parts of SX or MX, 9 parts of polyoxyethylene styrylphenyl ether, 5 parts of polyoxyethylene decyl ether (addition number of ethylene oxide: 5), 6 parts of calcium dodecylbenzenesulfonate, and 75 parts of xylene. obtain.

Pharmaceutical example 4
After pulverizing and mixing 2 parts of SX or MX, 1 part of silica, 2 parts of calcium lignin sulfonate, 30 parts of bentonite, and 65 parts of kaolinite, adding an appropriate amount of water, kneading, and granulating with a granulator, The formulation is obtained by drying.

Pharmaceutical example 5
10 parts of SX or MX 10 parts are mixed with a mixture of 18 parts of benzyl alcohol and 9 parts of DMSO, and 6.3 parts of GERONOL (registered trademark) TE250, Ethylan NS-500LQ (registered trademark) 2.7 parts, and solvent are prepared therein. Add 54 parts of naphtha and mix to obtain the formulation.

Pharmaceutical example 6
A pharmaceutical product is obtained by mixing 10 parts of SX or MX, 5 parts of nonylphenol ethoxylate, and 85 parts of propylene glycol.

Pharmaceutical example 7
A pharmaceutical product is obtained by mixing 10 parts of SX or MX and 20 parts of xylene and dispersing it in 68 parts of water containing 2 parts of polyvinyl alcohol.

Pharmaceutical example 8
30 parts of SX or MX, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and 65 parts of kaolin clay are pulverized and mixed, and an appropriate amount of water is added for kneading, granulating with a granulator, and then drying. Thereby, the preparation is obtained.

Pharmaceutical example 9
A mixture obtained by mixing 35 parts of a mixture of polyoxyethylene alkyl ether sulfate ammonium salt and white carbon (weight ratio 1: 1), 10 parts of SX or MX, and 55 parts of water and finely grinding them by a wet grinding method. Is granulated using a fluidized bed granulator to obtain a pharmaceutical product.

Formulation Example 10
A pharmaceutical product is obtained by mixing 20 parts of SX or MX, 5 parts of polyoxyethylene nonylphenyl ether, 3 parts of carboxylmethyl cellulose, and 72 parts of water.

Formulation Example 11
10 parts of SX or MX, 0.2 part of hexamethylene diisocyanate, and 10 parts of xylene are mixed and dispersed in 75.8 parts of water containing 2 parts of polyvinyl alcohol. A pharmaceutical product is obtained by adding 2 parts of ethylenediamine and advancing the encapsulation reaction while mixing.

Pharmaceutical example 12
A pharmaceutical product is obtained by grinding and mixing 2 parts of SX or 2 parts of MX, 88 parts of kaolin clay, and 10 parts of talc.

Pharmaceutical example 13
0.1 part of SX or 0.1 part of MX and 39.9 parts of kerosene are mixed and dissolved, put into an aerosol container, and liquefied petroleum gas (mixture of propane, isobutane and butane saturated vapor pressure: 0.47 MPa (25 ° C)) 60 parts. The formulation is obtained by filling with.

Pharmaceutical example 14
SX 0.02 part or MX 0.02 part, triethyl citrate 0.18 part, isopropyl myristate 3 part, paraffin solvent (neothiozole, manufactured by Chuo Kasei Co., Ltd.) 5.8 part, combination of glyceryl oleate and propylene glycol Mix and dissolve 0.8 part (Leodor MO-60, manufactured by Kao Co., Ltd.) and 0.2 part of polyoxyethylene sorbitan monooleate (Leodor TW-0120, manufactured by Kao Co., Ltd.). Put the mixture and 40 parts of water in an aerosol container, and fill 50 parts of dimethyl ether / liquefied petroleum gas (mixture saturated vapor pressure of propane, butane and isobutane: 0.35 MPa (25 ° C)) 1/1 (weight ratio). To obtain the formulation.

Pharmaceutical example 15
Mix 0.2 parts or MX 0.2 parts of SX, 50 parts of pyrethrum extract powder, 30 parts of tab powder, and 19.8 parts of wood powder, add an appropriate amount of water, knead, and then apply to an extruder to make a plate-shaped sheet. The pharmaceutical product is obtained by forming it into a spiral shape with a punching machine.

Formulation Example 16
10 parts of SX or MX and 90 parts of hydrocarbon solvent are mixed, and the obtained mixture is molded into a porous mat for impregnation (a mixture of wood pulp and linter pulp) having a length of 35 mm, a width of 22 mm, and a thickness of 2.8 mm. ) Is impregnated to obtain a formulation.

Pharmaceutical example 17
A pharmaceutical solution obtained by mixing and dissolving 3 parts of SX or 3 parts of MX and 97 parts of deodorizing kerosene is filled in a 45 ml plastic container, and a liquid absorbent core having a heater capable of heating the upper part via an inner plug is inserted to obtain a preparation. ..

Pharmaceutical example 18
A chemical solution is obtained by mixing and dissolving 1.5 parts of SX or MX 1.5 parts, 50 parts of diethylene glycol monobutyl ether, 1.8 parts of dibutylhydroxytoluene, and 46.7 parts of water, which is filled in a plastic bottle and plugged. An electric liquid mosquito repellent is obtained by inserting a liquid absorbing core whose upper part can be heated by a heater.

Pharmaceutical example 19
A pharmaceutical product is obtained by supporting 100 parts of SX or 100 parts of MX on a porous solid carrier (woven fabric, knitted fabric, non-woven fabric, paper, etc.).

Pharmaceutical example 20
SX50 parts or MX50 parts, white carbon (Carplex # 80, manufactured by EVONIK: average particle size: 15 μm) 18 parts, ethylene-vinyl acetate copolymer (Ultrasen 710, manufactured by Tosoh Corporation: vinyl in the copolymer) 20 parts of acetate (content rate: 28%) and 12 parts of LDPE (Suntech LDM6520, manufactured by Asahi Kasei Corporation) were kneaded at 120 to 140 ° C. to produce a pellet-shaped master batch.
Next, 100 parts by weight of the obtained pellets and 300 parts by weight of the LDPE are kneaded at 120 to 140 ° C., and then injection molded to obtain a pharmaceutical product.

Pharmaceutical example 21
4.4 parts of SX or MX 4.4 parts, 1.5 parts of diethylene glycol mono2-ethylhexyl ether, and 4.4 parts of hydroxymethylpentylcyclohexene carboxyamide are added to a polyester non-woven fabric (130 mm in the longitudinal direction, 64 mm in the lateral direction, thickness 0. A formulation is obtained by impregnating a predetermined amount with 46 mm and a coating amount of 170 g / m2).

Pharmaceutical example 22
22 parts of SX or MX22, 0.1 part of linalol, 2 parts of pregelatinized starch (Amicol H, manufactured by Nissho Chemical Co., Ltd.), 0.5 part of zinc oxide (manufactured by Shodo Chemical Industry Co., Ltd.), and azodicarbonamide (Uniform AZ). , Otsuka Chemical Co., Ltd.)) 75.4 parts are mixed, granulated and dried to obtain a columnar (circular diameter about 3 mm, length about 7 mm) preparation.

Pharmaceutical example 23
Mix 0.5 part or MX 0.5 part of SX, 4 parts of sesame oil, 2525 parts of starch syrup, 35 parts of glycerin, 1 part of gellan gum, and 34.5 parts of water to obtain a preparation.

Pharmaceutical example 24
SX100 parts or MX100 parts, lactose 68.75 parts, corn starch 237.5 parts, microcrystalline cellulose 43.75 parts, polyvinylpyrrolidone 18.75 parts, sodium carboxymethyl starch 28.75 parts, and magnesium stearate 2. A formulation is obtained by mixing 5 parts and compression molding.

Pharmaceutical example 25
A preparation is obtained by mixing 200 parts of SX or MX, 148 parts of lactose, and 2 parts of magnesium stearate and filling them in a hard gelatin capsule or a hydroxypropylmethylcellulose capsule.

Pharmaceutical example 26
After mixing 1 part of SX or MX, 74 parts of water for injection, and 25 parts of polyethylene glycol, the vial is filled with a vial and sterilized by an autoclave to obtain a pharmaceutical product.

Pharmaceutical example 27
After dissolving 5 parts of SX or MX 5 parts in 70 parts of diethylene glycol monoethyl ether, 25 parts of 2-octyldodecanol are mixed to obtain a preparation.

Pharmaceutical example 28
SX200 parts or MX200 parts, fumaric acid 50 parts, sodium chloride 200 parts, methylparaben 15 parts, propylparaben 5 parts, granule sugar 2500 parts, sorbitol (70% solution) 1300 parts, VeegumK (Vanderbilt Minerals, manufactured by LCC) 10 parts , 3.5 parts of fragrance, 50 parts of colorant, and 6000 parts of water are added and mixed to obtain a pharmaceutical product.

Pharmaceutical example 29
Mix 50 parts of SX or MX and 1.5 parts of dibutylhydroxytoluene (Sumilyzer BHT, manufactured by Sumitomo Chemical Co., Ltd.) to make 48.5 parts of porous silica (Carplex # 80, manufactured by EVONIK: average particle size 15 μm). Silica capsules were produced by adding, stirring and mixing.
31 parts of the silica capsule, 59.5 parts of linear low density polyethylene (Sumicasene-L GA807, manufactured by Sumitomo Chemical Co., Ltd .: density 0.912 kg / m ³ ), 5 parts of zinc stearate, and 4.5 parts of pigment. After melt-kneading at 150 ° C., it was extruded from an extruder and cut to produce resin pellets (diameter: 3 mm, length: 3 mm) containing a pest control component.
14 parts of the resin pellet, 85.4 parts of high-density polyethylene (Hi-Zex 5000S, manufactured by Mitsui Chemicals, Inc .: density 0.950 kg / m ³ ), and 0.6 part of zinc stearate are melt-spun at 220-240 ° C. Obtained a resin fiber. The fiber is knitted with Russell to obtain a net-like preparation.

Pharmaceutical example 30
Ethanol is added to SX2.291 g or MX2.291 g to obtain a total solution of 200 ml. On the other hand, ethanol is added to 18.94 g of the acrylic acid ester copolymer 44% emulsion to obtain a binder solution having a total volume of 100 ml. 14.5 ml of the solution and 25 ml of the binder solution are added to ethanol to obtain an impregnated solution having a total volume of 100 ml. The impregnated liquid is added to a polyester knitted fabric (length x width: 25 cm x 25 cm) made of multifilament, blended, and dried under light-shielding conditions overnight to obtain a net-like preparation.

Next, an example of application of Composition B to plant seeds will be shown.

Application example 1 (application to sorghum seeds)
By smearing 200 mL of any one of the formulations obtained by the method described in Formulation Example 1 onto 100 kg of dried sorghum seeds using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH). , Get the treated seeds.

Application example 2 (application to sorghum seeds)
200 mL of any one of the pharmaceuticals obtained by the method described in Formulation Example 1 is mixed with 180 g of Concep® II (manufactured by Syngenta) (including 136 g of oxabetrinyl). The resulting mixture is smeared onto 100 kg of dried sorghum seeds using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) to obtain treated seeds.

Application example 3 (application to sorghum seeds)
200 mL of any one of the formulations obtained by the method described in Formulation Example 1 is mixed with 2.1 L of Concep® III (manufactured by Syngenta) (including 40 g of fluxophenim). The resulting mixture is smeared onto 100 kg of dried sorghum seeds using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) to obtain treated seeds.

Application example 4 (application to corn seeds)
Using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), corn "SR corn" (acetyl CoA carboxylase inhibitor) was added to 10 mL of any one of the formulations obtained by the method described in Formulation Example 1. Treated seeds are obtained by smearing 10 kg of dried seeds (corn) imparted with resistance to.

Application example 5 (application to corn seeds)
Using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), 40 mL of any one of the preparations obtained by the method described in Preparation Example 1 was used to make corn "Mavera ™ Yield Gard ™ Maize". Treated seeds are obtained by smearing 10 kg of dried seeds (corn imparted with increased lysine production and resistance to vulture pests).

Application example 6 (application to corn seeds)
Using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), 100 mL of any one of the preparations obtained by the method described in Preparation Example 1 was used as a corn "Herculex Xtra" (glufosinate resistant, scaly order). Treated seeds are obtained by smearing 10 kg of dried seeds (corn that has been endowed with pest resistance and glufosinate pest resistance).

Application example 7 (application to corn seeds)
50 g of any one of the formulations obtained by the method described in Formulation Example 2 is powder-coated with 10 kg of dried seeds of corn "ZFN-12 maize" (corn having a reduced phytic acid content) to obtain treated seeds. obtain.

Application example 8 (application to soybean seeds)
Using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), 20 mL of any one of the formulations obtained by the method described in Formulation Example 1 is used to soybean "Plenish ™" (oleic acid content). The treated seeds are obtained by smearing 10 kg of dried seeds (soybeans to which the amount of sulfonylurea ALS-inhibiting herbicide resistance has been imparted).

Application example 9 (application to soybean seeds)
Using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), 100 mL of any one of the formulations obtained by the method described in Formulation Example 1 was used to soybean "Intacta ™ Roundup Ready ™". Treated seeds are obtained by smearing 10 kg of dried seeds of "2 Pro" (soybeans imparted with glyphosate resistance and scaly pest resistance).

Application example 10 (application to cotton seeds)
Using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), 50 mL of any one of the formulations obtained by the method described in Formulation Example 1 was added to the cotton "Bollgard (registered trademark) 3 Xtend Flex (registered trademark)". Treated seeds are obtained by smearing 10 kg of dried seeds of "Trademark)" (wat imparted with dicamba resistance, glyphosate resistance, glufosinate resistance and glufosinate pest resistance).

Application example 11 (application to canola seeds)
Using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), 50 mL of any one of the formulations obtained by the method described in Formulation Example 1 can be used as a canola "Clearfield (registered trademark) canola" (Imidazo). Each treated seed is obtained by smearing 10 kg of dried seeds (canola) imparted with Linon-based ALS-inhibiting herbicide resistance.

Application example 12 (application to rapeseed seeds)
By smearing 10 mL of any one of the formulations obtained by the method described in Formulation Example 1 on 10 kg of dried rapeseed seeds using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH). , Get the treated seeds.

Application example 13 (application to wheat seeds)
By smearing 50 mL of any one of the formulations obtained by the method described in Formulation Example 1 onto 10 kg of dried wheat seeds using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH). , Get the treated seeds.

Application example 14 (application to potato seed potatoes)
6 mL of any one of the pharmaceuticals obtained by the method described in Formulation Example 1 is spray-treated so as to be uniform on 10 kg of potato seed potatoes to obtain treated seed potatoes.

Application example 15
Put 10 kg of dried rice seeds (dried paddy) in a mesh bag, soak in a 50-fold water diluted solution of Benlate (registered trademark) wettable powder (Benomyl wettable powder, manufactured by Sumitomo Chemical Co., Ltd.) for 10 minutes, and then tap water. Soak in water for 3 days. The drained rice seeds are placed in a rotary pan-type rice seed coating machine and rotated to 5 times the 100 g of any one of the formulations obtained by the method described in Formulation Example 1, 5 kg of reduced iron powder, 600 g of roasted plaster, and 100 g of the prepared product. After adding the water-diluted solution and powder-coating, further powder-coat 300 g of roasted gypsum. Then, the rice seeds are taken out from the coating machine, dispersed on a vinyl sheet so as to have a thickness of 1 cm or less, and then allowed to stand and dried to obtain treated seeds.

Application example 16
10 kg of dried rice seeds (dried paddy) are placed in a net bag and immersed in a 20-fold aqueous diluted solution of Sterna (registered trademark) wettable powder (oxolinic acid wettable powder, manufactured by Sumitomo Chemical Co., Ltd.) for 10 minutes. Soak in tap water for 3 days. Described in Calper (registered trademark) powder granule 16 (calcium peroxide powder granule, Hodoya UPL Co., Ltd.) 20 kg and formulation example 2 while rotating the drained rice seed in a rotary pan type rice seed coating machine. Add 100 g of any one of the preparations obtained by the above method and coat with powder. Then, the rice seeds are taken out from the coating machine, dispersed on a vinyl sheet so as to have a thickness of 1 cm or less, and then allowed to stand and dried to obtain treated seeds.

Application example 17
Put 10 kg of dried rice seeds (dried paddy) in a net bag, soak in a 1500-fold diluted solution of Padang SG water solvent (Cartap hydrochloride water solvent, manufactured by Sumitomo Chemical Co., Ltd.) for 24 hours to disinfect, and then tap water. Soak in 3 days to germinate. While putting the drained rice seeds in a rotary pan type rice seed coating machine and rotating them, an appropriate amount of Zojirushi Noru washing glue (polyvinyl alcohol, Sanwa Yushi Kogyo Co., Ltd.) and molybdenum trioxide (Nippon Inorganic Chemical Industry Co., Ltd.) 200 g and A 2-fold aqueous diluted solution of 100 g of any one of the preparations obtained by the method described in Preparation Example 1 is added, and the surface of rice seeds is treated. Then, the rice seeds are taken out from the coating machine, dispersed on a vinyl sheet so as to have a thickness of 1 cm or less, and then allowed to stand and dried to obtain treated seeds.

Hereinafter, the effect of the present invention will be shown in a test example.

Test Example 1
The treated corn seeds obtained by the method described in Application Example 4 are sown at a depth of 5 cm at intervals of 15 cm using a sowing machine.
As a result, the effect of the SX or MX-treated maize on the seedling blight fungus (Rhizoctonia solani and Pythium spp.), Negusare nematode, and harmful arthropods that damage the maize can be confirmed.

Test Example 2
The treated soybean seeds obtained by the method described in Application Example 8 are sown and cultivated.
As a result, the effects of SX or MX-treated soybeans on Fusarium oxisporum, Rhizoctonia solani, soybean cyst nematodes, and harmful arthropods that damage soybeans can be confirmed.

Test Example 3
The treated seeds of canola obtained by the method described in Application Example 11 are sown and cultivated.
As a result, SX or MX-treated soybeans can be confirmed to have an effect on harmful arthropods that perpetrate Rhizoctonia solani, Rhizoctonia serrata, and canola.

Test Example 4
The rice seeds obtained in Application Example 15 are sown and cultivated in paddy fields.
As a result, it can be confirmed that the rice treated with SX or MX has an effect on rice worm, Lissorhoptrus chinensis, brown planthopper, brown planthopper, green planthopper, green rice leafhopper, green leafhopper, chilo suppressalis, chilo suppressalis, and locust. In addition, rice treated with SX or MX can control rice scabs and horizontal scabs to control these insect-borne rice dwarf diseases, Tungro disease, rice glassy stunt disease, rice rugged stunt disease, and rice stripe withering. The effects on diseases, black streak atrophy, rice southern black streak atrophy, yellow atrophy, rice yellow leaf disease, transitional yellowing disease and rice atrophy can be confirmed.

Test Example 5
Fill 24 kg of rice seeds in a cloth bag and soak the whole bag in water for 24 hours. The soaked rice seeds are placed on the concrete ground together with the above-mentioned bag, and allowed to stand for 36 hours while being appropriately sprinkled with water so as not to dry. The rice seeds taken out from the cloth bag after standing are spread on a sheet, and the aqueous diluted solution of the pharmaceutical product obtained by the method described in Pharmaceutical Example 2 is sprayed on the sheet, and the mixture is sufficiently stirred on the sheet. After plowing, watering, puddling, etc. in advance, the rice seeds are evenly and directly scattered by hand in the paddy fields where the flooding depth is maintained at about 2 cm by performing water drop treatment. Cultivate.
As a result, the effect of the rice treated with SX or MX can be confirmed on the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the green planthopper, the green rice leafhopper, the pyraloid moth, the pyraloid moth, the chilo suppressalis, and the itten oyster moth. The effect can also be confirmed on rice worms, rice planthoppers, brown planthoppers, green planthoppers, pyraloid moths, green rice leafhoppers, pyraloid moths, chilo suppressalis, chilo suppressalis, and pyraloid moths with reduced sensitivity to one or more compounds selected from groups a1 to a26. In particular, the effect can be confirmed against the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the brown planthopper, and the green rice leafhopper, which have reduced susceptibility to one or more compounds selected from the group a4. In addition, by controlling harmful insects belonging to the family Unka and Yokobai, rice dwarf disease, Tungro disease, rice glassy stunt disease, rice rugged stunt disease, rice stripe blight, and black streak atrophy transmitted by these insects. Rice can be protected from diseases, rice southern black streak atrophy, yellow atrophy, rice yellow leaf disease, transitional yellowing disease, and rice atrophy.

Test Example 6
After performing the puddling, the rice seeds obtained in Application Example 16 are sown and cultivated in a streak shape in a paddy field that has been managed to drop water for several days using a passenger seeding machine. At this time, the seeding amount per 10 ares is 4 kg of dry paddy.
As a result, it can be confirmed that the rice treated with SX or MX has an effect on the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the green leafhopper, the green leafhopper, the green leafhopper, the leafhopper, and the chilo suppressalis. Further, the effects on the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the green leafhopper, the green leafhopper, the green leafhopper, the leafhopper, and the chilo suppressalis, which are less sensitive to one or more compounds selected from the groups a1 to the group a26, can be confirmed. In particular, the effects on the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the brown planthopper, and the green rice leafhopper, which are less sensitive to one or more compounds selected from the group a4, can be confirmed. In addition, by controlling harmful insects belonging to the family Unka and Yokobai, rice dwarf disease, Tungro disease, rice glassy stunt disease, rice rugged stunt disease, rice stripe blight, and black streak atrophy transmitted by these insects. Rice can be protected from diseases, rice southern black streak atrophy, yellow atrophy, rice yellow leaf disease, transitional yellowing disease, and rice atrophy.

Test Example 7
The corn seeds obtained in Application Example 7 are sown at a depth of 5 cm at intervals of 15 cm using a sowing machine and cultivated.
As a result, the effect of the SX or MX-treated maize on the larvae of the click beetle family (collectively referred to as wire worms) represented by the genus Diabrotica such as Western corn root worm and the genus Agriotes and the genus Melanotus can be confirmed. The effect can also be confirmed on the above-mentioned click beetle larvae having reduced susceptibility to one or more compounds selected from groups a1 to a26.

Test Example 8
The soybean seeds obtained in Application Example 9 are sown and cultivated.
As a result, the effect of SX or MX-treated soybean on larvae of seed fly can be confirmed. The effect can also be confirmed on the larvae of the seed fly with reduced sensitivity to one or more compounds selected from the groups a1 to a26.

Test Example 9
The canola seeds obtained in Application Example 11 are sown and cultivated.
As a result, the canola treated with SX or MX can be confirmed to be effective against leaf beetle larvae. In addition, the effect can be confirmed on the larvae of the leaf beetle family, which are less sensitive to one or more compounds selected from the groups a1 to a26.

Test Example 10
The wheat seeds obtained in Application Example 13 are sown and cultivated.
As a result, the effect of the wheat treated with SX or MX can be confirmed against the larvae of the click beetle family. The effect can also be confirmed on larvae of the click beetle family with reduced sensitivity to one or more compounds selected from groups a1 to a26.

Test Example 11
The potato seed potato obtained in Application Example 14 is planted in the soil and cultivated.
As a result, SX or MX-treated potatoes can be confirmed to be effective against leaf beetle larvae. In addition, the effect can be confirmed on larvae of the family Chrysomelidae, which are less sensitive to one or more compounds selected from groups a1 to a26.

Test Example 12
The granules obtained in Formulation Example 4 are mixed with soil, and sugarcane stalk fragments are planted therein and cultivated.
As a result, the sugarcane treated with SX or MX can be confirmed to be effective against the larvae of the click beetle family. In addition, the effect can be confirmed on larvae of the click beetle family, which have reduced susceptibility to one or more compounds selected from groups a1 to a26.

Test Example 13
The aqueous diluted solution of the pharmaceutical product obtained by the method described in Pharmaceutical Example 1 is sprayed on a planting ditch for planting a sugarcane stalk fragment before soil covering, and then soil-covered and cultivated.
As a result, the sugarcane treated with SX or MX can be confirmed to be effective against the larvae of the click beetle family. In addition, the effect can be confirmed on larvae of the click beetle family whose sensitivity to one or more compounds selected from groups a1 to a26 is reduced.

Test Example 14
Rice seeds (150 g of dry paddy) are sterilized with a mixture of ipconazole and cupric hydroxide. A seedling box (width about 60 cm, length about 30 cm) is covered with floor soil, and seed-sterilized rice seeds are uniformly sown on it. Subsequently, 50 g of the granules obtained by the method described in Pharmaceutical Example 4 is uniformly sprayed, covered with soil, and the seedlings are raised. Rice seedlings grown in the 2.5-leaf stage are transplanted to paddy fields using a rice transplanter and cultivated.
As a result, the rice treated with SX or MX has an effect on rice planthoppers, chilo suppressalis, brown planthoppers, brown planthoppers, green leafhoppers, leafhoppers, leafhoppers, leafhoppers, chilo suppressalis, chilo suppressalis, and leafminers. In addition, rice worms, rice planthoppers, brown planthoppers, brown planthoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, and leafhoppers with reduced susceptibility to one or more compounds selected from groups a1 to a26. You can check the effect. In particular, the effect can be confirmed against the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the brown planthopper, and the green rice leafhopper, which have reduced susceptibility to one or more compounds selected from the group a4. In addition, by controlling harmful insects belonging to the family Unka and Yokobai, rice dwarf disease, Tungro disease, rice glassy stunt disease, rice rugged stunt disease, rice stripe blight, and black streak atrophy transmitted by these insects. Rice can be protected from diseases, rice southern black streak atrophy, yellow atrophy, rice yellow leaf disease, transitional yellowing disease, and rice atrophy.

Test Example 15
The pharmaceutical product obtained by the method described in Formulation Example 1 is diluted 400-fold with water. 500 mL of the obtained diluted solution is irrigated with a 3.5-leaf stage rice seedling cultivated in a nursery box (width about 60 cm, length about 30 cm) using a irrigation device. The treated rice seedlings are transplanted to paddy fields using a rice transplanter and cultivated.
As a result, the rice treated with SX or MX has an effect on rice planthoppers, chilo suppressalis, brown planthoppers, brown planthoppers, green leafhoppers, leafhoppers, leafhoppers, leafhoppers, chilo suppressalis, chilo suppressalis, and leafminers. In addition, rice worms, rice planthoppers, brown planthoppers, brown planthoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, and leafhoppers with reduced susceptibility to one or more compounds selected from groups a1 to a26. You can check the effect. In particular, the effect can be confirmed against the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the brown planthopper, and the green rice leafhopper, which have reduced susceptibility to one or more compounds selected from the group a4. In addition, by controlling harmful insects belonging to the family Unka and Yokobai, rice dwarf disease, Tungro disease, rice glassy stunt disease, rice rugged stunt disease, rice stripe blight, and black streak atrophy transmitted by these insects. Rice can be protected from diseases, rice southern black streak atrophy, yellow atrophy, rice yellow leaf disease, transitional yellowing disease, and rice atrophy.

Test Example 16
The pharmaceutical product obtained by the method described in Formulation Example 1 is diluted 200-fold with water. 500 mL of the obtained diluted solution is irrigated with a watering can on rice seedlings in the 2.5-leaf stage cultivated in a nursery box (width about 60 cm, length about 30 cm). The treated rice seedlings are transplanted to paddy fields using a rice transplanter and cultivated.
As a result, the rice treated with SX or MX has an effect on rice planthoppers, chilo suppressalis, brown planthoppers, brown planthoppers, green leafhoppers, leafhoppers, leafhoppers, leafhoppers, chilo suppressalis, chilo suppressalis, and leafminers. In addition, rice worms, rice planthoppers, brown planthoppers, brown planthoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, leafhoppers, and leafhoppers with reduced susceptibility to one or more compounds selected from groups a1 to a26. You can check the effect. In particular, the effect can be confirmed against the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the brown planthopper, and the green rice leafhopper, which have reduced susceptibility to one or more compounds selected from the group a4. In addition, by controlling harmful insects belonging to the family Unka and Yokobai, rice dwarf disease, Tungro disease, rice glassy stunt disease, rice rugged stunt disease, rice stripe blight, and black streak atrophy transmitted by these insects. Rice can be protected from diseases, rice southern black streak atrophy, yellow atrophy, rice yellow leaf disease, transitional yellowing disease, and rice atrophy.

Test Example 17
The SX or MX is prepared according to the method described in Formulation Example 1. Similarly, triflumesopyrim, flupyradiflon or flupyrimin are prepared according to the method described in Preparation Example 1 respectively. Spreading agent (trade name: Cindyne (registered trademark)) so that the above-mentioned preparations have active ingredient concentrations of 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume to obtain each diluent. Commercially available Admire wettable powder (active ingredient: Imidacloprid, manufactured by Bayer Crop Science Co., Ltd.) and Actara granule wettable powder (active ingredient: thiamethoxam, manufactured by Syngenta Japan Co., Ltd.) with an active ingredient concentration of 0.05 ppm. Dilute with water containing 0.05% by volume of the spreader (trade name: Cindein (registered trademark)) so as to be 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Obtain a diluted solution of. Cucumber seedlings planted in containers (second true leaf development stage) sensitive strains (strains bred for generations within Sumitomo Chemical Co., Ltd. Health Agriculture and Related Business Research Institute) or reduced susceptibility strains (in Miyazaki Prefecture in 2016) After collection, inoculate 30 cotton aphids (including all growth stages) of unselected strains that have been bred for generations. After 1 day, the seedlings are sprayed with the resulting diluent at a rate of 10 mL / seedling. On the other hand, cucumbers are cultivated in the same manner as in the treated plot except that the diluted solution containing SX or MX is not sprayed (this is referred to as the untreated plot). Six days after spraying, the number of surviving insects is observed, and the control value is determined by the formula 1).
Equation 1); Control value (%) = {1- (Cb × Tai) / (Cai × Tb)} × 100
The characters in the formula have the following meanings.
Cb: Number of test insects in the untreated plot Cai: Number of surviving insects in the untreated plot Tb: Number of test insects in the treated plot Tai: Number of surviving insects in the treated plot As a result, the nicotinic property of group a4 It is confirmed that the treatment groups of the acetylcholine receptor-competitive modulators triflumezopyrim, flupyradiflon, flupyrimin, imidacloprid or thiamethoxam are all less effective on the susceptible strains than on the susceptible strains. This confirms that the desensitized strain used in this study is a desensitized strain to the nicotinic acetylcholine receptor-competitive modulator. On the other hand, the treatment group of SX or MX can confirm the same effect on the susceptible strains on the susceptible strains.

Test Example 18
The SX or MX is prepared according to the method described in Formulation Example 1. Similarly, fulpyraziflon and fulpyrimin are prepared according to the method described in Preparation Example 4, respectively. Spreading agent (trade name: Cindyne (registered trademark)) so that the active ingredient concentrations of the above formulations are 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume. A commercially available Admire wettable powder (active ingredient: imidacloprid, manufactured by Bayer Crop Science Co., Ltd.) has an active ingredient concentration of 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or Dilute with water containing 0.05% by volume of the spreading agent (trade name: Cinderine (registered trademark)) so as to be 200 ppm. The diluted solution obtained on the seedlings (2.5th leaf stage) of rice (Oryza sativa) planted in a container is sprayed at a ratio of 10 mL / seedling. After that, the susceptible brown planthopper (a strain that has been bred for generations within the Institute for Health Agriculture and Related Businesses of Sumitomo Chemical Co., Ltd.) or the vulnerable brown planthopper (a strain that has been bred in Nagasaki Prefecture in 2016) has been bred for generations without selection. Release 20 3rd instar larvae of the strain). After 6 days, the number of surviving insects is investigated, and the dead insect rate is calculated by the formula 2). On the other hand, rice is cultivated in the same manner as in the treated plot except that the diluted solution containing SX or MX is not sprayed (this is referred to as the untreated plot).
Equation 2) Death rate (%) = {1-number of surviving insects / 20} x 100
As a result, it is confirmed that the treatment groups of flupyradiflon, flupyrimin or imidacloprid, which are nicotinic acetylcholine receptor-competitive modulators of group a4, are less effective on the susceptible strains than the effects on the susceptible strains. This confirms that the desensitized strain used in this study is a desensitized strain to the nicotinic acetylcholine receptor-competitive modulator. On the other hand, the treatment group of SX or MX can confirm the same effect on the susceptible strains on the susceptible strains.

Test Example 19
The SX or MX is prepared according to the method described in Formulation Example 1. Spreading agent (trade name: Cindyne (registered trademark)) so that the active ingredient concentrations of the above formulations are 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume. Commercially available Phoenix Granule Wettable Powder (active ingredient: flubendiamide, manufactured by Nihon Nohyaku Co., Ltd.), Prevason Flowable 5 (active ingredient: chlorantraniliprol, manufactured by Nissan Chemical Co., Ltd.) and Venevia OD (active ingredient:) Cyantraniriplol (manufactured by Kumiai Chemical Industry Co., Ltd.) as a spreading agent so that the active ingredient concentrations are 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Product name: Cindyne (registered trademark) Dilute with water containing 0.05% by volume. The diluted solution obtained on the cabbage (Brassicae oleracea) seedlings (3rd to 4th cotyledon developing stage) planted in the container is sprayed at a ratio of 20 mL / seedling. After that, the sensitive strain diamondback moth (a strain that has been bred for generations within the Institute for Health Agriculture and Related Businesses of Sumitomo Chemical Co., Ltd.) or the susceptibility-reduced diamondback moth (a strain that has been collected in Kumamoto Prefecture in 2016 and then bred for generations without selection). Release 10 3rd instar larvae of the strain). After 5 days, the number of surviving insects is counted and the dead insect rate is calculated from the formula 3). On the other hand, cabbage is cultivated in the same manner as in the treated plot except that the diluted solution containing SX or MX is not sprayed (this is referred to as the untreated plot).
Equation 3) Death rate (%) = (1-number of surviving insects / 10) x 100
As a result, the treatment groups of flubendiamide, chloranthraniliprole or cyantraniliprole, which are ryanodine receptor modulators of group a17, are less effective on the susceptible strains than the effects on the susceptible strains. It is confirmed. This confirms that the desensitized strain used in this study is a strain with reduced sensitivity to the ryanodine receptor modulator. On the other hand, the treatment group of SX or MX can confirm the same effect on the susceptible strains on the susceptible strains.

Test Example 20
The SX or MX is prepared according to the method described in Formulation Example 1. Similarly, fulpyraziflon and fulpyrimin are prepared according to the method described in Preparation Example 1, respectively. Spreading agent (trade name: Cindyne (registered trademark)) so that the active ingredient concentrations of the above formulations are 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume. Commercially available Admire Granule Wettable Powder (active ingredient: Imidacloprid, manufactured by Bayer Crop Science Co., Ltd.), Trebon Emulsion (active ingredient: Etophenprox, manufactured by Mitsui Kagaku Agro Co., Ltd.), Prince Flowable (active ingredient: Fipronil, BASF Japan Co., Ltd.), Kirap Flowable (active ingredient: Echiprol, Bayer Crop Science Co., Ltd.), Upflow Flowable (active ingredient: Buprofezin, Nippon Agricultural Chemicals Co., Ltd.) with active ingredient concentrations of 0.05 ppm and 0, respectively. Dilute with water containing 0.05% by volume of the spreading agent (trade name: Cinderine®) so as to be .2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm. The diluted solution obtained on the seedlings (2.5th leaf stage) of rice (Oryza sativa) planted in a container is sprayed at a ratio of 10 mL / seedling. After that, the sensitive strain Himetobiunka (a strain that has been bred for generations in the Health and Agriculture Business Research Institute of Sumitomo Chemical Co., Ltd.) or the susceptibility-reduced strain Himetobiunka (a strain that has been collected in Nagasaki Prefecture in 2016 and then bred for generations without selection). Release 20 3rd instar larvae of strain). After 6 days, the number of surviving insects is investigated, and the dead insect rate is calculated by the formula 2). On the other hand, rice is cultivated in the same manner as in the treated plot except that the diluted solution containing SX or MX is not sprayed (this is referred to as the untreated plot).
Equation 2) Death rate (%) = {1-number of surviving insects / 20} x 100
As a result, group a4 nicotinic acetylcholine receptor competitive modulators flupyraziflon, flupyrimin or imidacloprid, group a2 GABAergic chlorine ion channel blocker fipronil or etiprol, group a3 sodium channel modulator etofenprox or It is confirmed that the treatment group of buprofezin, which is a nicotine biosynthesis inhibitor in group a12, has a lower effect on the susceptible strains than the effect on the susceptible strains. From this, it is confirmed that the desensitized strain used in this test is a strain desensitized to these compounds. On the other hand, the treatment group of SX or MX can confirm the same effect on the susceptible strains on the susceptible strains.

Test Example 21
The SX or MX is prepared according to the method described in Formulation Example 1. Spreading agent (trade name: Cindyne (registered trademark)) so that the active ingredient concentrations of the above formulations are 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume. Commercially available Prince Flowable (active ingredient: Fipronil, manufactured by BASF Japan Co., Ltd.) and Kirap Flowable (active ingredient: Echiprol, manufactured by Bayer Crop Science Co., Ltd.) have active ingredient concentrations of 0.05 ppm and 0.2 ppm, respectively. Dilute with water containing 0.05% by volume of the spreading agent (trade name: Cindyne (registered trademark)) so as to be 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm. The diluted solution obtained on the rice seedlings (2.5th leaf stage) planted in the container is sprayed at a ratio of 10 mL / seedling. After that, the susceptible strain Sedirounka (a strain that has been bred for generations within the Institute for Health Agriculture and Related Businesses of Sumitomo Chemical Co., Ltd.) or the susceptibility-reduced strain Sedirounka (a strain that has been collected in Nagasaki Prefecture in 2016 and then bred for generations without selection). Release 20 3rd instar larvae of strain). After 6 days, the number of surviving insects is investigated, and the dead insect rate is calculated by the formula 2). On the other hand, rice is cultivated in the same manner as in the treated plot except that the diluted solution containing SX or MX is not sprayed (this is referred to as the untreated plot).
Equation 2) Death rate (%) = {1-number of surviving insects / 20} x 100
As a result, it is confirmed that the treatment group of fipronil or etiprol, which is a GABAergic chlorine ion channel blocker of group a2, has a lower effect on the susceptible strain than the effect on the susceptible strain. From this, it is confirmed that the desensitized strain used in this test is a strain desensitized to these compounds. On the other hand, the treatment group of this SX or MX can confirm the same effect on the susceptible strains on the susceptible strains.

Test Example 22
The SX or MX is prepared according to the method described in Formulation Example 1.
The above-mentioned preparation is diluted 100-fold with water. The obtained diluted solution is irrigated with 500 mL in a cell-molded seedling raising tray (width about 60 cm, length about 30 cm) of cabbage one day before planting, planted in a field, and cultivated.
As a result, the effect of the SX or MX-treated cabbage on harmful insects belonging to the family Plutellidae, Noctuidae and Pieridae can be confirmed. The effect can also be confirmed against harmful insects belonging to the family Plutellidae, Noctuidae and Pieridae, whose susceptibility to one or more compounds selected from groups a1 to a26 is reduced. In particular, the effect can be confirmed on diamondback moth having reduced sensitivity to one or more compounds selected from group a17.

Test Example 23
The SX or MX is prepared according to the method described in Formulation Example 4. After sowing, a few rice seeds coated with iron oxide powder were sown in a paddy field that had been managed to drop water for several days, and the above-mentioned preparation was sown at a ratio of 1 kg / 10a at the sowing position. Apply to a position directly below and at a depth of 1 cm. After that, rice is cultivated.
As a result, the rice treated with SX or MX has an effect on rice planthoppers, chilo suppressalis, brown planthoppers, brown planthoppers, green leafhoppers, leafhoppers, leafhoppers, leafhoppers, chilo suppressalis, chilo suppressalis, rice leafminers, and leafminers. Lissorhoptrus chinensis, Lissorhoptrus chinensis, Brown planthopper, Brown planthopper, Leafhopper, Nephotettix crab, Leafhopper, Chilo suppressalis, Agromyzidae, Chilo suppressalis You can check. In particular, the effect can be confirmed against the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the brown planthopper, and the green rice leafhopper, which are less sensitive to one or more compounds selected from the group a4. In addition, by controlling harmful insects belonging to the family Unka and Yokobai, rice dwarf disease, Tungro disease, rice glassy stunt disease, rice rugged stunt disease, rice stripe blight, and black streak atrophy transmitted by these insects. Rice can be protected from diseases, rice southern black streak atrophy, yellow atrophy, rice yellow leaf disease, transitional yellowing disease and rice atrophy.

Test Example 24
The SX or MX is prepared according to the method described in Formulation Example 4. Rice seeds coated with Calper (registered trademark) powder granule 16 (calcium peroxide powder granule, Hodoya UPL Co., Ltd.) were placed in a paddy field that had been managed to drop water for several days after being squeezed. While sowing several seeds, the above-mentioned preparation is applied at a ratio of 1 kg / 10a to a position 3 cm lateral and 3 cm deep at the sowing position. After that, rice is cultivated.
As a result, the rice treated with SX or MX has an effect on rice planthoppers, chilo suppressalis, brown planthoppers, brown planthoppers, green leafhoppers, leafhoppers, leafhoppers, leafhoppers, chilo suppressalis, chilo suppressalis, rice leafminers, and leafminers. Lissorhoptrus chinensis, Lissorhoptrus chinensis, Brown planthopper, Brown planthopper, Leafhopper, Nephotettix crab, Leafhopper, Chilo suppressalis, Agromyzidae, Chilo suppressalis You can check. In particular, the effect can be confirmed against the rice worm, the brown planthopper, the brown planthopper, the brown planthopper, the brown planthopper, and the green rice leafhopper, which are less sensitive to one or more compounds selected from the group a4. In addition, by controlling harmful insects belonging to the family Unka and Yokobai, rice dwarf disease, Tungro disease, rice glassy stunt disease, rice rugged stunt disease, rice stripe blight, and black streak atrophy transmitted by these insects. Rice can be protected from diseases, rice southern black streak atrophy, yellow atrophy, rice yellow leaf disease, transitional yellowing disease and rice atrophy.

According to the present invention, harmful arthropods can be controlled.

Claims (6)

Equation (I)

[In the ceremony,
Z represents an oxygen atom or a sulfur atom.
R ¹ is a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from the group W, and C3-C7 which may be substituted with one or more substituents selected from the group U. A cycloalkyl group, a phenyl group optionally substituted with one or more substituents selected from group V, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group V. , C (O) R ⁵¹ , C (O) OR ⁵¹ , or C (O) NR ⁵¹ R ⁵² .
R ⁵¹ and R ⁵² are the same or different, and may be substituted with a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, or one or more substituents selected from the group V. Represents a phenyl group, a 5- or 6-membered heterocyclic group optionally substituted with one or more substituents selected from group V, or a hydrogen atom.
R ² represents a C1-C6 alkyl group, cyclopropyl group, or cyclopropylmethyl group that may be substituted with one or more halogen atoms.
n represents 0, 1 or 2 and represents
G ¹ represents a nitrogen atom or CR ^3a
G ² represents a nitrogen atom or CR ^3b
G ³ represents a nitrogen atom or CR ^3c
G ⁴ represents a nitrogen atom or CR ^3d
R ^3a , R ^3b , R ^3c and R ^3d are the same or different, and may be substituted with one or more substituents selected from group B. C1-C6 chain hydrocarbon group, selected from group E 1 C3-C7 cycloalkyl group optionally substituted with the above substituents, phenyl group optionally substituted with one or more substituents selected from group H, substituted with one or more substituents selected from group H May be 5- or 6-membered aromatic heterocyclic groups, OR ¹² , NR ¹¹ R ¹² , NR ^11a R ^12a , NR ²⁴ NR ¹¹ R ¹² , NR ²⁴ OR ¹¹ , NR ¹¹ C (O) R ¹³ , NR. ²⁴ NR ¹¹ C (O) R ¹³ , NR ¹¹ C (O) OR ¹⁴ , NR ²⁴ NR ¹¹ C (O) OR ¹⁴ , NR ¹¹ C (O) NR ³¹ R ³² , NR ²⁴ NR ¹¹ C (O) NR ³¹ R ³² , N = CHNR ³¹ R ³² , N = S (O) _p R ¹⁵ R ¹⁶ , C (O) R ¹³ , C (O) OR ¹⁷ , C (O) NR ³¹ R ³² , C (O) Represents NR ¹¹ S (O) ₂ R ²³ , CR ³⁰ = NOR ¹⁷ , NR ¹¹ CR ²⁴ = NOR ¹⁷ , S (O) _m R ²³ , cyano group, nitro group, hydrogen atom, or halogen atom.
p represents 0 or 1 and represents
m represents 0, 1 or 2 and represents
R ³⁰ represents a C1-C6 chain hydrocarbon group, a halogen atom, OR ³⁵ , NR ³⁶ R ³⁷ , or a hydrogen atom which may be substituted with one or more halogen atoms.
R ³⁵ represents a C1-C6 chain hydrocarbon group that may be substituted with one or more halogen atoms.
R ¹⁷ represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from Group D, or a hydrogen atom. ,
R ¹¹ , R ²⁴ , R ³⁶ and R ³⁷ represent C1-C6 chain hydrocarbon groups or hydrogen atoms that are the same or different and may be substituted with one or more halogen atoms.
R ¹² is a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group F, and C3-C7 which may be substituted with one or more substituents selected from group J. Cycloalkyl group, C3-C7 cycloalkenyl group optionally substituted with 1 or more substituents selected from group J, phenyl group optionally substituted with 1 or more substituents selected from group D, group D Represents a 6-membered aromatic heterocyclic group, a hydrogen atom, or S (O) ₂ R ²³ , which may be substituted with one or more substituents of choice.
R ²³ represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms or a phenyl group optionally substituted with one or more substituents selected from Group D.
R ^11a and R ^12a together with the nitrogen atom to which they bind form a 3-7 member non-aromatic heterocyclic group which may be substituted with one or more substituents selected from group E.
R ¹³ is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C7 cycloalkyl group optionally substituted with one or more halogen atoms, and one or more halogen atoms. May be substituted (C3-C6 cycloalkyl) C1-C3 alkyl group, phenyl group optionally substituted with one or more substituents selected from group D, one or more substituents selected from group D Represents a optionally substituted 5- or 6-membered aromatic heterocyclic group, or a hydrogen atom.
R ¹⁴ is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C7 cycloalkyl group optionally substituted with one or more halogen atoms, and one or more halogen atoms. May be substituted (C3-C6 cycloalkyl) C1-C3 alkyl group or phenyl C1-C3 alkyl group {The phenyl moiety in the phenyl C1-C3 alkyl group is one or more substituents selected from Group D. May be replaced}
R ¹⁵ and R ¹⁶ represent C1-C6 alkyl groups that are identical or different and may be substituted with one or more halogen atoms.
R ³¹ represents a C1-C6 alkyl group or a hydrogen atom which may be substituted with one or more halogen atoms.
R ³² is a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group F, and C3-C7 which may be substituted with one or more substituents selected from group J. Represents a cycloalkyl group, S (O) ₂ R ²³ , or a hydrogen atom.
A ¹ represents a nitrogen atom or CR ^4a .
A ² represents a nitrogen atom or CR ^4b .
A ³ represents a nitrogen atom or CR ^4c .
A ⁴ represents a nitrogen atom or CR ^4d .
A ⁵ represents a nitrogen atom or CR ^4e (however, not all of A ² , A ³ and A ⁴ represent a nitrogen atom).
R ^4a and R ^4e are the same or different, and are substituted with a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from the group X, and one or more substituents selected from the group Y. C3-C6 cycloalkyl group may be substituted, a phenyl group may be substituted with one or more substituents selected from group Z, and one or more substituents selected from group Z may be substituted. Or 6-membered heterocyclic group, OR ⁴⁴ , S (O) _k R ⁴¹ , S (O) ₂ NR ⁴¹ R ⁴² , NR ⁴¹ R ⁴³ , NR ⁴¹ C (O) R ⁴² , NR ⁴¹ C (O) OR ⁴² , NR ⁴¹ S (O) ₂ R ⁴³ , C (O) R ⁴¹ , C (O) OR ⁴¹ , C (O) NR ⁴¹ R ⁴² , CR ⁴² = NOR ⁴¹ , hydroxy group, cyano group, nitro group, halogen Represents an atom or a hydrogen atom
When A ⁵ is CR ^4e , R ^4e and R ¹ may be combined to form -NR ⁴⁵ -CR ⁴¹ R ^42- # {# is with the nitrogen atom to which R ¹ is bonded. Represents the bond position},
R ^4b , R ^4c and R ^4d are the same or different and may be substituted with one or more substituents selected from group X, C1-C6 chain hydrocarbon groups, one or more substituteds selected from group Y. It is substituted with a C3-C6 cycloalkyl group which may be substituted with a group, a phenyl group which may be substituted with one or more substituents selected from group Z, and one or more substituents selected from group Z. Maybe 5- or 6-membered heterocyclic group, OR ⁴⁴ , S (O) _q R ⁴¹ , S (O) ₂ NR ⁴¹ R ⁴² , NR ⁴¹ R ⁴² , NR ⁴¹ C (O) R ⁴² , NR ⁴¹ C (O) ) OR ⁴² , NR ⁴¹ S (O) ₂ R ⁴³ , C (O) R ⁴¹ , C (O) OR ⁴¹ , C (O) NR ⁴¹ R ⁴² , CR ⁴² = NOR ⁴¹ , hydroxy group, cyano group, nitro Represents a group, halogen atom, or hydrogen atom (however, not all of the existing R ^4a , R ^4b , R ^4c , R ^4d , and R ^4e represent a hydrogen atom).
k represents 0, 1 or 2, and q represents 0, 1 or 2.
R ⁴¹ and R ⁴² may be substituted with a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, and may be substituted with one or more substituents selected from the group Z, which are the same or different from each other. Represents a phenyl group, a 5- or 6-membered heterocyclic group optionally substituted with one or more substituents selected from Group Z, or a hydrogen atom.
R ⁴³ is selected from a C1-C6 chain hydrocarbon group that may be substituted with one or more halogen atoms, a phenyl group that may be substituted with one or more substituents selected from group Z, or group Z. Represents a 5- or 6-membered heterocyclic group that may be substituted with one or more substituents.
^R44 represents a C1-C6 chain hydrocarbon group that may be substituted with one or more halogen atoms.
R ⁴⁵ is a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group W ² , and C3- which may be substituted with one or more substituents selected from group Y. A C7 cycloalkyl group, a phenyl group optionally substituted with one or more substituents selected from group Z, a 5- or 6-membered aromatic heterocycle optionally substituted with one or more substituents selected from group Z. Represents a group, C (O) R ⁴⁶ , C (O) OR ⁴⁶ , C (O) NR ⁴⁶ R ⁴⁷ , or a hydrogen atom.
R ⁴⁶ and R ⁴⁷ are the same or different, and may be substituted with a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, or one or more substituents selected from Group Z. Represents a phenyl group, a 5- or 6-membered heterocyclic group optionally substituted with one or more substituents selected from Group Z, or a hydrogen atom.
Group B: A C1-C6 alkoxy group that may be substituted with one or more halogen atoms, a C3-C6 alkenyloxy group that may be substituted with one or more halogen atoms, and one or more halogen atoms. A C3-C6 alkynyloxy group may be substituted with one or more halogen atoms, a C1-C6 alkylsulfanyl group may be substituted with one or more halogen atoms, and a C1-C6 alkylsulfinyl group may be substituted with one or more halogen atoms. A group consisting of a C1-C6 alkylsulfonyl group which may be substituted with a halogen atom, a C3-C6 cycloalkyl group which may be substituted with one or more halogen atoms, a cyano group, a hydroxy group, and a halogen atom.
Group C: C1-C6 chain hydrocarbon group optionally substituted with 1 or more halogen atoms, C1-C6 alkoxy group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms A group consisting of a C3-C6 alkenyloxy group which may be present, a C3-C6 alkynyloxy group which may be substituted with one or more halogen atoms, and a halogen atom.
Group D: C1-C6 chain hydrocarbon group optionally substituted with 1 or more halogen atoms, hydroxy group, C1-C6 alkoxy group optionally substituted with 1 or more halogen atoms, 1 or more halogen atoms C3-C6 alkenyloxy group optionally substituted with 1 or more halogen atoms C3-C6 alkynyloxy group, sulfanyl group optionally substituted with 1 or more halogen atoms C1- C6 alkylsulfanyl group, C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, amino group, NHR ²¹ , NR A group consisting of ²¹ R ²² , C (O) R ²¹ , OC (O) R ²¹ , C (O) OR ²¹ , a cyano group, a nitro group, and a halogen atom.
R ²¹ and R ²² represent C1-C6 alkyl groups that are identical or different and may be substituted with one or more halogen atoms.
Group E: C1-C6 chain hydrocarbon group optionally substituted with 1 or more halogen atoms, C1-C6 alkoxy group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms A group consisting of a C3-C6 alkenyloxy group which may be present, a C3-C6 alkynyloxy group which may be substituted with one or more halogen atoms, a halogen atom, an oxo group, a hydroxy group, a cyano group, and a nitro group.
Group F: C1-C6 alkoxy group optionally substituted with 1 or more halogen atoms, phenyl group optionally substituted with 1 or more substituents selected from group D, 1 or more substitutions selected from group D A 5- or 6-membered aromatic heterocyclic group optionally substituted with a group, a C3-C7 cycloalkyl group optionally substituted with one or more halogen atoms, substituted with one or more substituents selected from Group C. A group consisting of a 3-7-membered non-aromatic heterocyclic group, an amino group, NHR ²¹ , NR ²¹ R ²² , a halogen atom, and a cyano group.
Group H: C1-C6 alkyl group optionally substituted with one or more halogen atoms, 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from Group D, OR ¹⁰ , NR ⁹ R ¹⁰ , C (O) R ¹⁰ , C (O) NR ⁹ R ¹⁰ , OC (O) R ⁹ , OC (O) OR ⁹ , NR ¹⁰ C (O) R ⁹ , NR ¹⁰ C (O) ) OR ⁹ , C (O) OR ¹⁰ , halogen atom, nitro group, cyano group, and amino group.
R ⁹ represents a C1-C6 alkyl group optionally substituted with one or more halogen atoms or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms.
R ¹⁰ represents a C1-C6 alkyl group which may be substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be substituted with one or more halogen atoms, or a hydrogen atom.
Group J: A group consisting of C1-C6 alkyl groups, halogen atoms, and cyano groups that may be substituted with one or more halogen atoms.
Group U: A C1-C6 alkyl group that may be substituted with one or more halogen atoms, a C1-C6 alkoxy group that may be substituted with one or more halogen atoms, or a C1-C6 alkoxy group that may be substituted with one or more halogen atoms. From a good C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, and a halogen atom. A group of
Group V: A C1-C6 alkyl group that may be substituted with one or more halogen atoms, a C1-C6 alkoxy group that may be substituted with one or more halogen atoms, or a C1-C6 alkoxy group that may be substituted with one or more halogen atoms. Good C1-C6 alkyl sulfanyl group, C1-C6 alkyl sulphinyl group which may be substituted with one or more halogen atoms, C1-C6 alkyl sulfonyl group which may be substituted with one or more halogen atoms, one or more halogens. C1-C6 alkyl amino group optionally substituted with an atom, di (C1-C6 alkyl optionally substituted with 1 or more halogen atoms) amino group, C2 optionally substituted with 1 or more halogen atoms -A group consisting of a C6-C6 alkylcarbonyl group, a C2-C6 alkoxycarbonyl group which may be substituted with one or more halogen atoms, a hydroxy group, a sulfanyl group, an amino group, a cyano group, a nitro group, and a halogen atom.
Group W: C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from the group consisting of a halogen atom and a C1-C3 alkyl group, and C1- which may be substituted with one or more halogen atoms. C6 alkoxy group, C1-C6 alkylsulfanyl group optionally substituted with 1 or more halogen atoms, C1-C6 alkylsulfinyl group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms C1-C6 alkylsulfonyl group which may be substituted, C2-C6 alkylcarbonyl group which may be substituted with one or more halogen atoms, C2-C6 alkoxycarbonyl group which may be substituted with one or more halogen atoms, group. A phenyl group optionally substituted with one or more substituents selected from Z, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group Z, a hydroxy group, a cyano A group consisting of groups and halogen atoms.
Group X: C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from the group consisting of a halogen atom and a C1-C3 alkyl group, and C1- which may be substituted with one or more halogen atoms. C6 alkoxy group, C1-C6 alkylsulfanyl group optionally substituted with 1 or more halogen atoms, C1-C6 alkylsulfinyl group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms C1-C6 alkylsulfonyl group optionally substituted C2-C6 alkylcarbonyl group optionally substituted with 1 or more halogen atoms C2-C6 alkoxycarbonyl group optionally substituted with 1 or more halogen atoms, hydroxy A group consisting of a group, a sulfanyl group, a cyano group, and a halogen atom.
Group Y: A C1-C6 alkyl group that may be substituted with one or more halogen atoms, a C1-C6 alkoxy group that may be substituted with one or more halogen atoms, or a C1-C6 alkoxy group that may be substituted with one or more halogen atoms. From a good C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, and a halogen atom. A group of
Group Z: A C1-C6 alkyl group that may be substituted with one or more halogen atoms, a C1-C6 alkoxy group that may be substituted with one or more halogen atoms, or a C1-C6 alkoxy group that may be substituted with one or more halogen atoms. Good C1-C6 alkyl sulfanyl group, C1-C6 alkyl sulphinyl group which may be substituted with one or more halogen atoms, C1-C6 alkyl sulfonyl group which may be substituted with one or more halogen atoms, one or more halogens. C1-C6 alkyl amino group optionally substituted with an atom, di (C1-C6 alkyl optionally substituted with 1 or more halogen atoms) amino group, C2 optionally substituted with 1 or more halogen atoms -A group consisting of a C6-C6 alkylcarbonyl group, a C2-C6 alkoxycarbonyl group which may be substituted with one or more halogen atoms, a hydroxy group, a sulfanyl group, an amino group, a cyano group, a nitro group, and a halogen atom.
Group W ² : C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from the group consisting of a halogen atom and a C1-C3 alkyl group, and C1 which may be substituted with one or more halogen atoms. -C6 alkoxy group, C1-C6 alkylsulfanyl group optionally substituted with 1 or more halogen atoms, C1-C6 alkylsulfinyl group optionally substituted with 1 or more halogen atoms, substituted with 1 or more halogen atoms C1-C6 alkylsulfonyl group which may be substituted, C2-C6 alkylcarbonyl group which may be substituted with one or more halogen atoms, C2-C6 alkoxycarbonyl group which may be substituted with one or more halogen atoms, A phenyl group optionally substituted with one or more substituents selected from group Z, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group Z, a hydroxy group, A group consisting of a sulfanyl group, a cyano group, and a halogen atom. ]
A method for controlling harmful arthropods, which comprises a step of applying an effective amount of the compound represented by the above or its N oxide to a harmful arthropod, a habitat of the harmful arthropod, a plant, or a cultivation carrier of the plant. The method for controlling harmful arthropods according to claim 1, wherein the cultivation carrier of the plant is soil. A compound represented by the formula (I) according to claim 1, or an N oxide or an agriculturally acceptable salt thereof, and a group (a), a group (b), a group (c), a group (d), a group ( A composition containing one or more components selected from the group consisting of e), group (f), group (g), group (h), group (i) and group (j):
Group (a): A group consisting of an insecticidal active ingredient, an acaricidal active ingredient and a nematode active ingredient;
Group (b): bactericidal active ingredient;
Group (c): Plant growth regulating component;
Group (d): Ingredients for reducing phytotoxicity;
Group (e): synergist;
Group (f): repellent component;
Group (g): mollusc component;
Group (h): Insect pheromone;
Group (i): herbicidal active ingredient;
Group (j): Biological control material. A method for controlling harmful arthropods, which comprises a step of applying an effective amount of the composition according to claim 3 to a harmful arthropod, a habitat of the harmful arthropod, a plant, or a cultivation carrier of the plant. The method for controlling harmful arthropods according to claim 4, wherein the cultivation carrier of the plant is soil. A seed or vegetative organ that retains an effective amount of the compound represented by the formula (I) according to claim 1, its N oxide or an agriculturally acceptable salt, or the composition according to claim 3. ..